data_2dmm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dmm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 2.6 p90 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.928 0.394 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 pp -108.56 -35.43 6.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 17.5 ttpt -110.61 154.27 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.8 m -159.75 143.94 14.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.2 mm-40 -89.97 161.56 37.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 0.0 110.888 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.9 Cg_endo -69.75 141.49 45.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.658 2.239 . . . . 0.0 112.343 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 36.1 mm -69.91 132.17 88.81 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.698 . . . . 0.0 111.15 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 142.02 47.07 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.681 2.254 . . . . 0.0 112.348 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -61.3 -32.38 72.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -166.35 133.99 2.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -110.75 54.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -81.43 58.13 3.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.63 -168.51 11.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.514 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.454 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 53.4 Cg_endo -69.75 -48.81 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.716 2.277 . . . . 0.0 112.355 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.81 127.6 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -73.08 134.79 44.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -84.63 113.25 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.147 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.477 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 22.0 t -109.35 117.92 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.12 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -110.64 152.05 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.163 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -41.03 -34.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -64.51 -45.81 85.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 29.3 p30 -114.11 34.5 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.569 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 6.4 t80 -73.6 -56.99 4.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -66.99 -4.81 10.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -89.47 -42.94 11.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.5 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 18.2 mt -98.94 -46.42 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.569 HG11 ' CZ ' ' A' ' 37' ' ' PHE . 97.2 t -65.0 -62.12 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -67.8 113.98 6.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 40' ' ' ILE . 4.9 p30 -175.25 106.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.39 2.73 27.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -84.79 -43.53 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -135.31 150.64 50.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.36 148.29 41.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.7 t -146.85 144.36 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.437 HD23 ' CD1' ' A' ' 82' ' ' ILE . 14.5 tp -117.92 119.15 33.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.556 HG12 ' CE1' ' A' ' 52' ' ' PHE . 2.2 tp -101.46 129.78 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -119.53 111.45 18.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.556 ' CE1' HG12 ' A' ' 50' ' ' ILE . 34.7 m-85 -88.61 130.73 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -138.59 -175.12 4.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.529 ' HB2' ' CZ2' ' A' ' 56' ' ' TRP . . . -142.43 133.74 12.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.605 0.716 . . . . 0.0 111.098 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -25.44 28.84 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.711 2.274 . . . . 0.0 112.345 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.529 ' CZ2' ' HB2' ' A' ' 54' ' ' ALA . 2.2 p-90 -84.54 -28.13 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.6 t -68.73 138.5 54.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.91 -35.06 7.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.45 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -71.58 -26.77 62.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.885 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.3 m -83.37 -37.3 23.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -62.39 -45.41 93.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -60.85 -9.53 4.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 66' ' ' LYS . 11.9 tp -97.34 -22.53 16.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.521 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -34.6 -58.21 0.68 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.675 0.75 . . . . 0.0 110.887 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.5 Cg_endo -69.73 -24.57 29.65 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.715 2.276 . . . . 0.0 112.294 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 63' ' ' LEU . 1.6 mmmp? -75.27 -27.04 59.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 63.6 t80 -94.8 -39.7 10.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.886 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HG3' ' CG ' ' A' ' 28' ' ' PRO . 5.6 ttmm -46.22 -59.49 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.898 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -38.84 -60.15 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.472 ' N ' HD23 ' A' ' 124' ' ' LEU . 17.4 tp -38.39 -42.04 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.93 -58.74 12.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.515 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -70.5 -20.98 62.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 0.0 110.926 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -72.56 -46.31 55.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.0 mt -78.26 3.12 16.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.9 p -50.3 -25.0 3.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.835 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -79.09 11.62 2.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.922 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 4.6 t0 -117.82 97.95 51.2 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.566 0.698 . . . . 0.0 110.897 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.0 Cg_endo -69.72 -1.08 7.82 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.739 2.293 . . . . 0.0 112.311 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -109.77 -37.19 5.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.441 HD13 ' CB ' ' A' ' 135' ' ' ALA . 46.6 mt -93.8 133.26 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.078 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.3 t -129.74 117.33 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.437 ' CD1' HD23 ' A' ' 49' ' ' LEU . 50.1 mm -86.39 134.77 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.114 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' CB ' HG21 ' A' ' 32' ' ' VAL . . . -147.26 167.16 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -135.67 155.02 51.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.4 ' SD ' ' OD1' ' A' ' 90' ' ' ASN . 0.8 OUTLIER -148.87 132.05 16.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.899 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -84.83 94.96 8.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.87 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.04 -62.62 1.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.63 -35.06 12.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.421 ' C ' ' HE3' ' A' ' 17' ' ' LYS . . . -80.78 -22.21 40.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.12 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -150.44 123.31 8.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -47.55 148.13 1.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.43 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 93.3 t -100.2 137.75 20.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.626 0.727 . . . . 0.0 111.14 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.565 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.9 Cg_endo -69.74 -163.81 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.654 2.236 . . . . 0.0 112.316 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.486 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -128.32 160.88 59.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.648 0.737 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.72 -6.45 9.36 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.328 -0.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.446 ' C ' ' O ' ' A' ' 95' ' ' PRO . 89.8 m-85 -34.35 121.14 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -127.58 131.9 49.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 91.1 t -131.92 104.69 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -104.85 -39.62 6.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.86 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -128.21 132.48 7.37 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.461 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.532 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -100.03 154.24 37.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.637 0.732 . . . . 0.0 110.92 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.75 159.88 88.92 Favored 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.674 -1.802 . . . . 0.0 112.317 -0.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.4 m -135.02 102.97 5.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.439 HG21 ' N ' ' A' ' 105' ' ' TYR . 21.1 mt -98.78 134.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.135 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.439 ' N ' HG21 ' A' ' 104' ' ' ILE . 8.9 m-85 -132.75 166.6 21.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -134.96 132.34 38.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.9 t -105.75 94.76 9.31 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.629 0.728 . . . . 0.0 110.864 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.8 Cg_endo -69.76 175.71 7.74 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.687 2.258 . . . . 0.0 112.357 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.464 ' HB1' ' ND2' ' A' ' 110' ' ' ASN . . . -92.27 137.08 32.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.464 ' ND2' ' HB1' ' A' ' 109' ' ' ALA . 0.5 OUTLIER 49.31 25.59 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.445 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.2 mtmm -124.77 21.98 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 2.3 mptp? -50.85 -50.0 57.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -46.12 -38.92 8.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -134.26 91.48 22.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.602 0.715 . . . . 0.0 110.942 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -163.85 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.691 2.261 . . . . 0.0 112.344 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -142.26 145.51 34.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -119.6 117.87 29.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -57.33 111.47 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.931 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -125.12 91.56 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.5 -142.84 4.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.485 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.51 130.68 10.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.44 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 45.4 mtm-85 -81.1 47.58 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 124' ' ' LEU . 4.1 tt0 -103.76 133.65 48.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 70' ' ' LEU . 3.1 tm? -34.17 -53.68 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.972 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 128' ' ' ILE . 14.8 m -67.2 -51.0 58.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -42.75 -31.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 122' ' ' ARG . 68.7 m-85 -76.74 -40.44 48.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' A' ' 125' ' ' SER . 32.3 mt -62.11 -55.99 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -57.79 -31.42 66.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.503 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 68.1 t80 -63.46 -45.06 92.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.964 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.1 mt -76.59 -39.13 53.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.945 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -46.63 -24.2 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.7 ptp85 -112.69 -37.02 5.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.503 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 2.9 mm-40 -70.01 -59.64 2.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.889 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.441 ' CB ' HD13 ' A' ' 80' ' ' ILE . . . -45.72 107.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.106 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.7 t -44.35 -50.55 9.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.1 m -68.64 -58.34 4.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.459 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.491 ' CD2' ' HB3' ' A' ' 34' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.914 0.388 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 17' ' ' LYS . 3.3 pp -104.27 -40.61 6.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.414 ' N ' HD12 ' A' ' 16' ' ' LEU . 12.2 ttpt -109.1 154.73 21.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.42 ' CB ' ' HB2' ' A' ' 34' ' ' ALA . 90.1 p -155.59 144.74 20.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 3.8 mm-40 -91.77 161.23 34.42 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.638 0.732 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.429 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.7 Cg_endo -69.79 142.98 49.27 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.658 2.239 . . . . 0.0 112.366 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.464 HD12 ' CG2' ' A' ' 33' ' ' VAL . 40.2 mm -74.58 133.85 76.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 111.136 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 176.62 6.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.731 2.288 . . . . 0.0 112.326 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -101.54 -35.95 8.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.3 t -148.99 128.96 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -116.78 49.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.04 56.55 3.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.72 -171.89 13.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.489 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -38.71 7.47 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.687 2.258 . . . . 0.0 112.314 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.49 119.33 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.104 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -68.97 125.73 27.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.1 t -74.81 124.33 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.463 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 42.0 t -123.9 125.65 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 36' ' ' ASN . 21.1 m -119.14 149.46 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HB3' ' CD2' ' A' ' 15' ' ' TYR . . . -33.18 -42.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.064 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.447 ' CB ' HD13 ' A' ' 21' ' ' ILE . 9.4 mt-10 -55.57 -48.69 74.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' A' ' 33' ' ' VAL . 11.3 p-10 -114.08 38.85 2.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.557 ' CE1' ' HG3' ' A' ' 93' ' ' PRO . 4.6 t80 -77.95 -55.22 5.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.96 -11.12 55.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -83.28 -42.27 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.9 mt -99.24 -59.44 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.1 t -49.99 -62.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.149 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -66.46 115.77 6.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.84 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' A' ' 45' ' ' ASN . 2.4 t30 -173.75 110.37 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -87.17 -4.53 59.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.48 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 78.7 m-20 -73.96 -48.47 30.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HZ3' ' ND2' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -133.87 153.91 51.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -67.67 142.25 56.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.8 t -137.52 143.79 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.1 tp -121.31 121.28 37.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 tp -109.76 133.4 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' OE1' ' C ' ' A' ' 52' ' ' PHE . 0.3 OUTLIER -124.0 118.22 26.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.869 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.43 ' C ' ' OE1' ' A' ' 51' ' ' GLU . 54.4 m-85 -95.0 114.93 26.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CE1' ' OD1' ' A' ' 86' ' ' ASP . 17.2 p90 -120.23 -179.19 3.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.422 ' HB3' ' CB ' ' A' ' 57' ' ' CYS . . . -136.76 134.49 19.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.578 0.704 . . . . 0.0 111.083 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -11.05 30.04 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.708 2.272 . . . . 0.0 112.295 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -114.1 9.25 17.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . 48.4 t -106.32 113.27 26.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.71 -52.71 46.59 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.481 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -46.67 -39.13 10.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.731 0.301 . . . . 0.0 110.809 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 43.9 m -70.95 -39.84 72.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.912 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -40.58 76.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.894 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -73.21 -25.5 60.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.4 tp -83.24 -23.11 32.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.52 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -42.52 -57.88 4.23 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.623 0.725 . . . . 0.0 110.934 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.8 -36.03 11.43 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.679 2.252 . . . . 0.0 112.341 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -64.63 -28.34 69.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -93.04 -43.64 8.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -44.82 -58.52 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.925 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -41.64 -46.84 3.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.46 ' N ' HD23 ' A' ' 124' ' ' LEU . 12.1 tp -53.32 -36.54 61.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.962 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -57.97 -57.04 21.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.17 -24.34 57.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.911 0.386 . . . . 0.0 110.911 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -72.14 -42.16 66.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.3 mt -83.24 3.35 31.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.6 p -53.08 -39.67 63.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -57.88 -11.93 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.78 99.65 9.42 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.608 0.718 . . . . 0.0 110.859 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 0.15 6.1 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.639 2.226 . . . . 0.0 112.332 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -109.98 -35.86 6.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 60.9 mt -90.61 104.08 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.46 110.02 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 50.2 mm -82.87 127.17 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.159 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.4 166.37 23.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -138.21 154.05 49.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.503 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 9.7 ttt -150.42 136.82 18.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.96 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.441 ' OD1' ' CE1' ' A' ' 53' ' ' TYR . 4.0 t70 -92.75 94.96 9.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -50.13 -64.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.2 t -41.63 -26.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.117 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.68 -26.52 15.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.503 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -141.15 109.39 5.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -44.25 136.58 3.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.406 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 72.8 t -86.08 136.63 35.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.596 0.713 . . . . 0.0 111.144 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.557 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.4 Cg_endo -69.74 -167.76 0.24 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.712 2.275 . . . . 0.0 112.312 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.494 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -121.74 161.33 42.52 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.731 0.777 . . . . 0.0 110.83 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.0 Cg_endo -69.75 -9.24 10.89 Favored 'Cis proline' 0 C--O 1.232 0.223 0 C-N-CA 122.679 -1.801 . . . . 0.0 112.318 -0.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 95' ' ' PRO . 93.9 m-85 -33.98 126.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.905 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.82 128.35 36.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 88.6 t -127.5 94.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -116.18 28.89 8.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.825 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.32 113.81 0.36 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.531 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -98.09 153.64 38.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.659 0.742 . . . . 0.0 110.874 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.77 156.5 92.79 Favored 'Cis proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 -1.79 . . . . 0.0 112.339 0.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.7 m -135.0 128.18 31.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.408 HG21 ' N ' ' A' ' 105' ' ' TYR . 36.6 mt -123.36 136.65 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.527 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 9.8 m-85 -136.45 144.29 44.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -119.72 129.72 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -99.96 101.05 12.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.843 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.481 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.3 Cg_endo -69.76 168.09 22.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.706 2.27 . . . . 0.0 112.342 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.12 137.23 33.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 10.3 p30 51.86 24.94 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.481 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.2 mtmt -129.3 38.42 3.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 5.8 mmpt? -63.35 -59.34 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 112' ' ' LYS . 11.0 mp -35.41 -36.84 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -134.47 96.82 14.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.642 0.734 . . . . 0.0 110.839 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -178.44 2.33 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.661 2.24 . . . . 0.0 112.373 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 147.99 49.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.527 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 10.7 ttpt -118.43 125.92 50.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -67.86 115.65 7.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -123.5 102.84 8.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.63 -149.75 11.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.465 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.91 138.9 14.79 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.5 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -79.0 45.59 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.774 0.321 . . . . 0.0 110.829 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 124' ' ' LEU . 8.2 tt0 -101.64 128.32 47.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.465 ' CD1' HD12 ' A' ' 128' ' ' ILE . 3.2 tm? -34.14 -56.09 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.9 m -59.23 -45.92 89.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 130' ' ' TYR . 6.4 t0 -49.33 -39.97 33.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.448 ' CB ' HD12 ' A' ' 70' ' ' LEU . 58.6 m-85 -67.41 -41.41 84.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.465 HD12 ' CD1' ' A' ' 124' ' ' LEU . 23.4 mt -62.28 -65.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.089 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 m -56.25 -34.8 66.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.41 ' CB ' ' O ' ' A' ' 126' ' ' ASP . 14.6 t80 -57.22 -45.73 83.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.943 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.93 -35.44 32.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -38.56 -41.85 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -98.11 -57.98 2.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -44.17 -56.76 3.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.0 105.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.133 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.6 t -40.41 -49.96 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.6 m -113.14 40.54 2.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.802 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.3 p90 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.933 0.397 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.488 ' HG ' ' N ' ' A' ' 17' ' ' LYS . 1.2 pt? -95.7 -35.7 11.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.488 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 10.5 ptmt -117.34 176.36 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.3 p -174.99 150.5 1.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.824 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 12.1 mm-40 -96.6 159.15 32.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 0.0 110.853 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 141.91 46.68 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.2 mm -69.47 131.43 90.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.565 0.698 . . . . 0.0 111.135 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 141.52 45.52 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.671 2.247 . . . . 0.0 112.394 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.1 -34.88 74.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.1 t -156.88 137.21 12.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -121.21 48.2 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.65 52.21 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.39 -167.08 13.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -41.59 4.1 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.668 2.245 . . . . 0.0 112.361 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.72 128.23 74.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.106 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.47 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 12.5 mmmt -74.9 117.33 16.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.5 t -73.48 122.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 39.8 t -115.81 124.31 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.116 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 36' ' ' ASN . 30.6 m -115.84 146.06 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.151 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -34.34 -42.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.071 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -55.5 -47.2 76.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' VAL . 21.1 p-10 -114.07 33.42 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.569 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 13.5 t80 -72.2 -58.28 3.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -64.55 -6.09 6.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -89.31 -46.44 8.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 mt -97.11 -46.05 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.569 HG12 ' CZ ' ' A' ' 37' ' ' PHE . 50.0 t -63.44 -58.82 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.134 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -78.08 124.68 28.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 46' ' ' LYS . 5.1 p-10 -175.59 108.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.961 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' CD ' ' HA ' ' A' ' 110' ' ' ASN . 2.1 mm-40 -83.05 20.25 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -106.75 -39.55 5.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.503 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 16.8 pttm -137.74 166.6 23.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.42 ' C ' HG21 ' A' ' 48' ' ' VAL . 4.3 m-20 -94.17 139.24 31.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 49' ' ' LEU . 23.4 t -136.33 148.18 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 105' ' ' TYR . 6.6 tp -116.51 109.86 17.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 tp -91.64 135.73 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.076 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' OE2' ' C ' ' A' ' 52' ' ' PHE . 1.9 tm-20 -127.02 117.85 23.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.448 ' C ' ' OE2' ' A' ' 51' ' ' GLU . 45.8 m-85 -93.32 124.33 37.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -128.84 -175.02 3.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.1 131.66 15.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.594 0.711 . . . . 0.0 111.091 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -3.09 11.32 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.688 2.259 . . . . 0.0 112.327 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.566 ' CZ3' ' SG ' ' A' ' 57' ' ' CYS . 6.7 p-90 -119.45 -3.37 10.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.566 ' SG ' ' CZ3' ' A' ' 56' ' ' TRP . 1.3 m -93.44 133.5 36.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.93 -41.83 93.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.484 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -51.62 -28.06 13.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 64' ' ' GLU . 42.5 t -69.97 -44.73 68.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -62.81 -44.07 97.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -72.15 -34.41 68.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.8 tp -84.6 -19.19 33.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.518 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.9 OUTLIER -45.3 -58.3 6.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.676 0.75 . . . . 0.0 110.89 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.72 -30.85 21.82 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.337 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -70.06 -26.84 64.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -95.75 -41.89 8.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 71' ' ' GLY . 13.1 ttmt -48.84 -58.85 4.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.449 ' CD ' ' O ' ' A' ' 65' ' ' PRO . 1.2 mp0 -39.27 -51.25 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.469 ' N ' HD21 ' A' ' 124' ' ' LEU . 26.2 tp -48.65 -40.13 26.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.958 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 68' ' ' LYS . . . -61.47 -55.11 30.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.444 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -67.06 -28.1 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.94 0.4 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.51 -45.36 54.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.455 HD11 ' CG1' ' A' ' 82' ' ' ILE . 94.2 mt -83.14 3.04 32.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.918 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.3 t -49.97 -25.39 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.32 21.91 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.48 98.08 13.71 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.603 0.716 . . . . 0.0 110.837 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -4.29 13.75 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.658 2.239 . . . . 0.0 112.332 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -116.41 -39.77 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.8 mt -96.9 140.43 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.0 t -138.43 114.56 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.115 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.455 ' CG1' HD11 ' A' ' 74' ' ' LEU . 44.5 mm -81.51 126.78 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 30' ' ' LYS . . . -136.67 164.58 27.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.075 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.1 pttt -136.75 138.3 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.4 ttt -134.96 143.42 46.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.41 ' CG ' ' HB3' ' A' ' 89' ' ' ALA . 26.9 t0 -92.92 115.21 27.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 89' ' ' ALA . . . -68.89 -70.73 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.114 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -42.43 -23.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 87' ' ' ALA . . . -99.03 -31.81 11.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 14.4 m-80 -129.14 111.38 12.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.483 ' CG ' ' CD2' ' A' ' 16' ' ' LEU . 8.3 t0 -45.92 129.55 9.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -77.41 130.23 75.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 0.0 111.16 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.566 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.7 Cg_endo -69.73 -163.86 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.678 2.252 . . . . 0.0 112.317 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -130.61 161.47 60.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.636 0.732 . . . . 0.0 110.872 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.3 Cg_endo -69.74 -4.62 8.38 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.733 -1.778 . . . . 0.0 112.301 -0.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 95' ' ' PRO . 78.8 m-85 -33.27 125.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -125.09 132.46 53.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.457 HG11 ' CB ' ' A' ' 103' ' ' THR . 38.6 t -143.42 124.34 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -129.65 -39.31 1.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.47 123.31 5.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.484 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.525 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.5 154.82 37.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.664 0.745 . . . . 0.0 110.89 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.6 Cg_endo -69.8 161.75 85.65 Favored 'Cis proline' 0 C--O 1.232 0.186 0 C-N-CA 122.676 -1.801 . . . . 0.0 112.334 0.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.457 ' CB ' HG11 ' A' ' 98' ' ' VAL . 62.5 m -140.1 109.82 6.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.3 mt -104.12 134.0 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.182 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' A' ' 117' ' ' LYS . 7.9 m-85 -129.86 177.36 7.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -145.3 129.0 17.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.78 97.73 8.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.669 0.747 . . . . 0.0 110.851 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.486 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.5 Cg_endo -69.75 167.56 24.08 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 2.246 . . . . 0.0 112.328 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -83.12 137.63 34.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.108 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.0 OUTLIER 48.14 27.89 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.486 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.3 mtmm -129.4 29.78 5.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -53.87 -57.14 12.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.922 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 68.9 mt -43.3 -48.37 6.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.13 87.48 34.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.632 0.729 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -163.9 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.716 2.277 . . . . 0.0 112.287 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -149.79 131.78 15.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.564 ' HB2' ' CE2' ' A' ' 105' ' ' TYR . 21.6 tttt -102.49 136.46 42.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 70.2 t80 -66.42 110.93 3.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.32 97.31 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.88 -151.83 11.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.96 142.49 23.39 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.451 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -87.28 43.22 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 124' ' ' LEU . 2.7 tp10 -104.52 131.08 52.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.469 HD21 ' N ' ' A' ' 70' ' ' LEU . 2.8 tm? -34.07 -56.65 0.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 72.7 m -59.59 -50.73 72.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -46.6 -36.61 7.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 65.7 m-85 -70.3 -43.7 69.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.1 mt -58.73 -58.49 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.158 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.53 -31.36 69.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.455 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 52.2 t80 -60.31 -53.33 58.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' GLN . 43.7 mt -70.81 -39.78 72.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' LEU . 28.5 mm-40 -35.62 -36.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.8 mmp_? -106.77 -57.63 2.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 68.6 mm-40 -42.23 -49.5 4.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -61.66 109.57 1.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -33.99 -74.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.4 t -75.59 56.66 0.91 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.831 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.43 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.6 p90 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.89 0.376 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.423 HD11 ' C ' ' A' ' 16' ' ' LEU . 3.5 pp -103.86 -38.89 6.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 18' ' ' SER . 51.0 tttt -111.86 163.77 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.429 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 45.4 p -166.0 156.95 13.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 10.6 mm-40 -103.91 161.38 23.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.626 0.727 . . . . 0.0 110.865 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.7 144.15 53.42 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.694 2.263 . . . . 0.0 112.345 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.48 HD12 ' CG2' ' A' ' 33' ' ' VAL . 42.9 mm -74.92 130.95 79.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.73 . . . . 0.0 111.154 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 157.81 59.17 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.736 2.291 . . . . 0.0 112.321 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -70.77 -45.83 64.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.4 m -135.66 135.65 40.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -128.22 30.44 5.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.05 48.31 1.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.861 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.44 -162.95 18.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -40.65 5.07 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.326 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 84' ' ' LYS . 74.2 t -120.01 119.68 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -66.77 113.75 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.6 t -73.04 108.24 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.459 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 39.2 t -106.77 128.03 61.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.129 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.48 ' CG2' HD12 ' A' ' 21' ' ' ILE . 26.9 m -122.25 148.99 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -33.84 -40.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' CB ' HD13 ' A' ' 21' ' ' ILE . 16.0 mt-10 -56.42 -48.18 77.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 33' ' ' VAL . 22.0 p30 -115.12 35.41 4.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.473 ' CD2' HG22 ' A' ' 41' ' ' VAL . 15.7 t80 -75.17 -56.06 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.75 -5.02 10.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.834 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -92.23 -45.71 8.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.4 mt -96.88 -58.95 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.473 HG22 ' CD2' ' A' ' 37' ' ' PHE . 61.0 t -50.88 -60.83 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.126 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -70.62 115.16 9.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -167.28 111.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -88.49 6.61 36.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -92.19 -40.72 10.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 155.69 48.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.4 151.47 46.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.1 t -146.32 146.47 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 20.6 tp -125.15 127.75 47.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 tp -109.15 140.55 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.139 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 1.9 tt0 -126.95 107.59 10.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -85.82 110.57 19.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -119.26 167.93 11.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.42 127.97 24.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.599 0.714 . . . . 0.0 111.094 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -6.63 19.04 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -118.67 14.41 13.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.948 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.2 t -117.09 123.41 46.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -61.71 -61.37 6.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.508 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -39.65 -37.12 0.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.341 . . . . 0.0 110.853 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 81.8 m -74.98 -39.09 61.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' GLY . 5.4 ttmt -62.55 -35.73 80.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -73.86 -22.21 59.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.15 -23.71 23.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.523 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.4 tt0 -37.93 -58.14 1.47 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.635 0.731 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.75 -34.32 14.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.704 2.27 . . . . 0.0 112.334 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -66.39 -24.98 66.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 55.5 t80 -96.07 -38.86 10.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -47.78 -56.51 7.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.46 -56.1 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 127' ' ' PHE . 24.4 tp -40.61 -42.04 1.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.39 -68.88 1.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.54 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.87 -25.81 61.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.374 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -74.69 -39.53 61.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.952 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.458 HD12 ' CG1' ' A' ' 82' ' ' ILE . 95.1 mt -88.96 1.73 55.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.3 t -51.51 -20.86 2.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -91.41 18.34 7.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.918 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 97.1 m-20 -109.55 99.9 39.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.59 0.709 . . . . 0.0 110.89 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.9 Cg_endo -69.71 -1.33 8.24 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.721 2.28 . . . . 0.0 112.354 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.07 -35.13 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.883 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 51.0 mt -99.21 142.2 15.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.02 106.97 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.095 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.458 ' CG1' HD12 ' A' ' 74' ' ' LEU . 47.3 mm -74.36 126.43 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.448 ' HB3' ' CG2' ' A' ' 32' ' ' VAL . . . -130.59 169.14 15.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.043 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.446 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . 10.6 ptpp? -137.67 135.69 36.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.0 ttt -141.38 143.84 34.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 90' ' ' ASN . 10.3 t0 -98.63 117.92 34.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.46 -59.24 3.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -21.23 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.109 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 86' ' ' ASP . . . -99.79 -25.13 14.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 86' ' ' ASP . 4.5 m-80 -134.62 104.18 5.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -40.24 122.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.84 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.66 123.51 89.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.639 0.733 . . . . 0.0 111.107 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.8 Cg_endo -69.76 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.5 m -121.97 160.87 45.31 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.663 0.744 . . . . 0.0 110.848 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.76 -8.62 10.6 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.692 -1.795 . . . . 0.0 112.367 -0.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 95' ' ' PRO . 97.0 m-85 -34.14 123.08 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -130.45 115.34 16.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.447 HG23 ' CG2' ' A' ' 103' ' ' THR . 75.1 t -114.26 131.17 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 -50.05 1.02 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.88 125.77 6.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.464 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.517 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -96.77 154.71 38.28 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 0.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.73 154.96 93.38 Favored 'Cis proline' 0 C--O 1.232 0.207 0 C-N-CA 122.666 -1.806 . . . . 0.0 112.392 -0.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.447 ' CG2' HG23 ' A' ' 98' ' ' VAL . 61.2 m -132.78 102.11 5.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.157 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.419 HG12 ' CG ' ' A' ' 51' ' ' GLU . 74.8 mt -95.9 138.52 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.518 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 9.4 m-85 -135.87 140.29 44.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -114.88 130.47 56.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.3 m -101.91 97.63 8.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.669 0.747 . . . . 0.0 110.861 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.74 170.06 17.45 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.662 2.241 . . . . 0.0 112.37 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -86.0 142.16 28.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.5 p30 46.11 25.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.478 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.5 mtmt -126.09 39.13 4.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.461 ' O ' ' C ' ' A' ' 113' ' ' LEU . 36.4 mmtt -65.55 -61.38 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.893 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 112' ' ' LYS . 19.7 mt -33.66 -38.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.93 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 112' ' ' LYS . 7.1 m120 -134.31 99.75 13.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.624 0.726 . . . . 0.0 110.852 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 178.5 4.5 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.705 2.27 . . . . 0.0 112.299 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.67 127.01 41.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.518 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 15.6 ttpp -100.99 123.53 45.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -60.38 113.57 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -124.37 95.96 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.7 -148.82 7.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.535 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.84 136.49 14.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.484 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -83.67 45.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 110.869 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 124' ' ' LEU . 3.7 tp10 -104.83 132.05 51.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.456 HD23 ' N ' ' A' ' 70' ' ' LEU . 3.5 tm? -35.29 -53.06 0.63 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.0 m -63.63 -45.65 89.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -46.83 -42.58 17.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.461 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 74.5 m-85 -64.95 -46.82 79.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 mt -53.91 -59.66 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.1 t -59.1 -37.46 77.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -56.67 -55.2 37.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.954 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.67 -38.07 80.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -47.47 -44.54 25.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -93.72 -46.48 7.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.7 -62.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -39.2 105.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.063 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.3 t -42.45 -56.25 3.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.101 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.1 t -66.3 -44.22 84.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.432 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.4 p90 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.506 ' HG ' ' N ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -92.62 -38.23 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.506 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -116.38 174.35 6.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 88.0 p -170.95 165.6 7.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -113.56 160.2 32.6 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.611 0.72 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 145.75 57.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.697 2.264 . . . . 0.0 112.326 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.432 HD13 ' CB ' ' A' ' 35' ' ' GLU . 20.5 mm -69.42 134.96 88.71 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.659 0.742 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 53.7 Cg_endo -69.77 137.98 36.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.71 2.273 . . . . 0.0 112.324 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.36 -32.24 62.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.8 t -128.46 106.51 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.42 ' CG ' ' HD3' ' A' ' 30' ' ' LYS . 9.7 t-20 -111.35 46.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -110.93 49.43 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.876 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.25 -162.34 14.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -48.25 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.677 2.251 . . . . 0.0 112.321 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 84' ' ' LYS . 22.2 t -115.88 116.05 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.42 ' HD3' ' CG ' ' A' ' 25' ' ' ASN . 7.7 mmtt -57.42 123.82 16.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.9 t -76.88 109.63 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.088 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 29.0 t -107.31 123.99 62.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.069 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 36' ' ' ASN . 28.5 m -119.07 147.11 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -32.4 -45.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.14 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.432 ' CB ' HD13 ' A' ' 21' ' ' ILE . 7.0 mt-10 -52.93 -49.78 65.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 33' ' ' VAL . 12.2 p-10 -113.25 35.86 3.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.46 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 21.5 t80 -74.03 -59.18 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.64 -5.21 7.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -87.97 -43.46 11.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.461 HD12 ' ND2' ' A' ' 36' ' ' ASN . 25.5 mt -98.98 -54.07 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.123 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.6 t -55.08 -62.02 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.121 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -69.74 122.01 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -173.87 105.5 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -87.24 38.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -131.27 -40.83 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -129.83 151.56 50.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -75.54 127.19 32.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.84 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.17 143.24 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.0 tp -119.28 126.66 52.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 tp -113.07 135.56 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.21 118.51 26.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.907 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -93.06 128.76 39.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.44 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 6.9 p90 -136.12 174.05 11.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.18 135.02 25.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.585 0.707 . . . . 0.0 111.121 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -7.86 22.14 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.721 2.281 . . . . 0.0 112.327 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.557 ' CZ2' HG22 ' A' ' 88' ' ' THR . 7.0 p-90 -123.67 26.49 7.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 43.4 t -125.13 106.44 9.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -46.15 -66.07 1.82 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.504 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 58' ' ' GLY . 89.8 m-70 -35.33 -45.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.3 m -63.73 -50.2 70.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.34 -37.01 54.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -71.36 -27.82 63.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.457 ' O ' ' C ' ' A' ' 64' ' ' GLU . 12.2 tp -82.47 -32.69 28.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.513 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.8 OUTLIER -33.95 -58.12 0.61 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.651 0.739 . . . . 0.0 110.931 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.1 Cg_endo -69.82 -35.47 12.39 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.719 2.279 . . . . 0.0 112.27 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -65.3 -27.85 68.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.854 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -93.79 -41.61 9.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -46.74 -57.01 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -40.5 -48.48 2.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.462 ' N ' HD23 ' A' ' 124' ' ' LEU . 14.5 tp -52.2 -39.69 60.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.88 -48.6 69.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.501 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -74.95 -21.95 58.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.95 0.405 . . . . 0.0 110.895 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -79.56 -50.6 10.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.918 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 77' ' ' ASP . 79.8 mt -77.39 -2.02 33.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' LEU . 7.8 t -37.98 -29.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 74' ' ' LEU . 37.8 mtmt -87.1 29.56 0.82 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 74' ' ' LEU . 39.9 p30 -102.79 95.3 6.16 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.585 0.707 . . . . 0.0 110.851 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -2.83 10.84 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.71 2.273 . . . . 0.0 112.309 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -120.55 -45.46 2.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.465 HG21 ' N ' ' A' ' 81' ' ' VAL . 44.3 mt -87.11 145.42 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.465 ' N ' HG21 ' A' ' 80' ' ' ILE . 96.1 t -135.18 105.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.126 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.9 mm -73.53 131.03 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.408 ' CA ' HG11 ' A' ' 29' ' ' VAL . . . -145.93 160.64 41.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 29' ' ' VAL . 43.4 pttt -132.53 160.34 36.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.504 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 18.4 ttt -151.37 132.39 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -91.44 85.96 5.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -41.6 -65.74 0.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.557 HG22 ' CZ2' ' A' ' 56' ' ' TRP . 25.7 p -36.34 -35.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.24 -36.37 17.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.504 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.4 OUTLIER -129.02 112.7 14.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.447 ' CG ' HD21 ' A' ' 16' ' ' LEU . 26.6 t0 -41.22 155.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -103.21 125.58 34.73 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.63 0.728 . . . . 0.0 111.123 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.5 Cg_endo -69.84 -164.94 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.248 . . . . 0.0 112.313 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.487 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -122.19 161.23 44.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.596 0.713 . . . . 0.0 110.892 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.76 -11.74 11.99 Favored 'Cis proline' 0 C--O 1.232 0.182 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.352 -0.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.45 ' C ' ' O ' ' A' ' 95' ' ' PRO . 81.2 m-85 -33.05 125.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -134.04 117.04 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 83.7 t -119.53 108.73 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -106.25 -41.28 5.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.09 131.32 7.19 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.418 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.513 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.5 OUTLIER -97.28 155.63 37.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.679 0.752 . . . . 0.0 110.828 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.1 Cg_endo -69.79 162.14 84.81 Favored 'Cis proline' 0 C--O 1.232 0.207 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.352 0.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 84.1 m -142.22 116.06 9.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.176 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.409 HG23 ' CB ' ' A' ' 118' ' ' TYR . 27.5 mt -110.2 140.63 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 117' ' ' LYS . 11.9 m-85 -139.36 142.74 37.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -111.43 143.6 42.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.7 m -114.46 93.83 33.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.686 0.755 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.5 Cg_endo -69.77 167.86 23.23 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -84.25 136.8 33.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 13.8 p30 49.98 26.8 2.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.478 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 12.8 mtmm -128.97 39.25 3.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.455 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 7.7 mmpt? -67.98 -45.59 73.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.3 mp -50.85 -38.2 47.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -134.88 88.37 27.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.605 0.717 . . . . 0.0 110.845 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -171.76 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.724 2.282 . . . . 0.0 112.295 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -137.86 118.92 14.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 105' ' ' TYR . 22.3 tttt -91.47 120.22 32.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.409 ' CB ' HG23 ' A' ' 104' ' ' ILE . 39.3 t80 -55.04 112.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -123.68 101.01 7.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.9 -139.65 4.32 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.452 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.37 139.71 14.71 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.47 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.4 ' CZ ' ' HG3' ' A' ' 102' ' ' PRO . 26.8 mtp180 -83.88 43.79 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.883 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 124' ' ' LEU . 3.5 tp10 -102.05 129.65 48.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 70' ' ' LEU . 3.3 tm? -34.02 -55.46 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.93 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.2 t -59.43 -50.15 75.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -44.05 -35.72 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -73.31 -37.98 66.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.5 mt -63.03 -61.42 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.85 -34.86 73.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -57.46 -48.8 78.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 68.3 mt -75.68 -34.4 60.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -43.49 -38.86 3.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.448 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.2 ptm180 -101.03 -47.05 4.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.448 ' N ' ' HG3' ' A' ' 133' ' ' ARG . 16.6 mm-40 -52.63 -57.79 8.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -48.7 110.88 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -36.36 -71.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.163 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.6 t -59.48 -57.08 14.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.887 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.49 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.3 p90 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.929 0.395 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.506 ' HG ' ' N ' ' A' ' 17' ' ' LYS . 1.6 pt? -109.04 -38.62 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.506 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 30.3 tttt -112.61 149.54 32.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.7 p -161.72 146.5 13.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -94.3 158.8 35.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.707 0.765 . . . . 0.0 110.835 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 150.29 68.1 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.644 2.229 . . . . 0.0 112.357 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.467 HD11 ' CG2' ' A' ' 33' ' ' VAL . 39.2 mm -79.74 132.36 61.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.625 0.726 . . . . 0.0 111.132 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 173.34 11.12 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -97.31 -34.41 11.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p -141.99 135.79 29.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -132.23 38.76 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -78.43 57.73 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.83 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.98 -170.73 13.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.494 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -40.41 5.42 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.715 2.276 . . . . 0.0 112.374 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.5 t -120.63 117.11 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -64.22 143.08 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.893 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.2 t -91.44 119.6 38.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.55 126.5 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.467 ' CG2' HD11 ' A' ' 21' ' ' ILE . 29.1 m -122.34 156.9 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.154 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -48.47 -20.05 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -76.54 -34.21 58.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -129.12 33.72 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 37' ' ' PHE . 7.6 t80 -69.35 -52.96 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.84 -6.76 28.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -89.52 -43.45 10.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.4 mt -98.4 -61.89 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.5 t -47.9 -61.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.151 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.46 135.08 52.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -173.62 106.36 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.941 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -85.71 14.66 5.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -111.02 -41.94 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -137.18 164.11 29.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 63.7 m-20 -80.31 154.23 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 49' ' ' LEU . 28.2 t -145.2 147.74 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.412 ' N ' HG13 ' A' ' 48' ' ' VAL . 9.5 tp -119.09 129.74 55.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.917 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 tp -119.95 133.4 66.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' CG ' HG12 ' A' ' 104' ' ' ILE . 4.9 tm-20 -126.82 116.38 20.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -90.11 140.08 30.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.45 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 5.9 p90 -143.98 176.08 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.61 133.43 25.17 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.612 0.72 . . . . 0.0 111.072 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -8.28 23.21 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.748 2.298 . . . . 0.0 112.349 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.548 ' CZ2' HG23 ' A' ' 88' ' ' THR . 5.0 p-90 -118.32 21.73 12.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.5 t -123.34 110.51 15.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -49.27 -47.83 33.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.482 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 58' ' ' GLY . 12.9 m170 -34.74 -45.89 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 110.839 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.1 t -70.91 -50.93 29.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.936 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -47.32 -34.08 6.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.852 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -86.77 -29.17 22.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.837 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.417 ' CD1' ' HB2' ' A' ' 66' ' ' LYS . 63.2 tp -83.13 -14.36 53.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.512 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.9 tt0 -46.08 -58.28 6.67 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.641 0.734 . . . . 0.0 110.943 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.1 Cg_endo -69.73 -17.53 37.64 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.644 2.229 . . . . 0.0 112.387 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.417 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 1.1 mmmp? -84.74 -30.17 24.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -93.67 -41.32 9.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -46.58 -56.63 5.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 70' ' ' LEU . 15.6 mt-10 -42.02 -62.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.457 ' CD1' HG12 ' A' ' 128' ' ' ILE . 22.3 tp -37.16 -35.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.51 -57.06 19.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.504 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -75.38 -19.93 59.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.478 ' CD ' HD12 ' A' ' 124' ' ' LEU . 4.1 mtpm? -73.95 -45.07 52.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' A' ' 77' ' ' ASP . 90.0 mt -86.86 -2.4 58.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.3 t -39.63 -26.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 74' ' ' LEU . 9.3 ttpp -82.86 22.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 74' ' ' LEU . 42.2 p30 -102.93 95.51 6.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.628 0.728 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -0.83 7.47 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.656 2.238 . . . . 0.0 112.372 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.31 -44.45 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.471 HD12 ' CB ' ' A' ' 135' ' ' ALA . 15.7 mt -88.22 143.76 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.155 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.463 ' N ' HG22 ' A' ' 80' ' ' ILE . 78.0 t -133.28 115.41 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.137 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.8 mm -81.96 130.37 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -148.73 171.87 15.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.075 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -135.42 163.07 30.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.923 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.8 ttt -151.13 136.76 17.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -96.33 82.37 3.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -45.58 -58.35 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.548 HG23 ' CZ2' ' A' ' 56' ' ' TRP . 22.8 p -46.77 -22.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.35 -18.47 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -144.74 108.44 4.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.429 ' CB ' HD21 ' A' ' 16' ' ' LEU . 27.9 t70 -37.07 151.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -97.04 128.13 36.42 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.612 0.72 . . . . 0.0 111.12 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -173.34 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.492 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.6 m -118.7 160.54 39.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.658 0.742 . . . . 0.0 110.876 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.69 -8.97 10.66 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.353 -0.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 95' ' ' PRO . 81.3 m-85 -35.13 143.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -151.59 129.23 11.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.4 t -132.89 117.98 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.6 -36.92 3.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.23 121.55 4.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.526 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.28 154.16 38.17 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.66 0.743 . . . . 0.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.4 Cg_endo -69.69 160.03 88.47 Favored 'Cis proline' 0 C--O 1.231 0.143 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.382 -0.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.2 m -137.48 113.81 10.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.468 HG21 ' N ' ' A' ' 105' ' ' TYR . 16.8 mt -105.9 138.24 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.109 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.504 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 10.8 m-85 -132.88 173.03 11.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.961 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -142.97 127.35 17.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 t -100.51 99.64 10.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.639 0.733 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.453 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.76 178.84 4.16 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.701 2.268 . . . . 0.0 112.361 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.481 ' N ' ' OD1' ' A' ' 47' ' ' ASP . . . -92.93 131.05 38.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 11.4 p30 51.0 29.07 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.933 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.453 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.3 mtmm -128.05 23.0 6.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -50.72 -56.37 12.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.0 mt -39.78 -37.13 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -134.86 90.22 22.91 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.635 0.731 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -172.34 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.664 2.243 . . . . 0.0 112.358 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -139.34 128.16 23.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.504 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 4.8 ttpm? -94.44 124.24 38.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.534 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 67.8 t80 -55.75 105.14 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -115.9 100.89 8.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.6 -152.38 17.58 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.497 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.01 131.69 11.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.519 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.415 ' HB2' ' NH1' ' A' ' 122' ' ' ARG . 19.8 mtm105 -83.88 49.0 1.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.905 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 124' ' ' LEU . 13.0 tt0 -107.78 134.32 50.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.478 HD12 ' CD ' ' A' ' 73' ' ' LYS . 3.5 tm? -34.81 -52.69 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.8 m -67.73 -47.7 68.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -47.37 -36.16 9.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.534 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 58.6 m-85 -69.24 -42.65 75.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.914 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.457 HG12 ' CD1' ' A' ' 70' ' ' LEU . 23.1 mt -63.52 -53.34 46.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -63.57 -21.98 66.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.808 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.405 ' CD1' ' C ' ' A' ' 130' ' ' TYR . 6.1 t80 -72.22 -46.86 54.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.1 mt -76.56 -39.0 54.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -40.05 -42.49 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -97.13 -58.73 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -46.23 -56.36 5.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' CB ' HD12 ' A' ' 80' ' ' ILE . . . -45.29 120.56 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.48 -70.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.1 t -58.01 -44.16 87.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.475 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 2.4 p90 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.861 0.362 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 pp -114.2 -36.14 4.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.944 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -119.89 165.64 14.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.421 ' CB ' ' HG3' ' A' ' 35' ' ' GLU . 2.3 m -158.22 161.04 37.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.842 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -105.88 160.94 24.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.647 0.737 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 137.66 35.94 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.361 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.6 mm -71.41 129.46 88.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.606 0.717 . . . . 0.0 111.155 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 128.36 15.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.659 2.239 . . . . 0.0 112.335 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -40.37 -41.23 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -162.66 138.57 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -107.98 74.49 0.95 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -92.03 50.25 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.23 -178.13 15.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.467 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -39.99 5.9 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.662 2.241 . . . . 0.0 112.375 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.9 t -109.09 119.77 59.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 5.6 mmtp -66.96 128.47 36.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -82.86 117.56 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 21.8 t -112.93 124.3 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 37' ' ' PHE . 19.1 m -117.89 147.25 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.094 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -36.91 -40.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.421 ' HG3' ' CB ' ' A' ' 18' ' ' SER . 11.1 mt-10 -57.6 -49.02 77.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.466 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 17.7 p-10 -110.49 24.75 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.884 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.461 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 31.0 t80 -63.34 -55.51 23.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -67.14 -5.14 12.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -88.79 -45.61 9.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.461 HD13 ' ND2' ' A' ' 36' ' ' ASN . 21.5 mt -97.56 -59.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.121 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.447 HG23 ' CG1' ' A' ' 32' ' ' VAL . 38.7 t -49.16 -59.4 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.33 122.96 19.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -167.34 114.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.11 3.51 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.38 -40.92 6.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.24 140.79 48.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.73 149.21 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.09 137.64 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.147 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.408 HD23 ' CD1' ' A' ' 82' ' ' ILE . 13.2 tp -110.34 125.64 53.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 tp -113.48 131.15 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.58 109.53 12.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -84.84 128.97 34.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -128.79 179.9 5.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.24 128.55 17.44 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 0.0 111.136 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -6.75 19.36 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.515 ' CZ2' HG22 ' A' ' 88' ' ' THR . 4.1 p-90 -119.12 18.95 13.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.931 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 38.1 t -119.14 124.62 47.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.84 -61.73 7.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.514 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -42.8 -38.84 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.818 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.3 m -67.95 -44.26 77.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -64.76 -32.77 74.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -76.37 -21.7 55.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 18.4 tp -90.55 -18.63 24.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.514 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -41.19 -58.24 2.97 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.707 0.765 . . . . 0.0 110.943 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.73 -32.22 19.1 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.747 2.298 . . . . 0.0 112.331 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -68.69 -28.58 66.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -92.9 -38.65 11.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -47.42 -61.11 2.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -40.44 -55.13 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.457 ' N ' HD22 ' A' ' 124' ' ' LEU . 30.8 tp -41.25 -39.21 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.54 -64.94 3.56 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.477 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.18 -16.13 50.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -81.0 -44.89 17.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.903 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.433 HD12 ' CD1' ' A' ' 131' ' ' LEU . 95.3 mt -83.75 3.06 35.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.2 t -54.7 -19.02 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.02 10.48 16.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -110.61 98.63 38.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.552 0.692 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 0.18 6.08 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.704 2.269 . . . . 0.0 112.309 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -110.69 -30.87 7.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 55.1 mt -105.65 139.01 28.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.99 110.38 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.408 ' CD1' HD23 ' A' ' 49' ' ' LEU . 42.0 mm -79.11 134.7 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 30' ' ' LYS . . . -146.81 173.75 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -143.52 143.01 31.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.4 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 5.8 ttt -132.89 139.26 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -93.45 82.84 4.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -44.54 -57.45 3.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.515 HG22 ' CZ2' ' A' ' 56' ' ' TRP . 1.6 p -39.36 -27.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.195 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 87' ' ' ALA . . . -102.25 -29.79 11.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.109 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -120.51 120.38 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -55.66 116.83 3.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.441 ' CG1' HG23 ' A' ' 98' ' ' VAL . 90.9 t -68.72 111.7 9.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.588 0.709 . . . . 0.0 111.112 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.7 Cg_endo -69.82 -178.18 2.24 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.707 2.271 . . . . 0.0 112.351 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.497 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -97.57 159.37 31.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.855 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.509 ' O ' ' C ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.71 -27.29 6.88 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.734 -1.778 . . . . 0.0 112.353 -0.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.509 ' C ' ' O ' ' A' ' 95' ' ' PRO . 82.1 m-85 -28.51 111.16 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -117.5 84.07 2.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.441 HG23 ' CG1' ' A' ' 92' ' ' VAL . 99.2 t -77.21 106.69 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -129.65 25.81 5.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.52 115.57 0.37 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.503 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.533 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -98.74 154.2 37.54 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.644 0.735 . . . . 0.0 110.903 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.7 Cg_endo -69.64 151.34 91.03 Favored 'Cis proline' 0 C--O 1.232 0.208 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.392 -0.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -129.04 123.14 31.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.132 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.408 HG23 ' CB ' ' A' ' 118' ' ' TYR . 44.1 mt -119.3 126.65 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.454 ' CZ ' ' HE3' ' A' ' 117' ' ' LYS . 8.1 m-85 -126.78 154.54 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -125.83 129.76 50.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.9 t -101.88 97.59 8.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.694 0.759 . . . . 0.0 110.861 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.482 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.79 171.15 15.03 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.664 2.243 . . . . 0.0 112.335 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.495 ' O ' ' ND2' ' A' ' 110' ' ' ASN . . . -85.11 133.4 34.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER 49.65 29.5 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.482 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 10.5 mtmm -130.93 6.69 4.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.94 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.485 ' N ' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -35.92 -53.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.0 mt -39.06 -52.27 1.84 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -120.92 94.93 49.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.625 0.726 . . . . 0.0 110.906 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.729 2.286 . . . . 0.0 112.332 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -142.03 110.5 6.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HE3' ' CZ ' ' A' ' 105' ' ' TYR . 31.5 tttt -71.53 144.29 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.903 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.437 ' CZ ' ' CE1' ' A' ' 127' ' ' PHE . 35.4 t80 -90.48 106.82 18.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.9 100.75 7.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.894 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.19 -140.15 3.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.52 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.59 130.03 10.14 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.492 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -79.25 45.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 110.893 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 124' ' ' LEU . 18.2 tt0 -101.43 134.17 44.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 70' ' ' LEU . 3.2 tm? -36.28 -51.8 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.7 m -68.02 -45.99 72.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.38 -33.87 4.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.437 ' CE1' ' CZ ' ' A' ' 118' ' ' TYR . 54.0 m-85 -74.64 -42.01 59.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.3 mt -58.26 -53.01 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 t -65.27 -30.89 71.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.77 -47.83 84.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.433 ' CD1' HD12 ' A' ' 74' ' ' LEU . 30.6 mt -74.29 -42.52 59.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -39.54 -32.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -101.73 -60.68 1.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -47.98 -53.96 14.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.49 122.65 5.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -74.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.084 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.5 t -61.4 -54.91 37.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.51 -179.953 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 1.8 p90 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.86 0.362 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 pp -95.81 -36.03 11.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' HG2' ' N ' ' A' ' 18' ' ' SER . 25.9 tttp -118.04 157.45 26.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.447 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 58.2 p -159.57 158.02 30.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.419 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 9.1 mm-40 -107.99 160.79 25.59 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.641 0.734 . . . . 0.0 110.848 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.419 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.71 139.94 41.66 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.656 2.237 . . . . 0.0 112.346 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.2 mm -69.5 129.78 91.24 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.634 0.73 . . . . 0.0 111.126 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 132.34 23.15 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.675 2.25 . . . . 0.0 112.335 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 24' ' ' SER . 8.6 pt-20 -44.89 -42.71 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.431 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 3.3 m -159.44 137.75 10.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.825 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -111.32 80.65 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -101.94 55.35 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.32 -172.94 13.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.472 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -41.67 4.03 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.653 2.235 . . . . 0.0 112.297 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 t -114.8 122.62 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.164 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -68.26 130.33 42.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.3 t -81.11 110.36 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.48 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 39.2 t -105.16 114.97 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 36' ' ' ASN . 35.9 m -108.86 146.35 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -33.54 -47.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -51.55 -48.79 62.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' VAL . 16.9 p-10 -110.38 28.15 8.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.48 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 8.9 t80 -73.33 -44.16 59.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -75.15 -4.57 39.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.53 -39.09 10.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.6 mt -98.91 -63.49 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.4 t -53.47 -60.81 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.109 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 24.8 m-20 -63.99 118.75 8.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 42' ' ' ASN . 38.7 m-20 -175.1 114.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.26 31.69 2.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -125.33 -38.05 2.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.411 ' NZ ' HG23 ' A' ' 81' ' ' VAL . 17.0 pttp -127.88 161.13 29.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -80.94 137.92 36.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -144.51 136.9 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.0 tp -116.39 136.32 53.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 tp -116.45 137.14 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -127.25 110.97 13.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 103' ' ' THR . 69.8 m-85 -87.53 138.64 31.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 4.9 p90 -143.85 175.31 10.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.933 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.94 134.35 26.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.55 0.69 . . . . 0.0 111.107 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -16.36 37.48 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.689 2.259 . . . . 0.0 112.352 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -113.49 25.99 10.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.7 t -123.08 134.27 54.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.78 -59.77 8.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.475 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -38.26 -35.7 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.297 . . . . 0.0 110.832 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -52.59 61.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -57.19 -36.61 71.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -77.53 -35.85 52.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 tp -81.12 -19.45 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.512 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.6 tt0 -46.98 -58.39 7.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.668 0.747 . . . . 0.0 110.886 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.8 -28.03 25.58 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.654 2.236 . . . . 0.0 112.37 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -72.85 -27.36 61.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 41.5 t80 -96.32 -46.07 6.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -41.81 -59.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 70' ' ' LEU . 25.5 mt-10 -39.48 -63.47 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.447 ' N ' HD21 ' A' ' 124' ' ' LEU . 15.7 tp -37.25 -34.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.5 -51.4 42.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.516 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.4 -18.32 57.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.448 ' CD ' HD12 ' A' ' 124' ' ' LEU . 6.3 mtpm? -76.86 -53.74 7.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' ASP . 98.0 mt -79.41 1.78 24.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.1 t -43.06 -23.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 74' ' ' LEU . 16.4 mtpt -89.89 23.74 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.911 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' LEU . 50.1 p-10 -101.36 98.06 8.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.595 0.712 . . . . 0.0 110.845 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 1.04 4.8 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.683 2.255 . . . . 0.0 112.355 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -123.42 -43.29 2.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.456 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 62.1 mt -87.25 144.48 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.453 ' N ' HG21 ' A' ' 80' ' ' ILE . 60.5 t -134.95 97.8 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.5 mm -70.55 122.2 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -138.09 171.28 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.051 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -140.82 159.01 43.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.4 ttt -150.76 135.45 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 87' ' ' ALA . 30.9 t0 -89.51 80.89 6.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -35.91 -62.94 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.9 p -37.87 -39.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.44 -28.81 20.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 87' ' ' ALA . 14.3 m-80 -124.38 110.39 14.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -49.11 130.24 18.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.461 ' CG2' ' HB1' ' A' ' 87' ' ' ALA . 65.2 t -76.97 118.81 74.37 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.626 0.727 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -164.57 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 2.252 . . . . 0.0 112.34 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.48 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -121.06 161.14 42.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.626 0.726 . . . . 0.0 110.887 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.7 Cg_endo -69.77 -12.91 12.34 Favored 'Cis proline' 0 C--N 1.341 0.176 0 C-N-CA 122.681 -1.799 . . . . 0.0 112.359 -0.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 95' ' ' PRO . 88.2 m-85 -33.86 136.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -141.29 119.23 11.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.98 80.77 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.106 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -66.13 -45.43 81.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.67 -171.73 13.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.462 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.502 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -147.97 157.82 42.89 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.628 0.728 . . . . 0.0 110.861 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.8 166.99 72.73 Favored 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.68 -1.8 . . . . 0.0 112.323 0.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 52' ' ' PHE . 88.1 m -146.2 131.18 18.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.6 mt -124.92 129.43 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -125.49 159.34 32.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.518 ' HB3' ' CG ' ' A' ' 116' ' ' LYS . 21.2 t80 -119.89 151.19 39.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 m -121.64 87.63 46.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.673 0.749 . . . . 0.0 110.837 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.502 ' O ' ' CE ' ' A' ' 112' ' ' LYS . 54.0 Cg_endo -69.79 168.23 22.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.671 2.247 . . . . 0.0 112.332 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.478 ' C ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.16 139.03 32.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.478 ' CG ' ' C ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER 49.84 25.02 1.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.471 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.1 mtmt -128.0 18.23 6.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' CE ' ' O ' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -46.44 -34.07 4.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mt -82.76 -24.88 33.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 111' ' ' LYS . 10.9 m120 -119.43 63.02 7.09 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.616 0.722 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -164.72 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.363 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.518 ' CG ' ' HB3' ' A' ' 106' ' ' PHE . 0.8 OUTLIER -160.63 155.55 24.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.9 ttpp -117.72 126.75 53.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.41 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 60.1 t80 -54.97 101.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -115.2 94.65 4.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.73 -141.64 4.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.504 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.78 134.8 12.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.502 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.44 ' HB2' ' NH1' ' A' ' 122' ' ' ARG . 10.3 mtp-105 -84.37 49.74 1.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.876 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 124' ' ' LEU . 26.9 tt0 -109.66 133.85 52.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.448 HD12 ' CD ' ' A' ' 73' ' ' LYS . 3.3 tm? -36.28 -53.85 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.5 p -65.16 -42.7 93.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.09 -27.93 36.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.41 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 58.0 m-85 -78.8 -47.32 16.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.7 mt -53.19 -50.73 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.12 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.0 p -60.67 -55.32 34.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.828 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -44.44 -45.09 8.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 135' ' ' ALA . 18.9 mt -76.51 -37.55 56.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -48.18 -45.89 34.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 12.9 ptm180 -86.45 -40.04 15.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.462 ' OE1' ' CD ' ' A' ' 116' ' ' LYS . 46.7 mm-40 -68.89 -65.02 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.455 ' CB ' HD11 ' A' ' 80' ' ' ILE . . . -34.18 131.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -66.72 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.8 t -66.16 -43.88 85.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.451 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.438 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.2 p90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.927 0.394 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 pp -98.31 -43.87 6.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.488 ' CG ' ' N ' ' A' ' 18' ' ' SER . 7.4 ttpm? -110.71 166.38 11.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.488 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 98.1 p -170.78 152.0 3.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -96.23 158.45 33.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.623 0.725 . . . . 0.0 110.896 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 145.75 58.04 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.676 2.251 . . . . 0.0 112.365 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.6 mm -73.13 133.45 81.42 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.739 . . . . 0.0 111.108 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 174.11 9.99 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.361 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -97.23 -36.04 10.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -145.0 137.73 26.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -130.2 37.23 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.51 60.44 2.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.69 -168.43 12.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -41.14 4.54 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 0.0 112.332 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.7 t -119.13 122.14 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.59 131.13 42.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.0 t -78.77 135.14 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 38.8 t -132.15 120.03 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 36' ' ' ASN . 20.3 m -116.97 147.58 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.438 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -34.3 -44.11 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -53.77 -46.47 70.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 33' ' ' VAL . 18.1 p-10 -116.32 30.6 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.559 ' CZ ' ' HG3' ' A' ' 93' ' ' PRO . 5.2 t80 -69.98 -54.73 11.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.43 -5.69 20.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -90.6 -41.6 11.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.893 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.413 HD12 ' ND2' ' A' ' 36' ' ' ASN . 12.4 mt -97.5 -58.16 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.122 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.0 t -54.56 -60.1 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.09 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 34.3 m-20 -67.45 123.08 19.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.839 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 28.9 m-20 -171.89 108.5 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -83.43 0.42 46.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -85.68 -45.8 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -138.36 162.86 33.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.67 150.38 36.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 49' ' ' LEU . 49.1 t -142.98 140.99 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.457 ' N ' HG12 ' A' ' 48' ' ' VAL . 29.9 tp -112.95 126.07 55.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 tp -113.45 135.33 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.105 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.456 ' C ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -126.03 117.95 24.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -91.59 120.44 32.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.564 ' CE1' ' OD2' ' A' ' 86' ' ' ASP . 28.6 p90 -128.47 178.84 6.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.24 132.44 20.07 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.564 0.697 . . . . 0.0 111.094 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 -2.49 10.29 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.553 ' CZ3' ' SG ' ' A' ' 57' ' ' CYS . 7.3 p-90 -122.04 6.73 9.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.553 ' SG ' ' CZ3' ' A' ' 56' ' ' TRP . 1.3 m -96.23 137.34 35.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.98 -58.17 4.51 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -50.5 -39.19 47.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.324 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.6 m -64.06 -38.95 92.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -64.12 -45.91 86.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -68.34 -14.56 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 64' ' ' GLU . 14.2 tp -96.33 -24.76 16.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -37.62 -57.93 1.42 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.595 0.712 . . . . 0.0 110.875 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.4 Cg_endo -69.76 -27.74 26.11 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.686 2.257 . . . . 0.0 112.359 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -71.58 -32.5 68.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -88.69 -40.26 13.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -44.48 -59.33 2.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -38.78 -56.21 1.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.441 ' N ' HD23 ' A' ' 124' ' ' LEU . 28.0 tp -43.79 -39.89 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.07 -63.25 5.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.438 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.34 -26.28 67.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.875 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -72.12 -44.14 63.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.463 HD11 ' CD1' ' A' ' 82' ' ' ILE . 82.2 mt -89.55 3.19 53.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.1 t -52.09 -20.63 2.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -98.87 22.71 9.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.29 99.28 14.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.61 0.719 . . . . 0.0 110.865 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -3.25 11.62 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.726 2.284 . . . . 0.0 112.334 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.19 -19.09 9.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.2 mt -123.29 134.44 66.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.2 t -130.2 103.98 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.463 ' CD1' HD11 ' A' ' 74' ' ' LEU . 51.4 mm -69.61 132.36 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.146 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.63 167.75 22.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 pttt -139.92 156.36 46.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.411 ' SD ' ' OD1' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -149.18 132.91 16.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.564 ' OD2' ' CE1' ' A' ' 53' ' ' TYR . 1.2 m-20 -86.67 101.39 13.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -58.14 -64.96 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -45.35 -21.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' A' ' 87' ' ' ALA . . . -92.58 -29.74 16.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -142.79 130.37 21.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -47.04 150.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 93' ' ' PRO . 89.7 t -96.49 135.49 22.37 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.648 0.737 . . . . 0.0 111.088 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.559 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.5 Cg_endo -69.79 -163.55 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.683 2.255 . . . . 0.0 112.339 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.527 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -132.68 153.87 81.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.704 0.764 . . . . 0.0 110.839 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.85 -7.42 10.12 Favored 'Cis proline' 0 C--N 1.342 0.196 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.304 0.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.475 ' C ' ' O ' ' A' ' 95' ' ' PRO . 51.8 m-85 -31.7 131.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -142.77 126.74 17.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 81.8 t -133.83 115.59 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -123.0 -41.85 2.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.29 118.09 4.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.527 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -96.23 155.19 38.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.661 0.743 . . . . 0.0 110.905 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.77 161.11 86.88 Favored 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.318 -0.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.9 m -141.71 115.04 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -108.52 138.8 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.143 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -133.92 178.03 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.952 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -149.32 126.51 11.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.62 100.08 13.28 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.664 0.745 . . . . 0.0 110.833 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.481 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.75 171.04 15.18 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.609 2.206 . . . . 0.0 112.388 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.456 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.67 139.49 31.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.084 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.7 p30 46.85 25.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.481 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.2 mtmm -127.27 22.44 6.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 108' ' ' PRO . 7.7 mmpt? -45.86 -66.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 112' ' ' LYS . 6.9 mp -34.02 -44.43 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.942 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -122.44 90.14 49.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.593 0.711 . . . . 0.0 110.92 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -163.75 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.632 2.221 . . . . 0.0 112.31 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -141.7 131.31 24.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -100.04 134.13 43.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.85 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -79.24 111.84 15.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -124.15 98.3 5.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 179.57 -146.27 6.98 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.99 134.33 12.38 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.489 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -81.29 45.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.888 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 124' ' ' LEU . 9.0 tt0 -103.12 134.48 46.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 70' ' ' LEU . 3.2 tm? -36.84 -54.92 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 60.4 p -60.84 -48.93 79.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -47.8 -34.97 9.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -70.61 -37.31 73.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.4 mt -69.05 -57.55 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.113 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.6 t -60.29 -24.7 65.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -70.82 -48.57 53.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.935 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 25.8 mt -71.22 -38.18 72.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -40.24 -42.95 1.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -94.78 -67.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -40.53 -54.42 2.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 131' ' ' LEU . . . -44.57 100.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.069 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.444 HG21 ' N ' ' A' ' 137' ' ' SER . 1.3 t -44.2 -24.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.444 ' N ' HG21 ' A' ' 136' ' ' THR . 1.2 t -116.33 48.46 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 137' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.497 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.443 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.2 p90 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.912 0.387 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.417 HD11 ' N ' ' A' ' 17' ' ' LYS . 1.9 pp -104.21 -37.04 7.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.934 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.423 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 17.0 ttpt -109.86 158.2 18.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.413 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 90.9 p -164.22 149.1 10.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -98.86 160.7 27.15 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.656 0.741 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 143.57 51.32 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.648 2.232 . . . . 0.0 112.333 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.9 mm -68.87 129.15 92.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.633 0.73 . . . . 0.0 111.154 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 136.15 32.41 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.667 2.245 . . . . 0.0 112.355 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -49.05 -50.24 37.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.6 t -149.53 137.28 20.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -111.43 50.31 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.55 -25.05 59.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.84 169.94 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.405 ' HG3' ' CG ' ' A' ' 68' ' ' LYS . 53.5 Cg_endo -69.79 -29.67 23.37 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.686 2.258 . . . . 0.0 112.332 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.5 t -111.73 121.0 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -71.12 134.93 47.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.1 t -86.35 104.75 14.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.147 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.441 HG22 ' CB ' ' A' ' 83' ' ' ALA . 44.9 t -95.91 114.11 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.171 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 34' ' ' ALA . 26.3 m -109.53 144.74 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.86 -43.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -56.09 -50.82 69.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.452 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 28.5 p30 -105.41 21.58 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.417 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 14.4 t80 -62.8 -58.78 6.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.02 -6.97 7.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.858 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.97 -44.13 11.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.5 mt -97.21 -58.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -51.86 -61.55 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -69.06 114.61 7.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -167.08 106.72 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -91.11 31.88 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -126.4 -37.82 2.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.826 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.81 145.55 48.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.3 147.26 53.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.9 t -145.26 147.84 18.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.131 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.46 HD23 ' CD1' ' A' ' 82' ' ' ILE . 21.8 tp -124.57 126.9 46.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.945 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.2 tp -107.72 139.51 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -127.28 105.13 8.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -84.78 115.33 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -125.6 179.69 5.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.66 132.91 23.67 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.569 0.7 . . . . 0.0 111.12 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.425 ' HD2' ' CG2' ' A' ' 88' ' ' THR . 53.7 Cg_endo -69.72 -1.65 8.79 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.744 2.296 . . . . 0.0 112.348 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -122.96 5.59 9.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.427 ' HB3' ' NE2' ' A' ' 59' ' ' HIS . 1.3 m -98.64 130.31 45.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -66.11 -59.65 7.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.497 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.568 ' CD2' ' HD3' ' A' ' 102' ' ' PRO . 3.1 p-80 -38.41 -31.65 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.875 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLY . 9.5 t -68.54 -49.6 58.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -53.68 -45.53 70.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -72.49 -24.86 61.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.3 tp -87.68 -20.25 26.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.946 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.52 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -42.97 -58.31 4.11 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.657 0.741 . . . . 0.0 110.861 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.1 Cg_endo -69.74 -26.5 27.61 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.704 2.27 . . . . 0.0 112.328 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -74.24 -27.35 60.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 40.3 t80 -96.32 -33.57 11.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.405 ' CG ' ' HG3' ' A' ' 28' ' ' PRO . 1.2 ttmp? -51.77 -57.62 8.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -40.53 -60.75 1.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.47 ' N ' HD21 ' A' ' 124' ' ' LEU . 21.3 tp -38.48 -38.81 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.83 -65.61 3.21 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.84 -16.43 64.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -80.88 -42.66 21.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.471 HD12 ' CD1' ' A' ' 82' ' ' ILE . 80.6 mt -82.09 3.34 27.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.2 m -53.92 -24.78 17.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -78.1 6.9 7.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.917 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 4.1 t0 -113.49 98.98 48.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.659 0.742 . . . . 0.0 110.843 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.3 Cg_endo -69.72 0.3 5.82 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.71 2.273 . . . . 0.0 112.36 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -110.83 -36.83 5.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 81' ' ' VAL . 64.3 mt -92.55 137.97 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.468 ' N ' HG22 ' A' ' 80' ' ' ILE . 92.2 t -135.37 116.81 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.471 ' CD1' HD12 ' A' ' 74' ' ' LEU . 23.3 mm -89.05 132.45 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' A' ' 32' ' ' VAL . . . -142.03 171.53 13.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -139.74 138.13 35.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.489 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 12.4 ttt -132.5 143.19 49.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -95.88 95.27 8.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -48.77 -67.19 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.425 ' CG2' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -46.97 -23.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.423 ' C ' ' HE3' ' A' ' 17' ' ' LYS . . . -93.52 -25.12 17.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.489 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -141.07 125.29 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.0 128.97 36.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.52 128.56 74.64 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.591 0.71 . . . . 0.0 111.141 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -169.77 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.663 2.242 . . . . 0.0 112.343 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.487 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.5 m -121.25 160.84 43.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.667 0.746 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.2 Cg_endo -69.69 -8.62 10.47 Favored 'Cis proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 -1.801 . . . . 0.0 112.387 -0.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 95' ' ' PRO . 86.0 m-85 -34.04 123.37 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -125.74 130.16 50.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.885 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 65.8 t -133.09 120.48 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.093 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -128.87 -38.64 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.79 123.3 5.32 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.516 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.533 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.4 OUTLIER -97.14 154.0 38.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.738 . . . . 0.0 110.878 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.568 ' HD3' ' CD2' ' A' ' 59' ' ' HIS . 53.1 Cg_endo -69.83 155.33 93.49 Favored 'Cis proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.29 0.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 92.9 m -131.53 100.27 5.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.458 HD12 ' NE ' ' A' ' 122' ' ' ARG . 95.6 mt -94.79 141.93 14.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.151 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -140.88 161.59 37.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.942 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -128.25 136.95 51.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -105.3 93.27 6.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.843 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.486 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.6 Cg_endo -69.75 164.59 33.96 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.394 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.459 ' O ' ' CE ' ' A' ' 111' ' ' LYS . . . -78.04 145.44 35.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.2 p30 41.94 24.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.486 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.2 mtmt -128.66 68.07 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.427 ' HA ' ' NZ ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -90.57 -49.01 6.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.558 ' CD1' ' C ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -59.75 -25.47 64.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.462 ' HB2' ' CD1' ' A' ' 113' ' ' LEU . 2.8 t-20 -133.39 84.06 47.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.646 0.736 . . . . 0.0 110.91 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -163.8 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -148.43 137.09 21.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 118' ' ' TYR . 29.8 ttmt -105.19 151.4 24.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.549 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 68.4 t80 -94.58 108.83 20.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -121.58 100.0 6.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 178.73 -153.59 12.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.1 133.35 12.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.477 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.458 ' NE ' HD12 ' A' ' 104' ' ' ILE . 84.0 mmt-85 -80.36 45.96 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.844 0.355 . . . . 0.0 110.914 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 124' ' ' LEU . 8.8 tt0 -105.39 133.29 50.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.47 HD21 ' N ' ' A' ' 70' ' ' LEU . 3.4 tm? -34.8 -55.59 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.3 m -58.86 -52.21 66.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.827 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.03 -30.38 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.549 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 38.9 m-85 -78.19 -40.34 37.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 mt -63.64 -57.26 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.153 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -58.01 -35.49 71.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.566 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 16.9 t80 -53.95 -52.82 59.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.554 HD23 ' CE2' ' A' ' 130' ' ' TYR . 15.6 mt -74.84 -39.89 61.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -38.79 -39.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.93 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -98.98 -57.07 2.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.566 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 69.6 mm-40 -49.24 -53.68 20.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -42.51 104.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.157 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 2.1 t -46.83 -49.62 19.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.7 m -73.98 -45.38 50.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.504 -179.969 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 34' ' ' ALA . 14.5 p90 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.914 0.387 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 pp -131.88 -40.21 1.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.12 125.25 41.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.1 156.74 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.847 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 4.5 mm-40 -106.0 161.68 22.08 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.652 0.739 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.4 Cg_endo -69.83 143.47 50.6 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.701 2.268 . . . . 0.0 112.306 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.2 mm -68.78 127.47 93.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.618 0.723 . . . . 0.0 111.109 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.94 43.95 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.709 2.273 . . . . 0.0 112.351 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.59 -39.17 92.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 m -150.13 123.27 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -133.11 45.9 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.49 54.12 2.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.845 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.17 -160.11 23.4 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.491 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -41.55 4.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.63 2.22 . . . . 0.0 112.396 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.4 t -119.53 107.19 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.116 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -53.48 124.98 16.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.8 t -75.4 126.1 35.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.464 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 30.0 t -118.51 120.31 63.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 36' ' ' ASN . 31.6 m -113.44 145.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HB2' ' CE2' ' A' ' 15' ' ' TYR . . . -36.4 -38.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.091 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -59.51 -46.75 87.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' VAL . 22.2 p-10 -111.89 24.84 12.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.464 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 6.1 t80 -63.46 -58.06 8.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -65.29 -7.72 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -86.9 -44.22 11.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.7 mt -98.28 -62.3 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.445 HG21 ' CG1' ' A' ' 32' ' ' VAL . 97.1 t -48.14 -62.04 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.136 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -72.66 126.55 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.416 ' ND2' ' HE3' ' A' ' 46' ' ' LYS . 11.7 t-20 -172.91 108.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -87.6 29.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -124.14 -41.66 2.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HE3' ' ND2' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -136.28 130.13 32.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.57 151.95 5.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.499 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 89.4 t -146.33 152.58 13.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.8 tp -124.17 126.13 45.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 tp -114.1 129.38 70.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.121 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -123.83 114.35 19.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -85.38 133.82 34.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -143.0 169.14 18.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.04 131.42 23.85 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.589 0.709 . . . . 0.0 111.074 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -10.13 27.82 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.376 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -115.58 5.11 14.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 7.5 t -101.71 126.89 48.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.15 -59.14 8.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -42.36 -45.64 4.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.6 m -69.82 -43.72 71.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -55.67 -35.88 66.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -74.62 -29.9 61.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.9 tp -83.15 -20.88 33.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.53 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -41.16 -57.58 3.4 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.652 0.739 . . . . 0.0 110.864 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.71 -27.72 26.36 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.705 2.27 . . . . 0.0 112.345 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -71.92 -30.65 65.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -91.01 -37.07 13.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -47.57 -54.37 11.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.833 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -43.35 -56.21 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.47 ' N ' HD21 ' A' ' 124' ' ' LEU . 21.7 tp -42.99 -38.5 2.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.29 -65.16 3.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.438 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -60.83 -27.55 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 0.0 110.89 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mmtm -67.95 -46.46 71.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.472 HD13 ' CG1' ' A' ' 82' ' ' ILE . 91.5 mt -84.72 2.98 39.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.6 t -48.64 -24.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -93.57 24.24 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.45 97.63 12.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.583 0.706 . . . . 0.0 110.857 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -2.17 9.72 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.664 2.243 . . . . 0.0 112.364 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -117.5 -42.85 2.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.9 mt -92.77 145.07 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.179 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.1 t -138.99 106.82 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.472 ' CG1' HD13 ' A' ' 74' ' ' LEU . 21.2 mm -76.87 135.8 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . . . -145.62 169.17 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -143.34 149.51 37.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -144.06 138.45 28.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.85 107.0 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.82 -51.74 68.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.125 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -16.31 28.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.549 ' C ' ' ND2' ' A' ' 90' ' ' ASN . . . -106.88 0.69 24.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.549 ' ND2' ' C ' ' A' ' 89' ' ' ALA . 3.8 m-80 -162.87 124.61 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.92 130.05 42.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.4 t -78.34 125.33 85.01 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.641 0.734 . . . . 0.0 111.168 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -164.57 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -127.16 160.93 57.11 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.683 0.754 . . . . 0.0 110.857 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.0 Cg_endo -69.71 -3.03 7.38 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.74 -1.775 . . . . 0.0 112.381 -0.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.46 ' N ' ' HA ' ' A' ' 94' ' ' SER . 97.3 m-85 -36.4 125.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -129.31 125.11 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -130.99 103.54 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.142 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -104.93 -35.48 7.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.837 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.57 134.28 6.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.478 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.507 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -98.14 156.94 35.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 0.0 110.92 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.75 165.52 76.42 Favored 'Cis proline' 0 C--O 1.231 0.164 0 C-N-CA 122.732 -1.778 . . . . 0.0 112.373 -0.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 71.2 m -147.16 105.08 3.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.117 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.46 HG21 ' N ' ' A' ' 105' ' ' TYR . 21.2 mt -97.19 141.4 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.121 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.46 ' N ' HG21 ' A' ' 104' ' ' ILE . 8.3 m-85 -140.97 160.34 40.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 31.2 t80 -130.27 140.39 50.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.7 p -109.43 98.66 33.18 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.667 0.746 . . . . 0.0 110.859 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.488 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.76 166.49 27.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.622 2.215 . . . . 0.0 112.37 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -82.48 128.6 34.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.08 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.23 29.75 15.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.488 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.9 mtmt -135.0 40.93 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -64.05 -33.86 76.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.6 mp -67.47 -36.21 80.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -124.7 81.56 60.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.593 0.711 . . . . 0.0 110.875 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 178.11 4.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.481 ' CD ' ' HG3' ' A' ' 108' ' ' PRO . 7.9 mptt -114.93 127.41 55.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -101.92 108.0 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.435 ' CE1' ' CD2' ' A' ' 130' ' ' TYR . 55.3 t80 -55.21 108.69 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -125.52 90.92 3.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -172.73 -134.23 1.78 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.479 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.14 139.79 14.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.429 ' CZ ' ' HG3' ' A' ' 102' ' ' PRO . 32.9 mtp180 -84.8 37.86 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.757 0.313 . . . . 0.0 110.874 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 124' ' ' LEU . 15.1 tp10 -98.25 129.26 44.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.47 HD21 ' N ' ' A' ' 70' ' ' LEU . 3.2 tm? -34.28 -55.29 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.9 p -57.65 -45.71 85.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 123' ' ' GLU . 2.1 t70 -53.43 -33.53 54.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.43 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 88.7 m-85 -73.58 -40.33 63.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.7 mt -61.58 -57.41 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.181 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.34 -35.18 78.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.435 ' CD2' ' CE1' ' A' ' 118' ' ' TYR . 13.8 t80 -53.56 -48.1 69.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 28.9 mt -76.22 -39.24 55.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.908 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -39.92 -40.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.3 mtp85 -92.0 -64.4 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 135' ' ' ALA . 21.8 mm-40 -41.78 -60.15 1.45 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -35.19 116.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.1 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.6 OUTLIER -35.19 -75.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.122 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 m -75.81 -55.69 5.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 179.99 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 4.3 p90 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.882 0.372 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 pp -112.99 -36.91 4.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -109.69 155.5 21.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 35' ' ' GLU . 18.7 t -166.4 143.78 5.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.427 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.0 mm-40 -86.6 162.05 46.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.654 0.74 . . . . 0.0 110.882 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.427 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.77 142.32 47.56 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.649 2.233 . . . . 0.0 112.353 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.413 HD11 ' CB ' ' A' ' 35' ' ' GLU . 30.6 mm -71.65 131.83 85.83 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.644 0.735 . . . . 0.0 111.1 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 178.38 4.67 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.626 2.217 . . . . 0.0 112.37 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -103.13 -34.96 8.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 p -147.98 125.64 11.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -107.8 47.5 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -58.8 -26.92 64.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.53 168.87 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.486 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.436 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 54.1 Cg_endo -69.76 -25.66 28.35 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.685 2.256 . . . . 0.0 112.364 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.1 t -120.1 113.15 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -57.66 129.59 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.3 125.97 39.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.153 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.467 HG22 ' CB ' ' A' ' 83' ' ' ALA . 21.8 t -124.6 124.57 68.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 36' ' ' ASN . 20.9 m -122.64 148.46 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -32.75 -40.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.121 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.454 ' N ' ' OG ' ' A' ' 18' ' ' SER . 12.7 mt-10 -55.75 -49.56 72.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.857 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 33' ' ' VAL . 36.4 p-10 -115.77 34.91 4.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.464 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 21.4 t80 -71.09 -57.93 4.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -66.6 -5.67 12.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -87.08 -47.41 8.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.3 mt -96.92 -58.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.3 t -49.0 -61.64 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.167 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -68.56 126.91 31.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -174.33 118.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -95.64 0.45 52.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -95.54 -37.58 10.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -138.87 138.93 37.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.522 ' OD2' ' CG1' ' A' ' 80' ' ' ILE . 1.3 p30 -58.63 152.87 17.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.87 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.1 t -148.42 142.72 19.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.473 HD22 ' CD1' ' A' ' 82' ' ' ILE . 39.4 tp -117.91 140.51 49.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 tp -127.86 135.6 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.49 ' CD ' ' C ' ' A' ' 51' ' ' GLU . 5.8 tm-20 -126.77 121.88 33.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.549 ' CE1' HG22 ' A' ' 92' ' ' VAL . 78.9 m-85 -95.74 118.7 32.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -126.34 179.08 5.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.26 134.56 17.76 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.625 0.726 . . . . 0.0 111.123 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -16.96 37.93 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.69 2.26 . . . . 0.0 112.339 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.404 ' CZ3' ' HB2' ' A' ' 57' ' ' CYS . 2.4 p-90 -105.85 6.53 31.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . 42.1 t -107.16 112.7 25.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.876 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -57.98 -57.16 21.3 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -41.02 -37.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 97.5 m -73.75 -34.66 64.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 58' ' ' GLY . 2.1 ttmm -62.33 -35.48 79.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -73.77 -27.75 61.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 64' ' ' GLU . 13.2 tp -81.36 -25.15 36.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.514 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.1 tt0 -37.53 -58.37 1.28 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.645 0.736 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.3 Cg_endo -69.82 -31.5 20.13 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.692 2.261 . . . . 0.0 112.28 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -68.13 -29.98 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -92.47 -38.87 11.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.436 ' HG3' ' CG ' ' A' ' 28' ' ' PRO . 5.5 ttmm -50.07 -58.68 5.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 9.6 mt-10 -41.59 -49.25 4.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.44 ' N ' HD21 ' A' ' 124' ' ' LEU . 25.1 tp -47.09 -41.39 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.56 -66.96 2.48 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.478 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.06 -26.54 68.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.85 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 69' ' ' GLU . 17.2 mmtt -70.09 -39.94 75.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.5 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 64.3 mt -79.13 4.86 13.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.3 t -56.97 -11.96 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -82.68 -20.14 36.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CG ' ' O ' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -98.43 100.99 10.27 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.717 . . . . 0.0 110.855 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -2.91 10.98 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 0.0 112.322 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -107.7 -33.05 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.522 ' CG1' ' OD2' ' A' ' 47' ' ' ASP . 54.4 mt -92.05 117.93 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.1 t -118.2 125.44 74.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.106 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.474 ' CD1' HD13 ' A' ' 74' ' ' LEU . 30.7 mm -93.24 137.28 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.467 ' CB ' HG22 ' A' ' 32' ' ' VAL . . . -142.9 161.03 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.036 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -131.11 156.51 45.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.476 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 13.9 ttt -151.09 132.36 14.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 90' ' ' ASN . 26.1 t70 -91.32 95.85 10.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -52.28 -60.46 3.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -42.82 -27.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.38 -28.88 13.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.476 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.3 OUTLIER -134.88 114.97 13.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -47.2 131.24 13.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.549 HG22 ' CE1' ' A' ' 52' ' ' PHE . 93.0 t -80.86 132.85 56.2 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.59 0.709 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.439 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.6 Cg_endo -69.76 -165.83 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 0.0 112.326 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.486 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -124.13 160.89 50.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.645 0.736 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.5 Cg_endo -69.72 -8.75 10.59 Favored 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.356 -0.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 95' ' ' PRO . 98.3 m-85 -33.08 124.09 0.38 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -128.98 119.85 25.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 101' ' ' PHE . 71.0 t -121.66 96.47 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.17 -43.39 7.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.812 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.53 128.58 6.16 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.518 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -97.39 156.37 36.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.662 0.744 . . . . 0.0 110.858 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.6 Cg_endo -69.71 163.96 80.35 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.34 -0.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 50.2 m -145.73 106.09 4.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.5 mt -96.51 136.23 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -134.76 158.91 42.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -128.05 135.04 49.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.1 p -107.81 91.26 7.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.652 0.739 . . . . 0.0 110.832 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.483 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.8 Cg_endo -69.73 168.95 20.04 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.256 . . . . 0.0 112.339 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.24 140.11 35.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.01 31.36 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.483 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.7 mtmm -128.53 34.58 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 113' ' ' LEU . 27.3 mmtp -64.58 -58.24 6.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 112' ' ' LYS . 4.3 mm? -34.87 -41.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.909 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -134.97 92.64 18.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.572 0.701 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -173.44 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -135.66 121.02 19.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.25 123.89 34.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.63 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 60.6 t80 -57.45 96.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.906 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -109.7 95.04 5.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.918 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.34 -151.51 9.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.36 135.11 13.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.484 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 122' ' ' ARG . 13.1 mtm105 -80.59 45.62 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -102.43 137.05 41.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.44 HD21 ' N ' ' A' ' 70' ' ' LEU . 3.3 tm? -40.48 -52.43 2.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.8 m -66.3 -47.34 73.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -46.69 -36.75 7.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.918 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.63 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 65.3 m-85 -70.52 -44.68 67.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.4 mt -57.66 -56.41 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.119 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -65.68 -25.01 67.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.454 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 8.3 t80 -63.9 -50.62 68.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 132' ' ' GLN . 23.5 mt -71.69 -41.66 68.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 131' ' ' LEU . 36.3 mt-30 -37.74 -39.86 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -102.04 -51.4 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.454 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 7.4 mm-40 -51.98 -57.08 10.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.04 147.49 53.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.15 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.23 -49.06 20.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.2 m -42.88 -69.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.867 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 179.998 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.538 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 2.8 p90 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.903 0.382 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 pp -102.9 -39.12 7.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.948 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -100.93 159.69 14.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.4 p -172.47 149.69 2.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.493 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 15.9 mm-40 -103.6 161.81 21.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.623 0.725 . . . . 0.0 110.908 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.424 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.78 144.63 54.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.259 . . . . 0.0 112.31 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.475 HD11 ' CG2' ' A' ' 33' ' ' VAL . 39.0 mm -71.93 132.97 84.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.619 0.723 . . . . 0.0 111.124 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 179.47 3.69 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.616 2.211 . . . . 0.0 112.349 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -104.1 -34.69 8.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 m -150.85 126.42 10.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -110.14 43.12 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.26 -28.81 44.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.04 165.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -20.56 35.01 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.277 . . . . 0.0 112.344 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.32 110.75 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -55.79 138.48 47.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.7 t -91.91 110.6 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.487 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 39.1 t -105.4 124.0 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.096 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 36' ' ' ASN . 27.0 m -119.77 145.78 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -31.64 -44.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.115 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -54.74 -49.12 71.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 33' ' ' VAL . 9.2 p-10 -114.25 38.36 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.487 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 8.4 t80 -75.32 -55.49 5.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.4 -15.23 62.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -78.99 -44.8 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.456 HD13 ' ND2' ' A' ' 36' ' ' ASN . 22.7 mt -97.46 -58.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.436 HG22 ' CD2' ' A' ' 37' ' ' PHE . 48.6 t -49.65 -61.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -73.2 126.99 31.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -172.53 106.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -79.15 -14.57 59.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -73.16 -44.24 60.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -138.9 160.85 38.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.11 153.13 38.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.5 t -144.59 135.73 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.13 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.468 ' CD1' ' HB2' ' A' ' 106' ' ' PHE . 14.4 tp -112.68 119.91 39.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.407 HG13 ' N ' ' A' ' 51' ' ' GLU . 1.8 tp -106.64 136.71 40.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' OE2' ' C ' ' A' ' 52' ' ' PHE . 1.2 tm-20 -127.5 115.46 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.409 ' C ' ' OE2' ' A' ' 51' ' ' GLU . 35.5 m-85 -91.64 139.54 30.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 10.4 p90 -144.63 177.12 8.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' CD2' ' A' ' 56' ' ' TRP . . . -132.72 131.14 21.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.598 0.713 . . . . 0.0 111.096 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -9.26 25.67 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.382 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.414 ' CD2' ' HB2' ' A' ' 54' ' ' ALA . 2.1 p-90 -110.6 23.21 14.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.4 t -134.2 108.74 8.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.41 -35.9 2.94 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.49 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -42.59 -50.38 5.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.802 0.334 . . . . 0.0 110.872 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 64' ' ' GLU . 14.1 p -55.1 -42.13 72.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' N ' ' SG ' ' A' ' 60' ' ' CYS . 0.0 OUTLIER -62.37 -40.69 97.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.46 -36.96 71.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.4 tp -84.34 -20.07 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.529 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 3.3 tt0 -42.19 -57.95 3.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.738 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.82 -34.09 15.07 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.366 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -66.85 -28.67 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -93.53 -49.77 5.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 71' ' ' GLY . 6.4 ttmm -39.08 -64.33 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 22.2 mt-10 -39.58 -46.87 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.473 ' N ' HD23 ' A' ' 124' ' ' LEU . 19.5 tp -53.03 -39.48 63.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 68' ' ' LYS . . . -57.32 -65.5 3.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.504 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -67.43 -24.42 65.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.493 ' CG ' ' O ' ' A' ' 69' ' ' GLU . 16.5 mmtm -69.87 -46.13 66.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' A' ' 82' ' ' ILE . 93.6 mt -80.16 3.23 21.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.6 t -53.33 -36.09 60.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -59.88 -11.16 4.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.859 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.97 100.72 12.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.654 0.74 . . . . 0.0 110.874 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 1.07 4.77 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.722 2.281 . . . . 0.0 112.339 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -110.87 -39.56 4.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.2 mt -87.08 113.6 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.175 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.4 t -108.34 117.01 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.42 ' CD1' HD11 ' A' ' 74' ' ' LEU . 39.6 mm -91.98 123.05 43.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.175 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -138.01 171.29 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -138.96 154.94 48.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.5 ttt -148.02 134.11 19.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -86.03 87.76 7.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -42.73 -67.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.084 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -37.75 -30.93 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 87' ' ' ALA . . . -89.58 -35.7 15.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.9 m-80 -124.0 115.38 21.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -47.05 119.23 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.5 t -75.89 120.05 79.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.632 0.73 . . . . 0.0 111.15 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.75 -174.88 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.727 2.285 . . . . 0.0 112.346 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.494 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -105.07 159.62 28.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.674 0.75 . . . . 0.0 110.845 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.516 ' O ' ' C ' ' A' ' 96' ' ' TYR . 53.2 Cg_endo -69.82 -23.49 9.09 Favored 'Cis proline' 0 C--O 1.231 0.143 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.312 0.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.516 ' C ' ' O ' ' A' ' 95' ' ' PRO . 76.2 m-85 -27.47 114.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -127.22 90.38 3.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.533 HG13 ' CE2' ' A' ' 101' ' ' PHE . 78.6 t -80.0 99.43 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.157 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.7 mmm-85 -98.04 -44.18 6.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.91 133.37 7.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.533 ' CE2' HG13 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -101.78 156.86 34.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.608 0.718 . . . . 0.0 110.903 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.0 Cg_endo -69.79 145.4 79.38 Favored 'Cis proline' 0 C--O 1.232 0.206 0 C-N-CA 122.648 -1.813 . . . . 0.0 112.388 0.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.4 m -118.48 126.64 52.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.7 mt -121.34 127.19 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -127.53 152.1 48.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.468 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 21.5 t80 -126.44 130.22 50.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.858 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t -100.77 99.31 9.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.671 0.748 . . . . 0.0 110.843 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.486 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.81 164.14 35.71 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.672 2.248 . . . . 0.0 112.343 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' ND2' ' A' ' 110' ' ' ASN . . . -78.84 134.96 36.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.089 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER 48.33 31.81 2.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.486 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 20.7 mtmt -133.98 33.92 3.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -58.35 -55.07 39.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -43.17 -39.34 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -133.82 89.67 29.46 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.63 0.729 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -167.58 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.733 2.289 . . . . 0.0 112.293 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -135.16 111.36 9.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -82.18 128.41 34.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.629 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 75.3 t80 -69.67 99.8 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -112.08 90.89 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.847 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -171.68 -150.96 7.44 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.43 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.23 140.39 16.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -79.59 44.1 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 124' ' ' LEU . 6.4 tt0 -101.28 127.92 47.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 70' ' ' LEU . 3.2 tm? -35.11 -56.19 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 53.0 p -61.86 -47.31 85.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -47.16 -36.5 8.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.629 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 77.1 m-85 -72.49 -49.49 32.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.5 mt -50.33 -56.07 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -37.08 83.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.838 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.535 ' CE2' ' HG3' ' A' ' 134' ' ' GLU . 63.8 t80 -57.11 -45.52 83.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.915 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 132' ' ' GLN . 60.7 mt -72.83 -40.46 65.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.411 ' HB3' ' NH1' ' A' ' 133' ' ' ARG . 50.5 mt-30 -37.4 -41.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.411 ' NH1' ' HB3' ' A' ' 132' ' ' GLN . 12.8 mmp_? -100.49 -60.33 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.535 ' HG3' ' CE2' ' A' ' 130' ' ' TYR . 16.2 mm-40 -38.73 -52.99 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.72 152.11 46.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.36 -51.53 5.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.8 m -48.73 -60.95 2.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.957 0.408 . . . . 0.0 110.918 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.532 ' CD2' ' CG ' ' A' ' 91' ' ' ASP . 1.3 pt? -104.56 -36.99 7.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.5 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -121.46 174.0 7.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.955 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.415 ' CB ' ' HB1' ' A' ' 34' ' ' ALA . 89.0 p -172.84 171.17 4.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.505 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 5.3 mt-10 -106.44 159.9 28.14 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.625 0.726 . . . . 0.0 110.907 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 134.99 29.27 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.339 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.466 HD12 ' CG2' ' A' ' 33' ' ' VAL . 30.6 mm -68.93 122.3 84.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.647 0.737 . . . . 0.0 111.148 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 172.14 13.19 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.707 2.271 . . . . 0.0 112.318 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 24' ' ' SER . 6.4 pt-20 -99.94 -39.04 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.436 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 7.1 t -130.68 137.1 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -132.54 35.96 3.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.81 61.92 1.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.44 -174.36 13.69 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -33.45 16.53 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.653 2.235 . . . . 0.0 112.342 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.3 t -127.66 111.15 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.174 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -59.61 135.96 57.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.5 t -83.84 115.77 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 39.1 t -113.17 121.24 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.114 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 21' ' ' ILE . 4.5 m -114.13 148.14 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.154 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -33.88 -45.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -54.45 -50.21 68.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.859 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.463 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 9.5 p-10 -109.23 33.29 4.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.466 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 7.4 t80 -74.9 -48.08 26.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -72.64 -4.61 32.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -90.01 -42.75 10.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.3 mt -99.44 -62.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.171 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.43 HG23 ' CG1' ' A' ' 32' ' ' VAL . 41.1 t -50.2 -62.66 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -61.47 116.9 5.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.415 ' C ' ' HE3' ' A' ' 112' ' ' LYS . 3.3 t-20 -172.75 120.88 0.39 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.446 ' CA ' ' HE3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -106.92 30.34 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.63 -27.09 3.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -138.47 160.13 40.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.46 126.51 31.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.507 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 39.1 t -126.32 152.52 33.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.7 tp -132.4 125.45 30.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 tp -116.06 134.75 58.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.091 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -126.92 115.71 19.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.874 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -90.03 116.24 27.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.55 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 26.9 p90 -116.63 174.73 5.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.15 128.94 23.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.582 0.706 . . . . 0.0 111.136 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -19.14 36.63 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.676 2.251 . . . . 0.0 112.336 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.402 ' CE3' ' HB2' ' A' ' 57' ' ' CYS . 3.7 p-90 -101.51 14.87 30.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.402 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 2.0 t -129.19 103.87 7.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -37.41 -39.63 0.54 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.49 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' GLY . 32.7 m170 -36.89 -45.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.768 0.318 . . . . 0.0 110.836 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 64' ' ' GLU . 27.9 p -54.61 -48.07 72.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 58' ' ' GLY . 28.9 mmtt -63.0 -41.93 99.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -67.88 -30.66 70.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.0 tp -92.4 -19.42 22.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.529 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.6 tt0 -43.68 -57.99 5.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.598 0.713 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.77 -28.62 24.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.659 2.239 . . . . 0.0 112.38 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -72.06 -30.17 64.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -93.65 -46.45 7.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.012 0.434 . . . . 0.0 110.94 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 71' ' ' GLY . 14.2 ttmt -44.58 -60.69 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 68' ' ' LYS . 18.6 mt-10 -38.05 -54.66 1.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.466 ' N ' HD21 ' A' ' 124' ' ' LEU . 17.9 tp -49.08 -38.03 23.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.953 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 68' ' ' LYS . . . -58.89 -65.19 3.65 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -64.29 -27.67 69.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.916 0.389 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -69.73 -45.49 68.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.464 HD11 ' CD1' ' A' ' 82' ' ' ILE . 94.9 mt -80.71 3.19 23.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.9 t -54.57 -28.77 48.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.844 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.92 0.18 7.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.958 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.47 99.94 39.39 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.608 0.718 . . . . 0.0 110.866 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -0.16 6.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.361 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -110.56 -34.62 6.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.54 112.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.2 t -109.57 119.35 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.464 ' CD1' HD11 ' A' ' 74' ' ' LEU . 32.1 mm -93.29 117.47 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.4 ' CB ' HG22 ' A' ' 32' ' ' VAL . . . -128.42 166.18 19.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -134.37 155.77 49.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.938 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.9 ttt -149.24 161.29 42.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.55 ' OD1' ' CZ ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -109.2 119.58 39.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.0 -70.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -47.77 -28.05 2.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.18 -31.1 16.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 8.0 m-80 -131.1 102.18 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.532 ' CG ' ' CD2' ' A' ' 16' ' ' LEU . 9.5 t0 -41.16 122.89 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 92.2 t -82.04 121.67 79.16 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.661 0.744 . . . . 0.0 111.086 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.74 -167.21 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.717 2.278 . . . . 0.0 112.365 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.5 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -109.11 160.05 28.94 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.749 . . . . 0.0 110.833 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.509 ' O ' ' C ' ' A' ' 96' ' ' TYR . 53.5 Cg_endo -69.74 -20.18 10.85 Favored 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.634 -1.819 . . . . 0.0 112.373 -0.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.509 ' C ' ' O ' ' A' ' 95' ' ' PRO . 84.5 m-85 -28.55 113.36 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -122.87 85.85 2.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.8 t -77.2 120.57 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.0 mmm-85 -122.05 -48.12 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.12 130.11 7.87 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.506 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -102.42 156.09 35.7 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.658 0.742 . . . . 0.0 110.886 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.66 143.92 75.0 Favored 'Cis proline' 0 C--O 1.231 0.151 0 C-N-CA 122.713 -1.786 . . . . 0.0 112.338 -0.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 80.1 m -114.33 127.74 56.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.174 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.437 HG21 ' N ' ' A' ' 105' ' ' TYR . 17.5 mt -120.18 135.91 58.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.165 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.437 ' N ' HG21 ' A' ' 104' ' ' ILE . 9.4 m-85 -134.26 169.99 16.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 31.1 t80 -139.5 131.72 28.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.8 t -101.65 97.98 8.77 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.618 0.723 . . . . 0.0 110.842 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.434 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.79 169.29 19.29 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.718 2.279 . . . . 0.0 112.329 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.62 126.49 36.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 64.59 26.48 13.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.434 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.3 mtmm -131.78 26.5 4.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.482 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -47.42 -57.94 4.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.1 mp -39.38 -41.99 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.936 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -134.39 99.45 13.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.652 0.739 . . . . 0.0 110.874 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -164.29 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.672 2.248 . . . . 0.0 112.337 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 106' ' ' PHE . 15.4 mmtm -133.34 118.21 18.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -88.52 148.49 24.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.941 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -94.84 108.42 20.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.942 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -118.68 92.43 3.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.46 -143.74 4.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.454 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.01 142.83 16.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.468 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -82.01 41.71 0.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 110.846 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 124' ' ' LEU . 16.4 tp10 -98.06 129.68 44.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.466 HD21 ' N ' ' A' ' 70' ' ' LEU . 2.7 tm? -34.91 -56.55 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 64.7 p -57.62 -47.36 82.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.07 -32.61 22.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.461 ' CB ' HD12 ' A' ' 70' ' ' LEU . 52.2 m-85 -74.5 -39.3 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.9 mt -64.64 -65.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -54.08 -31.04 50.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.428 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 49.1 t80 -60.4 -47.91 84.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 48.7 mt -73.72 -39.17 64.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -38.66 -38.65 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -102.29 -51.04 3.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.428 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 5.2 mm-40 -51.54 -57.16 9.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.72 150.26 41.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.75 -50.98 10.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.2 m -75.87 49.31 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.525 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.9 p90 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.94 0.4 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.473 HD13 ' CB ' ' A' ' 17' ' ' LYS . 4.0 pp -106.28 -44.23 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.473 ' CB ' HD13 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -112.48 152.54 28.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.448 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 3.3 m -162.86 166.57 23.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.852 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.419 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.1 mm-40 -105.3 162.27 20.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.672 0.748 . . . . 0.0 110.841 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.419 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 54.2 Cg_endo -69.75 143.47 50.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.736 2.291 . . . . 0.0 112.331 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.418 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 12.4 mm -69.08 135.1 89.42 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.639 0.733 . . . . 0.0 111.125 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 53.3 Cg_endo -69.79 174.66 9.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.671 2.247 . . . . 0.0 112.303 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.6 -38.11 5.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 t -135.18 116.62 14.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -114.63 43.29 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.58 51.01 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.65 -176.83 16.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.517 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -42.21 3.57 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.692 2.261 . . . . 0.0 112.367 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.5 t -113.03 107.79 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.104 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -60.41 130.39 46.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.8 t -80.31 121.87 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.154 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.439 ' CG2' ' HB1' ' A' ' 83' ' ' ALA . 40.6 t -114.71 120.37 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.178 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 36' ' ' ASN . 18.6 m -111.69 142.88 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -33.49 -37.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 33' ' ' VAL . 9.4 mt-10 -60.52 -48.26 82.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 33' ' ' VAL . 14.5 p-10 -107.56 25.03 11.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.568 ' CD2' HG22 ' A' ' 41' ' ' VAL . 20.2 t80 -65.68 -55.21 18.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.418 ' HA ' ' CG ' ' A' ' 42' ' ' ASN . 6.2 t70 -67.72 -3.91 10.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -92.67 -43.57 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.506 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 14.2 mt -99.19 -52.65 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.179 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.568 HG22 ' CD2' ' A' ' 37' ' ' PHE . 89.3 t -60.79 -61.41 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.436 ' OD1' ' CE1' ' A' ' 37' ' ' PHE . 2.0 m-20 -67.31 123.22 19.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 41' ' ' VAL . 7.6 p30 -175.54 111.88 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.71 33.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -128.04 -30.14 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 34.5 pttt -138.16 166.31 24.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.86 144.86 25.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.42 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 93.1 t -146.58 148.76 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.4 tp -123.81 125.45 44.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.932 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.3 tp -110.83 134.35 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' OE1' ' CG1' ' A' ' 104' ' ' ILE . 3.1 tp10 -127.42 112.83 15.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.406 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 61.0 m-85 -87.21 115.57 24.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.95 171.81 7.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.968 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.13 131.78 23.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -6.24 18.12 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.727 2.285 . . . . 0.0 112.319 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.547 ' CZ2' HG21 ' A' ' 88' ' ' THR . 6.8 p-90 -124.39 25.98 7.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 10.2 t -128.75 112.46 14.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -52.14 -61.55 6.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.493 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -41.54 -37.91 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.838 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 88.7 m -74.35 -34.76 63.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 58' ' ' GLY . 3.8 ttmt -70.29 -35.1 73.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -72.3 -23.34 61.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 64' ' ' GLU . 11.8 tp -85.24 -29.74 24.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.554 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.6 tp10 -36.74 -55.92 1.46 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.658 0.742 . . . . 0.0 110.851 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.8 Cg_endo -69.75 -36.15 11.37 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.675 2.25 . . . . 0.0 112.367 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -66.1 -28.07 68.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -95.3 -38.72 10.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -45.73 -58.8 3.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -43.69 -50.13 7.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.469 ' N ' HD22 ' A' ' 124' ' ' LEU . 17.9 tp -46.09 -37.08 6.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.58 -62.3 6.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.473 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -68.37 -22.9 64.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -72.65 -49.41 31.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.442 HD13 ' CG1' ' A' ' 82' ' ' ILE . 95.0 mt -80.06 2.98 21.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.939 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.4 t -51.02 -24.11 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -86.5 17.13 4.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -110.21 98.11 33.81 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.592 0.71 . . . . 0.0 110.917 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -1.81 9.12 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 0.0 112.339 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -122.08 8.87 9.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 81' ' ' VAL . 98.0 mt -134.72 142.47 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.443 ' N ' HG22 ' A' ' 80' ' ' ILE . 87.1 t -139.12 106.64 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.442 ' CG1' HD13 ' A' ' 74' ' ' LEU . 46.3 mm -83.73 125.92 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.129 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HB1' ' CG2' ' A' ' 32' ' ' VAL . . . -143.35 170.92 14.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.133 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -140.63 154.01 46.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.3 ttt -140.85 142.51 34.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 89' ' ' ALA . 26.7 t0 -91.54 82.28 5.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.465 ' HB1' ' CG2' ' A' ' 92' ' ' VAL . . . -41.4 -48.54 3.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.547 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 19.9 p -57.38 -33.34 67.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.503 ' C ' ' ND2' ' A' ' 90' ' ' ASN . . . -103.31 13.29 34.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.503 ' ND2' ' C ' ' A' ' 89' ' ' ALA . 8.6 m-80 -162.91 107.77 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -44.97 127.65 6.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.465 ' CG2' ' HB1' ' A' ' 87' ' ' ALA . 90.6 t -78.01 122.57 85.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.597 0.713 . . . . 0.0 111.164 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -166.51 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.378 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.481 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -118.85 161.78 34.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.727 . . . . 0.0 110.85 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.2 Cg_endo -69.66 -13.78 12.24 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.679 -1.8 . . . . 0.0 112.373 -0.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.468 ' C ' ' O ' ' A' ' 95' ' ' PRO . 83.2 m-85 -32.09 120.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.941 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -129.68 76.46 1.72 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.4 t -74.41 125.17 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -123.2 -42.28 2.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.2 129.41 6.72 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.452 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.516 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.87 154.84 37.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.678 0.751 . . . . 0.0 110.848 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.1 Cg_endo -69.76 162.2 84.61 Favored 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.669 -1.805 . . . . 0.0 112.348 0.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.4 m -140.95 106.16 5.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.16 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.492 ' CG1' ' OE1' ' A' ' 51' ' ' GLU . 41.4 mt -101.1 123.86 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.485 ' CZ ' ' HE3' ' A' ' 117' ' ' LYS . 10.4 m-85 -123.92 147.05 48.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 24.6 t80 -117.78 133.79 55.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -103.73 94.46 6.26 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.678 0.751 . . . . 0.0 110.897 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.489 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.75 164.8 33.19 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.665 2.243 . . . . 0.0 112.356 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -80.75 139.74 35.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.8 p-10 47.85 25.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.489 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 23.4 mtmt -129.16 19.75 5.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.847 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.468 ' HE3' ' N ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -43.24 -68.28 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.929 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 112' ' ' LYS . 4.5 mm? -33.94 -51.75 0.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -112.16 96.19 33.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.721 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -170.78 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 0.0 112.34 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -138.85 110.1 6.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.485 ' HE3' ' CZ ' ' A' ' 105' ' ' TYR . 30.0 tttt -73.83 156.54 37.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -106.35 96.58 6.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -111.51 102.13 10.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 179.56 -151.31 9.98 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.83 130.91 10.0 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -79.58 44.5 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.323 . . . . 0.0 110.908 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 124' ' ' LEU . 9.8 tt0 -105.66 133.48 50.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 70' ' ' LEU . 2.9 tm? -35.56 -55.79 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 44.8 p -57.9 -46.99 84.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -51.19 -37.13 44.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.448 ' CB ' HD11 ' A' ' 70' ' ' LEU . 61.7 m-85 -69.89 -45.79 66.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 33.7 mt -59.0 -59.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.135 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -60.08 -30.27 69.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 130' ' ' TYR . 3.9 t80 -59.52 -45.63 91.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.927 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 132' ' ' GLN . 19.0 mt -76.02 -43.35 44.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.938 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 131' ' ' LEU . 45.1 mt-30 -36.12 -39.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.435 ' HB3' ' NH1' ' A' ' 133' ' ' ARG . 5.4 ptp180 -99.39 -48.43 4.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.78 -61.57 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -43.24 126.24 4.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.89 -74.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.114 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 t -51.2 -57.14 9.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.51 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.866 0.365 . . . . 0.0 110.94 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.411 ' CD1' ' HB3' ' A' ' 17' ' ' LYS . 3.9 pp -103.17 -41.86 5.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' HB3' ' CD1' ' A' ' 16' ' ' LEU . 18.7 ptmt -130.23 157.96 41.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.7 t -162.08 166.05 26.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.416 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 3.5 mm-40 -105.6 161.7 21.98 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.684 0.754 . . . . 0.0 110.835 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.78 145.34 56.71 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.67 2.247 . . . . 0.0 112.349 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.448 HD13 ' CB ' ' A' ' 35' ' ' GLU . 28.4 mm -68.78 132.04 90.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.62 0.724 . . . . 0.0 111.144 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 175.74 7.71 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.69 2.26 . . . . 0.0 112.386 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 24' ' ' SER . 6.6 pt-20 -108.72 -37.5 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.41 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 85.3 p -129.62 130.14 45.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.891 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -133.77 43.03 2.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 27' ' ' GLY . 2.9 m-20 -72.65 -19.13 61.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -45.54 173.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.505 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -30.13 22.8 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.7 2.266 . . . . 0.0 112.313 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.41 ' CG1' ' HG2' ' A' ' 84' ' ' LYS . 39.8 t -116.84 106.65 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.15 132.16 52.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.1 t -83.11 125.34 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.168 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.462 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 18.0 t -120.79 129.93 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 35' ' ' GLU . 15.0 m -121.86 145.85 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -37.8 -28.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 33' ' ' VAL . 3.9 mt-10 -66.71 -45.06 79.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.469 ' ND2' HD13 ' A' ' 40' ' ' ILE . 39.9 p-10 -119.41 37.45 4.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.524 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 8.3 t80 -71.63 -51.43 23.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.09 -12.33 61.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.41 -41.29 20.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.469 HD13 ' ND2' ' A' ' 36' ' ' ASN . 21.8 mt -99.34 -60.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.524 HG11 ' CZ ' ' A' ' 37' ' ' PHE . 43.6 t -52.82 -62.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -72.74 130.35 40.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -173.55 106.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -83.25 36.27 0.52 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -133.72 -36.43 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -139.08 145.79 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 1.4 m-20 -66.35 135.59 54.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -130.48 145.08 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.136 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.443 HD22 ' CD1' ' A' ' 82' ' ' ILE . 6.7 tp -124.6 118.8 27.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 tp -106.09 137.55 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.25 117.65 22.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -93.23 137.98 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.908 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 3.8 p90 -142.36 171.93 13.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.98 133.03 24.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 111.119 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -0.76 7.41 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 0.0 112.308 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.517 ' CZ2' HG23 ' A' ' 88' ' ' THR . 2.4 p-90 -128.63 24.41 5.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.0 t -120.31 110.81 17.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -40.87 -58.5 2.65 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.464 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.469 ' C ' ' O ' ' A' ' 58' ' ' GLY . 3.7 t-160 -32.98 -62.49 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 110.839 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' GLU . 3.9 t -40.15 -49.81 2.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.886 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -56.77 -48.88 76.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -70.76 -21.95 62.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.29 -19.99 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.521 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.1 tt0 -43.32 -57.91 4.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 0.0 110.938 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.5 Cg_endo -69.78 -33.38 16.63 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.693 2.262 . . . . 0.0 112.335 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -66.37 -32.23 73.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 68' ' ' LYS . 31.7 t80 -89.22 -47.77 7.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 67' ' ' TYR . 14.8 ttmt -37.75 -60.15 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -38.78 -59.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.471 ' N ' HD21 ' A' ' 124' ' ' LEU . 24.5 tp -41.99 -36.99 1.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.2 -69.14 1.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.459 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -64.58 -23.01 67.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -71.51 -39.97 70.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.475 HD11 ' CG1' ' A' ' 82' ' ' ILE . 85.1 mt -88.58 3.16 51.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 t -55.15 -31.73 61.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' A' ' 76' ' ' LYS . 25.5 ttpt -73.0 1.47 8.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -102.5 100.07 14.92 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.88 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 0.46 5.65 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.64 2.226 . . . . 0.0 112.34 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -111.69 -41.36 4.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 63.0 mt -90.74 138.09 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.9 t -133.94 113.5 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.475 ' CG1' HD11 ' A' ' 74' ' ' LEU . 39.6 mm -82.45 131.97 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.454 ' CB ' HG21 ' A' ' 32' ' ' VAL . . . -143.63 170.97 14.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.088 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.41 ' HG2' ' CG1' ' A' ' 29' ' ' VAL . 12.4 pttp -143.07 154.39 43.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.9 ttt -150.08 133.36 16.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -85.28 76.52 10.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -35.71 -61.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.06 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.517 HG23 ' CZ2' ' A' ' 56' ' ' TRP . 43.9 p -32.26 -41.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.136 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.66 -31.14 13.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.094 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 87' ' ' ALA . 35.9 m-80 -111.14 101.54 10.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -43.58 123.8 3.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.473 ' CG2' ' HB2' ' A' ' 87' ' ' ALA . 73.1 t -66.66 129.2 94.11 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.572 0.701 . . . . 0.0 111.172 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -163.53 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.625 2.217 . . . . 0.0 112.383 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.492 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -131.41 160.85 65.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.649 0.738 . . . . 0.0 110.828 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.1 Cg_endo -69.82 -4.55 8.45 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.706 -1.789 . . . . 0.0 112.304 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.439 ' C ' ' O ' ' A' ' 95' ' ' PRO . 65.9 m-85 -34.55 127.44 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.63 116.08 18.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.416 HG21 ' CG2' ' A' ' 103' ' ' THR . 57.9 t -123.64 115.94 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.88 -47.0 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.855 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.19 130.42 8.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.5 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.521 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -99.08 155.81 36.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.692 0.758 . . . . 0.0 110.875 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.2 Cg_endo -69.68 163.16 82.34 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.375 -0.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.416 ' CG2' HG21 ' A' ' 98' ' ' VAL . 26.5 m -142.36 106.29 4.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.2 mt -95.5 142.8 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -134.52 179.14 6.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' LYS . 19.3 t80 -147.75 135.49 20.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 33.8 t -104.72 94.62 7.59 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.696 0.76 . . . . 0.0 110.814 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.464 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.74 159.68 52.52 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.67 2.247 . . . . 0.0 112.38 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.38 130.82 34.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.125 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 64.71 24.98 12.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.464 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 14.0 mtmt -131.75 18.31 4.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.42 ' N ' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -44.25 -63.16 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.925 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -39.29 -32.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.408 ' O ' ' O ' ' A' ' 111' ' ' LYS . 1.9 t30 -134.02 98.31 14.48 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.647 0.737 . . . . 0.0 110.891 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.462 ' CD ' ' HG2' ' A' ' 95' ' ' PRO . 54.2 Cg_endo -69.75 179.24 3.83 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -134.77 125.18 26.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -90.65 146.22 24.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -83.92 121.87 27.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -122.24 104.09 9.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.91 -170.39 43.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.478 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.74 141.26 26.19 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.508 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.89 47.31 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 110.844 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 124' ' ' LEU . 27.2 tt0 -102.02 129.45 48.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.471 HD21 ' N ' ' A' ' 70' ' ' LEU . 2.4 tm? -33.75 -54.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.7 t -60.74 -47.1 87.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -44.35 -42.02 6.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.456 ' CB ' HD23 ' A' ' 70' ' ' LEU . 62.8 m-85 -68.31 -44.52 75.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.858 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.06 -53.12 52.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 t -65.31 -39.5 92.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.529 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 36.4 t80 -56.71 -53.07 61.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 132' ' ' GLN . 68.3 mt -67.21 -42.9 83.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 131' ' ' LEU . 35.3 mt-30 -36.96 -40.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -99.15 -61.68 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.529 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 11.3 mm-40 -42.2 -54.2 3.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.72 132.0 30.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.58 -75.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.9 t -48.7 -62.07 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.451 179.979 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.486 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.5 p90 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.928 0.394 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.4 HD11 ' C ' ' A' ' 16' ' ' LEU . 3.9 pp -94.79 -39.48 10.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -116.49 156.93 26.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 76.8 p -160.61 149.58 16.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.409 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 10.2 mm-40 -92.53 161.3 32.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.62 0.724 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.74 141.17 44.59 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.372 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.454 HD13 ' CB ' ' A' ' 35' ' ' GLU . 13.3 mm -69.44 130.84 90.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.731 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 160.59 49.13 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.682 2.255 . . . . 0.0 112.369 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.89 -38.65 13.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -141.77 105.3 4.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -122.65 46.56 2.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -87.5 39.48 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.12 -160.57 36.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.476 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -42.84 3.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 0.0 112.362 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.46 ' CG2' ' HA ' ' A' ' 68' ' ' LYS . 10.9 t -116.57 104.72 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -52.83 135.39 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.0 t -84.23 120.69 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.176 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 12.9 t -119.45 115.32 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.117 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 35' ' ' GLU . 27.9 m -111.52 141.71 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -30.44 -38.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 33' ' ' VAL . 6.7 mt-10 -56.3 -51.51 67.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 33' ' ' VAL . 53.1 p-10 -110.48 24.76 12.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.46 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 13.1 t80 -63.19 -51.15 67.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -4.95 18.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.831 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -92.17 -43.84 9.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.3 mt -97.11 -61.16 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.107 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.424 HG23 ' CG1' ' A' ' 32' ' ' VAL . 78.5 t -53.16 -62.17 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -65.46 120.18 12.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.413 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 4.1 t-20 -174.94 119.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' CA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -104.93 32.44 4.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -127.7 -31.22 2.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -138.29 136.95 36.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.81 138.6 53.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.57 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 40.9 t -137.31 159.13 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 106' ' ' PHE . 16.1 tp -140.21 132.17 27.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.923 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 51' ' ' GLU . 3.3 tp -116.21 141.36 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.175 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.545 ' OE2' ' CG ' ' A' ' 67' ' ' TYR . 2.5 tt0 -125.49 118.74 26.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -98.9 108.42 21.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -115.75 -179.15 3.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.73 132.98 21.9 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 0.0 111.085 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 -1.01 7.74 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.535 ' CZ2' HG23 ' A' ' 88' ' ' THR . 2.1 p-90 -126.31 5.79 7.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.3 m -99.89 129.47 45.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.836 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.16 -45.9 14.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.46 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -48.32 -27.72 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.836 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.0 m -80.13 -44.0 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -55.29 -42.33 73.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -70.49 -20.54 62.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 66' ' ' LYS . 8.4 tp -94.22 -23.16 18.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.544 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 5.1 tt0 -33.71 -57.13 0.64 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 0.0 110.914 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.78 -27.29 26.54 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.721 2.281 . . . . 0.0 112.328 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 63' ' ' LEU . 2.7 mmpt? -72.39 -30.97 65.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.545 ' CG ' ' OE2' ' A' ' 51' ' ' GLU . 37.9 t80 -95.97 -40.09 9.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.46 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -55.66 -43.28 76.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -53.54 -53.42 51.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.467 ' N ' HD23 ' A' ' 124' ' ' LEU . 20.3 tp -43.45 -38.35 2.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.08 -64.56 3.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.97 -21.36 66.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.937 0.398 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -79.32 -45.05 20.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ASP . 78.6 mt -84.06 1.64 43.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 m -40.19 -27.94 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -85.0 25.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 74' ' ' LEU . 51.2 p-10 -103.9 93.41 5.29 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.618 0.723 . . . . 0.0 110.863 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 0.58 5.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.334 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -122.91 -44.72 2.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.468 HG21 ' N ' ' A' ' 81' ' ' VAL . 37.0 mt -87.71 144.59 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.468 ' N ' HG21 ' A' ' 80' ' ' ILE . 86.5 t -136.0 107.38 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.179 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.2 mm -76.17 131.44 34.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.426 ' CB ' HG23 ' A' ' 32' ' ' VAL . . . -145.83 173.87 11.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -148.57 157.59 43.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -149.59 148.11 28.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 90' ' ' ASN . 49.8 t0 -97.74 99.65 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.94 80.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.535 HG23 ' CZ2' ' A' ' 56' ' ' TRP . 2.7 p -66.12 -17.27 64.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -117.89 -10.97 10.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.1 m-80 -139.62 107.63 5.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -42.27 138.06 1.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.427 ' CG2' HG22 ' A' ' 98' ' ' VAL . 74.6 t -80.51 128.32 72.83 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.625 0.726 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 54.4 Cg_endo -69.72 -165.64 0.16 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.723 2.282 . . . . 0.0 112.35 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.523 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 0.8 OUTLIER -127.44 154.59 77.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.655 0.741 . . . . 0.0 110.851 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.75 -6.03 9.19 Favored 'Cis proline' 0 N--CA 1.466 -0.13 0 C-N-CA 122.709 -1.788 . . . . 0.0 112.372 0.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.46 ' C ' ' O ' ' A' ' 95' ' ' PRO . 33.1 m-85 -33.01 137.45 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -151.63 120.89 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.843 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.452 HG13 ' CE2' ' A' ' 101' ' ' PHE . 39.7 t -113.42 110.07 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.11 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.8 -45.32 5.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -132.32 132.01 6.48 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.483 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.528 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -96.95 154.86 38.1 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.658 0.742 . . . . 0.0 110.899 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.528 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.0 Cg_endo -69.74 159.51 89.52 Favored 'Cis proline' 0 C--O 1.232 0.191 0 C-N-CA 122.696 -1.793 . . . . 0.0 112.379 0.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.4 m -137.98 111.55 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.147 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.443 HG12 ' CG ' ' A' ' 51' ' ' GLU . 86.9 mt -109.82 131.88 59.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -123.12 -176.38 3.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 29.1 t80 -152.82 132.22 12.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.887 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.2 t -103.6 96.31 8.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.69 0.757 . . . . 0.0 110.895 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.456 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.5 Cg_endo -69.68 168.26 21.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.719 2.279 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.2 135.15 33.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 54.67 25.73 6.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.456 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 10.6 mtmt -129.53 21.59 5.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -49.33 -41.63 39.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.417 HD21 ' N ' ' A' ' 113' ' ' LEU . 4.1 mm? -52.42 -39.7 61.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 6.8 m-80 -134.74 97.97 13.69 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.593 0.711 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 54.3 Cg_endo -69.69 -170.63 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.674 2.249 . . . . 0.0 112.372 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -136.27 139.07 42.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -107.21 137.03 46.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.433 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 62.8 t80 -78.85 107.84 11.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -124.03 95.17 4.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.39 -139.52 3.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.95 128.52 9.18 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -79.7 49.52 1.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.761 0.315 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 124' ' ' LEU . 5.4 tp10 -112.74 132.46 55.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 70' ' ' LEU . 3.5 tm? -34.44 -51.49 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.5 p -63.11 -53.22 56.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.17 -36.53 2.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.433 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 52.8 m-85 -68.91 -43.62 74.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.4 mt -55.89 -63.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.099 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.3 t -54.74 -36.54 64.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.431 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 44.3 t80 -55.18 -50.87 68.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.916 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.3 -42.15 69.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -43.61 -41.44 4.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.43 ' CG ' ' N ' ' A' ' 134' ' ' GLU . 12.9 ptm180 -91.57 -53.06 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.431 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 26.1 mm-40 -51.93 -62.87 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -37.41 105.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.078 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.8 t -49.84 -52.78 29.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.3 t -74.5 -41.51 60.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.465 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.54 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.972 0.415 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -106.3 -33.32 7.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.944 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.444 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 10.7 mtpp -101.57 163.86 12.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.0 p -166.5 134.28 2.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.462 ' CG ' ' HB2' ' A' ' 89' ' ' ALA . 2.4 mm-40 -98.24 161.63 24.75 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.887 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.9 Cg_endo -69.75 140.07 41.8 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.679 2.253 . . . . 0.0 112.336 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.451 HD13 ' CG2' ' A' ' 33' ' ' VAL . 15.8 mm -70.46 123.41 88.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 111.107 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 130.19 18.91 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.671 2.248 . . . . 0.0 112.35 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.21 -46.81 69.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 t -144.96 133.22 21.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -106.7 48.71 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -50.28 -33.16 18.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.07 164.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.445 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -22.99 31.29 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.674 2.249 . . . . 0.0 112.341 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.9 t -119.33 112.19 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -57.89 137.23 56.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.7 t -90.49 116.24 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.133 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 19.6 t -105.98 124.73 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.451 ' CG2' HD13 ' A' ' 21' ' ' ILE . 15.8 m -118.66 148.16 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.444 ' CB ' ' CD2' ' A' ' 15' ' ' TYR . . . -38.1 -36.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.152 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.421 ' CB ' HD11 ' A' ' 21' ' ' ILE . 29.3 mt-10 -62.78 -50.64 70.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.486 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 11.4 p-10 -108.33 28.57 8.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.469 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 5.5 t80 -67.51 -55.78 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.835 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -66.11 -5.26 9.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -88.42 -43.11 11.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.465 HD11 ' ND2' ' A' ' 36' ' ' ASN . 18.1 mt -98.35 -54.14 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.127 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.09 -61.58 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -67.44 112.67 4.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.412 ' ND2' ' HE2' ' A' ' 46' ' ' LYS . 13.4 t-20 -173.23 105.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.85 4.64 47.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -90.69 -35.03 15.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HE2' ' ND2' ' A' ' 43' ' ' ASN . 45.9 pttt -138.52 151.95 47.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.9 136.1 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.61 136.01 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.127 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.8 tp -116.11 119.24 35.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.4 ' O ' ' O ' ' A' ' 105' ' ' TYR . 2.3 tp -106.81 134.88 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.166 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -127.21 120.08 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -95.87 122.47 38.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CE1' ' OD1' ' A' ' 86' ' ' ASP . 13.1 p90 -124.4 -179.6 4.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.927 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.63 133.48 21.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.565 0.698 . . . . 0.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -6.28 18.2 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.687 2.258 . . . . 0.0 112.347 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.465 ' CZ2' HG23 ' A' ' 88' ' ' THR . 2.1 p-90 -122.89 21.92 9.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t -120.2 111.14 17.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.06 -47.71 6.43 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -46.68 -37.25 8.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.771 0.32 . . . . 0.0 110.858 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.403 ' SG ' ' CD1' ' A' ' 53' ' ' TYR . 34.7 t -63.46 -44.5 94.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.908 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -65.5 -42.16 92.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -72.68 -35.0 67.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 64' ' ' GLU . 14.0 tp -81.97 -26.77 33.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.516 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.3 tt0 -38.08 -58.1 1.54 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.608 0.718 . . . . 0.0 110.926 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.7 Cg_endo -69.82 -31.11 20.91 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.625 2.217 . . . . 0.0 112.332 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.41 ' NZ ' ' OE2' ' A' ' 123' ' ' GLU . 29.0 mtpt -68.63 -30.0 68.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -92.42 -45.21 8.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.933 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -41.65 -58.96 1.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.947 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 70' ' ' LEU . 16.4 mt-10 -41.07 -61.64 0.96 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.459 ' N ' HD21 ' A' ' 124' ' ' LEU . 22.2 tp -38.06 -35.63 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.35 -68.77 1.52 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.494 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -66.08 -19.69 65.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -75.28 -41.38 57.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.467 HD13 ' CG1' ' A' ' 82' ' ' ILE . 92.6 mt -86.46 3.35 44.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.2 t -54.07 -34.46 60.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -6.23 5.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 5.9 t70 -102.83 100.37 16.4 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.629 0.728 . . . . 0.0 110.873 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.7 Cg_endo -69.79 0.78 5.18 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.706 2.271 . . . . 0.0 112.346 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -110.46 -34.81 6.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.8 mt -93.43 126.98 45.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.09 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 84.1 t -124.47 110.92 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.125 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.467 ' CG1' HD13 ' A' ' 74' ' ' LEU . 49.9 mm -82.99 123.7 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.142 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.466 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . . . -133.75 161.47 34.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -134.65 150.43 50.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.455 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 10.7 ttt -141.45 140.12 33.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 53' ' ' TYR . 7.6 t0 -95.41 91.16 6.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.804 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -45.0 -49.18 11.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.1 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.465 HG23 ' CZ2' ' A' ' 56' ' ' TRP . 1.2 p -55.73 -28.56 56.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.14 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.462 ' HB2' ' CG ' ' A' ' 19' ' ' GLU . . . -94.05 -12.43 28.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.455 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.5 OUTLIER -157.26 123.54 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -57.38 135.91 56.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.9 t -82.95 128.19 66.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.628 0.728 . . . . 0.0 111.087 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.663 2.242 . . . . 0.0 112.351 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.481 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 m -115.73 162.0 27.58 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.712 0.768 . . . . 0.0 110.84 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.78 -10.83 11.73 Favored 'Cis proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 -1.795 . . . . 0.0 112.319 0.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 95' ' ' PRO . 98.0 m-85 -35.25 133.9 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -141.83 118.56 11.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.4 t -120.96 116.11 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.093 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -118.14 -44.64 2.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.34 123.42 5.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.509 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.523 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -98.31 154.89 37.43 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.674 0.75 . . . . 0.0 110.864 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.2 Cg_endo -69.74 162.08 84.8 Favored 'Cis proline' 0 C--O 1.231 0.162 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.327 -0.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.3 m -139.99 125.45 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.446 HG21 ' N ' ' A' ' 105' ' ' TYR . 22.8 mt -116.25 138.57 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.523 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 8.8 m-85 -134.54 162.66 31.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.946 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -133.5 136.33 45.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 t -104.47 93.02 5.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.882 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.495 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.3 Cg_endo -69.68 151.87 69.6 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.59 145.46 52.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.4 p30 44.83 25.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.495 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 24.9 mtmt -130.4 41.28 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -66.06 -51.37 58.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.862 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.421 ' CD2' ' H ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -48.19 -49.08 34.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -122.32 91.79 49.1 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 -163.8 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.661 2.241 . . . . 0.0 112.362 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -145.6 132.42 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.523 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 17.2 ttpt -98.8 137.34 37.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -73.14 104.69 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -116.97 98.42 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.88 -144.63 6.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.452 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.53 130.73 10.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.503 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 -79.57 45.5 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.745 0.307 . . . . 0.0 110.866 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.41 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 5.1 tp10 -106.42 132.83 51.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.459 HD21 ' N ' ' A' ' 70' ' ' LEU . 3.2 tm? -37.37 -52.51 1.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.1 m -61.69 -43.04 99.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -51.78 -42.11 62.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -63.18 -40.59 97.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mt -60.16 -61.73 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.3 t -56.26 -32.57 64.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.504 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 20.8 t80 -57.9 -58.48 8.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.0 -39.1 92.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -41.32 -40.87 1.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.1 ptp180 -102.9 -38.11 7.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 71.6 mm-40 -67.03 -60.94 2.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -44.47 132.35 6.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.088 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.42 -75.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 t -49.73 -56.69 9.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.527 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.932 0.396 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 pp -116.36 -36.93 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.929 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.489 ' HG2' ' N ' ' A' ' 18' ' ' SER . 6.6 ttpm? -119.78 163.25 17.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.489 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 85.7 p -165.12 155.57 13.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.428 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 4.4 mm-40 -103.3 162.23 20.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.652 0.739 . . . . 0.0 110.884 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.428 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.74 143.4 50.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 0.0 112.33 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.3 mm -70.04 132.56 88.32 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.722 . . . . 0.0 111.12 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 142.77 48.69 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.721 2.281 . . . . 0.0 112.347 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.25 -36.44 61.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.901 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 p -119.99 113.92 21.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.879 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.407 ' CG ' ' HD2' ' A' ' 30' ' ' LYS . 10.1 t-20 -125.11 47.0 2.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -111.11 61.74 0.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.15 -165.22 11.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.448 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -40.94 4.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.684 2.256 . . . . 0.0 112.35 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.6 108.9 23.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.407 ' HD2' ' CG ' ' A' ' 25' ' ' ASN . 1.5 mmmt -59.35 136.38 57.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.3 t -84.65 125.01 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 31.3 t -119.38 119.61 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 36' ' ' ASN . 18.1 m -115.54 148.11 18.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.088 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -35.31 -38.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.111 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -59.71 -48.93 79.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.449 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 14.8 p-10 -111.44 30.16 7.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.569 ' CZ ' ' HG3' ' A' ' 93' ' ' PRO . 15.4 t80 -68.48 -62.55 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.43 -8.8 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.56 -46.57 11.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.406 HD12 ' ND2' ' A' ' 36' ' ' ASN . 17.5 mt -97.46 -50.37 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' A' ' 37' ' ' PHE . 29.5 t -58.06 -60.88 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.104 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -76.16 125.34 28.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -169.13 105.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.28 -1.75 28.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -85.52 -46.63 10.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.01 166.62 23.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -83.12 151.0 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.41 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 9.3 t -141.82 149.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.155 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.43 HD22 ' CD1' ' A' ' 82' ' ' ILE . 6.4 tp -122.84 120.01 32.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.3 tp -107.4 137.11 40.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.49 ' OE1' ' CG1' ' A' ' 104' ' ' ILE . 3.7 tp10 -127.34 107.42 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.909 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.402 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 39.7 m-85 -83.82 126.62 33.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.442 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 9.6 p90 -132.87 176.0 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.893 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.03 133.07 24.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.713 . . . . 0.0 111.073 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -4.09 13.33 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.355 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.564 ' CZ2' HG21 ' A' ' 88' ' ' THR . 6.0 p-90 -123.56 17.7 9.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 43.6 t -116.09 100.63 8.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -41.3 -51.1 4.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 58' ' ' GLY . 97.2 m-70 -37.4 -38.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.762 0.315 . . . . 0.0 110.855 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 64' ' ' GLU . 6.2 t -69.33 -51.34 37.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.52 -53.1 19.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -64.95 -18.09 64.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.8 tp -97.25 -18.41 19.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.946 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.574 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.5 tp10 -45.32 -55.12 12.44 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.69 0.757 . . . . 0.0 110.915 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.1 Cg_endo -69.83 -24.64 29.14 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 0.0 112.283 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.443 ' NZ ' ' O ' ' A' ' 122' ' ' ARG . 1.0 OUTLIER -76.99 -33.25 57.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -90.0 -31.94 16.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -53.81 -56.49 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.914 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -41.98 -56.81 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.458 ' N ' HD21 ' A' ' 124' ' ' LEU . 37.7 tp -41.14 -40.52 1.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.87 -69.09 1.4 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.496 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -59.36 -20.3 53.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.926 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -76.78 -46.56 24.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 77' ' ' ASP . 96.8 mt -86.65 1.98 50.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -48.75 -22.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.02 22.91 4.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 72.6 m-20 -108.63 99.24 32.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.657 0.742 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.4 Cg_endo -69.66 -0.82 7.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 0.0 112.36 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -117.62 -36.78 3.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.45 129.0 51.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.4 t -124.35 109.99 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.43 ' CD1' HD22 ' A' ' 49' ' ' LEU . 27.2 mm -80.36 133.57 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.146 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -147.65 169.12 20.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -136.4 153.16 51.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.4 ttt -146.46 135.72 22.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.442 ' OD1' ' CZ ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -91.76 83.88 5.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.876 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -43.16 -55.95 3.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.564 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 33.7 p -46.95 -32.39 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.168 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.38 -19.82 21.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.61 122.49 17.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -51.6 130.84 28.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.469 ' CG2' ' HB3' ' A' ' 87' ' ' ALA . 95.7 t -72.81 131.83 83.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.589 0.709 . . . . 0.0 111.108 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.569 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.7 Cg_endo -69.81 -168.43 0.28 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.665 2.243 . . . . 0.0 112.371 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -129.6 161.22 60.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.661 0.744 . . . . 0.0 110.828 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.9 Cg_endo -69.71 -3.11 7.43 Favored 'Cis proline' 0 C--N 1.341 0.182 0 C-N-CA 122.69 -1.796 . . . . 0.0 112.361 -0.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.462 ' N ' ' HA ' ' A' ' 94' ' ' SER . 83.6 m-85 -33.77 127.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -131.7 102.42 5.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 74.8 t -105.82 115.5 47.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -114.65 -47.41 2.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.94 127.61 7.5 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.488 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.529 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -100.06 154.95 36.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 0.0 110.867 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.7 Cg_endo -69.75 157.9 91.53 Favored 'Cis proline' 0 C--O 1.231 0.166 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.369 -0.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.6 m -133.1 101.84 5.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.544 HD12 ' CE1' ' A' ' 127' ' ' PHE . 82.6 mt -95.18 125.55 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 7.8 m-85 -122.02 -176.98 3.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 41.6 t80 -150.91 136.25 17.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.8 t -105.52 92.42 5.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.78 155.63 65.38 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.668 2.246 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.89 128.55 33.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 67.43 25.02 8.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.478 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 14.0 mtmt -134.38 56.02 1.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 114' ' ' ASN . 31.4 mmtt -80.11 -56.27 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.9 mp -37.8 -28.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 112' ' ' LYS . 12.6 m120 -148.71 107.63 3.5 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.912 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.471 ' CD ' ' HG2' ' A' ' 95' ' ' PRO . 53.4 Cg_endo -69.77 -174.97 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.72 2.28 . . . . 0.0 112.336 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.2 120.82 29.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HB2' ' CE1' ' A' ' 105' ' ' TYR . 13.2 ttmm -94.38 130.19 40.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -76.71 111.52 12.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -124.68 98.23 5.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.53 -137.84 2.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.38 126.96 8.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.443 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 63.9 mtm-85 -78.92 45.47 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 110.863 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -101.97 138.56 38.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.458 HD21 ' N ' ' A' ' 70' ' ' LEU . 3.4 tm? -42.3 -51.3 4.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.7 p -70.59 -32.16 69.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -61.89 -34.65 76.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.544 ' CE1' HD12 ' A' ' 104' ' ' ILE . 31.0 m-85 -71.19 -35.21 71.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.2 mt -68.43 -52.01 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -63.75 -26.03 68.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -69.24 -47.68 64.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.923 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 133' ' ' ARG . 17.6 mt -77.0 -42.65 37.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.916 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' LEU . 15.1 mt-30 -37.48 -31.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 131' ' ' LEU . 22.2 mmm180 -104.1 -53.81 2.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -50.01 -58.5 5.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -38.77 116.64 0.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -33.91 -75.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -73.33 -55.31 6.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.464 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.6 p90 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.953 0.406 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 17' ' ' LYS . 2.9 pp -105.51 -41.24 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.434 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.9 tttp -96.78 160.83 14.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 93.0 p -168.2 150.16 5.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.834 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.493 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 8.7 mm-40 -104.52 161.53 22.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.64 0.733 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.71 142.88 49.36 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.723 2.282 . . . . 0.0 112.337 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.456 HD12 ' CB ' ' A' ' 35' ' ' GLU . 40.7 mm -72.56 129.14 87.5 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.627 0.727 . . . . 0.0 111.151 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 169.87 17.87 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -88.95 -37.11 15.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -156.34 134.81 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.439 ' CB ' ' HD3' ' A' ' 30' ' ' LYS . 41.1 m-20 -111.39 47.75 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -52.19 -33.22 39.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -41.99 166.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.32 36.42 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.698 2.265 . . . . 0.0 112.304 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.89 117.78 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.144 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 10.0 mmtm -64.99 132.57 49.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.898 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.9 t -86.51 102.8 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.139 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 40.4 t -95.95 127.18 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.145 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 36' ' ' ASN . 27.1 m -123.08 146.25 28.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -31.71 -44.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.09 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.456 ' CB ' HD12 ' A' ' 21' ' ' ILE . 23.9 mt-10 -53.71 -50.77 65.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 33' ' ' VAL . 12.1 p-10 -112.26 33.92 4.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.557 ' CD2' HG21 ' A' ' 41' ' ' VAL . 14.1 t80 -74.33 -58.46 3.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -62.53 -8.79 6.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.45 -43.9 11.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.419 HD13 ' ND2' ' A' ' 36' ' ' ASN . 21.4 mt -98.78 -52.99 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.557 HG21 ' CD2' ' A' ' 37' ' ' PHE . 45.8 t -57.01 -61.94 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.51 115.75 11.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -160.73 105.04 1.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -84.71 8.68 16.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -104.49 -43.44 5.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -129.64 159.8 35.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -78.51 148.08 33.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.1 t -146.54 122.36 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.121 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.0 tp -99.0 116.33 30.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 tp -105.25 130.75 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.08 115.35 21.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -89.68 116.6 27.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.54 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 18.6 p90 -121.6 171.6 8.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.966 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 56' ' ' TRP . . . -126.71 130.74 23.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.593 0.711 . . . . 0.0 111.104 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -8.52 23.8 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.479 ' CE2' ' HB1' ' A' ' 54' ' ' ALA . 2.2 p-90 -112.82 7.9 18.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.2 t -107.92 130.62 55.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.25 -52.6 39.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.551 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -37.81 -39.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -64.93 -55.66 17.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -42.55 -47.11 5.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -73.1 -23.4 60.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 60' ' ' CYS . 41.6 tp -87.9 -18.42 29.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.518 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -46.84 -58.29 7.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.642 0.734 . . . . 0.0 110.872 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.2 Cg_endo -69.76 -31.91 19.61 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.699 2.266 . . . . 0.0 112.351 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -68.2 -32.29 72.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.415 ' O ' ' C ' ' A' ' 68' ' ' LYS . 42.1 t80 -89.76 -50.41 6.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.87 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 67' ' ' TYR . 12.1 ttmt -36.9 -61.63 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -40.98 -56.66 2.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.846 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.469 ' N ' HD21 ' A' ' 124' ' ' LEU . 19.1 tp -42.48 -36.82 1.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -55.99 -69.05 1.39 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.45 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -66.88 -23.34 65.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.382 . . . . 0.0 110.874 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -67.44 -45.46 75.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.0 mt -85.82 3.74 40.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.5 p -52.4 -29.79 25.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -62.13 -7.57 4.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -103.57 101.08 21.58 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.619 0.723 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 1.67 4.22 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.338 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.476 ' C ' ' OD1' ' A' ' 47' ' ' ASP . 78.1 m-20 -113.55 -39.92 3.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.9 mt -84.79 106.49 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.124 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.9 t -99.79 116.28 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.138 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.7 mm -91.41 119.68 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.143 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 30' ' ' LYS . . . -133.37 175.83 9.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.112 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -146.62 139.5 25.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.458 ' CE ' ' HB2' ' A' ' 90' ' ' ASN . 1.8 tmm? -134.5 149.83 50.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.54 ' OD1' ' CZ ' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -100.93 96.16 7.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.813 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -43.73 -66.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -40.69 -29.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.77 -30.67 16.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 15.8 m-80 -130.81 119.75 22.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.827 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -57.86 118.94 5.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.6 t -72.72 116.58 51.41 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.575 0.702 . . . . 0.0 111.134 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.7 Cg_endo -69.78 -172.08 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.65 2.233 . . . . 0.0 112.378 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -105.45 159.71 28.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.618 0.723 . . . . 0.0 110.858 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.6 Cg_endo -69.79 -20.85 10.59 Favored 'Cis proline' 0 C--O 1.232 0.177 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.297 0.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.482 ' C ' ' O ' ' A' ' 95' ' ' PRO . 93.6 m-85 -30.64 131.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.955 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.455 ' OE1' ' CZ ' ' A' ' 99' ' ' ARG . 13.7 mm-40 -141.92 119.27 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.9 t -117.71 107.3 21.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.147 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.455 ' CZ ' ' OE1' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -125.41 33.1 5.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.59 113.66 0.29 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.523 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -97.72 155.09 37.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.664 0.745 . . . . 0.0 110.871 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.7 Cg_endo -69.79 145.54 79.79 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.651 -1.812 . . . . 0.0 112.334 0.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.8 m -122.57 124.29 43.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 105' ' ' TYR . 27.7 mt -120.26 134.64 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.158 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.439 ' N ' HG22 ' A' ' 104' ' ' ILE . 10.8 m-85 -134.07 161.1 35.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -136.59 126.08 25.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 5.7 p -99.87 102.93 19.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.716 0.769 . . . . 0.0 110.815 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.491 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.4 Cg_endo -69.76 167.85 23.25 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.679 2.253 . . . . 0.0 112.352 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.448 ' O ' ' CE ' ' A' ' 111' ' ' LYS . . . -78.37 140.75 38.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.8 29.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.491 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.1 mtmt -130.36 48.44 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.461 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 6.5 mmpt? -70.81 -57.57 4.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 112' ' ' LYS . 54.9 mt -35.74 -43.09 0.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -132.61 95.67 19.78 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.651 0.739 . . . . 0.0 110.871 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -164.44 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.719 2.28 . . . . 0.0 112.307 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -145.5 117.55 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.944 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -89.3 137.98 31.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.912 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.63 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 82.8 t80 -70.48 118.26 13.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -125.7 100.39 6.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.01 -155.38 25.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.18 139.58 22.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.472 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -82.5 52.84 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.84 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.414 ' HB3' ' CG ' ' A' ' 126' ' ' ASP . 13.0 tt0 -108.59 141.03 41.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.469 HD21 ' N ' ' A' ' 70' ' ' LEU . 3.5 tm? -44.73 -50.93 9.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.7 p -69.8 -42.25 73.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.414 ' CG ' ' HB3' ' A' ' 123' ' ' GLU . 3.8 m-20 -49.44 -34.71 17.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.63 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 65.1 m-85 -73.03 -44.87 60.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.6 mt -57.21 -48.64 81.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.8 p -62.58 -46.94 85.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.513 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 5.1 t80 -56.03 -44.84 79.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.949 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.3 mt -72.56 -41.2 65.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -38.09 -40.49 0.49 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -97.84 -57.28 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 39.5 mm-40 -45.45 -58.71 3.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.65 153.71 27.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.088 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.05 -50.1 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 84.8 p -47.31 -54.93 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.824 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 m -115.53 89.5 3.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.902 0.382 . . . . 0.0 110.856 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.3 p -171.52 168.0 6.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.25 116.59 2.02 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.524 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 m -104.24 94.91 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.876 0.37 . . . . 0.0 110.893 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.2 t -47.37 -49.98 23.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.27 -157.03 49.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.504 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.427 ' O ' ' CG ' ' A' ' 9' ' ' ASP . 11.7 t80 -170.39 133.14 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 0.0 110.838 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 8' ' ' PHE . 39.4 m-20 -166.16 122.03 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.92 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.86 46.01 0.66 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.479 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 43.78 52.4 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.13 95.18 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.439 ' O ' ' CE ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -160.07 163.32 34.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.4 tpt85 -163.58 138.36 6.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 2.6 p90 -157.7 151.98 24.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 pp -108.56 -35.43 6.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 17.5 ttpt -110.61 154.27 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.8 m -159.75 143.94 14.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.2 mm-40 -89.97 161.56 37.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 0.0 110.888 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.9 Cg_endo -69.75 141.49 45.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.658 2.239 . . . . 0.0 112.343 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 36.1 mm -69.91 132.17 88.81 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.698 . . . . 0.0 111.15 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 142.02 47.07 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.681 2.254 . . . . 0.0 112.348 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -61.3 -32.38 72.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -166.35 133.99 2.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -110.75 54.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -81.43 58.13 3.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.63 -168.51 11.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.514 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.454 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 53.4 Cg_endo -69.75 -48.81 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.716 2.277 . . . . 0.0 112.355 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.81 127.6 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -73.08 134.79 44.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -84.63 113.25 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.147 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.477 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 22.0 t -109.35 117.92 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.12 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -110.64 152.05 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.163 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -41.03 -34.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -64.51 -45.81 85.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 29.3 p30 -114.11 34.5 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.569 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 6.4 t80 -73.6 -56.99 4.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -66.99 -4.81 10.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -89.47 -42.94 11.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.5 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 18.2 mt -98.94 -46.42 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.569 HG11 ' CZ ' ' A' ' 37' ' ' PHE . 97.2 t -65.0 -62.12 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -67.8 113.98 6.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 40' ' ' ILE . 4.9 p30 -175.25 106.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.39 2.73 27.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -84.79 -43.53 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -135.31 150.64 50.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.36 148.29 41.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.7 t -146.85 144.36 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.437 HD23 ' CD1' ' A' ' 82' ' ' ILE . 14.5 tp -117.92 119.15 33.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.556 HG12 ' CE1' ' A' ' 52' ' ' PHE . 2.2 tp -101.46 129.78 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -119.53 111.45 18.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.556 ' CE1' HG12 ' A' ' 50' ' ' ILE . 34.7 m-85 -88.61 130.73 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -138.59 -175.12 4.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.529 ' HB2' ' CZ2' ' A' ' 56' ' ' TRP . . . -142.43 133.74 12.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.605 0.716 . . . . 0.0 111.098 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -25.44 28.84 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.711 2.274 . . . . 0.0 112.345 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.529 ' CZ2' ' HB2' ' A' ' 54' ' ' ALA . 2.2 p-90 -84.54 -28.13 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.6 t -68.73 138.5 54.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.91 -35.06 7.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.45 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -71.58 -26.77 62.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.885 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.3 m -83.37 -37.3 23.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -62.39 -45.41 93.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -60.85 -9.53 4.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 66' ' ' LYS . 11.9 tp -97.34 -22.53 16.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -34.6 -58.21 0.68 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.675 0.75 . . . . 0.0 110.887 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.5 Cg_endo -69.73 -24.57 29.65 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.715 2.276 . . . . 0.0 112.294 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 63' ' ' LEU . 1.6 mmmp? -75.27 -27.04 59.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 63.6 t80 -94.8 -39.7 10.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.886 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HG3' ' CG ' ' A' ' 28' ' ' PRO . 5.6 ttmm -46.22 -59.49 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.898 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -38.84 -60.15 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.472 ' N ' HD23 ' A' ' 124' ' ' LEU . 17.4 tp -38.39 -42.04 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.93 -58.74 12.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.515 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -70.5 -20.98 62.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 0.0 110.926 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -72.56 -46.31 55.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.0 mt -78.26 3.12 16.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.9 p -50.3 -25.0 3.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.835 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -79.09 11.62 2.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.922 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 4.6 t0 -117.82 97.95 51.2 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.566 0.698 . . . . 0.0 110.897 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.0 Cg_endo -69.72 -1.08 7.82 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.739 2.293 . . . . 0.0 112.311 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -109.77 -37.19 5.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.441 HD13 ' CB ' ' A' ' 135' ' ' ALA . 46.6 mt -93.8 133.26 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.078 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.3 t -129.74 117.33 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.437 ' CD1' HD23 ' A' ' 49' ' ' LEU . 50.1 mm -86.39 134.77 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.114 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' CB ' HG21 ' A' ' 32' ' ' VAL . . . -147.26 167.16 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -135.67 155.02 51.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.4 ' SD ' ' OD1' ' A' ' 90' ' ' ASN . 0.8 OUTLIER -148.87 132.05 16.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.899 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -84.83 94.96 8.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.87 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.04 -62.62 1.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.63 -35.06 12.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.421 ' C ' ' HE3' ' A' ' 17' ' ' LYS . . . -80.78 -22.21 40.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.12 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -150.44 123.31 8.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -47.55 148.13 1.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.43 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 93.3 t -100.2 137.75 20.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.626 0.727 . . . . 0.0 111.14 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.565 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.9 Cg_endo -69.74 -163.81 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.654 2.236 . . . . 0.0 112.316 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.486 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -128.32 160.88 59.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.648 0.737 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.72 -6.45 9.36 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.328 -0.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.446 ' C ' ' O ' ' A' ' 95' ' ' PRO . 89.8 m-85 -34.35 121.14 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -127.58 131.9 49.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 91.1 t -131.92 104.69 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -104.85 -39.62 6.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.86 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -128.21 132.48 7.37 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.461 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.532 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -100.03 154.24 37.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.637 0.732 . . . . 0.0 110.92 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.75 159.88 88.92 Favored 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.674 -1.802 . . . . 0.0 112.317 -0.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.4 m -135.02 102.97 5.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.439 HG21 ' N ' ' A' ' 105' ' ' TYR . 21.1 mt -98.78 134.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.135 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.439 ' N ' HG21 ' A' ' 104' ' ' ILE . 8.9 m-85 -132.75 166.6 21.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -134.96 132.34 38.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.9 t -105.75 94.76 9.31 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.629 0.728 . . . . 0.0 110.864 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.8 Cg_endo -69.76 175.71 7.74 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.687 2.258 . . . . 0.0 112.357 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.464 ' HB1' ' ND2' ' A' ' 110' ' ' ASN . . . -92.27 137.08 32.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.464 ' ND2' ' HB1' ' A' ' 109' ' ' ALA . 0.5 OUTLIER 49.31 25.59 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.445 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.2 mtmm -124.77 21.98 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 2.3 mptp? -50.85 -50.0 57.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -46.12 -38.92 8.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -134.26 91.48 22.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.602 0.715 . . . . 0.0 110.942 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -163.85 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.691 2.261 . . . . 0.0 112.344 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -142.26 145.51 34.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -119.6 117.87 29.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -57.33 111.47 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.931 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -125.12 91.56 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.5 -142.84 4.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.485 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.51 130.68 10.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.44 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 45.4 mtm-85 -81.1 47.58 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 124' ' ' LEU . 4.1 tt0 -103.76 133.65 48.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 70' ' ' LEU . 3.1 tm? -34.17 -53.68 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.972 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 128' ' ' ILE . 14.8 m -67.2 -51.0 58.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -42.75 -31.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 122' ' ' ARG . 68.7 m-85 -76.74 -40.44 48.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' A' ' 125' ' ' SER . 32.3 mt -62.11 -55.99 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -57.79 -31.42 66.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.503 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 68.1 t80 -63.46 -45.06 92.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.964 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.1 mt -76.59 -39.13 53.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.945 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -46.63 -24.2 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.7 ptp85 -112.69 -37.02 5.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.503 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 2.9 mm-40 -70.01 -59.64 2.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.889 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.441 ' CB ' HD13 ' A' ' 80' ' ' ILE . . . -45.72 107.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.106 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.7 t -44.35 -50.55 9.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.1 m -68.64 -58.34 4.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.95 169.37 7.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.459 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 155.66 65.41 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.68 2.253 . . . . 0.0 112.35 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.8 p -56.44 -42.08 77.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.5 p -98.41 90.95 4.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.49 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.7 p -66.72 115.09 6.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.912 0.387 . . . . 0.0 110.88 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 t -111.26 158.59 18.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.45 164.31 10.0 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.515 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.7 p -114.92 150.71 35.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 0.0 110.856 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.2 t -69.54 169.06 13.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.849 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 137.68 -162.49 25.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.493 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -110.97 137.38 48.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.889 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 9' ' ' ASP . 0.9 OUTLIER -115.13 114.54 25.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.02 176.54 22.02 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.518 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -125.34 104.26 8.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 0.0 110.883 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.447 ' N ' HD13 ' A' ' 12' ' ' LEU . 5.6 mp -88.02 97.31 10.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.939 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.487 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -157.36 135.91 11.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.884 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -152.93 124.4 7.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.491 ' CD2' ' HB3' ' A' ' 34' ' ' ALA . 2.4 p90 -145.62 155.98 43.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 17' ' ' LYS . 3.3 pp -104.27 -40.61 6.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.414 ' N ' HD12 ' A' ' 16' ' ' LEU . 12.2 ttpt -109.1 154.73 21.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.42 ' CB ' ' HB2' ' A' ' 34' ' ' ALA . 90.1 p -155.59 144.74 20.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 3.8 mm-40 -91.77 161.23 34.42 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.638 0.732 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.429 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.7 Cg_endo -69.79 142.98 49.27 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.658 2.239 . . . . 0.0 112.366 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.464 HD12 ' CG2' ' A' ' 33' ' ' VAL . 40.2 mm -74.58 133.85 76.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 111.136 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 176.62 6.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.731 2.288 . . . . 0.0 112.326 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -101.54 -35.95 8.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.3 t -148.99 128.96 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -116.78 49.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.04 56.55 3.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.72 -171.89 13.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.489 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -38.71 7.47 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.687 2.258 . . . . 0.0 112.314 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.49 119.33 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.104 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -68.97 125.73 27.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.1 t -74.81 124.33 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.463 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 42.0 t -123.9 125.65 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 36' ' ' ASN . 21.1 m -119.14 149.46 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HB3' ' CD2' ' A' ' 15' ' ' TYR . . . -33.18 -42.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.064 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.447 ' CB ' HD13 ' A' ' 21' ' ' ILE . 9.4 mt-10 -55.57 -48.69 74.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' A' ' 33' ' ' VAL . 11.3 p-10 -114.08 38.85 2.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.557 ' CE1' ' HG3' ' A' ' 93' ' ' PRO . 4.6 t80 -77.95 -55.22 5.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.96 -11.12 55.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -83.28 -42.27 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.9 mt -99.24 -59.44 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.1 t -49.99 -62.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.149 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -66.46 115.77 6.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.84 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' A' ' 45' ' ' ASN . 2.4 t30 -173.75 110.37 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -87.17 -4.53 59.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.48 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 78.7 m-20 -73.96 -48.47 30.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HZ3' ' ND2' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -133.87 153.91 51.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -67.67 142.25 56.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.8 t -137.52 143.79 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.1 tp -121.31 121.28 37.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 tp -109.76 133.4 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' OE1' ' C ' ' A' ' 52' ' ' PHE . 0.3 OUTLIER -124.0 118.22 26.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.869 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.43 ' C ' ' OE1' ' A' ' 51' ' ' GLU . 54.4 m-85 -95.0 114.93 26.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CE1' ' OD1' ' A' ' 86' ' ' ASP . 17.2 p90 -120.23 -179.19 3.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.422 ' HB3' ' CB ' ' A' ' 57' ' ' CYS . . . -136.76 134.49 19.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.578 0.704 . . . . 0.0 111.083 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -11.05 30.04 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.708 2.272 . . . . 0.0 112.295 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -114.1 9.25 17.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . 48.4 t -106.32 113.27 26.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.71 -52.71 46.59 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.481 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -46.67 -39.13 10.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.731 0.301 . . . . 0.0 110.809 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 43.9 m -70.95 -39.84 72.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.912 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -40.58 76.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.894 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -73.21 -25.5 60.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.4 tp -83.24 -23.11 32.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -42.52 -57.88 4.23 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.623 0.725 . . . . 0.0 110.934 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.8 -36.03 11.43 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.679 2.252 . . . . 0.0 112.341 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -64.63 -28.34 69.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -93.04 -43.64 8.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -44.82 -58.52 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.925 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -41.64 -46.84 3.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.46 ' N ' HD23 ' A' ' 124' ' ' LEU . 12.1 tp -53.32 -36.54 61.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.962 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -57.97 -57.04 21.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.17 -24.34 57.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.911 0.386 . . . . 0.0 110.911 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -72.14 -42.16 66.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.3 mt -83.24 3.35 31.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.6 p -53.08 -39.67 63.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -57.88 -11.93 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.78 99.65 9.42 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.608 0.718 . . . . 0.0 110.859 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 0.15 6.1 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.639 2.226 . . . . 0.0 112.332 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -109.98 -35.86 6.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 60.9 mt -90.61 104.08 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.46 110.02 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 50.2 mm -82.87 127.17 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.159 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.4 166.37 23.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -138.21 154.05 49.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.503 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 9.7 ttt -150.42 136.82 18.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.96 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.441 ' OD1' ' CE1' ' A' ' 53' ' ' TYR . 4.0 t70 -92.75 94.96 9.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -50.13 -64.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.2 t -41.63 -26.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.117 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.68 -26.52 15.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.503 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -141.15 109.39 5.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -44.25 136.58 3.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.406 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 72.8 t -86.08 136.63 35.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.596 0.713 . . . . 0.0 111.144 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.557 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.4 Cg_endo -69.74 -167.76 0.24 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.712 2.275 . . . . 0.0 112.312 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.494 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -121.74 161.33 42.52 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.731 0.777 . . . . 0.0 110.83 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.0 Cg_endo -69.75 -9.24 10.89 Favored 'Cis proline' 0 C--O 1.232 0.223 0 C-N-CA 122.679 -1.801 . . . . 0.0 112.318 -0.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 95' ' ' PRO . 93.9 m-85 -33.98 126.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.905 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.82 128.35 36.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 88.6 t -127.5 94.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -116.18 28.89 8.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.825 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.32 113.81 0.36 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.531 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -98.09 153.64 38.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.659 0.742 . . . . 0.0 110.874 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.77 156.5 92.79 Favored 'Cis proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 -1.79 . . . . 0.0 112.339 0.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.7 m -135.0 128.18 31.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.408 HG21 ' N ' ' A' ' 105' ' ' TYR . 36.6 mt -123.36 136.65 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.527 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 9.8 m-85 -136.45 144.29 44.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -119.72 129.72 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -99.96 101.05 12.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.843 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.481 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.3 Cg_endo -69.76 168.09 22.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.706 2.27 . . . . 0.0 112.342 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.12 137.23 33.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 10.3 p30 51.86 24.94 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.481 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.2 mtmt -129.3 38.42 3.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 5.8 mmpt? -63.35 -59.34 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 112' ' ' LYS . 11.0 mp -35.41 -36.84 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -134.47 96.82 14.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.642 0.734 . . . . 0.0 110.839 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -178.44 2.33 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.661 2.24 . . . . 0.0 112.373 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 147.99 49.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.527 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 10.7 ttpt -118.43 125.92 50.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -67.86 115.65 7.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -123.5 102.84 8.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.63 -149.75 11.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.465 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.91 138.9 14.79 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.5 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -79.0 45.59 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.774 0.321 . . . . 0.0 110.829 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 124' ' ' LEU . 8.2 tt0 -101.64 128.32 47.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.465 ' CD1' HD12 ' A' ' 128' ' ' ILE . 3.2 tm? -34.14 -56.09 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.9 m -59.23 -45.92 89.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 130' ' ' TYR . 6.4 t0 -49.33 -39.97 33.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.448 ' CB ' HD12 ' A' ' 70' ' ' LEU . 58.6 m-85 -67.41 -41.41 84.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.465 HD12 ' CD1' ' A' ' 124' ' ' LEU . 23.4 mt -62.28 -65.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.089 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 m -56.25 -34.8 66.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.41 ' CB ' ' O ' ' A' ' 126' ' ' ASP . 14.6 t80 -57.22 -45.73 83.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.943 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.93 -35.44 32.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -38.56 -41.85 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -98.11 -57.98 2.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -44.17 -56.76 3.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.0 105.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.133 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.6 t -40.41 -49.96 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.6 m -113.14 40.54 2.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.802 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -66.07 -173.78 5.11 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 148.09 64.48 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.6 p -174.14 113.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.5 m -95.91 83.74 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.531 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 m 48.51 48.43 19.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.843 0.354 . . . . 0.0 110.821 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 m -163.27 144.93 9.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.08 179.19 40.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.519 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 t -157.69 147.82 20.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.3 p -99.5 -59.1 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.48 -133.88 8.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.533 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -99.78 110.79 23.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.343 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -163.61 150.25 11.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.95 -39.83 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.511 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.4 ' C ' HD23 ' A' ' 12' ' ' LEU . 7.6 p30 -92.56 91.05 7.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.866 0.365 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.441 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -140.38 107.02 5.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.91 -179.72 3.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -170.56 136.56 1.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.3 p90 -151.46 148.04 27.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.488 ' HG ' ' N ' ' A' ' 17' ' ' LYS . 1.2 pt? -95.7 -35.7 11.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.488 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 10.5 ptmt -117.34 176.36 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.3 p -174.99 150.5 1.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.824 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 12.1 mm-40 -96.6 159.15 32.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 0.0 110.853 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 141.91 46.68 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.2 mm -69.47 131.43 90.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.565 0.698 . . . . 0.0 111.135 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 141.52 45.52 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.671 2.247 . . . . 0.0 112.394 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.1 -34.88 74.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.1 t -156.88 137.21 12.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -121.21 48.2 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.65 52.21 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.39 -167.08 13.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -41.59 4.1 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.668 2.245 . . . . 0.0 112.361 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.72 128.23 74.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.106 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.47 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 12.5 mmmt -74.9 117.33 16.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.5 t -73.48 122.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 39.8 t -115.81 124.31 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.116 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 36' ' ' ASN . 30.6 m -115.84 146.06 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.151 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -34.34 -42.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.071 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -55.5 -47.2 76.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' VAL . 21.1 p-10 -114.07 33.42 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.569 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 13.5 t80 -72.2 -58.28 3.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -64.55 -6.09 6.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -89.31 -46.44 8.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 mt -97.11 -46.05 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.569 HG12 ' CZ ' ' A' ' 37' ' ' PHE . 50.0 t -63.44 -58.82 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.134 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -78.08 124.68 28.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 46' ' ' LYS . 5.1 p-10 -175.59 108.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.961 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' CD ' ' HA ' ' A' ' 110' ' ' ASN . 2.1 mm-40 -83.05 20.25 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -106.75 -39.55 5.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.503 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 16.8 pttm -137.74 166.6 23.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.42 ' C ' HG21 ' A' ' 48' ' ' VAL . 4.3 m-20 -94.17 139.24 31.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 49' ' ' LEU . 23.4 t -136.33 148.18 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 105' ' ' TYR . 6.6 tp -116.51 109.86 17.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 tp -91.64 135.73 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.076 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' OE2' ' C ' ' A' ' 52' ' ' PHE . 1.9 tm-20 -127.02 117.85 23.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.448 ' C ' ' OE2' ' A' ' 51' ' ' GLU . 45.8 m-85 -93.32 124.33 37.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -128.84 -175.02 3.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -139.1 131.66 15.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.594 0.711 . . . . 0.0 111.091 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -3.09 11.32 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.688 2.259 . . . . 0.0 112.327 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.566 ' CZ3' ' SG ' ' A' ' 57' ' ' CYS . 6.7 p-90 -119.45 -3.37 10.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.566 ' SG ' ' CZ3' ' A' ' 56' ' ' TRP . 1.3 m -93.44 133.5 36.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.93 -41.83 93.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.484 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -51.62 -28.06 13.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 64' ' ' GLU . 42.5 t -69.97 -44.73 68.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -62.81 -44.07 97.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -72.15 -34.41 68.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.8 tp -84.6 -19.19 33.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.518 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.9 OUTLIER -45.3 -58.3 6.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.676 0.75 . . . . 0.0 110.89 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.72 -30.85 21.82 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.337 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -70.06 -26.84 64.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -95.75 -41.89 8.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 71' ' ' GLY . 13.1 ttmt -48.84 -58.85 4.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.449 ' CD ' ' O ' ' A' ' 65' ' ' PRO . 1.2 mp0 -39.27 -51.25 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.469 ' N ' HD21 ' A' ' 124' ' ' LEU . 26.2 tp -48.65 -40.13 26.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.958 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 68' ' ' LYS . . . -61.47 -55.11 30.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.444 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -67.06 -28.1 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.94 0.4 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.51 -45.36 54.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.455 HD11 ' CG1' ' A' ' 82' ' ' ILE . 94.2 mt -83.14 3.04 32.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.918 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.3 t -49.97 -25.39 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.32 21.91 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.48 98.08 13.71 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.603 0.716 . . . . 0.0 110.837 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -4.29 13.75 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.658 2.239 . . . . 0.0 112.332 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -116.41 -39.77 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.8 mt -96.9 140.43 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.0 t -138.43 114.56 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.115 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.455 ' CG1' HD11 ' A' ' 74' ' ' LEU . 44.5 mm -81.51 126.78 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 30' ' ' LYS . . . -136.67 164.58 27.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.075 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.1 pttt -136.75 138.3 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.4 ttt -134.96 143.42 46.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.41 ' CG ' ' HB3' ' A' ' 89' ' ' ALA . 26.9 t0 -92.92 115.21 27.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 89' ' ' ALA . . . -68.89 -70.73 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.114 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -42.43 -23.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 87' ' ' ALA . . . -99.03 -31.81 11.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 14.4 m-80 -129.14 111.38 12.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.483 ' CG ' ' CD2' ' A' ' 16' ' ' LEU . 8.3 t0 -45.92 129.55 9.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -77.41 130.23 75.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 0.0 111.16 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.566 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.7 Cg_endo -69.73 -163.86 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.678 2.252 . . . . 0.0 112.317 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -130.61 161.47 60.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.636 0.732 . . . . 0.0 110.872 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.3 Cg_endo -69.74 -4.62 8.38 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.733 -1.778 . . . . 0.0 112.301 -0.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 95' ' ' PRO . 78.8 m-85 -33.27 125.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -125.09 132.46 53.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.457 HG11 ' CB ' ' A' ' 103' ' ' THR . 38.6 t -143.42 124.34 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -129.65 -39.31 1.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.47 123.31 5.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.484 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.525 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.5 154.82 37.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.664 0.745 . . . . 0.0 110.89 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.6 Cg_endo -69.8 161.75 85.65 Favored 'Cis proline' 0 C--O 1.232 0.186 0 C-N-CA 122.676 -1.801 . . . . 0.0 112.334 0.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.457 ' CB ' HG11 ' A' ' 98' ' ' VAL . 62.5 m -140.1 109.82 6.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.3 mt -104.12 134.0 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.182 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' A' ' 117' ' ' LYS . 7.9 m-85 -129.86 177.36 7.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -145.3 129.0 17.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.78 97.73 8.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.669 0.747 . . . . 0.0 110.851 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.486 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.5 Cg_endo -69.75 167.56 24.08 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 2.246 . . . . 0.0 112.328 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -83.12 137.63 34.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.108 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.0 OUTLIER 48.14 27.89 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.486 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.3 mtmm -129.4 29.78 5.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -53.87 -57.14 12.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.922 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 68.9 mt -43.3 -48.37 6.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.13 87.48 34.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.632 0.729 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -163.9 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.716 2.277 . . . . 0.0 112.287 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -149.79 131.78 15.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.564 ' HB2' ' CE2' ' A' ' 105' ' ' TYR . 21.6 tttt -102.49 136.46 42.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 70.2 t80 -66.42 110.93 3.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.32 97.31 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.88 -151.83 11.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.96 142.49 23.39 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.451 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -87.28 43.22 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 124' ' ' LEU . 2.7 tp10 -104.52 131.08 52.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.469 HD21 ' N ' ' A' ' 70' ' ' LEU . 2.8 tm? -34.07 -56.65 0.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 72.7 m -59.59 -50.73 72.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -46.6 -36.61 7.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 65.7 m-85 -70.3 -43.7 69.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.1 mt -58.73 -58.49 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.158 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.53 -31.36 69.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.455 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 52.2 t80 -60.31 -53.33 58.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' GLN . 43.7 mt -70.81 -39.78 72.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' LEU . 28.5 mm-40 -35.62 -36.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.8 mmp_? -106.77 -57.63 2.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 68.6 mm-40 -42.23 -49.5 4.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -61.66 109.57 1.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -33.99 -74.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.4 t -75.59 56.66 0.91 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.831 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -42.84 147.81 0.67 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.43 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 158.11 58.05 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.653 2.236 . . . . 0.0 112.373 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.1 t -72.57 158.28 35.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.836 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.4 t 57.52 45.89 18.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.848 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.5 p -115.03 147.81 39.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.369 . . . . 0.0 110.856 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 t -116.38 122.1 43.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.839 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.27 -95.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.8 p -58.65 149.01 27.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.856 0.36 . . . . 0.0 110.871 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.5 m -100.58 -55.97 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.811 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.81 -86.39 1.02 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.45 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 47.31 46.95 16.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 0.0 110.853 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -112.98 146.44 39.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.01 83.56 0.36 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.46 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -117.89 -13.35 10.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.354 . . . . 0.0 110.868 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.431 ' N ' HD21 ' A' ' 12' ' ' LEU . 4.3 mm? -93.35 40.12 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -163.01 146.74 11.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.477 ' HD2' ' N ' ' A' ' 15' ' ' TYR . 1.8 tmm_? -173.55 118.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.477 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 1.6 p90 -142.72 157.23 44.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.423 HD11 ' C ' ' A' ' 16' ' ' LEU . 3.5 pp -103.86 -38.89 6.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 18' ' ' SER . 51.0 tttt -111.86 163.77 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.429 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 45.4 p -166.0 156.95 13.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 10.6 mm-40 -103.91 161.38 23.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.626 0.727 . . . . 0.0 110.865 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.7 144.15 53.42 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.694 2.263 . . . . 0.0 112.345 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.48 HD12 ' CG2' ' A' ' 33' ' ' VAL . 42.9 mm -74.92 130.95 79.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.73 . . . . 0.0 111.154 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 157.81 59.17 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.736 2.291 . . . . 0.0 112.321 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -70.77 -45.83 64.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.4 m -135.66 135.65 40.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -128.22 30.44 5.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.05 48.31 1.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.861 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.44 -162.95 18.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -40.65 5.07 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.326 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 84' ' ' LYS . 74.2 t -120.01 119.68 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -66.77 113.75 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.6 t -73.04 108.24 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.459 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 39.2 t -106.77 128.03 61.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.129 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.48 ' CG2' HD12 ' A' ' 21' ' ' ILE . 26.9 m -122.25 148.99 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -33.84 -40.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' CB ' HD13 ' A' ' 21' ' ' ILE . 16.0 mt-10 -56.42 -48.18 77.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 33' ' ' VAL . 22.0 p30 -115.12 35.41 4.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.473 ' CD2' HG22 ' A' ' 41' ' ' VAL . 15.7 t80 -75.17 -56.06 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.75 -5.02 10.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.834 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -92.23 -45.71 8.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.4 mt -96.88 -58.95 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.473 HG22 ' CD2' ' A' ' 37' ' ' PHE . 61.0 t -50.88 -60.83 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.126 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -70.62 115.16 9.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -167.28 111.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -88.49 6.61 36.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -92.19 -40.72 10.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 155.69 48.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.4 151.47 46.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.1 t -146.32 146.47 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 20.6 tp -125.15 127.75 47.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 tp -109.15 140.55 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.139 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 1.9 tt0 -126.95 107.59 10.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -85.82 110.57 19.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -119.26 167.93 11.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.42 127.97 24.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.599 0.714 . . . . 0.0 111.094 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -6.63 19.04 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -118.67 14.41 13.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.948 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.2 t -117.09 123.41 46.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -61.71 -61.37 6.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.508 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -39.65 -37.12 0.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.341 . . . . 0.0 110.853 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 81.8 m -74.98 -39.09 61.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' GLY . 5.4 ttmt -62.55 -35.73 80.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -73.86 -22.21 59.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.15 -23.71 23.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.523 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.4 tt0 -37.93 -58.14 1.47 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.635 0.731 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.75 -34.32 14.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.704 2.27 . . . . 0.0 112.334 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -66.39 -24.98 66.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 55.5 t80 -96.07 -38.86 10.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -47.78 -56.51 7.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.46 -56.1 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 127' ' ' PHE . 24.4 tp -40.61 -42.04 1.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.39 -68.88 1.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.54 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.87 -25.81 61.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.374 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -74.69 -39.53 61.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.952 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.458 HD12 ' CG1' ' A' ' 82' ' ' ILE . 95.1 mt -88.96 1.73 55.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.3 t -51.51 -20.86 2.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -91.41 18.34 7.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.918 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 97.1 m-20 -109.55 99.9 39.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.59 0.709 . . . . 0.0 110.89 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.9 Cg_endo -69.71 -1.33 8.24 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.721 2.28 . . . . 0.0 112.354 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.07 -35.13 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.883 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 51.0 mt -99.21 142.2 15.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.02 106.97 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.095 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.458 ' CG1' HD12 ' A' ' 74' ' ' LEU . 47.3 mm -74.36 126.43 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.448 ' HB3' ' CG2' ' A' ' 32' ' ' VAL . . . -130.59 169.14 15.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.043 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.446 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . 10.6 ptpp? -137.67 135.69 36.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.0 ttt -141.38 143.84 34.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 90' ' ' ASN . 10.3 t0 -98.63 117.92 34.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.46 -59.24 3.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -21.23 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.109 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 86' ' ' ASP . . . -99.79 -25.13 14.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 86' ' ' ASP . 4.5 m-80 -134.62 104.18 5.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -40.24 122.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.84 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.66 123.51 89.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.639 0.733 . . . . 0.0 111.107 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.8 Cg_endo -69.76 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.5 m -121.97 160.87 45.31 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.663 0.744 . . . . 0.0 110.848 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.76 -8.62 10.6 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.692 -1.795 . . . . 0.0 112.367 -0.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 95' ' ' PRO . 97.0 m-85 -34.14 123.08 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -130.45 115.34 16.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.447 HG23 ' CG2' ' A' ' 103' ' ' THR . 75.1 t -114.26 131.17 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 -50.05 1.02 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.88 125.77 6.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.464 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.517 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -96.77 154.71 38.28 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 0.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.73 154.96 93.38 Favored 'Cis proline' 0 C--O 1.232 0.207 0 C-N-CA 122.666 -1.806 . . . . 0.0 112.392 -0.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.447 ' CG2' HG23 ' A' ' 98' ' ' VAL . 61.2 m -132.78 102.11 5.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.157 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.419 HG12 ' CG ' ' A' ' 51' ' ' GLU . 74.8 mt -95.9 138.52 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.518 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 9.4 m-85 -135.87 140.29 44.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -114.88 130.47 56.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.3 m -101.91 97.63 8.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.669 0.747 . . . . 0.0 110.861 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.74 170.06 17.45 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.662 2.241 . . . . 0.0 112.37 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -86.0 142.16 28.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.5 p30 46.11 25.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.478 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.5 mtmt -126.09 39.13 4.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.461 ' O ' ' C ' ' A' ' 113' ' ' LEU . 36.4 mmtt -65.55 -61.38 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.893 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 112' ' ' LYS . 19.7 mt -33.66 -38.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.93 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 112' ' ' LYS . 7.1 m120 -134.31 99.75 13.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.624 0.726 . . . . 0.0 110.852 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 178.5 4.5 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.705 2.27 . . . . 0.0 112.299 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.67 127.01 41.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.518 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 15.6 ttpp -100.99 123.53 45.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -60.38 113.57 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -124.37 95.96 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.7 -148.82 7.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.535 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.84 136.49 14.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.484 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -83.67 45.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 110.869 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 124' ' ' LEU . 3.7 tp10 -104.83 132.05 51.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.456 HD23 ' N ' ' A' ' 70' ' ' LEU . 3.5 tm? -35.29 -53.06 0.63 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.0 m -63.63 -45.65 89.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -46.83 -42.58 17.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.461 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 74.5 m-85 -64.95 -46.82 79.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 mt -53.91 -59.66 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.1 t -59.1 -37.46 77.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -56.67 -55.2 37.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.954 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.67 -38.07 80.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -47.47 -44.54 25.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -93.72 -46.48 7.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.7 -62.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -39.2 105.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.063 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.3 t -42.45 -56.25 3.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.101 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.1 t -66.3 -44.22 84.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.98 158.9 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.432 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 133.2 24.95 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.69 2.26 . . . . 0.0 112.307 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.6 t -78.62 -62.62 1.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.2 p 40.03 41.95 1.02 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.858 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.501 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -117.75 42.41 2.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.875 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 t -161.75 156.81 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.53 136.63 9.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 p -166.14 155.66 11.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.915 0.388 . . . . 0.0 110.858 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.6 m -130.15 115.33 16.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.849 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.95 119.13 0.61 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.435 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -122.8 -58.89 1.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.863 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -96.69 -57.35 2.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.837 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.96 95.02 0.5 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -89.76 106.65 18.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 110.895 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.05 33.12 5.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.65 139.07 34.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.6 tpp85 -169.3 129.3 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.828 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.4 p90 -158.37 148.33 19.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.506 ' HG ' ' N ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -92.62 -38.23 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.506 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -116.38 174.35 6.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 88.0 p -170.95 165.6 7.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -113.56 160.2 32.6 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.611 0.72 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 145.75 57.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.697 2.264 . . . . 0.0 112.326 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.432 HD13 ' CB ' ' A' ' 35' ' ' GLU . 20.5 mm -69.42 134.96 88.71 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.659 0.742 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 53.7 Cg_endo -69.77 137.98 36.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.71 2.273 . . . . 0.0 112.324 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.36 -32.24 62.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.8 t -128.46 106.51 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.42 ' CG ' ' HD3' ' A' ' 30' ' ' LYS . 9.7 t-20 -111.35 46.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -110.93 49.43 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.876 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.25 -162.34 14.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -48.25 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.677 2.251 . . . . 0.0 112.321 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 84' ' ' LYS . 22.2 t -115.88 116.05 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.42 ' HD3' ' CG ' ' A' ' 25' ' ' ASN . 7.7 mmtt -57.42 123.82 16.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.9 t -76.88 109.63 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.088 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 29.0 t -107.31 123.99 62.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.069 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 36' ' ' ASN . 28.5 m -119.07 147.11 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -32.4 -45.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.14 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.432 ' CB ' HD13 ' A' ' 21' ' ' ILE . 7.0 mt-10 -52.93 -49.78 65.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 33' ' ' VAL . 12.2 p-10 -113.25 35.86 3.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.46 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 21.5 t80 -74.03 -59.18 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.64 -5.21 7.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -87.97 -43.46 11.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.461 HD12 ' ND2' ' A' ' 36' ' ' ASN . 25.5 mt -98.98 -54.07 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.123 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.6 t -55.08 -62.02 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.121 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -69.74 122.01 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -173.87 105.5 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -87.24 38.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -131.27 -40.83 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -129.83 151.56 50.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -75.54 127.19 32.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.84 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.17 143.24 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.0 tp -119.28 126.66 52.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 tp -113.07 135.56 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.21 118.51 26.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.907 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -93.06 128.76 39.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.44 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 6.9 p90 -136.12 174.05 11.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.18 135.02 25.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.585 0.707 . . . . 0.0 111.121 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -7.86 22.14 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.721 2.281 . . . . 0.0 112.327 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.557 ' CZ2' HG22 ' A' ' 88' ' ' THR . 7.0 p-90 -123.67 26.49 7.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 43.4 t -125.13 106.44 9.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -46.15 -66.07 1.82 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.504 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 58' ' ' GLY . 89.8 m-70 -35.33 -45.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.3 m -63.73 -50.2 70.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.34 -37.01 54.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -71.36 -27.82 63.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.457 ' O ' ' C ' ' A' ' 64' ' ' GLU . 12.2 tp -82.47 -32.69 28.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.513 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.8 OUTLIER -33.95 -58.12 0.61 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.651 0.739 . . . . 0.0 110.931 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.1 Cg_endo -69.82 -35.47 12.39 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.719 2.279 . . . . 0.0 112.27 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -65.3 -27.85 68.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.854 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -93.79 -41.61 9.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -46.74 -57.01 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -40.5 -48.48 2.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.462 ' N ' HD23 ' A' ' 124' ' ' LEU . 14.5 tp -52.2 -39.69 60.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.88 -48.6 69.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.501 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -74.95 -21.95 58.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.95 0.405 . . . . 0.0 110.895 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -79.56 -50.6 10.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.918 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 77' ' ' ASP . 79.8 mt -77.39 -2.02 33.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' LEU . 7.8 t -37.98 -29.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 74' ' ' LEU . 37.8 mtmt -87.1 29.56 0.82 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 74' ' ' LEU . 39.9 p30 -102.79 95.3 6.16 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.585 0.707 . . . . 0.0 110.851 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -2.83 10.84 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.71 2.273 . . . . 0.0 112.309 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -120.55 -45.46 2.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.465 HG21 ' N ' ' A' ' 81' ' ' VAL . 44.3 mt -87.11 145.42 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.465 ' N ' HG21 ' A' ' 80' ' ' ILE . 96.1 t -135.18 105.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.126 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.9 mm -73.53 131.03 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.408 ' CA ' HG11 ' A' ' 29' ' ' VAL . . . -145.93 160.64 41.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 29' ' ' VAL . 43.4 pttt -132.53 160.34 36.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.504 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 18.4 ttt -151.37 132.39 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -91.44 85.96 5.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -41.6 -65.74 0.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.557 HG22 ' CZ2' ' A' ' 56' ' ' TRP . 25.7 p -36.34 -35.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.24 -36.37 17.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.504 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.4 OUTLIER -129.02 112.7 14.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.447 ' CG ' HD21 ' A' ' 16' ' ' LEU . 26.6 t0 -41.22 155.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -103.21 125.58 34.73 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.63 0.728 . . . . 0.0 111.123 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.5 Cg_endo -69.84 -164.94 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.248 . . . . 0.0 112.313 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.487 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -122.19 161.23 44.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.596 0.713 . . . . 0.0 110.892 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.76 -11.74 11.99 Favored 'Cis proline' 0 C--O 1.232 0.182 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.352 -0.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.45 ' C ' ' O ' ' A' ' 95' ' ' PRO . 81.2 m-85 -33.05 125.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -134.04 117.04 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 83.7 t -119.53 108.73 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -106.25 -41.28 5.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.09 131.32 7.19 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.418 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.513 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.5 OUTLIER -97.28 155.63 37.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.679 0.752 . . . . 0.0 110.828 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.1 Cg_endo -69.79 162.14 84.81 Favored 'Cis proline' 0 C--O 1.232 0.207 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.352 0.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 84.1 m -142.22 116.06 9.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.176 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.409 HG23 ' CB ' ' A' ' 118' ' ' TYR . 27.5 mt -110.2 140.63 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 117' ' ' LYS . 11.9 m-85 -139.36 142.74 37.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -111.43 143.6 42.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.7 m -114.46 93.83 33.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.686 0.755 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.5 Cg_endo -69.77 167.86 23.23 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -84.25 136.8 33.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 13.8 p30 49.98 26.8 2.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.478 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 12.8 mtmm -128.97 39.25 3.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.455 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 7.7 mmpt? -67.98 -45.59 73.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.3 mp -50.85 -38.2 47.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -134.88 88.37 27.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.605 0.717 . . . . 0.0 110.845 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -171.76 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.724 2.282 . . . . 0.0 112.295 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -137.86 118.92 14.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 105' ' ' TYR . 22.3 tttt -91.47 120.22 32.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.409 ' CB ' HG23 ' A' ' 104' ' ' ILE . 39.3 t80 -55.04 112.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -123.68 101.01 7.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.9 -139.65 4.32 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.452 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.37 139.71 14.71 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.47 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.4 ' CZ ' ' HG3' ' A' ' 102' ' ' PRO . 26.8 mtp180 -83.88 43.79 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.883 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 124' ' ' LEU . 3.5 tp10 -102.05 129.65 48.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 70' ' ' LEU . 3.3 tm? -34.02 -55.46 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.93 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.2 t -59.43 -50.15 75.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -44.05 -35.72 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -73.31 -37.98 66.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.5 mt -63.03 -61.42 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.85 -34.86 73.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -57.46 -48.8 78.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 68.3 mt -75.68 -34.4 60.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -43.49 -38.86 3.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.448 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.2 ptm180 -101.03 -47.05 4.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.448 ' N ' ' HG3' ' A' ' 133' ' ' ARG . 16.6 mm-40 -52.63 -57.79 8.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -48.7 110.88 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -36.36 -71.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.163 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.6 t -59.48 -57.08 14.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.887 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.96 159.97 34.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.49 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 140' ' ' SER . 53.7 Cg_endo -69.72 -24.21 30.14 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.721 2.281 . . . . 0.0 112.383 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 139' ' ' PRO . 16.4 m 34.65 41.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.7 t -112.59 -52.66 2.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.888 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.463 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 t -98.43 152.63 19.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 110.842 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -82.96 98.66 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -125.25 75.08 0.4 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 m -66.24 -60.52 2.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 110.826 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 t 52.49 42.51 31.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.58 -175.8 14.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.462 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 59.45 43.43 16.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.867 0.365 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -126.11 128.0 46.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.83 158.34 3.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.507 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.433 ' O ' ' CD1' ' A' ' 12' ' ' LEU . 11.0 t-20 -108.81 24.18 13.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 110.867 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.433 ' CD1' ' O ' ' A' ' 11' ' ' ASN . 0.4 OUTLIER 37.35 50.81 1.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.28 71.05 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.878 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -123.97 124.08 41.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.3 p90 -159.22 164.69 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.506 ' HG ' ' N ' ' A' ' 17' ' ' LYS . 1.6 pt? -109.04 -38.62 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.506 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 30.3 tttt -112.61 149.54 32.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.7 p -161.72 146.5 13.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -94.3 158.8 35.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.707 0.765 . . . . 0.0 110.835 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 150.29 68.1 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.644 2.229 . . . . 0.0 112.357 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.467 HD11 ' CG2' ' A' ' 33' ' ' VAL . 39.2 mm -79.74 132.36 61.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.625 0.726 . . . . 0.0 111.132 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 173.34 11.12 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -97.31 -34.41 11.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p -141.99 135.79 29.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -132.23 38.76 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -78.43 57.73 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.83 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.98 -170.73 13.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.494 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -40.41 5.42 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.715 2.276 . . . . 0.0 112.374 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.5 t -120.63 117.11 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -64.22 143.08 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.893 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.2 t -91.44 119.6 38.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.55 126.5 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.467 ' CG2' HD11 ' A' ' 21' ' ' ILE . 29.1 m -122.34 156.9 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.154 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -48.47 -20.05 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -76.54 -34.21 58.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -129.12 33.72 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 37' ' ' PHE . 7.6 t80 -69.35 -52.96 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.84 -6.76 28.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -89.52 -43.45 10.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.4 mt -98.4 -61.89 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.5 t -47.9 -61.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.151 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.46 135.08 52.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -173.62 106.36 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.941 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -85.71 14.66 5.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -111.02 -41.94 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -137.18 164.11 29.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 63.7 m-20 -80.31 154.23 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 49' ' ' LEU . 28.2 t -145.2 147.74 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.412 ' N ' HG13 ' A' ' 48' ' ' VAL . 9.5 tp -119.09 129.74 55.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.917 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 tp -119.95 133.4 66.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' CG ' HG12 ' A' ' 104' ' ' ILE . 4.9 tm-20 -126.82 116.38 20.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -90.11 140.08 30.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.45 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 5.9 p90 -143.98 176.08 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.61 133.43 25.17 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.612 0.72 . . . . 0.0 111.072 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -8.28 23.21 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.748 2.298 . . . . 0.0 112.349 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.548 ' CZ2' HG23 ' A' ' 88' ' ' THR . 5.0 p-90 -118.32 21.73 12.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.5 t -123.34 110.51 15.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -49.27 -47.83 33.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.482 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 58' ' ' GLY . 12.9 m170 -34.74 -45.89 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 110.839 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.1 t -70.91 -50.93 29.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.936 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -47.32 -34.08 6.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.852 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -86.77 -29.17 22.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.837 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.417 ' CD1' ' HB2' ' A' ' 66' ' ' LYS . 63.2 tp -83.13 -14.36 53.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.512 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.9 tt0 -46.08 -58.28 6.67 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.641 0.734 . . . . 0.0 110.943 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.1 Cg_endo -69.73 -17.53 37.64 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.644 2.229 . . . . 0.0 112.387 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.417 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 1.1 mmmp? -84.74 -30.17 24.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -93.67 -41.32 9.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -46.58 -56.63 5.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 70' ' ' LEU . 15.6 mt-10 -42.02 -62.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.457 ' CD1' HG12 ' A' ' 128' ' ' ILE . 22.3 tp -37.16 -35.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.51 -57.06 19.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.504 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -75.38 -19.93 59.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.478 ' CD ' HD12 ' A' ' 124' ' ' LEU . 4.1 mtpm? -73.95 -45.07 52.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' A' ' 77' ' ' ASP . 90.0 mt -86.86 -2.4 58.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.3 t -39.63 -26.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 74' ' ' LEU . 9.3 ttpp -82.86 22.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 74' ' ' LEU . 42.2 p30 -102.93 95.51 6.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.628 0.728 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -0.83 7.47 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.656 2.238 . . . . 0.0 112.372 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.31 -44.45 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.471 HD12 ' CB ' ' A' ' 135' ' ' ALA . 15.7 mt -88.22 143.76 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.155 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.463 ' N ' HG22 ' A' ' 80' ' ' ILE . 78.0 t -133.28 115.41 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.137 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.8 mm -81.96 130.37 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -148.73 171.87 15.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.075 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -135.42 163.07 30.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.923 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.8 ttt -151.13 136.76 17.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -96.33 82.37 3.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -45.58 -58.35 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.548 HG23 ' CZ2' ' A' ' 56' ' ' TRP . 22.8 p -46.77 -22.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.35 -18.47 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -144.74 108.44 4.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.429 ' CB ' HD21 ' A' ' 16' ' ' LEU . 27.9 t70 -37.07 151.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -97.04 128.13 36.42 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.612 0.72 . . . . 0.0 111.12 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -173.34 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.492 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.6 m -118.7 160.54 39.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.658 0.742 . . . . 0.0 110.876 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.69 -8.97 10.66 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.353 -0.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 95' ' ' PRO . 81.3 m-85 -35.13 143.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -151.59 129.23 11.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.4 t -132.89 117.98 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.6 -36.92 3.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.23 121.55 4.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.526 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.28 154.16 38.17 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.66 0.743 . . . . 0.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.4 Cg_endo -69.69 160.03 88.47 Favored 'Cis proline' 0 C--O 1.231 0.143 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.382 -0.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.2 m -137.48 113.81 10.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.468 HG21 ' N ' ' A' ' 105' ' ' TYR . 16.8 mt -105.9 138.24 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.109 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.504 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 10.8 m-85 -132.88 173.03 11.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.961 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -142.97 127.35 17.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 t -100.51 99.64 10.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.639 0.733 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.453 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.76 178.84 4.16 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.701 2.268 . . . . 0.0 112.361 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.481 ' N ' ' OD1' ' A' ' 47' ' ' ASP . . . -92.93 131.05 38.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 11.4 p30 51.0 29.07 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.933 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.453 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.3 mtmm -128.05 23.0 6.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -50.72 -56.37 12.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.0 mt -39.78 -37.13 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -134.86 90.22 22.91 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.635 0.731 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -172.34 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.664 2.243 . . . . 0.0 112.358 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -139.34 128.16 23.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.504 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 4.8 ttpm? -94.44 124.24 38.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.534 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 67.8 t80 -55.75 105.14 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -115.9 100.89 8.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.6 -152.38 17.58 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.497 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.01 131.69 11.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.519 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.415 ' HB2' ' NH1' ' A' ' 122' ' ' ARG . 19.8 mtm105 -83.88 49.0 1.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.905 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 124' ' ' LEU . 13.0 tt0 -107.78 134.32 50.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.478 HD12 ' CD ' ' A' ' 73' ' ' LYS . 3.5 tm? -34.81 -52.69 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.8 m -67.73 -47.7 68.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -47.37 -36.16 9.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.534 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 58.6 m-85 -69.24 -42.65 75.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.914 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.457 HG12 ' CD1' ' A' ' 70' ' ' LEU . 23.1 mt -63.52 -53.34 46.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -63.57 -21.98 66.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.808 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.405 ' CD1' ' C ' ' A' ' 130' ' ' TYR . 6.1 t80 -72.22 -46.86 54.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.1 mt -76.56 -39.0 54.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -40.05 -42.49 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -97.13 -58.73 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -46.23 -56.36 5.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' CB ' HD12 ' A' ' 80' ' ' ILE . . . -45.29 120.56 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.48 -70.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.1 t -58.01 -44.16 87.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.89 160.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.475 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 167.38 24.56 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.647 2.231 . . . . 0.0 112.374 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 t -109.5 101.62 10.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -159.45 168.0 27.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.467 -179.971 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t 60.36 41.7 15.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 110.876 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.9 t -145.91 153.79 41.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.838 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 45.72 -105.77 0.1 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.477 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.0 m 49.9 42.29 24.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 110.829 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 t -112.88 119.2 37.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.888 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.01 117.81 0.78 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.486 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -139.72 110.58 6.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.873 0.368 . . . . 0.0 110.854 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.77 90.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.04 -107.98 1.12 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.436 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -101.63 78.33 1.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 0.0 110.893 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.48 37.08 2.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.927 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -168.92 144.93 3.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.41 128.79 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.835 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 2.4 p90 -147.7 172.19 14.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 pp -114.2 -36.14 4.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.944 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -119.89 165.64 14.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.421 ' CB ' ' HG3' ' A' ' 35' ' ' GLU . 2.3 m -158.22 161.04 37.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.842 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -105.88 160.94 24.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.647 0.737 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 137.66 35.94 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.361 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.6 mm -71.41 129.46 88.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.606 0.717 . . . . 0.0 111.155 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 128.36 15.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.659 2.239 . . . . 0.0 112.335 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -40.37 -41.23 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -162.66 138.57 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -107.98 74.49 0.95 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -92.03 50.25 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.23 -178.13 15.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.467 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -39.99 5.9 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.662 2.241 . . . . 0.0 112.375 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.9 t -109.09 119.77 59.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 5.6 mmtp -66.96 128.47 36.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -82.86 117.56 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 21.8 t -112.93 124.3 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 37' ' ' PHE . 19.1 m -117.89 147.25 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.094 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -36.91 -40.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.421 ' HG3' ' CB ' ' A' ' 18' ' ' SER . 11.1 mt-10 -57.6 -49.02 77.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.466 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 17.7 p-10 -110.49 24.75 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.884 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.461 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 31.0 t80 -63.34 -55.51 23.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -67.14 -5.14 12.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -88.79 -45.61 9.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.461 HD13 ' ND2' ' A' ' 36' ' ' ASN . 21.5 mt -97.56 -59.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.121 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.447 HG23 ' CG1' ' A' ' 32' ' ' VAL . 38.7 t -49.16 -59.4 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.33 122.96 19.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -167.34 114.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.11 3.51 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.38 -40.92 6.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.24 140.79 48.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.73 149.21 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.09 137.64 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.147 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.408 HD23 ' CD1' ' A' ' 82' ' ' ILE . 13.2 tp -110.34 125.64 53.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 tp -113.48 131.15 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.58 109.53 12.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -84.84 128.97 34.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -128.79 179.9 5.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.24 128.55 17.44 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 0.0 111.136 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -6.75 19.36 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.515 ' CZ2' HG22 ' A' ' 88' ' ' THR . 4.1 p-90 -119.12 18.95 13.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.931 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 38.1 t -119.14 124.62 47.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.84 -61.73 7.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.514 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -42.8 -38.84 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.818 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.3 m -67.95 -44.26 77.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -64.76 -32.77 74.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -76.37 -21.7 55.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 18.4 tp -90.55 -18.63 24.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.514 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -41.19 -58.24 2.97 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.707 0.765 . . . . 0.0 110.943 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.73 -32.22 19.1 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.747 2.298 . . . . 0.0 112.331 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -68.69 -28.58 66.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -92.9 -38.65 11.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -47.42 -61.11 2.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -40.44 -55.13 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.457 ' N ' HD22 ' A' ' 124' ' ' LEU . 30.8 tp -41.25 -39.21 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.54 -64.94 3.56 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.477 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.18 -16.13 50.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -81.0 -44.89 17.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.903 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.433 HD12 ' CD1' ' A' ' 131' ' ' LEU . 95.3 mt -83.75 3.06 35.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.2 t -54.7 -19.02 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.02 10.48 16.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -110.61 98.63 38.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.552 0.692 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 0.18 6.08 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.704 2.269 . . . . 0.0 112.309 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -110.69 -30.87 7.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 55.1 mt -105.65 139.01 28.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.99 110.38 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.408 ' CD1' HD23 ' A' ' 49' ' ' LEU . 42.0 mm -79.11 134.7 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 30' ' ' LYS . . . -146.81 173.75 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -143.52 143.01 31.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.4 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 5.8 ttt -132.89 139.26 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -93.45 82.84 4.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -44.54 -57.45 3.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.515 HG22 ' CZ2' ' A' ' 56' ' ' TRP . 1.6 p -39.36 -27.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.195 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 87' ' ' ALA . . . -102.25 -29.79 11.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.109 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -120.51 120.38 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -55.66 116.83 3.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.441 ' CG1' HG23 ' A' ' 98' ' ' VAL . 90.9 t -68.72 111.7 9.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.588 0.709 . . . . 0.0 111.112 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.7 Cg_endo -69.82 -178.18 2.24 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.707 2.271 . . . . 0.0 112.351 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.497 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -97.57 159.37 31.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.855 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.509 ' O ' ' C ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.71 -27.29 6.88 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.734 -1.778 . . . . 0.0 112.353 -0.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.509 ' C ' ' O ' ' A' ' 95' ' ' PRO . 82.1 m-85 -28.51 111.16 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -117.5 84.07 2.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.441 HG23 ' CG1' ' A' ' 92' ' ' VAL . 99.2 t -77.21 106.69 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -129.65 25.81 5.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.52 115.57 0.37 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.503 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.533 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -98.74 154.2 37.54 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.644 0.735 . . . . 0.0 110.903 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.7 Cg_endo -69.64 151.34 91.03 Favored 'Cis proline' 0 C--O 1.232 0.208 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.392 -0.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -129.04 123.14 31.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.132 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.408 HG23 ' CB ' ' A' ' 118' ' ' TYR . 44.1 mt -119.3 126.65 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.454 ' CZ ' ' HE3' ' A' ' 117' ' ' LYS . 8.1 m-85 -126.78 154.54 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -125.83 129.76 50.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.9 t -101.88 97.59 8.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.694 0.759 . . . . 0.0 110.861 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.482 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.79 171.15 15.03 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.664 2.243 . . . . 0.0 112.335 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.495 ' O ' ' ND2' ' A' ' 110' ' ' ASN . . . -85.11 133.4 34.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER 49.65 29.5 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.482 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 10.5 mtmm -130.93 6.69 4.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.94 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.485 ' N ' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -35.92 -53.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.0 mt -39.06 -52.27 1.84 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -120.92 94.93 49.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.625 0.726 . . . . 0.0 110.906 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.729 2.286 . . . . 0.0 112.332 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -142.03 110.5 6.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HE3' ' CZ ' ' A' ' 105' ' ' TYR . 31.5 tttt -71.53 144.29 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.903 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.437 ' CZ ' ' CE1' ' A' ' 127' ' ' PHE . 35.4 t80 -90.48 106.82 18.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.9 100.75 7.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.894 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.19 -140.15 3.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.52 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.59 130.03 10.14 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.492 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -79.25 45.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 110.893 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 124' ' ' LEU . 18.2 tt0 -101.43 134.17 44.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 70' ' ' LEU . 3.2 tm? -36.28 -51.8 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.7 m -68.02 -45.99 72.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.38 -33.87 4.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.437 ' CE1' ' CZ ' ' A' ' 118' ' ' TYR . 54.0 m-85 -74.64 -42.01 59.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.3 mt -58.26 -53.01 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 t -65.27 -30.89 71.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.77 -47.83 84.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.433 ' CD1' HD12 ' A' ' 74' ' ' LEU . 30.6 mt -74.29 -42.52 59.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -39.54 -32.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -101.73 -60.68 1.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -47.98 -53.96 14.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.49 122.65 5.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -74.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.084 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.5 t -61.4 -54.91 37.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.01 -172.25 49.42 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.51 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -20.33 35.19 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.675 2.25 . . . . 0.0 112.367 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.3 t -47.87 96.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.7 m -98.9 164.84 12.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.852 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.478 -179.978 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.5 p -160.15 125.3 3.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.4 . . . . 0.0 110.841 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.6 m -151.79 153.33 34.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.815 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.03 81.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.7 p -134.71 110.39 9.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.893 0.377 . . . . 0.0 110.844 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 t -174.25 135.54 0.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.831 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 174.96 47.49 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -75.06 120.04 20.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 110.842 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -143.79 137.23 27.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.39 154.31 11.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.446 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -58.95 90.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mt -71.41 92.99 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -157.56 129.97 7.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -174.28 122.07 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 1.8 p90 -151.64 150.53 30.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 pp -95.81 -36.03 11.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' HG2' ' N ' ' A' ' 18' ' ' SER . 25.9 tttp -118.04 157.45 26.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.447 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 58.2 p -159.57 158.02 30.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.419 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 9.1 mm-40 -107.99 160.79 25.59 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.641 0.734 . . . . 0.0 110.848 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.419 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.71 139.94 41.66 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.656 2.237 . . . . 0.0 112.346 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.2 mm -69.5 129.78 91.24 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.634 0.73 . . . . 0.0 111.126 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 132.34 23.15 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.675 2.25 . . . . 0.0 112.335 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 24' ' ' SER . 8.6 pt-20 -44.89 -42.71 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.431 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 3.3 m -159.44 137.75 10.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.825 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -111.32 80.65 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -101.94 55.35 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.32 -172.94 13.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.472 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -41.67 4.03 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.653 2.235 . . . . 0.0 112.297 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 t -114.8 122.62 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.164 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -68.26 130.33 42.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.3 t -81.11 110.36 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.48 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 39.2 t -105.16 114.97 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 36' ' ' ASN . 35.9 m -108.86 146.35 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -33.54 -47.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -51.55 -48.79 62.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' VAL . 16.9 p-10 -110.38 28.15 8.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.48 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 8.9 t80 -73.33 -44.16 59.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -75.15 -4.57 39.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.53 -39.09 10.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.6 mt -98.91 -63.49 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.4 t -53.47 -60.81 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.109 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 24.8 m-20 -63.99 118.75 8.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 42' ' ' ASN . 38.7 m-20 -175.1 114.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.26 31.69 2.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -125.33 -38.05 2.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' NZ ' HG23 ' A' ' 81' ' ' VAL . 17.0 pttp -127.88 161.13 29.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -80.94 137.92 36.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -144.51 136.9 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.0 tp -116.39 136.32 53.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 tp -116.45 137.14 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -127.25 110.97 13.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 103' ' ' THR . 69.8 m-85 -87.53 138.64 31.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 4.9 p90 -143.85 175.31 10.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.933 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.94 134.35 26.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.55 0.69 . . . . 0.0 111.107 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -16.36 37.48 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.689 2.259 . . . . 0.0 112.352 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -113.49 25.99 10.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.7 t -123.08 134.27 54.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.78 -59.77 8.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.475 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -38.26 -35.7 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.297 . . . . 0.0 110.832 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -52.59 61.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -57.19 -36.61 71.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -77.53 -35.85 52.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.8 tp -81.12 -19.45 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.512 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.6 tt0 -46.98 -58.39 7.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.668 0.747 . . . . 0.0 110.886 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.8 -28.03 25.58 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.654 2.236 . . . . 0.0 112.37 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -72.85 -27.36 61.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 41.5 t80 -96.32 -46.07 6.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -41.81 -59.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 70' ' ' LEU . 25.5 mt-10 -39.48 -63.47 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.447 ' N ' HD21 ' A' ' 124' ' ' LEU . 15.7 tp -37.25 -34.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.5 -51.4 42.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.516 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.4 -18.32 57.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.448 ' CD ' HD12 ' A' ' 124' ' ' LEU . 6.3 mtpm? -76.86 -53.74 7.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' ASP . 98.0 mt -79.41 1.78 24.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.1 t -43.06 -23.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 74' ' ' LEU . 16.4 mtpt -89.89 23.74 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.911 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' LEU . 50.1 p-10 -101.36 98.06 8.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.595 0.712 . . . . 0.0 110.845 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 1.04 4.8 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.683 2.255 . . . . 0.0 112.355 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -123.42 -43.29 2.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.456 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 62.1 mt -87.25 144.48 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.453 ' N ' HG21 ' A' ' 80' ' ' ILE . 60.5 t -134.95 97.8 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.5 mm -70.55 122.2 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -138.09 171.28 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.051 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -140.82 159.01 43.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.4 ttt -150.76 135.45 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 87' ' ' ALA . 30.9 t0 -89.51 80.89 6.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -35.91 -62.94 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.9 p -37.87 -39.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.44 -28.81 20.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 87' ' ' ALA . 14.3 m-80 -124.38 110.39 14.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -49.11 130.24 18.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.461 ' CG2' ' HB1' ' A' ' 87' ' ' ALA . 65.2 t -76.97 118.81 74.37 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.626 0.727 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -164.57 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 2.252 . . . . 0.0 112.34 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.48 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -121.06 161.14 42.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.626 0.726 . . . . 0.0 110.887 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.7 Cg_endo -69.77 -12.91 12.34 Favored 'Cis proline' 0 C--N 1.341 0.176 0 C-N-CA 122.681 -1.799 . . . . 0.0 112.359 -0.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 95' ' ' PRO . 88.2 m-85 -33.86 136.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -141.29 119.23 11.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.98 80.77 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.106 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -66.13 -45.43 81.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.67 -171.73 13.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.462 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.502 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -147.97 157.82 42.89 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.628 0.728 . . . . 0.0 110.861 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.8 166.99 72.73 Favored 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.68 -1.8 . . . . 0.0 112.323 0.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 52' ' ' PHE . 88.1 m -146.2 131.18 18.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.6 mt -124.92 129.43 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -125.49 159.34 32.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.518 ' HB3' ' CG ' ' A' ' 116' ' ' LYS . 21.2 t80 -119.89 151.19 39.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 m -121.64 87.63 46.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.673 0.749 . . . . 0.0 110.837 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.502 ' O ' ' CE ' ' A' ' 112' ' ' LYS . 54.0 Cg_endo -69.79 168.23 22.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.671 2.247 . . . . 0.0 112.332 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.478 ' C ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.16 139.03 32.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.478 ' CG ' ' C ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER 49.84 25.02 1.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.471 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.1 mtmt -128.0 18.23 6.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' CE ' ' O ' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -46.44 -34.07 4.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mt -82.76 -24.88 33.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 111' ' ' LYS . 10.9 m120 -119.43 63.02 7.09 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.616 0.722 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -164.72 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.363 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.518 ' CG ' ' HB3' ' A' ' 106' ' ' PHE . 0.8 OUTLIER -160.63 155.55 24.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.9 ttpp -117.72 126.75 53.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.41 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 60.1 t80 -54.97 101.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -115.2 94.65 4.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.73 -141.64 4.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.504 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.78 134.8 12.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.502 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.44 ' HB2' ' NH1' ' A' ' 122' ' ' ARG . 10.3 mtp-105 -84.37 49.74 1.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.876 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 124' ' ' LEU . 26.9 tt0 -109.66 133.85 52.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.448 HD12 ' CD ' ' A' ' 73' ' ' LYS . 3.3 tm? -36.28 -53.85 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.5 p -65.16 -42.7 93.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.09 -27.93 36.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.41 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 58.0 m-85 -78.8 -47.32 16.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.7 mt -53.19 -50.73 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.12 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.0 p -60.67 -55.32 34.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.828 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -44.44 -45.09 8.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 135' ' ' ALA . 18.9 mt -76.51 -37.55 56.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.412 ' CD ' ' HG2' ' A' ' 139' ' ' PRO . 17.9 mm-40 -48.18 -45.89 34.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 12.9 ptm180 -86.45 -40.04 15.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.462 ' OE1' ' CD ' ' A' ' 116' ' ' LYS . 46.7 mm-40 -68.89 -65.02 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.455 ' CB ' HD11 ' A' ' 80' ' ' ILE . . . -34.18 131.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -66.72 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.8 t -66.16 -43.88 85.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.07 135.55 0.43 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.451 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.412 ' HG2' ' CD ' ' A' ' 132' ' ' GLN . 53.1 Cg_endo -69.83 88.85 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.649 2.233 . . . . 0.0 112.32 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.5 m -158.19 118.43 3.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 55.6 m -146.45 166.95 24.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.85 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.486 -179.993 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.8 p -116.46 154.54 30.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.858 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 t -160.85 123.35 3.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.03 94.53 1.01 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.512 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -106.71 87.28 2.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.835 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -124.85 128.05 48.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.1 146.7 18.1 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 0.4 OUTLIER -123.34 81.7 1.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 110.892 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 8' ' ' PHE . 13.9 m-20 -166.7 167.05 15.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.16 126.65 2.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -123.57 111.14 15.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 0.0 110.874 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.06 18.45 14.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.925 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 144.96 48.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -170.36 121.77 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.438 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.2 p90 -154.1 156.22 36.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 pp -98.31 -43.87 6.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.488 ' CG ' ' N ' ' A' ' 18' ' ' SER . 7.4 ttpm? -110.71 166.38 11.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.488 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 98.1 p -170.78 152.0 3.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -96.23 158.45 33.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.623 0.725 . . . . 0.0 110.896 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 145.75 58.04 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.676 2.251 . . . . 0.0 112.365 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.6 mm -73.13 133.45 81.42 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.739 . . . . 0.0 111.108 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 174.11 9.99 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.361 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -97.23 -36.04 10.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -145.0 137.73 26.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -130.2 37.23 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.51 60.44 2.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.69 -168.43 12.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -41.14 4.54 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 0.0 112.332 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.7 t -119.13 122.14 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.59 131.13 42.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.0 t -78.77 135.14 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 38.8 t -132.15 120.03 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 36' ' ' ASN . 20.3 m -116.97 147.58 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.438 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -34.3 -44.11 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -53.77 -46.47 70.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 33' ' ' VAL . 18.1 p-10 -116.32 30.6 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.559 ' CZ ' ' HG3' ' A' ' 93' ' ' PRO . 5.2 t80 -69.98 -54.73 11.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.43 -5.69 20.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -90.6 -41.6 11.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.893 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.413 HD12 ' ND2' ' A' ' 36' ' ' ASN . 12.4 mt -97.5 -58.16 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.122 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.0 t -54.56 -60.1 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.09 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 34.3 m-20 -67.45 123.08 19.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.839 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 28.9 m-20 -171.89 108.5 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -83.43 0.42 46.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -85.68 -45.8 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -138.36 162.86 33.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.67 150.38 36.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 49' ' ' LEU . 49.1 t -142.98 140.99 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.457 ' N ' HG12 ' A' ' 48' ' ' VAL . 29.9 tp -112.95 126.07 55.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 tp -113.45 135.33 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.105 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' C ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -126.03 117.95 24.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -91.59 120.44 32.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.564 ' CE1' ' OD2' ' A' ' 86' ' ' ASP . 28.6 p90 -128.47 178.84 6.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.24 132.44 20.07 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.564 0.697 . . . . 0.0 111.094 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 -2.49 10.29 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.553 ' CZ3' ' SG ' ' A' ' 57' ' ' CYS . 7.3 p-90 -122.04 6.73 9.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.553 ' SG ' ' CZ3' ' A' ' 56' ' ' TRP . 1.3 m -96.23 137.34 35.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.98 -58.17 4.51 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -50.5 -39.19 47.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.324 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.6 m -64.06 -38.95 92.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -64.12 -45.91 86.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -68.34 -14.56 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 64' ' ' GLU . 14.2 tp -96.33 -24.76 16.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -37.62 -57.93 1.42 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.595 0.712 . . . . 0.0 110.875 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.4 Cg_endo -69.76 -27.74 26.11 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.686 2.257 . . . . 0.0 112.359 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -71.58 -32.5 68.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -88.69 -40.26 13.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -44.48 -59.33 2.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -38.78 -56.21 1.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.441 ' N ' HD23 ' A' ' 124' ' ' LEU . 28.0 tp -43.79 -39.89 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.07 -63.25 5.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.438 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.34 -26.28 67.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.875 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -72.12 -44.14 63.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.463 HD11 ' CD1' ' A' ' 82' ' ' ILE . 82.2 mt -89.55 3.19 53.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.1 t -52.09 -20.63 2.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -98.87 22.71 9.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.29 99.28 14.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.61 0.719 . . . . 0.0 110.865 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -3.25 11.62 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.726 2.284 . . . . 0.0 112.334 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.19 -19.09 9.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.2 mt -123.29 134.44 66.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.2 t -130.2 103.98 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.463 ' CD1' HD11 ' A' ' 74' ' ' LEU . 51.4 mm -69.61 132.36 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.146 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.63 167.75 22.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 pttt -139.92 156.36 46.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.411 ' SD ' ' OD1' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -149.18 132.91 16.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.564 ' OD2' ' CE1' ' A' ' 53' ' ' TYR . 1.2 m-20 -86.67 101.39 13.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -58.14 -64.96 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -45.35 -21.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' A' ' 87' ' ' ALA . . . -92.58 -29.74 16.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -142.79 130.37 21.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -47.04 150.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 93' ' ' PRO . 89.7 t -96.49 135.49 22.37 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.648 0.737 . . . . 0.0 111.088 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.559 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.5 Cg_endo -69.79 -163.55 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.683 2.255 . . . . 0.0 112.339 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.527 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -132.68 153.87 81.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.704 0.764 . . . . 0.0 110.839 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.85 -7.42 10.12 Favored 'Cis proline' 0 C--N 1.342 0.196 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.304 0.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.475 ' C ' ' O ' ' A' ' 95' ' ' PRO . 51.8 m-85 -31.7 131.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -142.77 126.74 17.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 81.8 t -133.83 115.59 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -123.0 -41.85 2.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.29 118.09 4.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.527 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -96.23 155.19 38.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.661 0.743 . . . . 0.0 110.905 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.77 161.11 86.88 Favored 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.318 -0.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.9 m -141.71 115.04 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -108.52 138.8 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.143 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -133.92 178.03 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.952 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -149.32 126.51 11.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.62 100.08 13.28 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.664 0.745 . . . . 0.0 110.833 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.481 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.75 171.04 15.18 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.609 2.206 . . . . 0.0 112.388 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.456 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.67 139.49 31.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.084 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.7 p30 46.85 25.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.481 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.2 mtmm -127.27 22.44 6.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 108' ' ' PRO . 7.7 mmpt? -45.86 -66.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 112' ' ' LYS . 6.9 mp -34.02 -44.43 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.942 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -122.44 90.14 49.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.593 0.711 . . . . 0.0 110.92 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -163.75 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.632 2.221 . . . . 0.0 112.31 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -141.7 131.31 24.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -100.04 134.13 43.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.85 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -79.24 111.84 15.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -124.15 98.3 5.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 179.57 -146.27 6.98 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.99 134.33 12.38 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.489 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -81.29 45.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.888 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 124' ' ' LEU . 9.0 tt0 -103.12 134.48 46.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 70' ' ' LEU . 3.2 tm? -36.84 -54.92 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 60.4 p -60.84 -48.93 79.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -47.8 -34.97 9.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -70.61 -37.31 73.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.4 mt -69.05 -57.55 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.113 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.6 t -60.29 -24.7 65.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -70.82 -48.57 53.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.935 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 25.8 mt -71.22 -38.18 72.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -40.24 -42.95 1.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -94.78 -67.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -40.53 -54.42 2.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 131' ' ' LEU . . . -44.57 100.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.069 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.444 HG21 ' N ' ' A' ' 137' ' ' SER . 1.3 t -44.2 -24.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.444 ' N ' HG21 ' A' ' 136' ' ' THR . 1.2 t -116.33 48.46 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 137' ' ' SER . . . -36.36 145.05 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.497 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 88.29 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.695 2.264 . . . . 0.0 112.333 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.3 t -99.23 123.79 43.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.5 m -42.39 100.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.488 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 m -148.71 145.48 27.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.904 0.383 . . . . 0.0 110.879 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 p -166.92 174.79 8.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.18 134.31 6.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.6 p -128.24 154.96 45.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 110.858 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.2 m -116.71 -43.53 2.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.87 172.19 21.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.451 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -107.84 118.16 36.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.898 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -62.34 -65.15 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.9 168.91 4.52 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.474 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -94.61 110.91 22.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 110.896 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.434 ' C ' HD13 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -83.56 166.47 18.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.92 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' C ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -169.08 146.1 3.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -175.13 124.16 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.443 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.2 p90 -166.59 154.2 9.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.417 HD11 ' N ' ' A' ' 17' ' ' LYS . 1.9 pp -104.21 -37.04 7.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.934 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.423 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 17.0 ttpt -109.86 158.2 18.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.413 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 90.9 p -164.22 149.1 10.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -98.86 160.7 27.15 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.656 0.741 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 143.57 51.32 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.648 2.232 . . . . 0.0 112.333 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.9 mm -68.87 129.15 92.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.633 0.73 . . . . 0.0 111.154 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 136.15 32.41 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.667 2.245 . . . . 0.0 112.355 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -49.05 -50.24 37.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.6 t -149.53 137.28 20.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -111.43 50.31 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.55 -25.05 59.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.84 169.94 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.405 ' HG3' ' CG ' ' A' ' 68' ' ' LYS . 53.5 Cg_endo -69.79 -29.67 23.37 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.686 2.258 . . . . 0.0 112.332 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.5 t -111.73 121.0 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -71.12 134.93 47.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.1 t -86.35 104.75 14.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.147 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.441 HG22 ' CB ' ' A' ' 83' ' ' ALA . 44.9 t -95.91 114.11 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.171 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 34' ' ' ALA . 26.3 m -109.53 144.74 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.86 -43.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -56.09 -50.82 69.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.452 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 28.5 p30 -105.41 21.58 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.417 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 14.4 t80 -62.8 -58.78 6.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.02 -6.97 7.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.858 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.97 -44.13 11.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.5 mt -97.21 -58.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -51.86 -61.55 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -69.06 114.61 7.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -167.08 106.72 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -91.11 31.88 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -126.4 -37.82 2.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.826 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.81 145.55 48.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.3 147.26 53.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.9 t -145.26 147.84 18.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.131 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.46 HD23 ' CD1' ' A' ' 82' ' ' ILE . 21.8 tp -124.57 126.9 46.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.945 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.2 tp -107.72 139.51 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -127.28 105.13 8.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -84.78 115.33 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -125.6 179.69 5.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.66 132.91 23.67 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.569 0.7 . . . . 0.0 111.12 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.425 ' HD2' ' CG2' ' A' ' 88' ' ' THR . 53.7 Cg_endo -69.72 -1.65 8.79 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.744 2.296 . . . . 0.0 112.348 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -122.96 5.59 9.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.427 ' HB3' ' NE2' ' A' ' 59' ' ' HIS . 1.3 m -98.64 130.31 45.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -66.11 -59.65 7.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.497 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.568 ' CD2' ' HD3' ' A' ' 102' ' ' PRO . 3.1 p-80 -38.41 -31.65 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.875 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLY . 9.5 t -68.54 -49.6 58.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -53.68 -45.53 70.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -72.49 -24.86 61.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.3 tp -87.68 -20.25 26.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.946 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -42.97 -58.31 4.11 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.657 0.741 . . . . 0.0 110.861 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.1 Cg_endo -69.74 -26.5 27.61 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.704 2.27 . . . . 0.0 112.328 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -74.24 -27.35 60.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 40.3 t80 -96.32 -33.57 11.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.405 ' CG ' ' HG3' ' A' ' 28' ' ' PRO . 1.2 ttmp? -51.77 -57.62 8.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -40.53 -60.75 1.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.47 ' N ' HD21 ' A' ' 124' ' ' LEU . 21.3 tp -38.48 -38.81 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.83 -65.61 3.21 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.84 -16.43 64.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -80.88 -42.66 21.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.471 HD12 ' CD1' ' A' ' 82' ' ' ILE . 80.6 mt -82.09 3.34 27.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.2 m -53.92 -24.78 17.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -78.1 6.9 7.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.917 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 4.1 t0 -113.49 98.98 48.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.659 0.742 . . . . 0.0 110.843 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.3 Cg_endo -69.72 0.3 5.82 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.71 2.273 . . . . 0.0 112.36 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -110.83 -36.83 5.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 81' ' ' VAL . 64.3 mt -92.55 137.97 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.468 ' N ' HG22 ' A' ' 80' ' ' ILE . 92.2 t -135.37 116.81 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.471 ' CD1' HD12 ' A' ' 74' ' ' LEU . 23.3 mm -89.05 132.45 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' A' ' 32' ' ' VAL . . . -142.03 171.53 13.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -139.74 138.13 35.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.489 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 12.4 ttt -132.5 143.19 49.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -95.88 95.27 8.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -48.77 -67.19 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.425 ' CG2' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -46.97 -23.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.423 ' C ' ' HE3' ' A' ' 17' ' ' LYS . . . -93.52 -25.12 17.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.489 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -141.07 125.29 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.0 128.97 36.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.52 128.56 74.64 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.591 0.71 . . . . 0.0 111.141 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -169.77 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.663 2.242 . . . . 0.0 112.343 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.487 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.5 m -121.25 160.84 43.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.667 0.746 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.2 Cg_endo -69.69 -8.62 10.47 Favored 'Cis proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 -1.801 . . . . 0.0 112.387 -0.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 95' ' ' PRO . 86.0 m-85 -34.04 123.37 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -125.74 130.16 50.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.885 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 65.8 t -133.09 120.48 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.093 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -128.87 -38.64 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.79 123.3 5.32 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.516 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.533 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.4 OUTLIER -97.14 154.0 38.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.738 . . . . 0.0 110.878 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.568 ' HD3' ' CD2' ' A' ' 59' ' ' HIS . 53.1 Cg_endo -69.83 155.33 93.49 Favored 'Cis proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.29 0.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 92.9 m -131.53 100.27 5.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.458 HD12 ' NE ' ' A' ' 122' ' ' ARG . 95.6 mt -94.79 141.93 14.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.151 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -140.88 161.59 37.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.942 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -128.25 136.95 51.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -105.3 93.27 6.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.843 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.486 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.6 Cg_endo -69.75 164.59 33.96 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.394 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.459 ' O ' ' CE ' ' A' ' 111' ' ' LYS . . . -78.04 145.44 35.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.2 p30 41.94 24.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.486 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.2 mtmt -128.66 68.07 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.427 ' HA ' ' NZ ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -90.57 -49.01 6.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.558 ' CD1' ' C ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -59.75 -25.47 64.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.462 ' HB2' ' CD1' ' A' ' 113' ' ' LEU . 2.8 t-20 -133.39 84.06 47.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.646 0.736 . . . . 0.0 110.91 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -163.8 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -148.43 137.09 21.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 118' ' ' TYR . 29.8 ttmt -105.19 151.4 24.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.549 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 68.4 t80 -94.58 108.83 20.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -121.58 100.0 6.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 178.73 -153.59 12.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.1 133.35 12.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.477 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.458 ' NE ' HD12 ' A' ' 104' ' ' ILE . 84.0 mmt-85 -80.36 45.96 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.844 0.355 . . . . 0.0 110.914 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 124' ' ' LEU . 8.8 tt0 -105.39 133.29 50.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.47 HD21 ' N ' ' A' ' 70' ' ' LEU . 3.4 tm? -34.8 -55.59 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.3 m -58.86 -52.21 66.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.827 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.03 -30.38 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.549 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 38.9 m-85 -78.19 -40.34 37.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 mt -63.64 -57.26 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.153 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -58.01 -35.49 71.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.566 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 16.9 t80 -53.95 -52.82 59.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.554 HD23 ' CE2' ' A' ' 130' ' ' TYR . 15.6 mt -74.84 -39.89 61.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -38.79 -39.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.93 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -98.98 -57.07 2.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.566 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 69.6 mm-40 -49.24 -53.68 20.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -42.51 104.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.157 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 2.1 t -46.83 -49.62 19.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.7 m -73.98 -45.38 50.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.91 168.14 31.36 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.504 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 148.47 65.56 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.367 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.2 t -63.88 131.93 49.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 57.7 p -111.82 89.99 3.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 t -156.71 155.71 32.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.88 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -99.98 -57.01 2.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.859 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.65 99.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -152.29 172.69 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.904 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.7 t -129.46 -55.59 1.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.851 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.54 -100.72 0.15 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.468 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -108.05 165.16 11.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.889 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -174.87 119.83 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.53 72.76 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 71.07 53.97 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.924 0.392 . . . . 0.0 110.905 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 tp -68.91 109.49 3.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.58 157.9 44.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -174.85 118.91 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 34' ' ' ALA . 14.5 p90 -162.61 174.79 12.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 pp -131.88 -40.21 1.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.12 125.25 41.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.1 156.74 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.847 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 4.5 mm-40 -106.0 161.68 22.08 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.652 0.739 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.417 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.4 Cg_endo -69.83 143.47 50.6 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.701 2.268 . . . . 0.0 112.306 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.2 mm -68.78 127.47 93.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.618 0.723 . . . . 0.0 111.109 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.94 43.95 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.709 2.273 . . . . 0.0 112.351 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.59 -39.17 92.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 m -150.13 123.27 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -133.11 45.9 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.49 54.12 2.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.845 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.17 -160.11 23.4 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.491 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -41.55 4.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.63 2.22 . . . . 0.0 112.396 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.4 t -119.53 107.19 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.116 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -53.48 124.98 16.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.8 t -75.4 126.1 35.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.464 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 30.0 t -118.51 120.31 63.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 36' ' ' ASN . 31.6 m -113.44 145.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HB2' ' CE2' ' A' ' 15' ' ' TYR . . . -36.4 -38.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.091 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -59.51 -46.75 87.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' VAL . 22.2 p-10 -111.89 24.84 12.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.464 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 6.1 t80 -63.46 -58.06 8.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -65.29 -7.72 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -86.9 -44.22 11.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.7 mt -98.28 -62.3 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.445 HG21 ' CG1' ' A' ' 32' ' ' VAL . 97.1 t -48.14 -62.04 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.136 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -72.66 126.55 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.416 ' ND2' ' HE3' ' A' ' 46' ' ' LYS . 11.7 t-20 -172.91 108.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -87.6 29.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -124.14 -41.66 2.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HE3' ' ND2' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -136.28 130.13 32.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.57 151.95 5.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.499 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 89.4 t -146.33 152.58 13.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.8 tp -124.17 126.13 45.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 tp -114.1 129.38 70.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.121 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -123.83 114.35 19.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -85.38 133.82 34.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -143.0 169.14 18.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.04 131.42 23.85 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.589 0.709 . . . . 0.0 111.074 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -10.13 27.82 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.376 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -115.58 5.11 14.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 7.5 t -101.71 126.89 48.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.15 -59.14 8.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -42.36 -45.64 4.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.6 m -69.82 -43.72 71.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -55.67 -35.88 66.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -74.62 -29.9 61.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.9 tp -83.15 -20.88 33.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.53 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -41.16 -57.58 3.4 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.652 0.739 . . . . 0.0 110.864 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.71 -27.72 26.36 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.705 2.27 . . . . 0.0 112.345 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -71.92 -30.65 65.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -91.01 -37.07 13.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -47.57 -54.37 11.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.833 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -43.35 -56.21 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.47 ' N ' HD21 ' A' ' 124' ' ' LEU . 21.7 tp -42.99 -38.5 2.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.29 -65.16 3.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.438 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -60.83 -27.55 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 0.0 110.89 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mmtm -67.95 -46.46 71.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.472 HD13 ' CG1' ' A' ' 82' ' ' ILE . 91.5 mt -84.72 2.98 39.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.6 t -48.64 -24.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -93.57 24.24 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.45 97.63 12.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.583 0.706 . . . . 0.0 110.857 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -2.17 9.72 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.664 2.243 . . . . 0.0 112.364 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -117.5 -42.85 2.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.9 mt -92.77 145.07 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.179 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.1 t -138.99 106.82 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.472 ' CG1' HD13 ' A' ' 74' ' ' LEU . 21.2 mm -76.87 135.8 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . . . -145.62 169.17 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -143.34 149.51 37.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -144.06 138.45 28.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.85 107.0 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.82 -51.74 68.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.125 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -16.31 28.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.549 ' C ' ' ND2' ' A' ' 90' ' ' ASN . . . -106.88 0.69 24.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.549 ' ND2' ' C ' ' A' ' 89' ' ' ALA . 3.8 m-80 -162.87 124.61 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.92 130.05 42.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.4 t -78.34 125.33 85.01 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.641 0.734 . . . . 0.0 111.168 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -164.57 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -127.16 160.93 57.11 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.683 0.754 . . . . 0.0 110.857 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.0 Cg_endo -69.71 -3.03 7.38 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.74 -1.775 . . . . 0.0 112.381 -0.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.46 ' N ' ' HA ' ' A' ' 94' ' ' SER . 97.3 m-85 -36.4 125.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -129.31 125.11 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -130.99 103.54 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.142 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -104.93 -35.48 7.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.837 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.57 134.28 6.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.478 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.507 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -98.14 156.94 35.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 0.0 110.92 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.75 165.52 76.42 Favored 'Cis proline' 0 C--O 1.231 0.164 0 C-N-CA 122.732 -1.778 . . . . 0.0 112.373 -0.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 71.2 m -147.16 105.08 3.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.117 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.46 HG21 ' N ' ' A' ' 105' ' ' TYR . 21.2 mt -97.19 141.4 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.121 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.46 ' N ' HG21 ' A' ' 104' ' ' ILE . 8.3 m-85 -140.97 160.34 40.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 31.2 t80 -130.27 140.39 50.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.7 p -109.43 98.66 33.18 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.667 0.746 . . . . 0.0 110.859 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.488 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.76 166.49 27.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.622 2.215 . . . . 0.0 112.37 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -82.48 128.6 34.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.08 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.23 29.75 15.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.488 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.9 mtmt -135.0 40.93 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -64.05 -33.86 76.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.6 mp -67.47 -36.21 80.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -124.7 81.56 60.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.593 0.711 . . . . 0.0 110.875 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 178.11 4.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.481 ' CD ' ' HG3' ' A' ' 108' ' ' PRO . 7.9 mptt -114.93 127.41 55.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -101.92 108.0 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.435 ' CE1' ' CD2' ' A' ' 130' ' ' TYR . 55.3 t80 -55.21 108.69 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -125.52 90.92 3.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -172.73 -134.23 1.78 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.479 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.14 139.79 14.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.429 ' CZ ' ' HG3' ' A' ' 102' ' ' PRO . 32.9 mtp180 -84.8 37.86 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.757 0.313 . . . . 0.0 110.874 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 124' ' ' LEU . 15.1 tp10 -98.25 129.26 44.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.47 HD21 ' N ' ' A' ' 70' ' ' LEU . 3.2 tm? -34.28 -55.29 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.9 p -57.65 -45.71 85.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 123' ' ' GLU . 2.1 t70 -53.43 -33.53 54.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.43 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 88.7 m-85 -73.58 -40.33 63.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.7 mt -61.58 -57.41 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.181 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.34 -35.18 78.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.435 ' CD2' ' CE1' ' A' ' 118' ' ' TYR . 13.8 t80 -53.56 -48.1 69.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 28.9 mt -76.22 -39.24 55.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.908 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -39.92 -40.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.3 mtp85 -92.0 -64.4 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 135' ' ' ALA . 21.8 mm-40 -41.78 -60.15 1.45 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -35.19 116.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.1 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.6 OUTLIER -35.19 -75.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.122 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 m -75.81 -55.69 5.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 100.13 -179.16 29.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 136.21 32.29 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.689 2.26 . . . . 0.0 112.322 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.7 t -61.04 125.8 25.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.0 m -113.64 42.28 2.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.453 -179.939 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t -138.78 161.25 37.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 110.827 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.0 p -76.51 163.48 26.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.05 137.16 38.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.506 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.4 m -107.24 96.64 6.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 0.0 110.841 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.6 m -135.31 128.56 31.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.848 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.57 -128.25 3.01 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.432 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -42.11 129.91 3.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -110.94 39.47 2.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.89 -130.47 17.11 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.504 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.415 ' CG ' ' HE2' ' A' ' 13' ' ' LYS . 11.8 t-20 -105.86 87.42 2.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.378 . . . . 0.0 110.918 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 tt -73.92 79.57 1.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HE2' ' CG ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -170.5 -178.02 2.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -175.65 129.29 0.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 4.3 p90 -156.25 153.94 29.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.958 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 pp -112.99 -36.91 4.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -109.69 155.5 21.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 35' ' ' GLU . 18.7 t -166.4 143.78 5.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.427 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.0 mm-40 -86.6 162.05 46.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.654 0.74 . . . . 0.0 110.882 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.427 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.77 142.32 47.56 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.649 2.233 . . . . 0.0 112.353 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.413 HD11 ' CB ' ' A' ' 35' ' ' GLU . 30.6 mm -71.65 131.83 85.83 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.644 0.735 . . . . 0.0 111.1 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 178.38 4.67 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.626 2.217 . . . . 0.0 112.37 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -103.13 -34.96 8.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 p -147.98 125.64 11.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -107.8 47.5 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -58.8 -26.92 64.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.53 168.87 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.486 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.436 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 54.1 Cg_endo -69.76 -25.66 28.35 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.685 2.256 . . . . 0.0 112.364 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.1 t -120.1 113.15 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -57.66 129.59 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.3 125.97 39.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.153 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.467 HG22 ' CB ' ' A' ' 83' ' ' ALA . 21.8 t -124.6 124.57 68.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 36' ' ' ASN . 20.9 m -122.64 148.46 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -32.75 -40.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.121 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.454 ' N ' ' OG ' ' A' ' 18' ' ' SER . 12.7 mt-10 -55.75 -49.56 72.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.857 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 33' ' ' VAL . 36.4 p-10 -115.77 34.91 4.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.464 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 21.4 t80 -71.09 -57.93 4.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -66.6 -5.67 12.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -87.08 -47.41 8.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.3 mt -96.92 -58.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.3 t -49.0 -61.64 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.167 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -68.56 126.91 31.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -174.33 118.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -95.64 0.45 52.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -95.54 -37.58 10.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -138.87 138.93 37.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.522 ' OD2' ' CG1' ' A' ' 80' ' ' ILE . 1.3 p30 -58.63 152.87 17.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.87 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.1 t -148.42 142.72 19.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.473 HD22 ' CD1' ' A' ' 82' ' ' ILE . 39.4 tp -117.91 140.51 49.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 tp -127.86 135.6 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.49 ' CD ' ' C ' ' A' ' 51' ' ' GLU . 5.8 tm-20 -126.77 121.88 33.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.549 ' CE1' HG22 ' A' ' 92' ' ' VAL . 78.9 m-85 -95.74 118.7 32.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -126.34 179.08 5.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.26 134.56 17.76 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.625 0.726 . . . . 0.0 111.123 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -16.96 37.93 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.69 2.26 . . . . 0.0 112.339 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.404 ' CZ3' ' HB2' ' A' ' 57' ' ' CYS . 2.4 p-90 -105.85 6.53 31.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . 42.1 t -107.16 112.7 25.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.876 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -57.98 -57.16 21.3 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -41.02 -37.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 97.5 m -73.75 -34.66 64.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 58' ' ' GLY . 2.1 ttmm -62.33 -35.48 79.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -73.77 -27.75 61.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 64' ' ' GLU . 13.2 tp -81.36 -25.15 36.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.514 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.1 tt0 -37.53 -58.37 1.28 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.645 0.736 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.3 Cg_endo -69.82 -31.5 20.13 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.692 2.261 . . . . 0.0 112.28 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -68.13 -29.98 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -92.47 -38.87 11.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.436 ' HG3' ' CG ' ' A' ' 28' ' ' PRO . 5.5 ttmm -50.07 -58.68 5.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 9.6 mt-10 -41.59 -49.25 4.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.44 ' N ' HD21 ' A' ' 124' ' ' LEU . 25.1 tp -47.09 -41.39 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.56 -66.96 2.48 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.478 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.06 -26.54 68.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.85 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 69' ' ' GLU . 17.2 mmtt -70.09 -39.94 75.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.5 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 64.3 mt -79.13 4.86 13.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.3 t -56.97 -11.96 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -82.68 -20.14 36.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CG ' ' O ' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -98.43 100.99 10.27 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.717 . . . . 0.0 110.855 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -2.91 10.98 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 0.0 112.322 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -107.7 -33.05 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.522 ' CG1' ' OD2' ' A' ' 47' ' ' ASP . 54.4 mt -92.05 117.93 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.1 t -118.2 125.44 74.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.106 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.474 ' CD1' HD13 ' A' ' 74' ' ' LEU . 30.7 mm -93.24 137.28 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.467 ' CB ' HG22 ' A' ' 32' ' ' VAL . . . -142.9 161.03 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.036 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -131.11 156.51 45.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.476 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 13.9 ttt -151.09 132.36 14.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 90' ' ' ASN . 26.1 t70 -91.32 95.85 10.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -52.28 -60.46 3.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -42.82 -27.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.38 -28.88 13.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.476 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.3 OUTLIER -134.88 114.97 13.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -47.2 131.24 13.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.549 HG22 ' CE1' ' A' ' 52' ' ' PHE . 93.0 t -80.86 132.85 56.2 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.59 0.709 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.439 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.6 Cg_endo -69.76 -165.83 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 0.0 112.326 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.486 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -124.13 160.89 50.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.645 0.736 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.5 Cg_endo -69.72 -8.75 10.59 Favored 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.356 -0.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 95' ' ' PRO . 98.3 m-85 -33.08 124.09 0.38 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -128.98 119.85 25.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 101' ' ' PHE . 71.0 t -121.66 96.47 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.17 -43.39 7.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.812 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.53 128.58 6.16 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.518 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -97.39 156.37 36.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.662 0.744 . . . . 0.0 110.858 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.6 Cg_endo -69.71 163.96 80.35 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.34 -0.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 50.2 m -145.73 106.09 4.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.5 mt -96.51 136.23 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -134.76 158.91 42.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -128.05 135.04 49.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.1 p -107.81 91.26 7.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.652 0.739 . . . . 0.0 110.832 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.483 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.8 Cg_endo -69.73 168.95 20.04 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.256 . . . . 0.0 112.339 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.24 140.11 35.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.01 31.36 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.483 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.7 mtmm -128.53 34.58 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 113' ' ' LEU . 27.3 mmtp -64.58 -58.24 6.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 112' ' ' LYS . 4.3 mm? -34.87 -41.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.909 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -134.97 92.64 18.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.572 0.701 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -173.44 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -135.66 121.02 19.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.25 123.89 34.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.63 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 60.6 t80 -57.45 96.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.906 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -109.7 95.04 5.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.918 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.34 -151.51 9.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.36 135.11 13.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.484 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 122' ' ' ARG . 13.1 mtm105 -80.59 45.62 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -102.43 137.05 41.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.44 HD21 ' N ' ' A' ' 70' ' ' LEU . 3.3 tm? -40.48 -52.43 2.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.8 m -66.3 -47.34 73.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -46.69 -36.75 7.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.918 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.63 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 65.3 m-85 -70.52 -44.68 67.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.4 mt -57.66 -56.41 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.119 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -65.68 -25.01 67.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.454 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 8.3 t80 -63.9 -50.62 68.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 132' ' ' GLN . 23.5 mt -71.69 -41.66 68.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 131' ' ' LEU . 36.3 mt-30 -37.74 -39.86 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -102.04 -51.4 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.454 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 7.4 mm-40 -51.98 -57.08 10.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.04 147.49 53.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.15 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.23 -49.06 20.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.2 m -42.88 -69.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.867 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.25 135.7 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -48.95 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.687 2.258 . . . . 0.0 112.368 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.6 m -147.99 126.38 12.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.84 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.3 m -135.71 133.97 38.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.6 p -171.09 167.17 7.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.377 . . . . 0.0 110.866 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -112.67 42.16 1.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.05 70.2 1.21 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 76.0 p -84.22 -44.48 13.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.914 0.388 . . . . 0.0 110.892 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 m -103.85 125.62 50.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.5 -172.19 13.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -83.43 103.71 13.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -107.34 178.4 4.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.56 60.96 0.39 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.5 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -96.47 83.39 3.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.854 0.359 . . . . 0.0 110.85 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.59 64.29 0.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HE3' ' C ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -118.78 75.32 1.02 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -124.4 121.32 34.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.538 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 2.8 p90 -165.73 152.63 10.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 pp -102.9 -39.12 7.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.948 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -100.93 159.69 14.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.4 p -172.47 149.69 2.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.493 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 15.9 mm-40 -103.6 161.81 21.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.623 0.725 . . . . 0.0 110.908 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.424 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.78 144.63 54.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.259 . . . . 0.0 112.31 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.475 HD11 ' CG2' ' A' ' 33' ' ' VAL . 39.0 mm -71.93 132.97 84.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.619 0.723 . . . . 0.0 111.124 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 179.47 3.69 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.616 2.211 . . . . 0.0 112.349 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -104.1 -34.69 8.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 m -150.85 126.42 10.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -110.14 43.12 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.26 -28.81 44.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.04 165.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -20.56 35.01 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.277 . . . . 0.0 112.344 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.32 110.75 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -55.79 138.48 47.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.7 t -91.91 110.6 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.487 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 39.1 t -105.4 124.0 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.096 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 36' ' ' ASN . 27.0 m -119.77 145.78 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB2' ' CD2' ' A' ' 15' ' ' TYR . . . -31.64 -44.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.115 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -54.74 -49.12 71.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 33' ' ' VAL . 9.2 p-10 -114.25 38.36 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.487 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 8.4 t80 -75.32 -55.49 5.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.4 -15.23 62.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -78.99 -44.8 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.456 HD13 ' ND2' ' A' ' 36' ' ' ASN . 22.7 mt -97.46 -58.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.436 HG22 ' CD2' ' A' ' 37' ' ' PHE . 48.6 t -49.65 -61.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -73.2 126.99 31.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -172.53 106.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -79.15 -14.57 59.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -73.16 -44.24 60.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -138.9 160.85 38.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.11 153.13 38.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.5 t -144.59 135.73 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.13 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.468 ' CD1' ' HB2' ' A' ' 106' ' ' PHE . 14.4 tp -112.68 119.91 39.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.407 HG13 ' N ' ' A' ' 51' ' ' GLU . 1.8 tp -106.64 136.71 40.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' OE2' ' C ' ' A' ' 52' ' ' PHE . 1.2 tm-20 -127.5 115.46 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.409 ' C ' ' OE2' ' A' ' 51' ' ' GLU . 35.5 m-85 -91.64 139.54 30.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 10.4 p90 -144.63 177.12 8.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' CD2' ' A' ' 56' ' ' TRP . . . -132.72 131.14 21.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.598 0.713 . . . . 0.0 111.096 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -9.26 25.67 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.382 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.414 ' CD2' ' HB2' ' A' ' 54' ' ' ALA . 2.1 p-90 -110.6 23.21 14.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.4 t -134.2 108.74 8.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.41 -35.9 2.94 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.49 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -42.59 -50.38 5.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.802 0.334 . . . . 0.0 110.872 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 64' ' ' GLU . 14.1 p -55.1 -42.13 72.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' N ' ' SG ' ' A' ' 60' ' ' CYS . 0.0 OUTLIER -62.37 -40.69 97.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.46 -36.96 71.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.4 tp -84.34 -20.07 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.529 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 3.3 tt0 -42.19 -57.95 3.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.738 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.82 -34.09 15.07 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.366 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -66.85 -28.67 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -93.53 -49.77 5.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 71' ' ' GLY . 6.4 ttmm -39.08 -64.33 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 22.2 mt-10 -39.58 -46.87 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.473 ' N ' HD23 ' A' ' 124' ' ' LEU . 19.5 tp -53.03 -39.48 63.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 68' ' ' LYS . . . -57.32 -65.5 3.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.504 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -67.43 -24.42 65.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.493 ' CG ' ' O ' ' A' ' 69' ' ' GLU . 16.5 mmtm -69.87 -46.13 66.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' A' ' 82' ' ' ILE . 93.6 mt -80.16 3.23 21.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.6 t -53.33 -36.09 60.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -59.88 -11.16 4.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.859 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.97 100.72 12.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.654 0.74 . . . . 0.0 110.874 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 1.07 4.77 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.722 2.281 . . . . 0.0 112.339 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -110.87 -39.56 4.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.2 mt -87.08 113.6 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.175 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.4 t -108.34 117.01 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.42 ' CD1' HD11 ' A' ' 74' ' ' LEU . 39.6 mm -91.98 123.05 43.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.175 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -138.01 171.29 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -138.96 154.94 48.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.5 ttt -148.02 134.11 19.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -86.03 87.76 7.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -42.73 -67.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.084 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -37.75 -30.93 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 87' ' ' ALA . . . -89.58 -35.7 15.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.9 m-80 -124.0 115.38 21.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -47.05 119.23 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.5 t -75.89 120.05 79.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.632 0.73 . . . . 0.0 111.15 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.75 -174.88 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.727 2.285 . . . . 0.0 112.346 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.494 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -105.07 159.62 28.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.674 0.75 . . . . 0.0 110.845 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.516 ' O ' ' C ' ' A' ' 96' ' ' TYR . 53.2 Cg_endo -69.82 -23.49 9.09 Favored 'Cis proline' 0 C--O 1.231 0.143 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.312 0.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.516 ' C ' ' O ' ' A' ' 95' ' ' PRO . 76.2 m-85 -27.47 114.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -127.22 90.38 3.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.533 HG13 ' CE2' ' A' ' 101' ' ' PHE . 78.6 t -80.0 99.43 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.157 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.7 mmm-85 -98.04 -44.18 6.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.91 133.37 7.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.533 ' CE2' HG13 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -101.78 156.86 34.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.608 0.718 . . . . 0.0 110.903 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.0 Cg_endo -69.79 145.4 79.38 Favored 'Cis proline' 0 C--O 1.232 0.206 0 C-N-CA 122.648 -1.813 . . . . 0.0 112.388 0.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.4 m -118.48 126.64 52.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.7 mt -121.34 127.19 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -127.53 152.1 48.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.468 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 21.5 t80 -126.44 130.22 50.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.858 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t -100.77 99.31 9.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.671 0.748 . . . . 0.0 110.843 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.486 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.81 164.14 35.71 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.672 2.248 . . . . 0.0 112.343 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' ND2' ' A' ' 110' ' ' ASN . . . -78.84 134.96 36.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.089 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER 48.33 31.81 2.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.486 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 20.7 mtmt -133.98 33.92 3.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -58.35 -55.07 39.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -43.17 -39.34 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -133.82 89.67 29.46 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.63 0.729 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -167.58 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.733 2.289 . . . . 0.0 112.293 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -135.16 111.36 9.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -82.18 128.41 34.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.629 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 75.3 t80 -69.67 99.8 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -112.08 90.89 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.847 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -171.68 -150.96 7.44 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.43 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.23 140.39 16.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -79.59 44.1 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 124' ' ' LEU . 6.4 tt0 -101.28 127.92 47.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 70' ' ' LEU . 3.2 tm? -35.11 -56.19 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 53.0 p -61.86 -47.31 85.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -47.16 -36.5 8.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.629 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 77.1 m-85 -72.49 -49.49 32.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.5 mt -50.33 -56.07 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -37.08 83.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.838 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.535 ' CE2' ' HG3' ' A' ' 134' ' ' GLU . 63.8 t80 -57.11 -45.52 83.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.915 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 132' ' ' GLN . 60.7 mt -72.83 -40.46 65.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.411 ' HB3' ' NH1' ' A' ' 133' ' ' ARG . 50.5 mt-30 -37.4 -41.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.411 ' NH1' ' HB3' ' A' ' 132' ' ' GLN . 12.8 mmp_? -100.49 -60.33 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.535 ' HG3' ' CE2' ' A' ' 130' ' ' TYR . 16.2 mm-40 -38.73 -52.99 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.72 152.11 46.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.36 -51.53 5.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.8 m -48.73 -60.95 2.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.87 145.33 0.32 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -25.01 29.12 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.668 2.245 . . . . 0.0 112.353 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.3 m 60.36 40.39 17.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.3 m 59.08 41.16 21.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.885 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 -179.981 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.5 t -131.01 -43.96 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.919 0.39 . . . . 0.0 110.831 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 t 58.49 42.65 20.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.38 84.34 0.17 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.485 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.5 m -65.87 138.23 57.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.6 t -169.34 125.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.84 -135.03 4.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.432 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -165.83 141.47 4.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.883 0.373 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -107.02 44.69 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.827 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.46 109.71 3.88 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.5 92.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 110.926 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.425 ' C ' HD22 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -101.71 21.68 14.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.943 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -89.56 134.84 33.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -157.46 127.29 6.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -156.22 156.16 33.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.532 ' CD2' ' CG ' ' A' ' 91' ' ' ASP . 1.3 pt? -104.56 -36.99 7.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.5 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -121.46 174.0 7.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.955 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.415 ' CB ' ' HB1' ' A' ' 34' ' ' ALA . 89.0 p -172.84 171.17 4.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.505 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 5.3 mt-10 -106.44 159.9 28.14 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.625 0.726 . . . . 0.0 110.907 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 134.99 29.27 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.339 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.466 HD12 ' CG2' ' A' ' 33' ' ' VAL . 30.6 mm -68.93 122.3 84.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.647 0.737 . . . . 0.0 111.148 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 172.14 13.19 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.707 2.271 . . . . 0.0 112.318 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 24' ' ' SER . 6.4 pt-20 -99.94 -39.04 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.436 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 7.1 t -130.68 137.1 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -132.54 35.96 3.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.81 61.92 1.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.44 -174.36 13.69 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -33.45 16.53 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.653 2.235 . . . . 0.0 112.342 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.3 t -127.66 111.15 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.174 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -59.61 135.96 57.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.5 t -83.84 115.77 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 39.1 t -113.17 121.24 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.114 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 21' ' ' ILE . 4.5 m -114.13 148.14 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.154 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -33.88 -45.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -54.45 -50.21 68.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.859 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.463 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 9.5 p-10 -109.23 33.29 4.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.466 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 7.4 t80 -74.9 -48.08 26.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -72.64 -4.61 32.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -90.01 -42.75 10.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.3 mt -99.44 -62.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.171 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.43 HG23 ' CG1' ' A' ' 32' ' ' VAL . 41.1 t -50.2 -62.66 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -61.47 116.9 5.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.415 ' C ' ' HE3' ' A' ' 112' ' ' LYS . 3.3 t-20 -172.75 120.88 0.39 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.446 ' CA ' ' HE3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -106.92 30.34 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.63 -27.09 3.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -138.47 160.13 40.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.46 126.51 31.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.507 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 39.1 t -126.32 152.52 33.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.7 tp -132.4 125.45 30.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 tp -116.06 134.75 58.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.091 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -126.92 115.71 19.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.874 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -90.03 116.24 27.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.55 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 26.9 p90 -116.63 174.73 5.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.15 128.94 23.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.582 0.706 . . . . 0.0 111.136 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -19.14 36.63 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.676 2.251 . . . . 0.0 112.336 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.402 ' CE3' ' HB2' ' A' ' 57' ' ' CYS . 3.7 p-90 -101.51 14.87 30.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.402 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 2.0 t -129.19 103.87 7.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -37.41 -39.63 0.54 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.49 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' GLY . 32.7 m170 -36.89 -45.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.768 0.318 . . . . 0.0 110.836 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 64' ' ' GLU . 27.9 p -54.61 -48.07 72.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 58' ' ' GLY . 28.9 mmtt -63.0 -41.93 99.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -67.88 -30.66 70.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.0 tp -92.4 -19.42 22.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.529 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.6 tt0 -43.68 -57.99 5.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.598 0.713 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.77 -28.62 24.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.659 2.239 . . . . 0.0 112.38 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -72.06 -30.17 64.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -93.65 -46.45 7.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.012 0.434 . . . . 0.0 110.94 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 71' ' ' GLY . 14.2 ttmt -44.58 -60.69 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 68' ' ' LYS . 18.6 mt-10 -38.05 -54.66 1.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.466 ' N ' HD21 ' A' ' 124' ' ' LEU . 17.9 tp -49.08 -38.03 23.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.953 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 68' ' ' LYS . . . -58.89 -65.19 3.65 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -64.29 -27.67 69.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.916 0.389 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -69.73 -45.49 68.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.464 HD11 ' CD1' ' A' ' 82' ' ' ILE . 94.9 mt -80.71 3.19 23.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.9 t -54.57 -28.77 48.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.844 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.92 0.18 7.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.958 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.47 99.94 39.39 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.608 0.718 . . . . 0.0 110.866 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -0.16 6.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.361 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -110.56 -34.62 6.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.54 112.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.2 t -109.57 119.35 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.464 ' CD1' HD11 ' A' ' 74' ' ' LEU . 32.1 mm -93.29 117.47 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.4 ' CB ' HG22 ' A' ' 32' ' ' VAL . . . -128.42 166.18 19.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -134.37 155.77 49.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.938 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.9 ttt -149.24 161.29 42.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.55 ' OD1' ' CZ ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -109.2 119.58 39.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.0 -70.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -47.77 -28.05 2.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.18 -31.1 16.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 8.0 m-80 -131.1 102.18 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.532 ' CG ' ' CD2' ' A' ' 16' ' ' LEU . 9.5 t0 -41.16 122.89 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 92.2 t -82.04 121.67 79.16 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.661 0.744 . . . . 0.0 111.086 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.74 -167.21 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.717 2.278 . . . . 0.0 112.365 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.5 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -109.11 160.05 28.94 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.749 . . . . 0.0 110.833 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.509 ' O ' ' C ' ' A' ' 96' ' ' TYR . 53.5 Cg_endo -69.74 -20.18 10.85 Favored 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.634 -1.819 . . . . 0.0 112.373 -0.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.509 ' C ' ' O ' ' A' ' 95' ' ' PRO . 84.5 m-85 -28.55 113.36 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -122.87 85.85 2.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.8 t -77.2 120.57 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.0 mmm-85 -122.05 -48.12 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.12 130.11 7.87 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.506 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -102.42 156.09 35.7 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.658 0.742 . . . . 0.0 110.886 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.66 143.92 75.0 Favored 'Cis proline' 0 C--O 1.231 0.151 0 C-N-CA 122.713 -1.786 . . . . 0.0 112.338 -0.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 80.1 m -114.33 127.74 56.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.174 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.437 HG21 ' N ' ' A' ' 105' ' ' TYR . 17.5 mt -120.18 135.91 58.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.165 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.437 ' N ' HG21 ' A' ' 104' ' ' ILE . 9.4 m-85 -134.26 169.99 16.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 31.1 t80 -139.5 131.72 28.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.8 t -101.65 97.98 8.77 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.618 0.723 . . . . 0.0 110.842 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.434 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.79 169.29 19.29 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.718 2.279 . . . . 0.0 112.329 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.62 126.49 36.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 64.59 26.48 13.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.434 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.3 mtmm -131.78 26.5 4.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.482 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -47.42 -57.94 4.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.1 mp -39.38 -41.99 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.936 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -134.39 99.45 13.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.652 0.739 . . . . 0.0 110.874 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -164.29 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.672 2.248 . . . . 0.0 112.337 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 106' ' ' PHE . 15.4 mmtm -133.34 118.21 18.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -88.52 148.49 24.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.941 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -94.84 108.42 20.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.942 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -118.68 92.43 3.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.46 -143.74 4.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.454 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.01 142.83 16.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.468 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -82.01 41.71 0.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 110.846 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 124' ' ' LEU . 16.4 tp10 -98.06 129.68 44.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.466 HD21 ' N ' ' A' ' 70' ' ' LEU . 2.7 tm? -34.91 -56.55 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 64.7 p -57.62 -47.36 82.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.07 -32.61 22.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.461 ' CB ' HD12 ' A' ' 70' ' ' LEU . 52.2 m-85 -74.5 -39.3 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.9 mt -64.64 -65.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -54.08 -31.04 50.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.428 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 49.1 t80 -60.4 -47.91 84.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 48.7 mt -73.72 -39.17 64.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -38.66 -38.65 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -102.29 -51.04 3.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.428 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 5.2 mm-40 -51.54 -57.16 9.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.72 150.26 41.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.75 -50.98 10.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.2 m -75.87 49.31 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -47.75 141.13 8.2 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.525 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 110.63 2.59 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.671 2.247 . . . . 0.0 112.394 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.4 t -84.29 80.12 9.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.852 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.8 p -45.33 151.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.838 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.454 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 m -81.92 45.46 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 0.0 110.824 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.2 t -85.74 148.35 25.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.5 107.2 0.25 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -81.17 107.37 13.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.368 . . . . 0.0 110.864 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m -107.78 110.13 21.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.822 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 8' ' ' PHE . . . -126.81 45.49 1.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.54 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' A' ' 7' ' ' GLY . 8.5 p90 -35.91 -53.0 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.797 0.332 . . . . 0.0 110.848 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -69.22 121.72 17.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.32 -151.21 15.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.506 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 57.15 40.88 27.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 110.872 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.459 ' CD2' ' O ' ' A' ' 94' ' ' SER . 2.4 tt -72.15 93.57 1.45 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.06 144.7 2.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -175.83 141.97 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -173.34 157.42 3.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.473 HD13 ' CB ' ' A' ' 17' ' ' LYS . 4.0 pp -106.28 -44.23 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.473 ' CB ' HD13 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -112.48 152.54 28.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.448 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 3.3 m -162.86 166.57 23.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.852 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.419 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.1 mm-40 -105.3 162.27 20.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.672 0.748 . . . . 0.0 110.841 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.419 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 54.2 Cg_endo -69.75 143.47 50.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.736 2.291 . . . . 0.0 112.331 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.418 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 12.4 mm -69.08 135.1 89.42 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.639 0.733 . . . . 0.0 111.125 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 53.3 Cg_endo -69.79 174.66 9.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.671 2.247 . . . . 0.0 112.303 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.6 -38.11 5.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 t -135.18 116.62 14.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -114.63 43.29 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.58 51.01 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.65 -176.83 16.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.517 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -42.21 3.57 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.692 2.261 . . . . 0.0 112.367 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.5 t -113.03 107.79 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.104 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -60.41 130.39 46.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.8 t -80.31 121.87 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.154 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.439 ' CG2' ' HB1' ' A' ' 83' ' ' ALA . 40.6 t -114.71 120.37 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.178 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 36' ' ' ASN . 18.6 m -111.69 142.88 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -33.49 -37.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 33' ' ' VAL . 9.4 mt-10 -60.52 -48.26 82.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 33' ' ' VAL . 14.5 p-10 -107.56 25.03 11.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.568 ' CD2' HG22 ' A' ' 41' ' ' VAL . 20.2 t80 -65.68 -55.21 18.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.418 ' HA ' ' CG ' ' A' ' 42' ' ' ASN . 6.2 t70 -67.72 -3.91 10.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -92.67 -43.57 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.506 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 14.2 mt -99.19 -52.65 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.179 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.568 HG22 ' CD2' ' A' ' 37' ' ' PHE . 89.3 t -60.79 -61.41 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.436 ' OD1' ' CE1' ' A' ' 37' ' ' PHE . 2.0 m-20 -67.31 123.22 19.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 41' ' ' VAL . 7.6 p30 -175.54 111.88 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.71 33.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -128.04 -30.14 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 34.5 pttt -138.16 166.31 24.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.86 144.86 25.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.42 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 93.1 t -146.58 148.76 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.4 tp -123.81 125.45 44.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.932 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.3 tp -110.83 134.35 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' OE1' ' CG1' ' A' ' 104' ' ' ILE . 3.1 tp10 -127.42 112.83 15.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.406 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 61.0 m-85 -87.21 115.57 24.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.95 171.81 7.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.968 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.13 131.78 23.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -6.24 18.12 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.727 2.285 . . . . 0.0 112.319 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.547 ' CZ2' HG21 ' A' ' 88' ' ' THR . 6.8 p-90 -124.39 25.98 7.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 10.2 t -128.75 112.46 14.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -52.14 -61.55 6.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.493 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -41.54 -37.91 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.838 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 88.7 m -74.35 -34.76 63.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 58' ' ' GLY . 3.8 ttmt -70.29 -35.1 73.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -72.3 -23.34 61.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 64' ' ' GLU . 11.8 tp -85.24 -29.74 24.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.554 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.6 tp10 -36.74 -55.92 1.46 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.658 0.742 . . . . 0.0 110.851 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.8 Cg_endo -69.75 -36.15 11.37 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.675 2.25 . . . . 0.0 112.367 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -66.1 -28.07 68.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -95.3 -38.72 10.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -45.73 -58.8 3.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -43.69 -50.13 7.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.469 ' N ' HD22 ' A' ' 124' ' ' LEU . 17.9 tp -46.09 -37.08 6.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.58 -62.3 6.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.473 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -68.37 -22.9 64.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -72.65 -49.41 31.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.442 HD13 ' CG1' ' A' ' 82' ' ' ILE . 95.0 mt -80.06 2.98 21.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.939 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.4 t -51.02 -24.11 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -86.5 17.13 4.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -110.21 98.11 33.81 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.592 0.71 . . . . 0.0 110.917 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -1.81 9.12 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 0.0 112.339 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -122.08 8.87 9.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 81' ' ' VAL . 98.0 mt -134.72 142.47 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.443 ' N ' HG22 ' A' ' 80' ' ' ILE . 87.1 t -139.12 106.64 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.442 ' CG1' HD13 ' A' ' 74' ' ' LEU . 46.3 mm -83.73 125.92 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.129 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HB1' ' CG2' ' A' ' 32' ' ' VAL . . . -143.35 170.92 14.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.133 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -140.63 154.01 46.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.3 ttt -140.85 142.51 34.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 89' ' ' ALA . 26.7 t0 -91.54 82.28 5.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.465 ' HB1' ' CG2' ' A' ' 92' ' ' VAL . . . -41.4 -48.54 3.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.547 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 19.9 p -57.38 -33.34 67.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.503 ' C ' ' ND2' ' A' ' 90' ' ' ASN . . . -103.31 13.29 34.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.503 ' ND2' ' C ' ' A' ' 89' ' ' ALA . 8.6 m-80 -162.91 107.77 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -44.97 127.65 6.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.465 ' CG2' ' HB1' ' A' ' 87' ' ' ALA . 90.6 t -78.01 122.57 85.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.597 0.713 . . . . 0.0 111.164 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -166.51 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.378 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.481 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -118.85 161.78 34.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.727 . . . . 0.0 110.85 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.2 Cg_endo -69.66 -13.78 12.24 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.679 -1.8 . . . . 0.0 112.373 -0.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.468 ' C ' ' O ' ' A' ' 95' ' ' PRO . 83.2 m-85 -32.09 120.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.941 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -129.68 76.46 1.72 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.4 t -74.41 125.17 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -123.2 -42.28 2.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.2 129.41 6.72 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.452 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.516 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.87 154.84 37.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.678 0.751 . . . . 0.0 110.848 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.1 Cg_endo -69.76 162.2 84.61 Favored 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.669 -1.805 . . . . 0.0 112.348 0.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.4 m -140.95 106.16 5.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.16 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.492 ' CG1' ' OE1' ' A' ' 51' ' ' GLU . 41.4 mt -101.1 123.86 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.485 ' CZ ' ' HE3' ' A' ' 117' ' ' LYS . 10.4 m-85 -123.92 147.05 48.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 24.6 t80 -117.78 133.79 55.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -103.73 94.46 6.26 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.678 0.751 . . . . 0.0 110.897 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.489 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.75 164.8 33.19 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.665 2.243 . . . . 0.0 112.356 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -80.75 139.74 35.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.8 p-10 47.85 25.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.489 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 23.4 mtmt -129.16 19.75 5.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.847 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.468 ' HE3' ' N ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -43.24 -68.28 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.929 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 112' ' ' LYS . 4.5 mm? -33.94 -51.75 0.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -112.16 96.19 33.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.721 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -170.78 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 0.0 112.34 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -138.85 110.1 6.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.485 ' HE3' ' CZ ' ' A' ' 105' ' ' TYR . 30.0 tttt -73.83 156.54 37.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -106.35 96.58 6.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -111.51 102.13 10.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 179.56 -151.31 9.98 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.83 130.91 10.0 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -79.58 44.5 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.323 . . . . 0.0 110.908 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 124' ' ' LEU . 9.8 tt0 -105.66 133.48 50.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 70' ' ' LEU . 2.9 tm? -35.56 -55.79 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 44.8 p -57.9 -46.99 84.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -51.19 -37.13 44.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.448 ' CB ' HD11 ' A' ' 70' ' ' LEU . 61.7 m-85 -69.89 -45.79 66.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 33.7 mt -59.0 -59.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.135 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -60.08 -30.27 69.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 130' ' ' TYR . 3.9 t80 -59.52 -45.63 91.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.927 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 132' ' ' GLN . 19.0 mt -76.02 -43.35 44.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.938 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 131' ' ' LEU . 45.1 mt-30 -36.12 -39.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.435 ' HB3' ' NH1' ' A' ' 133' ' ' ARG . 5.4 ptp180 -99.39 -48.43 4.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.78 -61.57 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -43.24 126.24 4.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.89 -74.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.114 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 t -51.2 -57.14 9.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.13 172.06 43.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.51 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 160.42 49.8 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.652 2.235 . . . . 0.0 112.39 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 m -43.9 162.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.847 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 96.4 p -147.8 125.88 12.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.517 -179.954 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 t -144.33 164.81 29.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 0.0 110.849 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 p -115.78 152.23 33.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.17 82.76 0.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.5 m -98.58 154.01 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.904 0.383 . . . . 0.0 110.858 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.0 t -146.06 117.11 7.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.839 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 149.13 90.2 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.506 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -106.58 -52.92 2.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 110.822 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.65 93.17 1.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.43 -170.68 14.95 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.439 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -95.51 81.84 3.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 0.0 110.876 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.68 15.04 2.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.897 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HE3' ' CG ' ' A' ' 38' ' ' ASP . 1.4 mmpt? -71.24 123.2 21.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -158.39 125.35 4.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.861 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -169.87 160.37 8.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.411 ' CD1' ' HB3' ' A' ' 17' ' ' LYS . 3.9 pp -103.17 -41.86 5.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' HB3' ' CD1' ' A' ' 16' ' ' LEU . 18.7 ptmt -130.23 157.96 41.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.7 t -162.08 166.05 26.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.416 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 3.5 mm-40 -105.6 161.7 21.98 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.684 0.754 . . . . 0.0 110.835 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.78 145.34 56.71 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.67 2.247 . . . . 0.0 112.349 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.448 HD13 ' CB ' ' A' ' 35' ' ' GLU . 28.4 mm -68.78 132.04 90.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.62 0.724 . . . . 0.0 111.144 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 175.74 7.71 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.69 2.26 . . . . 0.0 112.386 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 24' ' ' SER . 6.6 pt-20 -108.72 -37.5 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.41 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 85.3 p -129.62 130.14 45.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.891 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -133.77 43.03 2.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 27' ' ' GLY . 2.9 m-20 -72.65 -19.13 61.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -45.54 173.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.505 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -30.13 22.8 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.7 2.266 . . . . 0.0 112.313 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.41 ' CG1' ' HG2' ' A' ' 84' ' ' LYS . 39.8 t -116.84 106.65 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.15 132.16 52.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.1 t -83.11 125.34 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.168 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.462 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 18.0 t -120.79 129.93 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 35' ' ' GLU . 15.0 m -121.86 145.85 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -37.8 -28.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 33' ' ' VAL . 3.9 mt-10 -66.71 -45.06 79.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.469 ' ND2' HD13 ' A' ' 40' ' ' ILE . 39.9 p-10 -119.41 37.45 4.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.524 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 8.3 t80 -71.63 -51.43 23.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.427 ' CG ' ' HE3' ' A' ' 13' ' ' LYS . 3.4 m-20 -69.09 -12.33 61.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.41 -41.29 20.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.469 HD13 ' ND2' ' A' ' 36' ' ' ASN . 21.8 mt -99.34 -60.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.524 HG11 ' CZ ' ' A' ' 37' ' ' PHE . 43.6 t -52.82 -62.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -72.74 130.35 40.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -173.55 106.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -83.25 36.27 0.52 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -133.72 -36.43 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -139.08 145.79 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 1.4 m-20 -66.35 135.59 54.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -130.48 145.08 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.136 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.443 HD22 ' CD1' ' A' ' 82' ' ' ILE . 6.7 tp -124.6 118.8 27.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 tp -106.09 137.55 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.25 117.65 22.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -93.23 137.98 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.908 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 3.8 p90 -142.36 171.93 13.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.98 133.03 24.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 111.119 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -0.76 7.41 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 0.0 112.308 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.517 ' CZ2' HG23 ' A' ' 88' ' ' THR . 2.4 p-90 -128.63 24.41 5.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.0 t -120.31 110.81 17.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -40.87 -58.5 2.65 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.464 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.469 ' C ' ' O ' ' A' ' 58' ' ' GLY . 3.7 t-160 -32.98 -62.49 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 110.839 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' GLU . 3.9 t -40.15 -49.81 2.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.886 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -56.77 -48.88 76.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -70.76 -21.95 62.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.29 -19.99 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.1 tt0 -43.32 -57.91 4.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 0.0 110.938 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.5 Cg_endo -69.78 -33.38 16.63 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.693 2.262 . . . . 0.0 112.335 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -66.37 -32.23 73.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 68' ' ' LYS . 31.7 t80 -89.22 -47.77 7.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 67' ' ' TYR . 14.8 ttmt -37.75 -60.15 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -38.78 -59.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.471 ' N ' HD21 ' A' ' 124' ' ' LEU . 24.5 tp -41.99 -36.99 1.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.2 -69.14 1.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.459 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -64.58 -23.01 67.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -71.51 -39.97 70.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.475 HD11 ' CG1' ' A' ' 82' ' ' ILE . 85.1 mt -88.58 3.16 51.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 t -55.15 -31.73 61.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' A' ' 76' ' ' LYS . 25.5 ttpt -73.0 1.47 8.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -102.5 100.07 14.92 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.88 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 0.46 5.65 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.64 2.226 . . . . 0.0 112.34 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -111.69 -41.36 4.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 63.0 mt -90.74 138.09 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.9 t -133.94 113.5 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.475 ' CG1' HD11 ' A' ' 74' ' ' LEU . 39.6 mm -82.45 131.97 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.454 ' CB ' HG21 ' A' ' 32' ' ' VAL . . . -143.63 170.97 14.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.088 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.41 ' HG2' ' CG1' ' A' ' 29' ' ' VAL . 12.4 pttp -143.07 154.39 43.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.9 ttt -150.08 133.36 16.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -85.28 76.52 10.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -35.71 -61.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.06 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.517 HG23 ' CZ2' ' A' ' 56' ' ' TRP . 43.9 p -32.26 -41.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.136 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.66 -31.14 13.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.094 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 87' ' ' ALA . 35.9 m-80 -111.14 101.54 10.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -43.58 123.8 3.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.473 ' CG2' ' HB2' ' A' ' 87' ' ' ALA . 73.1 t -66.66 129.2 94.11 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.572 0.701 . . . . 0.0 111.172 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -163.53 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.625 2.217 . . . . 0.0 112.383 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.492 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -131.41 160.85 65.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.649 0.738 . . . . 0.0 110.828 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.1 Cg_endo -69.82 -4.55 8.45 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.706 -1.789 . . . . 0.0 112.304 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.439 ' C ' ' O ' ' A' ' 95' ' ' PRO . 65.9 m-85 -34.55 127.44 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.63 116.08 18.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.416 HG21 ' CG2' ' A' ' 103' ' ' THR . 57.9 t -123.64 115.94 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.88 -47.0 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.855 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.19 130.42 8.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.5 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.521 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -99.08 155.81 36.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.692 0.758 . . . . 0.0 110.875 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.2 Cg_endo -69.68 163.16 82.34 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.375 -0.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.416 ' CG2' HG21 ' A' ' 98' ' ' VAL . 26.5 m -142.36 106.29 4.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.2 mt -95.5 142.8 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -134.52 179.14 6.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' LYS . 19.3 t80 -147.75 135.49 20.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 33.8 t -104.72 94.62 7.59 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.696 0.76 . . . . 0.0 110.814 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.464 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.74 159.68 52.52 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.67 2.247 . . . . 0.0 112.38 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.38 130.82 34.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.125 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 64.71 24.98 12.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.464 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 14.0 mtmt -131.75 18.31 4.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.42 ' N ' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -44.25 -63.16 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.925 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -39.29 -32.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.408 ' O ' ' O ' ' A' ' 111' ' ' LYS . 1.9 t30 -134.02 98.31 14.48 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.647 0.737 . . . . 0.0 110.891 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.462 ' CD ' ' HG2' ' A' ' 95' ' ' PRO . 54.2 Cg_endo -69.75 179.24 3.83 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -134.77 125.18 26.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -90.65 146.22 24.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -83.92 121.87 27.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -122.24 104.09 9.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.91 -170.39 43.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.478 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.74 141.26 26.19 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.508 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.89 47.31 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 110.844 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 124' ' ' LEU . 27.2 tt0 -102.02 129.45 48.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.471 HD21 ' N ' ' A' ' 70' ' ' LEU . 2.4 tm? -33.75 -54.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.7 t -60.74 -47.1 87.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -44.35 -42.02 6.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.456 ' CB ' HD23 ' A' ' 70' ' ' LEU . 62.8 m-85 -68.31 -44.52 75.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.858 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.06 -53.12 52.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 t -65.31 -39.5 92.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.529 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 36.4 t80 -56.71 -53.07 61.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 132' ' ' GLN . 68.3 mt -67.21 -42.9 83.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 131' ' ' LEU . 35.3 mt-30 -36.96 -40.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -99.15 -61.68 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.529 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 11.3 mm-40 -42.2 -54.2 3.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.72 132.0 30.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.58 -75.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.9 t -48.7 -62.07 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.6 144.07 16.25 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.451 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 140' ' ' SER . 53.9 Cg_endo -69.75 2.9 3.11 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.694 2.263 . . . . 0.0 112.386 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 139' ' ' PRO . 83.5 p -33.48 114.33 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.836 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.3 p -123.9 105.53 9.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.86 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.446 179.97 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -140.12 162.12 35.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.875 0.369 . . . . 0.0 110.844 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.3 p -147.55 167.96 23.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.44 96.51 0.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.518 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -150.04 134.42 17.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.888 0.375 . . . . 0.0 110.849 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.9 p -99.86 130.33 46.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.832 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.13 102.47 2.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.512 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -162.17 115.49 1.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 110.836 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -130.14 119.94 23.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.48 164.22 27.03 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.476 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -70.77 88.54 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.39 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 25.5 tp -95.83 89.58 5.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.467 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 0.7 OUTLIER -159.88 159.67 32.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -173.71 129.29 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.486 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.5 p90 -161.23 147.79 14.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.4 HD11 ' C ' ' A' ' 16' ' ' LEU . 3.9 pp -94.79 -39.48 10.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -116.49 156.93 26.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 76.8 p -160.61 149.58 16.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.409 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 10.2 mm-40 -92.53 161.3 32.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.62 0.724 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.74 141.17 44.59 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.372 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.454 HD13 ' CB ' ' A' ' 35' ' ' GLU . 13.3 mm -69.44 130.84 90.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.731 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 160.59 49.13 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.682 2.255 . . . . 0.0 112.369 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.89 -38.65 13.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -141.77 105.3 4.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -122.65 46.56 2.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -87.5 39.48 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.12 -160.57 36.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.476 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -42.84 3.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 0.0 112.362 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.46 ' CG2' ' HA ' ' A' ' 68' ' ' LYS . 10.9 t -116.57 104.72 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -52.83 135.39 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.0 t -84.23 120.69 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.176 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 12.9 t -119.45 115.32 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.117 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 35' ' ' GLU . 27.9 m -111.52 141.71 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -30.44 -38.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 33' ' ' VAL . 6.7 mt-10 -56.3 -51.51 67.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 33' ' ' VAL . 53.1 p-10 -110.48 24.76 12.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.46 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 13.1 t80 -63.19 -51.15 67.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -4.95 18.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.831 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -92.17 -43.84 9.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.3 mt -97.11 -61.16 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.107 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.424 HG23 ' CG1' ' A' ' 32' ' ' VAL . 78.5 t -53.16 -62.17 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -65.46 120.18 12.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.413 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 4.1 t-20 -174.94 119.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' CA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -104.93 32.44 4.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -127.7 -31.22 2.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -138.29 136.95 36.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.81 138.6 53.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.57 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 40.9 t -137.31 159.13 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 106' ' ' PHE . 16.1 tp -140.21 132.17 27.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.923 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 51' ' ' GLU . 3.3 tp -116.21 141.36 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.175 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.545 ' OE2' ' CG ' ' A' ' 67' ' ' TYR . 2.5 tt0 -125.49 118.74 26.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -98.9 108.42 21.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -115.75 -179.15 3.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.73 132.98 21.9 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 0.0 111.085 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 -1.01 7.74 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.535 ' CZ2' HG23 ' A' ' 88' ' ' THR . 2.1 p-90 -126.31 5.79 7.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.3 m -99.89 129.47 45.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.836 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.16 -45.9 14.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.46 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -48.32 -27.72 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.836 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.0 m -80.13 -44.0 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -55.29 -42.33 73.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -70.49 -20.54 62.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 66' ' ' LYS . 8.4 tp -94.22 -23.16 18.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.544 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 5.1 tt0 -33.71 -57.13 0.64 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 0.0 110.914 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.78 -27.29 26.54 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.721 2.281 . . . . 0.0 112.328 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 63' ' ' LEU . 2.7 mmpt? -72.39 -30.97 65.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.545 ' CG ' ' OE2' ' A' ' 51' ' ' GLU . 37.9 t80 -95.97 -40.09 9.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.46 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -55.66 -43.28 76.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -53.54 -53.42 51.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.467 ' N ' HD23 ' A' ' 124' ' ' LEU . 20.3 tp -43.45 -38.35 2.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.08 -64.56 3.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.97 -21.36 66.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.937 0.398 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -79.32 -45.05 20.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ASP . 78.6 mt -84.06 1.64 43.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 m -40.19 -27.94 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -85.0 25.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 74' ' ' LEU . 51.2 p-10 -103.9 93.41 5.29 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.618 0.723 . . . . 0.0 110.863 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 0.58 5.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.334 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -122.91 -44.72 2.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.468 HG21 ' N ' ' A' ' 81' ' ' VAL . 37.0 mt -87.71 144.59 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.468 ' N ' HG21 ' A' ' 80' ' ' ILE . 86.5 t -136.0 107.38 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.179 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.2 mm -76.17 131.44 34.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.426 ' CB ' HG23 ' A' ' 32' ' ' VAL . . . -145.83 173.87 11.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -148.57 157.59 43.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -149.59 148.11 28.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 90' ' ' ASN . 49.8 t0 -97.74 99.65 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.94 80.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.535 HG23 ' CZ2' ' A' ' 56' ' ' TRP . 2.7 p -66.12 -17.27 64.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -117.89 -10.97 10.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.1 m-80 -139.62 107.63 5.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -42.27 138.06 1.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.427 ' CG2' HG22 ' A' ' 98' ' ' VAL . 74.6 t -80.51 128.32 72.83 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.625 0.726 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 54.4 Cg_endo -69.72 -165.64 0.16 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.723 2.282 . . . . 0.0 112.35 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.523 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 0.8 OUTLIER -127.44 154.59 77.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.655 0.741 . . . . 0.0 110.851 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.75 -6.03 9.19 Favored 'Cis proline' 0 N--CA 1.466 -0.13 0 C-N-CA 122.709 -1.788 . . . . 0.0 112.372 0.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.46 ' C ' ' O ' ' A' ' 95' ' ' PRO . 33.1 m-85 -33.01 137.45 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -151.63 120.89 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.843 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.452 HG13 ' CE2' ' A' ' 101' ' ' PHE . 39.7 t -113.42 110.07 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.11 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.8 -45.32 5.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -132.32 132.01 6.48 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.483 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.528 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -96.95 154.86 38.1 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.658 0.742 . . . . 0.0 110.899 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.528 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.0 Cg_endo -69.74 159.51 89.52 Favored 'Cis proline' 0 C--O 1.232 0.191 0 C-N-CA 122.696 -1.793 . . . . 0.0 112.379 0.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.4 m -137.98 111.55 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.147 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.443 HG12 ' CG ' ' A' ' 51' ' ' GLU . 86.9 mt -109.82 131.88 59.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -123.12 -176.38 3.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 29.1 t80 -152.82 132.22 12.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.887 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.2 t -103.6 96.31 8.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.69 0.757 . . . . 0.0 110.895 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.456 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.5 Cg_endo -69.68 168.26 21.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.719 2.279 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.2 135.15 33.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 54.67 25.73 6.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.456 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 10.6 mtmt -129.53 21.59 5.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -49.33 -41.63 39.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.417 HD21 ' N ' ' A' ' 113' ' ' LEU . 4.1 mm? -52.42 -39.7 61.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 6.8 m-80 -134.74 97.97 13.69 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.593 0.711 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 54.3 Cg_endo -69.69 -170.63 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.674 2.249 . . . . 0.0 112.372 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -136.27 139.07 42.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -107.21 137.03 46.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.433 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 62.8 t80 -78.85 107.84 11.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -124.03 95.17 4.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.39 -139.52 3.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.95 128.52 9.18 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -79.7 49.52 1.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.761 0.315 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 124' ' ' LEU . 5.4 tp10 -112.74 132.46 55.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 70' ' ' LEU . 3.5 tm? -34.44 -51.49 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.5 p -63.11 -53.22 56.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.17 -36.53 2.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.433 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 52.8 m-85 -68.91 -43.62 74.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.4 mt -55.89 -63.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.099 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.3 t -54.74 -36.54 64.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.431 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 44.3 t80 -55.18 -50.87 68.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.916 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.3 -42.15 69.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -43.61 -41.44 4.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.43 ' CG ' ' N ' ' A' ' 134' ' ' GLU . 12.9 ptm180 -91.57 -53.06 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.431 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 26.1 mm-40 -51.93 -62.87 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -37.41 105.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.078 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.8 t -49.84 -52.78 29.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.3 t -74.5 -41.51 60.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.02 161.6 0.2 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.465 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 114.63 3.77 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.716 2.277 . . . . 0.0 112.309 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.6 p -121.61 168.93 11.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.0 t -115.89 153.83 30.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.0 p -119.85 99.17 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.886 0.374 . . . . 0.0 110.855 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.0 t -153.4 159.15 42.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.855 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.89 111.35 1.07 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 t -134.42 139.59 45.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 t -172.99 155.85 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.24 174.49 35.69 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -95.4 143.06 27.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.6 -53.09 62.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.34 66.57 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -82.32 39.53 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.2 mt -97.3 45.84 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -115.11 141.33 48.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.463 ' HD3' ' N ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -174.72 121.95 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.54 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -151.49 154.59 36.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -106.3 -33.32 7.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.944 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.444 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 10.7 mtpp -101.57 163.86 12.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.0 p -166.5 134.28 2.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.462 ' CG ' ' HB2' ' A' ' 89' ' ' ALA . 2.4 mm-40 -98.24 161.63 24.75 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.887 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.9 Cg_endo -69.75 140.07 41.8 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.679 2.253 . . . . 0.0 112.336 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.451 HD13 ' CG2' ' A' ' 33' ' ' VAL . 15.8 mm -70.46 123.41 88.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 111.107 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 130.19 18.91 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.671 2.248 . . . . 0.0 112.35 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.21 -46.81 69.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 t -144.96 133.22 21.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -106.7 48.71 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -50.28 -33.16 18.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.07 164.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.445 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -22.99 31.29 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.674 2.249 . . . . 0.0 112.341 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.9 t -119.33 112.19 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -57.89 137.23 56.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.7 t -90.49 116.24 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.133 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 19.6 t -105.98 124.73 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.451 ' CG2' HD13 ' A' ' 21' ' ' ILE . 15.8 m -118.66 148.16 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.444 ' CB ' ' CD2' ' A' ' 15' ' ' TYR . . . -38.1 -36.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.152 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.421 ' CB ' HD11 ' A' ' 21' ' ' ILE . 29.3 mt-10 -62.78 -50.64 70.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.486 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 11.4 p-10 -108.33 28.57 8.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.469 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 5.5 t80 -67.51 -55.78 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.835 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -66.11 -5.26 9.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -88.42 -43.11 11.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.465 HD11 ' ND2' ' A' ' 36' ' ' ASN . 18.1 mt -98.35 -54.14 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.127 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.09 -61.58 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -67.44 112.67 4.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.412 ' ND2' ' HE2' ' A' ' 46' ' ' LYS . 13.4 t-20 -173.23 105.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.85 4.64 47.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -90.69 -35.03 15.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HE2' ' ND2' ' A' ' 43' ' ' ASN . 45.9 pttt -138.52 151.95 47.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.9 136.1 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.61 136.01 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.127 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.8 tp -116.11 119.24 35.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.4 ' O ' ' O ' ' A' ' 105' ' ' TYR . 2.3 tp -106.81 134.88 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.166 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -127.21 120.08 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -95.87 122.47 38.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CE1' ' OD1' ' A' ' 86' ' ' ASP . 13.1 p90 -124.4 -179.6 4.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.927 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.63 133.48 21.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.565 0.698 . . . . 0.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -6.28 18.2 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.687 2.258 . . . . 0.0 112.347 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.465 ' CZ2' HG23 ' A' ' 88' ' ' THR . 2.1 p-90 -122.89 21.92 9.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t -120.2 111.14 17.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.06 -47.71 6.43 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -46.68 -37.25 8.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.771 0.32 . . . . 0.0 110.858 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.403 ' SG ' ' CD1' ' A' ' 53' ' ' TYR . 34.7 t -63.46 -44.5 94.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.908 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -65.5 -42.16 92.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -72.68 -35.0 67.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 64' ' ' GLU . 14.0 tp -81.97 -26.77 33.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.3 tt0 -38.08 -58.1 1.54 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.608 0.718 . . . . 0.0 110.926 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.7 Cg_endo -69.82 -31.11 20.91 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.625 2.217 . . . . 0.0 112.332 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' NZ ' ' OE2' ' A' ' 123' ' ' GLU . 29.0 mtpt -68.63 -30.0 68.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -92.42 -45.21 8.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.933 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -41.65 -58.96 1.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.947 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 70' ' ' LEU . 16.4 mt-10 -41.07 -61.64 0.96 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.459 ' N ' HD21 ' A' ' 124' ' ' LEU . 22.2 tp -38.06 -35.63 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.35 -68.77 1.52 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.494 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -66.08 -19.69 65.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -75.28 -41.38 57.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.467 HD13 ' CG1' ' A' ' 82' ' ' ILE . 92.6 mt -86.46 3.35 44.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.2 t -54.07 -34.46 60.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -6.23 5.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 5.9 t70 -102.83 100.37 16.4 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.629 0.728 . . . . 0.0 110.873 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.7 Cg_endo -69.79 0.78 5.18 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.706 2.271 . . . . 0.0 112.346 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -110.46 -34.81 6.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.8 mt -93.43 126.98 45.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.09 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 84.1 t -124.47 110.92 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.125 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.467 ' CG1' HD13 ' A' ' 74' ' ' LEU . 49.9 mm -82.99 123.7 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.142 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.466 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . . . -133.75 161.47 34.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -134.65 150.43 50.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.455 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 10.7 ttt -141.45 140.12 33.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 53' ' ' TYR . 7.6 t0 -95.41 91.16 6.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.804 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -45.0 -49.18 11.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.1 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.465 HG23 ' CZ2' ' A' ' 56' ' ' TRP . 1.2 p -55.73 -28.56 56.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.14 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.462 ' HB2' ' CG ' ' A' ' 19' ' ' GLU . . . -94.05 -12.43 28.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.455 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.5 OUTLIER -157.26 123.54 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -57.38 135.91 56.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.9 t -82.95 128.19 66.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.628 0.728 . . . . 0.0 111.087 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.663 2.242 . . . . 0.0 112.351 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.481 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 m -115.73 162.0 27.58 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.712 0.768 . . . . 0.0 110.84 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.78 -10.83 11.73 Favored 'Cis proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 -1.795 . . . . 0.0 112.319 0.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 95' ' ' PRO . 98.0 m-85 -35.25 133.9 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -141.83 118.56 11.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.4 t -120.96 116.11 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.093 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -118.14 -44.64 2.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.34 123.42 5.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.509 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.523 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -98.31 154.89 37.43 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.674 0.75 . . . . 0.0 110.864 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.2 Cg_endo -69.74 162.08 84.8 Favored 'Cis proline' 0 C--O 1.231 0.162 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.327 -0.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.3 m -139.99 125.45 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.446 HG21 ' N ' ' A' ' 105' ' ' TYR . 22.8 mt -116.25 138.57 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.523 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 8.8 m-85 -134.54 162.66 31.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.946 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -133.5 136.33 45.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 t -104.47 93.02 5.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.882 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.495 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.3 Cg_endo -69.68 151.87 69.6 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.59 145.46 52.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.4 p30 44.83 25.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.495 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 24.9 mtmt -130.4 41.28 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -66.06 -51.37 58.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.862 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.421 ' CD2' ' H ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -48.19 -49.08 34.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -122.32 91.79 49.1 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 -163.8 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.661 2.241 . . . . 0.0 112.362 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -145.6 132.42 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.523 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 17.2 ttpt -98.8 137.34 37.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -73.14 104.69 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -116.97 98.42 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.88 -144.63 6.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.452 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.53 130.73 10.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.503 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 -79.57 45.5 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.745 0.307 . . . . 0.0 110.866 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.41 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 5.1 tp10 -106.42 132.83 51.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.459 HD21 ' N ' ' A' ' 70' ' ' LEU . 3.2 tm? -37.37 -52.51 1.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.1 m -61.69 -43.04 99.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -51.78 -42.11 62.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -63.18 -40.59 97.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mt -60.16 -61.73 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.3 t -56.26 -32.57 64.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.504 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 20.8 t80 -57.9 -58.48 8.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.0 -39.1 92.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -41.32 -40.87 1.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.1 ptp180 -102.9 -38.11 7.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 71.6 mm-40 -67.03 -60.94 2.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -44.47 132.35 6.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.088 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.42 -75.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 t -49.73 -56.69 9.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.51 -179.63 31.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.527 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -0.53 7.01 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.728 2.285 . . . . 0.0 112.336 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.2 p -47.59 126.47 10.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.843 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.1 m -134.23 139.11 45.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.888 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.449 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 t -170.29 118.2 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.823 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m -145.58 131.59 19.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.833 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.42 128.41 1.01 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 m -151.63 169.33 22.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.844 0.354 . . . . 0.0 110.871 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.3 t -165.2 171.13 14.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.819 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.25 131.95 5.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.493 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 52.94 39.43 29.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.889 0.376 . . . . 0.0 110.883 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' C ' ' OD1' ' A' ' 9' ' ' ASP . 0.7 OUTLIER -98.87 121.13 40.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.882 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.04 168.68 13.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 m120 60.43 35.67 20.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.349 . . . . 0.0 110.881 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.407 ' C ' HD13 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -104.53 43.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.571 ' HD2' ' CE1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -68.18 121.25 15.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.482 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 11.5 tpt180 -135.5 131.64 36.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.571 ' CE1' ' HD2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -175.08 164.57 3.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.926 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 pp -116.36 -36.93 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.929 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.489 ' HG2' ' N ' ' A' ' 18' ' ' SER . 6.6 ttpm? -119.78 163.25 17.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.489 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 85.7 p -165.12 155.57 13.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.428 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 4.4 mm-40 -103.3 162.23 20.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.652 0.739 . . . . 0.0 110.884 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.428 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.74 143.4 50.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 0.0 112.33 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.3 mm -70.04 132.56 88.32 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.722 . . . . 0.0 111.12 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 142.77 48.69 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.721 2.281 . . . . 0.0 112.347 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.25 -36.44 61.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.901 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 p -119.99 113.92 21.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.879 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.407 ' CG ' ' HD2' ' A' ' 30' ' ' LYS . 10.1 t-20 -125.11 47.0 2.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -111.11 61.74 0.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.15 -165.22 11.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.448 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -40.94 4.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.684 2.256 . . . . 0.0 112.35 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.6 108.9 23.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.407 ' HD2' ' CG ' ' A' ' 25' ' ' ASN . 1.5 mmmt -59.35 136.38 57.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.3 t -84.65 125.01 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 31.3 t -119.38 119.61 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 36' ' ' ASN . 18.1 m -115.54 148.11 18.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.088 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -35.31 -38.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.111 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -59.71 -48.93 79.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.449 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 14.8 p-10 -111.44 30.16 7.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.569 ' CZ ' ' HG3' ' A' ' 93' ' ' PRO . 15.4 t80 -68.48 -62.55 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.43 -8.8 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.56 -46.57 11.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.406 HD12 ' ND2' ' A' ' 36' ' ' ASN . 17.5 mt -97.46 -50.37 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' A' ' 37' ' ' PHE . 29.5 t -58.06 -60.88 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.104 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -76.16 125.34 28.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -169.13 105.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.28 -1.75 28.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -85.52 -46.63 10.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.01 166.62 23.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -83.12 151.0 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.41 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 9.3 t -141.82 149.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.155 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.43 HD22 ' CD1' ' A' ' 82' ' ' ILE . 6.4 tp -122.84 120.01 32.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.3 tp -107.4 137.11 40.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.49 ' OE1' ' CG1' ' A' ' 104' ' ' ILE . 3.7 tp10 -127.34 107.42 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.909 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.402 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 39.7 m-85 -83.82 126.62 33.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.442 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 9.6 p90 -132.87 176.0 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.893 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.03 133.07 24.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.713 . . . . 0.0 111.073 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -4.09 13.33 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.355 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.564 ' CZ2' HG21 ' A' ' 88' ' ' THR . 6.0 p-90 -123.56 17.7 9.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 43.6 t -116.09 100.63 8.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -41.3 -51.1 4.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 58' ' ' GLY . 97.2 m-70 -37.4 -38.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.762 0.315 . . . . 0.0 110.855 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 64' ' ' GLU . 6.2 t -69.33 -51.34 37.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.52 -53.1 19.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -64.95 -18.09 64.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.8 tp -97.25 -18.41 19.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.946 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.574 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.5 tp10 -45.32 -55.12 12.44 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.69 0.757 . . . . 0.0 110.915 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.1 Cg_endo -69.83 -24.64 29.14 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 0.0 112.283 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.443 ' NZ ' ' O ' ' A' ' 122' ' ' ARG . 1.0 OUTLIER -76.99 -33.25 57.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -90.0 -31.94 16.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -53.81 -56.49 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.914 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -41.98 -56.81 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.458 ' N ' HD21 ' A' ' 124' ' ' LEU . 37.7 tp -41.14 -40.52 1.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.87 -69.09 1.4 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.496 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -59.36 -20.3 53.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.926 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -76.78 -46.56 24.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 77' ' ' ASP . 96.8 mt -86.65 1.98 50.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -48.75 -22.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.02 22.91 4.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 72.6 m-20 -108.63 99.24 32.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.657 0.742 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.4 Cg_endo -69.66 -0.82 7.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 0.0 112.36 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -117.62 -36.78 3.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.45 129.0 51.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.4 t -124.35 109.99 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.43 ' CD1' HD22 ' A' ' 49' ' ' LEU . 27.2 mm -80.36 133.57 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.146 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -147.65 169.12 20.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -136.4 153.16 51.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.4 ttt -146.46 135.72 22.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.442 ' OD1' ' CZ ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -91.76 83.88 5.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.876 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -43.16 -55.95 3.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.564 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 33.7 p -46.95 -32.39 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.168 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.38 -19.82 21.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.61 122.49 17.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -51.6 130.84 28.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.469 ' CG2' ' HB3' ' A' ' 87' ' ' ALA . 95.7 t -72.81 131.83 83.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.589 0.709 . . . . 0.0 111.108 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.569 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.7 Cg_endo -69.81 -168.43 0.28 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.665 2.243 . . . . 0.0 112.371 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -129.6 161.22 60.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.661 0.744 . . . . 0.0 110.828 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.9 Cg_endo -69.71 -3.11 7.43 Favored 'Cis proline' 0 C--N 1.341 0.182 0 C-N-CA 122.69 -1.796 . . . . 0.0 112.361 -0.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.462 ' N ' ' HA ' ' A' ' 94' ' ' SER . 83.6 m-85 -33.77 127.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -131.7 102.42 5.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 74.8 t -105.82 115.5 47.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -114.65 -47.41 2.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.94 127.61 7.5 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.488 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.529 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -100.06 154.95 36.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 0.0 110.867 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.7 Cg_endo -69.75 157.9 91.53 Favored 'Cis proline' 0 C--O 1.231 0.166 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.369 -0.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.6 m -133.1 101.84 5.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.544 HD12 ' CE1' ' A' ' 127' ' ' PHE . 82.6 mt -95.18 125.55 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 7.8 m-85 -122.02 -176.98 3.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 41.6 t80 -150.91 136.25 17.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.8 t -105.52 92.42 5.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.78 155.63 65.38 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.668 2.246 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.89 128.55 33.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 67.43 25.02 8.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.478 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 14.0 mtmt -134.38 56.02 1.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 114' ' ' ASN . 31.4 mmtt -80.11 -56.27 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.9 mp -37.8 -28.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 112' ' ' LYS . 12.6 m120 -148.71 107.63 3.5 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.912 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.471 ' CD ' ' HG2' ' A' ' 95' ' ' PRO . 53.4 Cg_endo -69.77 -174.97 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.72 2.28 . . . . 0.0 112.336 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.2 120.82 29.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HB2' ' CE1' ' A' ' 105' ' ' TYR . 13.2 ttmm -94.38 130.19 40.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -76.71 111.52 12.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -124.68 98.23 5.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.53 -137.84 2.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.38 126.96 8.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.443 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 63.9 mtm-85 -78.92 45.47 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 110.863 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -101.97 138.56 38.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.458 HD21 ' N ' ' A' ' 70' ' ' LEU . 3.4 tm? -42.3 -51.3 4.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.7 p -70.59 -32.16 69.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -61.89 -34.65 76.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.544 ' CE1' HD12 ' A' ' 104' ' ' ILE . 31.0 m-85 -71.19 -35.21 71.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.2 mt -68.43 -52.01 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -63.75 -26.03 68.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -69.24 -47.68 64.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.923 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 133' ' ' ARG . 17.6 mt -77.0 -42.65 37.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.916 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' LEU . 15.1 mt-30 -37.48 -31.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 131' ' ' LEU . 22.2 mmm180 -104.1 -53.81 2.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -50.01 -58.5 5.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -38.77 116.64 0.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -33.91 -75.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -73.33 -55.31 6.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.07 176.79 50.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.464 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 130.1 18.69 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.69 2.26 . . . . 0.0 112.323 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 t -81.04 138.45 36.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.83 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.8 t -118.09 -49.63 2.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.844 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.464 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.2 m -139.76 174.34 10.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.858 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.8 p -86.23 -56.83 3.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.877 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.63 129.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.505 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.9 p -143.68 136.76 27.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.381 . . . . 0.0 110.84 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.5 t -158.3 165.96 33.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.14 -176.95 32.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.46 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -88.39 140.71 29.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.352 . . . . 0.0 110.888 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -130.07 153.07 48.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.858 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.07 -131.13 10.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.487 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 68.84 36.0 2.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 0.0 110.877 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 76.4 mt -105.36 93.73 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -157.35 141.52 16.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 179.833 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -169.69 120.1 0.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.6 p90 -153.07 157.08 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 17' ' ' LYS . 2.9 pp -105.51 -41.24 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.434 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.9 tttp -96.78 160.83 14.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 93.0 p -168.2 150.16 5.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.834 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.493 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 8.7 mm-40 -104.52 161.53 22.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.64 0.733 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.71 142.88 49.36 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.723 2.282 . . . . 0.0 112.337 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.456 HD12 ' CB ' ' A' ' 35' ' ' GLU . 40.7 mm -72.56 129.14 87.5 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.627 0.727 . . . . 0.0 111.151 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 169.87 17.87 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -88.95 -37.11 15.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -156.34 134.81 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.439 ' CB ' ' HD3' ' A' ' 30' ' ' LYS . 41.1 m-20 -111.39 47.75 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -52.19 -33.22 39.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -41.99 166.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.32 36.42 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.698 2.265 . . . . 0.0 112.304 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.89 117.78 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.144 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 10.0 mmtm -64.99 132.57 49.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.898 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.9 t -86.51 102.8 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.139 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 37' ' ' PHE . 40.4 t -95.95 127.18 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.145 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 36' ' ' ASN . 27.1 m -123.08 146.25 28.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -31.71 -44.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.09 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.456 ' CB ' HD12 ' A' ' 21' ' ' ILE . 23.9 mt-10 -53.71 -50.77 65.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 33' ' ' VAL . 12.1 p-10 -112.26 33.92 4.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.557 ' CD2' HG21 ' A' ' 41' ' ' VAL . 14.1 t80 -74.33 -58.46 3.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -62.53 -8.79 6.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.45 -43.9 11.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.419 HD13 ' ND2' ' A' ' 36' ' ' ASN . 21.4 mt -98.78 -52.99 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.557 HG21 ' CD2' ' A' ' 37' ' ' PHE . 45.8 t -57.01 -61.94 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.51 115.75 11.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -160.73 105.04 1.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -84.71 8.68 16.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -104.49 -43.44 5.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -129.64 159.8 35.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -78.51 148.08 33.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.1 t -146.54 122.36 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.121 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.0 tp -99.0 116.33 30.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 tp -105.25 130.75 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.08 115.35 21.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -89.68 116.6 27.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.54 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 18.6 p90 -121.6 171.6 8.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.966 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 56' ' ' TRP . . . -126.71 130.74 23.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.593 0.711 . . . . 0.0 111.104 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -8.52 23.8 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.479 ' CE2' ' HB1' ' A' ' 54' ' ' ALA . 2.2 p-90 -112.82 7.9 18.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.2 t -107.92 130.62 55.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.25 -52.6 39.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.551 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -37.81 -39.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -64.93 -55.66 17.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -42.55 -47.11 5.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -73.1 -23.4 60.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 60' ' ' CYS . 41.6 tp -87.9 -18.42 29.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.518 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -46.84 -58.29 7.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.642 0.734 . . . . 0.0 110.872 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.2 Cg_endo -69.76 -31.91 19.61 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.699 2.266 . . . . 0.0 112.351 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -68.2 -32.29 72.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' O ' ' C ' ' A' ' 68' ' ' LYS . 42.1 t80 -89.76 -50.41 6.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.87 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 67' ' ' TYR . 12.1 ttmt -36.9 -61.63 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -40.98 -56.66 2.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.846 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.469 ' N ' HD21 ' A' ' 124' ' ' LEU . 19.1 tp -42.48 -36.82 1.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -55.99 -69.05 1.39 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.45 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -66.88 -23.34 65.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.382 . . . . 0.0 110.874 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -67.44 -45.46 75.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.0 mt -85.82 3.74 40.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.5 p -52.4 -29.79 25.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -62.13 -7.57 4.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -103.57 101.08 21.58 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.619 0.723 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 1.67 4.22 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.338 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.476 ' C ' ' OD1' ' A' ' 47' ' ' ASP . 78.1 m-20 -113.55 -39.92 3.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.9 mt -84.79 106.49 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.124 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.9 t -99.79 116.28 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.138 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.7 mm -91.41 119.68 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.143 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 30' ' ' LYS . . . -133.37 175.83 9.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.112 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -146.62 139.5 25.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.458 ' CE ' ' HB2' ' A' ' 90' ' ' ASN . 1.8 tmm? -134.5 149.83 50.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.54 ' OD1' ' CZ ' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -100.93 96.16 7.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.813 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -43.73 -66.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -40.69 -29.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.77 -30.67 16.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 15.8 m-80 -130.81 119.75 22.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.827 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -57.86 118.94 5.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.6 t -72.72 116.58 51.41 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.575 0.702 . . . . 0.0 111.134 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.7 Cg_endo -69.78 -172.08 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.65 2.233 . . . . 0.0 112.378 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -105.45 159.71 28.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.618 0.723 . . . . 0.0 110.858 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.6 Cg_endo -69.79 -20.85 10.59 Favored 'Cis proline' 0 C--O 1.232 0.177 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.297 0.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.482 ' C ' ' O ' ' A' ' 95' ' ' PRO . 93.6 m-85 -30.64 131.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.955 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.455 ' OE1' ' CZ ' ' A' ' 99' ' ' ARG . 13.7 mm-40 -141.92 119.27 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.9 t -117.71 107.3 21.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.147 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.455 ' CZ ' ' OE1' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -125.41 33.1 5.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.59 113.66 0.29 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.523 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -97.72 155.09 37.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.664 0.745 . . . . 0.0 110.871 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.7 Cg_endo -69.79 145.54 79.79 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.651 -1.812 . . . . 0.0 112.334 0.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.8 m -122.57 124.29 43.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 105' ' ' TYR . 27.7 mt -120.26 134.64 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.158 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.439 ' N ' HG22 ' A' ' 104' ' ' ILE . 10.8 m-85 -134.07 161.1 35.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -136.59 126.08 25.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 5.7 p -99.87 102.93 19.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.716 0.769 . . . . 0.0 110.815 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.491 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.4 Cg_endo -69.76 167.85 23.25 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.679 2.253 . . . . 0.0 112.352 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.448 ' O ' ' CE ' ' A' ' 111' ' ' LYS . . . -78.37 140.75 38.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.8 29.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.491 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.1 mtmt -130.36 48.44 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.461 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 6.5 mmpt? -70.81 -57.57 4.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 112' ' ' LYS . 54.9 mt -35.74 -43.09 0.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -132.61 95.67 19.78 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.651 0.739 . . . . 0.0 110.871 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -164.44 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.719 2.28 . . . . 0.0 112.307 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -145.5 117.55 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.944 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -89.3 137.98 31.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.912 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.63 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 82.8 t80 -70.48 118.26 13.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -125.7 100.39 6.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.01 -155.38 25.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.18 139.58 22.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.472 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -82.5 52.84 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.84 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.414 ' HB3' ' CG ' ' A' ' 126' ' ' ASP . 13.0 tt0 -108.59 141.03 41.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.469 HD21 ' N ' ' A' ' 70' ' ' LEU . 3.5 tm? -44.73 -50.93 9.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.7 p -69.8 -42.25 73.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.414 ' CG ' ' HB3' ' A' ' 123' ' ' GLU . 3.8 m-20 -49.44 -34.71 17.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.63 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 65.1 m-85 -73.03 -44.87 60.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.6 mt -57.21 -48.64 81.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.8 p -62.58 -46.94 85.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.513 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 5.1 t80 -56.03 -44.84 79.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.949 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.3 mt -72.56 -41.2 65.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.494 ' CD ' ' CG ' ' A' ' 139' ' ' PRO . 14.8 mm-40 -38.09 -40.49 0.49 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -97.84 -57.28 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 39.5 mm-40 -45.45 -58.71 3.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.65 153.71 27.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.088 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.05 -50.1 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 84.8 p -47.31 -54.93 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.824 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.16 143.96 0.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.494 ' CG ' ' CD ' ' A' ' 132' ' ' GLN . 53.9 Cg_endo -69.76 -8.27 23.19 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.674 2.249 . . . . 0.0 112.336 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.3 m -105.4 126.96 52.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.5 t -103.77 90.53 3.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.804 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.495 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 2.6 p90 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.928 0.394 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 pp -108.56 -35.43 6.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 17.5 ttpt -110.61 154.27 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 4.8 m -159.75 143.94 14.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.437 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.2 mm-40 -89.97 161.56 37.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 0.0 110.888 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.437 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.9 Cg_endo -69.75 141.49 45.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.658 2.239 . . . . 0.0 112.343 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.689 HD13 HG21 ' A' ' 33' ' ' VAL . 36.1 mm -69.91 132.17 88.81 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.698 . . . . 0.0 111.15 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 142.02 47.07 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.681 2.254 . . . . 0.0 112.348 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -61.3 -32.38 72.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -166.35 133.99 2.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -110.75 54.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -81.43 58.13 3.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.63 -168.51 11.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.514 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.479 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 53.4 Cg_endo -69.75 -48.81 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.716 2.277 . . . . 0.0 112.355 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.81 127.6 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -73.08 134.79 44.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -84.63 113.25 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.147 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.862 HG11 HG23 ' A' ' 41' ' ' VAL . 22.0 t -109.35 117.92 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.12 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.689 HG21 HD13 ' A' ' 21' ' ' ILE . 18.2 m -110.64 152.05 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.163 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB2' ' HB2' ' A' ' 90' ' ' ASN . . . -41.03 -34.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.53 ' HB3' HD11 ' A' ' 21' ' ' ILE . 8.8 mt-10 -64.51 -45.81 85.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 29.3 p30 -114.11 34.5 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CE1' ' HG3' ' A' ' 93' ' ' PRO . 6.4 t80 -73.6 -56.99 4.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -66.99 -4.81 10.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -89.47 -42.94 11.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.2 mt -98.94 -46.42 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.141 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.862 HG23 HG11 ' A' ' 32' ' ' VAL . 97.2 t -65.0 -62.12 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -67.8 113.98 6.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -175.25 106.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.39 2.73 27.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -84.79 -43.53 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -135.31 150.64 50.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.36 148.29 41.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 81' ' ' VAL . 63.7 t -146.85 144.36 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 82' ' ' ILE . 14.5 tp -117.92 119.15 33.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.575 HG12 ' CE1' ' A' ' 52' ' ' PHE . 2.2 tp -101.46 129.78 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -119.53 111.45 18.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.575 ' CE1' HG12 ' A' ' 50' ' ' ILE . 34.7 m-85 -88.61 130.73 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -138.59 -175.12 4.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.631 ' HB1' ' CE2' ' A' ' 56' ' ' TRP . . . -142.43 133.74 12.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.605 0.716 . . . . 0.0 111.098 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -25.44 28.84 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.711 2.274 . . . . 0.0 112.345 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.631 ' CE2' ' HB1' ' A' ' 54' ' ' ALA . 2.2 p-90 -84.54 -28.13 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 4.6 t -68.73 138.5 54.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.835 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.91 -35.06 7.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.45 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.535 ' CE1' ' HG3' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -71.58 -26.77 62.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.885 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.3 m -83.37 -37.3 23.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -62.39 -45.41 93.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -60.85 -9.53 4.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.842 HD12 ' HB2' ' A' ' 66' ' ' LYS . 11.9 tp -97.34 -22.53 16.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.529 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -34.6 -58.21 0.68 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.675 0.75 . . . . 0.0 110.887 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.5 Cg_endo -69.73 -24.57 29.65 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.715 2.276 . . . . 0.0 112.294 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.842 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.6 mmmp? -75.27 -27.04 59.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 63.6 t80 -94.8 -39.7 10.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.886 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.479 ' HG3' ' CG ' ' A' ' 28' ' ' PRO . 5.6 ttmm -46.22 -59.49 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.898 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -38.84 -60.15 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.438 ' N ' HD21 ' A' ' 124' ' ' LEU . 17.4 tp -38.39 -42.04 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.93 -58.74 12.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.515 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -70.5 -20.98 62.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 0.0 110.926 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -72.56 -46.31 55.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.54 HD12 HD11 ' A' ' 82' ' ' ILE . 97.0 mt -78.26 3.12 16.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.9 p -50.3 -25.0 3.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.835 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -79.09 11.62 2.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.922 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.43 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 4.6 t0 -117.82 97.95 51.2 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.566 0.698 . . . . 0.0 110.897 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.0 Cg_endo -69.72 -1.08 7.82 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.739 2.293 . . . . 0.0 112.311 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -109.77 -37.19 5.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.448 HD11 ' CB ' ' A' ' 135' ' ' ALA . 46.6 mt -93.8 133.26 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.078 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 48' ' ' VAL . 54.3 t -129.74 117.33 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.54 HD11 HD12 ' A' ' 74' ' ' LEU . 50.1 mm -86.39 134.77 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.114 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.775 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -147.26 167.16 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -135.67 155.02 51.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.484 ' CB ' HD11 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -148.87 132.05 16.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.899 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.756 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -84.83 94.96 8.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.87 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.04 -62.62 1.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.443 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -48.63 -35.06 12.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.756 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -80.78 -22.21 40.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.12 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -150.44 123.31 8.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -47.55 148.13 1.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.614 HG13 ' HD2' ' A' ' 93' ' ' PRO . 93.3 t -100.2 137.75 20.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.626 0.727 . . . . 0.0 111.14 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.614 ' HD2' HG13 ' A' ' 92' ' ' VAL . 53.9 Cg_endo -69.74 -163.81 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.654 2.236 . . . . 0.0 112.316 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.497 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -128.32 160.88 59.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.648 0.737 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.72 -6.45 9.36 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.328 -0.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.446 ' C ' ' O ' ' A' ' 95' ' ' PRO . 89.8 m-85 -34.35 121.14 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -127.58 131.9 49.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.803 HG22 HG21 ' A' ' 103' ' ' THR . 91.1 t -131.92 104.69 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -104.85 -39.62 6.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.86 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -128.21 132.48 7.37 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.461 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.543 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -100.03 154.24 37.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.637 0.732 . . . . 0.0 110.92 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.75 159.88 88.92 Favored 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.674 -1.802 . . . . 0.0 112.317 -0.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.803 HG21 HG22 ' A' ' 98' ' ' VAL . 44.4 m -135.02 102.97 5.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.1 mt -98.78 134.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.135 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.412 ' O ' HD12 ' A' ' 49' ' ' LEU . 8.9 m-85 -132.75 166.6 21.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -134.96 132.34 38.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.407 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 1.9 t -105.75 94.76 9.31 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.629 0.728 . . . . 0.0 110.864 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.46 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.8 Cg_endo -69.76 175.71 7.74 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.687 2.258 . . . . 0.0 112.357 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.27 137.08 32.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.31 25.59 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.46 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.2 mtmm -124.77 21.98 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.487 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 2.3 mptp? -50.85 -50.0 57.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -46.12 -38.92 8.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -134.26 91.48 22.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.602 0.715 . . . . 0.0 110.942 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -163.85 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.691 2.261 . . . . 0.0 112.344 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -142.26 145.51 34.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -119.6 117.87 29.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -57.33 111.47 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.931 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -125.12 91.56 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.5 -142.84 4.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.485 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.51 130.68 10.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 127' ' ' PHE . 45.4 mtm-85 -81.1 47.58 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 124' ' ' LEU . 4.1 tt0 -103.76 133.65 48.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 123' ' ' GLU . 3.1 tm? -34.17 -53.68 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.972 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 128' ' ' ILE . 14.8 m -67.2 -51.0 58.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -42.75 -31.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 122' ' ' ARG . 68.7 m-85 -76.74 -40.44 48.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' A' ' 125' ' ' SER . 32.3 mt -62.11 -55.99 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -57.79 -31.42 66.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.513 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 68.1 t80 -63.46 -45.06 92.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.964 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.1 mt -76.59 -39.13 53.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.945 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -46.63 -24.2 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.43 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.7 ptp85 -112.69 -37.02 5.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 2.9 mm-40 -70.01 -59.64 2.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.889 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.448 ' CB ' HD11 ' A' ' 80' ' ' ILE . . . -45.72 107.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.106 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 137' ' ' SER . 1.7 t -44.35 -50.55 9.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.432 ' N ' HG23 ' A' ' 136' ' ' THR . 46.1 m -68.64 -58.34 4.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.459 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.648 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.914 0.388 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 pp -104.27 -40.61 6.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 12.2 ttpt -109.1 154.73 21.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.1 p -155.59 144.74 20.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.459 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 3.8 mm-40 -91.77 161.23 34.42 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.638 0.732 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.459 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.7 Cg_endo -69.79 142.98 49.27 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.658 2.239 . . . . 0.0 112.366 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.49 HD13 ' CG2' ' A' ' 33' ' ' VAL . 40.2 mm -74.58 133.85 76.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 111.136 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 21' ' ' ILE . 54.0 Cg_endo -69.74 176.62 6.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.731 2.288 . . . . 0.0 112.326 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -101.54 -35.95 8.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.3 t -148.99 128.96 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -116.78 49.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.04 56.55 3.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.72 -171.89 13.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.489 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -38.71 7.47 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.687 2.258 . . . . 0.0 112.314 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.529 HG12 ' HG2' ' A' ' 84' ' ' LYS . 21.6 t -119.49 119.33 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.104 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.616 ' HZ1' HD13 ' A' ' 40' ' ' ILE . 1.6 mmmp? -68.97 125.73 27.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.1 t -74.81 124.33 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.765 HG11 HG23 ' A' ' 41' ' ' VAL . 42.0 t -123.9 125.65 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 35' ' ' GLU . 21.1 m -119.14 149.46 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.648 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.18 -42.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.064 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.529 ' HB2' HG23 ' A' ' 33' ' ' VAL . 9.4 mt-10 -55.57 -48.69 74.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' A' ' 33' ' ' VAL . 11.3 p-10 -114.08 38.85 2.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.588 ' CE1' ' HG3' ' A' ' 93' ' ' PRO . 4.6 t80 -77.95 -55.22 5.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.96 -11.12 55.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -83.28 -42.27 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.707 HD12 HG22 ' A' ' 32' ' ' VAL . 24.9 mt -99.24 -59.44 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.765 HG23 HG11 ' A' ' 32' ' ' VAL . 94.1 t -49.99 -62.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -66.46 115.77 6.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.84 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -173.75 110.37 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -87.17 -4.53 59.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -73.96 -48.47 30.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.87 153.91 51.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -67.67 142.25 56.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.8 t -137.52 143.79 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.468 HD23 HD12 ' A' ' 82' ' ' ILE . 31.1 tp -121.31 121.28 37.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.581 HD13 HG22 ' A' ' 41' ' ' VAL . 2.4 tp -109.76 133.4 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' OE1' ' C ' ' A' ' 52' ' ' PHE . 0.3 OUTLIER -124.0 118.22 26.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.869 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.43 ' C ' ' OE1' ' A' ' 51' ' ' GLU . 54.4 m-85 -95.0 114.93 26.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CE1' ' OD1' ' A' ' 86' ' ' ASP . 17.2 p90 -120.23 -179.19 3.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.404 ' HB3' ' CB ' ' A' ' 57' ' ' CYS . . . -136.76 134.49 19.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.578 0.704 . . . . 0.0 111.083 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.733 ' HD2' HG21 ' A' ' 88' ' ' THR . 53.6 Cg_endo -69.76 -11.05 30.04 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.708 2.272 . . . . 0.0 112.295 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -114.1 9.25 17.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.404 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . 48.4 t -106.32 113.27 26.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.71 -52.71 46.59 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.481 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -46.67 -39.13 10.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.731 0.301 . . . . 0.0 110.809 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 43.9 m -70.95 -39.84 72.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.912 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -40.58 76.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.894 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -73.21 -25.5 60.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.605 HD13 ' HB3' ' A' ' 122' ' ' ARG . 29.4 tp -83.24 -23.11 32.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.529 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -42.52 -57.88 4.23 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.623 0.725 . . . . 0.0 110.934 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.8 -36.03 11.43 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.679 2.252 . . . . 0.0 112.341 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HB2' HD12 ' A' ' 63' ' ' LEU . 17.1 mtpp -64.63 -28.34 69.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.434 ' OH ' HG23 ' A' ' 82' ' ' ILE . 57.0 t80 -93.04 -43.64 8.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -44.82 -58.52 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.925 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -41.64 -46.84 3.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.512 HD13 ' HB2' ' A' ' 127' ' ' PHE . 12.1 tp -53.32 -36.54 61.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.962 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -57.97 -57.04 21.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.17 -24.34 57.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.911 0.386 . . . . 0.0 110.911 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -72.14 -42.16 66.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 80' ' ' ILE . 81.3 mt -83.24 3.35 31.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.6 p -53.08 -39.67 63.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 17.6 tttt -57.88 -11.93 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.78 99.65 9.42 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.608 0.718 . . . . 0.0 110.859 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.5 Cg_endo -69.82 0.15 6.1 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.639 2.226 . . . . 0.0 112.332 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -109.98 -35.86 6.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.562 HG21 HD13 ' A' ' 74' ' ' LEU . 60.9 mt -90.61 104.08 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.46 110.02 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.468 HD12 HD23 ' A' ' 49' ' ' LEU . 50.2 mm -82.87 127.17 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.159 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.56 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -134.4 166.37 23.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.529 ' HG2' HG12 ' A' ' 29' ' ' VAL . 15.2 pttp -138.21 154.05 49.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.503 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 9.7 ttt -150.42 136.82 18.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.96 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 4.0 t70 -92.75 94.96 9.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -50.13 -64.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.733 HG21 ' HD2' ' A' ' 55' ' ' PRO . 1.2 t -41.63 -26.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.117 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -96.68 -26.52 15.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.503 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -141.15 109.39 5.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -44.25 136.58 3.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.581 HG13 ' HD2' ' A' ' 93' ' ' PRO . 72.8 t -86.08 136.63 35.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.596 0.713 . . . . 0.0 111.144 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.588 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.4 Cg_endo -69.74 -167.76 0.24 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.712 2.275 . . . . 0.0 112.312 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.505 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -121.74 161.33 42.52 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.731 0.777 . . . . 0.0 110.83 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.0 Cg_endo -69.75 -9.24 10.89 Favored 'Cis proline' 0 C--O 1.232 0.223 0 C-N-CA 122.679 -1.801 . . . . 0.0 112.318 -0.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 95' ' ' PRO . 93.9 m-85 -33.98 126.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.905 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.82 128.35 36.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 103' ' ' THR . 88.6 t -127.5 94.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -116.18 28.89 8.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.825 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.32 113.81 0.36 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.543 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -98.09 153.64 38.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.659 0.742 . . . . 0.0 110.874 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.77 156.5 92.79 Favored 'Cis proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 -1.79 . . . . 0.0 112.339 0.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.555 HG21 HG22 ' A' ' 98' ' ' VAL . 6.7 m -135.0 128.18 31.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.424 HD13 ' HE1' ' A' ' 127' ' ' PHE . 36.6 mt -123.36 136.65 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.549 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 9.8 m-85 -136.45 144.29 44.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -119.72 129.72 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -99.96 101.05 12.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.843 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.495 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.3 Cg_endo -69.76 168.09 22.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.706 2.27 . . . . 0.0 112.342 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.12 137.23 33.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 0.7 OUTLIER 51.86 24.94 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.495 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.2 mtmt -129.3 38.42 3.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.468 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 5.8 mmpt? -63.35 -59.34 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 112' ' ' LYS . 11.0 mp -35.41 -36.84 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 2.3 t-20 -134.47 96.82 14.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.642 0.734 . . . . 0.0 110.839 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.9 Cg_endo -69.72 -178.44 2.33 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.661 2.24 . . . . 0.0 112.373 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 147.99 49.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.549 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 10.7 ttpt -118.43 125.92 50.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -67.86 115.65 7.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -123.5 102.84 8.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.63 -149.75 11.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.465 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.91 138.9 14.79 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.5 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.605 ' HB3' HD13 ' A' ' 63' ' ' LEU . 1.1 mpp_? -79.0 45.59 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.774 0.321 . . . . 0.0 110.829 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 124' ' ' LEU . 8.2 tt0 -101.64 128.32 47.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.566 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -34.14 -56.09 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.9 m -59.23 -45.92 89.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 130' ' ' TYR . 6.4 t0 -49.33 -39.97 33.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.512 ' HB2' HD13 ' A' ' 70' ' ' LEU . 58.6 m-85 -67.41 -41.41 84.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.486 HD11 ' CD1' ' A' ' 124' ' ' LEU . 23.4 mt -62.28 -65.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.089 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 m -56.25 -34.8 66.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.41 ' CB ' ' O ' ' A' ' 126' ' ' ASP . 14.6 t80 -57.22 -45.73 83.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.943 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.93 -35.44 32.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -38.56 -41.85 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -98.11 -57.98 2.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -44.17 -56.76 3.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.0 105.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.133 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.423 HG23 ' N ' ' A' ' 137' ' ' SER . 1.6 t -40.41 -49.96 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 136' ' ' THR . 16.6 m -113.14 40.54 2.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.802 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.3 p90 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.933 0.397 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.727 HD23 ' CG ' ' A' ' 91' ' ' ASP . 1.2 pt? -95.7 -35.7 11.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.502 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 10.5 ptmt -117.34 176.36 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.3 p -174.99 150.5 1.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.824 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 12.1 mm-40 -96.6 159.15 32.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 0.0 110.853 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 141.91 46.68 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.561 HD13 HG21 ' A' ' 33' ' ' VAL . 20.2 mm -69.47 131.43 90.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.565 0.698 . . . . 0.0 111.135 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 141.52 45.52 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.671 2.247 . . . . 0.0 112.394 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.1 -34.88 74.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.1 t -156.88 137.21 12.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -121.21 48.2 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.65 52.21 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.39 -167.08 13.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -41.59 4.1 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.668 2.245 . . . . 0.0 112.361 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.72 128.23 74.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.106 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.559 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 12.5 mmmt -74.9 117.33 16.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.581 HG22 ' HE3' ' A' ' 84' ' ' LYS . 78.5 t -73.48 122.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.95 HG11 HG23 ' A' ' 41' ' ' VAL . 39.8 t -115.81 124.31 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.116 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.561 HG21 HD13 ' A' ' 21' ' ' ILE . 30.6 m -115.84 146.06 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.151 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.449 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -34.34 -42.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.071 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.559 ' HB3' HD11 ' A' ' 21' ' ' ILE . 6.7 mt-10 -55.5 -47.2 76.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' VAL . 21.1 p-10 -114.07 33.42 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.781 ' CD2' HG21 ' A' ' 41' ' ' VAL . 13.5 t80 -72.2 -58.28 3.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -64.55 -6.09 6.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -89.31 -46.44 8.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 mt -97.11 -46.05 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.95 HG23 HG11 ' A' ' 32' ' ' VAL . 50.0 t -63.44 -58.82 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.134 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -78.08 124.68 28.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.738 HD21 HG23 ' A' ' 48' ' ' VAL . 5.1 p-10 -175.59 108.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.961 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.419 ' CD ' ' HA ' ' A' ' 110' ' ' ASN . 2.1 mm-40 -83.05 20.25 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -106.75 -39.55 5.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.503 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 16.8 pttm -137.74 166.6 23.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -94.17 139.24 31.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.738 HG23 HD21 ' A' ' 43' ' ' ASN . 23.4 t -136.33 148.18 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.815 HD12 ' O ' ' A' ' 105' ' ' TYR . 6.6 tp -116.51 109.86 17.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 tp -91.64 135.73 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.076 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' OE2' ' C ' ' A' ' 52' ' ' PHE . 1.9 tm-20 -127.02 117.85 23.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.448 ' C ' ' OE2' ' A' ' 51' ' ' GLU . 45.8 m-85 -93.32 124.33 37.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -128.84 -175.02 3.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.787 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -139.1 131.66 15.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.594 0.711 . . . . 0.0 111.091 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -3.09 11.32 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.688 2.259 . . . . 0.0 112.327 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.552 ' NE1' HG21 ' A' ' 88' ' ' THR . 6.7 p-90 -119.45 -3.37 10.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.787 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -93.44 133.5 36.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.93 -41.83 93.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.484 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -51.62 -28.06 13.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 64' ' ' GLU . 42.5 t -69.97 -44.73 68.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -62.81 -44.07 97.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -72.15 -34.41 68.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 66' ' ' LYS . 29.8 tp -84.6 -19.19 33.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.9 OUTLIER -45.3 -58.3 6.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.676 0.75 . . . . 0.0 110.89 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.72 -30.85 21.82 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.337 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.535 ' HB2' HD12 ' A' ' 63' ' ' LEU . 27.2 mtmm -70.06 -26.84 64.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.924 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -95.75 -41.89 8.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -48.84 -58.85 4.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.449 ' CD ' ' O ' ' A' ' 65' ' ' PRO . 1.2 mp0 -39.27 -51.25 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.408 ' N ' HD21 ' A' ' 124' ' ' LEU . 26.2 tp -48.65 -40.13 26.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.958 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.47 -55.11 30.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.444 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -67.06 -28.1 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.94 0.4 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.51 -45.36 54.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.604 HD12 HD11 ' A' ' 82' ' ' ILE . 94.2 mt -83.14 3.04 32.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.918 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.3 t -49.97 -25.39 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.32 21.91 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.42 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 0.9 OUTLIER -104.48 98.08 13.71 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.603 0.716 . . . . 0.0 110.837 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.6 Cg_endo -69.79 -4.29 13.75 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.658 2.239 . . . . 0.0 112.332 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -116.41 -39.77 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.8 mt -96.9 140.43 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 48' ' ' VAL . 72.0 t -138.43 114.56 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.115 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.604 HD11 HD12 ' A' ' 74' ' ' LEU . 44.5 mm -81.51 126.78 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -136.67 164.58 27.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.075 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.581 ' HE3' HG22 ' A' ' 31' ' ' VAL . 24.1 pttt -136.75 138.3 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.4 ttt -134.96 143.42 46.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 26.9 t0 -92.92 115.21 27.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 89' ' ' ALA . . . -68.89 -70.73 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.114 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.552 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -42.43 -23.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.606 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -99.03 -31.81 11.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 14.4 m-80 -129.14 111.38 12.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.727 ' CG ' HD23 ' A' ' 16' ' ' LEU . 8.3 t0 -45.92 129.55 9.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -77.41 130.23 75.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 0.0 111.16 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.6 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.7 Cg_endo -69.73 -163.86 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.678 2.252 . . . . 0.0 112.317 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -130.61 161.47 60.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.636 0.732 . . . . 0.0 110.872 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.3 Cg_endo -69.74 -4.62 8.38 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.733 -1.778 . . . . 0.0 112.301 -0.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 95' ' ' PRO . 78.8 m-85 -33.27 125.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -125.09 132.46 53.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.473 HG22 HG21 ' A' ' 103' ' ' THR . 38.6 t -143.42 124.34 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -129.65 -39.31 1.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.47 123.31 5.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.484 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.538 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.5 154.82 37.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.664 0.745 . . . . 0.0 110.89 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.538 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.6 Cg_endo -69.8 161.75 85.65 Favored 'Cis proline' 0 C--O 1.232 0.186 0 C-N-CA 122.676 -1.801 . . . . 0.0 112.334 0.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.473 HG21 HG22 ' A' ' 98' ' ' VAL . 62.5 m -140.1 109.82 6.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.3 mt -104.12 134.0 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.182 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.815 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.9 m-85 -129.86 177.36 7.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.405 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.6 t80 -145.3 129.0 17.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.78 97.73 8.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.669 0.747 . . . . 0.0 110.851 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.501 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.5 Cg_endo -69.75 167.56 24.08 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 2.246 . . . . 0.0 112.328 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -83.12 137.63 34.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.108 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.0 OUTLIER 48.14 27.89 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.501 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.3 mtmm -129.4 29.78 5.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -53.87 -57.14 12.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.922 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 68.9 mt -43.3 -48.37 6.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -119.13 87.48 34.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.632 0.729 . . . . 0.0 110.851 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -163.9 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.716 2.277 . . . . 0.0 112.287 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -149.79 131.78 15.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 105' ' ' TYR . 21.6 tttt -102.49 136.46 42.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 70.2 t80 -66.42 110.93 3.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.32 97.31 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.88 -151.83 11.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.96 142.49 23.39 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.451 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -87.28 43.22 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 124' ' ' LEU . 2.7 tp10 -104.52 131.08 52.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 123' ' ' GLU . 2.8 tm? -34.07 -56.65 0.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 72.7 m -59.59 -50.73 72.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -46.6 -36.61 7.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 65.7 m-85 -70.3 -43.7 69.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.1 mt -58.73 -58.49 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.158 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.53 -31.36 69.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.469 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 52.2 t80 -60.31 -53.33 58.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' GLN . 43.7 mt -70.81 -39.78 72.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' LEU . 28.5 mm-40 -35.62 -36.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.8 mmp_? -106.77 -57.63 2.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.469 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 68.6 mm-40 -42.23 -49.5 4.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -61.66 109.57 1.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -33.99 -74.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.4 t -75.59 56.66 0.91 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.831 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.43 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.733 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.6 p90 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.89 0.376 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 17' ' ' LYS . 3.5 pp -103.86 -38.89 6.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 18' ' ' SER . 51.0 tttt -111.86 163.77 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.664 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 45.4 p -166.0 156.95 13.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.453 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 10.6 mm-40 -103.91 161.38 23.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.626 0.727 . . . . 0.0 110.865 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.7 144.15 53.42 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.694 2.263 . . . . 0.0 112.345 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.519 HD13 ' CG2' ' A' ' 33' ' ' VAL . 42.9 mm -74.92 130.95 79.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.73 . . . . 0.0 111.154 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 157.81 59.17 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.736 2.291 . . . . 0.0 112.321 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -70.77 -45.83 64.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.4 m -135.66 135.65 40.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -128.22 30.44 5.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.05 48.31 1.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.861 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.44 -162.95 18.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -40.65 5.07 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.326 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.685 HG11 ' HB3' ' A' ' 84' ' ' LYS . 74.2 t -120.01 119.68 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -66.77 113.75 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.6 t -73.04 108.24 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.061 HG11 HG23 ' A' ' 41' ' ' VAL . 39.2 t -106.77 128.03 61.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.129 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.519 ' CG2' HD13 ' A' ' 21' ' ' ILE . 26.9 m -122.25 148.99 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.733 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.84 -40.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 33' ' ' VAL . 16.0 mt-10 -56.42 -48.18 77.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 33' ' ' VAL . 22.0 p30 -115.12 35.41 4.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.617 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 15.7 t80 -75.17 -56.06 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.75 -5.02 10.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.834 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -92.23 -45.71 8.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.4 mt -96.88 -58.95 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.061 HG23 HG11 ' A' ' 32' ' ' VAL . 61.0 t -50.88 -60.83 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.126 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -70.62 115.16 9.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -167.28 111.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -88.49 6.61 36.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -92.19 -40.72 10.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 155.69 48.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.4 151.47 46.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.1 t -146.32 146.47 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.64 HD23 HD12 ' A' ' 82' ' ' ILE . 20.6 tp -125.15 127.75 47.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.937 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 105' ' ' TYR . 2.5 tp -109.15 140.55 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.139 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 1.9 tt0 -126.95 107.59 10.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -85.82 110.57 19.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -119.26 167.93 11.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.42 127.97 24.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.599 0.714 . . . . 0.0 111.094 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -6.63 19.04 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.444 ' NE1' HG21 ' A' ' 88' ' ' THR . 7.2 p-90 -118.67 14.41 13.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.948 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.2 t -117.09 123.41 46.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -61.71 -61.37 6.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.508 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -39.65 -37.12 0.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.341 . . . . 0.0 110.853 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 81.8 m -74.98 -39.09 61.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' GLY . 5.4 ttmt -62.55 -35.73 80.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -73.86 -22.21 59.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 66' ' ' LYS . 18.7 tp -88.15 -23.71 23.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.532 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.4 tt0 -37.93 -58.14 1.47 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.635 0.731 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.75 -34.32 14.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.704 2.27 . . . . 0.0 112.334 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.682 ' HB2' HD12 ' A' ' 63' ' ' LEU . 20.1 mtpp -66.39 -24.98 66.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 55.5 t80 -96.07 -38.86 10.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -47.78 -56.51 7.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.46 -56.1 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 127' ' ' PHE . 24.4 tp -40.61 -42.04 1.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.39 -68.88 1.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.54 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.87 -25.81 61.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.374 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -74.69 -39.53 61.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.952 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.501 HD22 ' OD2' ' A' ' 77' ' ' ASP . 95.1 mt -88.96 1.73 55.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.3 t -51.51 -20.86 2.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -91.41 18.34 7.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.918 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.501 ' OD2' HD22 ' A' ' 74' ' ' LEU . 97.1 m-20 -109.55 99.9 39.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.59 0.709 . . . . 0.0 110.89 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.9 Cg_endo -69.71 -1.33 8.24 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.721 2.28 . . . . 0.0 112.354 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.07 -35.13 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.883 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 51.0 mt -99.21 142.2 15.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.02 106.97 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.095 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.64 HD12 HD23 ' A' ' 49' ' ' LEU . 47.3 mm -74.36 126.43 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.742 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -130.59 169.14 15.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.043 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.685 ' HB3' HG11 ' A' ' 29' ' ' VAL . 10.6 ptpp? -137.67 135.69 36.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.468 ' CB ' HD11 ' A' ' 50' ' ' ILE . 18.0 ttt -141.38 143.84 34.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.922 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 10.3 t0 -98.63 117.92 34.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.46 -59.24 3.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.444 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -56.03 -21.23 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.109 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.922 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -99.79 -25.13 14.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 86' ' ' ASP . 4.5 m-80 -134.62 104.18 5.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -40.24 122.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.84 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.66 123.51 89.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.639 0.733 . . . . 0.0 111.107 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.8 Cg_endo -69.76 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.508 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.5 m -121.97 160.87 45.31 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.663 0.744 . . . . 0.0 110.848 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.76 -8.62 10.6 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.692 -1.795 . . . . 0.0 112.367 -0.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 95' ' ' PRO . 97.0 m-85 -34.14 123.08 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -130.45 115.34 16.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.781 HG22 HG21 ' A' ' 103' ' ' THR . 75.1 t -114.26 131.17 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 -50.05 1.02 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.88 125.77 6.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.464 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.528 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -96.77 154.71 38.28 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 0.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.528 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.73 154.96 93.38 Favored 'Cis proline' 0 C--O 1.232 0.207 0 C-N-CA 122.666 -1.806 . . . . 0.0 112.392 -0.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.781 HG21 HG22 ' A' ' 98' ' ' VAL . 61.2 m -132.78 102.11 5.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.157 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.424 HG12 ' CG ' ' A' ' 51' ' ' GLU . 74.8 mt -95.9 138.52 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.537 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 9.4 m-85 -135.87 140.29 44.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.474 ' HA ' HD12 ' A' ' 49' ' ' LEU . 14.6 t80 -114.88 130.47 56.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 17.3 m -101.91 97.63 8.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.669 0.747 . . . . 0.0 110.861 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.492 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.74 170.06 17.45 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.662 2.241 . . . . 0.0 112.37 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -86.0 142.16 28.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.5 p30 46.11 25.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.492 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.5 mtmt -126.09 39.13 4.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.461 ' O ' ' C ' ' A' ' 113' ' ' LEU . 36.4 mmtt -65.55 -61.38 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.893 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 112' ' ' LYS . 19.7 mt -33.66 -38.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.93 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 7.1 m120 -134.31 99.75 13.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.624 0.726 . . . . 0.0 110.852 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.3 Cg_endo -69.75 178.5 4.5 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.705 2.27 . . . . 0.0 112.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.67 127.01 41.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.537 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 15.6 ttpp -100.99 123.53 45.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -60.38 113.57 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -124.37 95.96 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.7 -148.82 7.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.535 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.84 136.49 14.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.484 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -83.67 45.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 110.869 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 124' ' ' LEU . 3.7 tp10 -104.83 132.05 51.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.541 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.5 tm? -35.29 -53.06 0.63 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.0 m -63.63 -45.65 89.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -46.83 -42.58 17.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.556 ' HB2' HD13 ' A' ' 70' ' ' LEU . 74.5 m-85 -64.95 -46.82 79.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 mt -53.91 -59.66 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.1 t -59.1 -37.46 77.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.438 ' CD1' HD23 ' A' ' 131' ' ' LEU . 22.3 t80 -56.67 -55.2 37.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.954 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.483 HD12 HD11 ' A' ' 74' ' ' LEU . 18.3 mt -68.67 -38.07 80.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -47.47 -44.54 25.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -93.72 -46.48 7.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.7 -62.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 131' ' ' LEU . . . -39.2 105.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.063 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.585 HG23 ' H ' ' A' ' 137' ' ' SER . 1.3 t -42.45 -56.25 3.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.101 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.585 ' H ' HG23 ' A' ' 136' ' ' THR . 1.1 t -66.3 -44.22 84.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.432 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.523 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.4 p90 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.549 ' H ' HD23 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -92.62 -38.23 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.521 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -116.38 174.35 6.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 88.0 p -170.95 165.6 7.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.521 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 6.4 mm-40 -113.56 160.2 32.6 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.611 0.72 . . . . 0.0 110.906 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 145.75 57.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.697 2.264 . . . . 0.0 112.326 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 35' ' ' GLU . 20.5 mm -69.42 134.96 88.71 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.659 0.742 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.42 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 53.7 Cg_endo -69.77 137.98 36.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.71 2.273 . . . . 0.0 112.324 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.36 -32.24 62.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.8 t -128.46 106.51 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.442 ' CG ' ' HD3' ' A' ' 30' ' ' LYS . 9.7 t-20 -111.35 46.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -110.93 49.43 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.876 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.25 -162.34 14.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -48.25 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.677 2.251 . . . . 0.0 112.321 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 84' ' ' LYS . 22.2 t -115.88 116.05 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' HD3' ' CG ' ' A' ' 25' ' ' ASN . 7.7 mmtt -57.42 123.82 16.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.411 HG22 ' HE3' ' A' ' 84' ' ' LYS . 95.9 t -76.88 109.63 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.919 HG11 HG23 ' A' ' 41' ' ' VAL . 29.0 t -107.31 123.99 62.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.069 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 36' ' ' ASN . 28.5 m -119.07 147.11 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -32.4 -45.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.14 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.61 ' HB3' HD11 ' A' ' 21' ' ' ILE . 7.0 mt-10 -52.93 -49.78 65.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 33' ' ' VAL . 12.2 p-10 -113.25 35.86 3.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.576 ' CD2' HG21 ' A' ' 41' ' ' VAL . 21.5 t80 -74.03 -59.18 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.64 -5.21 7.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -87.97 -43.46 11.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mt -98.98 -54.07 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.123 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.919 HG23 HG11 ' A' ' 32' ' ' VAL . 57.6 t -55.08 -62.02 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.121 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -69.74 122.01 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -173.87 105.5 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -87.24 38.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -131.27 -40.83 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -129.83 151.56 50.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -75.54 127.19 32.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.84 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.17 143.24 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.422 HD22 HD11 ' A' ' 131' ' ' LEU . 38.0 tp -119.28 126.66 52.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 85' ' ' MET . 2.2 tp -113.07 135.56 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.21 118.51 26.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.907 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -93.06 128.76 39.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.44 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 6.9 p90 -136.12 174.05 11.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.18 135.02 25.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.585 0.707 . . . . 0.0 111.121 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -7.86 22.14 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.721 2.281 . . . . 0.0 112.327 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -123.67 26.49 7.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 43.4 t -125.13 106.44 9.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -46.15 -66.07 1.82 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.504 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 58' ' ' GLY . 89.8 m-70 -35.33 -45.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.3 m -63.73 -50.2 70.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.34 -37.01 54.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -71.36 -27.82 63.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.457 ' O ' ' C ' ' A' ' 64' ' ' GLU . 12.2 tp -82.47 -32.69 28.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.8 OUTLIER -33.95 -58.12 0.61 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.651 0.739 . . . . 0.0 110.931 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.1 Cg_endo -69.82 -35.47 12.39 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.719 2.279 . . . . 0.0 112.27 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -65.3 -27.85 68.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.854 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -93.79 -41.61 9.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -46.74 -57.01 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -40.5 -48.48 2.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.456 ' N ' HD21 ' A' ' 124' ' ' LEU . 14.5 tp -52.2 -39.69 60.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.88 -48.6 69.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.501 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -74.95 -21.95 58.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.95 0.405 . . . . 0.0 110.895 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -79.56 -50.6 10.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.918 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 77' ' ' ASP . 79.8 mt -77.39 -2.02 33.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' LEU . 7.8 t -37.98 -29.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 74' ' ' LEU . 37.8 mtmt -87.1 29.56 0.82 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 74' ' ' LEU . 39.9 p30 -102.79 95.3 6.16 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.585 0.707 . . . . 0.0 110.851 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 54.0 Cg_endo -69.77 -2.83 10.84 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.71 2.273 . . . . 0.0 112.309 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -120.55 -45.46 2.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.45 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 44.3 mt -87.11 145.42 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.1 t -135.18 105.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.126 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.626 HG22 HG13 ' A' ' 29' ' ' VAL . 34.9 mm -73.53 131.03 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.669 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -145.93 160.64 41.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.632 ' HB3' HG11 ' A' ' 29' ' ' VAL . 43.4 pttt -132.53 160.34 36.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.558 ' CB ' HD11 ' A' ' 50' ' ' ILE . 18.4 ttt -151.37 132.39 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -91.44 85.96 5.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -41.6 -65.74 0.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 87' ' ' ALA . 25.7 p -36.34 -35.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.521 ' HB1' ' CG ' ' A' ' 19' ' ' GLU . . . -87.24 -36.37 17.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.504 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.4 OUTLIER -129.02 112.7 14.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -41.22 155.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -103.21 125.58 34.73 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.63 0.728 . . . . 0.0 111.123 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.469 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.5 Cg_endo -69.84 -164.94 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.248 . . . . 0.0 112.313 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.496 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -122.19 161.23 44.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.596 0.713 . . . . 0.0 110.892 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.76 -11.74 11.99 Favored 'Cis proline' 0 C--O 1.232 0.182 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.352 -0.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.45 ' C ' ' O ' ' A' ' 95' ' ' PRO . 81.2 m-85 -33.05 125.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -134.04 117.04 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.874 HG22 HG21 ' A' ' 103' ' ' THR . 83.7 t -119.53 108.73 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -106.25 -41.28 5.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.09 131.32 7.19 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.418 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.524 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.5 OUTLIER -97.28 155.63 37.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.679 0.752 . . . . 0.0 110.828 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.1 Cg_endo -69.79 162.14 84.81 Favored 'Cis proline' 0 C--O 1.232 0.207 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.352 0.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.874 HG21 HG22 ' A' ' 98' ' ' VAL . 84.1 m -142.22 116.06 9.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.176 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.637 HD13 ' HE1' ' A' ' 127' ' ' PHE . 27.5 mt -110.2 140.63 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 117' ' ' LYS . 11.9 m-85 -139.36 142.74 37.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.404 ' HA ' HD12 ' A' ' 49' ' ' LEU . 29.9 t80 -111.43 143.6 42.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.7 m -114.46 93.83 33.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.686 0.755 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.494 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.5 Cg_endo -69.77 167.86 23.23 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -84.25 136.8 33.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 0.8 OUTLIER 49.98 26.8 2.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.494 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 12.8 mtmm -128.97 39.25 3.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 7.7 mmpt? -67.98 -45.59 73.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.3 mp -50.85 -38.2 47.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -134.88 88.37 27.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.605 0.717 . . . . 0.0 110.845 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -171.76 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.724 2.282 . . . . 0.0 112.295 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -137.86 118.92 14.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 105' ' ' TYR . 22.3 tttt -91.47 120.22 32.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -55.04 112.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -123.68 101.01 7.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.9 -139.65 4.32 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.452 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.37 139.71 14.71 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.47 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.428 ' CZ ' ' HG3' ' A' ' 102' ' ' PRO . 26.8 mtp180 -83.88 43.79 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.883 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 124' ' ' LEU . 3.5 tp10 -102.05 129.65 48.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.6 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.3 tm? -34.02 -55.46 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.93 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.2 t -59.43 -50.15 75.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 130' ' ' TYR . 6.0 t0 -44.05 -35.72 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.637 ' HE1' HD13 ' A' ' 104' ' ' ILE . 80.8 m-85 -73.31 -37.98 66.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.557 HD11 ' CD1' ' A' ' 124' ' ' LEU . 30.5 mt -63.03 -61.42 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.124 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.85 -34.86 73.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 126' ' ' ASP . 44.8 t80 -57.46 -48.8 78.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.422 HD11 HD22 ' A' ' 49' ' ' LEU . 68.3 mt -75.68 -34.4 60.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -43.49 -38.86 3.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.46 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.2 ptm180 -101.03 -47.05 4.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.46 ' N ' ' HG3' ' A' ' 133' ' ' ARG . 16.6 mm-40 -52.63 -57.79 8.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -48.7 110.88 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -36.36 -71.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.163 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.6 t -59.48 -57.08 14.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.887 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.49 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.3 p90 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.929 0.395 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.527 ' H ' HD23 ' A' ' 16' ' ' LEU . 1.6 pt? -109.04 -38.62 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.52 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 30.3 tttt -112.61 149.54 32.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.607 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 52.7 p -161.72 146.5 13.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -94.3 158.8 35.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.707 0.765 . . . . 0.0 110.835 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 150.29 68.1 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.644 2.229 . . . . 0.0 112.357 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.489 HD13 ' CG2' ' A' ' 33' ' ' VAL . 39.2 mm -79.74 132.36 61.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.625 0.726 . . . . 0.0 111.132 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' HG23 ' A' ' 21' ' ' ILE . 53.4 Cg_endo -69.76 173.34 11.12 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -97.31 -34.41 11.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p -141.99 135.79 29.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -132.23 38.76 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -78.43 57.73 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.83 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.98 -170.73 13.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.494 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -40.41 5.42 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.715 2.276 . . . . 0.0 112.374 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.462 HG13 HG22 ' A' ' 82' ' ' ILE . 23.5 t -120.63 117.11 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -64.22 143.08 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.893 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.48 HG22 ' HE3' ' A' ' 84' ' ' LYS . 73.2 t -91.44 119.6 38.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.997 HG11 HG23 ' A' ' 41' ' ' VAL . 21.2 t -116.55 126.5 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 35' ' ' GLU . 29.1 m -122.34 156.9 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.154 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.607 ' HB3' ' CB ' ' A' ' 18' ' ' SER . . . -48.47 -20.05 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.537 ' HB2' HG23 ' A' ' 33' ' ' VAL . 5.1 mt-10 -76.54 -34.21 58.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -129.12 33.72 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.668 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 7.6 t80 -69.35 -52.96 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.84 -6.76 28.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -89.52 -43.45 10.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.4 mt -98.4 -61.89 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.997 HG23 HG11 ' A' ' 32' ' ' VAL . 60.5 t -47.9 -61.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.151 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.46 135.08 52.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -173.62 106.36 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.941 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -85.71 14.66 5.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -111.02 -41.94 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -137.18 164.11 29.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 63.7 m-20 -80.31 154.23 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.2 t -145.2 147.74 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.5 tp -119.09 129.74 55.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.917 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 85' ' ' MET . 1.8 tp -119.95 133.4 66.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.468 ' CG ' HG12 ' A' ' 104' ' ' ILE . 4.9 tm-20 -126.82 116.38 20.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -90.11 140.08 30.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.45 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 5.9 p90 -143.98 176.08 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -128.61 133.43 25.17 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.612 0.72 . . . . 0.0 111.072 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -8.28 23.21 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.748 2.298 . . . . 0.0 112.349 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.434 ' CZ2' HG21 ' A' ' 88' ' ' THR . 5.0 p-90 -118.32 21.73 12.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 2.5 t -123.34 110.51 15.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -49.27 -47.83 33.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.482 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -34.74 -45.89 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 110.839 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.1 t -70.91 -50.93 29.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.936 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -47.32 -34.08 6.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.852 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -86.77 -29.17 22.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.837 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.965 HD12 ' HB2' ' A' ' 66' ' ' LYS . 63.2 tp -83.13 -14.36 53.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.522 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.9 tt0 -46.08 -58.28 6.67 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.641 0.734 . . . . 0.0 110.943 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.1 Cg_endo -69.73 -17.53 37.64 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.644 2.229 . . . . 0.0 112.387 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.965 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.1 mmmp? -84.74 -30.17 24.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -93.67 -41.32 9.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -46.58 -56.63 5.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 70' ' ' LEU . 15.6 mt-10 -42.02 -62.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.478 ' CD1' HG12 ' A' ' 128' ' ' ILE . 22.3 tp -37.16 -35.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.51 -57.06 19.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.504 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -75.38 -19.93 59.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.718 ' HD3' HD11 ' A' ' 124' ' ' LEU . 4.1 mtpm? -73.95 -45.07 52.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.662 HD21 HG23 ' A' ' 128' ' ' ILE . 90.0 mt -86.86 -2.4 58.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.3 t -39.63 -26.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 74' ' ' LEU . 9.3 ttpp -82.86 22.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 74' ' ' LEU . 42.2 p30 -102.93 95.51 6.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.628 0.728 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.6 Cg_endo -69.76 -0.83 7.47 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.656 2.238 . . . . 0.0 112.372 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.31 -44.45 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.482 HD11 ' CB ' ' A' ' 135' ' ' ALA . 15.7 mt -88.22 143.76 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.155 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.0 t -133.28 115.41 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.137 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 74' ' ' LEU . 30.8 mm -81.96 130.37 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.633 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -148.73 171.87 15.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.075 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.48 ' HE3' HG22 ' A' ' 31' ' ' VAL . 2.8 pttp -135.42 163.07 30.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.923 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.629 ' HB2' HD11 ' A' ' 50' ' ' ILE . 15.8 ttt -151.13 136.76 17.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -96.33 82.37 3.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -45.58 -58.35 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.434 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 22.8 p -46.77 -22.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.35 -18.47 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -144.74 108.44 4.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 90' ' ' ASN . 27.9 t70 -37.07 151.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -97.04 128.13 36.42 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.612 0.72 . . . . 0.0 111.12 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -173.34 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.6 m -118.7 160.54 39.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.658 0.742 . . . . 0.0 110.876 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.69 -8.97 10.66 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.353 -0.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 95' ' ' PRO . 81.3 m-85 -35.13 143.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -151.59 129.23 11.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.586 HG13 ' OG1' ' A' ' 103' ' ' THR . 45.4 t -132.89 117.98 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.6 -36.92 3.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.23 121.55 4.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.538 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.28 154.16 38.17 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.66 0.743 . . . . 0.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.538 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.4 Cg_endo -69.69 160.03 88.47 Favored 'Cis proline' 0 C--O 1.231 0.143 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.382 -0.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.586 ' OG1' HG13 ' A' ' 98' ' ' VAL . 34.2 m -137.48 113.81 10.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.468 HG12 ' CG ' ' A' ' 51' ' ' GLU . 16.8 mt -105.9 138.24 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.109 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.52 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 10.8 m-85 -132.88 173.03 11.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.961 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -142.97 127.35 17.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 t -100.51 99.64 10.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.639 0.733 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.76 178.84 4.16 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.701 2.268 . . . . 0.0 112.361 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.481 ' N ' ' OD1' ' A' ' 47' ' ' ASP . . . -92.93 131.05 38.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 11.4 p30 51.0 29.07 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.933 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.466 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.3 mtmm -128.05 23.0 6.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -50.72 -56.37 12.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.0 mt -39.78 -37.13 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -134.86 90.22 22.91 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.635 0.731 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -172.34 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.664 2.243 . . . . 0.0 112.358 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -139.34 128.16 23.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.52 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 4.8 ttpm? -94.44 124.24 38.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.534 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 67.8 t80 -55.75 105.14 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -115.9 100.89 8.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.6 -152.38 17.58 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.497 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.01 131.69 11.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.519 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.421 ' HB2' ' NH1' ' A' ' 122' ' ' ARG . 19.8 mtm105 -83.88 49.0 1.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.905 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 124' ' ' LEU . 13.0 tt0 -107.78 134.32 50.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.718 HD11 ' HD3' ' A' ' 73' ' ' LYS . 3.5 tm? -34.81 -52.69 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.8 m -67.73 -47.7 68.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -47.37 -36.16 9.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.534 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 58.6 m-85 -69.24 -42.65 75.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.914 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.662 HG23 HD21 ' A' ' 74' ' ' LEU . 23.1 mt -63.52 -53.34 46.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -63.57 -21.98 66.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.808 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.405 ' CD1' ' C ' ' A' ' 130' ' ' TYR . 6.1 t80 -72.22 -46.86 54.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.1 mt -76.56 -39.0 54.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -40.05 -42.49 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -97.13 -58.73 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -46.23 -56.36 5.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.482 ' CB ' HD11 ' A' ' 80' ' ' ILE . . . -45.29 120.56 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.48 -70.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.1 t -58.01 -44.16 87.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.475 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 2.4 p90 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.861 0.362 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' A' ' 17' ' ' LYS . 4.0 pp -114.2 -36.14 4.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.525 ' HB3' HD12 ' A' ' 16' ' ' LEU . 10.1 ptmt -119.89 165.64 14.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.441 ' CB ' ' HG3' ' A' ' 35' ' ' GLU . 2.3 m -158.22 161.04 37.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.842 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 4.2 mm-40 -105.88 160.94 24.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.647 0.737 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 54.0 Cg_endo -69.78 137.66 35.94 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.361 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.714 HD13 HG21 ' A' ' 33' ' ' VAL . 19.6 mm -71.41 129.46 88.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.606 0.717 . . . . 0.0 111.155 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 128.36 15.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.659 2.239 . . . . 0.0 112.335 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -40.37 -41.23 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -162.66 138.57 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -107.98 74.49 0.95 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -92.03 50.25 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.23 -178.13 15.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.467 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -39.99 5.9 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.662 2.241 . . . . 0.0 112.375 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.431 HG13 HG22 ' A' ' 82' ' ' ILE . 22.9 t -109.09 119.77 59.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.64 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 5.6 mmtp -66.96 128.47 36.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -82.86 117.56 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.102 HG11 HG23 ' A' ' 41' ' ' VAL . 21.8 t -112.93 124.3 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.714 HG21 HD13 ' A' ' 21' ' ' ILE . 19.1 m -117.89 147.25 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.094 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -36.91 -40.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HB3' HD11 ' A' ' 21' ' ' ILE . 11.1 mt-10 -57.6 -49.02 77.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.466 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 17.7 p-10 -110.49 24.75 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.884 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.741 ' CD2' HG21 ' A' ' 41' ' ' VAL . 31.0 t80 -63.34 -55.51 23.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -67.14 -5.14 12.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -88.79 -45.61 9.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.456 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 21.5 mt -97.56 -59.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.121 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.102 HG23 HG11 ' A' ' 32' ' ' VAL . 38.7 t -49.16 -59.4 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.33 122.96 19.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 40' ' ' ILE . 16.5 m-80 -167.34 114.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.11 3.51 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.38 -40.92 6.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.24 140.79 48.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.73 149.21 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.09 137.64 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.147 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 106' ' ' PHE . 13.2 tp -110.34 125.64 53.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 tp -113.48 131.15 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' CG ' HG12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -125.58 109.53 12.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -84.84 128.97 34.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -128.79 179.9 5.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.24 128.55 17.44 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 0.0 111.136 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -6.75 19.36 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 4.1 p-90 -119.12 18.95 13.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.931 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 38.1 t -119.14 124.62 47.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.84 -61.73 7.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.514 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -42.8 -38.84 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.818 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.3 m -67.95 -44.26 77.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -64.76 -32.77 74.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -76.37 -21.7 55.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.767 HD12 ' HB2' ' A' ' 66' ' ' LYS . 18.4 tp -90.55 -18.63 24.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -41.19 -58.24 2.97 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.707 0.765 . . . . 0.0 110.943 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.73 -32.22 19.1 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.747 2.298 . . . . 0.0 112.331 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.767 ' HB2' HD12 ' A' ' 63' ' ' LEU . 26.6 mtpt -68.69 -28.58 66.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -92.9 -38.65 11.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -47.42 -61.11 2.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -40.44 -55.13 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.405 ' N ' HD21 ' A' ' 124' ' ' LEU . 30.8 tp -41.25 -39.21 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.54 -64.94 3.56 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.477 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.18 -16.13 50.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -81.0 -44.89 17.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.903 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.631 HD12 HD11 ' A' ' 82' ' ' ILE . 95.3 mt -83.75 3.06 35.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.2 t -54.7 -19.02 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.02 10.48 16.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 53.1 m-20 -110.61 98.63 38.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.552 0.692 . . . . 0.0 110.859 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.2 Cg_endo -69.84 0.18 6.08 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.704 2.269 . . . . 0.0 112.309 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -110.69 -30.87 7.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 55.1 mt -105.65 139.01 28.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.99 110.38 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.631 HD11 HD12 ' A' ' 74' ' ' LEU . 42.0 mm -79.11 134.7 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.687 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -146.81 173.75 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -143.52 143.01 31.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.4 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 5.8 ttt -132.89 139.26 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -93.45 82.84 4.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -44.54 -57.45 3.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 88' ' ' THR . 1.6 p -39.36 -27.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.195 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 87' ' ' ALA . . . -102.25 -29.79 11.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.109 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -120.51 120.38 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -55.66 116.83 3.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.922 HG11 HG23 ' A' ' 98' ' ' VAL . 90.9 t -68.72 111.7 9.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.588 0.709 . . . . 0.0 111.112 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.7 Cg_endo -69.82 -178.18 2.24 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.707 2.271 . . . . 0.0 112.351 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.507 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -97.57 159.37 31.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.855 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.509 ' O ' ' C ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.71 -27.29 6.88 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.734 -1.778 . . . . 0.0 112.353 -0.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.509 ' C ' ' O ' ' A' ' 95' ' ' PRO . 82.1 m-85 -28.51 111.16 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -117.5 84.07 2.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.922 HG23 HG11 ' A' ' 92' ' ' VAL . 99.2 t -77.21 106.69 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -129.65 25.81 5.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.52 115.57 0.37 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.503 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.546 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -98.74 154.2 37.54 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.644 0.735 . . . . 0.0 110.903 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.7 Cg_endo -69.64 151.34 91.03 Favored 'Cis proline' 0 C--O 1.232 0.208 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.392 -0.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -129.04 123.14 31.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.132 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.403 HG12 ' CG ' ' A' ' 51' ' ' GLU . 44.1 mt -119.3 126.65 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.464 ' CZ ' ' HE3' ' A' ' 117' ' ' LYS . 8.1 m-85 -126.78 154.54 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.414 ' HA ' HD12 ' A' ' 49' ' ' LEU . 8.6 t80 -125.83 129.76 50.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.865 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.9 t -101.88 97.59 8.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.694 0.759 . . . . 0.0 110.861 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.498 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.79 171.15 15.03 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.664 2.243 . . . . 0.0 112.335 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.471 ' C ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.11 133.4 34.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.471 ' CG ' ' C ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER 49.65 29.5 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.498 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 10.5 mtmm -130.93 6.69 4.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.94 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.478 ' N ' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -35.92 -53.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.0 mt -39.06 -52.27 1.84 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 5.5 t30 -120.92 94.93 49.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.625 0.726 . . . . 0.0 110.906 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.7 Cg_endo -69.76 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.729 2.286 . . . . 0.0 112.332 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -142.03 110.5 6.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.464 ' HE3' ' CZ ' ' A' ' 105' ' ' TYR . 31.5 tttt -71.53 144.29 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.903 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.437 ' CZ ' ' CE1' ' A' ' 127' ' ' PHE . 35.4 t80 -90.48 106.82 18.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.9 100.75 7.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.894 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.19 -140.15 3.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.52 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.59 130.03 10.14 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.492 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -79.25 45.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 110.893 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 124' ' ' LEU . 18.2 tt0 -101.43 134.17 44.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.442 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -36.28 -51.8 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.7 m -68.02 -45.99 72.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.38 -33.87 4.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.437 ' CE1' ' CZ ' ' A' ' 118' ' ' TYR . 54.0 m-85 -74.64 -42.01 59.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.3 mt -58.26 -53.01 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 t -65.27 -30.89 71.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.77 -47.83 84.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.6 mt -74.29 -42.52 59.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -39.54 -32.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -101.73 -60.68 1.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -47.98 -53.96 14.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.49 122.65 5.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -74.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.084 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.5 t -61.4 -54.91 37.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.51 -179.953 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.591 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.8 p90 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.86 0.362 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 pp -95.81 -36.03 11.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 18' ' ' SER . 25.9 tttp -118.04 157.45 26.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.462 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 58.2 p -159.57 158.02 30.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 9.1 mm-40 -107.99 160.79 25.59 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.641 0.734 . . . . 0.0 110.848 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.71 139.94 41.66 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.656 2.237 . . . . 0.0 112.346 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.574 HD13 HG21 ' A' ' 33' ' ' VAL . 19.2 mm -69.5 129.78 91.24 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.634 0.73 . . . . 0.0 111.126 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 132.34 23.15 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.675 2.25 . . . . 0.0 112.335 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 24' ' ' SER . 8.6 pt-20 -44.89 -42.71 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.441 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 3.3 m -159.44 137.75 10.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.825 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -111.32 80.65 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -101.94 55.35 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.32 -172.94 13.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.472 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -41.67 4.03 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.653 2.235 . . . . 0.0 112.297 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 82' ' ' ILE . 7.4 t -114.8 122.62 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.164 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.43 ' HZ2' HD13 ' A' ' 40' ' ' ILE . 1.8 mmmp? -68.26 130.33 42.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.3 t -81.11 110.36 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.055 HG11 HG23 ' A' ' 41' ' ' VAL . 39.2 t -105.16 114.97 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.574 HG21 HD13 ' A' ' 21' ' ' ILE . 35.9 m -108.86 146.35 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.591 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.54 -47.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.453 ' HB3' HD11 ' A' ' 21' ' ' ILE . 1.9 mm-40 -51.55 -48.79 62.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' VAL . 16.9 p-10 -110.38 28.15 8.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.49 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 8.9 t80 -73.33 -44.16 59.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -75.15 -4.57 39.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.53 -39.09 10.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.53 HD12 HG22 ' A' ' 32' ' ' VAL . 4.6 mt -98.91 -63.49 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.055 HG23 HG11 ' A' ' 32' ' ' VAL . 93.4 t -53.47 -60.81 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.109 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 24.8 m-20 -63.99 118.75 8.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 42' ' ' ASN . 38.7 m-20 -175.1 114.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.26 31.69 2.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -125.33 -38.05 2.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -127.88 161.13 29.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -80.94 137.92 36.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -144.51 136.9 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.0 tp -116.39 136.32 53.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.401 HD13 ' CG2' ' A' ' 41' ' ' VAL . 3.0 tp -116.45 137.14 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.534 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -127.25 110.97 13.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 103' ' ' THR . 69.8 m-85 -87.53 138.64 31.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 4.9 p90 -143.85 175.31 10.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.933 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.94 134.35 26.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.55 0.69 . . . . 0.0 111.107 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -16.36 37.48 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.689 2.259 . . . . 0.0 112.352 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -113.49 25.99 10.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.7 t -123.08 134.27 54.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.78 -59.77 8.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.475 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -38.26 -35.7 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.297 . . . . 0.0 110.832 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -52.59 61.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -57.19 -36.61 71.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -77.53 -35.85 52.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 66' ' ' LYS . 27.8 tp -81.12 -19.45 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.521 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.6 tt0 -46.98 -58.39 7.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.668 0.747 . . . . 0.0 110.886 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.8 -28.03 25.58 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.654 2.236 . . . . 0.0 112.37 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HB2' HD12 ' A' ' 63' ' ' LEU . 24.1 mtpp -72.85 -27.36 61.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.534 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 41.5 t80 -96.32 -46.07 6.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -41.81 -59.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 70' ' ' LEU . 25.5 mt-10 -39.48 -63.47 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.432 ' N ' HD21 ' A' ' 124' ' ' LEU . 15.7 tp -37.25 -34.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.5 -51.4 42.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.516 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.4 -18.32 57.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.503 ' HD3' HD11 ' A' ' 124' ' ' LEU . 6.3 mtpm? -76.86 -53.74 7.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' ASP . 98.0 mt -79.41 1.78 24.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.1 t -43.06 -23.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 74' ' ' LEU . 16.4 mtpt -89.89 23.74 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.911 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' LEU . 50.1 p-10 -101.36 98.06 8.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.595 0.712 . . . . 0.0 110.845 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.9 Cg_endo -69.77 1.04 4.8 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.683 2.255 . . . . 0.0 112.355 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -123.42 -43.29 2.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.456 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 62.1 mt -87.25 144.48 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.5 t -134.95 97.8 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.444 HG22 HG13 ' A' ' 29' ' ' VAL . 30.5 mm -70.55 122.2 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.703 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -138.09 171.28 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.051 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.421 ' HB3' HG11 ' A' ' 29' ' ' VAL . 41.5 pttt -140.82 159.01 43.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.4 ttt -150.76 135.45 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 87' ' ' ALA . 30.9 t0 -89.51 80.89 6.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -35.91 -62.94 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 88' ' ' THR . 19.9 p -37.87 -39.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.44 -28.81 20.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 87' ' ' ALA . 14.3 m-80 -124.38 110.39 14.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -49.11 130.24 18.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.481 HG11 HG23 ' A' ' 98' ' ' VAL . 65.2 t -76.97 118.81 74.37 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.626 0.727 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -164.57 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 2.252 . . . . 0.0 112.34 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -121.06 161.14 42.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.626 0.726 . . . . 0.0 110.887 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.7 Cg_endo -69.77 -12.91 12.34 Favored 'Cis proline' 0 C--N 1.341 0.176 0 C-N-CA 122.681 -1.799 . . . . 0.0 112.359 -0.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 95' ' ' PRO . 88.2 m-85 -33.86 136.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -141.29 119.23 11.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.572 HG22 HG21 ' A' ' 103' ' ' THR . 99.1 t -122.98 80.77 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.106 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -66.13 -45.43 81.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.67 -171.73 13.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.462 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.513 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -147.97 157.82 42.89 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.628 0.728 . . . . 0.0 110.861 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.8 166.99 72.73 Favored 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.68 -1.8 . . . . 0.0 112.323 0.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.572 HG21 HG22 ' A' ' 98' ' ' VAL . 88.1 m -146.2 131.18 18.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.452 HD13 ' CE1' ' A' ' 127' ' ' PHE . 20.6 mt -124.92 129.43 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -125.49 159.34 32.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.533 ' HB3' ' CG ' ' A' ' 116' ' ' LYS . 21.2 t80 -119.89 151.19 39.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 m -121.64 87.63 46.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.673 0.749 . . . . 0.0 110.837 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.502 ' O ' ' CE ' ' A' ' 112' ' ' LYS . 54.0 Cg_endo -69.79 168.23 22.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.671 2.247 . . . . 0.0 112.332 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.478 ' C ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.16 139.03 32.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.478 ' CG ' ' C ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER 49.84 25.02 1.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.486 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.1 mtmt -128.0 18.23 6.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' CE ' ' O ' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -46.44 -34.07 4.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mt -82.76 -24.88 33.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 111' ' ' LYS . 10.9 m120 -119.43 63.02 7.09 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.616 0.722 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -164.72 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.363 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.533 ' CG ' ' HB3' ' A' ' 106' ' ' PHE . 0.8 OUTLIER -160.63 155.55 24.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.9 ttpp -117.72 126.75 53.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.41 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 60.1 t80 -54.97 101.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -115.2 94.65 4.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.73 -141.64 4.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.504 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.78 134.8 12.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.502 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.451 ' HB2' ' NH1' ' A' ' 122' ' ' ARG . 10.3 mtp-105 -84.37 49.74 1.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.876 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 124' ' ' LEU . 26.9 tt0 -109.66 133.85 52.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.503 HD11 ' HD3' ' A' ' 73' ' ' LYS . 3.3 tm? -36.28 -53.85 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.5 p -65.16 -42.7 93.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.09 -27.93 36.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.452 ' CE1' HD13 ' A' ' 104' ' ' ILE . 58.0 m-85 -78.8 -47.32 16.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.7 mt -53.19 -50.73 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.12 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.0 p -60.67 -55.32 34.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.828 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -44.44 -45.09 8.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 135' ' ' ALA . 18.9 mt -76.51 -37.55 56.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -48.18 -45.89 34.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.445 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 12.9 ptm180 -86.45 -40.04 15.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.462 ' OE1' ' CD ' ' A' ' 116' ' ' LYS . 46.7 mm-40 -68.89 -65.02 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 131' ' ' LEU . . . -34.18 131.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -66.72 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.8 t -66.16 -43.88 85.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.451 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.407 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.2 p90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.927 0.394 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.1 pp -98.31 -43.87 6.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.567 ' N ' HD12 ' A' ' 16' ' ' LEU . 7.4 ttpm? -110.71 166.38 11.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.488 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 98.1 p -170.78 152.0 3.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.441 ' CG ' HD22 ' A' ' 90' ' ' ASN . 5.6 mm-40 -96.23 158.45 33.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.623 0.725 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 145.75 58.04 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.676 2.251 . . . . 0.0 112.365 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 35' ' ' GLU . 29.6 mm -73.13 133.45 81.42 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.739 . . . . 0.0 111.108 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' A' ' 21' ' ' ILE . 54.2 Cg_endo -69.77 174.11 9.99 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.361 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -97.23 -36.04 10.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -145.0 137.73 26.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -130.2 37.23 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.51 60.44 2.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.69 -168.43 12.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -41.14 4.54 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 0.0 112.332 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG13 HG22 ' A' ' 82' ' ' ILE . 30.7 t -119.13 122.14 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.59 131.13 42.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.0 t -78.77 135.14 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.983 HG11 HG23 ' A' ' 41' ' ' VAL . 38.8 t -132.15 120.03 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 36' ' ' ASN . 20.3 m -116.97 147.58 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.476 ' HB3' ' CB ' ' A' ' 18' ' ' SER . . . -34.3 -44.11 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 33' ' ' VAL . 15.6 mt-10 -53.77 -46.47 70.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 33' ' ' VAL . 18.1 p-10 -116.32 30.6 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.592 ' CZ ' ' HG3' ' A' ' 93' ' ' PRO . 5.2 t80 -69.98 -54.73 11.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.43 -5.69 20.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -90.6 -41.6 11.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.893 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.4 mt -97.5 -58.16 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.983 HG23 HG11 ' A' ' 32' ' ' VAL . 24.0 t -54.56 -60.1 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.09 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 34.3 m-20 -67.45 123.08 19.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.839 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 28.9 m-20 -171.89 108.5 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -83.43 0.42 46.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -85.68 -45.8 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -138.36 162.86 33.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.67 150.38 36.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.98 140.99 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.502 HD23 HD12 ' A' ' 82' ' ' ILE . 29.9 tp -112.95 126.07 55.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 85' ' ' MET . 1.9 tp -113.45 135.33 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.105 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.456 ' C ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -126.03 117.95 24.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.54 ' CG ' HG21 ' A' ' 98' ' ' VAL . 60.1 m-85 -91.59 120.44 32.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.564 ' CE1' ' OD2' ' A' ' 86' ' ' ASP . 28.6 p90 -128.47 178.84 6.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -135.24 132.44 20.07 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.564 0.697 . . . . 0.0 111.094 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.539 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.3 Cg_endo -69.79 -2.49 10.29 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.487 ' CZ3' ' SG ' ' A' ' 57' ' ' CYS . 7.3 p-90 -122.04 6.73 9.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -96.23 137.34 35.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.98 -58.17 4.51 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -50.5 -39.19 47.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.324 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.6 m -64.06 -38.95 92.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -64.12 -45.91 86.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -68.34 -14.56 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.835 HD12 ' HB2' ' A' ' 66' ' ' LYS . 14.2 tp -96.33 -24.76 16.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.535 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -37.62 -57.93 1.42 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.595 0.712 . . . . 0.0 110.875 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.4 Cg_endo -69.76 -27.74 26.11 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.686 2.257 . . . . 0.0 112.359 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.835 ' HB2' HD12 ' A' ' 63' ' ' LEU . 4.5 mtpm? -71.58 -32.5 68.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -88.69 -40.26 13.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -44.48 -59.33 2.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -38.78 -56.21 1.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.407 ' N ' HD21 ' A' ' 124' ' ' LEU . 28.0 tp -43.79 -39.89 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.07 -63.25 5.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.438 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.34 -26.28 67.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.875 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -72.12 -44.14 63.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.663 HD12 HD11 ' A' ' 82' ' ' ILE . 82.2 mt -89.55 3.19 53.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.1 t -52.09 -20.63 2.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -98.87 22.71 9.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 1.2 m-20 -103.29 99.28 14.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.61 0.719 . . . . 0.0 110.865 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.1 Cg_endo -69.75 -3.25 11.62 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.726 2.284 . . . . 0.0 112.334 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.19 -19.09 9.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.2 mt -123.29 134.44 66.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.2 t -130.2 103.98 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.663 HD11 HD12 ' A' ' 74' ' ' LEU . 51.4 mm -69.61 132.36 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.146 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.541 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -146.63 167.75 22.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 pttt -139.92 156.36 46.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.553 ' HB3' HD11 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -149.18 132.91 16.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.564 ' OD2' ' CE1' ' A' ' 53' ' ' TYR . 1.2 m-20 -86.67 101.39 13.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -58.14 -64.96 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.539 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -45.35 -21.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -92.58 -29.74 16.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -142.79 130.37 21.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -47.04 150.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.534 HG13 ' HD2' ' A' ' 93' ' ' PRO . 89.7 t -96.49 135.49 22.37 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.648 0.737 . . . . 0.0 111.088 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.592 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.5 Cg_endo -69.79 -163.55 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.683 2.255 . . . . 0.0 112.339 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.539 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -132.68 153.87 81.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.704 0.764 . . . . 0.0 110.839 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.85 -7.42 10.12 Favored 'Cis proline' 0 C--N 1.342 0.196 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.304 0.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.475 ' C ' ' O ' ' A' ' 95' ' ' PRO . 51.8 m-85 -31.7 131.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -142.77 126.74 17.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.54 HG21 ' CG ' ' A' ' 52' ' ' PHE . 81.8 t -133.83 115.59 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -123.0 -41.85 2.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.29 118.09 4.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.539 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -96.23 155.19 38.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.661 0.743 . . . . 0.0 110.905 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.77 161.11 86.88 Favored 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.318 -0.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.506 HG21 HG22 ' A' ' 98' ' ' VAL . 57.9 m -141.71 115.04 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.508 HD13 ' CE1' ' A' ' 127' ' ' PHE . 68.3 mt -108.52 138.8 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.143 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.437 ' O ' HD12 ' A' ' 49' ' ' LEU . 10.5 m-85 -133.92 178.03 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.952 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -149.32 126.51 11.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -101.62 100.08 13.28 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.664 0.745 . . . . 0.0 110.833 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.496 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.75 171.04 15.18 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.609 2.206 . . . . 0.0 112.388 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.456 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.67 139.49 31.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.084 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.7 p30 46.85 25.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.496 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.2 mtmm -127.27 22.44 6.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 113' ' ' LEU . 7.7 mmpt? -45.86 -66.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 112' ' ' LYS . 6.9 mp -34.02 -44.43 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.942 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -122.44 90.14 49.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.593 0.711 . . . . 0.0 110.92 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -163.75 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.632 2.221 . . . . 0.0 112.31 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -141.7 131.31 24.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -100.04 134.13 43.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.85 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.453 ' HB3' HG22 ' A' ' 104' ' ' ILE . 60.3 t80 -79.24 111.84 15.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -124.15 98.3 5.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 179.57 -146.27 6.98 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.99 134.33 12.38 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.489 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -81.29 45.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.888 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 124' ' ' LEU . 9.0 tt0 -103.12 134.48 46.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.483 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -36.84 -54.92 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 60.4 p -60.84 -48.93 79.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -47.8 -34.97 9.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.508 ' CE1' HD13 ' A' ' 104' ' ' ILE . 33.1 m-85 -70.61 -37.31 73.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.4 mt -69.05 -57.55 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.113 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.6 t -60.29 -24.7 65.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -70.82 -48.57 53.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.935 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 25.8 mt -71.22 -38.18 72.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -40.24 -42.95 1.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -94.78 -67.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -40.53 -54.42 2.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 131' ' ' LEU . . . -44.57 100.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.069 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.3 t -44.2 -24.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 138' ' ' GLY . 1.2 t -116.33 48.46 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 137' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.497 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.691 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.2 p90 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.912 0.387 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 16' ' ' LEU . 1.9 pp -104.21 -37.04 7.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.934 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 17.0 ttpt -109.86 158.2 18.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.9 p -164.22 149.1 10.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -98.86 160.7 27.15 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.656 0.741 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 143.57 51.32 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.648 2.232 . . . . 0.0 112.333 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.602 HD13 HG21 ' A' ' 33' ' ' VAL . 20.9 mm -68.87 129.15 92.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.633 0.73 . . . . 0.0 111.154 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 136.15 32.41 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.667 2.245 . . . . 0.0 112.355 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 24' ' ' SER . 12.0 pt-20 -49.05 -50.24 37.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.874 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.407 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 11.6 t -149.53 137.28 20.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -111.43 50.31 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.55 -25.05 59.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.84 169.94 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.436 ' HG3' ' CG ' ' A' ' 68' ' ' LYS . 53.5 Cg_endo -69.79 -29.67 23.37 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.686 2.258 . . . . 0.0 112.332 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.5 t -111.73 121.0 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.42 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 9.0 mmtm -71.12 134.93 47.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.1 t -86.35 104.75 14.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.147 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.916 HG11 HG23 ' A' ' 41' ' ' VAL . 44.9 t -95.91 114.11 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.171 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.602 HG21 HD13 ' A' ' 21' ' ' ILE . 26.3 m -109.53 144.74 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.691 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.86 -43.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -56.09 -50.82 69.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.452 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 28.5 p30 -105.41 21.58 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CD2' HG21 ' A' ' 41' ' ' VAL . 14.4 t80 -62.8 -58.78 6.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.02 -6.97 7.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.858 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.97 -44.13 11.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.409 HD12 HG22 ' A' ' 32' ' ' VAL . 23.5 mt -97.21 -58.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.916 HG23 HG11 ' A' ' 32' ' ' VAL . 42.7 t -51.86 -61.55 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -69.06 114.61 7.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -167.08 106.72 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -91.11 31.88 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -126.4 -37.82 2.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.826 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.81 145.55 48.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.3 147.26 53.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.9 t -145.26 147.84 18.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.131 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.548 HD23 HD12 ' A' ' 82' ' ' ILE . 21.8 tp -124.57 126.9 46.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.945 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 41' ' ' VAL . 3.2 tp -107.72 139.51 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.083 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -127.28 105.13 8.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -84.78 115.33 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -125.6 179.69 5.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -131.66 132.91 23.67 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.569 0.7 . . . . 0.0 111.12 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.497 ' HD2' HG21 ' A' ' 88' ' ' THR . 53.7 Cg_endo -69.72 -1.65 8.79 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.744 2.296 . . . . 0.0 112.348 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.483 ' NE1' HG21 ' A' ' 88' ' ' THR . 6.9 p-90 -122.96 5.59 9.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.618 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -98.64 130.31 45.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -66.11 -59.65 7.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.497 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.559 ' CD2' ' HD3' ' A' ' 102' ' ' PRO . 3.1 p-80 -38.41 -31.65 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.875 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLY . 9.5 t -68.54 -49.6 58.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -53.68 -45.53 70.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -72.49 -24.86 61.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 66' ' ' LYS . 16.3 tp -87.68 -20.25 26.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.946 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -42.97 -58.31 4.11 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.657 0.741 . . . . 0.0 110.861 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.1 Cg_endo -69.74 -26.5 27.61 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.704 2.27 . . . . 0.0 112.328 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.621 ' HB2' HD12 ' A' ' 63' ' ' LEU . 42.1 mtpt -74.24 -27.35 60.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 40.3 t80 -96.32 -33.57 11.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.436 ' CG ' ' HG3' ' A' ' 28' ' ' PRO . 1.2 ttmp? -51.77 -57.62 8.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -40.53 -60.75 1.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.3 tp -38.48 -38.81 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.83 -65.61 3.21 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.84 -16.43 64.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -80.88 -42.66 21.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.633 HD12 HD11 ' A' ' 82' ' ' ILE . 80.6 mt -82.09 3.34 27.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.2 m -53.92 -24.78 17.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -78.1 6.9 7.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.917 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.435 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 4.1 t0 -113.49 98.98 48.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.659 0.742 . . . . 0.0 110.843 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.3 Cg_endo -69.72 0.3 5.82 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.71 2.273 . . . . 0.0 112.36 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -110.83 -36.83 5.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.475 HG21 HD13 ' A' ' 74' ' ' LEU . 64.3 mt -92.55 137.97 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.2 t -135.37 116.81 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.1 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.633 HD11 HD12 ' A' ' 74' ' ' LEU . 23.3 mm -89.05 132.45 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.844 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -142.03 171.53 13.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -139.74 138.13 35.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.489 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 12.4 ttt -132.5 143.19 49.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.746 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -95.88 95.27 8.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -48.77 -67.19 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.497 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -46.97 -23.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.746 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -93.52 -25.12 17.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.489 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -141.07 125.29 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.0 128.97 36.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.52 128.56 74.64 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.591 0.71 . . . . 0.0 111.141 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -169.77 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.663 2.242 . . . . 0.0 112.343 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.5 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.5 m -121.25 160.84 43.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.667 0.746 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.2 Cg_endo -69.69 -8.62 10.47 Favored 'Cis proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 -1.801 . . . . 0.0 112.387 -0.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 95' ' ' PRO . 86.0 m-85 -34.04 123.37 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -125.74 130.16 50.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.885 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.907 HG22 HG21 ' A' ' 103' ' ' THR . 65.8 t -133.09 120.48 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.093 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -128.87 -38.64 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.79 123.3 5.32 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.516 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.546 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.4 OUTLIER -97.14 154.0 38.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.738 . . . . 0.0 110.878 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.559 ' HD3' ' CD2' ' A' ' 59' ' ' HIS . 53.1 Cg_endo -69.83 155.33 93.49 Favored 'Cis proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.29 0.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.907 HG21 HG22 ' A' ' 98' ' ' VAL . 92.9 m -131.53 100.27 5.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.424 HG12 ' HG2' ' A' ' 51' ' ' GLU . 95.6 mt -94.79 141.93 14.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.151 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.418 ' HB2' HG23 ' A' ' 50' ' ' ILE . 8.9 m-85 -140.88 161.59 37.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 49' ' ' LEU . 15.4 t80 -128.25 136.95 51.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -105.3 93.27 6.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.843 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.498 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.6 Cg_endo -69.75 164.59 33.96 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.394 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.459 ' O ' ' CE ' ' A' ' 111' ' ' LYS . . . -78.04 145.44 35.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 41.94 24.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.498 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.2 mtmt -128.66 68.07 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HA ' ' NZ ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -90.57 -49.01 6.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.935 HD22 ' O ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -59.75 -25.47 64.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.554 ' N ' HD13 ' A' ' 113' ' ' LEU . 2.8 t-20 -133.39 84.06 47.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.646 0.736 . . . . 0.0 110.91 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -163.8 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -148.43 137.09 21.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.475 ' HG2' ' N ' ' A' ' 118' ' ' TYR . 29.8 ttmt -105.19 151.4 24.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.549 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 68.4 t80 -94.58 108.83 20.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -121.58 100.0 6.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 178.73 -153.59 12.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.1 133.35 12.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.477 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -80.36 45.96 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.844 0.355 . . . . 0.0 110.914 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 124' ' ' LEU . 8.8 tt0 -105.39 133.29 50.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.649 ' CD1' HD11 ' A' ' 128' ' ' ILE . 3.4 tm? -34.8 -55.59 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.3 m -58.86 -52.21 66.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.827 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.03 -30.38 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.549 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 38.9 m-85 -78.19 -40.34 37.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.649 HD11 ' CD1' ' A' ' 124' ' ' LEU . 37.5 mt -63.64 -57.26 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.153 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -58.01 -35.49 71.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.582 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 16.9 t80 -53.95 -52.82 59.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.6 mt -74.84 -39.89 61.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -38.79 -39.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.93 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -98.98 -57.07 2.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.582 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 69.6 mm-40 -49.24 -53.68 20.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -42.51 104.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.157 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 137' ' ' SER . 2.1 t -46.83 -49.62 19.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.444 ' N ' HG23 ' A' ' 136' ' ' THR . 23.7 m -73.98 -45.38 50.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.504 -179.969 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.706 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 14.5 p90 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.914 0.387 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 16' ' ' LEU . 1.5 pp -131.88 -40.21 1.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.933 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.4 ' HB3' ' H ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -97.12 125.25 41.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.735 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -142.1 156.74 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.847 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 4.5 mm-40 -106.0 161.68 22.08 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.652 0.739 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.4 Cg_endo -69.83 143.47 50.6 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.701 2.268 . . . . 0.0 112.306 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.57 HD13 HG21 ' A' ' 33' ' ' VAL . 23.2 mm -68.78 127.47 93.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.618 0.723 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.94 43.95 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.709 2.273 . . . . 0.0 112.351 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.59 -39.17 92.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 m -150.13 123.27 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -133.11 45.9 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.49 54.12 2.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.845 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.17 -160.11 23.4 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.491 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -41.55 4.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.63 2.22 . . . . 0.0 112.396 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 84' ' ' LYS . 18.4 t -119.53 107.19 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.116 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -53.48 124.98 16.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.8 t -75.4 126.1 35.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.033 HG11 HG23 ' A' ' 41' ' ' VAL . 30.0 t -118.51 120.31 63.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 21' ' ' ILE . 31.6 m -113.44 145.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 18' ' ' SER . . . -36.4 -38.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.091 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.536 ' HB3' HD11 ' A' ' 21' ' ' ILE . 10.7 mt-10 -59.51 -46.75 87.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' VAL . 22.2 p-10 -111.89 24.84 12.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.586 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 6.1 t80 -63.46 -58.06 8.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -65.29 -7.72 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -86.9 -44.22 11.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.7 mt -98.28 -62.3 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.033 HG23 HG11 ' A' ' 32' ' ' VAL . 97.1 t -48.14 -62.04 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.136 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -72.66 126.55 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.409 ' ND2' ' HE3' ' A' ' 46' ' ' LYS . 11.7 t-20 -172.91 108.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -87.6 29.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -124.14 -41.66 2.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HE3' ' ND2' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -136.28 130.13 32.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.57 151.95 5.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.499 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 89.4 t -146.33 152.58 13.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.599 HD23 HD12 ' A' ' 82' ' ' ILE . 39.8 tp -124.17 126.13 45.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.544 HD11 ' HB3' ' A' ' 85' ' ' MET . 1.8 tp -114.1 129.38 70.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.121 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 14.7 tm-20 -123.83 114.35 19.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -85.38 133.82 34.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -143.0 169.14 18.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.693 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -127.04 131.42 23.85 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.589 0.709 . . . . 0.0 111.074 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.465 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.2 Cg_endo -69.75 -10.13 27.82 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.376 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -115.58 5.11 14.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 7.5 t -101.71 126.89 48.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.15 -59.14 8.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -42.36 -45.64 4.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.6 m -69.82 -43.72 71.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -55.67 -35.88 66.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -74.62 -29.9 61.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.592 HD12 ' HB2' ' A' ' 66' ' ' LYS . 28.9 tp -83.15 -20.88 33.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.544 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -41.16 -57.58 3.4 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.652 0.739 . . . . 0.0 110.864 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.71 -27.72 26.36 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.705 2.27 . . . . 0.0 112.345 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.592 ' HB2' HD12 ' A' ' 63' ' ' LEU . 3.1 mmmt -71.92 -30.65 65.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 60.1 t80 -91.01 -37.07 13.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -47.57 -54.37 11.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.833 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -43.35 -56.21 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 127' ' ' PHE . 21.7 tp -42.99 -38.5 2.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.29 -65.16 3.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.438 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -60.83 -27.55 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 0.0 110.89 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mmtm -67.95 -46.46 71.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.573 HD12 ' CG1' ' A' ' 82' ' ' ILE . 91.5 mt -84.72 2.98 39.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.6 t -48.64 -24.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -93.57 24.24 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.45 97.63 12.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.583 0.706 . . . . 0.0 110.857 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -2.17 9.72 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.664 2.243 . . . . 0.0 112.364 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -117.5 -42.85 2.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.9 mt -92.77 145.07 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.179 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.1 t -138.99 106.82 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.599 HD12 HD23 ' A' ' 49' ' ' LEU . 21.2 mm -76.87 135.8 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -145.62 169.17 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.603 ' HB3' HG11 ' A' ' 29' ' ' VAL . 19.9 pttp -143.34 149.51 37.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.544 ' HB3' HD11 ' A' ' 50' ' ' ILE . 1.0 OUTLIER -144.06 138.45 28.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.815 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -86.85 107.0 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.82 -51.74 68.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.125 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.465 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -59.94 -16.31 28.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.815 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -106.88 0.69 24.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.549 ' ND2' ' C ' ' A' ' 89' ' ' ALA . 3.8 m-80 -162.87 124.61 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 17' ' ' LYS . 23.4 t70 -55.92 130.05 42.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.401 HG11 HG23 ' A' ' 98' ' ' VAL . 88.4 t -78.34 125.33 85.01 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.641 0.734 . . . . 0.0 111.168 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -164.57 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.502 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -127.16 160.93 57.11 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.683 0.754 . . . . 0.0 110.857 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.0 Cg_endo -69.71 -3.03 7.38 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.74 -1.775 . . . . 0.0 112.381 -0.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.471 ' N ' ' HA ' ' A' ' 94' ' ' SER . 97.3 m-85 -36.4 125.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -129.31 125.11 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.542 HG22 HG21 ' A' ' 103' ' ' THR . 58.2 t -130.99 103.54 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.142 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -104.93 -35.48 7.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.837 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.57 134.28 6.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.478 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.518 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -98.14 156.94 35.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 0.0 110.92 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.75 165.52 76.42 Favored 'Cis proline' 0 C--O 1.231 0.164 0 C-N-CA 122.732 -1.778 . . . . 0.0 112.373 -0.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.542 HG21 HG22 ' A' ' 98' ' ' VAL . 71.2 m -147.16 105.08 3.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.117 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.825 HD13 ' HE1' ' A' ' 127' ' ' PHE . 21.2 mt -97.19 141.4 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.121 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -140.97 160.34 40.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 31.2 t80 -130.27 140.39 50.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.7 p -109.43 98.66 33.18 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.667 0.746 . . . . 0.0 110.859 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.5 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.76 166.49 27.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.622 2.215 . . . . 0.0 112.37 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -82.48 128.6 34.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.08 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.23 29.75 15.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.5 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.9 mtmt -135.0 40.93 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -64.05 -33.86 76.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.6 mp -67.47 -36.21 80.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.405 ' ND2' ' HG2' ' A' ' 111' ' ' LYS . 0.5 OUTLIER -124.7 81.56 60.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.593 0.711 . . . . 0.0 110.875 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 178.11 4.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.463 ' CD ' ' HG3' ' A' ' 108' ' ' PRO . 7.9 mptt -114.93 127.41 55.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -101.92 108.0 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.435 ' CE1' ' CD2' ' A' ' 130' ' ' TYR . 55.3 t80 -55.21 108.69 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -125.52 90.92 3.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -172.73 -134.23 1.78 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.479 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.14 139.79 14.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 102' ' ' PRO . 32.9 mtp180 -84.8 37.86 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.757 0.313 . . . . 0.0 110.874 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 124' ' ' LEU . 15.1 tp10 -98.25 129.26 44.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.604 ' CD1' HD11 ' A' ' 128' ' ' ILE . 3.2 tm? -34.28 -55.29 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.9 p -57.65 -45.71 85.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 123' ' ' GLU . 2.1 t70 -53.43 -33.53 54.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.825 ' HE1' HD13 ' A' ' 104' ' ' ILE . 88.7 m-85 -73.58 -40.33 63.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.604 HD11 ' CD1' ' A' ' 124' ' ' LEU . 42.7 mt -61.58 -57.41 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.181 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.34 -35.18 78.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.435 ' CD2' ' CE1' ' A' ' 118' ' ' TYR . 13.8 t80 -53.56 -48.1 69.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.424 HD11 HD22 ' A' ' 49' ' ' LEU . 28.9 mt -76.22 -39.24 55.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.908 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -39.92 -40.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.3 mtp85 -92.0 -64.4 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 135' ' ' ALA . 21.8 mm-40 -41.78 -60.15 1.45 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -35.19 116.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.1 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.6 OUTLIER -35.19 -75.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.122 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 m -75.81 -55.69 5.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 179.99 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.627 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 4.3 p90 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.882 0.372 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.1 pp -112.99 -36.91 4.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.433 ' N ' HD12 ' A' ' 16' ' ' LEU . 31.2 tttt -109.69 155.5 21.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.569 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 18.7 t -166.4 143.78 5.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.0 mm-40 -86.6 162.05 46.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.654 0.74 . . . . 0.0 110.882 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.77 142.32 47.56 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.649 2.233 . . . . 0.0 112.353 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.463 HD13 ' CG2' ' A' ' 33' ' ' VAL . 30.6 mm -71.65 131.83 85.83 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.644 0.735 . . . . 0.0 111.1 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 178.38 4.67 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.626 2.217 . . . . 0.0 112.37 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -103.13 -34.96 8.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 p -147.98 125.64 11.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -107.8 47.5 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -58.8 -26.92 64.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.53 168.87 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.486 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.459 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 54.1 Cg_endo -69.76 -25.66 28.35 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.685 2.256 . . . . 0.0 112.364 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.546 HG12 ' HG2' ' A' ' 84' ' ' LYS . 62.1 t -120.1 113.15 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -57.66 129.59 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.3 125.97 39.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.153 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.045 HG11 HG23 ' A' ' 41' ' ' VAL . 21.8 t -124.6 124.57 68.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.662 HG22 ' OD1' ' A' ' 36' ' ' ASN . 20.9 m -122.64 148.46 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.627 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -32.75 -40.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.121 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.583 ' HB2' HG23 ' A' ' 33' ' ' VAL . 12.7 mt-10 -55.75 -49.56 72.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.857 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.662 ' OD1' HG22 ' A' ' 33' ' ' VAL . 36.4 p-10 -115.77 34.91 4.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.615 ' CD2' HG21 ' A' ' 41' ' ' VAL . 21.4 t80 -71.09 -57.93 4.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -66.6 -5.67 12.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -87.08 -47.41 8.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.3 mt -96.92 -58.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.045 HG23 HG11 ' A' ' 32' ' ' VAL . 41.3 t -49.0 -61.64 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.167 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -68.56 126.91 31.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -174.33 118.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -95.64 0.45 52.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -95.54 -37.58 10.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -138.87 138.93 37.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.522 ' OD2' ' CG1' ' A' ' 80' ' ' ILE . 1.3 p30 -58.63 152.87 17.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.87 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 41' ' ' VAL . 52.1 t -148.42 142.72 19.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.445 HD23 HD12 ' A' ' 82' ' ' ILE . 39.4 tp -117.91 140.51 49.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.579 HD11 ' CB ' ' A' ' 85' ' ' MET . 2.1 tp -127.86 135.6 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.49 ' CD ' ' C ' ' A' ' 51' ' ' GLU . 5.8 tm-20 -126.77 121.88 33.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -95.74 118.7 32.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -126.34 179.08 5.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.26 134.56 17.76 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.625 0.726 . . . . 0.0 111.123 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.712 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.1 Cg_endo -69.73 -16.96 37.93 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.69 2.26 . . . . 0.0 112.339 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.413 ' CZ3' ' HB2' ' A' ' 57' ' ' CYS . 2.4 p-90 -105.85 6.53 31.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.413 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . 42.1 t -107.16 112.7 25.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.876 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -57.98 -57.16 21.3 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -41.02 -37.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 97.5 m -73.75 -34.66 64.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 58' ' ' GLY . 2.1 ttmm -62.33 -35.48 79.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -73.77 -27.75 61.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 66' ' ' LYS . 13.2 tp -81.36 -25.15 36.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.1 tt0 -37.53 -58.37 1.28 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.645 0.736 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.3 Cg_endo -69.82 -31.5 20.13 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.692 2.261 . . . . 0.0 112.28 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.632 ' HB2' HD12 ' A' ' 63' ' ' LEU . 16.0 mtpp -68.13 -29.98 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -92.47 -38.87 11.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HG3' ' CG ' ' A' ' 28' ' ' PRO . 5.5 ttmm -50.07 -58.68 5.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 9.6 mt-10 -41.59 -49.25 4.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 127' ' ' PHE . 25.1 tp -47.09 -41.39 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.56 -66.96 2.48 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.478 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.06 -26.54 68.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.85 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 69' ' ' GLU . 17.2 mmtt -70.09 -39.94 75.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.784 HD12 ' CG1' ' A' ' 82' ' ' ILE . 64.3 mt -79.13 4.86 13.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.3 t -56.97 -11.96 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.41 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 14.5 mmtp -82.68 -20.14 36.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.882 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CG ' ' O ' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -98.43 100.99 10.27 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.717 . . . . 0.0 110.855 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.4 Cg_endo -69.77 -2.91 10.98 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 0.0 112.322 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -107.7 -33.05 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.522 ' CG1' ' OD2' ' A' ' 47' ' ' ASP . 54.4 mt -92.05 117.93 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.1 t -118.2 125.44 74.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.106 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.784 ' CG1' HD12 ' A' ' 74' ' ' LEU . 30.7 mm -93.24 137.28 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.781 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -142.9 161.03 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.036 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.546 ' HG2' HG12 ' A' ' 29' ' ' VAL . 32.4 pttt -131.11 156.51 45.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.579 ' CB ' HD11 ' A' ' 50' ' ' ILE . 13.9 ttt -151.09 132.36 14.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 90' ' ' ASN . 26.1 t70 -91.32 95.85 10.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -52.28 -60.46 3.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.712 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -42.82 -27.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.38 -28.88 13.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.476 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.3 OUTLIER -134.88 114.97 13.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -47.2 131.24 13.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.423 HG13 ' HD2' ' A' ' 93' ' ' PRO . 93.0 t -80.86 132.85 56.2 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.59 0.709 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.468 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.6 Cg_endo -69.76 -165.83 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 0.0 112.326 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -124.13 160.89 50.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.645 0.736 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.5 Cg_endo -69.72 -8.75 10.59 Favored 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.356 -0.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 95' ' ' PRO . 98.3 m-85 -33.08 124.09 0.38 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -128.98 119.85 25.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.585 HG22 HG21 ' A' ' 103' ' ' THR . 71.0 t -121.66 96.47 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.17 -43.39 7.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.812 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.53 128.58 6.16 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.532 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -97.39 156.37 36.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.662 0.744 . . . . 0.0 110.858 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.6 Cg_endo -69.71 163.96 80.35 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.34 -0.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.585 HG21 HG22 ' A' ' 98' ' ' VAL . 50.2 m -145.73 106.09 4.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.407 HG22 ' CB ' ' A' ' 118' ' ' TYR . 22.5 mt -96.51 136.23 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.422 ' O ' HD12 ' A' ' 49' ' ' LEU . 8.4 m-85 -134.76 158.91 42.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -128.05 135.04 49.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 5.1 p -107.81 91.26 7.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.652 0.739 . . . . 0.0 110.832 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.497 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.8 Cg_endo -69.73 168.95 20.04 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.256 . . . . 0.0 112.339 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.24 140.11 35.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 41.01 31.36 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.497 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.7 mtmm -128.53 34.58 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 113' ' ' LEU . 27.3 mmtp -64.58 -58.24 6.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 112' ' ' LYS . 4.3 mm? -34.87 -41.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.909 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.405 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 6.4 m120 -134.97 92.64 18.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.572 0.701 . . . . 0.0 110.86 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.8 Cg_endo -69.79 -173.44 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -135.66 121.02 19.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.25 123.89 34.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.63 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 60.6 t80 -57.45 96.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.906 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -109.7 95.04 5.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.918 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.34 -151.51 9.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.36 135.11 13.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.484 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 122' ' ' ARG . 13.1 mtm105 -80.59 45.62 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -102.43 137.05 41.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.476 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.3 tm? -40.48 -52.43 2.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.8 m -66.3 -47.34 73.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -46.69 -36.75 7.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.918 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.63 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 65.3 m-85 -70.52 -44.68 67.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.4 mt -57.66 -56.41 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.119 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -65.68 -25.01 67.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.456 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 8.3 t80 -63.9 -50.62 68.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 132' ' ' GLN . 23.5 mt -71.69 -41.66 68.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 131' ' ' LEU . 10.2 mt-30 -37.74 -39.86 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -102.04 -51.4 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 7.4 mm-40 -51.98 -57.08 10.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.04 147.49 53.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.15 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.23 -49.06 20.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.2 m -42.88 -69.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.867 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 179.998 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.664 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 2.8 p90 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.903 0.382 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 pp -102.9 -39.12 7.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.948 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -100.93 159.69 14.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.489 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 61.4 p -172.47 149.69 2.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 15.9 mm-40 -103.6 161.81 21.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.623 0.725 . . . . 0.0 110.908 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.78 144.63 54.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.259 . . . . 0.0 112.31 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.509 HD13 HG21 ' A' ' 33' ' ' VAL . 39.0 mm -71.93 132.97 84.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.619 0.723 . . . . 0.0 111.124 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 21' ' ' ILE . 54.0 Cg_endo -69.79 179.47 3.69 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.616 2.211 . . . . 0.0 112.349 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -104.1 -34.69 8.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 m -150.85 126.42 10.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -110.14 43.12 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.26 -28.81 44.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.04 165.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.421 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 53.6 Cg_endo -69.69 -20.56 35.01 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.277 . . . . 0.0 112.344 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.32 110.75 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -55.79 138.48 47.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.7 t -91.91 110.6 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.988 HG11 HG23 ' A' ' 41' ' ' VAL . 39.1 t -105.4 124.0 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.096 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 21' ' ' ILE . 27.0 m -119.77 145.78 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.664 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -31.64 -44.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.115 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -54.74 -49.12 71.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 33' ' ' VAL . 9.2 p-10 -114.25 38.36 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.741 ' CD2' HG21 ' A' ' 41' ' ' VAL . 8.4 t80 -75.32 -55.49 5.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.4 -15.23 62.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -78.99 -44.8 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.429 HD12 HG22 ' A' ' 32' ' ' VAL . 22.7 mt -97.46 -58.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.988 HG23 HG11 ' A' ' 32' ' ' VAL . 48.6 t -49.65 -61.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -73.2 126.99 31.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -172.53 106.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -79.15 -14.57 59.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -73.16 -44.24 60.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HE3' HG21 ' A' ' 81' ' ' VAL . 19.3 pttm -138.9 160.85 38.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.11 153.13 38.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.5 t -144.59 135.73 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.13 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 106' ' ' PHE . 14.4 tp -112.68 119.91 39.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' A' ' 85' ' ' MET . 1.8 tp -106.64 136.71 40.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' N ' HG13 ' A' ' 50' ' ' ILE . 1.2 tm-20 -127.5 115.46 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.409 ' C ' ' OE2' ' A' ' 51' ' ' GLU . 35.5 m-85 -91.64 139.54 30.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 10.4 p90 -144.63 177.12 8.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.536 ' HB1' ' CE2' ' A' ' 56' ' ' TRP . . . -132.72 131.14 21.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.598 0.713 . . . . 0.0 111.096 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.56 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.1 Cg_endo -69.72 -9.26 25.67 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.382 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.536 ' CE2' ' HB1' ' A' ' 54' ' ' ALA . 2.1 p-90 -110.6 23.21 14.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.4 t -134.2 108.74 8.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.41 -35.9 2.94 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.49 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.426 ' CD2' ' H ' ' A' ' 59' ' ' HIS . 16.3 m170 -42.59 -50.38 5.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.802 0.334 . . . . 0.0 110.872 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 64' ' ' GLU . 14.1 p -55.1 -42.13 72.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' N ' ' SG ' ' A' ' 60' ' ' CYS . 0.0 OUTLIER -62.37 -40.69 97.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.46 -36.96 71.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.71 HD12 ' HB2' ' A' ' 66' ' ' LYS . 39.4 tp -84.34 -20.07 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.543 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 3.3 tt0 -42.19 -57.95 3.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.738 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.82 -34.09 15.07 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.366 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.71 ' HB2' HD12 ' A' ' 63' ' ' LEU . 26.6 mtmt -66.85 -28.67 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -93.53 -49.77 5.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 71' ' ' GLY . 6.4 ttmm -39.08 -64.33 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 22.2 mt-10 -39.58 -46.87 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.453 ' N ' HD21 ' A' ' 124' ' ' LEU . 19.5 tp -53.03 -39.48 63.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 68' ' ' LYS . . . -57.32 -65.5 3.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.504 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -67.43 -24.42 65.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.493 ' CG ' ' O ' ' A' ' 69' ' ' GLU . 16.5 mmtm -69.87 -46.13 66.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.578 HD12 HD11 ' A' ' 82' ' ' ILE . 93.6 mt -80.16 3.23 21.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.6 t -53.33 -36.09 60.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -59.88 -11.16 4.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.859 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.97 100.72 12.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.654 0.74 . . . . 0.0 110.874 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 1.07 4.77 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.722 2.281 . . . . 0.0 112.339 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -110.87 -39.56 4.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.2 mt -87.08 113.6 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.175 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.421 HG21 ' HE3' ' A' ' 46' ' ' LYS . 96.4 t -108.34 117.01 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.578 HD11 HD12 ' A' ' 74' ' ' LEU . 39.6 mm -91.98 123.05 43.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.175 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.829 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -138.01 171.29 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -138.96 154.94 48.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.417 ' HB3' HD11 ' A' ' 50' ' ' ILE . 6.5 ttt -148.02 134.11 19.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.57 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 8.9 t0 -86.03 87.76 7.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -42.73 -67.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.084 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.56 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -37.75 -30.93 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -89.58 -35.7 15.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 2.9 m-80 -124.0 115.38 21.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -47.05 119.23 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.5 t -75.89 120.05 79.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.632 0.73 . . . . 0.0 111.15 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.75 -174.88 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.727 2.285 . . . . 0.0 112.346 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.505 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -105.07 159.62 28.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.674 0.75 . . . . 0.0 110.845 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.516 ' O ' ' C ' ' A' ' 96' ' ' TYR . 53.2 Cg_endo -69.82 -23.49 9.09 Favored 'Cis proline' 0 C--O 1.231 0.143 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.312 0.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.516 ' C ' ' O ' ' A' ' 95' ' ' PRO . 76.2 m-85 -27.47 114.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -127.22 90.38 3.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 103' ' ' THR . 78.6 t -80.0 99.43 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.157 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.7 mmm-85 -98.04 -44.18 6.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.91 133.37 7.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.52 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -101.78 156.86 34.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.608 0.718 . . . . 0.0 110.903 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.0 Cg_endo -69.79 145.4 79.38 Favored 'Cis proline' 0 C--O 1.232 0.206 0 C-N-CA 122.648 -1.813 . . . . 0.0 112.388 0.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.599 HG21 HG22 ' A' ' 98' ' ' VAL . 56.4 m -118.48 126.64 52.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.509 HD13 ' CE1' ' A' ' 127' ' ' PHE . 25.7 mt -121.34 127.19 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -127.53 152.1 48.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.461 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 21.5 t80 -126.44 130.22 50.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.858 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 33.3 t -100.77 99.31 9.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.671 0.748 . . . . 0.0 110.843 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.499 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.81 164.14 35.71 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.672 2.248 . . . . 0.0 112.343 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' ND2' ' A' ' 110' ' ' ASN . . . -78.84 134.96 36.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.089 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER 48.33 31.81 2.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.499 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 20.7 mtmt -133.98 33.92 3.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -58.35 -55.07 39.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -43.17 -39.34 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -133.82 89.67 29.46 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.63 0.729 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HG3' ' HG2' ' A' ' 95' ' ' PRO . 53.1 Cg_endo -69.81 -167.58 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.733 2.289 . . . . 0.0 112.293 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -135.16 111.36 9.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -82.18 128.41 34.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.629 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 75.3 t80 -69.67 99.8 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -112.08 90.89 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.847 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -171.68 -150.96 7.44 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.43 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.23 140.39 16.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -79.59 44.1 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 124' ' ' LEU . 6.4 tt0 -101.28 127.92 47.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.458 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -35.11 -56.19 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 53.0 p -61.86 -47.31 85.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -47.16 -36.5 8.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.629 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 77.1 m-85 -72.49 -49.49 32.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.5 mt -50.33 -56.07 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -37.08 83.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.838 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.535 ' CE2' ' HG3' ' A' ' 134' ' ' GLU . 63.8 t80 -57.11 -45.52 83.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.915 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 132' ' ' GLN . 60.7 mt -72.83 -40.46 65.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.429 ' HB3' ' NH1' ' A' ' 133' ' ' ARG . 30.4 mt-30 -37.4 -41.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.429 ' NH1' ' HB3' ' A' ' 132' ' ' GLN . 12.8 mmp_? -100.49 -60.33 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.535 ' HG3' ' CE2' ' A' ' 130' ' ' TYR . 16.2 mm-40 -38.73 -52.99 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.72 152.11 46.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.36 -51.53 5.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.8 m -48.73 -60.95 2.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.957 0.408 . . . . 0.0 110.918 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.704 HD23 ' CG ' ' A' ' 91' ' ' ASP . 1.3 pt? -104.56 -36.99 7.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.515 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -121.46 174.0 7.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.955 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 89.0 p -172.84 171.17 4.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.505 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 5.3 mt-10 -106.44 159.9 28.14 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.625 0.726 . . . . 0.0 110.907 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 134.99 29.27 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.339 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.454 HD13 ' CG2' ' A' ' 33' ' ' VAL . 30.6 mm -68.93 122.3 84.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.647 0.737 . . . . 0.0 111.148 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 172.14 13.19 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.707 2.271 . . . . 0.0 112.318 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 24' ' ' SER . 6.4 pt-20 -99.94 -39.04 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.444 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 7.1 t -130.68 137.1 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -132.54 35.96 3.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.81 61.92 1.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.44 -174.36 13.69 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -33.45 16.53 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.653 2.235 . . . . 0.0 112.342 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.3 t -127.66 111.15 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.174 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -59.61 135.96 57.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.5 t -83.84 115.77 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.017 HG11 HG23 ' A' ' 41' ' ' VAL . 39.1 t -113.17 121.24 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.114 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 35' ' ' GLU . 4.5 m -114.13 148.14 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.154 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -33.88 -45.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.485 ' HB2' HG23 ' A' ' 33' ' ' VAL . 2.2 mm-40 -54.45 -50.21 68.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.859 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.463 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 9.5 p-10 -109.23 33.29 4.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.477 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 7.4 t80 -74.9 -48.08 26.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -72.64 -4.61 32.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -90.01 -42.75 10.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.618 HD12 HG22 ' A' ' 32' ' ' VAL . 14.3 mt -99.44 -62.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.171 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.017 HG23 HG11 ' A' ' 32' ' ' VAL . 41.1 t -50.2 -62.66 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -61.47 116.9 5.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.431 ' C ' ' HE3' ' A' ' 112' ' ' LYS . 3.3 t-20 -172.75 120.88 0.39 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CA ' ' HE3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -106.92 30.34 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -124.63 -27.09 3.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -138.47 160.13 40.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.46 126.51 31.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.507 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 39.1 t -126.32 152.52 33.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.49 HD13 HD21 ' A' ' 131' ' ' LEU . 14.7 tp -132.4 125.45 30.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.561 HD11 ' CB ' ' A' ' 85' ' ' MET . 1.9 tp -116.06 134.75 58.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.091 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -126.92 115.71 19.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.874 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -90.03 116.24 27.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.55 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 26.9 p90 -116.63 174.73 5.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.15 128.94 23.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.582 0.706 . . . . 0.0 111.136 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -19.14 36.63 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.676 2.251 . . . . 0.0 112.336 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.515 ' NE1' HG21 ' A' ' 88' ' ' THR . 3.7 p-90 -101.51 14.87 30.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.404 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 2.0 t -129.19 103.87 7.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -37.41 -39.63 0.54 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.49 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' GLY . 32.7 m170 -36.89 -45.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.768 0.318 . . . . 0.0 110.836 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 64' ' ' GLU . 27.9 p -54.61 -48.07 72.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 58' ' ' GLY . 28.9 mmtt -63.0 -41.93 99.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -67.88 -30.66 70.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 66' ' ' LYS . 67.0 tp -92.4 -19.42 22.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.543 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.6 tt0 -43.68 -57.99 5.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.598 0.713 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.77 -28.62 24.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.659 2.239 . . . . 0.0 112.38 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.913 ' HB2' HD12 ' A' ' 63' ' ' LEU . 13.7 mtpp -72.06 -30.17 64.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -93.65 -46.45 7.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.012 0.434 . . . . 0.0 110.94 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 71' ' ' GLY . 14.2 ttmt -44.58 -60.69 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 68' ' ' LYS . 18.6 mt-10 -38.05 -54.66 1.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' A' ' 127' ' ' PHE . 17.9 tp -49.08 -38.03 23.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.953 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 68' ' ' LYS . . . -58.89 -65.19 3.65 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -64.29 -27.67 69.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.916 0.389 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -69.73 -45.49 68.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.521 HD12 HD11 ' A' ' 82' ' ' ILE . 94.9 mt -80.71 3.19 23.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.9 t -54.57 -28.77 48.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.844 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.92 0.18 7.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.958 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.47 99.94 39.39 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.608 0.718 . . . . 0.0 110.866 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -0.16 6.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.361 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -110.56 -34.62 6.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.54 112.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.2 t -109.57 119.35 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 74' ' ' LEU . 32.1 mm -93.29 117.47 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.76 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -128.42 166.18 19.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -134.37 155.77 49.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.938 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.561 ' CB ' HD11 ' A' ' 50' ' ' ILE . 11.9 ttt -149.24 161.29 42.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.908 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -109.2 119.58 39.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.0 -70.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.515 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.5 OUTLIER -47.77 -28.05 2.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.908 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -91.18 -31.1 16.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 8.0 m-80 -131.1 102.18 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.704 ' CG ' HD23 ' A' ' 16' ' ' LEU . 9.5 t0 -41.16 122.89 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 98' ' ' VAL . 92.2 t -82.04 121.67 79.16 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.661 0.744 . . . . 0.0 111.086 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.74 -167.21 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.717 2.278 . . . . 0.0 112.365 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.512 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -109.11 160.05 28.94 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.749 . . . . 0.0 110.833 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.5 Cg_endo -69.74 -20.18 10.85 Favored 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.634 -1.819 . . . . 0.0 112.373 -0.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.509 ' C ' ' O ' ' A' ' 95' ' ' PRO . 84.5 m-85 -28.55 113.36 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -122.87 85.85 2.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 92' ' ' VAL . 85.8 t -77.2 120.57 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.0 mmm-85 -122.05 -48.12 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.12 130.11 7.87 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.519 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -102.42 156.09 35.7 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.658 0.742 . . . . 0.0 110.886 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.66 143.92 75.0 Favored 'Cis proline' 0 C--O 1.231 0.151 0 C-N-CA 122.713 -1.786 . . . . 0.0 112.338 -0.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.544 HG21 HG22 ' A' ' 98' ' ' VAL . 80.1 m -114.33 127.74 56.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.174 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.5 mt -120.18 135.91 58.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.165 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -134.26 169.99 16.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 31.1 t80 -139.5 131.72 28.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.8 t -101.65 97.98 8.77 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.618 0.723 . . . . 0.0 110.842 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.447 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.79 169.29 19.29 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.718 2.279 . . . . 0.0 112.329 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.62 126.49 36.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 64.59 26.48 13.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.3 mtmm -131.78 26.5 4.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -47.42 -57.94 4.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.1 mp -39.38 -41.99 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.936 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -134.39 99.45 13.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.652 0.739 . . . . 0.0 110.874 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -164.29 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.672 2.248 . . . . 0.0 112.337 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 106' ' ' PHE . 15.4 mmtm -133.34 118.21 18.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -88.52 148.49 24.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.941 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -94.84 108.42 20.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.942 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -118.68 92.43 3.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.46 -143.74 4.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.454 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.01 142.83 16.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.468 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -82.01 41.71 0.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 110.846 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 124' ' ' LEU . 16.4 tp10 -98.06 129.68 44.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.592 ' CD1' HD11 ' A' ' 128' ' ' ILE . 2.7 tm? -34.91 -56.55 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 64.7 p -57.62 -47.36 82.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.07 -32.61 22.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.555 ' HB3' HD22 ' A' ' 70' ' ' LEU . 52.2 m-85 -74.5 -39.3 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.592 HD11 ' CD1' ' A' ' 124' ' ' LEU . 24.9 mt -64.64 -65.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -54.08 -31.04 50.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.438 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 49.1 t80 -60.4 -47.91 84.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 49' ' ' LEU . 48.7 mt -73.72 -39.17 64.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -38.66 -38.65 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -102.29 -51.04 3.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.438 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 5.2 mm-40 -51.54 -57.16 9.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.72 150.26 41.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.75 -50.98 10.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.2 m -75.87 49.31 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.525 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.9 p90 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.94 0.4 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.0 pp -106.28 -44.23 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.568 ' N ' HD12 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -112.48 152.54 28.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.433 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 3.3 m -162.86 166.57 23.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.852 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.453 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.1 mm-40 -105.3 162.27 20.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.672 0.748 . . . . 0.0 110.841 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 54.2 Cg_endo -69.75 143.47 50.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.736 2.291 . . . . 0.0 112.331 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.597 HD13 HG21 ' A' ' 33' ' ' VAL . 12.4 mm -69.08 135.1 89.42 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.639 0.733 . . . . 0.0 111.125 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 21' ' ' ILE . 53.3 Cg_endo -69.79 174.66 9.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.671 2.247 . . . . 0.0 112.303 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.6 -38.11 5.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 t -135.18 116.62 14.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -114.63 43.29 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.58 51.01 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.65 -176.83 16.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.517 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -42.21 3.57 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.692 2.261 . . . . 0.0 112.367 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.558 HG12 ' HG2' ' A' ' 84' ' ' LYS . 49.5 t -113.03 107.79 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.104 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.575 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -60.41 130.39 46.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.8 t -80.31 121.87 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.154 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.996 HG11 HG23 ' A' ' 41' ' ' VAL . 40.6 t -114.71 120.37 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.178 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 21' ' ' ILE . 18.6 m -111.69 142.88 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -33.49 -37.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HB3' HD11 ' A' ' 21' ' ' ILE . 9.4 mt-10 -60.52 -48.26 82.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 33' ' ' VAL . 14.5 p-10 -107.56 25.03 11.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.659 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 20.2 t80 -65.68 -55.21 18.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.427 ' HA ' ' CG ' ' A' ' 42' ' ' ASN . 6.2 t70 -67.72 -3.91 10.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -92.67 -43.57 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.2 mt -99.19 -52.65 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.179 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.996 HG23 HG11 ' A' ' 32' ' ' VAL . 89.3 t -60.79 -61.41 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.436 ' OD1' ' CE1' ' A' ' 37' ' ' PHE . 2.0 m-20 -67.31 123.22 19.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -175.54 111.88 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.71 33.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -128.04 -30.14 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.555 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 34.5 pttt -138.16 166.31 24.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.86 144.86 25.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.522 HG22 ' HB ' ' A' ' 81' ' ' VAL . 93.1 t -146.58 148.76 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.4 tp -123.81 125.45 44.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.932 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.3 tp -110.83 134.35 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' OE1' ' CG1' ' A' ' 104' ' ' ILE . 3.1 tp10 -127.42 112.83 15.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.406 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 61.0 m-85 -87.21 115.57 24.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.95 171.81 7.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.968 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.13 131.78 23.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -6.24 18.12 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.727 2.285 . . . . 0.0 112.319 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.483 ' CZ2' HG21 ' A' ' 88' ' ' THR . 6.8 p-90 -124.39 25.98 7.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 10.2 t -128.75 112.46 14.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -52.14 -61.55 6.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.493 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -41.54 -37.91 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.838 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 88.7 m -74.35 -34.76 63.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 58' ' ' GLY . 3.8 ttmt -70.29 -35.1 73.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -72.3 -23.34 61.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 64' ' ' GLU . 11.8 tp -85.24 -29.74 24.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.562 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.6 tp10 -36.74 -55.92 1.46 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.658 0.742 . . . . 0.0 110.851 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.8 Cg_endo -69.75 -36.15 11.37 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.675 2.25 . . . . 0.0 112.367 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -66.1 -28.07 68.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CZ ' HG23 ' A' ' 82' ' ' ILE . 35.9 t80 -95.3 -38.72 10.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -45.73 -58.8 3.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -43.69 -50.13 7.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.477 ' N ' HD21 ' A' ' 124' ' ' LEU . 17.9 tp -46.09 -37.08 6.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.58 -62.3 6.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.473 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -68.37 -22.9 64.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -72.65 -49.41 31.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.466 HD22 ' OD2' ' A' ' 77' ' ' ASP . 95.0 mt -80.06 2.98 21.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.939 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.4 t -51.02 -24.11 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -86.5 17.13 4.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.466 ' OD2' HD22 ' A' ' 74' ' ' LEU . 75.5 m-20 -110.21 98.11 33.81 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.592 0.71 . . . . 0.0 110.917 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.6 Cg_endo -69.78 -1.81 9.12 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 0.0 112.339 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -122.08 8.87 9.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.0 mt -134.72 142.47 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.522 ' HB ' HG22 ' A' ' 48' ' ' VAL . 87.1 t -139.12 106.64 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.53 HG23 ' CZ ' ' A' ' 67' ' ' TYR . 46.3 mm -83.73 125.92 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.129 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.744 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -143.35 170.92 14.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.133 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.558 ' HG2' HG12 ' A' ' 29' ' ' VAL . 54.5 pttt -140.63 154.01 46.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.3 ttt -140.85 142.51 34.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 26.7 t0 -91.54 82.28 5.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -41.4 -48.54 3.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.483 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 19.9 p -57.38 -33.34 67.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -103.31 13.29 34.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.503 ' ND2' ' C ' ' A' ' 89' ' ' ALA . 8.6 m-80 -162.91 107.77 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -44.97 127.65 6.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.409 HG11 HG23 ' A' ' 98' ' ' VAL . 90.6 t -78.01 122.57 85.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.597 0.713 . . . . 0.0 111.164 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -166.51 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.378 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.494 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -118.85 161.78 34.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.727 . . . . 0.0 110.85 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.2 Cg_endo -69.66 -13.78 12.24 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.679 -1.8 . . . . 0.0 112.373 -0.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.468 ' C ' ' O ' ' A' ' 95' ' ' PRO . 83.2 m-85 -32.09 120.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.941 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -129.68 76.46 1.72 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.543 HG22 HG21 ' A' ' 103' ' ' THR . 86.4 t -74.41 125.17 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -123.2 -42.28 2.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.2 129.41 6.72 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.452 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.529 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.87 154.84 37.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.678 0.751 . . . . 0.0 110.848 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.1 Cg_endo -69.76 162.2 84.61 Favored 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.669 -1.805 . . . . 0.0 112.348 0.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.543 HG21 HG22 ' A' ' 98' ' ' VAL . 31.4 m -140.95 106.16 5.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.16 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.584 HD13 ' HE1' ' A' ' 127' ' ' PHE . 41.4 mt -101.1 123.86 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.49 ' CZ ' ' HE3' ' A' ' 117' ' ' LYS . 10.4 m-85 -123.92 147.05 48.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 24.6 t80 -117.78 133.79 55.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -103.73 94.46 6.26 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.678 0.751 . . . . 0.0 110.897 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.503 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.75 164.8 33.19 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.665 2.243 . . . . 0.0 112.356 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -80.75 139.74 35.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.8 p-10 47.85 25.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.503 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 23.4 mtmt -129.16 19.75 5.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.847 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -43.24 -68.28 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.929 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 112' ' ' LYS . 4.5 mm? -33.94 -51.75 0.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 11.5 m120 -112.16 96.19 33.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.721 . . . . 0.0 110.898 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.5 Cg_endo -69.75 -170.78 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 0.0 112.34 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -138.85 110.1 6.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.49 ' HE3' ' CZ ' ' A' ' 105' ' ' TYR . 30.0 tttt -73.83 156.54 37.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -106.35 96.58 6.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -111.51 102.13 10.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 179.56 -151.31 9.98 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.83 130.91 10.0 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -79.58 44.5 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.323 . . . . 0.0 110.908 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 124' ' ' LEU . 9.8 tt0 -105.66 133.48 50.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.602 HD13 ' C ' ' A' ' 124' ' ' LEU . 2.9 tm? -35.56 -55.79 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 44.8 p -57.9 -46.99 84.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -51.19 -37.13 44.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.584 ' HE1' HD13 ' A' ' 104' ' ' ILE . 61.7 m-85 -69.89 -45.79 66.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 124' ' ' LEU . 33.7 mt -59.0 -59.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -60.08 -30.27 69.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 130' ' ' TYR . 3.9 t80 -59.52 -45.63 91.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.927 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 132' ' ' GLN . 19.0 mt -76.02 -43.35 44.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.938 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 131' ' ' LEU . 15.9 mt-30 -36.12 -39.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.447 ' HB3' ' NH1' ' A' ' 133' ' ' ARG . 5.4 ptp180 -99.39 -48.43 4.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.78 -61.57 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -43.24 126.24 4.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.421 HG23 ' NZ ' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -52.89 -74.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.114 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 t -51.2 -57.14 9.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.51 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.866 0.365 . . . . 0.0 110.94 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 17' ' ' LYS . 3.9 pp -103.17 -41.86 5.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.691 ' HB3' HD12 ' A' ' 16' ' ' LEU . 18.7 ptmt -130.23 157.96 41.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.52 ' OG ' ' HB3' ' A' ' 34' ' ' ALA . 8.7 t -162.08 166.05 26.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 3.5 mm-40 -105.6 161.7 21.98 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.684 0.754 . . . . 0.0 110.835 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.447 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.78 145.34 56.71 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.67 2.247 . . . . 0.0 112.349 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.683 HD11 ' HB3' ' A' ' 35' ' ' GLU . 28.4 mm -68.78 132.04 90.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.62 0.724 . . . . 0.0 111.144 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 175.74 7.71 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.69 2.26 . . . . 0.0 112.386 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 24' ' ' SER . 6.6 pt-20 -108.72 -37.5 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.419 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 85.3 p -129.62 130.14 45.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.891 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -133.77 43.03 2.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 27' ' ' GLY . 2.9 m-20 -72.65 -19.13 61.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -45.54 173.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.505 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -30.13 22.8 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.7 2.266 . . . . 0.0 112.313 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.676 HG12 ' HG2' ' A' ' 84' ' ' LYS . 39.8 t -116.84 106.65 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.15 132.16 52.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.1 t -83.11 125.34 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.168 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.827 HG11 HG23 ' A' ' 41' ' ' VAL . 18.0 t -120.79 129.93 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.515 HG22 ' OD1' ' A' ' 36' ' ' ASN . 15.0 m -121.86 145.85 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HB3' ' OG ' ' A' ' 18' ' ' SER . . . -37.8 -28.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.683 ' HB3' HD11 ' A' ' 21' ' ' ILE . 3.9 mt-10 -66.71 -45.06 79.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.515 ' OD1' HG22 ' A' ' 33' ' ' VAL . 39.9 p-10 -119.41 37.45 4.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.585 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 8.3 t80 -71.63 -51.43 23.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.09 -12.33 61.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.41 -41.29 20.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.8 mt -99.34 -60.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.827 HG23 HG11 ' A' ' 32' ' ' VAL . 43.6 t -52.82 -62.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -72.74 130.35 40.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -173.55 106.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.416 ' HB3' ' NZ ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -83.25 36.27 0.52 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -133.72 -36.43 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -139.08 145.79 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 1.4 m-20 -66.35 135.59 54.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' A' ' 41' ' ' VAL . 60.7 t -130.48 145.08 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.841 HD13 HD21 ' A' ' 131' ' ' LEU . 6.7 tp -124.6 118.8 27.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.607 HD13 ' CG2' ' A' ' 41' ' ' VAL . 2.0 tp -106.09 137.55 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.25 117.65 22.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -93.23 137.98 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.908 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 3.8 p90 -142.36 171.93 13.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.98 133.03 24.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 111.119 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -0.76 7.41 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 0.0 112.308 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.422 ' CZ2' ' CG2' ' A' ' 88' ' ' THR . 2.4 p-90 -128.63 24.41 5.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.0 t -120.31 110.81 17.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -40.87 -58.5 2.65 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.464 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.469 ' C ' ' O ' ' A' ' 58' ' ' GLY . 3.7 t-160 -32.98 -62.49 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 110.839 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' GLU . 3.9 t -40.15 -49.81 2.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.886 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -56.77 -48.88 76.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -70.76 -21.95 62.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.29 -19.99 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.1 tt0 -43.32 -57.91 4.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 0.0 110.938 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.5 Cg_endo -69.78 -33.38 16.63 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.693 2.262 . . . . 0.0 112.335 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -66.37 -32.23 73.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 68' ' ' LYS . 31.7 t80 -89.22 -47.77 7.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 67' ' ' TYR . 14.8 ttmt -37.75 -60.15 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -38.78 -59.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 127' ' ' PHE . 24.5 tp -41.99 -36.99 1.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.2 -69.14 1.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.459 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -64.58 -23.01 67.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -71.51 -39.97 70.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.597 HD12 HD11 ' A' ' 82' ' ' ILE . 85.1 mt -88.58 3.16 51.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 t -55.15 -31.73 61.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' A' ' 76' ' ' LYS . 25.5 ttpt -73.0 1.47 8.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 3.6 t70 -102.5 100.07 14.92 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.88 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.4 Cg_endo -69.81 0.46 5.65 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.64 2.226 . . . . 0.0 112.34 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -111.69 -41.36 4.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.529 HG21 HD13 ' A' ' 74' ' ' LEU . 63.0 mt -90.74 138.09 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.9 t -133.94 113.5 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.597 HD11 HD12 ' A' ' 74' ' ' LEU . 39.6 mm -82.45 131.97 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.781 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -143.63 170.97 14.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.088 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.676 ' HG2' HG12 ' A' ' 29' ' ' VAL . 12.4 pttp -143.07 154.39 43.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.9 ttt -150.08 133.36 16.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -85.28 76.52 10.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -35.71 -61.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.06 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 87' ' ' ALA . 43.9 p -32.26 -41.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.136 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HB3' ' OD2' ' A' ' 86' ' ' ASP . . . -94.66 -31.14 13.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.094 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 87' ' ' ALA . 35.9 m-80 -111.14 101.54 10.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -43.58 123.8 3.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.448 HG11 HG23 ' A' ' 98' ' ' VAL . 73.1 t -66.66 129.2 94.11 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.572 0.701 . . . . 0.0 111.172 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -163.53 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.625 2.217 . . . . 0.0 112.383 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.503 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -131.41 160.85 65.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.649 0.738 . . . . 0.0 110.828 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.1 Cg_endo -69.82 -4.55 8.45 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.706 -1.789 . . . . 0.0 112.304 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.447 ' N ' ' HA ' ' A' ' 94' ' ' SER . 65.9 m-85 -34.55 127.44 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.63 116.08 18.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.678 HG22 HG21 ' A' ' 103' ' ' THR . 57.9 t -123.64 115.94 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.88 -47.0 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.855 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.19 130.42 8.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.5 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.534 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -99.08 155.81 36.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.692 0.758 . . . . 0.0 110.875 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.2 Cg_endo -69.68 163.16 82.34 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.375 -0.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.678 HG21 HG22 ' A' ' 98' ' ' VAL . 26.5 m -142.36 106.29 4.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.2 mt -95.5 142.8 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.479 ' HB2' HG23 ' A' ' 50' ' ' ILE . 7.5 m-85 -134.52 179.14 6.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' LYS . 19.3 t80 -147.75 135.49 20.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.43 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 33.8 t -104.72 94.62 7.59 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.696 0.76 . . . . 0.0 110.814 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.476 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.74 159.68 52.52 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.67 2.247 . . . . 0.0 112.38 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.38 130.82 34.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.125 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 64.71 24.98 12.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.476 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 14.0 mtmt -131.75 18.31 4.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -44.25 -63.16 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.925 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -39.29 -32.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 1.9 t30 -134.02 98.31 14.48 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.647 0.737 . . . . 0.0 110.891 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.49 ' CD ' ' HG2' ' A' ' 95' ' ' PRO . 54.2 Cg_endo -69.75 179.24 3.83 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -134.77 125.18 26.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -90.65 146.22 24.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -83.92 121.87 27.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -122.24 104.09 9.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.91 -170.39 43.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.478 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.74 141.26 26.19 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.508 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.89 47.31 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 110.844 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 124' ' ' LEU . 27.2 tt0 -102.02 129.45 48.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.447 HD21 ' N ' ' A' ' 70' ' ' LEU . 2.4 tm? -33.75 -54.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.7 t -60.74 -47.1 87.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -44.35 -42.02 6.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.457 ' HB2' HD13 ' A' ' 70' ' ' LEU . 62.8 m-85 -68.31 -44.52 75.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.858 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.06 -53.12 52.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 t -65.31 -39.5 92.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.53 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 36.4 t80 -56.71 -53.07 61.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.841 HD21 HD13 ' A' ' 49' ' ' LEU . 68.3 mt -67.21 -42.9 83.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 131' ' ' LEU . 16.3 mt-30 -36.96 -40.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -99.15 -61.68 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.53 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 11.3 mm-40 -42.2 -54.2 3.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.72 132.0 30.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.58 -75.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.9 t -48.7 -62.07 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.451 179.979 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.468 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.5 p90 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.928 0.394 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.54 HD12 ' HB3' ' A' ' 17' ' ' LYS . 3.9 pp -94.79 -39.48 10.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.54 ' HB3' HD12 ' A' ' 16' ' ' LEU . 7.7 ptmt -116.49 156.93 26.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 76.8 p -160.61 149.58 16.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.437 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 10.2 mm-40 -92.53 161.3 32.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.62 0.724 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.437 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.74 141.17 44.59 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.372 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.465 HD13 ' CG2' ' A' ' 33' ' ' VAL . 13.3 mm -69.44 130.84 90.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.731 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 160.59 49.13 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.682 2.255 . . . . 0.0 112.369 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.89 -38.65 13.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -141.77 105.3 4.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -122.65 46.56 2.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -87.5 39.48 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.12 -160.57 36.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.476 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -42.84 3.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 0.0 112.362 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.565 HG13 HG22 ' A' ' 82' ' ' ILE . 10.9 t -116.57 104.72 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -52.83 135.39 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.0 t -84.23 120.69 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.176 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.159 HG11 HG23 ' A' ' 41' ' ' VAL . 12.9 t -119.45 115.32 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.117 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 35' ' ' GLU . 27.9 m -111.52 141.71 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -30.44 -38.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 33' ' ' VAL . 6.7 mt-10 -56.3 -51.51 67.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 33' ' ' VAL . 53.1 p-10 -110.48 24.76 12.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.765 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 13.1 t80 -63.19 -51.15 67.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -4.95 18.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.831 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -92.17 -43.84 9.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.3 mt -97.11 -61.16 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.107 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.159 HG23 HG11 ' A' ' 32' ' ' VAL . 78.5 t -53.16 -62.17 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -65.46 120.18 12.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.435 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 4.1 t-20 -174.94 119.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.431 ' CA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -104.93 32.44 4.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -127.7 -31.22 2.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 14.3 pttp -138.29 136.95 36.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.81 138.6 53.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.57 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 40.9 t -137.31 159.13 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.51 ' N ' HG12 ' A' ' 48' ' ' VAL . 16.1 tp -140.21 132.17 27.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.923 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' A' ' 96' ' ' TYR . 3.3 tp -116.21 141.36 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.175 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.545 ' OE2' ' CG ' ' A' ' 67' ' ' TYR . 2.5 tt0 -125.49 118.74 26.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -98.9 108.42 21.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -115.75 -179.15 3.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.779 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -133.73 132.98 21.9 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 0.0 111.085 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 -1.01 7.74 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -126.31 5.79 7.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.779 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -99.89 129.47 45.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.836 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.16 -45.9 14.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.46 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -48.32 -27.72 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.836 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.0 m -80.13 -44.0 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -55.29 -42.33 73.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -70.49 -20.54 62.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.946 HD12 ' HB2' ' A' ' 66' ' ' LYS . 8.4 tp -94.22 -23.16 18.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.557 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 5.1 tt0 -33.71 -57.13 0.64 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 0.0 110.914 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.78 -27.29 26.54 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.721 2.281 . . . . 0.0 112.328 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.946 ' HB2' HD12 ' A' ' 63' ' ' LEU . 2.7 mmpt? -72.39 -30.97 65.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.545 ' CG ' ' OE2' ' A' ' 51' ' ' GLU . 37.9 t80 -95.97 -40.09 9.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.471 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -55.66 -43.28 76.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -53.54 -53.42 51.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.463 ' N ' HD21 ' A' ' 124' ' ' LEU . 20.3 tp -43.45 -38.35 2.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.08 -64.56 3.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.97 -21.36 66.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.937 0.398 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -79.32 -45.05 20.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ASP . 78.6 mt -84.06 1.64 43.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 m -40.19 -27.94 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -85.0 25.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 74' ' ' LEU . 51.2 p-10 -103.9 93.41 5.29 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.618 0.723 . . . . 0.0 110.863 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 54.1 Cg_endo -69.78 0.58 5.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.334 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -122.91 -44.72 2.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.452 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 37.0 mt -87.71 144.59 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.5 t -136.0 107.38 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.179 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.565 HG22 HG13 ' A' ' 29' ' ' VAL . 38.2 mm -76.17 131.44 34.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.678 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -145.83 173.87 11.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.561 ' HG2' HG12 ' A' ' 29' ' ' VAL . 25.1 pttt -148.57 157.59 43.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.448 ' CB ' HD11 ' A' ' 50' ' ' ILE . 1.9 tmm? -149.59 148.11 28.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 90' ' ' ASN . 49.8 t0 -97.74 99.65 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.94 80.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 88' ' ' THR . 2.7 p -66.12 -17.27 64.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -117.89 -10.97 10.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.1 m-80 -139.62 107.63 5.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.41 ' HB3' ' CB ' ' A' ' 15' ' ' TYR . 7.0 t0 -42.27 138.06 1.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.516 HG21 ' CG2' ' A' ' 98' ' ' VAL . 74.6 t -80.51 128.32 72.83 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.625 0.726 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 54.4 Cg_endo -69.72 -165.64 0.16 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.723 2.282 . . . . 0.0 112.35 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.535 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 0.8 OUTLIER -127.44 154.59 77.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.655 0.741 . . . . 0.0 110.851 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.75 -6.03 9.19 Favored 'Cis proline' 0 N--CA 1.466 -0.13 0 C-N-CA 122.709 -1.788 . . . . 0.0 112.372 0.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.525 ' HE2' HG21 ' A' ' 50' ' ' ILE . 33.1 m-85 -33.01 137.45 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -151.63 120.89 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.843 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.516 ' CG2' HG21 ' A' ' 92' ' ' VAL . 39.7 t -113.42 110.07 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.11 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.8 -45.32 5.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -132.32 132.01 6.48 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.483 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.539 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -96.95 154.86 38.1 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.658 0.742 . . . . 0.0 110.899 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.0 Cg_endo -69.74 159.51 89.52 Favored 'Cis proline' 0 C--O 1.232 0.191 0 C-N-CA 122.696 -1.793 . . . . 0.0 112.379 0.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.457 ' OG1' HG13 ' A' ' 98' ' ' VAL . 93.4 m -137.98 111.55 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.147 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.451 HG12 ' CG ' ' A' ' 51' ' ' GLU . 86.9 mt -109.82 131.88 59.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -123.12 -176.38 3.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 29.1 t80 -152.82 132.22 12.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.887 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.2 t -103.6 96.31 8.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.69 0.757 . . . . 0.0 110.895 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.473 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.5 Cg_endo -69.68 168.26 21.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.719 2.279 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.404 ' HB3' HG21 ' A' ' 136' ' ' THR . . . -87.2 135.15 33.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 54.67 25.73 6.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.473 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 10.6 mtmt -129.53 21.59 5.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.513 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -49.33 -41.63 39.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -52.42 -39.7 61.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 7.6 m120 -134.74 97.97 13.69 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.593 0.711 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 54.3 Cg_endo -69.69 -170.63 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.674 2.249 . . . . 0.0 112.372 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -136.27 139.07 42.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -107.21 137.03 46.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.433 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 62.8 t80 -78.85 107.84 11.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -124.03 95.17 4.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.39 -139.52 3.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.95 128.52 9.18 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -79.7 49.52 1.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.761 0.315 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 124' ' ' LEU . 5.4 tp10 -112.74 132.46 55.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.563 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.5 tm? -34.44 -51.49 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.5 p -63.11 -53.22 56.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.17 -36.53 2.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.433 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 52.8 m-85 -68.91 -43.62 74.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.4 mt -55.89 -63.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.099 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.3 t -54.74 -36.54 64.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 44.3 t80 -55.18 -50.87 68.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.916 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.3 -42.15 69.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -43.61 -41.44 4.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.43 ' CG ' ' N ' ' A' ' 134' ' ' GLU . 12.9 ptm180 -91.57 -53.06 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.435 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 26.1 mm-40 -51.93 -62.87 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -37.41 105.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.078 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 137' ' ' SER . 1.8 t -49.84 -52.78 29.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.494 ' H ' HG23 ' A' ' 136' ' ' THR . 1.3 t -74.5 -41.51 60.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.465 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.879 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.972 0.415 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -106.3 -33.32 7.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.944 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.456 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 10.7 mtpp -101.57 163.86 12.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.0 p -166.5 134.28 2.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.726 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 2.4 mm-40 -98.24 161.63 24.75 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.887 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.9 Cg_endo -69.75 140.07 41.8 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.679 2.253 . . . . 0.0 112.336 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.604 HD13 HG21 ' A' ' 33' ' ' VAL . 15.8 mm -70.46 123.41 88.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 111.107 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 130.19 18.91 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.671 2.248 . . . . 0.0 112.35 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.21 -46.81 69.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 t -144.96 133.22 21.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -106.7 48.71 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -50.28 -33.16 18.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.07 164.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.445 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -22.99 31.29 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.674 2.249 . . . . 0.0 112.341 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.454 HG13 HG22 ' A' ' 82' ' ' ILE . 32.9 t -119.33 112.19 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -57.89 137.23 56.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.7 t -90.49 116.24 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.133 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.819 HG11 HG23 ' A' ' 41' ' ' VAL . 19.6 t -105.98 124.73 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 21' ' ' ILE . 15.8 m -118.66 148.16 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.879 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -38.1 -36.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.152 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -62.78 -50.64 70.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.486 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 11.4 p-10 -108.33 28.57 8.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.583 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 5.5 t80 -67.51 -55.78 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.835 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -66.11 -5.26 9.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -88.42 -43.11 11.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.43 HD12 HG22 ' A' ' 32' ' ' VAL . 18.1 mt -98.35 -54.14 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.127 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.819 HG23 HG11 ' A' ' 32' ' ' VAL . 40.4 t -56.09 -61.58 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -67.44 112.67 4.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' ND2' ' HE2' ' A' ' 46' ' ' LYS . 13.4 t-20 -173.23 105.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.85 4.64 47.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -90.69 -35.03 15.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HE2' ' ND2' ' A' ' 43' ' ' ASN . 45.9 pttt -138.52 151.95 47.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.9 136.1 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.61 136.01 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.127 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.8 tp -116.11 119.24 35.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 105' ' ' TYR . 2.3 tp -106.81 134.88 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.166 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -127.21 120.08 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -95.87 122.47 38.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CE1' ' OD1' ' A' ' 86' ' ' ASP . 13.1 p90 -124.4 -179.6 4.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.927 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.63 133.48 21.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.565 0.698 . . . . 0.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.426 ' HD2' HG21 ' A' ' 88' ' ' THR . 53.6 Cg_endo -69.73 -6.28 18.2 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.687 2.258 . . . . 0.0 112.347 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -122.89 21.92 9.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t -120.2 111.14 17.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.06 -47.71 6.43 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -46.68 -37.25 8.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.771 0.32 . . . . 0.0 110.858 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 34.7 t -63.46 -44.5 94.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.908 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -65.5 -42.16 92.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -72.68 -35.0 67.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' A' ' 66' ' ' LYS . 14.0 tp -81.97 -26.77 33.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.527 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.3 tt0 -38.08 -58.1 1.54 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.608 0.718 . . . . 0.0 110.926 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.7 Cg_endo -69.82 -31.11 20.91 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.625 2.217 . . . . 0.0 112.332 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HB2' HD12 ' A' ' 63' ' ' LEU . 29.0 mtpt -68.63 -30.0 68.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -92.42 -45.21 8.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.933 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -41.65 -58.96 1.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.947 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 70' ' ' LEU . 16.4 mt-10 -41.07 -61.64 0.96 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.487 ' N ' HD21 ' A' ' 124' ' ' LEU . 22.2 tp -38.06 -35.63 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.35 -68.77 1.52 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.494 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -66.08 -19.69 65.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -75.28 -41.38 57.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.607 HD12 HD11 ' A' ' 82' ' ' ILE . 92.6 mt -86.46 3.35 44.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.2 t -54.07 -34.46 60.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -6.23 5.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 5.9 t70 -102.83 100.37 16.4 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.629 0.728 . . . . 0.0 110.873 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.7 Cg_endo -69.79 0.78 5.18 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.706 2.271 . . . . 0.0 112.346 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -110.46 -34.81 6.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 74' ' ' LEU . 71.8 mt -93.43 126.98 45.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 84.1 t -124.47 110.92 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.125 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.607 HD11 HD12 ' A' ' 74' ' ' LEU . 49.9 mm -82.99 123.7 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.142 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -133.75 161.47 34.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -134.65 150.43 50.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.455 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 10.7 ttt -141.45 140.12 33.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.629 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 7.6 t0 -95.41 91.16 6.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.804 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -45.0 -49.18 11.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.1 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.426 HG21 ' HD2' ' A' ' 55' ' ' PRO . 1.2 p -55.73 -28.56 56.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.14 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.726 ' HB1' ' CG ' ' A' ' 19' ' ' GLU . . . -94.05 -12.43 28.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.455 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.5 OUTLIER -157.26 123.54 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.435 ' OD2' HD23 ' A' ' 16' ' ' LEU . 12.0 t0 -57.38 135.91 56.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.874 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.9 t -82.95 128.19 66.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.628 0.728 . . . . 0.0 111.087 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.663 2.242 . . . . 0.0 112.351 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 m -115.73 162.0 27.58 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.712 0.768 . . . . 0.0 110.84 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.78 -10.83 11.73 Favored 'Cis proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 -1.795 . . . . 0.0 112.319 0.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 95' ' ' PRO . 98.0 m-85 -35.25 133.9 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -141.83 118.56 11.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.492 HG22 HG21 ' A' ' 103' ' ' THR . 77.4 t -120.96 116.11 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.093 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -118.14 -44.64 2.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.34 123.42 5.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.509 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.536 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -98.31 154.89 37.43 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.674 0.75 . . . . 0.0 110.864 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.536 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.2 Cg_endo -69.74 162.08 84.8 Favored 'Cis proline' 0 C--O 1.231 0.162 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.327 -0.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.492 HG21 HG22 ' A' ' 98' ' ' VAL . 52.3 m -139.99 125.45 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.8 mt -116.25 138.57 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.54 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 8.8 m-85 -134.54 162.66 31.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.946 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -133.5 136.33 45.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 t -104.47 93.02 5.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.882 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.502 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.3 Cg_endo -69.68 151.87 69.6 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.403 ' O ' ' HE3' ' A' ' 111' ' ' LYS . . . -69.59 145.46 52.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.4 p30 44.83 25.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.502 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 24.9 mtmt -130.4 41.28 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -66.06 -51.37 58.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.862 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -48.19 -49.08 34.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 2.9 m120 -122.32 91.79 49.1 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 54.4 Cg_endo -69.74 -163.8 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.661 2.241 . . . . 0.0 112.362 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -145.6 132.42 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.54 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 17.2 ttpt -98.8 137.34 37.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -73.14 104.69 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -116.97 98.42 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.88 -144.63 6.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.452 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.53 130.73 10.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.503 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 -79.57 45.5 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.745 0.307 . . . . 0.0 110.866 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 124' ' ' LEU . 5.1 tp10 -106.42 132.83 51.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.628 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -37.37 -52.51 1.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.1 m -61.69 -43.04 99.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -51.78 -42.11 62.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -63.18 -40.59 97.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mt -60.16 -61.73 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.3 t -56.26 -32.57 64.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 20.8 t80 -57.9 -58.48 8.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.0 -39.1 92.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -41.32 -40.87 1.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.1 ptp180 -102.9 -38.11 7.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 71.6 mm-40 -67.03 -60.94 2.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -44.47 132.35 6.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.088 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.42 -75.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 t -49.73 -56.69 9.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.527 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.932 0.396 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.0 pp -116.36 -36.93 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' A' ' 18' ' ' SER . 6.6 ttpm? -119.78 163.25 17.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.508 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 85.7 p -165.12 155.57 13.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.459 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 4.4 mm-40 -103.3 162.23 20.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.652 0.739 . . . . 0.0 110.884 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.459 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.74 143.4 50.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 0.0 112.33 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 35' ' ' GLU . 17.3 mm -70.04 132.56 88.32 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.722 . . . . 0.0 111.12 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 142.77 48.69 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.721 2.281 . . . . 0.0 112.347 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.25 -36.44 61.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.901 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 p -119.99 113.92 21.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.879 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.431 ' CG ' ' HD2' ' A' ' 30' ' ' LYS . 10.1 t-20 -125.11 47.0 2.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -111.11 61.74 0.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.15 -165.22 11.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.448 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -40.94 4.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.684 2.256 . . . . 0.0 112.35 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.501 HG12 ' HG2' ' A' ' 84' ' ' LYS . 21.3 t -120.6 108.9 23.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HD2' ' CG ' ' A' ' 25' ' ' ASN . 1.5 mmmt -59.35 136.38 57.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.431 HG22 ' HE3' ' A' ' 84' ' ' LYS . 95.3 t -84.65 125.01 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.88 HG11 HG23 ' A' ' 41' ' ' VAL . 31.3 t -119.38 119.61 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.479 HG21 HD13 ' A' ' 21' ' ' ILE . 18.1 m -115.54 148.11 18.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.088 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -35.31 -38.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.111 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' A' ' 21' ' ' ILE . 15.7 mt-10 -59.71 -48.93 79.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.449 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 14.8 p-10 -111.44 30.16 7.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.739 ' CD2' HG21 ' A' ' 41' ' ' VAL . 15.4 t80 -68.48 -62.55 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.43 -8.8 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.56 -46.57 11.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.5 mt -97.46 -50.37 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.88 HG23 HG11 ' A' ' 32' ' ' VAL . 29.5 t -58.06 -60.88 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.104 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -76.16 125.34 28.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -169.13 105.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.28 -1.75 28.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -85.52 -46.63 10.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.01 166.62 23.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -83.12 151.0 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.41 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 9.3 t -141.82 149.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.155 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.695 HD13 HD21 ' A' ' 131' ' ' LEU . 6.4 tp -122.84 120.01 32.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.411 HD11 ' CB ' ' A' ' 85' ' ' MET . 2.3 tp -107.4 137.11 40.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.49 ' OE1' ' CG1' ' A' ' 104' ' ' ILE . 3.7 tp10 -127.34 107.42 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.909 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.402 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 39.7 m-85 -83.82 126.62 33.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.442 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 9.6 p90 -132.87 176.0 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.893 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.03 133.07 24.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.713 . . . . 0.0 111.073 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -4.09 13.33 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.355 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.508 ' CZ2' HG21 ' A' ' 88' ' ' THR . 6.0 p-90 -123.56 17.7 9.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 43.6 t -116.09 100.63 8.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -41.3 -51.1 4.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 58' ' ' GLY . 97.2 m-70 -37.4 -38.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.762 0.315 . . . . 0.0 110.855 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 64' ' ' GLU . 6.2 t -69.33 -51.34 37.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.52 -53.1 19.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -64.95 -18.09 64.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.688 HD12 ' HB2' ' A' ' 66' ' ' LYS . 45.8 tp -97.25 -18.41 19.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.585 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.5 tp10 -45.32 -55.12 12.44 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.69 0.757 . . . . 0.0 110.915 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.1 Cg_endo -69.83 -24.64 29.14 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 0.0 112.283 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.688 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -76.99 -33.25 57.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -90.0 -31.94 16.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -53.81 -56.49 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.914 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -41.98 -56.81 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.469 ' N ' HD21 ' A' ' 124' ' ' LEU . 37.7 tp -41.14 -40.52 1.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.87 -69.09 1.4 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.496 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -59.36 -20.3 53.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.926 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -76.78 -46.56 24.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.693 HD12 HD11 ' A' ' 82' ' ' ILE . 96.8 mt -86.65 1.98 50.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -48.75 -22.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.02 22.91 4.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.607 ' OD2' HD22 ' A' ' 74' ' ' LEU . 72.6 m-20 -108.63 99.24 32.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.657 0.742 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.4 Cg_endo -69.66 -0.82 7.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 0.0 112.36 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -117.62 -36.78 3.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.45 129.0 51.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.4 t -124.35 109.99 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.693 HD11 HD12 ' A' ' 74' ' ' LEU . 27.2 mm -80.36 133.57 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.146 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.754 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -147.65 169.12 20.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.501 ' HG2' HG12 ' A' ' 29' ' ' VAL . 40.2 pttt -136.4 153.16 51.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.411 ' CB ' HD11 ' A' ' 50' ' ' ILE . 14.4 ttt -146.46 135.72 22.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.442 ' OD1' ' CZ ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -91.76 83.88 5.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.876 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -43.16 -55.95 3.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.508 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 33.7 p -46.95 -32.39 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.168 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.38 -19.82 21.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.61 122.49 17.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -51.6 130.84 28.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.439 HG21 ' HB ' ' A' ' 98' ' ' VAL . 95.7 t -72.81 131.83 83.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.589 0.709 . . . . 0.0 111.108 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.602 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.7 Cg_endo -69.81 -168.43 0.28 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.665 2.243 . . . . 0.0 112.371 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.502 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -129.6 161.22 60.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.661 0.744 . . . . 0.0 110.828 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.9 Cg_endo -69.71 -3.11 7.43 Favored 'Cis proline' 0 C--N 1.341 0.182 0 C-N-CA 122.69 -1.796 . . . . 0.0 112.361 -0.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.473 ' N ' ' HA ' ' A' ' 94' ' ' SER . 83.6 m-85 -33.77 127.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -131.7 102.42 5.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.736 HG22 HG21 ' A' ' 103' ' ' THR . 74.8 t -105.82 115.5 47.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -114.65 -47.41 2.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.94 127.61 7.5 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.488 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.541 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -100.06 154.95 36.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 0.0 110.867 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.7 Cg_endo -69.75 157.9 91.53 Favored 'Cis proline' 0 C--O 1.231 0.166 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.369 -0.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.736 HG21 HG22 ' A' ' 98' ' ' VAL . 44.6 m -133.1 101.84 5.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.515 HD13 ' CE1' ' A' ' 127' ' ' PHE . 82.6 mt -95.18 125.55 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 7.8 m-85 -122.02 -176.98 3.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 41.6 t80 -150.91 136.25 17.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.8 t -105.52 92.42 5.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.491 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.78 155.63 65.38 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.668 2.246 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.89 128.55 33.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 67.43 25.02 8.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.491 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 14.0 mtmt -134.38 56.02 1.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 114' ' ' ASN . 31.4 mmtt -80.11 -56.27 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.9 mp -37.8 -28.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 112' ' ' LYS . 12.6 m120 -148.71 107.63 3.5 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.912 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.502 ' CD ' ' HG2' ' A' ' 95' ' ' PRO . 53.4 Cg_endo -69.77 -174.97 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.72 2.28 . . . . 0.0 112.336 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.2 120.82 29.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 105' ' ' TYR . 13.2 ttmm -94.38 130.19 40.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -76.71 111.52 12.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -124.68 98.23 5.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.53 -137.84 2.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.38 126.96 8.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.443 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 63.9 mtm-85 -78.92 45.47 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 110.863 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -101.97 138.56 38.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.522 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.4 tm? -42.3 -51.3 4.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.7 p -70.59 -32.16 69.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -61.89 -34.65 76.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.515 ' CE1' HD13 ' A' ' 104' ' ' ILE . 31.0 m-85 -71.19 -35.21 71.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.2 mt -68.43 -52.01 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -63.75 -26.03 68.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -69.24 -47.68 64.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.923 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.695 HD21 HD13 ' A' ' 49' ' ' LEU . 17.6 mt -77.0 -42.65 37.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.916 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' LEU . 15.1 mt-30 -37.48 -31.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 131' ' ' LEU . 22.2 mmm180 -104.1 -53.81 2.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -50.01 -58.5 5.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -38.77 116.64 0.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -33.91 -75.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -73.33 -55.31 6.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.464 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.871 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.6 p90 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.953 0.406 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.443 ' C ' HD12 ' A' ' 16' ' ' LEU . 2.9 pp -105.51 -41.24 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.42 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.9 tttp -96.78 160.83 14.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.462 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 93.0 p -168.2 150.16 5.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.834 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.493 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 8.7 mm-40 -104.52 161.53 22.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.64 0.733 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.71 142.88 49.36 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.723 2.282 . . . . 0.0 112.337 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.489 HD11 ' CB ' ' A' ' 35' ' ' GLU . 40.7 mm -72.56 129.14 87.5 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.627 0.727 . . . . 0.0 111.151 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 169.87 17.87 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -88.95 -37.11 15.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -156.34 134.81 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.445 ' CB ' ' HD3' ' A' ' 30' ' ' LYS . 41.1 m-20 -111.39 47.75 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -52.19 -33.22 39.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -41.99 166.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.32 36.42 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.698 2.265 . . . . 0.0 112.304 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.89 117.78 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.144 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.647 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 10.0 mmtm -64.99 132.57 49.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.898 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.9 t -86.51 102.8 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.139 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.008 HG11 HG23 ' A' ' 41' ' ' VAL . 40.4 t -95.95 127.18 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.145 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 21' ' ' ILE . 27.1 m -123.08 146.25 28.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.871 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -31.71 -44.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.09 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.489 ' CB ' HD11 ' A' ' 21' ' ' ILE . 23.9 mt-10 -53.71 -50.77 65.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 33' ' ' VAL . 12.1 p-10 -112.26 33.92 4.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.9 ' CD2' HG21 ' A' ' 41' ' ' VAL . 14.1 t80 -74.33 -58.46 3.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -62.53 -8.79 6.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.45 -43.9 11.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.4 mt -98.78 -52.99 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.008 HG23 HG11 ' A' ' 32' ' ' VAL . 45.8 t -57.01 -61.94 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.51 115.75 11.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -160.73 105.04 1.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -84.71 8.68 16.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -104.49 -43.44 5.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -129.64 159.8 35.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -78.51 148.08 33.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.1 t -146.54 122.36 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.121 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 105' ' ' TYR . 16.0 tp -99.0 116.33 30.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 tp -105.25 130.75 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.08 115.35 21.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -89.68 116.6 27.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.54 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 18.6 p90 -121.6 171.6 8.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.966 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.448 ' HB1' ' CE2' ' A' ' 56' ' ' TRP . . . -126.71 130.74 23.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.593 0.711 . . . . 0.0 111.104 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.414 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.3 Cg_endo -69.76 -8.52 23.8 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 0.0 112.364 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.448 ' CE2' ' HB1' ' A' ' 54' ' ' ALA . 2.2 p-90 -112.82 7.9 18.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.2 t -107.92 130.62 55.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.25 -52.6 39.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.551 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -37.81 -39.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -64.93 -55.66 17.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -42.55 -47.11 5.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -73.1 -23.4 60.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 66' ' ' LYS . 41.6 tp -87.9 -18.42 29.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.53 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -46.84 -58.29 7.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.642 0.734 . . . . 0.0 110.872 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.2 Cg_endo -69.76 -31.91 19.61 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.699 2.266 . . . . 0.0 112.351 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.496 ' HB2' HD12 ' A' ' 63' ' ' LEU . 44.1 mtpt -68.2 -32.29 72.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.415 ' O ' ' C ' ' A' ' 68' ' ' LYS . 42.1 t80 -89.76 -50.41 6.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.87 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 67' ' ' TYR . 12.1 ttmt -36.9 -61.63 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -40.98 -56.66 2.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.846 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.462 ' N ' HD21 ' A' ' 124' ' ' LEU . 19.1 tp -42.48 -36.82 1.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -55.99 -69.05 1.39 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.45 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -66.88 -23.34 65.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.382 . . . . 0.0 110.874 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -67.44 -45.46 75.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 82' ' ' ILE . 95.0 mt -85.82 3.74 40.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.5 p -52.4 -29.79 25.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -62.13 -7.57 4.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -103.57 101.08 21.58 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.619 0.723 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 1.67 4.22 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.338 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.476 ' C ' ' OD1' ' A' ' 47' ' ' ASP . 31.5 m120 -113.55 -39.92 3.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.9 mt -84.79 106.49 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.124 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.9 t -99.79 116.28 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.138 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 74' ' ' LEU . 31.7 mm -91.41 119.68 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.143 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.837 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -133.37 175.83 9.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.112 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -146.62 139.5 25.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.48 ' CE ' ' HB2' ' A' ' 90' ' ' ASN . 1.8 tmm? -134.5 149.83 50.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.54 ' OD1' ' CZ ' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -100.93 96.16 7.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.813 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -43.73 -66.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -40.69 -29.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -91.77 -30.67 16.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 15.8 m-80 -130.81 119.75 22.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.827 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -57.86 118.94 5.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.6 t -72.72 116.58 51.41 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.575 0.702 . . . . 0.0 111.134 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.7 Cg_endo -69.78 -172.08 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.65 2.233 . . . . 0.0 112.378 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.509 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -105.45 159.71 28.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.618 0.723 . . . . 0.0 110.858 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.6 Cg_endo -69.79 -20.85 10.59 Favored 'Cis proline' 0 C--O 1.232 0.177 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.297 0.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.482 ' C ' ' O ' ' A' ' 95' ' ' PRO . 93.6 m-85 -30.64 131.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.955 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.455 ' OE1' ' CZ ' ' A' ' 99' ' ' ARG . 13.7 mm-40 -141.92 119.27 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.881 HG22 HG21 ' A' ' 103' ' ' THR . 45.9 t -117.71 107.3 21.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.455 ' CZ ' ' OE1' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -125.41 33.1 5.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.59 113.66 0.29 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.533 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -97.72 155.09 37.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.664 0.745 . . . . 0.0 110.871 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.7 Cg_endo -69.79 145.54 79.79 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.651 -1.812 . . . . 0.0 112.334 0.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.881 HG21 HG22 ' A' ' 98' ' ' VAL . 9.8 m -122.57 124.29 43.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.475 HD12 ' NH1' ' A' ' 122' ' ' ARG . 27.7 mt -120.26 134.64 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.158 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.413 ' O ' HD12 ' A' ' 49' ' ' LEU . 10.8 m-85 -134.07 161.1 35.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -136.59 126.08 25.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 5.7 p -99.87 102.93 19.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.716 0.769 . . . . 0.0 110.815 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.501 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.4 Cg_endo -69.76 167.85 23.25 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.679 2.253 . . . . 0.0 112.352 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.448 ' O ' ' CE ' ' A' ' 111' ' ' LYS . . . -78.37 140.75 38.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.8 29.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.501 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.1 mtmt -130.36 48.44 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.465 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 6.5 mmpt? -70.81 -57.57 4.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 112' ' ' LYS . 54.9 mt -35.74 -43.09 0.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.417 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 3.4 m120 -132.61 95.67 19.78 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.651 0.739 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.7 Cg_endo -69.73 -164.44 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.719 2.28 . . . . 0.0 112.307 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -145.5 117.55 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.944 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -89.3 137.98 31.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.912 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.63 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 82.8 t80 -70.48 118.26 13.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -125.7 100.39 6.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.01 -155.38 25.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.18 139.58 22.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.472 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.475 ' NH1' HD12 ' A' ' 104' ' ' ILE . 53.4 mtt-85 -82.5 52.84 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.84 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 126' ' ' ASP . 13.0 tt0 -108.59 141.03 41.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.51 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.5 tm? -44.73 -50.93 9.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.7 p -69.8 -42.25 73.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.435 ' CG ' ' HB3' ' A' ' 123' ' ' GLU . 3.8 m-20 -49.44 -34.71 17.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.63 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 65.1 m-85 -73.03 -44.87 60.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.6 mt -57.21 -48.64 81.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.8 p -62.58 -46.94 85.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.508 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 5.1 t80 -56.03 -44.84 79.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.949 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.3 mt -72.56 -41.2 65.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -38.09 -40.49 0.49 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -97.84 -57.28 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.508 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 39.5 mm-40 -45.45 -58.71 3.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.65 153.71 27.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.088 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.05 -50.1 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 84.8 p -47.31 -54.93 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.824 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 m -115.53 89.5 3.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.902 0.382 . . . . 0.0 110.856 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.3 p -171.52 168.0 6.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.25 116.59 2.02 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.524 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 m -104.24 94.91 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.876 0.37 . . . . 0.0 110.893 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.2 t -47.37 -49.98 23.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.27 -157.03 49.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.504 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.427 ' O ' ' CG ' ' A' ' 9' ' ' ASP . 11.7 t80 -170.39 133.14 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 0.0 110.838 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 8' ' ' PHE . 39.4 m-20 -166.16 122.03 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.92 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.86 46.01 0.66 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.479 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 43.78 52.4 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.609 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -64.13 95.18 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.454 ' HE3' ' C ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -160.07 163.32 34.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.4 tpt85 -163.58 138.36 6.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 2.6 p90 -157.7 151.98 24.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 pp -108.56 -35.43 6.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 17.5 ttpt -110.61 154.27 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 4.8 m -159.75 143.94 14.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.437 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.2 mm-40 -89.97 161.56 37.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 0.0 110.888 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.437 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.9 Cg_endo -69.75 141.49 45.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.658 2.239 . . . . 0.0 112.343 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.689 HD13 HG21 ' A' ' 33' ' ' VAL . 36.1 mm -69.91 132.17 88.81 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.698 . . . . 0.0 111.15 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 142.02 47.07 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.681 2.254 . . . . 0.0 112.348 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -61.3 -32.38 72.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -166.35 133.99 2.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -110.75 54.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -81.43 58.13 3.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.63 -168.51 11.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.514 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.479 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 53.4 Cg_endo -69.75 -48.81 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.716 2.277 . . . . 0.0 112.355 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.81 127.6 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -73.08 134.79 44.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -84.63 113.25 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.147 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.862 HG11 HG23 ' A' ' 41' ' ' VAL . 22.0 t -109.35 117.92 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.12 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.689 HG21 HD13 ' A' ' 21' ' ' ILE . 18.2 m -110.64 152.05 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.163 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB2' ' HB2' ' A' ' 90' ' ' ASN . . . -41.03 -34.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.53 ' HB3' HD11 ' A' ' 21' ' ' ILE . 8.8 mt-10 -64.51 -45.81 85.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 29.3 p30 -114.11 34.5 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CE1' ' HG3' ' A' ' 93' ' ' PRO . 6.4 t80 -73.6 -56.99 4.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -66.99 -4.81 10.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -89.47 -42.94 11.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.2 mt -98.94 -46.42 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.141 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.862 HG23 HG11 ' A' ' 32' ' ' VAL . 97.2 t -65.0 -62.12 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -67.8 113.98 6.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -175.25 106.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.39 2.73 27.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -84.79 -43.53 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -135.31 150.64 50.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.36 148.29 41.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 81' ' ' VAL . 63.7 t -146.85 144.36 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 82' ' ' ILE . 14.5 tp -117.92 119.15 33.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.575 HG12 ' CE1' ' A' ' 52' ' ' PHE . 2.2 tp -101.46 129.78 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -119.53 111.45 18.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.575 ' CE1' HG12 ' A' ' 50' ' ' ILE . 34.7 m-85 -88.61 130.73 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -138.59 -175.12 4.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.631 ' HB1' ' CE2' ' A' ' 56' ' ' TRP . . . -142.43 133.74 12.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.605 0.716 . . . . 0.0 111.098 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -25.44 28.84 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.711 2.274 . . . . 0.0 112.345 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.631 ' CE2' ' HB1' ' A' ' 54' ' ' ALA . 2.2 p-90 -84.54 -28.13 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 4.6 t -68.73 138.5 54.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.835 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.91 -35.06 7.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.45 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.535 ' CE1' ' HG3' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -71.58 -26.77 62.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.885 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.3 m -83.37 -37.3 23.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -62.39 -45.41 93.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -60.85 -9.53 4.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.842 HD12 ' HB2' ' A' ' 66' ' ' LYS . 11.9 tp -97.34 -22.53 16.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.529 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -34.6 -58.21 0.68 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.675 0.75 . . . . 0.0 110.887 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.5 Cg_endo -69.73 -24.57 29.65 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.715 2.276 . . . . 0.0 112.294 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.842 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.6 mmmp? -75.27 -27.04 59.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 63.6 t80 -94.8 -39.7 10.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.886 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.479 ' HG3' ' CG ' ' A' ' 28' ' ' PRO . 5.6 ttmm -46.22 -59.49 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.898 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -38.84 -60.15 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' N ' HD21 ' A' ' 124' ' ' LEU . 17.4 tp -38.39 -42.04 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.93 -58.74 12.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.515 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -70.5 -20.98 62.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 0.0 110.926 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -72.56 -46.31 55.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.54 HD12 HD11 ' A' ' 82' ' ' ILE . 97.0 mt -78.26 3.12 16.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.9 p -50.3 -25.0 3.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.835 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -79.09 11.62 2.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.922 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.43 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 4.6 t0 -117.82 97.95 51.2 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.566 0.698 . . . . 0.0 110.897 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.0 Cg_endo -69.72 -1.08 7.82 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.739 2.293 . . . . 0.0 112.311 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -109.77 -37.19 5.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.448 HD11 ' CB ' ' A' ' 135' ' ' ALA . 46.6 mt -93.8 133.26 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.078 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 48' ' ' VAL . 54.3 t -129.74 117.33 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.54 HD11 HD12 ' A' ' 74' ' ' LEU . 50.1 mm -86.39 134.77 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.114 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.775 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -147.26 167.16 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -135.67 155.02 51.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.484 ' CB ' HD11 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -148.87 132.05 16.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.899 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.756 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -84.83 94.96 8.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.87 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.04 -62.62 1.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.443 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -48.63 -35.06 12.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.756 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -80.78 -22.21 40.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.12 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -150.44 123.31 8.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -47.55 148.13 1.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.614 HG13 ' HD2' ' A' ' 93' ' ' PRO . 93.3 t -100.2 137.75 20.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.626 0.727 . . . . 0.0 111.14 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.614 ' HD2' HG13 ' A' ' 92' ' ' VAL . 53.9 Cg_endo -69.74 -163.81 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.654 2.236 . . . . 0.0 112.316 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.497 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -128.32 160.88 59.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.648 0.737 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.72 -6.45 9.36 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.328 -0.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.446 ' C ' ' O ' ' A' ' 95' ' ' PRO . 89.8 m-85 -34.35 121.14 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -127.58 131.9 49.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.803 HG22 HG21 ' A' ' 103' ' ' THR . 91.1 t -131.92 104.69 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -104.85 -39.62 6.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.86 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -128.21 132.48 7.37 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.461 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.543 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -100.03 154.24 37.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.637 0.732 . . . . 0.0 110.92 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.75 159.88 88.92 Favored 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.674 -1.802 . . . . 0.0 112.317 -0.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.803 HG21 HG22 ' A' ' 98' ' ' VAL . 44.4 m -135.02 102.97 5.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.1 mt -98.78 134.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.135 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.412 ' O ' HD12 ' A' ' 49' ' ' LEU . 8.9 m-85 -132.75 166.6 21.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -134.96 132.34 38.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.407 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 1.9 t -105.75 94.76 9.31 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.629 0.728 . . . . 0.0 110.864 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.46 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.8 Cg_endo -69.76 175.71 7.74 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.687 2.258 . . . . 0.0 112.357 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.27 137.08 32.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.31 25.59 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.46 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.2 mtmm -124.77 21.98 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.487 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 2.3 mptp? -50.85 -50.0 57.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -46.12 -38.92 8.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -134.26 91.48 22.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.602 0.715 . . . . 0.0 110.942 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -163.85 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.691 2.261 . . . . 0.0 112.344 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -142.26 145.51 34.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -119.6 117.87 29.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -57.33 111.47 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.931 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -125.12 91.56 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.5 -142.84 4.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.485 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.51 130.68 10.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 127' ' ' PHE . 45.4 mtm-85 -81.1 47.58 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 124' ' ' LEU . 4.1 tt0 -103.76 133.65 48.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 123' ' ' GLU . 3.1 tm? -34.17 -53.68 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.972 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 128' ' ' ILE . 14.8 m -67.2 -51.0 58.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -42.75 -31.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 122' ' ' ARG . 68.7 m-85 -76.74 -40.44 48.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' A' ' 125' ' ' SER . 32.3 mt -62.11 -55.99 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -57.79 -31.42 66.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.513 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 68.1 t80 -63.46 -45.06 92.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.964 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.1 mt -76.59 -39.13 53.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.945 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -46.63 -24.2 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.43 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.7 ptp85 -112.69 -37.02 5.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 2.9 mm-40 -70.01 -59.64 2.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.889 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.448 ' CB ' HD11 ' A' ' 80' ' ' ILE . . . -45.72 107.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.106 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 137' ' ' SER . 1.7 t -44.35 -50.55 9.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.432 ' N ' HG23 ' A' ' 136' ' ' THR . 46.1 m -68.64 -58.34 4.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.95 169.37 7.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.459 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 155.66 65.41 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.68 2.253 . . . . 0.0 112.35 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.8 p -56.44 -42.08 77.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.5 p -98.41 90.95 4.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.49 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.7 p -66.72 115.09 6.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.912 0.387 . . . . 0.0 110.88 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 t -111.26 158.59 18.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.45 164.31 10.0 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.515 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.7 p -114.92 150.71 35.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 0.0 110.856 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.2 t -69.54 169.06 13.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.849 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 137.68 -162.49 25.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.493 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -110.97 137.38 48.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.889 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 9' ' ' ASP . 0.9 OUTLIER -115.13 114.54 25.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.02 176.54 22.02 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.518 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -125.34 104.26 8.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 0.0 110.883 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 12' ' ' LEU . 5.6 mp -88.02 97.31 10.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.939 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -157.36 135.91 11.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.884 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -152.93 124.4 7.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.648 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 2.4 p90 -145.62 155.98 43.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 pp -104.27 -40.61 6.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 12.2 ttpt -109.1 154.73 21.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.1 p -155.59 144.74 20.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.459 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 3.8 mm-40 -91.77 161.23 34.42 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.638 0.732 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.459 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.7 Cg_endo -69.79 142.98 49.27 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.658 2.239 . . . . 0.0 112.366 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.49 HD13 ' CG2' ' A' ' 33' ' ' VAL . 40.2 mm -74.58 133.85 76.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 111.136 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 21' ' ' ILE . 54.0 Cg_endo -69.74 176.62 6.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.731 2.288 . . . . 0.0 112.326 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -101.54 -35.95 8.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.3 t -148.99 128.96 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -116.78 49.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.04 56.55 3.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.72 -171.89 13.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.489 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -38.71 7.47 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.687 2.258 . . . . 0.0 112.314 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.529 HG12 ' HG2' ' A' ' 84' ' ' LYS . 21.6 t -119.49 119.33 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.104 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.616 ' HZ1' HD13 ' A' ' 40' ' ' ILE . 1.6 mmmp? -68.97 125.73 27.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.1 t -74.81 124.33 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.765 HG11 HG23 ' A' ' 41' ' ' VAL . 42.0 t -123.9 125.65 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 35' ' ' GLU . 21.1 m -119.14 149.46 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.648 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.18 -42.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.064 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.529 ' HB2' HG23 ' A' ' 33' ' ' VAL . 9.4 mt-10 -55.57 -48.69 74.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' A' ' 33' ' ' VAL . 11.3 p-10 -114.08 38.85 2.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.588 ' CE1' ' HG3' ' A' ' 93' ' ' PRO . 4.6 t80 -77.95 -55.22 5.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.96 -11.12 55.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -83.28 -42.27 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.707 HD12 HG22 ' A' ' 32' ' ' VAL . 24.9 mt -99.24 -59.44 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.765 HG23 HG11 ' A' ' 32' ' ' VAL . 94.1 t -49.99 -62.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -66.46 115.77 6.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.84 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -173.75 110.37 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -87.17 -4.53 59.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -73.96 -48.47 30.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.87 153.91 51.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -67.67 142.25 56.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.8 t -137.52 143.79 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.468 HD23 HD12 ' A' ' 82' ' ' ILE . 31.1 tp -121.31 121.28 37.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.581 HD13 HG22 ' A' ' 41' ' ' VAL . 2.4 tp -109.76 133.4 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' OE1' ' C ' ' A' ' 52' ' ' PHE . 0.3 OUTLIER -124.0 118.22 26.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.869 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.43 ' C ' ' OE1' ' A' ' 51' ' ' GLU . 54.4 m-85 -95.0 114.93 26.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CE1' ' OD1' ' A' ' 86' ' ' ASP . 17.2 p90 -120.23 -179.19 3.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.404 ' HB3' ' CB ' ' A' ' 57' ' ' CYS . . . -136.76 134.49 19.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.578 0.704 . . . . 0.0 111.083 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.733 ' HD2' HG21 ' A' ' 88' ' ' THR . 53.6 Cg_endo -69.76 -11.05 30.04 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.708 2.272 . . . . 0.0 112.295 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -114.1 9.25 17.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.404 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . 48.4 t -106.32 113.27 26.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.71 -52.71 46.59 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.481 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -46.67 -39.13 10.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.731 0.301 . . . . 0.0 110.809 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 43.9 m -70.95 -39.84 72.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.912 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -40.58 76.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.894 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -73.21 -25.5 60.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.605 HD13 ' HB3' ' A' ' 122' ' ' ARG . 29.4 tp -83.24 -23.11 32.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.529 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -42.52 -57.88 4.23 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.623 0.725 . . . . 0.0 110.934 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.8 -36.03 11.43 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.679 2.252 . . . . 0.0 112.341 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HB2' HD12 ' A' ' 63' ' ' LEU . 17.1 mtpp -64.63 -28.34 69.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.434 ' OH ' HG23 ' A' ' 82' ' ' ILE . 57.0 t80 -93.04 -43.64 8.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -44.82 -58.52 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.925 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -41.64 -46.84 3.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.512 HD13 ' HB2' ' A' ' 127' ' ' PHE . 12.1 tp -53.32 -36.54 61.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.962 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -57.97 -57.04 21.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.17 -24.34 57.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.911 0.386 . . . . 0.0 110.911 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -72.14 -42.16 66.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 80' ' ' ILE . 81.3 mt -83.24 3.35 31.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.6 p -53.08 -39.67 63.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 17.6 tttt -57.88 -11.93 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.78 99.65 9.42 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.608 0.718 . . . . 0.0 110.859 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.5 Cg_endo -69.82 0.15 6.1 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.639 2.226 . . . . 0.0 112.332 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -109.98 -35.86 6.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.562 HG21 HD13 ' A' ' 74' ' ' LEU . 60.9 mt -90.61 104.08 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.46 110.02 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.468 HD12 HD23 ' A' ' 49' ' ' LEU . 50.2 mm -82.87 127.17 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.159 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.56 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -134.4 166.37 23.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.529 ' HG2' HG12 ' A' ' 29' ' ' VAL . 15.2 pttp -138.21 154.05 49.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.503 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 9.7 ttt -150.42 136.82 18.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.96 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 4.0 t70 -92.75 94.96 9.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -50.13 -64.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.733 HG21 ' HD2' ' A' ' 55' ' ' PRO . 1.2 t -41.63 -26.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.117 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -96.68 -26.52 15.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.503 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -141.15 109.39 5.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -44.25 136.58 3.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.581 HG13 ' HD2' ' A' ' 93' ' ' PRO . 72.8 t -86.08 136.63 35.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.596 0.713 . . . . 0.0 111.144 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.588 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.4 Cg_endo -69.74 -167.76 0.24 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.712 2.275 . . . . 0.0 112.312 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.505 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -121.74 161.33 42.52 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.731 0.777 . . . . 0.0 110.83 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.0 Cg_endo -69.75 -9.24 10.89 Favored 'Cis proline' 0 C--O 1.232 0.223 0 C-N-CA 122.679 -1.801 . . . . 0.0 112.318 -0.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 95' ' ' PRO . 93.9 m-85 -33.98 126.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.905 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.82 128.35 36.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 103' ' ' THR . 88.6 t -127.5 94.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -116.18 28.89 8.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.825 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.32 113.81 0.36 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.543 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -98.09 153.64 38.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.659 0.742 . . . . 0.0 110.874 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.77 156.5 92.79 Favored 'Cis proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 -1.79 . . . . 0.0 112.339 0.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.555 HG21 HG22 ' A' ' 98' ' ' VAL . 6.7 m -135.0 128.18 31.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.424 HD13 ' HE1' ' A' ' 127' ' ' PHE . 36.6 mt -123.36 136.65 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.549 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 9.8 m-85 -136.45 144.29 44.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -119.72 129.72 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -99.96 101.05 12.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.843 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.495 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.3 Cg_endo -69.76 168.09 22.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.706 2.27 . . . . 0.0 112.342 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.12 137.23 33.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 0.7 OUTLIER 51.86 24.94 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.495 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.2 mtmt -129.3 38.42 3.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.468 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 5.8 mmpt? -63.35 -59.34 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 112' ' ' LYS . 11.0 mp -35.41 -36.84 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 2.3 t-20 -134.47 96.82 14.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.642 0.734 . . . . 0.0 110.839 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.9 Cg_endo -69.72 -178.44 2.33 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.661 2.24 . . . . 0.0 112.373 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 147.99 49.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.549 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 10.7 ttpt -118.43 125.92 50.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -67.86 115.65 7.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -123.5 102.84 8.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.63 -149.75 11.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.465 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.91 138.9 14.79 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.5 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.605 ' HB3' HD13 ' A' ' 63' ' ' LEU . 1.1 mpp_? -79.0 45.59 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.774 0.321 . . . . 0.0 110.829 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 124' ' ' LEU . 8.2 tt0 -101.64 128.32 47.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.566 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -34.14 -56.09 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.9 m -59.23 -45.92 89.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 130' ' ' TYR . 6.4 t0 -49.33 -39.97 33.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.512 ' HB2' HD13 ' A' ' 70' ' ' LEU . 58.6 m-85 -67.41 -41.41 84.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.486 HD11 ' CD1' ' A' ' 124' ' ' LEU . 23.4 mt -62.28 -65.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.089 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 m -56.25 -34.8 66.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.41 ' CB ' ' O ' ' A' ' 126' ' ' ASP . 14.6 t80 -57.22 -45.73 83.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.943 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.93 -35.44 32.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -38.56 -41.85 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -98.11 -57.98 2.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -44.17 -56.76 3.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.0 105.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.133 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.423 HG23 ' N ' ' A' ' 137' ' ' SER . 1.6 t -40.41 -49.96 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 136' ' ' THR . 16.6 m -113.14 40.54 2.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.802 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -66.07 -173.78 5.11 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 148.09 64.48 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.6 p -174.14 113.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.5 m -95.91 83.74 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.531 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 m 48.51 48.43 19.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.843 0.354 . . . . 0.0 110.821 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 m -163.27 144.93 9.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.08 179.19 40.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.519 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 t -157.69 147.82 20.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.3 p -99.5 -59.1 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.48 -133.88 8.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.533 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -99.78 110.79 23.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.343 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.401 ' CG ' HD21 ' A' ' 113' ' ' LEU . 2.9 p30 -163.61 150.25 11.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' C ' HD23 ' A' ' 12' ' ' LEU . . . -170.95 -39.83 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.511 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.41 ' C ' HD23 ' A' ' 12' ' ' LEU . 7.6 p30 -92.56 91.05 7.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.866 0.365 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.591 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -140.38 107.02 5.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.91 -179.72 3.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.425 ' HD3' ' N ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -170.56 136.56 1.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.3 p90 -151.46 148.04 27.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.727 HD23 ' CG ' ' A' ' 91' ' ' ASP . 1.2 pt? -95.7 -35.7 11.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.502 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 10.5 ptmt -117.34 176.36 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.3 p -174.99 150.5 1.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.824 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 12.1 mm-40 -96.6 159.15 32.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 0.0 110.853 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 141.91 46.68 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.561 HD13 HG21 ' A' ' 33' ' ' VAL . 20.2 mm -69.47 131.43 90.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.565 0.698 . . . . 0.0 111.135 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 141.52 45.52 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.671 2.247 . . . . 0.0 112.394 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.1 -34.88 74.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.1 t -156.88 137.21 12.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -121.21 48.2 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.65 52.21 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.39 -167.08 13.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -41.59 4.1 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.668 2.245 . . . . 0.0 112.361 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.72 128.23 74.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.106 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.559 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 12.5 mmmt -74.9 117.33 16.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.581 HG22 ' HE3' ' A' ' 84' ' ' LYS . 78.5 t -73.48 122.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.95 HG11 HG23 ' A' ' 41' ' ' VAL . 39.8 t -115.81 124.31 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.116 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.561 HG21 HD13 ' A' ' 21' ' ' ILE . 30.6 m -115.84 146.06 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.151 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.449 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -34.34 -42.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.071 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.559 ' HB3' HD11 ' A' ' 21' ' ' ILE . 6.7 mt-10 -55.5 -47.2 76.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' VAL . 21.1 p-10 -114.07 33.42 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.781 ' CD2' HG21 ' A' ' 41' ' ' VAL . 13.5 t80 -72.2 -58.28 3.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -64.55 -6.09 6.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -89.31 -46.44 8.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 mt -97.11 -46.05 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.95 HG23 HG11 ' A' ' 32' ' ' VAL . 50.0 t -63.44 -58.82 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.134 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -78.08 124.68 28.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.738 HD21 HG23 ' A' ' 48' ' ' VAL . 5.1 p-10 -175.59 108.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.961 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.419 ' CD ' ' HA ' ' A' ' 110' ' ' ASN . 2.1 mm-40 -83.05 20.25 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -106.75 -39.55 5.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.503 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 16.8 pttm -137.74 166.6 23.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -94.17 139.24 31.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.738 HG23 HD21 ' A' ' 43' ' ' ASN . 23.4 t -136.33 148.18 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.815 HD12 ' O ' ' A' ' 105' ' ' TYR . 6.6 tp -116.51 109.86 17.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 tp -91.64 135.73 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.076 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' OE2' ' C ' ' A' ' 52' ' ' PHE . 1.9 tm-20 -127.02 117.85 23.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.448 ' C ' ' OE2' ' A' ' 51' ' ' GLU . 45.8 m-85 -93.32 124.33 37.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -128.84 -175.02 3.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.787 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -139.1 131.66 15.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.594 0.711 . . . . 0.0 111.091 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -3.09 11.32 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.688 2.259 . . . . 0.0 112.327 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.552 ' NE1' HG21 ' A' ' 88' ' ' THR . 6.7 p-90 -119.45 -3.37 10.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.787 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -93.44 133.5 36.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.93 -41.83 93.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.484 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -51.62 -28.06 13.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 64' ' ' GLU . 42.5 t -69.97 -44.73 68.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -62.81 -44.07 97.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -72.15 -34.41 68.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 66' ' ' LYS . 29.8 tp -84.6 -19.19 33.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.9 OUTLIER -45.3 -58.3 6.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.676 0.75 . . . . 0.0 110.89 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.72 -30.85 21.82 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.337 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.535 ' HB2' HD12 ' A' ' 63' ' ' LEU . 27.2 mtmm -70.06 -26.84 64.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.924 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -95.75 -41.89 8.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -48.84 -58.85 4.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.449 ' CD ' ' O ' ' A' ' 65' ' ' PRO . 1.2 mp0 -39.27 -51.25 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.408 ' N ' HD21 ' A' ' 124' ' ' LEU . 26.2 tp -48.65 -40.13 26.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.958 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.47 -55.11 30.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.444 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -67.06 -28.1 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.94 0.4 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.51 -45.36 54.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.604 HD12 HD11 ' A' ' 82' ' ' ILE . 94.2 mt -83.14 3.04 32.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.918 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.3 t -49.97 -25.39 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.32 21.91 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.42 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 0.9 OUTLIER -104.48 98.08 13.71 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.603 0.716 . . . . 0.0 110.837 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.6 Cg_endo -69.79 -4.29 13.75 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.658 2.239 . . . . 0.0 112.332 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -116.41 -39.77 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.8 mt -96.9 140.43 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 48' ' ' VAL . 72.0 t -138.43 114.56 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.115 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.604 HD11 HD12 ' A' ' 74' ' ' LEU . 44.5 mm -81.51 126.78 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -136.67 164.58 27.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.075 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.581 ' HE3' HG22 ' A' ' 31' ' ' VAL . 24.1 pttt -136.75 138.3 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.4 ttt -134.96 143.42 46.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 26.9 t0 -92.92 115.21 27.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 89' ' ' ALA . . . -68.89 -70.73 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.114 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.552 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -42.43 -23.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.606 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -99.03 -31.81 11.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 14.4 m-80 -129.14 111.38 12.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.727 ' CG ' HD23 ' A' ' 16' ' ' LEU . 8.3 t0 -45.92 129.55 9.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -77.41 130.23 75.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 0.0 111.16 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.6 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.7 Cg_endo -69.73 -163.86 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.678 2.252 . . . . 0.0 112.317 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -130.61 161.47 60.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.636 0.732 . . . . 0.0 110.872 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.3 Cg_endo -69.74 -4.62 8.38 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.733 -1.778 . . . . 0.0 112.301 -0.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 95' ' ' PRO . 78.8 m-85 -33.27 125.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -125.09 132.46 53.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.473 HG22 HG21 ' A' ' 103' ' ' THR . 38.6 t -143.42 124.34 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -129.65 -39.31 1.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.47 123.31 5.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.484 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.538 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.5 154.82 37.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.664 0.745 . . . . 0.0 110.89 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.538 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.6 Cg_endo -69.8 161.75 85.65 Favored 'Cis proline' 0 C--O 1.232 0.186 0 C-N-CA 122.676 -1.801 . . . . 0.0 112.334 0.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.473 HG21 HG22 ' A' ' 98' ' ' VAL . 62.5 m -140.1 109.82 6.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.3 mt -104.12 134.0 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.182 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.815 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.9 m-85 -129.86 177.36 7.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.405 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.6 t80 -145.3 129.0 17.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.78 97.73 8.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.669 0.747 . . . . 0.0 110.851 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.501 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.5 Cg_endo -69.75 167.56 24.08 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 2.246 . . . . 0.0 112.328 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -83.12 137.63 34.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.108 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.0 OUTLIER 48.14 27.89 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.501 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.3 mtmm -129.4 29.78 5.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -53.87 -57.14 12.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.922 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.401 HD21 ' CG ' ' A' ' 9' ' ' ASP . 68.9 mt -43.3 -48.37 6.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -119.13 87.48 34.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.632 0.729 . . . . 0.0 110.851 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -163.9 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.716 2.277 . . . . 0.0 112.287 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -149.79 131.78 15.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 105' ' ' TYR . 21.6 tttt -102.49 136.46 42.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 70.2 t80 -66.42 110.93 3.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.32 97.31 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.88 -151.83 11.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.96 142.49 23.39 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.451 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -87.28 43.22 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 124' ' ' LEU . 2.7 tp10 -104.52 131.08 52.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 123' ' ' GLU . 2.8 tm? -34.07 -56.65 0.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 72.7 m -59.59 -50.73 72.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -46.6 -36.61 7.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 65.7 m-85 -70.3 -43.7 69.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.1 mt -58.73 -58.49 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.158 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.53 -31.36 69.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.469 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 52.2 t80 -60.31 -53.33 58.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' GLN . 43.7 mt -70.81 -39.78 72.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' LEU . 28.5 mm-40 -35.62 -36.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.8 mmp_? -106.77 -57.63 2.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.469 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 68.6 mm-40 -42.23 -49.5 4.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -61.66 109.57 1.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -33.99 -74.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.4 t -75.59 56.66 0.91 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.831 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -42.84 147.81 0.67 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.43 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 158.11 58.05 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.653 2.236 . . . . 0.0 112.373 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.1 t -72.57 158.28 35.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.836 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.4 t 57.52 45.89 18.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.848 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.5 p -115.03 147.81 39.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.369 . . . . 0.0 110.856 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 t -116.38 122.1 43.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.839 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.27 -95.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.8 p -58.65 149.01 27.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.856 0.36 . . . . 0.0 110.871 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.5 m -100.58 -55.97 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.811 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.81 -86.39 1.02 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.45 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 47.31 46.95 16.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 0.0 110.853 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -112.98 146.44 39.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.01 83.56 0.36 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.46 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -117.89 -13.35 10.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.354 . . . . 0.0 110.868 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.35 40.12 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -163.01 146.74 11.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 15' ' ' TYR . 1.8 tmm_? -173.55 118.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.733 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.6 p90 -142.72 157.23 44.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 17' ' ' LYS . 3.5 pp -103.86 -38.89 6.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 18' ' ' SER . 51.0 tttt -111.86 163.77 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.664 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 45.4 p -166.0 156.95 13.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.453 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 10.6 mm-40 -103.91 161.38 23.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.626 0.727 . . . . 0.0 110.865 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.7 144.15 53.42 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.694 2.263 . . . . 0.0 112.345 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.519 HD13 ' CG2' ' A' ' 33' ' ' VAL . 42.9 mm -74.92 130.95 79.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.73 . . . . 0.0 111.154 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 157.81 59.17 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.736 2.291 . . . . 0.0 112.321 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -70.77 -45.83 64.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.4 m -135.66 135.65 40.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -128.22 30.44 5.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.05 48.31 1.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.861 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.44 -162.95 18.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -40.65 5.07 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.326 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.685 HG11 ' HB3' ' A' ' 84' ' ' LYS . 74.2 t -120.01 119.68 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -66.77 113.75 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.6 t -73.04 108.24 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.061 HG11 HG23 ' A' ' 41' ' ' VAL . 39.2 t -106.77 128.03 61.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.129 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.519 ' CG2' HD13 ' A' ' 21' ' ' ILE . 26.9 m -122.25 148.99 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.733 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.84 -40.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 33' ' ' VAL . 16.0 mt-10 -56.42 -48.18 77.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 33' ' ' VAL . 22.0 p30 -115.12 35.41 4.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.617 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 15.7 t80 -75.17 -56.06 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.75 -5.02 10.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.834 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -92.23 -45.71 8.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.4 mt -96.88 -58.95 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.061 HG23 HG11 ' A' ' 32' ' ' VAL . 61.0 t -50.88 -60.83 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.126 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -70.62 115.16 9.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -167.28 111.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -88.49 6.61 36.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -92.19 -40.72 10.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 155.69 48.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.4 151.47 46.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.1 t -146.32 146.47 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.64 HD23 HD12 ' A' ' 82' ' ' ILE . 20.6 tp -125.15 127.75 47.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.937 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 105' ' ' TYR . 2.5 tp -109.15 140.55 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.139 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 1.9 tt0 -126.95 107.59 10.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -85.82 110.57 19.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -119.26 167.93 11.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.42 127.97 24.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.599 0.714 . . . . 0.0 111.094 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -6.63 19.04 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.444 ' NE1' HG21 ' A' ' 88' ' ' THR . 7.2 p-90 -118.67 14.41 13.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.948 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.2 t -117.09 123.41 46.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -61.71 -61.37 6.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.508 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -39.65 -37.12 0.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.341 . . . . 0.0 110.853 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 81.8 m -74.98 -39.09 61.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' GLY . 5.4 ttmt -62.55 -35.73 80.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -73.86 -22.21 59.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 66' ' ' LYS . 18.7 tp -88.15 -23.71 23.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.532 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.4 tt0 -37.93 -58.14 1.47 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.635 0.731 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.75 -34.32 14.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.704 2.27 . . . . 0.0 112.334 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.682 ' HB2' HD12 ' A' ' 63' ' ' LEU . 20.1 mtpp -66.39 -24.98 66.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 55.5 t80 -96.07 -38.86 10.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -47.78 -56.51 7.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.46 -56.1 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 127' ' ' PHE . 24.4 tp -40.61 -42.04 1.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.39 -68.88 1.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.54 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.87 -25.81 61.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.374 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -74.69 -39.53 61.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.952 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.501 HD22 ' OD2' ' A' ' 77' ' ' ASP . 95.1 mt -88.96 1.73 55.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.3 t -51.51 -20.86 2.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -91.41 18.34 7.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.918 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.501 ' OD2' HD22 ' A' ' 74' ' ' LEU . 97.1 m-20 -109.55 99.9 39.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.59 0.709 . . . . 0.0 110.89 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.9 Cg_endo -69.71 -1.33 8.24 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.721 2.28 . . . . 0.0 112.354 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.07 -35.13 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.883 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 51.0 mt -99.21 142.2 15.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.02 106.97 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.095 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.64 HD12 HD23 ' A' ' 49' ' ' LEU . 47.3 mm -74.36 126.43 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.742 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -130.59 169.14 15.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.043 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.685 ' HB3' HG11 ' A' ' 29' ' ' VAL . 10.6 ptpp? -137.67 135.69 36.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.468 ' CB ' HD11 ' A' ' 50' ' ' ILE . 18.0 ttt -141.38 143.84 34.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.922 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 10.3 t0 -98.63 117.92 34.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.46 -59.24 3.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.444 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -56.03 -21.23 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.109 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.922 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -99.79 -25.13 14.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 86' ' ' ASP . 4.5 m-80 -134.62 104.18 5.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -40.24 122.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.84 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.66 123.51 89.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.639 0.733 . . . . 0.0 111.107 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.8 Cg_endo -69.76 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.508 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.5 m -121.97 160.87 45.31 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.663 0.744 . . . . 0.0 110.848 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.76 -8.62 10.6 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.692 -1.795 . . . . 0.0 112.367 -0.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 95' ' ' PRO . 97.0 m-85 -34.14 123.08 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -130.45 115.34 16.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.781 HG22 HG21 ' A' ' 103' ' ' THR . 75.1 t -114.26 131.17 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 -50.05 1.02 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.88 125.77 6.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.464 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.528 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -96.77 154.71 38.28 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 0.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.528 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.73 154.96 93.38 Favored 'Cis proline' 0 C--O 1.232 0.207 0 C-N-CA 122.666 -1.806 . . . . 0.0 112.392 -0.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.781 HG21 HG22 ' A' ' 98' ' ' VAL . 61.2 m -132.78 102.11 5.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.157 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.424 HG12 ' CG ' ' A' ' 51' ' ' GLU . 74.8 mt -95.9 138.52 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.537 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 9.4 m-85 -135.87 140.29 44.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.474 ' HA ' HD12 ' A' ' 49' ' ' LEU . 14.6 t80 -114.88 130.47 56.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 17.3 m -101.91 97.63 8.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.669 0.747 . . . . 0.0 110.861 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.492 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.74 170.06 17.45 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.662 2.241 . . . . 0.0 112.37 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -86.0 142.16 28.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.5 p30 46.11 25.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.492 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.5 mtmt -126.09 39.13 4.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.461 ' O ' ' C ' ' A' ' 113' ' ' LEU . 36.4 mmtt -65.55 -61.38 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.893 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 112' ' ' LYS . 19.7 mt -33.66 -38.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.93 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 7.1 m120 -134.31 99.75 13.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.624 0.726 . . . . 0.0 110.852 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.3 Cg_endo -69.75 178.5 4.5 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.705 2.27 . . . . 0.0 112.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.67 127.01 41.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.537 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 15.6 ttpp -100.99 123.53 45.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -60.38 113.57 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -124.37 95.96 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.7 -148.82 7.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.535 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.84 136.49 14.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.484 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -83.67 45.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 110.869 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 124' ' ' LEU . 3.7 tp10 -104.83 132.05 51.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.541 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.5 tm? -35.29 -53.06 0.63 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.0 m -63.63 -45.65 89.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -46.83 -42.58 17.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.556 ' HB2' HD13 ' A' ' 70' ' ' LEU . 74.5 m-85 -64.95 -46.82 79.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 mt -53.91 -59.66 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.1 t -59.1 -37.46 77.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.438 ' CD1' HD23 ' A' ' 131' ' ' LEU . 22.3 t80 -56.67 -55.2 37.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.954 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.483 HD12 HD11 ' A' ' 74' ' ' LEU . 18.3 mt -68.67 -38.07 80.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -47.47 -44.54 25.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -93.72 -46.48 7.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.7 -62.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 131' ' ' LEU . . . -39.2 105.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.063 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.585 HG23 ' H ' ' A' ' 137' ' ' SER . 1.3 t -42.45 -56.25 3.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.101 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.585 ' H ' HG23 ' A' ' 136' ' ' THR . 1.1 t -66.3 -44.22 84.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.98 158.9 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.432 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 133.2 24.95 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.69 2.26 . . . . 0.0 112.307 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.6 t -78.62 -62.62 1.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.2 p 40.03 41.95 1.02 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.858 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.501 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -117.75 42.41 2.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.875 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 t -161.75 156.81 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.53 136.63 9.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 p -166.14 155.66 11.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.915 0.388 . . . . 0.0 110.858 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.6 m -130.15 115.33 16.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.849 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.95 119.13 0.61 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.435 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -122.8 -58.89 1.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.863 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -96.69 -57.35 2.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.837 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.96 95.02 0.5 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -89.76 106.65 18.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 110.895 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.548 ' H ' HD12 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -118.05 33.12 5.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.65 139.07 34.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.6 tpp85 -169.3 129.3 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.828 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.523 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.4 p90 -158.37 148.33 19.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.549 ' H ' HD23 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -92.62 -38.23 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.521 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -116.38 174.35 6.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 88.0 p -170.95 165.6 7.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.521 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 6.4 mm-40 -113.56 160.2 32.6 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.611 0.72 . . . . 0.0 110.906 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 145.75 57.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.697 2.264 . . . . 0.0 112.326 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 35' ' ' GLU . 20.5 mm -69.42 134.96 88.71 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.659 0.742 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.42 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 53.7 Cg_endo -69.77 137.98 36.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.71 2.273 . . . . 0.0 112.324 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.36 -32.24 62.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.8 t -128.46 106.51 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.442 ' CG ' ' HD3' ' A' ' 30' ' ' LYS . 9.7 t-20 -111.35 46.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -110.93 49.43 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.876 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.25 -162.34 14.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -48.25 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.677 2.251 . . . . 0.0 112.321 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 84' ' ' LYS . 22.2 t -115.88 116.05 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' HD3' ' CG ' ' A' ' 25' ' ' ASN . 7.7 mmtt -57.42 123.82 16.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.411 HG22 ' HE3' ' A' ' 84' ' ' LYS . 95.9 t -76.88 109.63 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.919 HG11 HG23 ' A' ' 41' ' ' VAL . 29.0 t -107.31 123.99 62.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.069 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 36' ' ' ASN . 28.5 m -119.07 147.11 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -32.4 -45.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.14 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.61 ' HB3' HD11 ' A' ' 21' ' ' ILE . 7.0 mt-10 -52.93 -49.78 65.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 33' ' ' VAL . 12.2 p-10 -113.25 35.86 3.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.576 ' CD2' HG21 ' A' ' 41' ' ' VAL . 21.5 t80 -74.03 -59.18 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.64 -5.21 7.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -87.97 -43.46 11.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mt -98.98 -54.07 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.123 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.919 HG23 HG11 ' A' ' 32' ' ' VAL . 57.6 t -55.08 -62.02 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.121 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -69.74 122.01 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -173.87 105.5 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -87.24 38.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -131.27 -40.83 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -129.83 151.56 50.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -75.54 127.19 32.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.84 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.17 143.24 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.422 HD22 HD11 ' A' ' 131' ' ' LEU . 38.0 tp -119.28 126.66 52.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 85' ' ' MET . 2.2 tp -113.07 135.56 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.21 118.51 26.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.907 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -93.06 128.76 39.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.44 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 6.9 p90 -136.12 174.05 11.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.18 135.02 25.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.585 0.707 . . . . 0.0 111.121 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -7.86 22.14 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.721 2.281 . . . . 0.0 112.327 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -123.67 26.49 7.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 43.4 t -125.13 106.44 9.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -46.15 -66.07 1.82 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.504 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 58' ' ' GLY . 89.8 m-70 -35.33 -45.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.3 m -63.73 -50.2 70.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.34 -37.01 54.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -71.36 -27.82 63.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.457 ' O ' ' C ' ' A' ' 64' ' ' GLU . 12.2 tp -82.47 -32.69 28.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.8 OUTLIER -33.95 -58.12 0.61 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.651 0.739 . . . . 0.0 110.931 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.1 Cg_endo -69.82 -35.47 12.39 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.719 2.279 . . . . 0.0 112.27 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -65.3 -27.85 68.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.854 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -93.79 -41.61 9.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -46.74 -57.01 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -40.5 -48.48 2.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.456 ' N ' HD21 ' A' ' 124' ' ' LEU . 14.5 tp -52.2 -39.69 60.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.88 -48.6 69.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.501 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -74.95 -21.95 58.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.95 0.405 . . . . 0.0 110.895 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -79.56 -50.6 10.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.918 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 77' ' ' ASP . 79.8 mt -77.39 -2.02 33.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' LEU . 7.8 t -37.98 -29.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 74' ' ' LEU . 37.8 mtmt -87.1 29.56 0.82 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 74' ' ' LEU . 39.9 p30 -102.79 95.3 6.16 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.585 0.707 . . . . 0.0 110.851 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 54.0 Cg_endo -69.77 -2.83 10.84 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.71 2.273 . . . . 0.0 112.309 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -120.55 -45.46 2.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.45 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 44.3 mt -87.11 145.42 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.1 t -135.18 105.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.126 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.626 HG22 HG13 ' A' ' 29' ' ' VAL . 34.9 mm -73.53 131.03 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.669 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -145.93 160.64 41.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.632 ' HB3' HG11 ' A' ' 29' ' ' VAL . 43.4 pttt -132.53 160.34 36.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.558 ' CB ' HD11 ' A' ' 50' ' ' ILE . 18.4 ttt -151.37 132.39 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -91.44 85.96 5.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -41.6 -65.74 0.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 87' ' ' ALA . 25.7 p -36.34 -35.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.521 ' HB1' ' CG ' ' A' ' 19' ' ' GLU . . . -87.24 -36.37 17.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.504 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.4 OUTLIER -129.02 112.7 14.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -41.22 155.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -103.21 125.58 34.73 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.63 0.728 . . . . 0.0 111.123 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.469 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.5 Cg_endo -69.84 -164.94 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.248 . . . . 0.0 112.313 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.496 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -122.19 161.23 44.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.596 0.713 . . . . 0.0 110.892 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.76 -11.74 11.99 Favored 'Cis proline' 0 C--O 1.232 0.182 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.352 -0.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.45 ' C ' ' O ' ' A' ' 95' ' ' PRO . 81.2 m-85 -33.05 125.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -134.04 117.04 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.874 HG22 HG21 ' A' ' 103' ' ' THR . 83.7 t -119.53 108.73 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -106.25 -41.28 5.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.09 131.32 7.19 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.418 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.524 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.5 OUTLIER -97.28 155.63 37.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.679 0.752 . . . . 0.0 110.828 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.1 Cg_endo -69.79 162.14 84.81 Favored 'Cis proline' 0 C--O 1.232 0.207 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.352 0.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.874 HG21 HG22 ' A' ' 98' ' ' VAL . 84.1 m -142.22 116.06 9.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.176 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.637 HD13 ' HE1' ' A' ' 127' ' ' PHE . 27.5 mt -110.2 140.63 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 117' ' ' LYS . 11.9 m-85 -139.36 142.74 37.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.404 ' HA ' HD12 ' A' ' 49' ' ' LEU . 29.9 t80 -111.43 143.6 42.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.7 m -114.46 93.83 33.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.686 0.755 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.494 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.5 Cg_endo -69.77 167.86 23.23 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -84.25 136.8 33.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 0.8 OUTLIER 49.98 26.8 2.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.494 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 12.8 mtmm -128.97 39.25 3.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 7.7 mmpt? -67.98 -45.59 73.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.3 mp -50.85 -38.2 47.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -134.88 88.37 27.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.605 0.717 . . . . 0.0 110.845 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -171.76 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.724 2.282 . . . . 0.0 112.295 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -137.86 118.92 14.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 105' ' ' TYR . 22.3 tttt -91.47 120.22 32.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -55.04 112.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -123.68 101.01 7.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.9 -139.65 4.32 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.452 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.37 139.71 14.71 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.47 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.428 ' CZ ' ' HG3' ' A' ' 102' ' ' PRO . 26.8 mtp180 -83.88 43.79 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.883 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 124' ' ' LEU . 3.5 tp10 -102.05 129.65 48.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.6 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.3 tm? -34.02 -55.46 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.93 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.2 t -59.43 -50.15 75.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 130' ' ' TYR . 6.0 t0 -44.05 -35.72 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.637 ' HE1' HD13 ' A' ' 104' ' ' ILE . 80.8 m-85 -73.31 -37.98 66.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.557 HD11 ' CD1' ' A' ' 124' ' ' LEU . 30.5 mt -63.03 -61.42 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.124 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.85 -34.86 73.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 126' ' ' ASP . 44.8 t80 -57.46 -48.8 78.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.422 HD11 HD22 ' A' ' 49' ' ' LEU . 68.3 mt -75.68 -34.4 60.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -43.49 -38.86 3.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.46 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.2 ptm180 -101.03 -47.05 4.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.46 ' N ' ' HG3' ' A' ' 133' ' ' ARG . 16.6 mm-40 -52.63 -57.79 8.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -48.7 110.88 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -36.36 -71.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.163 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.6 t -59.48 -57.08 14.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.887 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.96 159.97 34.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.49 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 140' ' ' SER . 53.7 Cg_endo -69.72 -24.21 30.14 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.721 2.281 . . . . 0.0 112.383 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 139' ' ' PRO . 16.4 m 34.65 41.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.7 t -112.59 -52.66 2.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.888 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.463 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 t -98.43 152.63 19.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 110.842 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -82.96 98.66 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -125.25 75.08 0.4 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 m -66.24 -60.52 2.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 110.826 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 t 52.49 42.51 31.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.58 -175.8 14.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.462 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 59.45 43.43 16.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.867 0.365 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -126.11 128.0 46.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.83 158.34 3.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.507 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.821 ' O ' HD12 ' A' ' 12' ' ' LEU . 11.0 t-20 -108.81 24.18 13.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 110.867 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 11' ' ' ASN . 0.4 OUTLIER 37.35 50.81 1.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.28 71.05 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.878 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -123.97 124.08 41.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.3 p90 -159.22 164.69 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.527 ' H ' HD23 ' A' ' 16' ' ' LEU . 1.6 pt? -109.04 -38.62 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.52 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 30.3 tttt -112.61 149.54 32.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.607 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 52.7 p -161.72 146.5 13.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -94.3 158.8 35.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.707 0.765 . . . . 0.0 110.835 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 150.29 68.1 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.644 2.229 . . . . 0.0 112.357 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.489 HD13 ' CG2' ' A' ' 33' ' ' VAL . 39.2 mm -79.74 132.36 61.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.625 0.726 . . . . 0.0 111.132 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' HG23 ' A' ' 21' ' ' ILE . 53.4 Cg_endo -69.76 173.34 11.12 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -97.31 -34.41 11.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p -141.99 135.79 29.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -132.23 38.76 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -78.43 57.73 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.83 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.98 -170.73 13.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.494 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -40.41 5.42 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.715 2.276 . . . . 0.0 112.374 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.462 HG13 HG22 ' A' ' 82' ' ' ILE . 23.5 t -120.63 117.11 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -64.22 143.08 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.893 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.48 HG22 ' HE3' ' A' ' 84' ' ' LYS . 73.2 t -91.44 119.6 38.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.997 HG11 HG23 ' A' ' 41' ' ' VAL . 21.2 t -116.55 126.5 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 35' ' ' GLU . 29.1 m -122.34 156.9 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.154 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.607 ' HB3' ' CB ' ' A' ' 18' ' ' SER . . . -48.47 -20.05 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.537 ' HB2' HG23 ' A' ' 33' ' ' VAL . 5.1 mt-10 -76.54 -34.21 58.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -129.12 33.72 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.668 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 7.6 t80 -69.35 -52.96 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.84 -6.76 28.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -89.52 -43.45 10.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.4 mt -98.4 -61.89 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.997 HG23 HG11 ' A' ' 32' ' ' VAL . 60.5 t -47.9 -61.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.151 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.46 135.08 52.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -173.62 106.36 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.941 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -85.71 14.66 5.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -111.02 -41.94 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -137.18 164.11 29.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 63.7 m-20 -80.31 154.23 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.2 t -145.2 147.74 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.5 tp -119.09 129.74 55.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.917 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 85' ' ' MET . 1.8 tp -119.95 133.4 66.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.468 ' CG ' HG12 ' A' ' 104' ' ' ILE . 4.9 tm-20 -126.82 116.38 20.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -90.11 140.08 30.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.45 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 5.9 p90 -143.98 176.08 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -128.61 133.43 25.17 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.612 0.72 . . . . 0.0 111.072 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -8.28 23.21 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.748 2.298 . . . . 0.0 112.349 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.434 ' CZ2' HG21 ' A' ' 88' ' ' THR . 5.0 p-90 -118.32 21.73 12.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 2.5 t -123.34 110.51 15.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -49.27 -47.83 33.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.482 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -34.74 -45.89 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 110.839 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.1 t -70.91 -50.93 29.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.936 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -47.32 -34.08 6.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.852 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -86.77 -29.17 22.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.837 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.965 HD12 ' HB2' ' A' ' 66' ' ' LYS . 63.2 tp -83.13 -14.36 53.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.522 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.9 tt0 -46.08 -58.28 6.67 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.641 0.734 . . . . 0.0 110.943 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.1 Cg_endo -69.73 -17.53 37.64 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.644 2.229 . . . . 0.0 112.387 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.965 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.1 mmmp? -84.74 -30.17 24.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -93.67 -41.32 9.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -46.58 -56.63 5.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 70' ' ' LEU . 15.6 mt-10 -42.02 -62.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.478 ' CD1' HG12 ' A' ' 128' ' ' ILE . 22.3 tp -37.16 -35.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.51 -57.06 19.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.504 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -75.38 -19.93 59.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.718 ' HD3' HD11 ' A' ' 124' ' ' LEU . 4.1 mtpm? -73.95 -45.07 52.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.662 HD21 HG23 ' A' ' 128' ' ' ILE . 90.0 mt -86.86 -2.4 58.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.3 t -39.63 -26.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 74' ' ' LEU . 9.3 ttpp -82.86 22.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 74' ' ' LEU . 42.2 p30 -102.93 95.51 6.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.628 0.728 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.6 Cg_endo -69.76 -0.83 7.47 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.656 2.238 . . . . 0.0 112.372 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.31 -44.45 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.482 HD11 ' CB ' ' A' ' 135' ' ' ALA . 15.7 mt -88.22 143.76 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.155 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.0 t -133.28 115.41 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.137 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 74' ' ' LEU . 30.8 mm -81.96 130.37 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.633 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -148.73 171.87 15.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.075 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.48 ' HE3' HG22 ' A' ' 31' ' ' VAL . 2.8 pttp -135.42 163.07 30.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.923 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.629 ' HB2' HD11 ' A' ' 50' ' ' ILE . 15.8 ttt -151.13 136.76 17.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -96.33 82.37 3.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -45.58 -58.35 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.434 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 22.8 p -46.77 -22.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.35 -18.47 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -144.74 108.44 4.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 90' ' ' ASN . 27.9 t70 -37.07 151.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -97.04 128.13 36.42 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.612 0.72 . . . . 0.0 111.12 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -173.34 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.6 m -118.7 160.54 39.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.658 0.742 . . . . 0.0 110.876 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.69 -8.97 10.66 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.353 -0.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 95' ' ' PRO . 81.3 m-85 -35.13 143.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -151.59 129.23 11.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.586 HG13 ' OG1' ' A' ' 103' ' ' THR . 45.4 t -132.89 117.98 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.6 -36.92 3.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.23 121.55 4.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.538 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.28 154.16 38.17 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.66 0.743 . . . . 0.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.538 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.4 Cg_endo -69.69 160.03 88.47 Favored 'Cis proline' 0 C--O 1.231 0.143 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.382 -0.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.586 ' OG1' HG13 ' A' ' 98' ' ' VAL . 34.2 m -137.48 113.81 10.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.468 HG12 ' CG ' ' A' ' 51' ' ' GLU . 16.8 mt -105.9 138.24 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.109 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.52 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 10.8 m-85 -132.88 173.03 11.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.961 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -142.97 127.35 17.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 t -100.51 99.64 10.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.639 0.733 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.76 178.84 4.16 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.701 2.268 . . . . 0.0 112.361 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.481 ' N ' ' OD1' ' A' ' 47' ' ' ASP . . . -92.93 131.05 38.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 11.4 p30 51.0 29.07 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.933 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.466 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.3 mtmm -128.05 23.0 6.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -50.72 -56.37 12.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.0 mt -39.78 -37.13 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -134.86 90.22 22.91 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.635 0.731 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -172.34 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.664 2.243 . . . . 0.0 112.358 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -139.34 128.16 23.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.52 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 4.8 ttpm? -94.44 124.24 38.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.534 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 67.8 t80 -55.75 105.14 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -115.9 100.89 8.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.6 -152.38 17.58 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.497 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.01 131.69 11.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.519 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.421 ' HB2' ' NH1' ' A' ' 122' ' ' ARG . 19.8 mtm105 -83.88 49.0 1.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.905 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 124' ' ' LEU . 13.0 tt0 -107.78 134.32 50.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.718 HD11 ' HD3' ' A' ' 73' ' ' LYS . 3.5 tm? -34.81 -52.69 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.8 m -67.73 -47.7 68.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -47.37 -36.16 9.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.534 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 58.6 m-85 -69.24 -42.65 75.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.914 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.662 HG23 HD21 ' A' ' 74' ' ' LEU . 23.1 mt -63.52 -53.34 46.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -63.57 -21.98 66.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.808 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.405 ' CD1' ' C ' ' A' ' 130' ' ' TYR . 6.1 t80 -72.22 -46.86 54.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.1 mt -76.56 -39.0 54.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -40.05 -42.49 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -97.13 -58.73 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -46.23 -56.36 5.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.482 ' CB ' HD11 ' A' ' 80' ' ' ILE . . . -45.29 120.56 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.48 -70.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.1 t -58.01 -44.16 87.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.89 160.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.475 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 167.38 24.56 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.647 2.231 . . . . 0.0 112.374 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 t -109.5 101.62 10.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -159.45 168.0 27.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.467 -179.971 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t 60.36 41.7 15.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 110.876 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.9 t -145.91 153.79 41.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.838 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 45.72 -105.77 0.1 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.477 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.0 m 49.9 42.29 24.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 110.829 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 t -112.88 119.2 37.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.888 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.01 117.81 0.78 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.486 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -139.72 110.58 6.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.873 0.368 . . . . 0.0 110.854 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.77 90.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.04 -107.98 1.12 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.436 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.63 78.33 1.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 0.0 110.893 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.48 37.08 2.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.927 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.92 144.93 3.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.41 128.79 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.835 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 2.4 p90 -147.7 172.19 14.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' A' ' 17' ' ' LYS . 4.0 pp -114.2 -36.14 4.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.525 ' HB3' HD12 ' A' ' 16' ' ' LEU . 10.1 ptmt -119.89 165.64 14.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.441 ' CB ' ' HG3' ' A' ' 35' ' ' GLU . 2.3 m -158.22 161.04 37.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.842 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 4.2 mm-40 -105.88 160.94 24.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.647 0.737 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 54.0 Cg_endo -69.78 137.66 35.94 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.361 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.714 HD13 HG21 ' A' ' 33' ' ' VAL . 19.6 mm -71.41 129.46 88.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.606 0.717 . . . . 0.0 111.155 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 128.36 15.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.659 2.239 . . . . 0.0 112.335 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -40.37 -41.23 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -162.66 138.57 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -107.98 74.49 0.95 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -92.03 50.25 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.23 -178.13 15.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.467 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -39.99 5.9 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.662 2.241 . . . . 0.0 112.375 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.431 HG13 HG22 ' A' ' 82' ' ' ILE . 22.9 t -109.09 119.77 59.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.64 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 5.6 mmtp -66.96 128.47 36.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -82.86 117.56 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.102 HG11 HG23 ' A' ' 41' ' ' VAL . 21.8 t -112.93 124.3 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.714 HG21 HD13 ' A' ' 21' ' ' ILE . 19.1 m -117.89 147.25 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.094 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -36.91 -40.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HB3' HD11 ' A' ' 21' ' ' ILE . 11.1 mt-10 -57.6 -49.02 77.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.466 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 17.7 p-10 -110.49 24.75 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.884 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.741 ' CD2' HG21 ' A' ' 41' ' ' VAL . 31.0 t80 -63.34 -55.51 23.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -67.14 -5.14 12.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -88.79 -45.61 9.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.456 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 21.5 mt -97.56 -59.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.121 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.102 HG23 HG11 ' A' ' 32' ' ' VAL . 38.7 t -49.16 -59.4 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.33 122.96 19.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 40' ' ' ILE . 16.5 m-80 -167.34 114.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.11 3.51 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.38 -40.92 6.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.24 140.79 48.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.73 149.21 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.09 137.64 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.147 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 106' ' ' PHE . 13.2 tp -110.34 125.64 53.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 tp -113.48 131.15 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' CG ' HG12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -125.58 109.53 12.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -84.84 128.97 34.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -128.79 179.9 5.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.24 128.55 17.44 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 0.0 111.136 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -6.75 19.36 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 4.1 p-90 -119.12 18.95 13.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.931 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 38.1 t -119.14 124.62 47.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.84 -61.73 7.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.514 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -42.8 -38.84 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.818 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.3 m -67.95 -44.26 77.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -64.76 -32.77 74.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -76.37 -21.7 55.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.767 HD12 ' HB2' ' A' ' 66' ' ' LYS . 18.4 tp -90.55 -18.63 24.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -41.19 -58.24 2.97 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.707 0.765 . . . . 0.0 110.943 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.73 -32.22 19.1 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.747 2.298 . . . . 0.0 112.331 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.767 ' HB2' HD12 ' A' ' 63' ' ' LEU . 26.6 mtpt -68.69 -28.58 66.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -92.9 -38.65 11.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -47.42 -61.11 2.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -40.44 -55.13 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.405 ' N ' HD21 ' A' ' 124' ' ' LEU . 30.8 tp -41.25 -39.21 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.54 -64.94 3.56 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.477 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.18 -16.13 50.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -81.0 -44.89 17.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.903 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.631 HD12 HD11 ' A' ' 82' ' ' ILE . 95.3 mt -83.75 3.06 35.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.2 t -54.7 -19.02 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.02 10.48 16.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 53.1 m-20 -110.61 98.63 38.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.552 0.692 . . . . 0.0 110.859 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.2 Cg_endo -69.84 0.18 6.08 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.704 2.269 . . . . 0.0 112.309 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -110.69 -30.87 7.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 55.1 mt -105.65 139.01 28.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.99 110.38 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.631 HD11 HD12 ' A' ' 74' ' ' LEU . 42.0 mm -79.11 134.7 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.687 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -146.81 173.75 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -143.52 143.01 31.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.4 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 5.8 ttt -132.89 139.26 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -93.45 82.84 4.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -44.54 -57.45 3.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 88' ' ' THR . 1.6 p -39.36 -27.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.195 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 87' ' ' ALA . . . -102.25 -29.79 11.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.109 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -120.51 120.38 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -55.66 116.83 3.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.922 HG11 HG23 ' A' ' 98' ' ' VAL . 90.9 t -68.72 111.7 9.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.588 0.709 . . . . 0.0 111.112 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.7 Cg_endo -69.82 -178.18 2.24 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.707 2.271 . . . . 0.0 112.351 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.507 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -97.57 159.37 31.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.855 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.509 ' O ' ' C ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.71 -27.29 6.88 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.734 -1.778 . . . . 0.0 112.353 -0.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.509 ' C ' ' O ' ' A' ' 95' ' ' PRO . 82.1 m-85 -28.51 111.16 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -117.5 84.07 2.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.922 HG23 HG11 ' A' ' 92' ' ' VAL . 99.2 t -77.21 106.69 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -129.65 25.81 5.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.52 115.57 0.37 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.503 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.546 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -98.74 154.2 37.54 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.644 0.735 . . . . 0.0 110.903 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.7 Cg_endo -69.64 151.34 91.03 Favored 'Cis proline' 0 C--O 1.232 0.208 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.392 -0.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -129.04 123.14 31.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.132 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.403 HG12 ' CG ' ' A' ' 51' ' ' GLU . 44.1 mt -119.3 126.65 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.464 ' CZ ' ' HE3' ' A' ' 117' ' ' LYS . 8.1 m-85 -126.78 154.54 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.414 ' HA ' HD12 ' A' ' 49' ' ' LEU . 8.6 t80 -125.83 129.76 50.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.865 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.9 t -101.88 97.59 8.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.694 0.759 . . . . 0.0 110.861 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.498 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.79 171.15 15.03 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.664 2.243 . . . . 0.0 112.335 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.471 ' C ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.11 133.4 34.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.471 ' CG ' ' C ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER 49.65 29.5 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.498 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 10.5 mtmm -130.93 6.69 4.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.94 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' N ' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -35.92 -53.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.0 mt -39.06 -52.27 1.84 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 5.5 t30 -120.92 94.93 49.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.625 0.726 . . . . 0.0 110.906 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.7 Cg_endo -69.76 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.729 2.286 . . . . 0.0 112.332 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -142.03 110.5 6.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.464 ' HE3' ' CZ ' ' A' ' 105' ' ' TYR . 31.5 tttt -71.53 144.29 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.903 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.437 ' CZ ' ' CE1' ' A' ' 127' ' ' PHE . 35.4 t80 -90.48 106.82 18.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.9 100.75 7.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.894 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.19 -140.15 3.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.52 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.59 130.03 10.14 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.492 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -79.25 45.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 110.893 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 124' ' ' LEU . 18.2 tt0 -101.43 134.17 44.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.442 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -36.28 -51.8 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.7 m -68.02 -45.99 72.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.38 -33.87 4.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.437 ' CE1' ' CZ ' ' A' ' 118' ' ' TYR . 54.0 m-85 -74.64 -42.01 59.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.3 mt -58.26 -53.01 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 t -65.27 -30.89 71.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.77 -47.83 84.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.6 mt -74.29 -42.52 59.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -39.54 -32.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -101.73 -60.68 1.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -47.98 -53.96 14.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.49 122.65 5.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -74.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.084 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.5 t -61.4 -54.91 37.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.01 -172.25 49.42 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.51 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -20.33 35.19 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.675 2.25 . . . . 0.0 112.367 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.3 t -47.87 96.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.7 m -98.9 164.84 12.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.852 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.478 -179.978 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.5 p -160.15 125.3 3.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.4 . . . . 0.0 110.841 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.6 m -151.79 153.33 34.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.815 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.03 81.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.7 p -134.71 110.39 9.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.893 0.377 . . . . 0.0 110.844 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 t -174.25 135.54 0.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.831 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 174.96 47.49 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -75.06 120.04 20.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 110.842 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -143.79 137.23 27.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.39 154.31 11.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.446 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -58.95 90.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.424 HD11 HD23 ' A' ' 113' ' ' LEU . 4.5 mt -71.41 92.99 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.916 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.56 129.97 7.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -174.28 122.07 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.591 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.8 p90 -151.64 150.53 30.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 pp -95.81 -36.03 11.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 18' ' ' SER . 25.9 tttp -118.04 157.45 26.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.462 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 58.2 p -159.57 158.02 30.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 9.1 mm-40 -107.99 160.79 25.59 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.641 0.734 . . . . 0.0 110.848 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.71 139.94 41.66 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.656 2.237 . . . . 0.0 112.346 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.574 HD13 HG21 ' A' ' 33' ' ' VAL . 19.2 mm -69.5 129.78 91.24 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.634 0.73 . . . . 0.0 111.126 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 132.34 23.15 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.675 2.25 . . . . 0.0 112.335 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 24' ' ' SER . 8.6 pt-20 -44.89 -42.71 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.441 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 3.3 m -159.44 137.75 10.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.825 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -111.32 80.65 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -101.94 55.35 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.32 -172.94 13.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.472 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -41.67 4.03 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.653 2.235 . . . . 0.0 112.297 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 82' ' ' ILE . 7.4 t -114.8 122.62 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.164 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.43 ' HZ2' HD13 ' A' ' 40' ' ' ILE . 1.8 mmmp? -68.26 130.33 42.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.3 t -81.11 110.36 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.055 HG11 HG23 ' A' ' 41' ' ' VAL . 39.2 t -105.16 114.97 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.574 HG21 HD13 ' A' ' 21' ' ' ILE . 35.9 m -108.86 146.35 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.591 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.54 -47.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.453 ' HB3' HD11 ' A' ' 21' ' ' ILE . 1.9 mm-40 -51.55 -48.79 62.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' VAL . 16.9 p-10 -110.38 28.15 8.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.49 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 8.9 t80 -73.33 -44.16 59.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -75.15 -4.57 39.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.53 -39.09 10.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.53 HD12 HG22 ' A' ' 32' ' ' VAL . 4.6 mt -98.91 -63.49 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.055 HG23 HG11 ' A' ' 32' ' ' VAL . 93.4 t -53.47 -60.81 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.109 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 24.8 m-20 -63.99 118.75 8.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 42' ' ' ASN . 38.7 m-20 -175.1 114.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.26 31.69 2.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -125.33 -38.05 2.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -127.88 161.13 29.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -80.94 137.92 36.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -144.51 136.9 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.0 tp -116.39 136.32 53.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.401 HD13 ' CG2' ' A' ' 41' ' ' VAL . 3.0 tp -116.45 137.14 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.534 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -127.25 110.97 13.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 103' ' ' THR . 69.8 m-85 -87.53 138.64 31.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 4.9 p90 -143.85 175.31 10.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.933 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.94 134.35 26.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.55 0.69 . . . . 0.0 111.107 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -16.36 37.48 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.689 2.259 . . . . 0.0 112.352 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -113.49 25.99 10.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.7 t -123.08 134.27 54.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.78 -59.77 8.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.475 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -38.26 -35.7 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.297 . . . . 0.0 110.832 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -52.59 61.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -57.19 -36.61 71.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -77.53 -35.85 52.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 66' ' ' LYS . 27.8 tp -81.12 -19.45 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.6 tt0 -46.98 -58.39 7.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.668 0.747 . . . . 0.0 110.886 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.8 -28.03 25.58 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.654 2.236 . . . . 0.0 112.37 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HB2' HD12 ' A' ' 63' ' ' LEU . 24.1 mtpp -72.85 -27.36 61.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.534 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 41.5 t80 -96.32 -46.07 6.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -41.81 -59.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 70' ' ' LEU . 25.5 mt-10 -39.48 -63.47 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.432 ' N ' HD21 ' A' ' 124' ' ' LEU . 15.7 tp -37.25 -34.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.5 -51.4 42.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.516 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.4 -18.32 57.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.503 ' HD3' HD11 ' A' ' 124' ' ' LEU . 6.3 mtpm? -76.86 -53.74 7.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' ASP . 98.0 mt -79.41 1.78 24.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.1 t -43.06 -23.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 74' ' ' LEU . 16.4 mtpt -89.89 23.74 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.911 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' LEU . 50.1 p-10 -101.36 98.06 8.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.595 0.712 . . . . 0.0 110.845 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.9 Cg_endo -69.77 1.04 4.8 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.683 2.255 . . . . 0.0 112.355 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -123.42 -43.29 2.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.456 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 62.1 mt -87.25 144.48 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.5 t -134.95 97.8 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.444 HG22 HG13 ' A' ' 29' ' ' VAL . 30.5 mm -70.55 122.2 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.703 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -138.09 171.28 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.051 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.421 ' HB3' HG11 ' A' ' 29' ' ' VAL . 41.5 pttt -140.82 159.01 43.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.4 ttt -150.76 135.45 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 87' ' ' ALA . 30.9 t0 -89.51 80.89 6.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -35.91 -62.94 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 88' ' ' THR . 19.9 p -37.87 -39.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.44 -28.81 20.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 87' ' ' ALA . 14.3 m-80 -124.38 110.39 14.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -49.11 130.24 18.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.481 HG11 HG23 ' A' ' 98' ' ' VAL . 65.2 t -76.97 118.81 74.37 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.626 0.727 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -164.57 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 2.252 . . . . 0.0 112.34 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -121.06 161.14 42.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.626 0.726 . . . . 0.0 110.887 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.7 Cg_endo -69.77 -12.91 12.34 Favored 'Cis proline' 0 C--N 1.341 0.176 0 C-N-CA 122.681 -1.799 . . . . 0.0 112.359 -0.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 95' ' ' PRO . 88.2 m-85 -33.86 136.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -141.29 119.23 11.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.572 HG22 HG21 ' A' ' 103' ' ' THR . 99.1 t -122.98 80.77 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.106 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -66.13 -45.43 81.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.67 -171.73 13.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.462 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.513 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -147.97 157.82 42.89 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.628 0.728 . . . . 0.0 110.861 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.8 166.99 72.73 Favored 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.68 -1.8 . . . . 0.0 112.323 0.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.572 HG21 HG22 ' A' ' 98' ' ' VAL . 88.1 m -146.2 131.18 18.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.452 HD13 ' CE1' ' A' ' 127' ' ' PHE . 20.6 mt -124.92 129.43 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -125.49 159.34 32.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.533 ' HB3' ' CG ' ' A' ' 116' ' ' LYS . 21.2 t80 -119.89 151.19 39.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 m -121.64 87.63 46.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.673 0.749 . . . . 0.0 110.837 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.502 ' O ' ' CE ' ' A' ' 112' ' ' LYS . 54.0 Cg_endo -69.79 168.23 22.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.671 2.247 . . . . 0.0 112.332 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.478 ' C ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.16 139.03 32.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.478 ' CG ' ' C ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER 49.84 25.02 1.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.486 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.1 mtmt -128.0 18.23 6.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' CE ' ' O ' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -46.44 -34.07 4.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.424 HD23 HD11 ' A' ' 12' ' ' LEU . 2.9 mt -82.76 -24.88 33.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 111' ' ' LYS . 10.9 m120 -119.43 63.02 7.09 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.616 0.722 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -164.72 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.363 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.533 ' CG ' ' HB3' ' A' ' 106' ' ' PHE . 0.8 OUTLIER -160.63 155.55 24.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.9 ttpp -117.72 126.75 53.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.41 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 60.1 t80 -54.97 101.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -115.2 94.65 4.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.73 -141.64 4.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.504 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.78 134.8 12.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.502 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.451 ' HB2' ' NH1' ' A' ' 122' ' ' ARG . 10.3 mtp-105 -84.37 49.74 1.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.876 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 124' ' ' LEU . 26.9 tt0 -109.66 133.85 52.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.503 HD11 ' HD3' ' A' ' 73' ' ' LYS . 3.3 tm? -36.28 -53.85 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.5 p -65.16 -42.7 93.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.09 -27.93 36.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.452 ' CE1' HD13 ' A' ' 104' ' ' ILE . 58.0 m-85 -78.8 -47.32 16.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.7 mt -53.19 -50.73 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.12 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.0 p -60.67 -55.32 34.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.828 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -44.44 -45.09 8.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 135' ' ' ALA . 18.9 mt -76.51 -37.55 56.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.432 ' CD ' ' HG2' ' A' ' 139' ' ' PRO . 17.9 mm-40 -48.18 -45.89 34.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.445 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 12.9 ptm180 -86.45 -40.04 15.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.462 ' OE1' ' CD ' ' A' ' 116' ' ' LYS . 46.7 mm-40 -68.89 -65.02 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 131' ' ' LEU . . . -34.18 131.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -66.72 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.8 t -66.16 -43.88 85.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.07 135.55 0.43 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.451 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.432 ' HG2' ' CD ' ' A' ' 132' ' ' GLN . 53.1 Cg_endo -69.83 88.85 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.649 2.233 . . . . 0.0 112.32 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.5 m -158.19 118.43 3.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 55.6 m -146.45 166.95 24.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.85 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.486 -179.993 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.8 p -116.46 154.54 30.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.858 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 t -160.85 123.35 3.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.03 94.53 1.01 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.512 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -106.71 87.28 2.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.835 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -124.85 128.05 48.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.1 146.7 18.1 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 0.4 OUTLIER -123.34 81.7 1.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 110.892 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 8' ' ' PHE . 13.9 m-20 -166.7 167.05 15.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.16 126.65 2.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -123.57 111.14 15.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 0.0 110.874 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -97.06 18.45 14.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.925 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 144.96 48.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -170.36 121.77 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.407 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.2 p90 -154.1 156.22 36.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.1 pp -98.31 -43.87 6.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.567 ' N ' HD12 ' A' ' 16' ' ' LEU . 7.4 ttpm? -110.71 166.38 11.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.488 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 98.1 p -170.78 152.0 3.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.441 ' CG ' HD22 ' A' ' 90' ' ' ASN . 5.6 mm-40 -96.23 158.45 33.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.623 0.725 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 145.75 58.04 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.676 2.251 . . . . 0.0 112.365 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 35' ' ' GLU . 29.6 mm -73.13 133.45 81.42 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.739 . . . . 0.0 111.108 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' A' ' 21' ' ' ILE . 54.2 Cg_endo -69.77 174.11 9.99 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.361 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -97.23 -36.04 10.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -145.0 137.73 26.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -130.2 37.23 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.51 60.44 2.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.69 -168.43 12.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -41.14 4.54 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 0.0 112.332 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG13 HG22 ' A' ' 82' ' ' ILE . 30.7 t -119.13 122.14 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.59 131.13 42.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.0 t -78.77 135.14 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.983 HG11 HG23 ' A' ' 41' ' ' VAL . 38.8 t -132.15 120.03 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 36' ' ' ASN . 20.3 m -116.97 147.58 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.476 ' HB3' ' CB ' ' A' ' 18' ' ' SER . . . -34.3 -44.11 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 33' ' ' VAL . 15.6 mt-10 -53.77 -46.47 70.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 33' ' ' VAL . 18.1 p-10 -116.32 30.6 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.592 ' CZ ' ' HG3' ' A' ' 93' ' ' PRO . 5.2 t80 -69.98 -54.73 11.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.43 -5.69 20.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -90.6 -41.6 11.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.893 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.4 mt -97.5 -58.16 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.983 HG23 HG11 ' A' ' 32' ' ' VAL . 24.0 t -54.56 -60.1 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.09 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 34.3 m-20 -67.45 123.08 19.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.839 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 28.9 m-20 -171.89 108.5 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -83.43 0.42 46.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -85.68 -45.8 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -138.36 162.86 33.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.67 150.38 36.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.98 140.99 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.502 HD23 HD12 ' A' ' 82' ' ' ILE . 29.9 tp -112.95 126.07 55.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 85' ' ' MET . 1.9 tp -113.45 135.33 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.105 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' C ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -126.03 117.95 24.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.54 ' CG ' HG21 ' A' ' 98' ' ' VAL . 60.1 m-85 -91.59 120.44 32.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.564 ' CE1' ' OD2' ' A' ' 86' ' ' ASP . 28.6 p90 -128.47 178.84 6.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -135.24 132.44 20.07 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.564 0.697 . . . . 0.0 111.094 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.539 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.3 Cg_endo -69.79 -2.49 10.29 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.487 ' CZ3' ' SG ' ' A' ' 57' ' ' CYS . 7.3 p-90 -122.04 6.73 9.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -96.23 137.34 35.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.98 -58.17 4.51 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -50.5 -39.19 47.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.324 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.6 m -64.06 -38.95 92.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -64.12 -45.91 86.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -68.34 -14.56 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.835 HD12 ' HB2' ' A' ' 66' ' ' LYS . 14.2 tp -96.33 -24.76 16.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.535 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -37.62 -57.93 1.42 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.595 0.712 . . . . 0.0 110.875 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.4 Cg_endo -69.76 -27.74 26.11 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.686 2.257 . . . . 0.0 112.359 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.835 ' HB2' HD12 ' A' ' 63' ' ' LEU . 4.5 mtpm? -71.58 -32.5 68.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -88.69 -40.26 13.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -44.48 -59.33 2.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -38.78 -56.21 1.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.407 ' N ' HD21 ' A' ' 124' ' ' LEU . 28.0 tp -43.79 -39.89 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.07 -63.25 5.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.438 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.34 -26.28 67.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.875 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -72.12 -44.14 63.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.663 HD12 HD11 ' A' ' 82' ' ' ILE . 82.2 mt -89.55 3.19 53.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.1 t -52.09 -20.63 2.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -98.87 22.71 9.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 1.2 m-20 -103.29 99.28 14.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.61 0.719 . . . . 0.0 110.865 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.1 Cg_endo -69.75 -3.25 11.62 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.726 2.284 . . . . 0.0 112.334 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.19 -19.09 9.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.2 mt -123.29 134.44 66.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.2 t -130.2 103.98 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.663 HD11 HD12 ' A' ' 74' ' ' LEU . 51.4 mm -69.61 132.36 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.146 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.541 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -146.63 167.75 22.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 pttt -139.92 156.36 46.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.553 ' HB3' HD11 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -149.18 132.91 16.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.564 ' OD2' ' CE1' ' A' ' 53' ' ' TYR . 1.2 m-20 -86.67 101.39 13.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -58.14 -64.96 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.539 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -45.35 -21.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -92.58 -29.74 16.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -142.79 130.37 21.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -47.04 150.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.534 HG13 ' HD2' ' A' ' 93' ' ' PRO . 89.7 t -96.49 135.49 22.37 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.648 0.737 . . . . 0.0 111.088 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.592 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.5 Cg_endo -69.79 -163.55 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.683 2.255 . . . . 0.0 112.339 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.539 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -132.68 153.87 81.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.704 0.764 . . . . 0.0 110.839 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.85 -7.42 10.12 Favored 'Cis proline' 0 C--N 1.342 0.196 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.304 0.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.475 ' C ' ' O ' ' A' ' 95' ' ' PRO . 51.8 m-85 -31.7 131.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -142.77 126.74 17.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.54 HG21 ' CG ' ' A' ' 52' ' ' PHE . 81.8 t -133.83 115.59 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -123.0 -41.85 2.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.29 118.09 4.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.539 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -96.23 155.19 38.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.661 0.743 . . . . 0.0 110.905 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.77 161.11 86.88 Favored 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.318 -0.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.506 HG21 HG22 ' A' ' 98' ' ' VAL . 57.9 m -141.71 115.04 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.508 HD13 ' CE1' ' A' ' 127' ' ' PHE . 68.3 mt -108.52 138.8 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.143 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.437 ' O ' HD12 ' A' ' 49' ' ' LEU . 10.5 m-85 -133.92 178.03 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.952 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -149.32 126.51 11.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -101.62 100.08 13.28 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.664 0.745 . . . . 0.0 110.833 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.496 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.75 171.04 15.18 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.609 2.206 . . . . 0.0 112.388 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.456 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.67 139.49 31.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.084 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.7 p30 46.85 25.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.496 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.2 mtmm -127.27 22.44 6.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 113' ' ' LEU . 7.7 mmpt? -45.86 -66.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 112' ' ' LYS . 6.9 mp -34.02 -44.43 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.942 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -122.44 90.14 49.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.593 0.711 . . . . 0.0 110.92 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -163.75 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.632 2.221 . . . . 0.0 112.31 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -141.7 131.31 24.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -100.04 134.13 43.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.85 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.453 ' HB3' HG22 ' A' ' 104' ' ' ILE . 60.3 t80 -79.24 111.84 15.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -124.15 98.3 5.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 179.57 -146.27 6.98 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.99 134.33 12.38 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.489 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -81.29 45.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.888 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 124' ' ' LEU . 9.0 tt0 -103.12 134.48 46.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.483 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -36.84 -54.92 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 60.4 p -60.84 -48.93 79.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -47.8 -34.97 9.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.508 ' CE1' HD13 ' A' ' 104' ' ' ILE . 33.1 m-85 -70.61 -37.31 73.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.4 mt -69.05 -57.55 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.113 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.6 t -60.29 -24.7 65.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -70.82 -48.57 53.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.935 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 25.8 mt -71.22 -38.18 72.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -40.24 -42.95 1.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -94.78 -67.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -40.53 -54.42 2.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 131' ' ' LEU . . . -44.57 100.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.069 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.3 t -44.2 -24.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 138' ' ' GLY . 1.2 t -116.33 48.46 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 137' ' ' SER . . . -36.36 145.05 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.497 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 88.29 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.695 2.264 . . . . 0.0 112.333 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.3 t -99.23 123.79 43.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.5 m -42.39 100.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.488 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 m -148.71 145.48 27.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.904 0.383 . . . . 0.0 110.879 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 p -166.92 174.79 8.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.18 134.31 6.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.6 p -128.24 154.96 45.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 110.858 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.2 m -116.71 -43.53 2.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.87 172.19 21.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.451 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -107.84 118.16 36.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.898 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -62.34 -65.15 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.9 168.91 4.52 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.474 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -94.61 110.91 22.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 110.896 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.483 ' H ' HD12 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -83.56 166.47 18.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.92 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.413 ' C ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -169.08 146.1 3.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -175.13 124.16 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.691 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.2 p90 -166.59 154.2 9.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 16' ' ' LEU . 1.9 pp -104.21 -37.04 7.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.934 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 17.0 ttpt -109.86 158.2 18.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.9 p -164.22 149.1 10.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -98.86 160.7 27.15 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.656 0.741 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 143.57 51.32 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.648 2.232 . . . . 0.0 112.333 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.602 HD13 HG21 ' A' ' 33' ' ' VAL . 20.9 mm -68.87 129.15 92.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.633 0.73 . . . . 0.0 111.154 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 136.15 32.41 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.667 2.245 . . . . 0.0 112.355 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 24' ' ' SER . 12.0 pt-20 -49.05 -50.24 37.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.874 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.407 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 11.6 t -149.53 137.28 20.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -111.43 50.31 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.55 -25.05 59.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.84 169.94 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.436 ' HG3' ' CG ' ' A' ' 68' ' ' LYS . 53.5 Cg_endo -69.79 -29.67 23.37 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.686 2.258 . . . . 0.0 112.332 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.5 t -111.73 121.0 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.42 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 9.0 mmtm -71.12 134.93 47.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.1 t -86.35 104.75 14.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.147 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.916 HG11 HG23 ' A' ' 41' ' ' VAL . 44.9 t -95.91 114.11 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.171 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.602 HG21 HD13 ' A' ' 21' ' ' ILE . 26.3 m -109.53 144.74 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.691 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.86 -43.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -56.09 -50.82 69.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.452 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 28.5 p30 -105.41 21.58 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CD2' HG21 ' A' ' 41' ' ' VAL . 14.4 t80 -62.8 -58.78 6.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.02 -6.97 7.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.858 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.97 -44.13 11.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.409 HD12 HG22 ' A' ' 32' ' ' VAL . 23.5 mt -97.21 -58.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.916 HG23 HG11 ' A' ' 32' ' ' VAL . 42.7 t -51.86 -61.55 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -69.06 114.61 7.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -167.08 106.72 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -91.11 31.88 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -126.4 -37.82 2.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.826 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.81 145.55 48.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.3 147.26 53.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.9 t -145.26 147.84 18.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.131 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.548 HD23 HD12 ' A' ' 82' ' ' ILE . 21.8 tp -124.57 126.9 46.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.945 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 41' ' ' VAL . 3.2 tp -107.72 139.51 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.083 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -127.28 105.13 8.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -84.78 115.33 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -125.6 179.69 5.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -131.66 132.91 23.67 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.569 0.7 . . . . 0.0 111.12 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.497 ' HD2' HG21 ' A' ' 88' ' ' THR . 53.7 Cg_endo -69.72 -1.65 8.79 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.744 2.296 . . . . 0.0 112.348 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.483 ' NE1' HG21 ' A' ' 88' ' ' THR . 6.9 p-90 -122.96 5.59 9.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.618 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -98.64 130.31 45.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -66.11 -59.65 7.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.497 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.559 ' CD2' ' HD3' ' A' ' 102' ' ' PRO . 3.1 p-80 -38.41 -31.65 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.875 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLY . 9.5 t -68.54 -49.6 58.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -53.68 -45.53 70.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -72.49 -24.86 61.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 66' ' ' LYS . 16.3 tp -87.68 -20.25 26.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.946 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -42.97 -58.31 4.11 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.657 0.741 . . . . 0.0 110.861 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.1 Cg_endo -69.74 -26.5 27.61 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.704 2.27 . . . . 0.0 112.328 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.621 ' HB2' HD12 ' A' ' 63' ' ' LEU . 42.1 mtpt -74.24 -27.35 60.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 40.3 t80 -96.32 -33.57 11.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.436 ' CG ' ' HG3' ' A' ' 28' ' ' PRO . 1.2 ttmp? -51.77 -57.62 8.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -40.53 -60.75 1.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.3 tp -38.48 -38.81 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.83 -65.61 3.21 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.84 -16.43 64.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -80.88 -42.66 21.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.633 HD12 HD11 ' A' ' 82' ' ' ILE . 80.6 mt -82.09 3.34 27.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.2 m -53.92 -24.78 17.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -78.1 6.9 7.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.917 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.435 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 4.1 t0 -113.49 98.98 48.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.659 0.742 . . . . 0.0 110.843 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.3 Cg_endo -69.72 0.3 5.82 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.71 2.273 . . . . 0.0 112.36 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -110.83 -36.83 5.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.475 HG21 HD13 ' A' ' 74' ' ' LEU . 64.3 mt -92.55 137.97 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.2 t -135.37 116.81 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.1 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.633 HD11 HD12 ' A' ' 74' ' ' LEU . 23.3 mm -89.05 132.45 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.844 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -142.03 171.53 13.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -139.74 138.13 35.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.489 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 12.4 ttt -132.5 143.19 49.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.746 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -95.88 95.27 8.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -48.77 -67.19 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.497 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -46.97 -23.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.746 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -93.52 -25.12 17.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.489 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -141.07 125.29 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.0 128.97 36.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.52 128.56 74.64 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.591 0.71 . . . . 0.0 111.141 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -169.77 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.663 2.242 . . . . 0.0 112.343 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.5 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.5 m -121.25 160.84 43.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.667 0.746 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.2 Cg_endo -69.69 -8.62 10.47 Favored 'Cis proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 -1.801 . . . . 0.0 112.387 -0.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 95' ' ' PRO . 86.0 m-85 -34.04 123.37 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -125.74 130.16 50.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.885 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.907 HG22 HG21 ' A' ' 103' ' ' THR . 65.8 t -133.09 120.48 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.093 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -128.87 -38.64 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.79 123.3 5.32 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.516 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.546 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.4 OUTLIER -97.14 154.0 38.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.738 . . . . 0.0 110.878 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.559 ' HD3' ' CD2' ' A' ' 59' ' ' HIS . 53.1 Cg_endo -69.83 155.33 93.49 Favored 'Cis proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.29 0.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.907 HG21 HG22 ' A' ' 98' ' ' VAL . 92.9 m -131.53 100.27 5.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.424 HG12 ' HG2' ' A' ' 51' ' ' GLU . 95.6 mt -94.79 141.93 14.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.151 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.418 ' HB2' HG23 ' A' ' 50' ' ' ILE . 8.9 m-85 -140.88 161.59 37.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 49' ' ' LEU . 15.4 t80 -128.25 136.95 51.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -105.3 93.27 6.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.843 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.498 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.6 Cg_endo -69.75 164.59 33.96 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.394 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.459 ' O ' ' CE ' ' A' ' 111' ' ' LYS . . . -78.04 145.44 35.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 41.94 24.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.498 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.2 mtmt -128.66 68.07 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HA ' ' NZ ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -90.57 -49.01 6.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.935 HD22 ' O ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -59.75 -25.47 64.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.554 ' N ' HD13 ' A' ' 113' ' ' LEU . 2.8 t-20 -133.39 84.06 47.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.646 0.736 . . . . 0.0 110.91 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -163.8 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -148.43 137.09 21.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.475 ' HG2' ' N ' ' A' ' 118' ' ' TYR . 29.8 ttmt -105.19 151.4 24.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.549 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 68.4 t80 -94.58 108.83 20.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -121.58 100.0 6.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 178.73 -153.59 12.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.1 133.35 12.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.477 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -80.36 45.96 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.844 0.355 . . . . 0.0 110.914 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 124' ' ' LEU . 8.8 tt0 -105.39 133.29 50.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.649 ' CD1' HD11 ' A' ' 128' ' ' ILE . 3.4 tm? -34.8 -55.59 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.3 m -58.86 -52.21 66.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.827 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.03 -30.38 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.549 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 38.9 m-85 -78.19 -40.34 37.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.649 HD11 ' CD1' ' A' ' 124' ' ' LEU . 37.5 mt -63.64 -57.26 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.153 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -58.01 -35.49 71.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.582 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 16.9 t80 -53.95 -52.82 59.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.6 mt -74.84 -39.89 61.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -38.79 -39.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.93 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -98.98 -57.07 2.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.582 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 69.6 mm-40 -49.24 -53.68 20.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -42.51 104.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.157 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 137' ' ' SER . 2.1 t -46.83 -49.62 19.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.444 ' N ' HG23 ' A' ' 136' ' ' THR . 23.7 m -73.98 -45.38 50.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.91 168.14 31.36 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.504 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 148.47 65.56 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.367 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.2 t -63.88 131.93 49.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 57.7 p -111.82 89.99 3.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 t -156.71 155.71 32.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.88 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -99.98 -57.01 2.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.859 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.65 99.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -152.29 172.69 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.904 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.7 t -129.46 -55.59 1.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.851 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.54 -100.72 0.15 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.468 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.446 ' O ' HD11 ' A' ' 113' ' ' LEU . 19.9 m-85 -108.05 165.16 11.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.889 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -174.87 119.83 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.53 72.76 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 71.07 53.97 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.924 0.392 . . . . 0.0 110.905 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 tp -68.91 109.49 3.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.58 157.9 44.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -174.85 118.91 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.706 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 14.5 p90 -162.61 174.79 12.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 16' ' ' LEU . 1.5 pp -131.88 -40.21 1.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.933 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.4 ' HB3' ' H ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -97.12 125.25 41.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.735 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -142.1 156.74 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.847 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 4.5 mm-40 -106.0 161.68 22.08 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.652 0.739 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.4 Cg_endo -69.83 143.47 50.6 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.701 2.268 . . . . 0.0 112.306 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.57 HD13 HG21 ' A' ' 33' ' ' VAL . 23.2 mm -68.78 127.47 93.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.618 0.723 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.94 43.95 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.709 2.273 . . . . 0.0 112.351 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.59 -39.17 92.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 m -150.13 123.27 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -133.11 45.9 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.49 54.12 2.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.845 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.17 -160.11 23.4 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.491 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -41.55 4.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.63 2.22 . . . . 0.0 112.396 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 84' ' ' LYS . 18.4 t -119.53 107.19 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.116 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -53.48 124.98 16.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.8 t -75.4 126.1 35.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.033 HG11 HG23 ' A' ' 41' ' ' VAL . 30.0 t -118.51 120.31 63.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 21' ' ' ILE . 31.6 m -113.44 145.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 18' ' ' SER . . . -36.4 -38.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.091 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.536 ' HB3' HD11 ' A' ' 21' ' ' ILE . 10.7 mt-10 -59.51 -46.75 87.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' VAL . 22.2 p-10 -111.89 24.84 12.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.586 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 6.1 t80 -63.46 -58.06 8.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -65.29 -7.72 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -86.9 -44.22 11.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.7 mt -98.28 -62.3 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.033 HG23 HG11 ' A' ' 32' ' ' VAL . 97.1 t -48.14 -62.04 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.136 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -72.66 126.55 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.409 ' ND2' ' HE3' ' A' ' 46' ' ' LYS . 11.7 t-20 -172.91 108.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -87.6 29.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -124.14 -41.66 2.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HE3' ' ND2' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -136.28 130.13 32.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.57 151.95 5.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.499 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 89.4 t -146.33 152.58 13.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.599 HD23 HD12 ' A' ' 82' ' ' ILE . 39.8 tp -124.17 126.13 45.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.544 HD11 ' HB3' ' A' ' 85' ' ' MET . 1.8 tp -114.1 129.38 70.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.121 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 14.7 tm-20 -123.83 114.35 19.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -85.38 133.82 34.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -143.0 169.14 18.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.693 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -127.04 131.42 23.85 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.589 0.709 . . . . 0.0 111.074 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.465 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.2 Cg_endo -69.75 -10.13 27.82 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.376 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -115.58 5.11 14.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 7.5 t -101.71 126.89 48.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.15 -59.14 8.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -42.36 -45.64 4.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.6 m -69.82 -43.72 71.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -55.67 -35.88 66.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -74.62 -29.9 61.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.592 HD12 ' HB2' ' A' ' 66' ' ' LYS . 28.9 tp -83.15 -20.88 33.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.544 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -41.16 -57.58 3.4 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.652 0.739 . . . . 0.0 110.864 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.71 -27.72 26.36 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.705 2.27 . . . . 0.0 112.345 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.592 ' HB2' HD12 ' A' ' 63' ' ' LEU . 3.1 mmmt -71.92 -30.65 65.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 60.1 t80 -91.01 -37.07 13.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -47.57 -54.37 11.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.833 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -43.35 -56.21 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 127' ' ' PHE . 21.7 tp -42.99 -38.5 2.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.29 -65.16 3.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.438 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -60.83 -27.55 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 0.0 110.89 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mmtm -67.95 -46.46 71.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.573 HD12 ' CG1' ' A' ' 82' ' ' ILE . 91.5 mt -84.72 2.98 39.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.6 t -48.64 -24.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -93.57 24.24 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.45 97.63 12.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.583 0.706 . . . . 0.0 110.857 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -2.17 9.72 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.664 2.243 . . . . 0.0 112.364 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -117.5 -42.85 2.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.9 mt -92.77 145.07 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.179 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.1 t -138.99 106.82 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.599 HD12 HD23 ' A' ' 49' ' ' LEU . 21.2 mm -76.87 135.8 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -145.62 169.17 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.603 ' HB3' HG11 ' A' ' 29' ' ' VAL . 19.9 pttp -143.34 149.51 37.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.544 ' HB3' HD11 ' A' ' 50' ' ' ILE . 1.0 OUTLIER -144.06 138.45 28.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.815 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -86.85 107.0 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.82 -51.74 68.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.125 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.465 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -59.94 -16.31 28.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.815 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -106.88 0.69 24.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.549 ' ND2' ' C ' ' A' ' 89' ' ' ALA . 3.8 m-80 -162.87 124.61 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 17' ' ' LYS . 23.4 t70 -55.92 130.05 42.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.401 HG11 HG23 ' A' ' 98' ' ' VAL . 88.4 t -78.34 125.33 85.01 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.641 0.734 . . . . 0.0 111.168 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -164.57 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.502 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -127.16 160.93 57.11 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.683 0.754 . . . . 0.0 110.857 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.0 Cg_endo -69.71 -3.03 7.38 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.74 -1.775 . . . . 0.0 112.381 -0.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.471 ' N ' ' HA ' ' A' ' 94' ' ' SER . 97.3 m-85 -36.4 125.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -129.31 125.11 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.542 HG22 HG21 ' A' ' 103' ' ' THR . 58.2 t -130.99 103.54 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.142 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -104.93 -35.48 7.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.837 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.57 134.28 6.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.478 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.518 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -98.14 156.94 35.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 0.0 110.92 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.75 165.52 76.42 Favored 'Cis proline' 0 C--O 1.231 0.164 0 C-N-CA 122.732 -1.778 . . . . 0.0 112.373 -0.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.542 HG21 HG22 ' A' ' 98' ' ' VAL . 71.2 m -147.16 105.08 3.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.117 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.825 HD13 ' HE1' ' A' ' 127' ' ' PHE . 21.2 mt -97.19 141.4 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.121 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -140.97 160.34 40.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 31.2 t80 -130.27 140.39 50.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.7 p -109.43 98.66 33.18 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.667 0.746 . . . . 0.0 110.859 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.5 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.76 166.49 27.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.622 2.215 . . . . 0.0 112.37 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -82.48 128.6 34.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.08 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.23 29.75 15.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.5 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.9 mtmt -135.0 40.93 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -64.05 -33.86 76.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.446 HD11 ' O ' ' A' ' 8' ' ' PHE . 4.6 mp -67.47 -36.21 80.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.405 ' ND2' ' HG2' ' A' ' 111' ' ' LYS . 0.5 OUTLIER -124.7 81.56 60.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.593 0.711 . . . . 0.0 110.875 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 178.11 4.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.463 ' CD ' ' HG3' ' A' ' 108' ' ' PRO . 7.9 mptt -114.93 127.41 55.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -101.92 108.0 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.435 ' CE1' ' CD2' ' A' ' 130' ' ' TYR . 55.3 t80 -55.21 108.69 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -125.52 90.92 3.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -172.73 -134.23 1.78 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.479 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.14 139.79 14.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 102' ' ' PRO . 32.9 mtp180 -84.8 37.86 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.757 0.313 . . . . 0.0 110.874 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 124' ' ' LEU . 15.1 tp10 -98.25 129.26 44.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.604 ' CD1' HD11 ' A' ' 128' ' ' ILE . 3.2 tm? -34.28 -55.29 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.9 p -57.65 -45.71 85.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 123' ' ' GLU . 2.1 t70 -53.43 -33.53 54.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.825 ' HE1' HD13 ' A' ' 104' ' ' ILE . 88.7 m-85 -73.58 -40.33 63.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.604 HD11 ' CD1' ' A' ' 124' ' ' LEU . 42.7 mt -61.58 -57.41 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.181 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.34 -35.18 78.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.435 ' CD2' ' CE1' ' A' ' 118' ' ' TYR . 13.8 t80 -53.56 -48.1 69.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.424 HD11 HD22 ' A' ' 49' ' ' LEU . 28.9 mt -76.22 -39.24 55.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.908 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -39.92 -40.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.3 mtp85 -92.0 -64.4 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 135' ' ' ALA . 21.8 mm-40 -41.78 -60.15 1.45 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -35.19 116.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.1 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.6 OUTLIER -35.19 -75.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.122 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 m -75.81 -55.69 5.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 100.13 -179.16 29.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 136.21 32.29 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.689 2.26 . . . . 0.0 112.322 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.7 t -61.04 125.8 25.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.0 m -113.64 42.28 2.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.453 -179.939 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t -138.78 161.25 37.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 110.827 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.0 p -76.51 163.48 26.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.05 137.16 38.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.506 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.4 m -107.24 96.64 6.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 0.0 110.841 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.6 m -135.31 128.56 31.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.848 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.57 -128.25 3.01 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.432 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -42.11 129.91 3.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -110.94 39.47 2.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.89 -130.47 17.11 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.504 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.416 ' CG ' ' HE2' ' A' ' 13' ' ' LYS . 11.8 t-20 -105.86 87.42 2.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.378 . . . . 0.0 110.918 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 tt -73.92 79.57 1.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HE2' ' CG ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -170.5 -178.02 2.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -175.65 129.29 0.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.627 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 4.3 p90 -156.25 153.94 29.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.958 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.1 pp -112.99 -36.91 4.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' N ' HD12 ' A' ' 16' ' ' LEU . 31.2 tttt -109.69 155.5 21.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.569 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 18.7 t -166.4 143.78 5.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.0 mm-40 -86.6 162.05 46.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.654 0.74 . . . . 0.0 110.882 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.77 142.32 47.56 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.649 2.233 . . . . 0.0 112.353 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.463 HD13 ' CG2' ' A' ' 33' ' ' VAL . 30.6 mm -71.65 131.83 85.83 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.644 0.735 . . . . 0.0 111.1 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 178.38 4.67 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.626 2.217 . . . . 0.0 112.37 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -103.13 -34.96 8.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 p -147.98 125.64 11.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -107.8 47.5 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -58.8 -26.92 64.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.53 168.87 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.486 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.459 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 54.1 Cg_endo -69.76 -25.66 28.35 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.685 2.256 . . . . 0.0 112.364 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.546 HG12 ' HG2' ' A' ' 84' ' ' LYS . 62.1 t -120.1 113.15 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -57.66 129.59 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.3 125.97 39.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.153 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.045 HG11 HG23 ' A' ' 41' ' ' VAL . 21.8 t -124.6 124.57 68.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.662 HG22 ' OD1' ' A' ' 36' ' ' ASN . 20.9 m -122.64 148.46 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.627 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -32.75 -40.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.121 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.583 ' HB2' HG23 ' A' ' 33' ' ' VAL . 12.7 mt-10 -55.75 -49.56 72.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.857 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.662 ' OD1' HG22 ' A' ' 33' ' ' VAL . 36.4 p-10 -115.77 34.91 4.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.615 ' CD2' HG21 ' A' ' 41' ' ' VAL . 21.4 t80 -71.09 -57.93 4.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -66.6 -5.67 12.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -87.08 -47.41 8.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.3 mt -96.92 -58.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.045 HG23 HG11 ' A' ' 32' ' ' VAL . 41.3 t -49.0 -61.64 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.167 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -68.56 126.91 31.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -174.33 118.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -95.64 0.45 52.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -95.54 -37.58 10.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -138.87 138.93 37.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.522 ' OD2' ' CG1' ' A' ' 80' ' ' ILE . 1.3 p30 -58.63 152.87 17.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.87 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 41' ' ' VAL . 52.1 t -148.42 142.72 19.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.445 HD23 HD12 ' A' ' 82' ' ' ILE . 39.4 tp -117.91 140.51 49.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.579 HD11 ' CB ' ' A' ' 85' ' ' MET . 2.1 tp -127.86 135.6 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.49 ' CD ' ' C ' ' A' ' 51' ' ' GLU . 5.8 tm-20 -126.77 121.88 33.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -95.74 118.7 32.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -126.34 179.08 5.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.26 134.56 17.76 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.625 0.726 . . . . 0.0 111.123 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.712 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.1 Cg_endo -69.73 -16.96 37.93 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.69 2.26 . . . . 0.0 112.339 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.413 ' CZ3' ' HB2' ' A' ' 57' ' ' CYS . 2.4 p-90 -105.85 6.53 31.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.413 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . 42.1 t -107.16 112.7 25.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.876 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -57.98 -57.16 21.3 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -41.02 -37.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 97.5 m -73.75 -34.66 64.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 58' ' ' GLY . 2.1 ttmm -62.33 -35.48 79.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -73.77 -27.75 61.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 66' ' ' LYS . 13.2 tp -81.36 -25.15 36.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.1 tt0 -37.53 -58.37 1.28 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.645 0.736 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.3 Cg_endo -69.82 -31.5 20.13 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.692 2.261 . . . . 0.0 112.28 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.632 ' HB2' HD12 ' A' ' 63' ' ' LEU . 16.0 mtpp -68.13 -29.98 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -92.47 -38.87 11.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HG3' ' CG ' ' A' ' 28' ' ' PRO . 5.5 ttmm -50.07 -58.68 5.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 9.6 mt-10 -41.59 -49.25 4.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 127' ' ' PHE . 25.1 tp -47.09 -41.39 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.56 -66.96 2.48 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.478 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.06 -26.54 68.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.85 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 69' ' ' GLU . 17.2 mmtt -70.09 -39.94 75.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.784 HD12 ' CG1' ' A' ' 82' ' ' ILE . 64.3 mt -79.13 4.86 13.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.3 t -56.97 -11.96 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.41 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 14.5 mmtp -82.68 -20.14 36.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.882 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CG ' ' O ' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -98.43 100.99 10.27 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.717 . . . . 0.0 110.855 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.4 Cg_endo -69.77 -2.91 10.98 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 0.0 112.322 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -107.7 -33.05 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.522 ' CG1' ' OD2' ' A' ' 47' ' ' ASP . 54.4 mt -92.05 117.93 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.1 t -118.2 125.44 74.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.106 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.784 ' CG1' HD12 ' A' ' 74' ' ' LEU . 30.7 mm -93.24 137.28 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.781 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -142.9 161.03 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.036 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.546 ' HG2' HG12 ' A' ' 29' ' ' VAL . 32.4 pttt -131.11 156.51 45.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.579 ' CB ' HD11 ' A' ' 50' ' ' ILE . 13.9 ttt -151.09 132.36 14.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 90' ' ' ASN . 26.1 t70 -91.32 95.85 10.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -52.28 -60.46 3.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.712 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -42.82 -27.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.38 -28.88 13.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.476 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.3 OUTLIER -134.88 114.97 13.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -47.2 131.24 13.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.423 HG13 ' HD2' ' A' ' 93' ' ' PRO . 93.0 t -80.86 132.85 56.2 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.59 0.709 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.468 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.6 Cg_endo -69.76 -165.83 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 0.0 112.326 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -124.13 160.89 50.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.645 0.736 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.5 Cg_endo -69.72 -8.75 10.59 Favored 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.356 -0.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 95' ' ' PRO . 98.3 m-85 -33.08 124.09 0.38 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -128.98 119.85 25.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.585 HG22 HG21 ' A' ' 103' ' ' THR . 71.0 t -121.66 96.47 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.17 -43.39 7.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.812 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.53 128.58 6.16 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.532 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -97.39 156.37 36.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.662 0.744 . . . . 0.0 110.858 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.6 Cg_endo -69.71 163.96 80.35 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.34 -0.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.585 HG21 HG22 ' A' ' 98' ' ' VAL . 50.2 m -145.73 106.09 4.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.407 HG22 ' CB ' ' A' ' 118' ' ' TYR . 22.5 mt -96.51 136.23 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.422 ' O ' HD12 ' A' ' 49' ' ' LEU . 8.4 m-85 -134.76 158.91 42.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -128.05 135.04 49.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 5.1 p -107.81 91.26 7.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.652 0.739 . . . . 0.0 110.832 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.497 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.8 Cg_endo -69.73 168.95 20.04 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.256 . . . . 0.0 112.339 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.24 140.11 35.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 41.01 31.36 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.497 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.7 mtmm -128.53 34.58 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 113' ' ' LEU . 27.3 mmtp -64.58 -58.24 6.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 112' ' ' LYS . 4.3 mm? -34.87 -41.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.909 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.405 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 6.4 m120 -134.97 92.64 18.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.572 0.701 . . . . 0.0 110.86 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.8 Cg_endo -69.79 -173.44 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -135.66 121.02 19.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.25 123.89 34.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.63 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 60.6 t80 -57.45 96.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.906 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -109.7 95.04 5.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.918 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.34 -151.51 9.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.36 135.11 13.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.484 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 122' ' ' ARG . 13.1 mtm105 -80.59 45.62 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -102.43 137.05 41.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.476 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.3 tm? -40.48 -52.43 2.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.8 m -66.3 -47.34 73.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -46.69 -36.75 7.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.918 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.63 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 65.3 m-85 -70.52 -44.68 67.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.4 mt -57.66 -56.41 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.119 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -65.68 -25.01 67.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.456 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 8.3 t80 -63.9 -50.62 68.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 132' ' ' GLN . 23.5 mt -71.69 -41.66 68.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 131' ' ' LEU . 10.2 mt-30 -37.74 -39.86 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -102.04 -51.4 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 7.4 mm-40 -51.98 -57.08 10.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.04 147.49 53.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.15 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.23 -49.06 20.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.2 m -42.88 -69.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.867 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.25 135.7 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -48.95 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.687 2.258 . . . . 0.0 112.368 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.6 m -147.99 126.38 12.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.84 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.3 m -135.71 133.97 38.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.6 p -171.09 167.17 7.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.377 . . . . 0.0 110.866 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -112.67 42.16 1.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.05 70.2 1.21 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 76.0 p -84.22 -44.48 13.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.914 0.388 . . . . 0.0 110.892 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 m -103.85 125.62 50.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.5 -172.19 13.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -83.43 103.71 13.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -107.34 178.4 4.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.56 60.96 0.39 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.5 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -96.47 83.39 3.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.854 0.359 . . . . 0.0 110.85 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.59 64.29 0.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.451 ' H ' ' CE ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -118.78 75.32 1.02 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -124.4 121.32 34.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.664 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 2.8 p90 -165.73 152.63 10.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 pp -102.9 -39.12 7.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.948 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -100.93 159.69 14.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.489 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 61.4 p -172.47 149.69 2.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 15.9 mm-40 -103.6 161.81 21.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.623 0.725 . . . . 0.0 110.908 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.78 144.63 54.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.259 . . . . 0.0 112.31 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.509 HD13 HG21 ' A' ' 33' ' ' VAL . 39.0 mm -71.93 132.97 84.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.619 0.723 . . . . 0.0 111.124 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 21' ' ' ILE . 54.0 Cg_endo -69.79 179.47 3.69 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.616 2.211 . . . . 0.0 112.349 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -104.1 -34.69 8.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 m -150.85 126.42 10.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -110.14 43.12 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.26 -28.81 44.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.04 165.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.421 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 53.6 Cg_endo -69.69 -20.56 35.01 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.277 . . . . 0.0 112.344 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.32 110.75 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -55.79 138.48 47.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.7 t -91.91 110.6 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.988 HG11 HG23 ' A' ' 41' ' ' VAL . 39.1 t -105.4 124.0 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.096 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 21' ' ' ILE . 27.0 m -119.77 145.78 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.664 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -31.64 -44.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.115 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -54.74 -49.12 71.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 33' ' ' VAL . 9.2 p-10 -114.25 38.36 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.741 ' CD2' HG21 ' A' ' 41' ' ' VAL . 8.4 t80 -75.32 -55.49 5.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.4 -15.23 62.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -78.99 -44.8 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.429 HD12 HG22 ' A' ' 32' ' ' VAL . 22.7 mt -97.46 -58.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.988 HG23 HG11 ' A' ' 32' ' ' VAL . 48.6 t -49.65 -61.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -73.2 126.99 31.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -172.53 106.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -79.15 -14.57 59.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -73.16 -44.24 60.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HE3' HG21 ' A' ' 81' ' ' VAL . 19.3 pttm -138.9 160.85 38.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.11 153.13 38.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.5 t -144.59 135.73 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.13 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 106' ' ' PHE . 14.4 tp -112.68 119.91 39.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' A' ' 85' ' ' MET . 1.8 tp -106.64 136.71 40.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' N ' HG13 ' A' ' 50' ' ' ILE . 1.2 tm-20 -127.5 115.46 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.409 ' C ' ' OE2' ' A' ' 51' ' ' GLU . 35.5 m-85 -91.64 139.54 30.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 10.4 p90 -144.63 177.12 8.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.536 ' HB1' ' CE2' ' A' ' 56' ' ' TRP . . . -132.72 131.14 21.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.598 0.713 . . . . 0.0 111.096 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.56 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.1 Cg_endo -69.72 -9.26 25.67 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.382 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.536 ' CE2' ' HB1' ' A' ' 54' ' ' ALA . 2.1 p-90 -110.6 23.21 14.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.4 t -134.2 108.74 8.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.41 -35.9 2.94 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.49 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.426 ' CD2' ' H ' ' A' ' 59' ' ' HIS . 16.3 m170 -42.59 -50.38 5.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.802 0.334 . . . . 0.0 110.872 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 64' ' ' GLU . 14.1 p -55.1 -42.13 72.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' N ' ' SG ' ' A' ' 60' ' ' CYS . 0.0 OUTLIER -62.37 -40.69 97.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.46 -36.96 71.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.71 HD12 ' HB2' ' A' ' 66' ' ' LYS . 39.4 tp -84.34 -20.07 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.543 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 3.3 tt0 -42.19 -57.95 3.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.738 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.82 -34.09 15.07 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.366 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.71 ' HB2' HD12 ' A' ' 63' ' ' LEU . 26.6 mtmt -66.85 -28.67 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -93.53 -49.77 5.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 71' ' ' GLY . 6.4 ttmm -39.08 -64.33 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 22.2 mt-10 -39.58 -46.87 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.453 ' N ' HD21 ' A' ' 124' ' ' LEU . 19.5 tp -53.03 -39.48 63.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 68' ' ' LYS . . . -57.32 -65.5 3.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.504 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -67.43 -24.42 65.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.493 ' CG ' ' O ' ' A' ' 69' ' ' GLU . 16.5 mmtm -69.87 -46.13 66.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.578 HD12 HD11 ' A' ' 82' ' ' ILE . 93.6 mt -80.16 3.23 21.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.6 t -53.33 -36.09 60.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -59.88 -11.16 4.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.859 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.97 100.72 12.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.654 0.74 . . . . 0.0 110.874 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 1.07 4.77 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.722 2.281 . . . . 0.0 112.339 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -110.87 -39.56 4.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.2 mt -87.08 113.6 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.175 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.421 HG21 ' HE3' ' A' ' 46' ' ' LYS . 96.4 t -108.34 117.01 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.578 HD11 HD12 ' A' ' 74' ' ' LEU . 39.6 mm -91.98 123.05 43.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.175 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.829 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -138.01 171.29 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -138.96 154.94 48.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.417 ' HB3' HD11 ' A' ' 50' ' ' ILE . 6.5 ttt -148.02 134.11 19.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.57 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 8.9 t0 -86.03 87.76 7.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -42.73 -67.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.084 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.56 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -37.75 -30.93 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -89.58 -35.7 15.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 2.9 m-80 -124.0 115.38 21.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -47.05 119.23 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.5 t -75.89 120.05 79.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.632 0.73 . . . . 0.0 111.15 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.75 -174.88 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.727 2.285 . . . . 0.0 112.346 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.505 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -105.07 159.62 28.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.674 0.75 . . . . 0.0 110.845 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.516 ' O ' ' C ' ' A' ' 96' ' ' TYR . 53.2 Cg_endo -69.82 -23.49 9.09 Favored 'Cis proline' 0 C--O 1.231 0.143 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.312 0.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.516 ' C ' ' O ' ' A' ' 95' ' ' PRO . 76.2 m-85 -27.47 114.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -127.22 90.38 3.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 103' ' ' THR . 78.6 t -80.0 99.43 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.157 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.7 mmm-85 -98.04 -44.18 6.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.91 133.37 7.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.52 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -101.78 156.86 34.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.608 0.718 . . . . 0.0 110.903 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.0 Cg_endo -69.79 145.4 79.38 Favored 'Cis proline' 0 C--O 1.232 0.206 0 C-N-CA 122.648 -1.813 . . . . 0.0 112.388 0.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.599 HG21 HG22 ' A' ' 98' ' ' VAL . 56.4 m -118.48 126.64 52.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.509 HD13 ' CE1' ' A' ' 127' ' ' PHE . 25.7 mt -121.34 127.19 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -127.53 152.1 48.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.461 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 21.5 t80 -126.44 130.22 50.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.858 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 33.3 t -100.77 99.31 9.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.671 0.748 . . . . 0.0 110.843 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.499 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.81 164.14 35.71 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.672 2.248 . . . . 0.0 112.343 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' ND2' ' A' ' 110' ' ' ASN . . . -78.84 134.96 36.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.089 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER 48.33 31.81 2.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.499 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 20.7 mtmt -133.98 33.92 3.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -58.35 -55.07 39.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -43.17 -39.34 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -133.82 89.67 29.46 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.63 0.729 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HG3' ' HG2' ' A' ' 95' ' ' PRO . 53.1 Cg_endo -69.81 -167.58 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.733 2.289 . . . . 0.0 112.293 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -135.16 111.36 9.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -82.18 128.41 34.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.629 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 75.3 t80 -69.67 99.8 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -112.08 90.89 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.847 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -171.68 -150.96 7.44 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.43 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.23 140.39 16.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -79.59 44.1 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 124' ' ' LEU . 6.4 tt0 -101.28 127.92 47.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.458 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -35.11 -56.19 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 53.0 p -61.86 -47.31 85.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -47.16 -36.5 8.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.629 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 77.1 m-85 -72.49 -49.49 32.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.5 mt -50.33 -56.07 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -37.08 83.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.838 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.535 ' CE2' ' HG3' ' A' ' 134' ' ' GLU . 63.8 t80 -57.11 -45.52 83.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.915 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 132' ' ' GLN . 60.7 mt -72.83 -40.46 65.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.429 ' HB3' ' NH1' ' A' ' 133' ' ' ARG . 30.4 mt-30 -37.4 -41.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.429 ' NH1' ' HB3' ' A' ' 132' ' ' GLN . 12.8 mmp_? -100.49 -60.33 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.535 ' HG3' ' CE2' ' A' ' 130' ' ' TYR . 16.2 mm-40 -38.73 -52.99 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.72 152.11 46.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.36 -51.53 5.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.8 m -48.73 -60.95 2.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.87 145.33 0.32 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -25.01 29.12 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.668 2.245 . . . . 0.0 112.353 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.3 m 60.36 40.39 17.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.3 m 59.08 41.16 21.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.885 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 -179.981 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.5 t -131.01 -43.96 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.919 0.39 . . . . 0.0 110.831 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 t 58.49 42.65 20.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.38 84.34 0.17 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.485 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.5 m -65.87 138.23 57.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.6 t -169.34 125.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.84 -135.03 4.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.432 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -165.83 141.47 4.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.883 0.373 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -107.02 44.69 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.827 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.46 109.71 3.88 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.5 92.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 110.926 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.493 ' H ' ' CD2' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -101.71 21.68 14.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.943 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -89.56 134.84 33.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -157.46 127.29 6.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -156.22 156.16 33.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.704 HD23 ' CG ' ' A' ' 91' ' ' ASP . 1.3 pt? -104.56 -36.99 7.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.515 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -121.46 174.0 7.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.955 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 89.0 p -172.84 171.17 4.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.505 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 5.3 mt-10 -106.44 159.9 28.14 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.625 0.726 . . . . 0.0 110.907 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 134.99 29.27 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.339 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.454 HD13 ' CG2' ' A' ' 33' ' ' VAL . 30.6 mm -68.93 122.3 84.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.647 0.737 . . . . 0.0 111.148 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 172.14 13.19 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.707 2.271 . . . . 0.0 112.318 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 24' ' ' SER . 6.4 pt-20 -99.94 -39.04 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.444 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 7.1 t -130.68 137.1 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -132.54 35.96 3.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.81 61.92 1.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.44 -174.36 13.69 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -33.45 16.53 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.653 2.235 . . . . 0.0 112.342 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.3 t -127.66 111.15 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.174 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -59.61 135.96 57.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.5 t -83.84 115.77 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.017 HG11 HG23 ' A' ' 41' ' ' VAL . 39.1 t -113.17 121.24 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.114 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 35' ' ' GLU . 4.5 m -114.13 148.14 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.154 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -33.88 -45.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.485 ' HB2' HG23 ' A' ' 33' ' ' VAL . 2.2 mm-40 -54.45 -50.21 68.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.859 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.463 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 9.5 p-10 -109.23 33.29 4.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.477 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 7.4 t80 -74.9 -48.08 26.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -72.64 -4.61 32.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -90.01 -42.75 10.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.618 HD12 HG22 ' A' ' 32' ' ' VAL . 14.3 mt -99.44 -62.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.171 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.017 HG23 HG11 ' A' ' 32' ' ' VAL . 41.1 t -50.2 -62.66 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -61.47 116.9 5.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.431 ' C ' ' HE3' ' A' ' 112' ' ' LYS . 3.3 t-20 -172.75 120.88 0.39 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CA ' ' HE3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -106.92 30.34 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -124.63 -27.09 3.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -138.47 160.13 40.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.46 126.51 31.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.507 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 39.1 t -126.32 152.52 33.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.49 HD13 HD21 ' A' ' 131' ' ' LEU . 14.7 tp -132.4 125.45 30.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.561 HD11 ' CB ' ' A' ' 85' ' ' MET . 1.9 tp -116.06 134.75 58.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.091 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -126.92 115.71 19.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.874 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -90.03 116.24 27.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.55 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 26.9 p90 -116.63 174.73 5.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.15 128.94 23.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.582 0.706 . . . . 0.0 111.136 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -19.14 36.63 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.676 2.251 . . . . 0.0 112.336 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.515 ' NE1' HG21 ' A' ' 88' ' ' THR . 3.7 p-90 -101.51 14.87 30.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.404 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 2.0 t -129.19 103.87 7.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -37.41 -39.63 0.54 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.49 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' GLY . 32.7 m170 -36.89 -45.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.768 0.318 . . . . 0.0 110.836 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 64' ' ' GLU . 27.9 p -54.61 -48.07 72.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 58' ' ' GLY . 28.9 mmtt -63.0 -41.93 99.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -67.88 -30.66 70.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 66' ' ' LYS . 67.0 tp -92.4 -19.42 22.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.543 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.6 tt0 -43.68 -57.99 5.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.598 0.713 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.77 -28.62 24.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.659 2.239 . . . . 0.0 112.38 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.913 ' HB2' HD12 ' A' ' 63' ' ' LEU . 13.7 mtpp -72.06 -30.17 64.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -93.65 -46.45 7.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.012 0.434 . . . . 0.0 110.94 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 71' ' ' GLY . 14.2 ttmt -44.58 -60.69 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 68' ' ' LYS . 18.6 mt-10 -38.05 -54.66 1.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' A' ' 127' ' ' PHE . 17.9 tp -49.08 -38.03 23.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.953 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 68' ' ' LYS . . . -58.89 -65.19 3.65 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -64.29 -27.67 69.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.916 0.389 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -69.73 -45.49 68.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.521 HD12 HD11 ' A' ' 82' ' ' ILE . 94.9 mt -80.71 3.19 23.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.9 t -54.57 -28.77 48.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.844 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.92 0.18 7.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.958 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.47 99.94 39.39 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.608 0.718 . . . . 0.0 110.866 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -0.16 6.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.361 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -110.56 -34.62 6.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.54 112.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.2 t -109.57 119.35 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 74' ' ' LEU . 32.1 mm -93.29 117.47 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.76 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -128.42 166.18 19.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -134.37 155.77 49.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.938 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.561 ' CB ' HD11 ' A' ' 50' ' ' ILE . 11.9 ttt -149.24 161.29 42.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.908 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -109.2 119.58 39.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.0 -70.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.515 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.5 OUTLIER -47.77 -28.05 2.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.908 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -91.18 -31.1 16.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 8.0 m-80 -131.1 102.18 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.704 ' CG ' HD23 ' A' ' 16' ' ' LEU . 9.5 t0 -41.16 122.89 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 98' ' ' VAL . 92.2 t -82.04 121.67 79.16 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.661 0.744 . . . . 0.0 111.086 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.74 -167.21 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.717 2.278 . . . . 0.0 112.365 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.512 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -109.11 160.05 28.94 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.749 . . . . 0.0 110.833 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.5 Cg_endo -69.74 -20.18 10.85 Favored 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.634 -1.819 . . . . 0.0 112.373 -0.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.509 ' C ' ' O ' ' A' ' 95' ' ' PRO . 84.5 m-85 -28.55 113.36 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -122.87 85.85 2.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 92' ' ' VAL . 85.8 t -77.2 120.57 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.0 mmm-85 -122.05 -48.12 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.12 130.11 7.87 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.519 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -102.42 156.09 35.7 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.658 0.742 . . . . 0.0 110.886 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.66 143.92 75.0 Favored 'Cis proline' 0 C--O 1.231 0.151 0 C-N-CA 122.713 -1.786 . . . . 0.0 112.338 -0.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.544 HG21 HG22 ' A' ' 98' ' ' VAL . 80.1 m -114.33 127.74 56.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.174 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.5 mt -120.18 135.91 58.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.165 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -134.26 169.99 16.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 31.1 t80 -139.5 131.72 28.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.8 t -101.65 97.98 8.77 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.618 0.723 . . . . 0.0 110.842 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.447 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.79 169.29 19.29 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.718 2.279 . . . . 0.0 112.329 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.62 126.49 36.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 64.59 26.48 13.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.3 mtmm -131.78 26.5 4.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -47.42 -57.94 4.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.1 mp -39.38 -41.99 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.936 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -134.39 99.45 13.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.652 0.739 . . . . 0.0 110.874 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -164.29 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.672 2.248 . . . . 0.0 112.337 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 106' ' ' PHE . 15.4 mmtm -133.34 118.21 18.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -88.52 148.49 24.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.941 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -94.84 108.42 20.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.942 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -118.68 92.43 3.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.46 -143.74 4.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.454 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.01 142.83 16.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.468 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -82.01 41.71 0.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 110.846 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 124' ' ' LEU . 16.4 tp10 -98.06 129.68 44.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.592 ' CD1' HD11 ' A' ' 128' ' ' ILE . 2.7 tm? -34.91 -56.55 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 64.7 p -57.62 -47.36 82.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.07 -32.61 22.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.555 ' HB3' HD22 ' A' ' 70' ' ' LEU . 52.2 m-85 -74.5 -39.3 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.592 HD11 ' CD1' ' A' ' 124' ' ' LEU . 24.9 mt -64.64 -65.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -54.08 -31.04 50.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.438 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 49.1 t80 -60.4 -47.91 84.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 49' ' ' LEU . 48.7 mt -73.72 -39.17 64.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -38.66 -38.65 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -102.29 -51.04 3.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.438 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 5.2 mm-40 -51.54 -57.16 9.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.72 150.26 41.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.75 -50.98 10.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.2 m -75.87 49.31 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -47.75 141.13 8.2 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.525 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 110.63 2.59 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.671 2.247 . . . . 0.0 112.394 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.4 t -84.29 80.12 9.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.852 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.8 p -45.33 151.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.838 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.454 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 m -81.92 45.46 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 0.0 110.824 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.2 t -85.74 148.35 25.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.5 107.2 0.25 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -81.17 107.37 13.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.368 . . . . 0.0 110.864 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m -107.78 110.13 21.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.822 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 8' ' ' PHE . . . -126.81 45.49 1.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.54 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' A' ' 7' ' ' GLY . 8.5 p90 -35.91 -53.0 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.797 0.332 . . . . 0.0 110.848 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -69.22 121.72 17.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.32 -151.21 15.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.506 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 57.15 40.88 27.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 110.872 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.459 ' CD2' ' O ' ' A' ' 94' ' ' SER . 2.4 tt -72.15 93.57 1.45 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.06 144.7 2.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -175.83 141.97 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -173.34 157.42 3.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.0 pp -106.28 -44.23 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.568 ' N ' HD12 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -112.48 152.54 28.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.433 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 3.3 m -162.86 166.57 23.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.852 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.453 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.1 mm-40 -105.3 162.27 20.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.672 0.748 . . . . 0.0 110.841 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 54.2 Cg_endo -69.75 143.47 50.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.736 2.291 . . . . 0.0 112.331 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.597 HD13 HG21 ' A' ' 33' ' ' VAL . 12.4 mm -69.08 135.1 89.42 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.639 0.733 . . . . 0.0 111.125 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 21' ' ' ILE . 53.3 Cg_endo -69.79 174.66 9.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.671 2.247 . . . . 0.0 112.303 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.6 -38.11 5.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 t -135.18 116.62 14.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -114.63 43.29 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.58 51.01 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.65 -176.83 16.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.517 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -42.21 3.57 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.692 2.261 . . . . 0.0 112.367 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.558 HG12 ' HG2' ' A' ' 84' ' ' LYS . 49.5 t -113.03 107.79 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.104 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.575 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -60.41 130.39 46.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.8 t -80.31 121.87 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.154 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.996 HG11 HG23 ' A' ' 41' ' ' VAL . 40.6 t -114.71 120.37 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.178 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 21' ' ' ILE . 18.6 m -111.69 142.88 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -33.49 -37.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HB3' HD11 ' A' ' 21' ' ' ILE . 9.4 mt-10 -60.52 -48.26 82.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 33' ' ' VAL . 14.5 p-10 -107.56 25.03 11.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.659 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 20.2 t80 -65.68 -55.21 18.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.427 ' HA ' ' CG ' ' A' ' 42' ' ' ASN . 6.2 t70 -67.72 -3.91 10.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -92.67 -43.57 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.2 mt -99.19 -52.65 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.179 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.996 HG23 HG11 ' A' ' 32' ' ' VAL . 89.3 t -60.79 -61.41 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.436 ' OD1' ' CE1' ' A' ' 37' ' ' PHE . 2.0 m-20 -67.31 123.22 19.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -175.54 111.88 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.71 33.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -128.04 -30.14 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.555 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 34.5 pttt -138.16 166.31 24.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.86 144.86 25.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.522 HG22 ' HB ' ' A' ' 81' ' ' VAL . 93.1 t -146.58 148.76 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.4 tp -123.81 125.45 44.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.932 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.3 tp -110.83 134.35 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' OE1' ' CG1' ' A' ' 104' ' ' ILE . 3.1 tp10 -127.42 112.83 15.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.406 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 61.0 m-85 -87.21 115.57 24.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.95 171.81 7.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.968 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.13 131.78 23.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -6.24 18.12 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.727 2.285 . . . . 0.0 112.319 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.483 ' CZ2' HG21 ' A' ' 88' ' ' THR . 6.8 p-90 -124.39 25.98 7.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 10.2 t -128.75 112.46 14.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -52.14 -61.55 6.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.493 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -41.54 -37.91 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.838 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 88.7 m -74.35 -34.76 63.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 58' ' ' GLY . 3.8 ttmt -70.29 -35.1 73.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -72.3 -23.34 61.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 64' ' ' GLU . 11.8 tp -85.24 -29.74 24.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.562 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.6 tp10 -36.74 -55.92 1.46 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.658 0.742 . . . . 0.0 110.851 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.8 Cg_endo -69.75 -36.15 11.37 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.675 2.25 . . . . 0.0 112.367 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -66.1 -28.07 68.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CZ ' HG23 ' A' ' 82' ' ' ILE . 35.9 t80 -95.3 -38.72 10.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -45.73 -58.8 3.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -43.69 -50.13 7.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.477 ' N ' HD21 ' A' ' 124' ' ' LEU . 17.9 tp -46.09 -37.08 6.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.58 -62.3 6.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.473 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -68.37 -22.9 64.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -72.65 -49.41 31.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.466 HD22 ' OD2' ' A' ' 77' ' ' ASP . 95.0 mt -80.06 2.98 21.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.939 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.4 t -51.02 -24.11 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -86.5 17.13 4.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.466 ' OD2' HD22 ' A' ' 74' ' ' LEU . 75.5 m-20 -110.21 98.11 33.81 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.592 0.71 . . . . 0.0 110.917 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.6 Cg_endo -69.78 -1.81 9.12 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 0.0 112.339 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -122.08 8.87 9.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.0 mt -134.72 142.47 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.522 ' HB ' HG22 ' A' ' 48' ' ' VAL . 87.1 t -139.12 106.64 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.53 HG23 ' CZ ' ' A' ' 67' ' ' TYR . 46.3 mm -83.73 125.92 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.129 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.744 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -143.35 170.92 14.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.133 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.558 ' HG2' HG12 ' A' ' 29' ' ' VAL . 54.5 pttt -140.63 154.01 46.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.3 ttt -140.85 142.51 34.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 26.7 t0 -91.54 82.28 5.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -41.4 -48.54 3.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.483 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 19.9 p -57.38 -33.34 67.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -103.31 13.29 34.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.503 ' ND2' ' C ' ' A' ' 89' ' ' ALA . 8.6 m-80 -162.91 107.77 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -44.97 127.65 6.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.409 HG11 HG23 ' A' ' 98' ' ' VAL . 90.6 t -78.01 122.57 85.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.597 0.713 . . . . 0.0 111.164 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -166.51 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.378 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.494 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -118.85 161.78 34.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.727 . . . . 0.0 110.85 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.2 Cg_endo -69.66 -13.78 12.24 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.679 -1.8 . . . . 0.0 112.373 -0.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.468 ' C ' ' O ' ' A' ' 95' ' ' PRO . 83.2 m-85 -32.09 120.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.941 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -129.68 76.46 1.72 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.543 HG22 HG21 ' A' ' 103' ' ' THR . 86.4 t -74.41 125.17 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -123.2 -42.28 2.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.2 129.41 6.72 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.452 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.529 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.87 154.84 37.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.678 0.751 . . . . 0.0 110.848 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.1 Cg_endo -69.76 162.2 84.61 Favored 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.669 -1.805 . . . . 0.0 112.348 0.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.543 HG21 HG22 ' A' ' 98' ' ' VAL . 31.4 m -140.95 106.16 5.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.16 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.584 HD13 ' HE1' ' A' ' 127' ' ' PHE . 41.4 mt -101.1 123.86 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.49 ' CZ ' ' HE3' ' A' ' 117' ' ' LYS . 10.4 m-85 -123.92 147.05 48.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 24.6 t80 -117.78 133.79 55.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -103.73 94.46 6.26 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.678 0.751 . . . . 0.0 110.897 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.503 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.75 164.8 33.19 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.665 2.243 . . . . 0.0 112.356 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -80.75 139.74 35.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.8 p-10 47.85 25.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.503 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 23.4 mtmt -129.16 19.75 5.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.847 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -43.24 -68.28 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.929 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 112' ' ' LYS . 4.5 mm? -33.94 -51.75 0.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 11.5 m120 -112.16 96.19 33.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.721 . . . . 0.0 110.898 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.5 Cg_endo -69.75 -170.78 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 0.0 112.34 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -138.85 110.1 6.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.49 ' HE3' ' CZ ' ' A' ' 105' ' ' TYR . 30.0 tttt -73.83 156.54 37.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -106.35 96.58 6.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -111.51 102.13 10.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 179.56 -151.31 9.98 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.83 130.91 10.0 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -79.58 44.5 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.323 . . . . 0.0 110.908 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 124' ' ' LEU . 9.8 tt0 -105.66 133.48 50.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.602 HD13 ' C ' ' A' ' 124' ' ' LEU . 2.9 tm? -35.56 -55.79 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 44.8 p -57.9 -46.99 84.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -51.19 -37.13 44.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.584 ' HE1' HD13 ' A' ' 104' ' ' ILE . 61.7 m-85 -69.89 -45.79 66.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 124' ' ' LEU . 33.7 mt -59.0 -59.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -60.08 -30.27 69.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 130' ' ' TYR . 3.9 t80 -59.52 -45.63 91.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.927 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 132' ' ' GLN . 19.0 mt -76.02 -43.35 44.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.938 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 131' ' ' LEU . 15.9 mt-30 -36.12 -39.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.447 ' HB3' ' NH1' ' A' ' 133' ' ' ARG . 5.4 ptp180 -99.39 -48.43 4.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.78 -61.57 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -43.24 126.24 4.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.421 HG23 ' NZ ' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -52.89 -74.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.114 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 t -51.2 -57.14 9.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.13 172.06 43.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.51 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 160.42 49.8 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.652 2.235 . . . . 0.0 112.39 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 m -43.9 162.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.847 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 96.4 p -147.8 125.88 12.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.517 -179.954 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 t -144.33 164.81 29.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 0.0 110.849 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 p -115.78 152.23 33.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.17 82.76 0.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.5 m -98.58 154.01 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.904 0.383 . . . . 0.0 110.858 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.0 t -146.06 117.11 7.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.839 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 149.13 90.2 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.506 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -106.58 -52.92 2.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 110.822 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.65 93.17 1.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.43 -170.68 14.95 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.439 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -95.51 81.84 3.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 0.0 110.876 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.666 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -82.68 15.04 2.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.897 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HE3' ' CG ' ' A' ' 38' ' ' ASP . 1.4 mmpt? -71.24 123.2 21.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -158.39 125.35 4.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.861 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -169.87 160.37 8.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 17' ' ' LYS . 3.9 pp -103.17 -41.86 5.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.691 ' HB3' HD12 ' A' ' 16' ' ' LEU . 18.7 ptmt -130.23 157.96 41.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.52 ' OG ' ' HB3' ' A' ' 34' ' ' ALA . 8.7 t -162.08 166.05 26.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 3.5 mm-40 -105.6 161.7 21.98 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.684 0.754 . . . . 0.0 110.835 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.447 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.78 145.34 56.71 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.67 2.247 . . . . 0.0 112.349 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.683 HD11 ' HB3' ' A' ' 35' ' ' GLU . 28.4 mm -68.78 132.04 90.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.62 0.724 . . . . 0.0 111.144 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 175.74 7.71 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.69 2.26 . . . . 0.0 112.386 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 24' ' ' SER . 6.6 pt-20 -108.72 -37.5 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.419 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 85.3 p -129.62 130.14 45.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.891 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -133.77 43.03 2.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 27' ' ' GLY . 2.9 m-20 -72.65 -19.13 61.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -45.54 173.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.505 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -30.13 22.8 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.7 2.266 . . . . 0.0 112.313 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.676 HG12 ' HG2' ' A' ' 84' ' ' LYS . 39.8 t -116.84 106.65 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.15 132.16 52.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.1 t -83.11 125.34 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.168 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.827 HG11 HG23 ' A' ' 41' ' ' VAL . 18.0 t -120.79 129.93 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.515 HG22 ' OD1' ' A' ' 36' ' ' ASN . 15.0 m -121.86 145.85 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HB3' ' OG ' ' A' ' 18' ' ' SER . . . -37.8 -28.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.683 ' HB3' HD11 ' A' ' 21' ' ' ILE . 3.9 mt-10 -66.71 -45.06 79.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.515 ' OD1' HG22 ' A' ' 33' ' ' VAL . 39.9 p-10 -119.41 37.45 4.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.585 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 8.3 t80 -71.63 -51.43 23.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.43 ' CG ' ' HE3' ' A' ' 13' ' ' LYS . 3.4 m-20 -69.09 -12.33 61.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.41 -41.29 20.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.8 mt -99.34 -60.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.827 HG23 HG11 ' A' ' 32' ' ' VAL . 43.6 t -52.82 -62.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -72.74 130.35 40.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -173.55 106.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.416 ' HB3' ' NZ ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -83.25 36.27 0.52 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -133.72 -36.43 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -139.08 145.79 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 1.4 m-20 -66.35 135.59 54.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' A' ' 41' ' ' VAL . 60.7 t -130.48 145.08 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.841 HD13 HD21 ' A' ' 131' ' ' LEU . 6.7 tp -124.6 118.8 27.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.607 HD13 ' CG2' ' A' ' 41' ' ' VAL . 2.0 tp -106.09 137.55 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.25 117.65 22.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -93.23 137.98 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.908 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 3.8 p90 -142.36 171.93 13.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.98 133.03 24.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 111.119 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -0.76 7.41 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 0.0 112.308 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.422 ' CZ2' ' CG2' ' A' ' 88' ' ' THR . 2.4 p-90 -128.63 24.41 5.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.0 t -120.31 110.81 17.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -40.87 -58.5 2.65 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.464 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.469 ' C ' ' O ' ' A' ' 58' ' ' GLY . 3.7 t-160 -32.98 -62.49 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 110.839 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' GLU . 3.9 t -40.15 -49.81 2.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.886 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -56.77 -48.88 76.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -70.76 -21.95 62.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.29 -19.99 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.1 tt0 -43.32 -57.91 4.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 0.0 110.938 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.5 Cg_endo -69.78 -33.38 16.63 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.693 2.262 . . . . 0.0 112.335 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -66.37 -32.23 73.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 68' ' ' LYS . 31.7 t80 -89.22 -47.77 7.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 67' ' ' TYR . 14.8 ttmt -37.75 -60.15 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -38.78 -59.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 127' ' ' PHE . 24.5 tp -41.99 -36.99 1.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.2 -69.14 1.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.459 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -64.58 -23.01 67.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -71.51 -39.97 70.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.597 HD12 HD11 ' A' ' 82' ' ' ILE . 85.1 mt -88.58 3.16 51.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 t -55.15 -31.73 61.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' A' ' 76' ' ' LYS . 25.5 ttpt -73.0 1.47 8.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 3.6 t70 -102.5 100.07 14.92 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.88 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.4 Cg_endo -69.81 0.46 5.65 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.64 2.226 . . . . 0.0 112.34 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -111.69 -41.36 4.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.529 HG21 HD13 ' A' ' 74' ' ' LEU . 63.0 mt -90.74 138.09 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.9 t -133.94 113.5 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.597 HD11 HD12 ' A' ' 74' ' ' LEU . 39.6 mm -82.45 131.97 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.781 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -143.63 170.97 14.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.088 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.676 ' HG2' HG12 ' A' ' 29' ' ' VAL . 12.4 pttp -143.07 154.39 43.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.9 ttt -150.08 133.36 16.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -85.28 76.52 10.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -35.71 -61.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.06 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 87' ' ' ALA . 43.9 p -32.26 -41.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.136 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HB3' ' OD2' ' A' ' 86' ' ' ASP . . . -94.66 -31.14 13.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.094 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 87' ' ' ALA . 35.9 m-80 -111.14 101.54 10.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -43.58 123.8 3.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.448 HG11 HG23 ' A' ' 98' ' ' VAL . 73.1 t -66.66 129.2 94.11 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.572 0.701 . . . . 0.0 111.172 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -163.53 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.625 2.217 . . . . 0.0 112.383 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.503 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -131.41 160.85 65.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.649 0.738 . . . . 0.0 110.828 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.1 Cg_endo -69.82 -4.55 8.45 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.706 -1.789 . . . . 0.0 112.304 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.447 ' N ' ' HA ' ' A' ' 94' ' ' SER . 65.9 m-85 -34.55 127.44 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.63 116.08 18.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.678 HG22 HG21 ' A' ' 103' ' ' THR . 57.9 t -123.64 115.94 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.88 -47.0 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.855 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.19 130.42 8.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.5 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.534 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -99.08 155.81 36.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.692 0.758 . . . . 0.0 110.875 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.2 Cg_endo -69.68 163.16 82.34 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.375 -0.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.678 HG21 HG22 ' A' ' 98' ' ' VAL . 26.5 m -142.36 106.29 4.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.2 mt -95.5 142.8 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.479 ' HB2' HG23 ' A' ' 50' ' ' ILE . 7.5 m-85 -134.52 179.14 6.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' LYS . 19.3 t80 -147.75 135.49 20.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.43 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 33.8 t -104.72 94.62 7.59 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.696 0.76 . . . . 0.0 110.814 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.476 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.74 159.68 52.52 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.67 2.247 . . . . 0.0 112.38 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.38 130.82 34.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.125 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 64.71 24.98 12.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.476 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 14.0 mtmt -131.75 18.31 4.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -44.25 -63.16 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.925 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -39.29 -32.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 1.9 t30 -134.02 98.31 14.48 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.647 0.737 . . . . 0.0 110.891 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.49 ' CD ' ' HG2' ' A' ' 95' ' ' PRO . 54.2 Cg_endo -69.75 179.24 3.83 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -134.77 125.18 26.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -90.65 146.22 24.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -83.92 121.87 27.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -122.24 104.09 9.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.91 -170.39 43.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.478 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.74 141.26 26.19 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.508 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.89 47.31 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 110.844 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 124' ' ' LEU . 27.2 tt0 -102.02 129.45 48.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.447 HD21 ' N ' ' A' ' 70' ' ' LEU . 2.4 tm? -33.75 -54.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.7 t -60.74 -47.1 87.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -44.35 -42.02 6.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.457 ' HB2' HD13 ' A' ' 70' ' ' LEU . 62.8 m-85 -68.31 -44.52 75.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.858 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.06 -53.12 52.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 t -65.31 -39.5 92.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.53 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 36.4 t80 -56.71 -53.07 61.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.841 HD21 HD13 ' A' ' 49' ' ' LEU . 68.3 mt -67.21 -42.9 83.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 131' ' ' LEU . 16.3 mt-30 -36.96 -40.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -99.15 -61.68 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.53 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 11.3 mm-40 -42.2 -54.2 3.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.72 132.0 30.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.58 -75.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.9 t -48.7 -62.07 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.6 144.07 16.25 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.451 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 140' ' ' SER . 53.9 Cg_endo -69.75 2.9 3.11 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.694 2.263 . . . . 0.0 112.386 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 139' ' ' PRO . 83.5 p -33.48 114.33 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.836 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.3 p -123.9 105.53 9.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.86 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.446 179.97 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -140.12 162.12 35.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.875 0.369 . . . . 0.0 110.844 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.3 p -147.55 167.96 23.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.44 96.51 0.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.518 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -150.04 134.42 17.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.888 0.375 . . . . 0.0 110.849 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.9 p -99.86 130.33 46.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.832 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.13 102.47 2.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.512 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -162.17 115.49 1.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 110.836 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -130.14 119.94 23.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.48 164.22 27.03 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.476 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -70.77 88.54 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.39 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.615 HD21 ' HD3' ' A' ' 95' ' ' PRO . 25.5 tp -95.83 89.58 5.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.465 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 0.7 OUTLIER -159.88 159.67 32.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -173.71 129.29 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.468 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.5 p90 -161.23 147.79 14.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.54 HD12 ' HB3' ' A' ' 17' ' ' LYS . 3.9 pp -94.79 -39.48 10.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.54 ' HB3' HD12 ' A' ' 16' ' ' LEU . 7.7 ptmt -116.49 156.93 26.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 76.8 p -160.61 149.58 16.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.437 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 10.2 mm-40 -92.53 161.3 32.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.62 0.724 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.437 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.74 141.17 44.59 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.372 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.465 HD13 ' CG2' ' A' ' 33' ' ' VAL . 13.3 mm -69.44 130.84 90.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.731 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 160.59 49.13 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.682 2.255 . . . . 0.0 112.369 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.89 -38.65 13.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -141.77 105.3 4.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -122.65 46.56 2.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -87.5 39.48 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.12 -160.57 36.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.476 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -42.84 3.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 0.0 112.362 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.565 HG13 HG22 ' A' ' 82' ' ' ILE . 10.9 t -116.57 104.72 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -52.83 135.39 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.0 t -84.23 120.69 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.176 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.159 HG11 HG23 ' A' ' 41' ' ' VAL . 12.9 t -119.45 115.32 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.117 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 35' ' ' GLU . 27.9 m -111.52 141.71 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -30.44 -38.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 33' ' ' VAL . 6.7 mt-10 -56.3 -51.51 67.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 33' ' ' VAL . 53.1 p-10 -110.48 24.76 12.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.765 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 13.1 t80 -63.19 -51.15 67.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -4.95 18.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.831 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -92.17 -43.84 9.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.3 mt -97.11 -61.16 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.107 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.159 HG23 HG11 ' A' ' 32' ' ' VAL . 78.5 t -53.16 -62.17 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -65.46 120.18 12.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.435 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 4.1 t-20 -174.94 119.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' CA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -104.93 32.44 4.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -127.7 -31.22 2.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 14.3 pttp -138.29 136.95 36.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.81 138.6 53.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.57 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 40.9 t -137.31 159.13 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.51 ' N ' HG12 ' A' ' 48' ' ' VAL . 16.1 tp -140.21 132.17 27.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.923 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' A' ' 96' ' ' TYR . 3.3 tp -116.21 141.36 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.175 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.545 ' OE2' ' CG ' ' A' ' 67' ' ' TYR . 2.5 tt0 -125.49 118.74 26.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -98.9 108.42 21.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -115.75 -179.15 3.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.779 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -133.73 132.98 21.9 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 0.0 111.085 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 -1.01 7.74 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -126.31 5.79 7.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.779 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -99.89 129.47 45.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.836 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.16 -45.9 14.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.46 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -48.32 -27.72 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.836 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.0 m -80.13 -44.0 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -55.29 -42.33 73.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -70.49 -20.54 62.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.946 HD12 ' HB2' ' A' ' 66' ' ' LYS . 8.4 tp -94.22 -23.16 18.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.557 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 5.1 tt0 -33.71 -57.13 0.64 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 0.0 110.914 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.78 -27.29 26.54 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.721 2.281 . . . . 0.0 112.328 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.946 ' HB2' HD12 ' A' ' 63' ' ' LEU . 2.7 mmpt? -72.39 -30.97 65.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.545 ' CG ' ' OE2' ' A' ' 51' ' ' GLU . 37.9 t80 -95.97 -40.09 9.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.471 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -55.66 -43.28 76.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -53.54 -53.42 51.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.463 ' N ' HD21 ' A' ' 124' ' ' LEU . 20.3 tp -43.45 -38.35 2.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.08 -64.56 3.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.97 -21.36 66.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.937 0.398 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -79.32 -45.05 20.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ASP . 78.6 mt -84.06 1.64 43.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 m -40.19 -27.94 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -85.0 25.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 74' ' ' LEU . 51.2 p-10 -103.9 93.41 5.29 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.618 0.723 . . . . 0.0 110.863 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 54.1 Cg_endo -69.78 0.58 5.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.334 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -122.91 -44.72 2.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.452 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 37.0 mt -87.71 144.59 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.5 t -136.0 107.38 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.179 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.565 HG22 HG13 ' A' ' 29' ' ' VAL . 38.2 mm -76.17 131.44 34.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.678 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -145.83 173.87 11.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.561 ' HG2' HG12 ' A' ' 29' ' ' VAL . 25.1 pttt -148.57 157.59 43.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.448 ' CB ' HD11 ' A' ' 50' ' ' ILE . 1.9 tmm? -149.59 148.11 28.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 90' ' ' ASN . 49.8 t0 -97.74 99.65 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.94 80.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 88' ' ' THR . 2.7 p -66.12 -17.27 64.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -117.89 -10.97 10.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.1 m-80 -139.62 107.63 5.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.41 ' HB3' ' CB ' ' A' ' 15' ' ' TYR . 7.0 t0 -42.27 138.06 1.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.516 HG21 ' CG2' ' A' ' 98' ' ' VAL . 74.6 t -80.51 128.32 72.83 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.625 0.726 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 54.4 Cg_endo -69.72 -165.64 0.16 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.723 2.282 . . . . 0.0 112.35 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.535 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 0.8 OUTLIER -127.44 154.59 77.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.655 0.741 . . . . 0.0 110.851 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.615 ' HD3' HD21 ' A' ' 12' ' ' LEU . 54.1 Cg_endo -69.75 -6.03 9.19 Favored 'Cis proline' 0 N--CA 1.466 -0.13 0 C-N-CA 122.709 -1.788 . . . . 0.0 112.372 0.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.525 ' HE2' HG21 ' A' ' 50' ' ' ILE . 33.1 m-85 -33.01 137.45 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -151.63 120.89 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.843 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.516 ' CG2' HG21 ' A' ' 92' ' ' VAL . 39.7 t -113.42 110.07 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.11 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.8 -45.32 5.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -132.32 132.01 6.48 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.483 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.539 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -96.95 154.86 38.1 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.658 0.742 . . . . 0.0 110.899 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.0 Cg_endo -69.74 159.51 89.52 Favored 'Cis proline' 0 C--O 1.232 0.191 0 C-N-CA 122.696 -1.793 . . . . 0.0 112.379 0.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.457 ' OG1' HG13 ' A' ' 98' ' ' VAL . 93.4 m -137.98 111.55 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.147 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.451 HG12 ' CG ' ' A' ' 51' ' ' GLU . 86.9 mt -109.82 131.88 59.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -123.12 -176.38 3.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 29.1 t80 -152.82 132.22 12.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.887 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.2 t -103.6 96.31 8.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.69 0.757 . . . . 0.0 110.895 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.473 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.5 Cg_endo -69.68 168.26 21.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.719 2.279 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.404 ' HB3' HG21 ' A' ' 136' ' ' THR . . . -87.2 135.15 33.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 54.67 25.73 6.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.473 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 10.6 mtmt -129.53 21.59 5.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.513 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -49.33 -41.63 39.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -52.42 -39.7 61.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 7.6 m120 -134.74 97.97 13.69 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.593 0.711 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 54.3 Cg_endo -69.69 -170.63 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.674 2.249 . . . . 0.0 112.372 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -136.27 139.07 42.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -107.21 137.03 46.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.433 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 62.8 t80 -78.85 107.84 11.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -124.03 95.17 4.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.39 -139.52 3.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.95 128.52 9.18 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -79.7 49.52 1.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.761 0.315 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 124' ' ' LEU . 5.4 tp10 -112.74 132.46 55.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.563 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.5 tm? -34.44 -51.49 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.5 p -63.11 -53.22 56.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.17 -36.53 2.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.433 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 52.8 m-85 -68.91 -43.62 74.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.4 mt -55.89 -63.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.099 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.3 t -54.74 -36.54 64.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 44.3 t80 -55.18 -50.87 68.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.916 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.3 -42.15 69.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -43.61 -41.44 4.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.43 ' CG ' ' N ' ' A' ' 134' ' ' GLU . 12.9 ptm180 -91.57 -53.06 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.435 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 26.1 mm-40 -51.93 -62.87 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -37.41 105.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.078 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 137' ' ' SER . 1.8 t -49.84 -52.78 29.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.494 ' H ' HG23 ' A' ' 136' ' ' THR . 1.3 t -74.5 -41.51 60.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.02 161.6 0.2 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.465 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 114.63 3.77 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.716 2.277 . . . . 0.0 112.309 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.6 p -121.61 168.93 11.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.0 t -115.89 153.83 30.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.0 p -119.85 99.17 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.886 0.374 . . . . 0.0 110.855 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.0 t -153.4 159.15 42.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.855 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.89 111.35 1.07 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 t -134.42 139.59 45.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 t -172.99 155.85 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.24 174.49 35.69 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -95.4 143.06 27.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.6 -53.09 62.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.34 66.57 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -82.32 39.53 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.2 mt -97.3 45.84 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -115.11 141.33 48.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.479 ' HD3' ' N ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -174.72 121.95 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.879 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -151.49 154.59 36.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -106.3 -33.32 7.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.944 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.456 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 10.7 mtpp -101.57 163.86 12.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.0 p -166.5 134.28 2.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.726 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 2.4 mm-40 -98.24 161.63 24.75 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.887 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.9 Cg_endo -69.75 140.07 41.8 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.679 2.253 . . . . 0.0 112.336 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.604 HD13 HG21 ' A' ' 33' ' ' VAL . 15.8 mm -70.46 123.41 88.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 111.107 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 130.19 18.91 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.671 2.248 . . . . 0.0 112.35 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.21 -46.81 69.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 t -144.96 133.22 21.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -106.7 48.71 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -50.28 -33.16 18.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.07 164.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.445 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -22.99 31.29 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.674 2.249 . . . . 0.0 112.341 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.454 HG13 HG22 ' A' ' 82' ' ' ILE . 32.9 t -119.33 112.19 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -57.89 137.23 56.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.7 t -90.49 116.24 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.133 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.819 HG11 HG23 ' A' ' 41' ' ' VAL . 19.6 t -105.98 124.73 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 21' ' ' ILE . 15.8 m -118.66 148.16 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.879 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -38.1 -36.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.152 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -62.78 -50.64 70.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.486 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 11.4 p-10 -108.33 28.57 8.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.583 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 5.5 t80 -67.51 -55.78 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.835 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -66.11 -5.26 9.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -88.42 -43.11 11.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.43 HD12 HG22 ' A' ' 32' ' ' VAL . 18.1 mt -98.35 -54.14 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.127 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.819 HG23 HG11 ' A' ' 32' ' ' VAL . 40.4 t -56.09 -61.58 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -67.44 112.67 4.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' ND2' ' HE2' ' A' ' 46' ' ' LYS . 13.4 t-20 -173.23 105.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.85 4.64 47.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -90.69 -35.03 15.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HE2' ' ND2' ' A' ' 43' ' ' ASN . 45.9 pttt -138.52 151.95 47.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.9 136.1 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.61 136.01 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.127 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.8 tp -116.11 119.24 35.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 105' ' ' TYR . 2.3 tp -106.81 134.88 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.166 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -127.21 120.08 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -95.87 122.47 38.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CE1' ' OD1' ' A' ' 86' ' ' ASP . 13.1 p90 -124.4 -179.6 4.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.927 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.63 133.48 21.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.565 0.698 . . . . 0.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.426 ' HD2' HG21 ' A' ' 88' ' ' THR . 53.6 Cg_endo -69.73 -6.28 18.2 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.687 2.258 . . . . 0.0 112.347 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -122.89 21.92 9.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t -120.2 111.14 17.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.06 -47.71 6.43 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -46.68 -37.25 8.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.771 0.32 . . . . 0.0 110.858 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 34.7 t -63.46 -44.5 94.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.908 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -65.5 -42.16 92.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -72.68 -35.0 67.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' A' ' 66' ' ' LYS . 14.0 tp -81.97 -26.77 33.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.527 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.3 tt0 -38.08 -58.1 1.54 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.608 0.718 . . . . 0.0 110.926 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.7 Cg_endo -69.82 -31.11 20.91 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.625 2.217 . . . . 0.0 112.332 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HB2' HD12 ' A' ' 63' ' ' LEU . 29.0 mtpt -68.63 -30.0 68.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -92.42 -45.21 8.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.933 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -41.65 -58.96 1.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.947 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 70' ' ' LEU . 16.4 mt-10 -41.07 -61.64 0.96 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.487 ' N ' HD21 ' A' ' 124' ' ' LEU . 22.2 tp -38.06 -35.63 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.35 -68.77 1.52 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.494 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -66.08 -19.69 65.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -75.28 -41.38 57.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.607 HD12 HD11 ' A' ' 82' ' ' ILE . 92.6 mt -86.46 3.35 44.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.2 t -54.07 -34.46 60.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -6.23 5.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 5.9 t70 -102.83 100.37 16.4 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.629 0.728 . . . . 0.0 110.873 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.7 Cg_endo -69.79 0.78 5.18 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.706 2.271 . . . . 0.0 112.346 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -110.46 -34.81 6.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 74' ' ' LEU . 71.8 mt -93.43 126.98 45.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 84.1 t -124.47 110.92 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.125 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.607 HD11 HD12 ' A' ' 74' ' ' LEU . 49.9 mm -82.99 123.7 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.142 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -133.75 161.47 34.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -134.65 150.43 50.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.455 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 10.7 ttt -141.45 140.12 33.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.629 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 7.6 t0 -95.41 91.16 6.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.804 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -45.0 -49.18 11.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.1 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.426 HG21 ' HD2' ' A' ' 55' ' ' PRO . 1.2 p -55.73 -28.56 56.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.14 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.726 ' HB1' ' CG ' ' A' ' 19' ' ' GLU . . . -94.05 -12.43 28.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.455 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.5 OUTLIER -157.26 123.54 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.435 ' OD2' HD23 ' A' ' 16' ' ' LEU . 12.0 t0 -57.38 135.91 56.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.874 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.9 t -82.95 128.19 66.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.628 0.728 . . . . 0.0 111.087 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.663 2.242 . . . . 0.0 112.351 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 m -115.73 162.0 27.58 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.712 0.768 . . . . 0.0 110.84 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.78 -10.83 11.73 Favored 'Cis proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 -1.795 . . . . 0.0 112.319 0.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 95' ' ' PRO . 98.0 m-85 -35.25 133.9 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -141.83 118.56 11.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.492 HG22 HG21 ' A' ' 103' ' ' THR . 77.4 t -120.96 116.11 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.093 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -118.14 -44.64 2.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.34 123.42 5.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.509 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.536 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -98.31 154.89 37.43 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.674 0.75 . . . . 0.0 110.864 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.536 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.2 Cg_endo -69.74 162.08 84.8 Favored 'Cis proline' 0 C--O 1.231 0.162 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.327 -0.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.492 HG21 HG22 ' A' ' 98' ' ' VAL . 52.3 m -139.99 125.45 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.8 mt -116.25 138.57 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.54 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 8.8 m-85 -134.54 162.66 31.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.946 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -133.5 136.33 45.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 t -104.47 93.02 5.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.882 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.502 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.3 Cg_endo -69.68 151.87 69.6 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.403 ' O ' ' HE3' ' A' ' 111' ' ' LYS . . . -69.59 145.46 52.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.4 p30 44.83 25.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.502 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 24.9 mtmt -130.4 41.28 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -66.06 -51.37 58.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.862 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -48.19 -49.08 34.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 2.9 m120 -122.32 91.79 49.1 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 54.4 Cg_endo -69.74 -163.8 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.661 2.241 . . . . 0.0 112.362 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -145.6 132.42 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.54 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 17.2 ttpt -98.8 137.34 37.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -73.14 104.69 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -116.97 98.42 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.88 -144.63 6.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.452 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.53 130.73 10.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.503 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 -79.57 45.5 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.745 0.307 . . . . 0.0 110.866 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 124' ' ' LEU . 5.1 tp10 -106.42 132.83 51.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.628 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -37.37 -52.51 1.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.1 m -61.69 -43.04 99.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -51.78 -42.11 62.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -63.18 -40.59 97.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mt -60.16 -61.73 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.3 t -56.26 -32.57 64.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 20.8 t80 -57.9 -58.48 8.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.0 -39.1 92.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -41.32 -40.87 1.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.1 ptp180 -102.9 -38.11 7.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 71.6 mm-40 -67.03 -60.94 2.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -44.47 132.35 6.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.088 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.42 -75.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 t -49.73 -56.69 9.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.51 -179.63 31.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.527 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -0.53 7.01 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.728 2.285 . . . . 0.0 112.336 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.2 p -47.59 126.47 10.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.843 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.1 m -134.23 139.11 45.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.888 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.449 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 t -170.29 118.2 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.823 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m -145.58 131.59 19.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.833 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.42 128.41 1.01 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 m -151.63 169.33 22.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.844 0.354 . . . . 0.0 110.871 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.3 t -165.2 171.13 14.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.819 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.25 131.95 5.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.493 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 52.94 39.43 29.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.889 0.376 . . . . 0.0 110.883 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' C ' ' OD1' ' A' ' 9' ' ' ASP . 0.7 OUTLIER -98.87 121.13 40.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.882 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.04 168.68 13.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 m120 60.43 35.67 20.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.349 . . . . 0.0 110.881 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.445 ' H ' HD12 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -104.53 43.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.592 ' HD2' ' CE1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -68.18 121.25 15.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.488 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 11.5 tpt180 -135.5 131.64 36.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.592 ' CE1' ' HD2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -175.08 164.57 3.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.926 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.0 pp -116.36 -36.93 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' A' ' 18' ' ' SER . 6.6 ttpm? -119.78 163.25 17.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.508 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 85.7 p -165.12 155.57 13.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.459 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 4.4 mm-40 -103.3 162.23 20.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.652 0.739 . . . . 0.0 110.884 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.459 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.74 143.4 50.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 0.0 112.33 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 35' ' ' GLU . 17.3 mm -70.04 132.56 88.32 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.722 . . . . 0.0 111.12 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 142.77 48.69 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.721 2.281 . . . . 0.0 112.347 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.25 -36.44 61.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.901 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 p -119.99 113.92 21.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.879 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.431 ' CG ' ' HD2' ' A' ' 30' ' ' LYS . 10.1 t-20 -125.11 47.0 2.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -111.11 61.74 0.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.15 -165.22 11.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.448 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -40.94 4.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.684 2.256 . . . . 0.0 112.35 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.501 HG12 ' HG2' ' A' ' 84' ' ' LYS . 21.3 t -120.6 108.9 23.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HD2' ' CG ' ' A' ' 25' ' ' ASN . 1.5 mmmt -59.35 136.38 57.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.431 HG22 ' HE3' ' A' ' 84' ' ' LYS . 95.3 t -84.65 125.01 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.88 HG11 HG23 ' A' ' 41' ' ' VAL . 31.3 t -119.38 119.61 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.479 HG21 HD13 ' A' ' 21' ' ' ILE . 18.1 m -115.54 148.11 18.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.088 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -35.31 -38.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.111 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' A' ' 21' ' ' ILE . 15.7 mt-10 -59.71 -48.93 79.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.449 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 14.8 p-10 -111.44 30.16 7.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.739 ' CD2' HG21 ' A' ' 41' ' ' VAL . 15.4 t80 -68.48 -62.55 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.43 -8.8 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.56 -46.57 11.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.5 mt -97.46 -50.37 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.88 HG23 HG11 ' A' ' 32' ' ' VAL . 29.5 t -58.06 -60.88 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.104 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -76.16 125.34 28.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -169.13 105.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.28 -1.75 28.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -85.52 -46.63 10.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.01 166.62 23.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -83.12 151.0 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.41 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 9.3 t -141.82 149.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.155 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.695 HD13 HD21 ' A' ' 131' ' ' LEU . 6.4 tp -122.84 120.01 32.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.411 HD11 ' CB ' ' A' ' 85' ' ' MET . 2.3 tp -107.4 137.11 40.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.49 ' OE1' ' CG1' ' A' ' 104' ' ' ILE . 3.7 tp10 -127.34 107.42 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.909 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.402 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 39.7 m-85 -83.82 126.62 33.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.442 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 9.6 p90 -132.87 176.0 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.893 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.03 133.07 24.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.713 . . . . 0.0 111.073 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -4.09 13.33 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.355 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.508 ' CZ2' HG21 ' A' ' 88' ' ' THR . 6.0 p-90 -123.56 17.7 9.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 43.6 t -116.09 100.63 8.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -41.3 -51.1 4.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 58' ' ' GLY . 97.2 m-70 -37.4 -38.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.762 0.315 . . . . 0.0 110.855 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 64' ' ' GLU . 6.2 t -69.33 -51.34 37.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.52 -53.1 19.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -64.95 -18.09 64.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.688 HD12 ' HB2' ' A' ' 66' ' ' LYS . 45.8 tp -97.25 -18.41 19.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.585 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.5 tp10 -45.32 -55.12 12.44 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.69 0.757 . . . . 0.0 110.915 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.1 Cg_endo -69.83 -24.64 29.14 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 0.0 112.283 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.688 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -76.99 -33.25 57.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -90.0 -31.94 16.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -53.81 -56.49 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.914 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -41.98 -56.81 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.469 ' N ' HD21 ' A' ' 124' ' ' LEU . 37.7 tp -41.14 -40.52 1.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.87 -69.09 1.4 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.496 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -59.36 -20.3 53.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.926 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -76.78 -46.56 24.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.693 HD12 HD11 ' A' ' 82' ' ' ILE . 96.8 mt -86.65 1.98 50.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -48.75 -22.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.02 22.91 4.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.607 ' OD2' HD22 ' A' ' 74' ' ' LEU . 72.6 m-20 -108.63 99.24 32.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.657 0.742 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.4 Cg_endo -69.66 -0.82 7.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 0.0 112.36 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -117.62 -36.78 3.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.45 129.0 51.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.4 t -124.35 109.99 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.693 HD11 HD12 ' A' ' 74' ' ' LEU . 27.2 mm -80.36 133.57 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.146 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.754 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -147.65 169.12 20.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.501 ' HG2' HG12 ' A' ' 29' ' ' VAL . 40.2 pttt -136.4 153.16 51.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.411 ' CB ' HD11 ' A' ' 50' ' ' ILE . 14.4 ttt -146.46 135.72 22.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.442 ' OD1' ' CZ ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -91.76 83.88 5.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.876 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -43.16 -55.95 3.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.508 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 33.7 p -46.95 -32.39 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.168 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.38 -19.82 21.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.61 122.49 17.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -51.6 130.84 28.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.439 HG21 ' HB ' ' A' ' 98' ' ' VAL . 95.7 t -72.81 131.83 83.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.589 0.709 . . . . 0.0 111.108 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.602 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.7 Cg_endo -69.81 -168.43 0.28 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.665 2.243 . . . . 0.0 112.371 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.502 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -129.6 161.22 60.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.661 0.744 . . . . 0.0 110.828 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.9 Cg_endo -69.71 -3.11 7.43 Favored 'Cis proline' 0 C--N 1.341 0.182 0 C-N-CA 122.69 -1.796 . . . . 0.0 112.361 -0.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.473 ' N ' ' HA ' ' A' ' 94' ' ' SER . 83.6 m-85 -33.77 127.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -131.7 102.42 5.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.736 HG22 HG21 ' A' ' 103' ' ' THR . 74.8 t -105.82 115.5 47.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -114.65 -47.41 2.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.94 127.61 7.5 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.488 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.541 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -100.06 154.95 36.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 0.0 110.867 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.7 Cg_endo -69.75 157.9 91.53 Favored 'Cis proline' 0 C--O 1.231 0.166 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.369 -0.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.736 HG21 HG22 ' A' ' 98' ' ' VAL . 44.6 m -133.1 101.84 5.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.515 HD13 ' CE1' ' A' ' 127' ' ' PHE . 82.6 mt -95.18 125.55 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 7.8 m-85 -122.02 -176.98 3.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 41.6 t80 -150.91 136.25 17.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.8 t -105.52 92.42 5.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.491 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.78 155.63 65.38 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.668 2.246 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.89 128.55 33.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 67.43 25.02 8.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.491 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 14.0 mtmt -134.38 56.02 1.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 114' ' ' ASN . 31.4 mmtt -80.11 -56.27 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.9 mp -37.8 -28.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 112' ' ' LYS . 12.6 m120 -148.71 107.63 3.5 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.912 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.502 ' CD ' ' HG2' ' A' ' 95' ' ' PRO . 53.4 Cg_endo -69.77 -174.97 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.72 2.28 . . . . 0.0 112.336 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.2 120.82 29.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 105' ' ' TYR . 13.2 ttmm -94.38 130.19 40.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -76.71 111.52 12.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -124.68 98.23 5.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.53 -137.84 2.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.38 126.96 8.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.443 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 63.9 mtm-85 -78.92 45.47 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 110.863 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -101.97 138.56 38.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.522 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.4 tm? -42.3 -51.3 4.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.7 p -70.59 -32.16 69.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -61.89 -34.65 76.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.515 ' CE1' HD13 ' A' ' 104' ' ' ILE . 31.0 m-85 -71.19 -35.21 71.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.2 mt -68.43 -52.01 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -63.75 -26.03 68.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -69.24 -47.68 64.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.923 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.695 HD21 HD13 ' A' ' 49' ' ' LEU . 17.6 mt -77.0 -42.65 37.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.916 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' LEU . 15.1 mt-30 -37.48 -31.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 131' ' ' LEU . 22.2 mmm180 -104.1 -53.81 2.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -50.01 -58.5 5.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -38.77 116.64 0.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -33.91 -75.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -73.33 -55.31 6.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.07 176.79 50.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.464 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 130.1 18.69 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.69 2.26 . . . . 0.0 112.323 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 t -81.04 138.45 36.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.83 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.8 t -118.09 -49.63 2.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.844 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.464 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.2 m -139.76 174.34 10.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.858 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.8 p -86.23 -56.83 3.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.877 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.63 129.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.505 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.9 p -143.68 136.76 27.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.381 . . . . 0.0 110.84 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.5 t -158.3 165.96 33.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.14 -176.95 32.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.46 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -88.39 140.71 29.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.352 . . . . 0.0 110.888 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -130.07 153.07 48.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.858 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.07 -131.13 10.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.487 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 68.84 36.0 2.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 0.0 110.877 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 76.4 mt -105.36 93.73 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -157.35 141.52 16.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 179.833 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -169.69 120.1 0.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.871 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.6 p90 -153.07 157.08 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.443 ' C ' HD12 ' A' ' 16' ' ' LEU . 2.9 pp -105.51 -41.24 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.42 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.9 tttp -96.78 160.83 14.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.462 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 93.0 p -168.2 150.16 5.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.834 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.493 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 8.7 mm-40 -104.52 161.53 22.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.64 0.733 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.71 142.88 49.36 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.723 2.282 . . . . 0.0 112.337 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.489 HD11 ' CB ' ' A' ' 35' ' ' GLU . 40.7 mm -72.56 129.14 87.5 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.627 0.727 . . . . 0.0 111.151 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 169.87 17.87 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -88.95 -37.11 15.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -156.34 134.81 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.445 ' CB ' ' HD3' ' A' ' 30' ' ' LYS . 41.1 m-20 -111.39 47.75 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -52.19 -33.22 39.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -41.99 166.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.32 36.42 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.698 2.265 . . . . 0.0 112.304 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.89 117.78 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.144 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.647 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 10.0 mmtm -64.99 132.57 49.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.898 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.9 t -86.51 102.8 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.139 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.008 HG11 HG23 ' A' ' 41' ' ' VAL . 40.4 t -95.95 127.18 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.145 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 21' ' ' ILE . 27.1 m -123.08 146.25 28.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.871 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -31.71 -44.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.09 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.489 ' CB ' HD11 ' A' ' 21' ' ' ILE . 23.9 mt-10 -53.71 -50.77 65.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 33' ' ' VAL . 12.1 p-10 -112.26 33.92 4.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.9 ' CD2' HG21 ' A' ' 41' ' ' VAL . 14.1 t80 -74.33 -58.46 3.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -62.53 -8.79 6.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.45 -43.9 11.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.4 mt -98.78 -52.99 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.008 HG23 HG11 ' A' ' 32' ' ' VAL . 45.8 t -57.01 -61.94 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.51 115.75 11.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -160.73 105.04 1.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -84.71 8.68 16.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -104.49 -43.44 5.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -129.64 159.8 35.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -78.51 148.08 33.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.1 t -146.54 122.36 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.121 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 105' ' ' TYR . 16.0 tp -99.0 116.33 30.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 tp -105.25 130.75 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.08 115.35 21.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -89.68 116.6 27.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.54 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 18.6 p90 -121.6 171.6 8.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.966 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.448 ' HB1' ' CE2' ' A' ' 56' ' ' TRP . . . -126.71 130.74 23.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.593 0.711 . . . . 0.0 111.104 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.414 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.3 Cg_endo -69.76 -8.52 23.8 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 0.0 112.364 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.448 ' CE2' ' HB1' ' A' ' 54' ' ' ALA . 2.2 p-90 -112.82 7.9 18.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.2 t -107.92 130.62 55.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.25 -52.6 39.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.551 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -37.81 -39.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -64.93 -55.66 17.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -42.55 -47.11 5.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -73.1 -23.4 60.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 66' ' ' LYS . 41.6 tp -87.9 -18.42 29.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.53 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -46.84 -58.29 7.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.642 0.734 . . . . 0.0 110.872 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.2 Cg_endo -69.76 -31.91 19.61 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.699 2.266 . . . . 0.0 112.351 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.496 ' HB2' HD12 ' A' ' 63' ' ' LEU . 44.1 mtpt -68.2 -32.29 72.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' O ' ' C ' ' A' ' 68' ' ' LYS . 42.1 t80 -89.76 -50.41 6.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.87 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 67' ' ' TYR . 12.1 ttmt -36.9 -61.63 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -40.98 -56.66 2.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.846 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.462 ' N ' HD21 ' A' ' 124' ' ' LEU . 19.1 tp -42.48 -36.82 1.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -55.99 -69.05 1.39 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.45 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -66.88 -23.34 65.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.382 . . . . 0.0 110.874 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -67.44 -45.46 75.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 82' ' ' ILE . 95.0 mt -85.82 3.74 40.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.5 p -52.4 -29.79 25.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -62.13 -7.57 4.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -103.57 101.08 21.58 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.619 0.723 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 1.67 4.22 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.338 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.476 ' C ' ' OD1' ' A' ' 47' ' ' ASP . 31.5 m120 -113.55 -39.92 3.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.9 mt -84.79 106.49 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.124 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.9 t -99.79 116.28 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.138 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 74' ' ' LEU . 31.7 mm -91.41 119.68 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.143 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.837 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -133.37 175.83 9.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.112 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -146.62 139.5 25.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.48 ' CE ' ' HB2' ' A' ' 90' ' ' ASN . 1.8 tmm? -134.5 149.83 50.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.54 ' OD1' ' CZ ' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -100.93 96.16 7.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.813 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -43.73 -66.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -40.69 -29.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -91.77 -30.67 16.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 15.8 m-80 -130.81 119.75 22.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.827 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -57.86 118.94 5.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.6 t -72.72 116.58 51.41 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.575 0.702 . . . . 0.0 111.134 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.7 Cg_endo -69.78 -172.08 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.65 2.233 . . . . 0.0 112.378 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.509 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -105.45 159.71 28.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.618 0.723 . . . . 0.0 110.858 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.6 Cg_endo -69.79 -20.85 10.59 Favored 'Cis proline' 0 C--O 1.232 0.177 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.297 0.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.482 ' C ' ' O ' ' A' ' 95' ' ' PRO . 93.6 m-85 -30.64 131.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.955 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.455 ' OE1' ' CZ ' ' A' ' 99' ' ' ARG . 13.7 mm-40 -141.92 119.27 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.881 HG22 HG21 ' A' ' 103' ' ' THR . 45.9 t -117.71 107.3 21.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.455 ' CZ ' ' OE1' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -125.41 33.1 5.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.59 113.66 0.29 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.533 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -97.72 155.09 37.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.664 0.745 . . . . 0.0 110.871 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.7 Cg_endo -69.79 145.54 79.79 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.651 -1.812 . . . . 0.0 112.334 0.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.881 HG21 HG22 ' A' ' 98' ' ' VAL . 9.8 m -122.57 124.29 43.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.475 HD12 ' NH1' ' A' ' 122' ' ' ARG . 27.7 mt -120.26 134.64 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.158 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.413 ' O ' HD12 ' A' ' 49' ' ' LEU . 10.8 m-85 -134.07 161.1 35.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -136.59 126.08 25.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 5.7 p -99.87 102.93 19.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.716 0.769 . . . . 0.0 110.815 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.501 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.4 Cg_endo -69.76 167.85 23.25 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.679 2.253 . . . . 0.0 112.352 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.448 ' O ' ' CE ' ' A' ' 111' ' ' LYS . . . -78.37 140.75 38.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.8 29.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.501 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.1 mtmt -130.36 48.44 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.465 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 6.5 mmpt? -70.81 -57.57 4.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 112' ' ' LYS . 54.9 mt -35.74 -43.09 0.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.417 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 3.4 m120 -132.61 95.67 19.78 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.651 0.739 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.7 Cg_endo -69.73 -164.44 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.719 2.28 . . . . 0.0 112.307 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -145.5 117.55 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.944 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -89.3 137.98 31.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.912 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.63 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 82.8 t80 -70.48 118.26 13.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -125.7 100.39 6.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.01 -155.38 25.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.18 139.58 22.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.472 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.475 ' NH1' HD12 ' A' ' 104' ' ' ILE . 53.4 mtt-85 -82.5 52.84 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.84 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 126' ' ' ASP . 13.0 tt0 -108.59 141.03 41.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.51 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.5 tm? -44.73 -50.93 9.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.7 p -69.8 -42.25 73.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.435 ' CG ' ' HB3' ' A' ' 123' ' ' GLU . 3.8 m-20 -49.44 -34.71 17.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.63 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 65.1 m-85 -73.03 -44.87 60.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.6 mt -57.21 -48.64 81.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.8 p -62.58 -46.94 85.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.508 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 5.1 t80 -56.03 -44.84 79.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.949 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.3 mt -72.56 -41.2 65.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.494 ' CD ' ' CG ' ' A' ' 139' ' ' PRO . 14.8 mm-40 -38.09 -40.49 0.49 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -97.84 -57.28 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.508 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 39.5 mm-40 -45.45 -58.71 3.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.65 153.71 27.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.088 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.05 -50.1 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 84.8 p -47.31 -54.93 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.824 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.16 143.96 0.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.494 ' CG ' ' CD ' ' A' ' 132' ' ' GLN . 53.9 Cg_endo -69.76 -8.27 23.19 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.674 2.249 . . . . 0.0 112.336 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.3 m -105.4 126.96 52.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.5 t -103.77 90.53 3.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.804 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.495 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 2.6 p90 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.928 0.394 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 pp -108.56 -35.43 6.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 17.5 ttpt -110.61 154.27 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 4.8 m -159.75 143.94 14.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.437 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.2 mm-40 -89.97 161.56 37.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 0.0 110.888 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.437 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.9 Cg_endo -69.75 141.49 45.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.658 2.239 . . . . 0.0 112.343 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.689 HD13 HG21 ' A' ' 33' ' ' VAL . 36.1 mm -69.91 132.17 88.81 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.698 . . . . 0.0 111.15 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 142.02 47.07 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.681 2.254 . . . . 0.0 112.348 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -61.3 -32.38 72.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -166.35 133.99 2.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -110.75 54.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -81.43 58.13 3.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.63 -168.51 11.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.514 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.479 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 53.4 Cg_endo -69.75 -48.81 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.716 2.277 . . . . 0.0 112.355 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.81 127.6 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -73.08 134.79 44.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -84.63 113.25 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.147 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.862 HG11 HG23 ' A' ' 41' ' ' VAL . 22.0 t -109.35 117.92 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.12 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.689 HG21 HD13 ' A' ' 21' ' ' ILE . 18.2 m -110.64 152.05 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.163 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB2' ' HB2' ' A' ' 90' ' ' ASN . . . -41.03 -34.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.53 ' HB3' HD11 ' A' ' 21' ' ' ILE . 8.8 mt-10 -64.51 -45.81 85.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 29.3 p30 -114.11 34.5 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CE1' ' HG3' ' A' ' 93' ' ' PRO . 6.4 t80 -73.6 -56.99 4.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -66.99 -4.81 10.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -89.47 -42.94 11.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.5 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 18.2 mt -98.94 -46.42 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.862 HG23 HG11 ' A' ' 32' ' ' VAL . 97.2 t -65.0 -62.12 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -67.8 113.98 6.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.75 HD21 HG21 ' A' ' 48' ' ' VAL . 4.9 p30 -175.25 106.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.39 2.73 27.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -84.79 -43.53 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -135.31 150.64 50.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.36 148.29 41.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.75 HG21 HD21 ' A' ' 43' ' ' ASN . 63.7 t -146.85 144.36 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 82' ' ' ILE . 14.5 tp -117.92 119.15 33.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.575 HG12 ' CE1' ' A' ' 52' ' ' PHE . 2.2 tp -101.46 129.78 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -119.53 111.45 18.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.575 ' CE1' HG12 ' A' ' 50' ' ' ILE . 34.7 m-85 -88.61 130.73 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -138.59 -175.12 4.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.631 ' HB1' ' CE2' ' A' ' 56' ' ' TRP . . . -142.43 133.74 12.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.605 0.716 . . . . 0.0 111.098 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -25.44 28.84 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.711 2.274 . . . . 0.0 112.345 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.631 ' CE2' ' HB1' ' A' ' 54' ' ' ALA . 2.2 p-90 -84.54 -28.13 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 4.6 t -68.73 138.5 54.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.835 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.91 -35.06 7.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.45 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -71.58 -26.77 62.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.885 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.3 m -83.37 -37.3 23.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -62.39 -45.41 93.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -60.85 -9.53 4.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.842 HD12 ' HB2' ' A' ' 66' ' ' LYS . 11.9 tp -97.34 -22.53 16.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.529 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -34.6 -58.21 0.68 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.675 0.75 . . . . 0.0 110.887 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.5 Cg_endo -69.73 -24.57 29.65 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.715 2.276 . . . . 0.0 112.294 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.842 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.6 mmmp? -75.27 -27.04 59.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 63.6 t80 -94.8 -39.7 10.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.886 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.479 ' HG3' ' CG ' ' A' ' 28' ' ' PRO . 5.6 ttmm -46.22 -59.49 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.898 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -38.84 -60.15 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.438 ' N ' HD21 ' A' ' 124' ' ' LEU . 17.4 tp -38.39 -42.04 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.93 -58.74 12.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.515 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -70.5 -20.98 62.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 0.0 110.926 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -72.56 -46.31 55.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.54 HD12 HD11 ' A' ' 82' ' ' ILE . 97.0 mt -78.26 3.12 16.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.9 p -50.3 -25.0 3.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.835 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -79.09 11.62 2.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.922 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.43 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 4.6 t0 -117.82 97.95 51.2 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.566 0.698 . . . . 0.0 110.897 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.0 Cg_endo -69.72 -1.08 7.82 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.739 2.293 . . . . 0.0 112.311 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -109.77 -37.19 5.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.448 HD11 ' CB ' ' A' ' 135' ' ' ALA . 46.6 mt -93.8 133.26 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.078 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 48' ' ' VAL . 54.3 t -129.74 117.33 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.54 HD11 HD12 ' A' ' 74' ' ' LEU . 50.1 mm -86.39 134.77 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.114 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.775 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -147.26 167.16 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -135.67 155.02 51.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.484 ' CB ' HD11 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -148.87 132.05 16.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.899 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.756 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -84.83 94.96 8.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.87 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.04 -62.62 1.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.443 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -48.63 -35.06 12.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.756 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -80.78 -22.21 40.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.12 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -150.44 123.31 8.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -47.55 148.13 1.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.614 HG13 ' HD2' ' A' ' 93' ' ' PRO . 93.3 t -100.2 137.75 20.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.626 0.727 . . . . 0.0 111.14 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.614 ' HD2' HG13 ' A' ' 92' ' ' VAL . 53.9 Cg_endo -69.74 -163.81 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.654 2.236 . . . . 0.0 112.316 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.497 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -128.32 160.88 59.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.648 0.737 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.72 -6.45 9.36 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.328 -0.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.446 ' C ' ' O ' ' A' ' 95' ' ' PRO . 89.8 m-85 -34.35 121.14 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -127.58 131.9 49.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.803 HG22 HG21 ' A' ' 103' ' ' THR . 91.1 t -131.92 104.69 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -104.85 -39.62 6.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.86 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -128.21 132.48 7.37 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.461 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.543 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -100.03 154.24 37.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.637 0.732 . . . . 0.0 110.92 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.75 159.88 88.92 Favored 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.674 -1.802 . . . . 0.0 112.317 -0.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.803 HG21 HG22 ' A' ' 98' ' ' VAL . 44.4 m -135.02 102.97 5.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.1 mt -98.78 134.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.135 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.412 ' O ' HD12 ' A' ' 49' ' ' LEU . 8.9 m-85 -132.75 166.6 21.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -134.96 132.34 38.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.407 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 1.9 t -105.75 94.76 9.31 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.629 0.728 . . . . 0.0 110.864 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.46 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.8 Cg_endo -69.76 175.71 7.74 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.687 2.258 . . . . 0.0 112.357 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.27 137.08 32.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 49.31 25.59 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.46 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.2 mtmm -124.77 21.98 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.487 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 2.3 mptp? -50.85 -50.0 57.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -46.12 -38.92 8.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -134.26 91.48 22.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.602 0.715 . . . . 0.0 110.942 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -163.85 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.691 2.261 . . . . 0.0 112.344 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -142.26 145.51 34.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -119.6 117.87 29.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -57.33 111.47 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.931 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -125.12 91.56 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.5 -142.84 4.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.485 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.51 130.68 10.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 127' ' ' PHE . 45.4 mtm-85 -81.1 47.58 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 124' ' ' LEU . 4.1 tt0 -103.76 133.65 48.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 123' ' ' GLU . 3.1 tm? -34.17 -53.68 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.972 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 128' ' ' ILE . 14.8 m -67.2 -51.0 58.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -42.75 -31.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 122' ' ' ARG . 68.7 m-85 -76.74 -40.44 48.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' A' ' 125' ' ' SER . 32.3 mt -62.11 -55.99 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -57.79 -31.42 66.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.513 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 68.1 t80 -63.46 -45.06 92.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.964 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.1 mt -76.59 -39.13 53.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.945 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -46.63 -24.2 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.43 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.7 ptp85 -112.69 -37.02 5.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 2.9 mm-40 -70.01 -59.64 2.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.889 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.448 ' CB ' HD11 ' A' ' 80' ' ' ILE . . . -45.72 107.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.106 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 137' ' ' SER . 1.7 t -44.35 -50.55 9.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.432 ' N ' HG23 ' A' ' 136' ' ' THR . 46.1 m -68.64 -58.34 4.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.459 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.648 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.914 0.388 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 pp -104.27 -40.61 6.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 12.2 ttpt -109.1 154.73 21.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.1 p -155.59 144.74 20.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.459 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 3.8 mm-40 -91.77 161.23 34.42 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.638 0.732 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.459 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.7 Cg_endo -69.79 142.98 49.27 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.658 2.239 . . . . 0.0 112.366 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.49 HD13 ' CG2' ' A' ' 33' ' ' VAL . 40.2 mm -74.58 133.85 76.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 111.136 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 21' ' ' ILE . 54.0 Cg_endo -69.74 176.62 6.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.731 2.288 . . . . 0.0 112.326 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -101.54 -35.95 8.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.3 t -148.99 128.96 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -116.78 49.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.04 56.55 3.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.72 -171.89 13.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.489 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -38.71 7.47 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.687 2.258 . . . . 0.0 112.314 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.529 HG12 ' HG2' ' A' ' 84' ' ' LYS . 21.6 t -119.49 119.33 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.104 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.616 ' HZ1' HD13 ' A' ' 40' ' ' ILE . 1.6 mmmp? -68.97 125.73 27.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.1 t -74.81 124.33 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.765 HG11 HG23 ' A' ' 41' ' ' VAL . 42.0 t -123.9 125.65 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 35' ' ' GLU . 21.1 m -119.14 149.46 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.648 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.18 -42.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.064 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.529 ' HB2' HG23 ' A' ' 33' ' ' VAL . 9.4 mt-10 -55.57 -48.69 74.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' A' ' 33' ' ' VAL . 11.3 p-10 -114.08 38.85 2.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.588 ' CE1' ' HG3' ' A' ' 93' ' ' PRO . 4.6 t80 -77.95 -55.22 5.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.96 -11.12 55.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -83.28 -42.27 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.707 HD12 HG22 ' A' ' 32' ' ' VAL . 24.9 mt -99.24 -59.44 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.765 HG23 HG11 ' A' ' 32' ' ' VAL . 94.1 t -49.99 -62.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -66.46 115.77 6.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.84 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 45' ' ' ASN . 2.4 t30 -173.75 110.37 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -87.17 -4.53 59.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.478 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 78.7 m-20 -73.96 -48.47 30.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.87 153.91 51.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -67.67 142.25 56.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.8 t -137.52 143.79 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.468 HD23 HD12 ' A' ' 82' ' ' ILE . 31.1 tp -121.31 121.28 37.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.581 HD13 HG22 ' A' ' 41' ' ' VAL . 2.4 tp -109.76 133.4 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' OE1' ' C ' ' A' ' 52' ' ' PHE . 0.3 OUTLIER -124.0 118.22 26.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.869 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.43 ' C ' ' OE1' ' A' ' 51' ' ' GLU . 54.4 m-85 -95.0 114.93 26.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CE1' ' OD1' ' A' ' 86' ' ' ASP . 17.2 p90 -120.23 -179.19 3.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.404 ' HB3' ' CB ' ' A' ' 57' ' ' CYS . . . -136.76 134.49 19.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.578 0.704 . . . . 0.0 111.083 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.733 ' HD2' HG21 ' A' ' 88' ' ' THR . 53.6 Cg_endo -69.76 -11.05 30.04 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.708 2.272 . . . . 0.0 112.295 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -114.1 9.25 17.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.404 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . 48.4 t -106.32 113.27 26.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.71 -52.71 46.59 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.481 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -46.67 -39.13 10.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.731 0.301 . . . . 0.0 110.809 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 43.9 m -70.95 -39.84 72.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.912 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -40.58 76.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.894 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -73.21 -25.5 60.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.605 HD13 ' HB3' ' A' ' 122' ' ' ARG . 29.4 tp -83.24 -23.11 32.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.529 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -42.52 -57.88 4.23 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.623 0.725 . . . . 0.0 110.934 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.8 -36.03 11.43 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.679 2.252 . . . . 0.0 112.341 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HB2' HD12 ' A' ' 63' ' ' LEU . 17.1 mtpp -64.63 -28.34 69.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.434 ' OH ' HG23 ' A' ' 82' ' ' ILE . 57.0 t80 -93.04 -43.64 8.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -44.82 -58.52 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.925 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -41.64 -46.84 3.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.512 HD13 ' HB2' ' A' ' 127' ' ' PHE . 12.1 tp -53.32 -36.54 61.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.962 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -57.97 -57.04 21.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.17 -24.34 57.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.911 0.386 . . . . 0.0 110.911 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -72.14 -42.16 66.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 80' ' ' ILE . 81.3 mt -83.24 3.35 31.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.6 p -53.08 -39.67 63.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 17.6 tttt -57.88 -11.93 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.78 99.65 9.42 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.608 0.718 . . . . 0.0 110.859 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.5 Cg_endo -69.82 0.15 6.1 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.639 2.226 . . . . 0.0 112.332 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -109.98 -35.86 6.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.562 HG21 HD13 ' A' ' 74' ' ' LEU . 60.9 mt -90.61 104.08 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.46 110.02 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.468 HD12 HD23 ' A' ' 49' ' ' LEU . 50.2 mm -82.87 127.17 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.159 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.56 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -134.4 166.37 23.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.529 ' HG2' HG12 ' A' ' 29' ' ' VAL . 15.2 pttp -138.21 154.05 49.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.503 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 9.7 ttt -150.42 136.82 18.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.96 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 4.0 t70 -92.75 94.96 9.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -50.13 -64.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.733 HG21 ' HD2' ' A' ' 55' ' ' PRO . 1.2 t -41.63 -26.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.117 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -96.68 -26.52 15.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.503 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -141.15 109.39 5.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -44.25 136.58 3.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.581 HG13 ' HD2' ' A' ' 93' ' ' PRO . 72.8 t -86.08 136.63 35.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.596 0.713 . . . . 0.0 111.144 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.588 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.4 Cg_endo -69.74 -167.76 0.24 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.712 2.275 . . . . 0.0 112.312 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.505 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -121.74 161.33 42.52 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.731 0.777 . . . . 0.0 110.83 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.0 Cg_endo -69.75 -9.24 10.89 Favored 'Cis proline' 0 C--O 1.232 0.223 0 C-N-CA 122.679 -1.801 . . . . 0.0 112.318 -0.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 95' ' ' PRO . 93.9 m-85 -33.98 126.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.905 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.82 128.35 36.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 103' ' ' THR . 88.6 t -127.5 94.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -116.18 28.89 8.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.825 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.32 113.81 0.36 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.543 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -98.09 153.64 38.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.659 0.742 . . . . 0.0 110.874 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.77 156.5 92.79 Favored 'Cis proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 -1.79 . . . . 0.0 112.339 0.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.555 HG21 HG22 ' A' ' 98' ' ' VAL . 6.7 m -135.0 128.18 31.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.424 HD13 ' HE1' ' A' ' 127' ' ' PHE . 36.6 mt -123.36 136.65 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.549 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 9.8 m-85 -136.45 144.29 44.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -119.72 129.72 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -99.96 101.05 12.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.843 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.495 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.3 Cg_endo -69.76 168.09 22.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.706 2.27 . . . . 0.0 112.342 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.12 137.23 33.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 10.3 p30 51.86 24.94 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.495 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.2 mtmt -129.3 38.42 3.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.468 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 5.8 mmpt? -63.35 -59.34 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 112' ' ' LYS . 11.0 mp -35.41 -36.84 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 2.3 t-20 -134.47 96.82 14.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.642 0.734 . . . . 0.0 110.839 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.9 Cg_endo -69.72 -178.44 2.33 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.661 2.24 . . . . 0.0 112.373 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 147.99 49.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.549 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 10.7 ttpt -118.43 125.92 50.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -67.86 115.65 7.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -123.5 102.84 8.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.63 -149.75 11.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.465 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.91 138.9 14.79 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.5 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.605 ' HB3' HD13 ' A' ' 63' ' ' LEU . 1.1 mpp_? -79.0 45.59 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.774 0.321 . . . . 0.0 110.829 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 124' ' ' LEU . 8.2 tt0 -101.64 128.32 47.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.566 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -34.14 -56.09 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.9 m -59.23 -45.92 89.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 130' ' ' TYR . 6.4 t0 -49.33 -39.97 33.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.512 ' HB2' HD13 ' A' ' 70' ' ' LEU . 58.6 m-85 -67.41 -41.41 84.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.486 HD11 ' CD1' ' A' ' 124' ' ' LEU . 23.4 mt -62.28 -65.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.089 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 m -56.25 -34.8 66.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.41 ' CB ' ' O ' ' A' ' 126' ' ' ASP . 14.6 t80 -57.22 -45.73 83.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.943 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.93 -35.44 32.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -38.56 -41.85 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -98.11 -57.98 2.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -44.17 -56.76 3.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.0 105.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.133 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.423 HG23 ' N ' ' A' ' 137' ' ' SER . 1.6 t -40.41 -49.96 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 136' ' ' THR . 16.6 m -113.14 40.54 2.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.802 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.3 p90 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.933 0.397 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.727 HD23 ' CG ' ' A' ' 91' ' ' ASP . 1.2 pt? -95.7 -35.7 11.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.502 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 10.5 ptmt -117.34 176.36 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.3 p -174.99 150.5 1.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.824 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 12.1 mm-40 -96.6 159.15 32.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 0.0 110.853 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 141.91 46.68 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.561 HD13 HG21 ' A' ' 33' ' ' VAL . 20.2 mm -69.47 131.43 90.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.565 0.698 . . . . 0.0 111.135 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 141.52 45.52 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.671 2.247 . . . . 0.0 112.394 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.1 -34.88 74.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.1 t -156.88 137.21 12.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -121.21 48.2 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.65 52.21 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.39 -167.08 13.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -41.59 4.1 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.668 2.245 . . . . 0.0 112.361 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.72 128.23 74.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.106 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.559 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 12.5 mmmt -74.9 117.33 16.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.581 HG22 ' HE3' ' A' ' 84' ' ' LYS . 78.5 t -73.48 122.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.95 HG11 HG23 ' A' ' 41' ' ' VAL . 39.8 t -115.81 124.31 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.116 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.561 HG21 HD13 ' A' ' 21' ' ' ILE . 30.6 m -115.84 146.06 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.151 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.449 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -34.34 -42.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.071 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.559 ' HB3' HD11 ' A' ' 21' ' ' ILE . 6.7 mt-10 -55.5 -47.2 76.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' VAL . 21.1 p-10 -114.07 33.42 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.781 ' CD2' HG21 ' A' ' 41' ' ' VAL . 13.5 t80 -72.2 -58.28 3.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -64.55 -6.09 6.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -89.31 -46.44 8.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 mt -97.11 -46.05 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.95 HG23 HG11 ' A' ' 32' ' ' VAL . 50.0 t -63.44 -58.82 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.134 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -78.08 124.68 28.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.738 HD21 HG23 ' A' ' 48' ' ' VAL . 5.1 p-10 -175.59 108.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.961 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.419 ' CD ' ' HA ' ' A' ' 110' ' ' ASN . 2.1 mm-40 -83.05 20.25 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -106.75 -39.55 5.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.503 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 16.8 pttm -137.74 166.6 23.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -94.17 139.24 31.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.738 HG23 HD21 ' A' ' 43' ' ' ASN . 23.4 t -136.33 148.18 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.815 HD12 ' O ' ' A' ' 105' ' ' TYR . 6.6 tp -116.51 109.86 17.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 tp -91.64 135.73 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.076 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' OE2' ' C ' ' A' ' 52' ' ' PHE . 1.9 tm-20 -127.02 117.85 23.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.448 ' C ' ' OE2' ' A' ' 51' ' ' GLU . 45.8 m-85 -93.32 124.33 37.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -128.84 -175.02 3.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.787 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -139.1 131.66 15.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.594 0.711 . . . . 0.0 111.091 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -3.09 11.32 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.688 2.259 . . . . 0.0 112.327 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.552 ' NE1' HG21 ' A' ' 88' ' ' THR . 6.7 p-90 -119.45 -3.37 10.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.787 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -93.44 133.5 36.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.93 -41.83 93.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.484 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -51.62 -28.06 13.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 64' ' ' GLU . 42.5 t -69.97 -44.73 68.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -62.81 -44.07 97.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -72.15 -34.41 68.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 66' ' ' LYS . 29.8 tp -84.6 -19.19 33.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.9 OUTLIER -45.3 -58.3 6.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.676 0.75 . . . . 0.0 110.89 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.72 -30.85 21.82 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.337 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.535 ' HB2' HD12 ' A' ' 63' ' ' LEU . 27.2 mtmm -70.06 -26.84 64.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.924 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -95.75 -41.89 8.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -48.84 -58.85 4.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.449 ' CD ' ' O ' ' A' ' 65' ' ' PRO . 1.2 mp0 -39.27 -51.25 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.408 ' N ' HD21 ' A' ' 124' ' ' LEU . 26.2 tp -48.65 -40.13 26.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.958 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.47 -55.11 30.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.444 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -67.06 -28.1 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.94 0.4 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.51 -45.36 54.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.604 HD12 HD11 ' A' ' 82' ' ' ILE . 94.2 mt -83.14 3.04 32.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.918 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.3 t -49.97 -25.39 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.32 21.91 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.42 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 0.9 OUTLIER -104.48 98.08 13.71 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.603 0.716 . . . . 0.0 110.837 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.6 Cg_endo -69.79 -4.29 13.75 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.658 2.239 . . . . 0.0 112.332 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -116.41 -39.77 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.8 mt -96.9 140.43 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 48' ' ' VAL . 72.0 t -138.43 114.56 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.115 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.604 HD11 HD12 ' A' ' 74' ' ' LEU . 44.5 mm -81.51 126.78 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -136.67 164.58 27.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.075 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.581 ' HE3' HG22 ' A' ' 31' ' ' VAL . 24.1 pttt -136.75 138.3 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.4 ttt -134.96 143.42 46.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 26.9 t0 -92.92 115.21 27.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 89' ' ' ALA . . . -68.89 -70.73 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.114 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.552 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -42.43 -23.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.606 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -99.03 -31.81 11.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 14.4 m-80 -129.14 111.38 12.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.727 ' CG ' HD23 ' A' ' 16' ' ' LEU . 8.3 t0 -45.92 129.55 9.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -77.41 130.23 75.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 0.0 111.16 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.6 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.7 Cg_endo -69.73 -163.86 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.678 2.252 . . . . 0.0 112.317 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -130.61 161.47 60.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.636 0.732 . . . . 0.0 110.872 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.3 Cg_endo -69.74 -4.62 8.38 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.733 -1.778 . . . . 0.0 112.301 -0.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 95' ' ' PRO . 78.8 m-85 -33.27 125.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -125.09 132.46 53.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.473 HG22 HG21 ' A' ' 103' ' ' THR . 38.6 t -143.42 124.34 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -129.65 -39.31 1.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.47 123.31 5.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.484 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.538 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.5 154.82 37.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.664 0.745 . . . . 0.0 110.89 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.538 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.6 Cg_endo -69.8 161.75 85.65 Favored 'Cis proline' 0 C--O 1.232 0.186 0 C-N-CA 122.676 -1.801 . . . . 0.0 112.334 0.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.473 HG21 HG22 ' A' ' 98' ' ' VAL . 62.5 m -140.1 109.82 6.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.3 mt -104.12 134.0 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.182 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.815 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.9 m-85 -129.86 177.36 7.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.405 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.6 t80 -145.3 129.0 17.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.78 97.73 8.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.669 0.747 . . . . 0.0 110.851 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.501 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.5 Cg_endo -69.75 167.56 24.08 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 2.246 . . . . 0.0 112.328 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -83.12 137.63 34.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.108 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.0 OUTLIER 48.14 27.89 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.501 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.3 mtmm -129.4 29.78 5.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -53.87 -57.14 12.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.922 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 68.9 mt -43.3 -48.37 6.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.13 87.48 34.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.632 0.729 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -163.9 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.716 2.277 . . . . 0.0 112.287 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -149.79 131.78 15.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 105' ' ' TYR . 21.6 tttt -102.49 136.46 42.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 70.2 t80 -66.42 110.93 3.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.32 97.31 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.88 -151.83 11.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.96 142.49 23.39 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.451 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -87.28 43.22 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 124' ' ' LEU . 2.7 tp10 -104.52 131.08 52.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 123' ' ' GLU . 2.8 tm? -34.07 -56.65 0.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 72.7 m -59.59 -50.73 72.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -46.6 -36.61 7.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 65.7 m-85 -70.3 -43.7 69.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.1 mt -58.73 -58.49 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.158 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.53 -31.36 69.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.469 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 52.2 t80 -60.31 -53.33 58.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' GLN . 43.7 mt -70.81 -39.78 72.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' LEU . 28.5 mm-40 -35.62 -36.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.8 mmp_? -106.77 -57.63 2.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.469 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 68.6 mm-40 -42.23 -49.5 4.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -61.66 109.57 1.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -33.99 -74.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.4 t -75.59 56.66 0.91 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.831 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.43 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.733 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.6 p90 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.89 0.376 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 17' ' ' LYS . 3.5 pp -103.86 -38.89 6.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 18' ' ' SER . 51.0 tttt -111.86 163.77 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.664 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 45.4 p -166.0 156.95 13.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.453 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 10.6 mm-40 -103.91 161.38 23.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.626 0.727 . . . . 0.0 110.865 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.7 144.15 53.42 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.694 2.263 . . . . 0.0 112.345 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.519 HD13 ' CG2' ' A' ' 33' ' ' VAL . 42.9 mm -74.92 130.95 79.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.73 . . . . 0.0 111.154 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 157.81 59.17 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.736 2.291 . . . . 0.0 112.321 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -70.77 -45.83 64.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.4 m -135.66 135.65 40.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -128.22 30.44 5.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.05 48.31 1.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.861 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.44 -162.95 18.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -40.65 5.07 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.326 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.685 HG11 ' HB3' ' A' ' 84' ' ' LYS . 74.2 t -120.01 119.68 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -66.77 113.75 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.6 t -73.04 108.24 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.061 HG11 HG23 ' A' ' 41' ' ' VAL . 39.2 t -106.77 128.03 61.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.129 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.519 ' CG2' HD13 ' A' ' 21' ' ' ILE . 26.9 m -122.25 148.99 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.733 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.84 -40.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 33' ' ' VAL . 16.0 mt-10 -56.42 -48.18 77.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 33' ' ' VAL . 22.0 p30 -115.12 35.41 4.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.617 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 15.7 t80 -75.17 -56.06 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.75 -5.02 10.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.834 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -92.23 -45.71 8.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.4 mt -96.88 -58.95 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.061 HG23 HG11 ' A' ' 32' ' ' VAL . 61.0 t -50.88 -60.83 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.126 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -70.62 115.16 9.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -167.28 111.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -88.49 6.61 36.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -92.19 -40.72 10.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 155.69 48.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.4 151.47 46.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.1 t -146.32 146.47 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.64 HD23 HD12 ' A' ' 82' ' ' ILE . 20.6 tp -125.15 127.75 47.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.937 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 105' ' ' TYR . 2.5 tp -109.15 140.55 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.139 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 1.9 tt0 -126.95 107.59 10.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -85.82 110.57 19.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -119.26 167.93 11.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.42 127.97 24.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.599 0.714 . . . . 0.0 111.094 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -6.63 19.04 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.444 ' NE1' HG21 ' A' ' 88' ' ' THR . 7.2 p-90 -118.67 14.41 13.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.948 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.2 t -117.09 123.41 46.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -61.71 -61.37 6.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.508 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -39.65 -37.12 0.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.341 . . . . 0.0 110.853 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 81.8 m -74.98 -39.09 61.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' GLY . 5.4 ttmt -62.55 -35.73 80.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -73.86 -22.21 59.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 66' ' ' LYS . 18.7 tp -88.15 -23.71 23.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.532 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.4 tt0 -37.93 -58.14 1.47 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.635 0.731 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.75 -34.32 14.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.704 2.27 . . . . 0.0 112.334 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.682 ' HB2' HD12 ' A' ' 63' ' ' LEU . 20.1 mtpp -66.39 -24.98 66.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 55.5 t80 -96.07 -38.86 10.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -47.78 -56.51 7.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.46 -56.1 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 127' ' ' PHE . 24.4 tp -40.61 -42.04 1.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.39 -68.88 1.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.54 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.87 -25.81 61.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.374 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -74.69 -39.53 61.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.952 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.501 HD22 ' OD2' ' A' ' 77' ' ' ASP . 95.1 mt -88.96 1.73 55.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.3 t -51.51 -20.86 2.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -91.41 18.34 7.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.918 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.501 ' OD2' HD22 ' A' ' 74' ' ' LEU . 97.1 m-20 -109.55 99.9 39.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.59 0.709 . . . . 0.0 110.89 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.9 Cg_endo -69.71 -1.33 8.24 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.721 2.28 . . . . 0.0 112.354 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.07 -35.13 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.883 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 51.0 mt -99.21 142.2 15.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.02 106.97 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.095 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.64 HD12 HD23 ' A' ' 49' ' ' LEU . 47.3 mm -74.36 126.43 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.742 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -130.59 169.14 15.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.043 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.685 ' HB3' HG11 ' A' ' 29' ' ' VAL . 10.6 ptpp? -137.67 135.69 36.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.468 ' CB ' HD11 ' A' ' 50' ' ' ILE . 18.0 ttt -141.38 143.84 34.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.922 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 10.3 t0 -98.63 117.92 34.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.46 -59.24 3.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.444 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -56.03 -21.23 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.109 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.922 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -99.79 -25.13 14.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 86' ' ' ASP . 4.5 m-80 -134.62 104.18 5.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -40.24 122.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.84 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.66 123.51 89.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.639 0.733 . . . . 0.0 111.107 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.8 Cg_endo -69.76 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.508 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.5 m -121.97 160.87 45.31 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.663 0.744 . . . . 0.0 110.848 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.76 -8.62 10.6 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.692 -1.795 . . . . 0.0 112.367 -0.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 95' ' ' PRO . 97.0 m-85 -34.14 123.08 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -130.45 115.34 16.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.781 HG22 HG21 ' A' ' 103' ' ' THR . 75.1 t -114.26 131.17 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 -50.05 1.02 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.88 125.77 6.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.464 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.528 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -96.77 154.71 38.28 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 0.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.528 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.73 154.96 93.38 Favored 'Cis proline' 0 C--O 1.232 0.207 0 C-N-CA 122.666 -1.806 . . . . 0.0 112.392 -0.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.781 HG21 HG22 ' A' ' 98' ' ' VAL . 61.2 m -132.78 102.11 5.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.157 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.424 HG12 ' CG ' ' A' ' 51' ' ' GLU . 74.8 mt -95.9 138.52 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.537 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 9.4 m-85 -135.87 140.29 44.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.474 ' HA ' HD12 ' A' ' 49' ' ' LEU . 14.6 t80 -114.88 130.47 56.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 17.3 m -101.91 97.63 8.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.669 0.747 . . . . 0.0 110.861 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.492 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.74 170.06 17.45 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.662 2.241 . . . . 0.0 112.37 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -86.0 142.16 28.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.5 p30 46.11 25.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.492 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.5 mtmt -126.09 39.13 4.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.461 ' O ' ' C ' ' A' ' 113' ' ' LEU . 36.4 mmtt -65.55 -61.38 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.893 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 112' ' ' LYS . 19.7 mt -33.66 -38.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.93 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 7.1 m120 -134.31 99.75 13.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.624 0.726 . . . . 0.0 110.852 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.3 Cg_endo -69.75 178.5 4.5 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.705 2.27 . . . . 0.0 112.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.67 127.01 41.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.537 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 15.6 ttpp -100.99 123.53 45.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -60.38 113.57 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -124.37 95.96 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.7 -148.82 7.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.535 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.84 136.49 14.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.484 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -83.67 45.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 110.869 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 124' ' ' LEU . 3.7 tp10 -104.83 132.05 51.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.541 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.5 tm? -35.29 -53.06 0.63 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.0 m -63.63 -45.65 89.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -46.83 -42.58 17.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.556 ' HB2' HD13 ' A' ' 70' ' ' LEU . 74.5 m-85 -64.95 -46.82 79.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 mt -53.91 -59.66 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.1 t -59.1 -37.46 77.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.438 ' CD1' HD23 ' A' ' 131' ' ' LEU . 22.3 t80 -56.67 -55.2 37.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.954 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.483 HD12 HD11 ' A' ' 74' ' ' LEU . 18.3 mt -68.67 -38.07 80.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -47.47 -44.54 25.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -93.72 -46.48 7.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.7 -62.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 131' ' ' LEU . . . -39.2 105.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.063 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.585 HG23 ' H ' ' A' ' 137' ' ' SER . 1.3 t -42.45 -56.25 3.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.101 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.585 ' H ' HG23 ' A' ' 136' ' ' THR . 1.1 t -66.3 -44.22 84.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.432 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.523 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.4 p90 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.549 ' H ' HD23 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -92.62 -38.23 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.521 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -116.38 174.35 6.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 88.0 p -170.95 165.6 7.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.521 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 6.4 mm-40 -113.56 160.2 32.6 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.611 0.72 . . . . 0.0 110.906 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 145.75 57.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.697 2.264 . . . . 0.0 112.326 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 35' ' ' GLU . 20.5 mm -69.42 134.96 88.71 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.659 0.742 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.42 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 53.7 Cg_endo -69.77 137.98 36.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.71 2.273 . . . . 0.0 112.324 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.36 -32.24 62.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.8 t -128.46 106.51 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.442 ' CG ' ' HD3' ' A' ' 30' ' ' LYS . 9.7 t-20 -111.35 46.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -110.93 49.43 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.876 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.25 -162.34 14.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -48.25 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.677 2.251 . . . . 0.0 112.321 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 84' ' ' LYS . 22.2 t -115.88 116.05 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' HD3' ' CG ' ' A' ' 25' ' ' ASN . 7.7 mmtt -57.42 123.82 16.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.411 HG22 ' HE3' ' A' ' 84' ' ' LYS . 95.9 t -76.88 109.63 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.919 HG11 HG23 ' A' ' 41' ' ' VAL . 29.0 t -107.31 123.99 62.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.069 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 36' ' ' ASN . 28.5 m -119.07 147.11 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -32.4 -45.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.14 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.61 ' HB3' HD11 ' A' ' 21' ' ' ILE . 7.0 mt-10 -52.93 -49.78 65.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 33' ' ' VAL . 12.2 p-10 -113.25 35.86 3.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.576 ' CD2' HG21 ' A' ' 41' ' ' VAL . 21.5 t80 -74.03 -59.18 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.64 -5.21 7.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -87.97 -43.46 11.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mt -98.98 -54.07 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.123 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.919 HG23 HG11 ' A' ' 32' ' ' VAL . 57.6 t -55.08 -62.02 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.121 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -69.74 122.01 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -173.87 105.5 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -87.24 38.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -131.27 -40.83 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -129.83 151.56 50.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -75.54 127.19 32.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.84 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.17 143.24 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.422 HD22 HD11 ' A' ' 131' ' ' LEU . 38.0 tp -119.28 126.66 52.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 85' ' ' MET . 2.2 tp -113.07 135.56 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.21 118.51 26.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.907 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -93.06 128.76 39.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.44 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 6.9 p90 -136.12 174.05 11.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.18 135.02 25.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.585 0.707 . . . . 0.0 111.121 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -7.86 22.14 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.721 2.281 . . . . 0.0 112.327 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -123.67 26.49 7.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 43.4 t -125.13 106.44 9.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -46.15 -66.07 1.82 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.504 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 58' ' ' GLY . 89.8 m-70 -35.33 -45.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.3 m -63.73 -50.2 70.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.34 -37.01 54.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -71.36 -27.82 63.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.457 ' O ' ' C ' ' A' ' 64' ' ' GLU . 12.2 tp -82.47 -32.69 28.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.8 OUTLIER -33.95 -58.12 0.61 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.651 0.739 . . . . 0.0 110.931 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.1 Cg_endo -69.82 -35.47 12.39 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.719 2.279 . . . . 0.0 112.27 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -65.3 -27.85 68.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.854 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -93.79 -41.61 9.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -46.74 -57.01 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -40.5 -48.48 2.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.456 ' N ' HD21 ' A' ' 124' ' ' LEU . 14.5 tp -52.2 -39.69 60.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.88 -48.6 69.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.501 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -74.95 -21.95 58.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.95 0.405 . . . . 0.0 110.895 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -79.56 -50.6 10.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.918 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 77' ' ' ASP . 79.8 mt -77.39 -2.02 33.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' LEU . 7.8 t -37.98 -29.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 74' ' ' LEU . 37.8 mtmt -87.1 29.56 0.82 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 74' ' ' LEU . 39.9 p30 -102.79 95.3 6.16 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.585 0.707 . . . . 0.0 110.851 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 54.0 Cg_endo -69.77 -2.83 10.84 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.71 2.273 . . . . 0.0 112.309 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -120.55 -45.46 2.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.45 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 44.3 mt -87.11 145.42 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.1 t -135.18 105.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.126 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.626 HG22 HG13 ' A' ' 29' ' ' VAL . 34.9 mm -73.53 131.03 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.669 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -145.93 160.64 41.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.632 ' HB3' HG11 ' A' ' 29' ' ' VAL . 43.4 pttt -132.53 160.34 36.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.558 ' CB ' HD11 ' A' ' 50' ' ' ILE . 18.4 ttt -151.37 132.39 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -91.44 85.96 5.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -41.6 -65.74 0.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 87' ' ' ALA . 25.7 p -36.34 -35.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.521 ' HB1' ' CG ' ' A' ' 19' ' ' GLU . . . -87.24 -36.37 17.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.504 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.4 OUTLIER -129.02 112.7 14.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -41.22 155.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -103.21 125.58 34.73 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.63 0.728 . . . . 0.0 111.123 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.469 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.5 Cg_endo -69.84 -164.94 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.248 . . . . 0.0 112.313 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.496 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -122.19 161.23 44.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.596 0.713 . . . . 0.0 110.892 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.76 -11.74 11.99 Favored 'Cis proline' 0 C--O 1.232 0.182 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.352 -0.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.45 ' C ' ' O ' ' A' ' 95' ' ' PRO . 81.2 m-85 -33.05 125.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -134.04 117.04 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.874 HG22 HG21 ' A' ' 103' ' ' THR . 83.7 t -119.53 108.73 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -106.25 -41.28 5.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.09 131.32 7.19 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.418 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.524 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.5 OUTLIER -97.28 155.63 37.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.679 0.752 . . . . 0.0 110.828 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.1 Cg_endo -69.79 162.14 84.81 Favored 'Cis proline' 0 C--O 1.232 0.207 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.352 0.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.874 HG21 HG22 ' A' ' 98' ' ' VAL . 84.1 m -142.22 116.06 9.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.176 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.637 HD13 ' HE1' ' A' ' 127' ' ' PHE . 27.5 mt -110.2 140.63 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 117' ' ' LYS . 11.9 m-85 -139.36 142.74 37.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.404 ' HA ' HD12 ' A' ' 49' ' ' LEU . 29.9 t80 -111.43 143.6 42.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.7 m -114.46 93.83 33.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.686 0.755 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.494 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.5 Cg_endo -69.77 167.86 23.23 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -84.25 136.8 33.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 13.8 p30 49.98 26.8 2.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.494 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 12.8 mtmm -128.97 39.25 3.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 7.7 mmpt? -67.98 -45.59 73.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.3 mp -50.85 -38.2 47.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -134.88 88.37 27.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.605 0.717 . . . . 0.0 110.845 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -171.76 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.724 2.282 . . . . 0.0 112.295 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -137.86 118.92 14.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 105' ' ' TYR . 22.3 tttt -91.47 120.22 32.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -55.04 112.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -123.68 101.01 7.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.9 -139.65 4.32 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.452 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.37 139.71 14.71 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.47 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.428 ' CZ ' ' HG3' ' A' ' 102' ' ' PRO . 26.8 mtp180 -83.88 43.79 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.883 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 124' ' ' LEU . 3.5 tp10 -102.05 129.65 48.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.6 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.3 tm? -34.02 -55.46 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.93 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.2 t -59.43 -50.15 75.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 130' ' ' TYR . 6.0 t0 -44.05 -35.72 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.637 ' HE1' HD13 ' A' ' 104' ' ' ILE . 80.8 m-85 -73.31 -37.98 66.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.557 HD11 ' CD1' ' A' ' 124' ' ' LEU . 30.5 mt -63.03 -61.42 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.124 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.85 -34.86 73.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 126' ' ' ASP . 44.8 t80 -57.46 -48.8 78.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.422 HD11 HD22 ' A' ' 49' ' ' LEU . 68.3 mt -75.68 -34.4 60.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -43.49 -38.86 3.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.46 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.2 ptm180 -101.03 -47.05 4.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.46 ' N ' ' HG3' ' A' ' 133' ' ' ARG . 16.6 mm-40 -52.63 -57.79 8.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -48.7 110.88 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -36.36 -71.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.163 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.6 t -59.48 -57.08 14.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.887 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.49 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.3 p90 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.929 0.395 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.527 ' H ' HD23 ' A' ' 16' ' ' LEU . 1.6 pt? -109.04 -38.62 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.52 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 30.3 tttt -112.61 149.54 32.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.607 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 52.7 p -161.72 146.5 13.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -94.3 158.8 35.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.707 0.765 . . . . 0.0 110.835 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 150.29 68.1 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.644 2.229 . . . . 0.0 112.357 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.489 HD13 ' CG2' ' A' ' 33' ' ' VAL . 39.2 mm -79.74 132.36 61.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.625 0.726 . . . . 0.0 111.132 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' HG23 ' A' ' 21' ' ' ILE . 53.4 Cg_endo -69.76 173.34 11.12 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -97.31 -34.41 11.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p -141.99 135.79 29.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -132.23 38.76 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -78.43 57.73 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.83 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.98 -170.73 13.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.494 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -40.41 5.42 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.715 2.276 . . . . 0.0 112.374 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.462 HG13 HG22 ' A' ' 82' ' ' ILE . 23.5 t -120.63 117.11 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -64.22 143.08 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.893 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.48 HG22 ' HE3' ' A' ' 84' ' ' LYS . 73.2 t -91.44 119.6 38.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.997 HG11 HG23 ' A' ' 41' ' ' VAL . 21.2 t -116.55 126.5 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 35' ' ' GLU . 29.1 m -122.34 156.9 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.154 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.607 ' HB3' ' CB ' ' A' ' 18' ' ' SER . . . -48.47 -20.05 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.537 ' HB2' HG23 ' A' ' 33' ' ' VAL . 5.1 mt-10 -76.54 -34.21 58.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -129.12 33.72 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.668 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 7.6 t80 -69.35 -52.96 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.84 -6.76 28.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -89.52 -43.45 10.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.4 mt -98.4 -61.89 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.997 HG23 HG11 ' A' ' 32' ' ' VAL . 60.5 t -47.9 -61.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.151 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.46 135.08 52.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -173.62 106.36 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.941 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -85.71 14.66 5.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -111.02 -41.94 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -137.18 164.11 29.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 63.7 m-20 -80.31 154.23 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.2 t -145.2 147.74 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.5 tp -119.09 129.74 55.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.917 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 85' ' ' MET . 1.8 tp -119.95 133.4 66.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.468 ' CG ' HG12 ' A' ' 104' ' ' ILE . 4.9 tm-20 -126.82 116.38 20.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -90.11 140.08 30.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.45 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 5.9 p90 -143.98 176.08 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -128.61 133.43 25.17 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.612 0.72 . . . . 0.0 111.072 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -8.28 23.21 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.748 2.298 . . . . 0.0 112.349 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.434 ' CZ2' HG21 ' A' ' 88' ' ' THR . 5.0 p-90 -118.32 21.73 12.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 2.5 t -123.34 110.51 15.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -49.27 -47.83 33.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.482 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 58' ' ' GLY . 12.9 m170 -34.74 -45.89 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 110.839 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.1 t -70.91 -50.93 29.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.936 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -47.32 -34.08 6.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.852 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -86.77 -29.17 22.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.837 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.965 HD12 ' HB2' ' A' ' 66' ' ' LYS . 63.2 tp -83.13 -14.36 53.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.522 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.9 tt0 -46.08 -58.28 6.67 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.641 0.734 . . . . 0.0 110.943 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.1 Cg_endo -69.73 -17.53 37.64 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.644 2.229 . . . . 0.0 112.387 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.965 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.1 mmmp? -84.74 -30.17 24.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -93.67 -41.32 9.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -46.58 -56.63 5.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 70' ' ' LEU . 15.6 mt-10 -42.02 -62.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.478 ' CD1' HG12 ' A' ' 128' ' ' ILE . 22.3 tp -37.16 -35.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.51 -57.06 19.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.504 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -75.38 -19.93 59.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.718 ' HD3' HD11 ' A' ' 124' ' ' LEU . 4.1 mtpm? -73.95 -45.07 52.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.662 HD21 HG23 ' A' ' 128' ' ' ILE . 90.0 mt -86.86 -2.4 58.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.3 t -39.63 -26.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 74' ' ' LEU . 9.3 ttpp -82.86 22.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 74' ' ' LEU . 42.2 p30 -102.93 95.51 6.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.628 0.728 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.6 Cg_endo -69.76 -0.83 7.47 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.656 2.238 . . . . 0.0 112.372 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.31 -44.45 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.482 HD11 ' CB ' ' A' ' 135' ' ' ALA . 15.7 mt -88.22 143.76 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.155 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.0 t -133.28 115.41 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.137 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 74' ' ' LEU . 30.8 mm -81.96 130.37 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.633 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -148.73 171.87 15.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.075 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.48 ' HE3' HG22 ' A' ' 31' ' ' VAL . 2.8 pttp -135.42 163.07 30.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.923 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.629 ' HB2' HD11 ' A' ' 50' ' ' ILE . 15.8 ttt -151.13 136.76 17.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -96.33 82.37 3.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -45.58 -58.35 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.434 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 22.8 p -46.77 -22.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.35 -18.47 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -144.74 108.44 4.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 90' ' ' ASN . 27.9 t70 -37.07 151.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -97.04 128.13 36.42 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.612 0.72 . . . . 0.0 111.12 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -173.34 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.6 m -118.7 160.54 39.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.658 0.742 . . . . 0.0 110.876 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.69 -8.97 10.66 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.353 -0.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 95' ' ' PRO . 81.3 m-85 -35.13 143.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -151.59 129.23 11.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.586 HG13 ' OG1' ' A' ' 103' ' ' THR . 45.4 t -132.89 117.98 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.6 -36.92 3.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.23 121.55 4.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.538 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.28 154.16 38.17 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.66 0.743 . . . . 0.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.538 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.4 Cg_endo -69.69 160.03 88.47 Favored 'Cis proline' 0 C--O 1.231 0.143 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.382 -0.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.586 ' OG1' HG13 ' A' ' 98' ' ' VAL . 34.2 m -137.48 113.81 10.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.468 HG12 ' CG ' ' A' ' 51' ' ' GLU . 16.8 mt -105.9 138.24 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.109 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.52 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 10.8 m-85 -132.88 173.03 11.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.961 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -142.97 127.35 17.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 t -100.51 99.64 10.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.639 0.733 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.76 178.84 4.16 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.701 2.268 . . . . 0.0 112.361 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.481 ' N ' ' OD1' ' A' ' 47' ' ' ASP . . . -92.93 131.05 38.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 11.4 p30 51.0 29.07 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.933 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.466 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.3 mtmm -128.05 23.0 6.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -50.72 -56.37 12.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.0 mt -39.78 -37.13 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -134.86 90.22 22.91 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.635 0.731 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -172.34 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.664 2.243 . . . . 0.0 112.358 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -139.34 128.16 23.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.52 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 4.8 ttpm? -94.44 124.24 38.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.534 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 67.8 t80 -55.75 105.14 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -115.9 100.89 8.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.6 -152.38 17.58 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.497 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.01 131.69 11.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.519 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.421 ' HB2' ' NH1' ' A' ' 122' ' ' ARG . 19.8 mtm105 -83.88 49.0 1.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.905 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 124' ' ' LEU . 13.0 tt0 -107.78 134.32 50.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.718 HD11 ' HD3' ' A' ' 73' ' ' LYS . 3.5 tm? -34.81 -52.69 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.8 m -67.73 -47.7 68.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -47.37 -36.16 9.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.534 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 58.6 m-85 -69.24 -42.65 75.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.914 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.662 HG23 HD21 ' A' ' 74' ' ' LEU . 23.1 mt -63.52 -53.34 46.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -63.57 -21.98 66.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.808 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.405 ' CD1' ' C ' ' A' ' 130' ' ' TYR . 6.1 t80 -72.22 -46.86 54.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.1 mt -76.56 -39.0 54.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -40.05 -42.49 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -97.13 -58.73 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -46.23 -56.36 5.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.482 ' CB ' HD11 ' A' ' 80' ' ' ILE . . . -45.29 120.56 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.48 -70.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.1 t -58.01 -44.16 87.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.475 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 2.4 p90 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.861 0.362 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' A' ' 17' ' ' LYS . 4.0 pp -114.2 -36.14 4.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.525 ' HB3' HD12 ' A' ' 16' ' ' LEU . 10.1 ptmt -119.89 165.64 14.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.441 ' CB ' ' HG3' ' A' ' 35' ' ' GLU . 2.3 m -158.22 161.04 37.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.842 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 4.2 mm-40 -105.88 160.94 24.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.647 0.737 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 54.0 Cg_endo -69.78 137.66 35.94 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.361 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.714 HD13 HG21 ' A' ' 33' ' ' VAL . 19.6 mm -71.41 129.46 88.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.606 0.717 . . . . 0.0 111.155 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 128.36 15.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.659 2.239 . . . . 0.0 112.335 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -40.37 -41.23 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -162.66 138.57 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -107.98 74.49 0.95 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -92.03 50.25 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.23 -178.13 15.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.467 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -39.99 5.9 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.662 2.241 . . . . 0.0 112.375 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.431 HG13 HG22 ' A' ' 82' ' ' ILE . 22.9 t -109.09 119.77 59.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.64 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 5.6 mmtp -66.96 128.47 36.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -82.86 117.56 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.102 HG11 HG23 ' A' ' 41' ' ' VAL . 21.8 t -112.93 124.3 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.714 HG21 HD13 ' A' ' 21' ' ' ILE . 19.1 m -117.89 147.25 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.094 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -36.91 -40.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HB3' HD11 ' A' ' 21' ' ' ILE . 11.1 mt-10 -57.6 -49.02 77.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.466 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 17.7 p-10 -110.49 24.75 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.884 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.741 ' CD2' HG21 ' A' ' 41' ' ' VAL . 31.0 t80 -63.34 -55.51 23.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -67.14 -5.14 12.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -88.79 -45.61 9.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.5 mt -97.56 -59.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.121 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.102 HG23 HG11 ' A' ' 32' ' ' VAL . 38.7 t -49.16 -59.4 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.33 122.96 19.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -167.34 114.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.11 3.51 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.38 -40.92 6.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.24 140.79 48.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.73 149.21 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.09 137.64 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.147 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 106' ' ' PHE . 13.2 tp -110.34 125.64 53.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 tp -113.48 131.15 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' CG ' HG12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -125.58 109.53 12.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -84.84 128.97 34.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -128.79 179.9 5.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.24 128.55 17.44 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 0.0 111.136 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -6.75 19.36 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 4.1 p-90 -119.12 18.95 13.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.931 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 38.1 t -119.14 124.62 47.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.84 -61.73 7.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.514 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -42.8 -38.84 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.818 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.3 m -67.95 -44.26 77.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -64.76 -32.77 74.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -76.37 -21.7 55.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.767 HD12 ' HB2' ' A' ' 66' ' ' LYS . 18.4 tp -90.55 -18.63 24.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -41.19 -58.24 2.97 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.707 0.765 . . . . 0.0 110.943 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.73 -32.22 19.1 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.747 2.298 . . . . 0.0 112.331 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.767 ' HB2' HD12 ' A' ' 63' ' ' LEU . 26.6 mtpt -68.69 -28.58 66.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -92.9 -38.65 11.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -47.42 -61.11 2.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -40.44 -55.13 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.405 ' N ' HD21 ' A' ' 124' ' ' LEU . 30.8 tp -41.25 -39.21 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.54 -64.94 3.56 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.477 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.18 -16.13 50.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -81.0 -44.89 17.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.903 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.631 HD12 HD11 ' A' ' 82' ' ' ILE . 95.3 mt -83.75 3.06 35.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.2 t -54.7 -19.02 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.02 10.48 16.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 53.1 m-20 -110.61 98.63 38.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.552 0.692 . . . . 0.0 110.859 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.2 Cg_endo -69.84 0.18 6.08 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.704 2.269 . . . . 0.0 112.309 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -110.69 -30.87 7.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 55.1 mt -105.65 139.01 28.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.99 110.38 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.631 HD11 HD12 ' A' ' 74' ' ' LEU . 42.0 mm -79.11 134.7 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.687 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -146.81 173.75 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -143.52 143.01 31.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.4 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 5.8 ttt -132.89 139.26 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -93.45 82.84 4.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -44.54 -57.45 3.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 88' ' ' THR . 1.6 p -39.36 -27.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.195 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 87' ' ' ALA . . . -102.25 -29.79 11.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.109 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -120.51 120.38 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -55.66 116.83 3.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.922 HG11 HG23 ' A' ' 98' ' ' VAL . 90.9 t -68.72 111.7 9.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.588 0.709 . . . . 0.0 111.112 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.7 Cg_endo -69.82 -178.18 2.24 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.707 2.271 . . . . 0.0 112.351 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.507 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -97.57 159.37 31.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.855 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.509 ' O ' ' C ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.71 -27.29 6.88 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.734 -1.778 . . . . 0.0 112.353 -0.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.509 ' C ' ' O ' ' A' ' 95' ' ' PRO . 82.1 m-85 -28.51 111.16 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -117.5 84.07 2.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.922 HG23 HG11 ' A' ' 92' ' ' VAL . 99.2 t -77.21 106.69 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -129.65 25.81 5.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.52 115.57 0.37 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.503 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.546 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -98.74 154.2 37.54 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.644 0.735 . . . . 0.0 110.903 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.7 Cg_endo -69.64 151.34 91.03 Favored 'Cis proline' 0 C--O 1.232 0.208 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.392 -0.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -129.04 123.14 31.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.132 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.403 HG12 ' CG ' ' A' ' 51' ' ' GLU . 44.1 mt -119.3 126.65 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.464 ' CZ ' ' HE3' ' A' ' 117' ' ' LYS . 8.1 m-85 -126.78 154.54 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.414 ' HA ' HD12 ' A' ' 49' ' ' LEU . 8.6 t80 -125.83 129.76 50.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.865 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.9 t -101.88 97.59 8.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.694 0.759 . . . . 0.0 110.861 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.498 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.79 171.15 15.03 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.664 2.243 . . . . 0.0 112.335 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.495 ' O ' ' ND2' ' A' ' 110' ' ' ASN . . . -85.11 133.4 34.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER 49.65 29.5 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.498 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 10.5 mtmm -130.93 6.69 4.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.94 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.478 ' N ' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -35.92 -53.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.0 mt -39.06 -52.27 1.84 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 5.5 t30 -120.92 94.93 49.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.625 0.726 . . . . 0.0 110.906 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.7 Cg_endo -69.76 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.729 2.286 . . . . 0.0 112.332 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -142.03 110.5 6.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.464 ' HE3' ' CZ ' ' A' ' 105' ' ' TYR . 31.5 tttt -71.53 144.29 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.903 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.437 ' CZ ' ' CE1' ' A' ' 127' ' ' PHE . 35.4 t80 -90.48 106.82 18.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.9 100.75 7.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.894 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.19 -140.15 3.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.52 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.59 130.03 10.14 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.492 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -79.25 45.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 110.893 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 124' ' ' LEU . 18.2 tt0 -101.43 134.17 44.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.442 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -36.28 -51.8 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.7 m -68.02 -45.99 72.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.38 -33.87 4.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.437 ' CE1' ' CZ ' ' A' ' 118' ' ' TYR . 54.0 m-85 -74.64 -42.01 59.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.3 mt -58.26 -53.01 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 t -65.27 -30.89 71.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.77 -47.83 84.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.6 mt -74.29 -42.52 59.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -39.54 -32.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -101.73 -60.68 1.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -47.98 -53.96 14.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.49 122.65 5.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -74.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.084 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.5 t -61.4 -54.91 37.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.51 -179.953 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.591 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.8 p90 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.86 0.362 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 pp -95.81 -36.03 11.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 18' ' ' SER . 25.9 tttp -118.04 157.45 26.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.462 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 58.2 p -159.57 158.02 30.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 9.1 mm-40 -107.99 160.79 25.59 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.641 0.734 . . . . 0.0 110.848 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.71 139.94 41.66 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.656 2.237 . . . . 0.0 112.346 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.574 HD13 HG21 ' A' ' 33' ' ' VAL . 19.2 mm -69.5 129.78 91.24 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.634 0.73 . . . . 0.0 111.126 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 132.34 23.15 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.675 2.25 . . . . 0.0 112.335 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 24' ' ' SER . 8.6 pt-20 -44.89 -42.71 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.441 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 3.3 m -159.44 137.75 10.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.825 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -111.32 80.65 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -101.94 55.35 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.32 -172.94 13.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.472 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -41.67 4.03 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.653 2.235 . . . . 0.0 112.297 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 82' ' ' ILE . 7.4 t -114.8 122.62 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.164 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.43 ' HZ2' HD13 ' A' ' 40' ' ' ILE . 1.8 mmmp? -68.26 130.33 42.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.3 t -81.11 110.36 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.055 HG11 HG23 ' A' ' 41' ' ' VAL . 39.2 t -105.16 114.97 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.574 HG21 HD13 ' A' ' 21' ' ' ILE . 35.9 m -108.86 146.35 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.591 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.54 -47.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.453 ' HB3' HD11 ' A' ' 21' ' ' ILE . 1.9 mm-40 -51.55 -48.79 62.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' VAL . 16.9 p-10 -110.38 28.15 8.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.49 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 8.9 t80 -73.33 -44.16 59.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -75.15 -4.57 39.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.53 -39.09 10.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.53 HD12 HG22 ' A' ' 32' ' ' VAL . 4.6 mt -98.91 -63.49 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.055 HG23 HG11 ' A' ' 32' ' ' VAL . 93.4 t -53.47 -60.81 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.109 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 24.8 m-20 -63.99 118.75 8.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 42' ' ' ASN . 38.7 m-20 -175.1 114.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.26 31.69 2.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -125.33 -38.05 2.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -127.88 161.13 29.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -80.94 137.92 36.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -144.51 136.9 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.0 tp -116.39 136.32 53.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.401 HD13 ' CG2' ' A' ' 41' ' ' VAL . 3.0 tp -116.45 137.14 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.534 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -127.25 110.97 13.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 103' ' ' THR . 69.8 m-85 -87.53 138.64 31.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 4.9 p90 -143.85 175.31 10.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.933 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.94 134.35 26.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.55 0.69 . . . . 0.0 111.107 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -16.36 37.48 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.689 2.259 . . . . 0.0 112.352 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -113.49 25.99 10.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.7 t -123.08 134.27 54.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.78 -59.77 8.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.475 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -38.26 -35.7 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.297 . . . . 0.0 110.832 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -52.59 61.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -57.19 -36.61 71.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -77.53 -35.85 52.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 66' ' ' LYS . 27.8 tp -81.12 -19.45 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.521 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.6 tt0 -46.98 -58.39 7.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.668 0.747 . . . . 0.0 110.886 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.8 -28.03 25.58 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.654 2.236 . . . . 0.0 112.37 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HB2' HD12 ' A' ' 63' ' ' LEU . 24.1 mtpp -72.85 -27.36 61.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.534 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 41.5 t80 -96.32 -46.07 6.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -41.81 -59.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 70' ' ' LEU . 25.5 mt-10 -39.48 -63.47 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.432 ' N ' HD21 ' A' ' 124' ' ' LEU . 15.7 tp -37.25 -34.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.5 -51.4 42.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.516 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.4 -18.32 57.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.503 ' HD3' HD11 ' A' ' 124' ' ' LEU . 6.3 mtpm? -76.86 -53.74 7.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' ASP . 98.0 mt -79.41 1.78 24.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.1 t -43.06 -23.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 74' ' ' LEU . 16.4 mtpt -89.89 23.74 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.911 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' LEU . 50.1 p-10 -101.36 98.06 8.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.595 0.712 . . . . 0.0 110.845 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.9 Cg_endo -69.77 1.04 4.8 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.683 2.255 . . . . 0.0 112.355 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -123.42 -43.29 2.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.456 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 62.1 mt -87.25 144.48 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.5 t -134.95 97.8 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.444 HG22 HG13 ' A' ' 29' ' ' VAL . 30.5 mm -70.55 122.2 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.703 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -138.09 171.28 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.051 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.421 ' HB3' HG11 ' A' ' 29' ' ' VAL . 41.5 pttt -140.82 159.01 43.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.4 ttt -150.76 135.45 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 87' ' ' ALA . 30.9 t0 -89.51 80.89 6.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -35.91 -62.94 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 88' ' ' THR . 19.9 p -37.87 -39.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.44 -28.81 20.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 87' ' ' ALA . 14.3 m-80 -124.38 110.39 14.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -49.11 130.24 18.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.481 HG11 HG23 ' A' ' 98' ' ' VAL . 65.2 t -76.97 118.81 74.37 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.626 0.727 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -164.57 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 2.252 . . . . 0.0 112.34 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -121.06 161.14 42.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.626 0.726 . . . . 0.0 110.887 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.7 Cg_endo -69.77 -12.91 12.34 Favored 'Cis proline' 0 C--N 1.341 0.176 0 C-N-CA 122.681 -1.799 . . . . 0.0 112.359 -0.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 95' ' ' PRO . 88.2 m-85 -33.86 136.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -141.29 119.23 11.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.572 HG22 HG21 ' A' ' 103' ' ' THR . 99.1 t -122.98 80.77 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.106 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -66.13 -45.43 81.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.67 -171.73 13.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.462 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.513 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -147.97 157.82 42.89 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.628 0.728 . . . . 0.0 110.861 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.8 166.99 72.73 Favored 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.68 -1.8 . . . . 0.0 112.323 0.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.572 HG21 HG22 ' A' ' 98' ' ' VAL . 88.1 m -146.2 131.18 18.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.452 HD13 ' CE1' ' A' ' 127' ' ' PHE . 20.6 mt -124.92 129.43 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -125.49 159.34 32.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.533 ' HB3' ' CG ' ' A' ' 116' ' ' LYS . 21.2 t80 -119.89 151.19 39.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 m -121.64 87.63 46.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.673 0.749 . . . . 0.0 110.837 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.502 ' O ' ' CE ' ' A' ' 112' ' ' LYS . 54.0 Cg_endo -69.79 168.23 22.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.671 2.247 . . . . 0.0 112.332 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.478 ' C ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.16 139.03 32.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.478 ' CG ' ' C ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER 49.84 25.02 1.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.486 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.1 mtmt -128.0 18.23 6.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' CE ' ' O ' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -46.44 -34.07 4.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mt -82.76 -24.88 33.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 111' ' ' LYS . 10.9 m120 -119.43 63.02 7.09 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.616 0.722 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -164.72 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.363 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.533 ' CG ' ' HB3' ' A' ' 106' ' ' PHE . 0.8 OUTLIER -160.63 155.55 24.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.9 ttpp -117.72 126.75 53.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.41 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 60.1 t80 -54.97 101.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -115.2 94.65 4.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.73 -141.64 4.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.504 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.78 134.8 12.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.502 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.451 ' HB2' ' NH1' ' A' ' 122' ' ' ARG . 10.3 mtp-105 -84.37 49.74 1.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.876 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 124' ' ' LEU . 26.9 tt0 -109.66 133.85 52.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.503 HD11 ' HD3' ' A' ' 73' ' ' LYS . 3.3 tm? -36.28 -53.85 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.5 p -65.16 -42.7 93.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.09 -27.93 36.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.452 ' CE1' HD13 ' A' ' 104' ' ' ILE . 58.0 m-85 -78.8 -47.32 16.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.7 mt -53.19 -50.73 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.12 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.0 p -60.67 -55.32 34.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.828 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -44.44 -45.09 8.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 135' ' ' ALA . 18.9 mt -76.51 -37.55 56.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -48.18 -45.89 34.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.445 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 12.9 ptm180 -86.45 -40.04 15.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.462 ' OE1' ' CD ' ' A' ' 116' ' ' LYS . 46.7 mm-40 -68.89 -65.02 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 131' ' ' LEU . . . -34.18 131.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -66.72 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.8 t -66.16 -43.88 85.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.451 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.407 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.2 p90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.927 0.394 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.1 pp -98.31 -43.87 6.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.567 ' N ' HD12 ' A' ' 16' ' ' LEU . 7.4 ttpm? -110.71 166.38 11.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.488 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 98.1 p -170.78 152.0 3.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.441 ' CG ' HD22 ' A' ' 90' ' ' ASN . 5.6 mm-40 -96.23 158.45 33.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.623 0.725 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 145.75 58.04 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.676 2.251 . . . . 0.0 112.365 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 35' ' ' GLU . 29.6 mm -73.13 133.45 81.42 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.739 . . . . 0.0 111.108 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' A' ' 21' ' ' ILE . 54.2 Cg_endo -69.77 174.11 9.99 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.361 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -97.23 -36.04 10.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -145.0 137.73 26.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -130.2 37.23 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.51 60.44 2.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.69 -168.43 12.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -41.14 4.54 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 0.0 112.332 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG13 HG22 ' A' ' 82' ' ' ILE . 30.7 t -119.13 122.14 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.59 131.13 42.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.0 t -78.77 135.14 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.983 HG11 HG23 ' A' ' 41' ' ' VAL . 38.8 t -132.15 120.03 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 36' ' ' ASN . 20.3 m -116.97 147.58 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.476 ' HB3' ' CB ' ' A' ' 18' ' ' SER . . . -34.3 -44.11 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 33' ' ' VAL . 15.6 mt-10 -53.77 -46.47 70.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 33' ' ' VAL . 18.1 p-10 -116.32 30.6 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.592 ' CZ ' ' HG3' ' A' ' 93' ' ' PRO . 5.2 t80 -69.98 -54.73 11.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.43 -5.69 20.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -90.6 -41.6 11.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.893 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.4 mt -97.5 -58.16 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.983 HG23 HG11 ' A' ' 32' ' ' VAL . 24.0 t -54.56 -60.1 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.09 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 34.3 m-20 -67.45 123.08 19.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.839 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 28.9 m-20 -171.89 108.5 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -83.43 0.42 46.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -85.68 -45.8 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -138.36 162.86 33.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.67 150.38 36.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.98 140.99 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.502 HD23 HD12 ' A' ' 82' ' ' ILE . 29.9 tp -112.95 126.07 55.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 85' ' ' MET . 1.9 tp -113.45 135.33 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.105 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.456 ' C ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -126.03 117.95 24.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.54 ' CG ' HG21 ' A' ' 98' ' ' VAL . 60.1 m-85 -91.59 120.44 32.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.564 ' CE1' ' OD2' ' A' ' 86' ' ' ASP . 28.6 p90 -128.47 178.84 6.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -135.24 132.44 20.07 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.564 0.697 . . . . 0.0 111.094 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.539 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.3 Cg_endo -69.79 -2.49 10.29 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.487 ' CZ3' ' SG ' ' A' ' 57' ' ' CYS . 7.3 p-90 -122.04 6.73 9.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -96.23 137.34 35.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.98 -58.17 4.51 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -50.5 -39.19 47.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.324 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.6 m -64.06 -38.95 92.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -64.12 -45.91 86.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -68.34 -14.56 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.835 HD12 ' HB2' ' A' ' 66' ' ' LYS . 14.2 tp -96.33 -24.76 16.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.535 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -37.62 -57.93 1.42 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.595 0.712 . . . . 0.0 110.875 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.4 Cg_endo -69.76 -27.74 26.11 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.686 2.257 . . . . 0.0 112.359 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.835 ' HB2' HD12 ' A' ' 63' ' ' LEU . 4.5 mtpm? -71.58 -32.5 68.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -88.69 -40.26 13.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -44.48 -59.33 2.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -38.78 -56.21 1.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.407 ' N ' HD21 ' A' ' 124' ' ' LEU . 28.0 tp -43.79 -39.89 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.07 -63.25 5.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.438 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.34 -26.28 67.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.875 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -72.12 -44.14 63.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.663 HD12 HD11 ' A' ' 82' ' ' ILE . 82.2 mt -89.55 3.19 53.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.1 t -52.09 -20.63 2.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -98.87 22.71 9.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 1.2 m-20 -103.29 99.28 14.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.61 0.719 . . . . 0.0 110.865 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.1 Cg_endo -69.75 -3.25 11.62 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.726 2.284 . . . . 0.0 112.334 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.19 -19.09 9.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.2 mt -123.29 134.44 66.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.2 t -130.2 103.98 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.663 HD11 HD12 ' A' ' 74' ' ' LEU . 51.4 mm -69.61 132.36 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.146 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.541 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -146.63 167.75 22.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 pttt -139.92 156.36 46.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.553 ' HB3' HD11 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -149.18 132.91 16.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.564 ' OD2' ' CE1' ' A' ' 53' ' ' TYR . 1.2 m-20 -86.67 101.39 13.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -58.14 -64.96 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.539 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -45.35 -21.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -92.58 -29.74 16.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -142.79 130.37 21.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -47.04 150.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.534 HG13 ' HD2' ' A' ' 93' ' ' PRO . 89.7 t -96.49 135.49 22.37 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.648 0.737 . . . . 0.0 111.088 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.592 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.5 Cg_endo -69.79 -163.55 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.683 2.255 . . . . 0.0 112.339 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.539 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -132.68 153.87 81.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.704 0.764 . . . . 0.0 110.839 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.85 -7.42 10.12 Favored 'Cis proline' 0 C--N 1.342 0.196 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.304 0.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.475 ' C ' ' O ' ' A' ' 95' ' ' PRO . 51.8 m-85 -31.7 131.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -142.77 126.74 17.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.54 HG21 ' CG ' ' A' ' 52' ' ' PHE . 81.8 t -133.83 115.59 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -123.0 -41.85 2.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.29 118.09 4.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.539 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -96.23 155.19 38.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.661 0.743 . . . . 0.0 110.905 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.77 161.11 86.88 Favored 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.318 -0.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.506 HG21 HG22 ' A' ' 98' ' ' VAL . 57.9 m -141.71 115.04 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.508 HD13 ' CE1' ' A' ' 127' ' ' PHE . 68.3 mt -108.52 138.8 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.143 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.437 ' O ' HD12 ' A' ' 49' ' ' LEU . 10.5 m-85 -133.92 178.03 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.952 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -149.32 126.51 11.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -101.62 100.08 13.28 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.664 0.745 . . . . 0.0 110.833 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.496 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.75 171.04 15.18 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.609 2.206 . . . . 0.0 112.388 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.456 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.67 139.49 31.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.084 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.7 p30 46.85 25.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.496 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.2 mtmm -127.27 22.44 6.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 113' ' ' LEU . 7.7 mmpt? -45.86 -66.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 112' ' ' LYS . 6.9 mp -34.02 -44.43 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.942 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -122.44 90.14 49.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.593 0.711 . . . . 0.0 110.92 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -163.75 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.632 2.221 . . . . 0.0 112.31 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -141.7 131.31 24.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -100.04 134.13 43.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.85 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.453 ' HB3' HG22 ' A' ' 104' ' ' ILE . 60.3 t80 -79.24 111.84 15.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -124.15 98.3 5.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 179.57 -146.27 6.98 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.99 134.33 12.38 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.489 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -81.29 45.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.888 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 124' ' ' LEU . 9.0 tt0 -103.12 134.48 46.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.483 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -36.84 -54.92 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 60.4 p -60.84 -48.93 79.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -47.8 -34.97 9.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.508 ' CE1' HD13 ' A' ' 104' ' ' ILE . 33.1 m-85 -70.61 -37.31 73.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.4 mt -69.05 -57.55 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.113 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.6 t -60.29 -24.7 65.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -70.82 -48.57 53.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.935 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 25.8 mt -71.22 -38.18 72.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -40.24 -42.95 1.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -94.78 -67.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -40.53 -54.42 2.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 131' ' ' LEU . . . -44.57 100.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.069 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.3 t -44.2 -24.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 138' ' ' GLY . 1.2 t -116.33 48.46 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 137' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.497 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.691 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.2 p90 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.912 0.387 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 16' ' ' LEU . 1.9 pp -104.21 -37.04 7.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.934 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 17.0 ttpt -109.86 158.2 18.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.9 p -164.22 149.1 10.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -98.86 160.7 27.15 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.656 0.741 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 143.57 51.32 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.648 2.232 . . . . 0.0 112.333 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.602 HD13 HG21 ' A' ' 33' ' ' VAL . 20.9 mm -68.87 129.15 92.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.633 0.73 . . . . 0.0 111.154 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 136.15 32.41 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.667 2.245 . . . . 0.0 112.355 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 24' ' ' SER . 12.0 pt-20 -49.05 -50.24 37.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.874 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.407 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 11.6 t -149.53 137.28 20.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -111.43 50.31 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.55 -25.05 59.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.84 169.94 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.436 ' HG3' ' CG ' ' A' ' 68' ' ' LYS . 53.5 Cg_endo -69.79 -29.67 23.37 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.686 2.258 . . . . 0.0 112.332 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.5 t -111.73 121.0 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.42 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 9.0 mmtm -71.12 134.93 47.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.1 t -86.35 104.75 14.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.147 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.916 HG11 HG23 ' A' ' 41' ' ' VAL . 44.9 t -95.91 114.11 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.171 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.602 HG21 HD13 ' A' ' 21' ' ' ILE . 26.3 m -109.53 144.74 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.691 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.86 -43.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -56.09 -50.82 69.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.452 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 28.5 p30 -105.41 21.58 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CD2' HG21 ' A' ' 41' ' ' VAL . 14.4 t80 -62.8 -58.78 6.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.02 -6.97 7.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.858 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.97 -44.13 11.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.409 HD12 HG22 ' A' ' 32' ' ' VAL . 23.5 mt -97.21 -58.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.916 HG23 HG11 ' A' ' 32' ' ' VAL . 42.7 t -51.86 -61.55 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -69.06 114.61 7.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -167.08 106.72 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -91.11 31.88 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -126.4 -37.82 2.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.826 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.81 145.55 48.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.3 147.26 53.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.9 t -145.26 147.84 18.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.131 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.548 HD23 HD12 ' A' ' 82' ' ' ILE . 21.8 tp -124.57 126.9 46.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.945 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 41' ' ' VAL . 3.2 tp -107.72 139.51 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.083 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -127.28 105.13 8.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -84.78 115.33 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -125.6 179.69 5.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -131.66 132.91 23.67 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.569 0.7 . . . . 0.0 111.12 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.497 ' HD2' HG21 ' A' ' 88' ' ' THR . 53.7 Cg_endo -69.72 -1.65 8.79 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.744 2.296 . . . . 0.0 112.348 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.483 ' NE1' HG21 ' A' ' 88' ' ' THR . 6.9 p-90 -122.96 5.59 9.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.618 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -98.64 130.31 45.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -66.11 -59.65 7.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.497 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.559 ' CD2' ' HD3' ' A' ' 102' ' ' PRO . 3.1 p-80 -38.41 -31.65 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.875 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLY . 9.5 t -68.54 -49.6 58.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -53.68 -45.53 70.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -72.49 -24.86 61.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 66' ' ' LYS . 16.3 tp -87.68 -20.25 26.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.946 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -42.97 -58.31 4.11 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.657 0.741 . . . . 0.0 110.861 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.1 Cg_endo -69.74 -26.5 27.61 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.704 2.27 . . . . 0.0 112.328 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.621 ' HB2' HD12 ' A' ' 63' ' ' LEU . 42.1 mtpt -74.24 -27.35 60.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 40.3 t80 -96.32 -33.57 11.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.436 ' CG ' ' HG3' ' A' ' 28' ' ' PRO . 1.2 ttmp? -51.77 -57.62 8.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -40.53 -60.75 1.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.3 tp -38.48 -38.81 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.83 -65.61 3.21 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.84 -16.43 64.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -80.88 -42.66 21.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.633 HD12 HD11 ' A' ' 82' ' ' ILE . 80.6 mt -82.09 3.34 27.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.2 m -53.92 -24.78 17.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -78.1 6.9 7.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.917 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.435 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 4.1 t0 -113.49 98.98 48.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.659 0.742 . . . . 0.0 110.843 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.3 Cg_endo -69.72 0.3 5.82 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.71 2.273 . . . . 0.0 112.36 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -110.83 -36.83 5.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.475 HG21 HD13 ' A' ' 74' ' ' LEU . 64.3 mt -92.55 137.97 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.2 t -135.37 116.81 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.1 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.633 HD11 HD12 ' A' ' 74' ' ' LEU . 23.3 mm -89.05 132.45 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.844 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -142.03 171.53 13.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -139.74 138.13 35.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.489 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 12.4 ttt -132.5 143.19 49.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.746 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -95.88 95.27 8.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -48.77 -67.19 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.497 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -46.97 -23.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.746 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -93.52 -25.12 17.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.489 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -141.07 125.29 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.0 128.97 36.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.52 128.56 74.64 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.591 0.71 . . . . 0.0 111.141 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -169.77 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.663 2.242 . . . . 0.0 112.343 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.5 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.5 m -121.25 160.84 43.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.667 0.746 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.2 Cg_endo -69.69 -8.62 10.47 Favored 'Cis proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 -1.801 . . . . 0.0 112.387 -0.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 95' ' ' PRO . 86.0 m-85 -34.04 123.37 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -125.74 130.16 50.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.885 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.907 HG22 HG21 ' A' ' 103' ' ' THR . 65.8 t -133.09 120.48 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.093 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -128.87 -38.64 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.79 123.3 5.32 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.516 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.546 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.4 OUTLIER -97.14 154.0 38.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.738 . . . . 0.0 110.878 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.559 ' HD3' ' CD2' ' A' ' 59' ' ' HIS . 53.1 Cg_endo -69.83 155.33 93.49 Favored 'Cis proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.29 0.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.907 HG21 HG22 ' A' ' 98' ' ' VAL . 92.9 m -131.53 100.27 5.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.424 HG12 ' HG2' ' A' ' 51' ' ' GLU . 95.6 mt -94.79 141.93 14.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.151 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.418 ' HB2' HG23 ' A' ' 50' ' ' ILE . 8.9 m-85 -140.88 161.59 37.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 49' ' ' LEU . 15.4 t80 -128.25 136.95 51.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -105.3 93.27 6.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.843 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.498 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.6 Cg_endo -69.75 164.59 33.96 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.394 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.459 ' O ' ' CE ' ' A' ' 111' ' ' LYS . . . -78.04 145.44 35.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.2 p30 41.94 24.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.498 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.2 mtmt -128.66 68.07 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HA ' ' NZ ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -90.57 -49.01 6.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.935 HD22 ' O ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -59.75 -25.47 64.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.554 ' N ' HD13 ' A' ' 113' ' ' LEU . 2.8 t-20 -133.39 84.06 47.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.646 0.736 . . . . 0.0 110.91 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -163.8 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -148.43 137.09 21.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.475 ' HG2' ' N ' ' A' ' 118' ' ' TYR . 29.8 ttmt -105.19 151.4 24.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.549 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 68.4 t80 -94.58 108.83 20.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -121.58 100.0 6.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 178.73 -153.59 12.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.1 133.35 12.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.477 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -80.36 45.96 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.844 0.355 . . . . 0.0 110.914 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 124' ' ' LEU . 8.8 tt0 -105.39 133.29 50.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.649 ' CD1' HD11 ' A' ' 128' ' ' ILE . 3.4 tm? -34.8 -55.59 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.3 m -58.86 -52.21 66.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.827 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.03 -30.38 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.549 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 38.9 m-85 -78.19 -40.34 37.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.649 HD11 ' CD1' ' A' ' 124' ' ' LEU . 37.5 mt -63.64 -57.26 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.153 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -58.01 -35.49 71.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.582 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 16.9 t80 -53.95 -52.82 59.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.6 mt -74.84 -39.89 61.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -38.79 -39.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.93 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -98.98 -57.07 2.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.582 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 69.6 mm-40 -49.24 -53.68 20.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -42.51 104.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.157 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 137' ' ' SER . 2.1 t -46.83 -49.62 19.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.444 ' N ' HG23 ' A' ' 136' ' ' THR . 23.7 m -73.98 -45.38 50.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.504 -179.969 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.706 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 14.5 p90 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.914 0.387 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 16' ' ' LEU . 1.5 pp -131.88 -40.21 1.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.933 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.4 ' HB3' ' H ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -97.12 125.25 41.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.735 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -142.1 156.74 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.847 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 4.5 mm-40 -106.0 161.68 22.08 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.652 0.739 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.4 Cg_endo -69.83 143.47 50.6 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.701 2.268 . . . . 0.0 112.306 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.57 HD13 HG21 ' A' ' 33' ' ' VAL . 23.2 mm -68.78 127.47 93.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.618 0.723 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.94 43.95 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.709 2.273 . . . . 0.0 112.351 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.59 -39.17 92.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 m -150.13 123.27 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -133.11 45.9 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.49 54.12 2.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.845 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.17 -160.11 23.4 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.491 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -41.55 4.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.63 2.22 . . . . 0.0 112.396 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 84' ' ' LYS . 18.4 t -119.53 107.19 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.116 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -53.48 124.98 16.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.8 t -75.4 126.1 35.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.033 HG11 HG23 ' A' ' 41' ' ' VAL . 30.0 t -118.51 120.31 63.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 21' ' ' ILE . 31.6 m -113.44 145.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 18' ' ' SER . . . -36.4 -38.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.091 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.536 ' HB3' HD11 ' A' ' 21' ' ' ILE . 10.7 mt-10 -59.51 -46.75 87.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' VAL . 22.2 p-10 -111.89 24.84 12.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.586 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 6.1 t80 -63.46 -58.06 8.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -65.29 -7.72 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -86.9 -44.22 11.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.7 mt -98.28 -62.3 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.033 HG23 HG11 ' A' ' 32' ' ' VAL . 97.1 t -48.14 -62.04 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.136 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -72.66 126.55 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.409 ' ND2' ' HE3' ' A' ' 46' ' ' LYS . 11.7 t-20 -172.91 108.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -87.6 29.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -124.14 -41.66 2.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HE3' ' ND2' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -136.28 130.13 32.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.57 151.95 5.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.499 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 89.4 t -146.33 152.58 13.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.599 HD23 HD12 ' A' ' 82' ' ' ILE . 39.8 tp -124.17 126.13 45.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.544 HD11 ' HB3' ' A' ' 85' ' ' MET . 1.8 tp -114.1 129.38 70.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.121 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 14.7 tm-20 -123.83 114.35 19.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -85.38 133.82 34.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -143.0 169.14 18.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.693 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -127.04 131.42 23.85 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.589 0.709 . . . . 0.0 111.074 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.465 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.2 Cg_endo -69.75 -10.13 27.82 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.376 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -115.58 5.11 14.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 7.5 t -101.71 126.89 48.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.15 -59.14 8.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -42.36 -45.64 4.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.6 m -69.82 -43.72 71.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -55.67 -35.88 66.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -74.62 -29.9 61.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.592 HD12 ' HB2' ' A' ' 66' ' ' LYS . 28.9 tp -83.15 -20.88 33.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.544 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -41.16 -57.58 3.4 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.652 0.739 . . . . 0.0 110.864 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.71 -27.72 26.36 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.705 2.27 . . . . 0.0 112.345 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.592 ' HB2' HD12 ' A' ' 63' ' ' LEU . 3.1 mmmt -71.92 -30.65 65.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 60.1 t80 -91.01 -37.07 13.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -47.57 -54.37 11.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.833 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -43.35 -56.21 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 127' ' ' PHE . 21.7 tp -42.99 -38.5 2.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.29 -65.16 3.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.438 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -60.83 -27.55 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 0.0 110.89 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mmtm -67.95 -46.46 71.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.573 HD12 ' CG1' ' A' ' 82' ' ' ILE . 91.5 mt -84.72 2.98 39.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.6 t -48.64 -24.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -93.57 24.24 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.45 97.63 12.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.583 0.706 . . . . 0.0 110.857 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -2.17 9.72 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.664 2.243 . . . . 0.0 112.364 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -117.5 -42.85 2.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.9 mt -92.77 145.07 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.179 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.1 t -138.99 106.82 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.599 HD12 HD23 ' A' ' 49' ' ' LEU . 21.2 mm -76.87 135.8 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -145.62 169.17 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.603 ' HB3' HG11 ' A' ' 29' ' ' VAL . 19.9 pttp -143.34 149.51 37.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.544 ' HB3' HD11 ' A' ' 50' ' ' ILE . 1.0 OUTLIER -144.06 138.45 28.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.815 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -86.85 107.0 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.82 -51.74 68.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.125 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.465 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -59.94 -16.31 28.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.815 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -106.88 0.69 24.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.549 ' ND2' ' C ' ' A' ' 89' ' ' ALA . 3.8 m-80 -162.87 124.61 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 17' ' ' LYS . 23.4 t70 -55.92 130.05 42.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.401 HG11 HG23 ' A' ' 98' ' ' VAL . 88.4 t -78.34 125.33 85.01 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.641 0.734 . . . . 0.0 111.168 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -164.57 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.502 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -127.16 160.93 57.11 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.683 0.754 . . . . 0.0 110.857 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.0 Cg_endo -69.71 -3.03 7.38 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.74 -1.775 . . . . 0.0 112.381 -0.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.471 ' N ' ' HA ' ' A' ' 94' ' ' SER . 97.3 m-85 -36.4 125.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -129.31 125.11 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.542 HG22 HG21 ' A' ' 103' ' ' THR . 58.2 t -130.99 103.54 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.142 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -104.93 -35.48 7.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.837 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.57 134.28 6.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.478 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.518 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -98.14 156.94 35.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 0.0 110.92 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.75 165.52 76.42 Favored 'Cis proline' 0 C--O 1.231 0.164 0 C-N-CA 122.732 -1.778 . . . . 0.0 112.373 -0.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.542 HG21 HG22 ' A' ' 98' ' ' VAL . 71.2 m -147.16 105.08 3.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.117 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.825 HD13 ' HE1' ' A' ' 127' ' ' PHE . 21.2 mt -97.19 141.4 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.121 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -140.97 160.34 40.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 31.2 t80 -130.27 140.39 50.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.7 p -109.43 98.66 33.18 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.667 0.746 . . . . 0.0 110.859 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.5 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.76 166.49 27.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.622 2.215 . . . . 0.0 112.37 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -82.48 128.6 34.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.08 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.23 29.75 15.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.5 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.9 mtmt -135.0 40.93 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -64.05 -33.86 76.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.6 mp -67.47 -36.21 80.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -124.7 81.56 60.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.593 0.711 . . . . 0.0 110.875 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 178.11 4.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.463 ' CD ' ' HG3' ' A' ' 108' ' ' PRO . 7.9 mptt -114.93 127.41 55.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -101.92 108.0 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.435 ' CE1' ' CD2' ' A' ' 130' ' ' TYR . 55.3 t80 -55.21 108.69 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -125.52 90.92 3.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -172.73 -134.23 1.78 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.479 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.14 139.79 14.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 102' ' ' PRO . 32.9 mtp180 -84.8 37.86 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.757 0.313 . . . . 0.0 110.874 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 124' ' ' LEU . 15.1 tp10 -98.25 129.26 44.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.604 ' CD1' HD11 ' A' ' 128' ' ' ILE . 3.2 tm? -34.28 -55.29 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.9 p -57.65 -45.71 85.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 123' ' ' GLU . 2.1 t70 -53.43 -33.53 54.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.825 ' HE1' HD13 ' A' ' 104' ' ' ILE . 88.7 m-85 -73.58 -40.33 63.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.604 HD11 ' CD1' ' A' ' 124' ' ' LEU . 42.7 mt -61.58 -57.41 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.181 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.34 -35.18 78.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.435 ' CD2' ' CE1' ' A' ' 118' ' ' TYR . 13.8 t80 -53.56 -48.1 69.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.424 HD11 HD22 ' A' ' 49' ' ' LEU . 28.9 mt -76.22 -39.24 55.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.908 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -39.92 -40.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.3 mtp85 -92.0 -64.4 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 135' ' ' ALA . 21.8 mm-40 -41.78 -60.15 1.45 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -35.19 116.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.1 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.6 OUTLIER -35.19 -75.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.122 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 m -75.81 -55.69 5.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 179.99 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.627 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 4.3 p90 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.882 0.372 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.1 pp -112.99 -36.91 4.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.433 ' N ' HD12 ' A' ' 16' ' ' LEU . 31.2 tttt -109.69 155.5 21.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.569 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 18.7 t -166.4 143.78 5.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.0 mm-40 -86.6 162.05 46.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.654 0.74 . . . . 0.0 110.882 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.77 142.32 47.56 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.649 2.233 . . . . 0.0 112.353 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.463 HD13 ' CG2' ' A' ' 33' ' ' VAL . 30.6 mm -71.65 131.83 85.83 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.644 0.735 . . . . 0.0 111.1 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 178.38 4.67 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.626 2.217 . . . . 0.0 112.37 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -103.13 -34.96 8.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 p -147.98 125.64 11.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -107.8 47.5 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -58.8 -26.92 64.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.53 168.87 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.486 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.459 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 54.1 Cg_endo -69.76 -25.66 28.35 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.685 2.256 . . . . 0.0 112.364 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.546 HG12 ' HG2' ' A' ' 84' ' ' LYS . 62.1 t -120.1 113.15 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -57.66 129.59 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.3 125.97 39.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.153 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.045 HG11 HG23 ' A' ' 41' ' ' VAL . 21.8 t -124.6 124.57 68.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.662 HG22 ' OD1' ' A' ' 36' ' ' ASN . 20.9 m -122.64 148.46 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.627 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -32.75 -40.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.121 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.583 ' HB2' HG23 ' A' ' 33' ' ' VAL . 12.7 mt-10 -55.75 -49.56 72.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.857 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.662 ' OD1' HG22 ' A' ' 33' ' ' VAL . 36.4 p-10 -115.77 34.91 4.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.615 ' CD2' HG21 ' A' ' 41' ' ' VAL . 21.4 t80 -71.09 -57.93 4.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -66.6 -5.67 12.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -87.08 -47.41 8.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.3 mt -96.92 -58.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.045 HG23 HG11 ' A' ' 32' ' ' VAL . 41.3 t -49.0 -61.64 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.167 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -68.56 126.91 31.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -174.33 118.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -95.64 0.45 52.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -95.54 -37.58 10.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -138.87 138.93 37.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.522 ' OD2' ' CG1' ' A' ' 80' ' ' ILE . 1.3 p30 -58.63 152.87 17.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.87 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 41' ' ' VAL . 52.1 t -148.42 142.72 19.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.445 HD23 HD12 ' A' ' 82' ' ' ILE . 39.4 tp -117.91 140.51 49.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.579 HD11 ' CB ' ' A' ' 85' ' ' MET . 2.1 tp -127.86 135.6 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.49 ' CD ' ' C ' ' A' ' 51' ' ' GLU . 5.8 tm-20 -126.77 121.88 33.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -95.74 118.7 32.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -126.34 179.08 5.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.26 134.56 17.76 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.625 0.726 . . . . 0.0 111.123 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.712 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.1 Cg_endo -69.73 -16.96 37.93 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.69 2.26 . . . . 0.0 112.339 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.413 ' CZ3' ' HB2' ' A' ' 57' ' ' CYS . 2.4 p-90 -105.85 6.53 31.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.413 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . 42.1 t -107.16 112.7 25.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.876 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -57.98 -57.16 21.3 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -41.02 -37.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 97.5 m -73.75 -34.66 64.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 58' ' ' GLY . 2.1 ttmm -62.33 -35.48 79.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -73.77 -27.75 61.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 66' ' ' LYS . 13.2 tp -81.36 -25.15 36.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.1 tt0 -37.53 -58.37 1.28 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.645 0.736 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.3 Cg_endo -69.82 -31.5 20.13 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.692 2.261 . . . . 0.0 112.28 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.632 ' HB2' HD12 ' A' ' 63' ' ' LEU . 16.0 mtpp -68.13 -29.98 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -92.47 -38.87 11.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HG3' ' CG ' ' A' ' 28' ' ' PRO . 5.5 ttmm -50.07 -58.68 5.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 9.6 mt-10 -41.59 -49.25 4.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 127' ' ' PHE . 25.1 tp -47.09 -41.39 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.56 -66.96 2.48 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.478 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.06 -26.54 68.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.85 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 69' ' ' GLU . 17.2 mmtt -70.09 -39.94 75.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.784 HD12 ' CG1' ' A' ' 82' ' ' ILE . 64.3 mt -79.13 4.86 13.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.3 t -56.97 -11.96 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.41 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 14.5 mmtp -82.68 -20.14 36.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.882 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CG ' ' O ' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -98.43 100.99 10.27 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.717 . . . . 0.0 110.855 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.4 Cg_endo -69.77 -2.91 10.98 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 0.0 112.322 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -107.7 -33.05 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.522 ' CG1' ' OD2' ' A' ' 47' ' ' ASP . 54.4 mt -92.05 117.93 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.1 t -118.2 125.44 74.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.106 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.784 ' CG1' HD12 ' A' ' 74' ' ' LEU . 30.7 mm -93.24 137.28 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.781 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -142.9 161.03 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.036 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.546 ' HG2' HG12 ' A' ' 29' ' ' VAL . 32.4 pttt -131.11 156.51 45.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.579 ' CB ' HD11 ' A' ' 50' ' ' ILE . 13.9 ttt -151.09 132.36 14.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 90' ' ' ASN . 26.1 t70 -91.32 95.85 10.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -52.28 -60.46 3.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.712 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -42.82 -27.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.38 -28.88 13.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.476 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.3 OUTLIER -134.88 114.97 13.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -47.2 131.24 13.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.423 HG13 ' HD2' ' A' ' 93' ' ' PRO . 93.0 t -80.86 132.85 56.2 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.59 0.709 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.468 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.6 Cg_endo -69.76 -165.83 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 0.0 112.326 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -124.13 160.89 50.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.645 0.736 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.5 Cg_endo -69.72 -8.75 10.59 Favored 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.356 -0.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 95' ' ' PRO . 98.3 m-85 -33.08 124.09 0.38 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -128.98 119.85 25.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.585 HG22 HG21 ' A' ' 103' ' ' THR . 71.0 t -121.66 96.47 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.17 -43.39 7.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.812 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.53 128.58 6.16 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.532 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -97.39 156.37 36.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.662 0.744 . . . . 0.0 110.858 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.6 Cg_endo -69.71 163.96 80.35 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.34 -0.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.585 HG21 HG22 ' A' ' 98' ' ' VAL . 50.2 m -145.73 106.09 4.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.407 HG22 ' CB ' ' A' ' 118' ' ' TYR . 22.5 mt -96.51 136.23 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.422 ' O ' HD12 ' A' ' 49' ' ' LEU . 8.4 m-85 -134.76 158.91 42.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -128.05 135.04 49.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 5.1 p -107.81 91.26 7.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.652 0.739 . . . . 0.0 110.832 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.497 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.8 Cg_endo -69.73 168.95 20.04 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.256 . . . . 0.0 112.339 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.24 140.11 35.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.01 31.36 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.497 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.7 mtmm -128.53 34.58 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 113' ' ' LEU . 27.3 mmtp -64.58 -58.24 6.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 112' ' ' LYS . 4.3 mm? -34.87 -41.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.909 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.405 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 4.8 m-80 -134.97 92.64 18.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.572 0.701 . . . . 0.0 110.86 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.8 Cg_endo -69.79 -173.44 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -135.66 121.02 19.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.25 123.89 34.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.63 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 60.6 t80 -57.45 96.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.906 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -109.7 95.04 5.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.918 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.34 -151.51 9.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.36 135.11 13.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.484 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 122' ' ' ARG . 13.1 mtm105 -80.59 45.62 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -102.43 137.05 41.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.476 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.3 tm? -40.48 -52.43 2.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.8 m -66.3 -47.34 73.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -46.69 -36.75 7.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.918 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.63 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 65.3 m-85 -70.52 -44.68 67.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.44 HG22 HE21 ' A' ' 132' ' ' GLN . 28.4 mt -57.66 -56.41 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.119 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -65.68 -25.01 67.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.456 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 8.3 t80 -63.9 -50.62 68.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 132' ' ' GLN . 23.5 mt -71.69 -41.66 68.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.44 HE21 HG22 ' A' ' 128' ' ' ILE . 36.3 mt-30 -37.74 -39.86 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -102.04 -51.4 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 7.4 mm-40 -51.98 -57.08 10.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.04 147.49 53.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.15 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.23 -49.06 20.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.2 m -42.88 -69.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.867 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 179.998 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.664 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 2.8 p90 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.903 0.382 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 pp -102.9 -39.12 7.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.948 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -100.93 159.69 14.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.489 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 61.4 p -172.47 149.69 2.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 15.9 mm-40 -103.6 161.81 21.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.623 0.725 . . . . 0.0 110.908 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.78 144.63 54.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.259 . . . . 0.0 112.31 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.509 HD13 HG21 ' A' ' 33' ' ' VAL . 39.0 mm -71.93 132.97 84.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.619 0.723 . . . . 0.0 111.124 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 21' ' ' ILE . 54.0 Cg_endo -69.79 179.47 3.69 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.616 2.211 . . . . 0.0 112.349 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -104.1 -34.69 8.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 m -150.85 126.42 10.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -110.14 43.12 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.26 -28.81 44.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.04 165.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.421 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 53.6 Cg_endo -69.69 -20.56 35.01 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.277 . . . . 0.0 112.344 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.32 110.75 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -55.79 138.48 47.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.7 t -91.91 110.6 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.988 HG11 HG23 ' A' ' 41' ' ' VAL . 39.1 t -105.4 124.0 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.096 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 21' ' ' ILE . 27.0 m -119.77 145.78 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.664 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -31.64 -44.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.115 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -54.74 -49.12 71.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 33' ' ' VAL . 9.2 p-10 -114.25 38.36 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.741 ' CD2' HG21 ' A' ' 41' ' ' VAL . 8.4 t80 -75.32 -55.49 5.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.4 -15.23 62.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -78.99 -44.8 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.429 HD12 HG22 ' A' ' 32' ' ' VAL . 22.7 mt -97.46 -58.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.988 HG23 HG11 ' A' ' 32' ' ' VAL . 48.6 t -49.65 -61.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -73.2 126.99 31.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -172.53 106.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -79.15 -14.57 59.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -73.16 -44.24 60.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HE3' HG21 ' A' ' 81' ' ' VAL . 19.3 pttm -138.9 160.85 38.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.11 153.13 38.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.5 t -144.59 135.73 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.13 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 106' ' ' PHE . 14.4 tp -112.68 119.91 39.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' A' ' 85' ' ' MET . 1.8 tp -106.64 136.71 40.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' N ' HG13 ' A' ' 50' ' ' ILE . 1.2 tm-20 -127.5 115.46 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.409 ' C ' ' OE2' ' A' ' 51' ' ' GLU . 35.5 m-85 -91.64 139.54 30.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 10.4 p90 -144.63 177.12 8.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.536 ' HB1' ' CE2' ' A' ' 56' ' ' TRP . . . -132.72 131.14 21.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.598 0.713 . . . . 0.0 111.096 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.56 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.1 Cg_endo -69.72 -9.26 25.67 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.382 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.536 ' CE2' ' HB1' ' A' ' 54' ' ' ALA . 2.1 p-90 -110.6 23.21 14.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.4 t -134.2 108.74 8.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.41 -35.9 2.94 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.49 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.426 ' CD2' ' H ' ' A' ' 59' ' ' HIS . 16.3 m170 -42.59 -50.38 5.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.802 0.334 . . . . 0.0 110.872 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 64' ' ' GLU . 14.1 p -55.1 -42.13 72.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' N ' ' SG ' ' A' ' 60' ' ' CYS . 0.0 OUTLIER -62.37 -40.69 97.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.46 -36.96 71.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.71 HD12 ' HB2' ' A' ' 66' ' ' LYS . 39.4 tp -84.34 -20.07 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.543 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 3.3 tt0 -42.19 -57.95 3.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.738 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.82 -34.09 15.07 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.366 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.71 ' HB2' HD12 ' A' ' 63' ' ' LEU . 26.6 mtmt -66.85 -28.67 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -93.53 -49.77 5.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 71' ' ' GLY . 6.4 ttmm -39.08 -64.33 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 22.2 mt-10 -39.58 -46.87 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.453 ' N ' HD21 ' A' ' 124' ' ' LEU . 19.5 tp -53.03 -39.48 63.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 68' ' ' LYS . . . -57.32 -65.5 3.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.504 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -67.43 -24.42 65.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.493 ' CG ' ' O ' ' A' ' 69' ' ' GLU . 16.5 mmtm -69.87 -46.13 66.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.578 HD12 HD11 ' A' ' 82' ' ' ILE . 93.6 mt -80.16 3.23 21.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.6 t -53.33 -36.09 60.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -59.88 -11.16 4.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.859 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.97 100.72 12.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.654 0.74 . . . . 0.0 110.874 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 1.07 4.77 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.722 2.281 . . . . 0.0 112.339 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -110.87 -39.56 4.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.2 mt -87.08 113.6 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.175 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.421 HG21 ' HE3' ' A' ' 46' ' ' LYS . 96.4 t -108.34 117.01 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.578 HD11 HD12 ' A' ' 74' ' ' LEU . 39.6 mm -91.98 123.05 43.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.175 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.829 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -138.01 171.29 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -138.96 154.94 48.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.417 ' HB3' HD11 ' A' ' 50' ' ' ILE . 6.5 ttt -148.02 134.11 19.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.57 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 8.9 t0 -86.03 87.76 7.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -42.73 -67.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.084 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.56 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -37.75 -30.93 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -89.58 -35.7 15.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 2.9 m-80 -124.0 115.38 21.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -47.05 119.23 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.5 t -75.89 120.05 79.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.632 0.73 . . . . 0.0 111.15 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.75 -174.88 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.727 2.285 . . . . 0.0 112.346 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.505 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -105.07 159.62 28.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.674 0.75 . . . . 0.0 110.845 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.516 ' O ' ' C ' ' A' ' 96' ' ' TYR . 53.2 Cg_endo -69.82 -23.49 9.09 Favored 'Cis proline' 0 C--O 1.231 0.143 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.312 0.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.516 ' C ' ' O ' ' A' ' 95' ' ' PRO . 76.2 m-85 -27.47 114.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -127.22 90.38 3.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 103' ' ' THR . 78.6 t -80.0 99.43 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.157 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.7 mmm-85 -98.04 -44.18 6.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.91 133.37 7.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.52 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -101.78 156.86 34.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.608 0.718 . . . . 0.0 110.903 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.0 Cg_endo -69.79 145.4 79.38 Favored 'Cis proline' 0 C--O 1.232 0.206 0 C-N-CA 122.648 -1.813 . . . . 0.0 112.388 0.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.599 HG21 HG22 ' A' ' 98' ' ' VAL . 56.4 m -118.48 126.64 52.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.509 HD13 ' CE1' ' A' ' 127' ' ' PHE . 25.7 mt -121.34 127.19 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -127.53 152.1 48.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.461 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 21.5 t80 -126.44 130.22 50.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.858 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 33.3 t -100.77 99.31 9.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.671 0.748 . . . . 0.0 110.843 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.499 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.81 164.14 35.71 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.672 2.248 . . . . 0.0 112.343 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' ND2' ' A' ' 110' ' ' ASN . . . -78.84 134.96 36.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.089 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER 48.33 31.81 2.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.499 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 20.7 mtmt -133.98 33.92 3.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -58.35 -55.07 39.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -43.17 -39.34 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -133.82 89.67 29.46 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.63 0.729 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HG3' ' HG2' ' A' ' 95' ' ' PRO . 53.1 Cg_endo -69.81 -167.58 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.733 2.289 . . . . 0.0 112.293 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -135.16 111.36 9.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -82.18 128.41 34.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.629 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 75.3 t80 -69.67 99.8 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -112.08 90.89 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.847 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -171.68 -150.96 7.44 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.43 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.23 140.39 16.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -79.59 44.1 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 124' ' ' LEU . 6.4 tt0 -101.28 127.92 47.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.458 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -35.11 -56.19 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 53.0 p -61.86 -47.31 85.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -47.16 -36.5 8.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.629 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 77.1 m-85 -72.49 -49.49 32.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.5 mt -50.33 -56.07 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -37.08 83.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.838 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.535 ' CE2' ' HG3' ' A' ' 134' ' ' GLU . 63.8 t80 -57.11 -45.52 83.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.915 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 132' ' ' GLN . 60.7 mt -72.83 -40.46 65.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.429 ' HB3' ' NH1' ' A' ' 133' ' ' ARG . 50.5 mt-30 -37.4 -41.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.429 ' NH1' ' HB3' ' A' ' 132' ' ' GLN . 12.8 mmp_? -100.49 -60.33 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.535 ' HG3' ' CE2' ' A' ' 130' ' ' TYR . 16.2 mm-40 -38.73 -52.99 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.72 152.11 46.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.36 -51.53 5.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.8 m -48.73 -60.95 2.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.957 0.408 . . . . 0.0 110.918 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.704 HD23 ' CG ' ' A' ' 91' ' ' ASP . 1.3 pt? -104.56 -36.99 7.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.515 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -121.46 174.0 7.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.955 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 89.0 p -172.84 171.17 4.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.505 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 5.3 mt-10 -106.44 159.9 28.14 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.625 0.726 . . . . 0.0 110.907 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 134.99 29.27 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.339 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.454 HD13 ' CG2' ' A' ' 33' ' ' VAL . 30.6 mm -68.93 122.3 84.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.647 0.737 . . . . 0.0 111.148 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 172.14 13.19 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.707 2.271 . . . . 0.0 112.318 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 24' ' ' SER . 6.4 pt-20 -99.94 -39.04 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.444 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 7.1 t -130.68 137.1 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -132.54 35.96 3.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.81 61.92 1.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.44 -174.36 13.69 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -33.45 16.53 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.653 2.235 . . . . 0.0 112.342 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.3 t -127.66 111.15 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.174 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -59.61 135.96 57.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.5 t -83.84 115.77 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.017 HG11 HG23 ' A' ' 41' ' ' VAL . 39.1 t -113.17 121.24 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.114 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 35' ' ' GLU . 4.5 m -114.13 148.14 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.154 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -33.88 -45.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.485 ' HB2' HG23 ' A' ' 33' ' ' VAL . 2.2 mm-40 -54.45 -50.21 68.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.859 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.463 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 9.5 p-10 -109.23 33.29 4.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.477 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 7.4 t80 -74.9 -48.08 26.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -72.64 -4.61 32.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -90.01 -42.75 10.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.618 HD12 HG22 ' A' ' 32' ' ' VAL . 14.3 mt -99.44 -62.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.171 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.017 HG23 HG11 ' A' ' 32' ' ' VAL . 41.1 t -50.2 -62.66 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -61.47 116.9 5.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.431 ' C ' ' HE3' ' A' ' 112' ' ' LYS . 3.3 t-20 -172.75 120.88 0.39 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CA ' ' HE3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -106.92 30.34 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.63 -27.09 3.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -138.47 160.13 40.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.46 126.51 31.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.507 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 39.1 t -126.32 152.52 33.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.49 HD13 HD21 ' A' ' 131' ' ' LEU . 14.7 tp -132.4 125.45 30.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.561 HD11 ' CB ' ' A' ' 85' ' ' MET . 1.9 tp -116.06 134.75 58.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.091 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -126.92 115.71 19.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.874 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -90.03 116.24 27.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.55 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 26.9 p90 -116.63 174.73 5.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.15 128.94 23.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.582 0.706 . . . . 0.0 111.136 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -19.14 36.63 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.676 2.251 . . . . 0.0 112.336 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.515 ' NE1' HG21 ' A' ' 88' ' ' THR . 3.7 p-90 -101.51 14.87 30.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.404 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 2.0 t -129.19 103.87 7.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -37.41 -39.63 0.54 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.49 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' GLY . 32.7 m170 -36.89 -45.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.768 0.318 . . . . 0.0 110.836 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 64' ' ' GLU . 27.9 p -54.61 -48.07 72.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 58' ' ' GLY . 28.9 mmtt -63.0 -41.93 99.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -67.88 -30.66 70.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 66' ' ' LYS . 67.0 tp -92.4 -19.42 22.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.543 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.6 tt0 -43.68 -57.99 5.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.598 0.713 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.77 -28.62 24.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.659 2.239 . . . . 0.0 112.38 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.913 ' HB2' HD12 ' A' ' 63' ' ' LEU . 13.7 mtpp -72.06 -30.17 64.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -93.65 -46.45 7.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.012 0.434 . . . . 0.0 110.94 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 71' ' ' GLY . 14.2 ttmt -44.58 -60.69 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 68' ' ' LYS . 18.6 mt-10 -38.05 -54.66 1.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' A' ' 127' ' ' PHE . 17.9 tp -49.08 -38.03 23.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.953 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 68' ' ' LYS . . . -58.89 -65.19 3.65 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -64.29 -27.67 69.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.916 0.389 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -69.73 -45.49 68.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.521 HD12 HD11 ' A' ' 82' ' ' ILE . 94.9 mt -80.71 3.19 23.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.9 t -54.57 -28.77 48.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.844 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.92 0.18 7.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.958 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.47 99.94 39.39 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.608 0.718 . . . . 0.0 110.866 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -0.16 6.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.361 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -110.56 -34.62 6.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.54 112.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.2 t -109.57 119.35 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 74' ' ' LEU . 32.1 mm -93.29 117.47 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.76 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -128.42 166.18 19.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -134.37 155.77 49.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.938 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.561 ' CB ' HD11 ' A' ' 50' ' ' ILE . 11.9 ttt -149.24 161.29 42.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.908 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -109.2 119.58 39.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.0 -70.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.515 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.5 OUTLIER -47.77 -28.05 2.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.908 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -91.18 -31.1 16.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 8.0 m-80 -131.1 102.18 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.704 ' CG ' HD23 ' A' ' 16' ' ' LEU . 9.5 t0 -41.16 122.89 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 98' ' ' VAL . 92.2 t -82.04 121.67 79.16 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.661 0.744 . . . . 0.0 111.086 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.74 -167.21 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.717 2.278 . . . . 0.0 112.365 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.512 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -109.11 160.05 28.94 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.749 . . . . 0.0 110.833 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.5 Cg_endo -69.74 -20.18 10.85 Favored 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.634 -1.819 . . . . 0.0 112.373 -0.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.509 ' C ' ' O ' ' A' ' 95' ' ' PRO . 84.5 m-85 -28.55 113.36 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -122.87 85.85 2.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 92' ' ' VAL . 85.8 t -77.2 120.57 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.0 mmm-85 -122.05 -48.12 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.12 130.11 7.87 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.519 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -102.42 156.09 35.7 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.658 0.742 . . . . 0.0 110.886 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.66 143.92 75.0 Favored 'Cis proline' 0 C--O 1.231 0.151 0 C-N-CA 122.713 -1.786 . . . . 0.0 112.338 -0.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.544 HG21 HG22 ' A' ' 98' ' ' VAL . 80.1 m -114.33 127.74 56.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.174 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.5 mt -120.18 135.91 58.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.165 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -134.26 169.99 16.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 31.1 t80 -139.5 131.72 28.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.8 t -101.65 97.98 8.77 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.618 0.723 . . . . 0.0 110.842 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.447 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.79 169.29 19.29 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.718 2.279 . . . . 0.0 112.329 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.62 126.49 36.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 64.59 26.48 13.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.3 mtmm -131.78 26.5 4.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -47.42 -57.94 4.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.1 mp -39.38 -41.99 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.936 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -134.39 99.45 13.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.652 0.739 . . . . 0.0 110.874 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -164.29 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.672 2.248 . . . . 0.0 112.337 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 106' ' ' PHE . 15.4 mmtm -133.34 118.21 18.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -88.52 148.49 24.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.941 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -94.84 108.42 20.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.942 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -118.68 92.43 3.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.46 -143.74 4.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.454 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.01 142.83 16.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.468 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -82.01 41.71 0.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 110.846 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 124' ' ' LEU . 16.4 tp10 -98.06 129.68 44.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.592 ' CD1' HD11 ' A' ' 128' ' ' ILE . 2.7 tm? -34.91 -56.55 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 64.7 p -57.62 -47.36 82.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.07 -32.61 22.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.555 ' HB3' HD22 ' A' ' 70' ' ' LEU . 52.2 m-85 -74.5 -39.3 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.592 HD11 ' CD1' ' A' ' 124' ' ' LEU . 24.9 mt -64.64 -65.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -54.08 -31.04 50.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.438 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 49.1 t80 -60.4 -47.91 84.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 49' ' ' LEU . 48.7 mt -73.72 -39.17 64.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -38.66 -38.65 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -102.29 -51.04 3.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.438 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 5.2 mm-40 -51.54 -57.16 9.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.72 150.26 41.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.75 -50.98 10.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.2 m -75.87 49.31 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.525 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.9 p90 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.94 0.4 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.0 pp -106.28 -44.23 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.568 ' N ' HD12 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -112.48 152.54 28.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.433 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 3.3 m -162.86 166.57 23.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.852 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.453 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.1 mm-40 -105.3 162.27 20.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.672 0.748 . . . . 0.0 110.841 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 54.2 Cg_endo -69.75 143.47 50.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.736 2.291 . . . . 0.0 112.331 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.597 HD13 HG21 ' A' ' 33' ' ' VAL . 12.4 mm -69.08 135.1 89.42 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.639 0.733 . . . . 0.0 111.125 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 21' ' ' ILE . 53.3 Cg_endo -69.79 174.66 9.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.671 2.247 . . . . 0.0 112.303 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.6 -38.11 5.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 t -135.18 116.62 14.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -114.63 43.29 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.58 51.01 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.65 -176.83 16.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.517 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -42.21 3.57 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.692 2.261 . . . . 0.0 112.367 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.558 HG12 ' HG2' ' A' ' 84' ' ' LYS . 49.5 t -113.03 107.79 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.104 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.575 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -60.41 130.39 46.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.8 t -80.31 121.87 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.154 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.996 HG11 HG23 ' A' ' 41' ' ' VAL . 40.6 t -114.71 120.37 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.178 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 21' ' ' ILE . 18.6 m -111.69 142.88 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -33.49 -37.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HB3' HD11 ' A' ' 21' ' ' ILE . 9.4 mt-10 -60.52 -48.26 82.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 33' ' ' VAL . 14.5 p-10 -107.56 25.03 11.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.659 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 20.2 t80 -65.68 -55.21 18.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.427 ' HA ' ' CG ' ' A' ' 42' ' ' ASN . 6.2 t70 -67.72 -3.91 10.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -92.67 -43.57 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.506 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 14.2 mt -99.19 -52.65 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.179 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.996 HG23 HG11 ' A' ' 32' ' ' VAL . 89.3 t -60.79 -61.41 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.436 ' OD1' ' CE1' ' A' ' 37' ' ' PHE . 2.0 m-20 -67.31 123.22 19.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.616 HD21 HG21 ' A' ' 48' ' ' VAL . 7.6 p30 -175.54 111.88 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.71 33.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -128.04 -30.14 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.475 ' NZ ' HG21 ' A' ' 81' ' ' VAL . 34.5 pttt -138.16 166.31 24.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.86 144.86 25.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.616 HG21 HD21 ' A' ' 43' ' ' ASN . 93.1 t -146.58 148.76 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.4 tp -123.81 125.45 44.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.932 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.3 tp -110.83 134.35 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' OE1' ' CG1' ' A' ' 104' ' ' ILE . 3.1 tp10 -127.42 112.83 15.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.406 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 61.0 m-85 -87.21 115.57 24.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.95 171.81 7.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.968 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.13 131.78 23.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -6.24 18.12 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.727 2.285 . . . . 0.0 112.319 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.483 ' CZ2' HG21 ' A' ' 88' ' ' THR . 6.8 p-90 -124.39 25.98 7.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 10.2 t -128.75 112.46 14.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -52.14 -61.55 6.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.493 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -41.54 -37.91 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.838 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 88.7 m -74.35 -34.76 63.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 58' ' ' GLY . 3.8 ttmt -70.29 -35.1 73.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -72.3 -23.34 61.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 64' ' ' GLU . 11.8 tp -85.24 -29.74 24.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.562 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.6 tp10 -36.74 -55.92 1.46 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.658 0.742 . . . . 0.0 110.851 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.8 Cg_endo -69.75 -36.15 11.37 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.675 2.25 . . . . 0.0 112.367 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -66.1 -28.07 68.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CZ ' HG23 ' A' ' 82' ' ' ILE . 35.9 t80 -95.3 -38.72 10.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -45.73 -58.8 3.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -43.69 -50.13 7.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.477 ' N ' HD21 ' A' ' 124' ' ' LEU . 17.9 tp -46.09 -37.08 6.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.58 -62.3 6.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.473 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -68.37 -22.9 64.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -72.65 -49.41 31.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.466 HD22 ' OD2' ' A' ' 77' ' ' ASP . 95.0 mt -80.06 2.98 21.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.939 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.4 t -51.02 -24.11 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -86.5 17.13 4.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.466 ' OD2' HD22 ' A' ' 74' ' ' LEU . 75.5 m-20 -110.21 98.11 33.81 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.592 0.71 . . . . 0.0 110.917 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.6 Cg_endo -69.78 -1.81 9.12 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 0.0 112.339 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -122.08 8.87 9.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.0 mt -134.72 142.47 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.522 ' HB ' HG22 ' A' ' 48' ' ' VAL . 87.1 t -139.12 106.64 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.53 HG23 ' CZ ' ' A' ' 67' ' ' TYR . 46.3 mm -83.73 125.92 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.129 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.744 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -143.35 170.92 14.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.133 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.558 ' HG2' HG12 ' A' ' 29' ' ' VAL . 54.5 pttt -140.63 154.01 46.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.3 ttt -140.85 142.51 34.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 26.7 t0 -91.54 82.28 5.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -41.4 -48.54 3.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.483 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 19.9 p -57.38 -33.34 67.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -103.31 13.29 34.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.503 ' ND2' ' C ' ' A' ' 89' ' ' ALA . 8.6 m-80 -162.91 107.77 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -44.97 127.65 6.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.409 HG11 HG23 ' A' ' 98' ' ' VAL . 90.6 t -78.01 122.57 85.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.597 0.713 . . . . 0.0 111.164 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -166.51 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.378 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.494 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -118.85 161.78 34.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.727 . . . . 0.0 110.85 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.2 Cg_endo -69.66 -13.78 12.24 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.679 -1.8 . . . . 0.0 112.373 -0.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.468 ' C ' ' O ' ' A' ' 95' ' ' PRO . 83.2 m-85 -32.09 120.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.941 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -129.68 76.46 1.72 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.543 HG22 HG21 ' A' ' 103' ' ' THR . 86.4 t -74.41 125.17 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -123.2 -42.28 2.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.2 129.41 6.72 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.452 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.529 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.87 154.84 37.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.678 0.751 . . . . 0.0 110.848 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.1 Cg_endo -69.76 162.2 84.61 Favored 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.669 -1.805 . . . . 0.0 112.348 0.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.543 HG21 HG22 ' A' ' 98' ' ' VAL . 31.4 m -140.95 106.16 5.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.16 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.584 HD13 ' HE1' ' A' ' 127' ' ' PHE . 41.4 mt -101.1 123.86 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.49 ' CZ ' ' HE3' ' A' ' 117' ' ' LYS . 10.4 m-85 -123.92 147.05 48.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 24.6 t80 -117.78 133.79 55.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -103.73 94.46 6.26 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.678 0.751 . . . . 0.0 110.897 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.503 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.75 164.8 33.19 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.665 2.243 . . . . 0.0 112.356 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -80.75 139.74 35.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.8 p-10 47.85 25.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.503 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 23.4 mtmt -129.16 19.75 5.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.847 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -43.24 -68.28 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.929 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 112' ' ' LYS . 4.5 mm? -33.94 -51.75 0.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 11.5 m120 -112.16 96.19 33.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.721 . . . . 0.0 110.898 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.5 Cg_endo -69.75 -170.78 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 0.0 112.34 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -138.85 110.1 6.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.49 ' HE3' ' CZ ' ' A' ' 105' ' ' TYR . 30.0 tttt -73.83 156.54 37.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -106.35 96.58 6.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -111.51 102.13 10.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 179.56 -151.31 9.98 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.83 130.91 10.0 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -79.58 44.5 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.323 . . . . 0.0 110.908 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 124' ' ' LEU . 9.8 tt0 -105.66 133.48 50.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.602 HD13 ' C ' ' A' ' 124' ' ' LEU . 2.9 tm? -35.56 -55.79 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 44.8 p -57.9 -46.99 84.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -51.19 -37.13 44.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.584 ' HE1' HD13 ' A' ' 104' ' ' ILE . 61.7 m-85 -69.89 -45.79 66.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 124' ' ' LEU . 33.7 mt -59.0 -59.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -60.08 -30.27 69.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 130' ' ' TYR . 3.9 t80 -59.52 -45.63 91.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.927 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 132' ' ' GLN . 19.0 mt -76.02 -43.35 44.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.938 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 131' ' ' LEU . 45.1 mt-30 -36.12 -39.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.447 ' HB3' ' NH1' ' A' ' 133' ' ' ARG . 5.4 ptp180 -99.39 -48.43 4.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.78 -61.57 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -43.24 126.24 4.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.421 HG23 ' NZ ' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -52.89 -74.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.114 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 t -51.2 -57.14 9.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.51 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.866 0.365 . . . . 0.0 110.94 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 17' ' ' LYS . 3.9 pp -103.17 -41.86 5.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.691 ' HB3' HD12 ' A' ' 16' ' ' LEU . 18.7 ptmt -130.23 157.96 41.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.52 ' OG ' ' HB3' ' A' ' 34' ' ' ALA . 8.7 t -162.08 166.05 26.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 3.5 mm-40 -105.6 161.7 21.98 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.684 0.754 . . . . 0.0 110.835 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.447 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.78 145.34 56.71 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.67 2.247 . . . . 0.0 112.349 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.683 HD11 ' HB3' ' A' ' 35' ' ' GLU . 28.4 mm -68.78 132.04 90.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.62 0.724 . . . . 0.0 111.144 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 175.74 7.71 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.69 2.26 . . . . 0.0 112.386 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 24' ' ' SER . 6.6 pt-20 -108.72 -37.5 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.419 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 85.3 p -129.62 130.14 45.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.891 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -133.77 43.03 2.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 27' ' ' GLY . 2.9 m-20 -72.65 -19.13 61.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -45.54 173.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.505 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -30.13 22.8 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.7 2.266 . . . . 0.0 112.313 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.676 HG12 ' HG2' ' A' ' 84' ' ' LYS . 39.8 t -116.84 106.65 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.15 132.16 52.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.1 t -83.11 125.34 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.168 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.827 HG11 HG23 ' A' ' 41' ' ' VAL . 18.0 t -120.79 129.93 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.515 HG22 ' OD1' ' A' ' 36' ' ' ASN . 15.0 m -121.86 145.85 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HB3' ' OG ' ' A' ' 18' ' ' SER . . . -37.8 -28.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.683 ' HB3' HD11 ' A' ' 21' ' ' ILE . 3.9 mt-10 -66.71 -45.06 79.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.515 ' OD1' HG22 ' A' ' 33' ' ' VAL . 39.9 p-10 -119.41 37.45 4.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.585 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 8.3 t80 -71.63 -51.43 23.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.09 -12.33 61.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.41 -41.29 20.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.8 mt -99.34 -60.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.827 HG23 HG11 ' A' ' 32' ' ' VAL . 43.6 t -52.82 -62.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -72.74 130.35 40.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -173.55 106.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.416 ' HB3' ' NZ ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -83.25 36.27 0.52 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -133.72 -36.43 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -139.08 145.79 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 1.4 m-20 -66.35 135.59 54.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' A' ' 41' ' ' VAL . 60.7 t -130.48 145.08 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.841 HD13 HD21 ' A' ' 131' ' ' LEU . 6.7 tp -124.6 118.8 27.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.607 HD13 ' CG2' ' A' ' 41' ' ' VAL . 2.0 tp -106.09 137.55 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.25 117.65 22.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -93.23 137.98 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.908 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 3.8 p90 -142.36 171.93 13.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.98 133.03 24.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 111.119 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -0.76 7.41 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 0.0 112.308 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.422 ' CZ2' ' CG2' ' A' ' 88' ' ' THR . 2.4 p-90 -128.63 24.41 5.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.0 t -120.31 110.81 17.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -40.87 -58.5 2.65 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.464 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.469 ' C ' ' O ' ' A' ' 58' ' ' GLY . 3.7 t-160 -32.98 -62.49 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 110.839 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' GLU . 3.9 t -40.15 -49.81 2.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.886 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -56.77 -48.88 76.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -70.76 -21.95 62.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.29 -19.99 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.1 tt0 -43.32 -57.91 4.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 0.0 110.938 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.5 Cg_endo -69.78 -33.38 16.63 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.693 2.262 . . . . 0.0 112.335 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -66.37 -32.23 73.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 68' ' ' LYS . 31.7 t80 -89.22 -47.77 7.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 67' ' ' TYR . 14.8 ttmt -37.75 -60.15 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -38.78 -59.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 127' ' ' PHE . 24.5 tp -41.99 -36.99 1.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.2 -69.14 1.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.459 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -64.58 -23.01 67.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -71.51 -39.97 70.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.597 HD12 HD11 ' A' ' 82' ' ' ILE . 85.1 mt -88.58 3.16 51.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 t -55.15 -31.73 61.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' A' ' 76' ' ' LYS . 25.5 ttpt -73.0 1.47 8.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 3.6 t70 -102.5 100.07 14.92 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.88 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.4 Cg_endo -69.81 0.46 5.65 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.64 2.226 . . . . 0.0 112.34 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -111.69 -41.36 4.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.529 HG21 HD13 ' A' ' 74' ' ' LEU . 63.0 mt -90.74 138.09 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.9 t -133.94 113.5 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.597 HD11 HD12 ' A' ' 74' ' ' LEU . 39.6 mm -82.45 131.97 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.781 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -143.63 170.97 14.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.088 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.676 ' HG2' HG12 ' A' ' 29' ' ' VAL . 12.4 pttp -143.07 154.39 43.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.9 ttt -150.08 133.36 16.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -85.28 76.52 10.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -35.71 -61.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.06 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 87' ' ' ALA . 43.9 p -32.26 -41.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.136 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HB3' ' OD2' ' A' ' 86' ' ' ASP . . . -94.66 -31.14 13.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.094 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 87' ' ' ALA . 35.9 m-80 -111.14 101.54 10.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -43.58 123.8 3.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.448 HG11 HG23 ' A' ' 98' ' ' VAL . 73.1 t -66.66 129.2 94.11 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.572 0.701 . . . . 0.0 111.172 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -163.53 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.625 2.217 . . . . 0.0 112.383 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.503 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -131.41 160.85 65.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.649 0.738 . . . . 0.0 110.828 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.1 Cg_endo -69.82 -4.55 8.45 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.706 -1.789 . . . . 0.0 112.304 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.447 ' N ' ' HA ' ' A' ' 94' ' ' SER . 65.9 m-85 -34.55 127.44 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.63 116.08 18.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.678 HG22 HG21 ' A' ' 103' ' ' THR . 57.9 t -123.64 115.94 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.88 -47.0 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.855 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.19 130.42 8.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.5 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.534 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -99.08 155.81 36.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.692 0.758 . . . . 0.0 110.875 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.2 Cg_endo -69.68 163.16 82.34 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.375 -0.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.678 HG21 HG22 ' A' ' 98' ' ' VAL . 26.5 m -142.36 106.29 4.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.2 mt -95.5 142.8 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.479 ' HB2' HG23 ' A' ' 50' ' ' ILE . 7.5 m-85 -134.52 179.14 6.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' LYS . 19.3 t80 -147.75 135.49 20.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.43 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 33.8 t -104.72 94.62 7.59 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.696 0.76 . . . . 0.0 110.814 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.476 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.74 159.68 52.52 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.67 2.247 . . . . 0.0 112.38 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.38 130.82 34.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.125 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 64.71 24.98 12.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.476 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 14.0 mtmt -131.75 18.31 4.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -44.25 -63.16 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.925 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -39.29 -32.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 1.9 t30 -134.02 98.31 14.48 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.647 0.737 . . . . 0.0 110.891 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.49 ' CD ' ' HG2' ' A' ' 95' ' ' PRO . 54.2 Cg_endo -69.75 179.24 3.83 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -134.77 125.18 26.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -90.65 146.22 24.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -83.92 121.87 27.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -122.24 104.09 9.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.91 -170.39 43.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.478 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.74 141.26 26.19 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.508 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.89 47.31 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 110.844 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 124' ' ' LEU . 27.2 tt0 -102.02 129.45 48.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.447 HD21 ' N ' ' A' ' 70' ' ' LEU . 2.4 tm? -33.75 -54.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.7 t -60.74 -47.1 87.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -44.35 -42.02 6.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.457 ' HB2' HD13 ' A' ' 70' ' ' LEU . 62.8 m-85 -68.31 -44.52 75.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.858 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.872 HG22 HE21 ' A' ' 132' ' ' GLN . 33.0 mt -59.06 -53.12 52.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 t -65.31 -39.5 92.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.53 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 36.4 t80 -56.71 -53.07 61.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.841 HD21 HD13 ' A' ' 49' ' ' LEU . 68.3 mt -67.21 -42.9 83.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.872 HE21 HG22 ' A' ' 128' ' ' ILE . 35.3 mt-30 -36.96 -40.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -99.15 -61.68 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.53 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 11.3 mm-40 -42.2 -54.2 3.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.72 132.0 30.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.58 -75.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.9 t -48.7 -62.07 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.451 179.979 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.468 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.5 p90 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.928 0.394 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.54 HD12 ' HB3' ' A' ' 17' ' ' LYS . 3.9 pp -94.79 -39.48 10.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.54 ' HB3' HD12 ' A' ' 16' ' ' LEU . 7.7 ptmt -116.49 156.93 26.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 76.8 p -160.61 149.58 16.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.437 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 10.2 mm-40 -92.53 161.3 32.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.62 0.724 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.437 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.74 141.17 44.59 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.372 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.465 HD13 ' CG2' ' A' ' 33' ' ' VAL . 13.3 mm -69.44 130.84 90.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.731 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 160.59 49.13 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.682 2.255 . . . . 0.0 112.369 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.89 -38.65 13.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -141.77 105.3 4.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -122.65 46.56 2.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -87.5 39.48 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.12 -160.57 36.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.476 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -42.84 3.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 0.0 112.362 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.565 HG13 HG22 ' A' ' 82' ' ' ILE . 10.9 t -116.57 104.72 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -52.83 135.39 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.0 t -84.23 120.69 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.176 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.159 HG11 HG23 ' A' ' 41' ' ' VAL . 12.9 t -119.45 115.32 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.117 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 35' ' ' GLU . 27.9 m -111.52 141.71 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -30.44 -38.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 33' ' ' VAL . 6.7 mt-10 -56.3 -51.51 67.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 33' ' ' VAL . 53.1 p-10 -110.48 24.76 12.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.765 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 13.1 t80 -63.19 -51.15 67.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -4.95 18.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.831 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -92.17 -43.84 9.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.3 mt -97.11 -61.16 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.107 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.159 HG23 HG11 ' A' ' 32' ' ' VAL . 78.5 t -53.16 -62.17 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -65.46 120.18 12.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.435 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 4.1 t-20 -174.94 119.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.431 ' CA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -104.93 32.44 4.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -127.7 -31.22 2.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 14.3 pttp -138.29 136.95 36.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.81 138.6 53.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.57 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 40.9 t -137.31 159.13 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.51 ' N ' HG12 ' A' ' 48' ' ' VAL . 16.1 tp -140.21 132.17 27.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.923 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' A' ' 96' ' ' TYR . 3.3 tp -116.21 141.36 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.175 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.545 ' OE2' ' CG ' ' A' ' 67' ' ' TYR . 2.5 tt0 -125.49 118.74 26.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -98.9 108.42 21.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -115.75 -179.15 3.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.779 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -133.73 132.98 21.9 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 0.0 111.085 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 -1.01 7.74 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -126.31 5.79 7.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.779 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -99.89 129.47 45.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.836 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.16 -45.9 14.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.46 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -48.32 -27.72 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.836 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.0 m -80.13 -44.0 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -55.29 -42.33 73.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -70.49 -20.54 62.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.946 HD12 ' HB2' ' A' ' 66' ' ' LYS . 8.4 tp -94.22 -23.16 18.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.557 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 5.1 tt0 -33.71 -57.13 0.64 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 0.0 110.914 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.78 -27.29 26.54 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.721 2.281 . . . . 0.0 112.328 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.946 ' HB2' HD12 ' A' ' 63' ' ' LEU . 2.7 mmpt? -72.39 -30.97 65.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.545 ' CG ' ' OE2' ' A' ' 51' ' ' GLU . 37.9 t80 -95.97 -40.09 9.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.471 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -55.66 -43.28 76.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -53.54 -53.42 51.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.463 ' N ' HD21 ' A' ' 124' ' ' LEU . 20.3 tp -43.45 -38.35 2.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.08 -64.56 3.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.97 -21.36 66.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.937 0.398 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -79.32 -45.05 20.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ASP . 78.6 mt -84.06 1.64 43.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 m -40.19 -27.94 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -85.0 25.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 74' ' ' LEU . 51.2 p-10 -103.9 93.41 5.29 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.618 0.723 . . . . 0.0 110.863 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 54.1 Cg_endo -69.78 0.58 5.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.334 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -122.91 -44.72 2.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.452 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 37.0 mt -87.71 144.59 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.5 t -136.0 107.38 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.179 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.565 HG22 HG13 ' A' ' 29' ' ' VAL . 38.2 mm -76.17 131.44 34.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.678 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -145.83 173.87 11.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.561 ' HG2' HG12 ' A' ' 29' ' ' VAL . 25.1 pttt -148.57 157.59 43.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.448 ' CB ' HD11 ' A' ' 50' ' ' ILE . 1.9 tmm? -149.59 148.11 28.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 90' ' ' ASN . 49.8 t0 -97.74 99.65 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.94 80.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 88' ' ' THR . 2.7 p -66.12 -17.27 64.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -117.89 -10.97 10.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.1 m-80 -139.62 107.63 5.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.41 ' HB3' ' CB ' ' A' ' 15' ' ' TYR . 7.0 t0 -42.27 138.06 1.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.516 HG21 ' CG2' ' A' ' 98' ' ' VAL . 74.6 t -80.51 128.32 72.83 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.625 0.726 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 54.4 Cg_endo -69.72 -165.64 0.16 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.723 2.282 . . . . 0.0 112.35 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.535 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 0.8 OUTLIER -127.44 154.59 77.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.655 0.741 . . . . 0.0 110.851 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.75 -6.03 9.19 Favored 'Cis proline' 0 N--CA 1.466 -0.13 0 C-N-CA 122.709 -1.788 . . . . 0.0 112.372 0.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.525 ' HE2' HG21 ' A' ' 50' ' ' ILE . 33.1 m-85 -33.01 137.45 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -151.63 120.89 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.843 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.516 ' CG2' HG21 ' A' ' 92' ' ' VAL . 39.7 t -113.42 110.07 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.11 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.8 -45.32 5.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -132.32 132.01 6.48 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.483 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.539 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -96.95 154.86 38.1 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.658 0.742 . . . . 0.0 110.899 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.0 Cg_endo -69.74 159.51 89.52 Favored 'Cis proline' 0 C--O 1.232 0.191 0 C-N-CA 122.696 -1.793 . . . . 0.0 112.379 0.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.457 ' OG1' HG13 ' A' ' 98' ' ' VAL . 93.4 m -137.98 111.55 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.147 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.451 HG12 ' CG ' ' A' ' 51' ' ' GLU . 86.9 mt -109.82 131.88 59.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -123.12 -176.38 3.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 29.1 t80 -152.82 132.22 12.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.887 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.2 t -103.6 96.31 8.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.69 0.757 . . . . 0.0 110.895 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.473 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.5 Cg_endo -69.68 168.26 21.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.719 2.279 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.404 ' HB3' HG21 ' A' ' 136' ' ' THR . . . -87.2 135.15 33.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 54.67 25.73 6.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.473 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 10.6 mtmt -129.53 21.59 5.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.513 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -49.33 -41.63 39.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -52.42 -39.7 61.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 6.8 m-80 -134.74 97.97 13.69 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.593 0.711 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 54.3 Cg_endo -69.69 -170.63 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.674 2.249 . . . . 0.0 112.372 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -136.27 139.07 42.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -107.21 137.03 46.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.433 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 62.8 t80 -78.85 107.84 11.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -124.03 95.17 4.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.39 -139.52 3.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.95 128.52 9.18 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -79.7 49.52 1.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.761 0.315 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 124' ' ' LEU . 5.4 tp10 -112.74 132.46 55.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.563 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.5 tm? -34.44 -51.49 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.5 p -63.11 -53.22 56.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.17 -36.53 2.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.433 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 52.8 m-85 -68.91 -43.62 74.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.4 mt -55.89 -63.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.099 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.3 t -54.74 -36.54 64.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 44.3 t80 -55.18 -50.87 68.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.916 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.3 -42.15 69.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -43.61 -41.44 4.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.43 ' CG ' ' N ' ' A' ' 134' ' ' GLU . 12.9 ptm180 -91.57 -53.06 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.435 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 26.1 mm-40 -51.93 -62.87 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -37.41 105.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.078 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 137' ' ' SER . 1.8 t -49.84 -52.78 29.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.494 ' H ' HG23 ' A' ' 136' ' ' THR . 1.3 t -74.5 -41.51 60.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.465 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.879 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.972 0.415 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -106.3 -33.32 7.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.944 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.456 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 10.7 mtpp -101.57 163.86 12.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.0 p -166.5 134.28 2.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.726 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 2.4 mm-40 -98.24 161.63 24.75 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.887 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.9 Cg_endo -69.75 140.07 41.8 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.679 2.253 . . . . 0.0 112.336 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.604 HD13 HG21 ' A' ' 33' ' ' VAL . 15.8 mm -70.46 123.41 88.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 111.107 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 130.19 18.91 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.671 2.248 . . . . 0.0 112.35 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.21 -46.81 69.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 t -144.96 133.22 21.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -106.7 48.71 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -50.28 -33.16 18.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.07 164.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.445 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -22.99 31.29 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.674 2.249 . . . . 0.0 112.341 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.454 HG13 HG22 ' A' ' 82' ' ' ILE . 32.9 t -119.33 112.19 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -57.89 137.23 56.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.7 t -90.49 116.24 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.133 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.819 HG11 HG23 ' A' ' 41' ' ' VAL . 19.6 t -105.98 124.73 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 21' ' ' ILE . 15.8 m -118.66 148.16 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.879 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -38.1 -36.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.152 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -62.78 -50.64 70.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.486 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 11.4 p-10 -108.33 28.57 8.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.583 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 5.5 t80 -67.51 -55.78 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.835 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -66.11 -5.26 9.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -88.42 -43.11 11.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.43 HD12 HG22 ' A' ' 32' ' ' VAL . 18.1 mt -98.35 -54.14 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.127 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.819 HG23 HG11 ' A' ' 32' ' ' VAL . 40.4 t -56.09 -61.58 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -67.44 112.67 4.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' ND2' ' HE2' ' A' ' 46' ' ' LYS . 13.4 t-20 -173.23 105.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.85 4.64 47.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -90.69 -35.03 15.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HE2' ' ND2' ' A' ' 43' ' ' ASN . 45.9 pttt -138.52 151.95 47.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.9 136.1 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.61 136.01 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.127 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.8 tp -116.11 119.24 35.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 105' ' ' TYR . 2.3 tp -106.81 134.88 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.166 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -127.21 120.08 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -95.87 122.47 38.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CE1' ' OD1' ' A' ' 86' ' ' ASP . 13.1 p90 -124.4 -179.6 4.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.927 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.63 133.48 21.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.565 0.698 . . . . 0.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.426 ' HD2' HG21 ' A' ' 88' ' ' THR . 53.6 Cg_endo -69.73 -6.28 18.2 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.687 2.258 . . . . 0.0 112.347 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -122.89 21.92 9.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t -120.2 111.14 17.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.06 -47.71 6.43 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -46.68 -37.25 8.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.771 0.32 . . . . 0.0 110.858 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 34.7 t -63.46 -44.5 94.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.908 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -65.5 -42.16 92.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -72.68 -35.0 67.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' A' ' 66' ' ' LYS . 14.0 tp -81.97 -26.77 33.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.527 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.3 tt0 -38.08 -58.1 1.54 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.608 0.718 . . . . 0.0 110.926 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.7 Cg_endo -69.82 -31.11 20.91 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.625 2.217 . . . . 0.0 112.332 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HB2' HD12 ' A' ' 63' ' ' LEU . 29.0 mtpt -68.63 -30.0 68.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -92.42 -45.21 8.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.933 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -41.65 -58.96 1.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.947 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 70' ' ' LEU . 16.4 mt-10 -41.07 -61.64 0.96 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.487 ' N ' HD21 ' A' ' 124' ' ' LEU . 22.2 tp -38.06 -35.63 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.35 -68.77 1.52 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.494 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -66.08 -19.69 65.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -75.28 -41.38 57.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.607 HD12 HD11 ' A' ' 82' ' ' ILE . 92.6 mt -86.46 3.35 44.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.2 t -54.07 -34.46 60.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -6.23 5.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 5.9 t70 -102.83 100.37 16.4 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.629 0.728 . . . . 0.0 110.873 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.7 Cg_endo -69.79 0.78 5.18 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.706 2.271 . . . . 0.0 112.346 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -110.46 -34.81 6.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 74' ' ' LEU . 71.8 mt -93.43 126.98 45.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 84.1 t -124.47 110.92 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.125 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.607 HD11 HD12 ' A' ' 74' ' ' LEU . 49.9 mm -82.99 123.7 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.142 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -133.75 161.47 34.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -134.65 150.43 50.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.455 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 10.7 ttt -141.45 140.12 33.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.629 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 7.6 t0 -95.41 91.16 6.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.804 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -45.0 -49.18 11.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.1 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.426 HG21 ' HD2' ' A' ' 55' ' ' PRO . 1.2 p -55.73 -28.56 56.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.14 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.726 ' HB1' ' CG ' ' A' ' 19' ' ' GLU . . . -94.05 -12.43 28.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.455 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.5 OUTLIER -157.26 123.54 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.435 ' OD2' HD23 ' A' ' 16' ' ' LEU . 12.0 t0 -57.38 135.91 56.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.874 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.9 t -82.95 128.19 66.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.628 0.728 . . . . 0.0 111.087 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.663 2.242 . . . . 0.0 112.351 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 m -115.73 162.0 27.58 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.712 0.768 . . . . 0.0 110.84 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.78 -10.83 11.73 Favored 'Cis proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 -1.795 . . . . 0.0 112.319 0.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 95' ' ' PRO . 98.0 m-85 -35.25 133.9 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -141.83 118.56 11.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.492 HG22 HG21 ' A' ' 103' ' ' THR . 77.4 t -120.96 116.11 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.093 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -118.14 -44.64 2.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.34 123.42 5.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.509 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.536 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -98.31 154.89 37.43 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.674 0.75 . . . . 0.0 110.864 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.536 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.2 Cg_endo -69.74 162.08 84.8 Favored 'Cis proline' 0 C--O 1.231 0.162 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.327 -0.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.492 HG21 HG22 ' A' ' 98' ' ' VAL . 52.3 m -139.99 125.45 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.8 mt -116.25 138.57 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.54 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 8.8 m-85 -134.54 162.66 31.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.946 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -133.5 136.33 45.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 t -104.47 93.02 5.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.882 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.502 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.3 Cg_endo -69.68 151.87 69.6 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.403 ' O ' ' HE3' ' A' ' 111' ' ' LYS . . . -69.59 145.46 52.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.4 p30 44.83 25.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.502 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 24.9 mtmt -130.4 41.28 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -66.06 -51.37 58.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.862 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -48.19 -49.08 34.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 2.9 m120 -122.32 91.79 49.1 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 54.4 Cg_endo -69.74 -163.8 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.661 2.241 . . . . 0.0 112.362 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -145.6 132.42 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.54 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 17.2 ttpt -98.8 137.34 37.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -73.14 104.69 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -116.97 98.42 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.88 -144.63 6.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.452 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.53 130.73 10.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.503 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 -79.57 45.5 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.745 0.307 . . . . 0.0 110.866 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 124' ' ' LEU . 5.1 tp10 -106.42 132.83 51.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.628 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -37.37 -52.51 1.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.1 m -61.69 -43.04 99.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -51.78 -42.11 62.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -63.18 -40.59 97.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mt -60.16 -61.73 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.3 t -56.26 -32.57 64.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 20.8 t80 -57.9 -58.48 8.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.0 -39.1 92.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -41.32 -40.87 1.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.1 ptp180 -102.9 -38.11 7.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 71.6 mm-40 -67.03 -60.94 2.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -44.47 132.35 6.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.088 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.42 -75.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 t -49.73 -56.69 9.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.527 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.932 0.396 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.0 pp -116.36 -36.93 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' A' ' 18' ' ' SER . 6.6 ttpm? -119.78 163.25 17.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.508 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 85.7 p -165.12 155.57 13.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.459 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 4.4 mm-40 -103.3 162.23 20.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.652 0.739 . . . . 0.0 110.884 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.459 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.74 143.4 50.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 0.0 112.33 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 35' ' ' GLU . 17.3 mm -70.04 132.56 88.32 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.722 . . . . 0.0 111.12 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 142.77 48.69 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.721 2.281 . . . . 0.0 112.347 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.25 -36.44 61.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.901 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 p -119.99 113.92 21.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.879 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.431 ' CG ' ' HD2' ' A' ' 30' ' ' LYS . 10.1 t-20 -125.11 47.0 2.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -111.11 61.74 0.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.15 -165.22 11.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.448 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -40.94 4.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.684 2.256 . . . . 0.0 112.35 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.501 HG12 ' HG2' ' A' ' 84' ' ' LYS . 21.3 t -120.6 108.9 23.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HD2' ' CG ' ' A' ' 25' ' ' ASN . 1.5 mmmt -59.35 136.38 57.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.431 HG22 ' HE3' ' A' ' 84' ' ' LYS . 95.3 t -84.65 125.01 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.88 HG11 HG23 ' A' ' 41' ' ' VAL . 31.3 t -119.38 119.61 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.479 HG21 HD13 ' A' ' 21' ' ' ILE . 18.1 m -115.54 148.11 18.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.088 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -35.31 -38.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.111 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' A' ' 21' ' ' ILE . 15.7 mt-10 -59.71 -48.93 79.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.449 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 14.8 p-10 -111.44 30.16 7.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.739 ' CD2' HG21 ' A' ' 41' ' ' VAL . 15.4 t80 -68.48 -62.55 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.43 -8.8 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.56 -46.57 11.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.5 mt -97.46 -50.37 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.88 HG23 HG11 ' A' ' 32' ' ' VAL . 29.5 t -58.06 -60.88 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.104 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -76.16 125.34 28.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -169.13 105.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.28 -1.75 28.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -85.52 -46.63 10.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.01 166.62 23.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -83.12 151.0 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.41 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 9.3 t -141.82 149.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.155 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.695 HD13 HD21 ' A' ' 131' ' ' LEU . 6.4 tp -122.84 120.01 32.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.411 HD11 ' CB ' ' A' ' 85' ' ' MET . 2.3 tp -107.4 137.11 40.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.49 ' OE1' ' CG1' ' A' ' 104' ' ' ILE . 3.7 tp10 -127.34 107.42 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.909 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.402 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 39.7 m-85 -83.82 126.62 33.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.442 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 9.6 p90 -132.87 176.0 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.893 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.03 133.07 24.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.713 . . . . 0.0 111.073 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -4.09 13.33 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.355 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.508 ' CZ2' HG21 ' A' ' 88' ' ' THR . 6.0 p-90 -123.56 17.7 9.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 43.6 t -116.09 100.63 8.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -41.3 -51.1 4.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 58' ' ' GLY . 97.2 m-70 -37.4 -38.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.762 0.315 . . . . 0.0 110.855 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 64' ' ' GLU . 6.2 t -69.33 -51.34 37.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.52 -53.1 19.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -64.95 -18.09 64.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.688 HD12 ' HB2' ' A' ' 66' ' ' LYS . 45.8 tp -97.25 -18.41 19.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.585 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.5 tp10 -45.32 -55.12 12.44 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.69 0.757 . . . . 0.0 110.915 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.1 Cg_endo -69.83 -24.64 29.14 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 0.0 112.283 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.688 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -76.99 -33.25 57.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -90.0 -31.94 16.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -53.81 -56.49 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.914 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -41.98 -56.81 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.469 ' N ' HD21 ' A' ' 124' ' ' LEU . 37.7 tp -41.14 -40.52 1.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.87 -69.09 1.4 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.496 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -59.36 -20.3 53.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.926 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -76.78 -46.56 24.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.693 HD12 HD11 ' A' ' 82' ' ' ILE . 96.8 mt -86.65 1.98 50.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -48.75 -22.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.02 22.91 4.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.607 ' OD2' HD22 ' A' ' 74' ' ' LEU . 72.6 m-20 -108.63 99.24 32.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.657 0.742 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.4 Cg_endo -69.66 -0.82 7.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 0.0 112.36 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -117.62 -36.78 3.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.45 129.0 51.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.4 t -124.35 109.99 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.693 HD11 HD12 ' A' ' 74' ' ' LEU . 27.2 mm -80.36 133.57 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.146 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.754 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -147.65 169.12 20.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.501 ' HG2' HG12 ' A' ' 29' ' ' VAL . 40.2 pttt -136.4 153.16 51.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.411 ' CB ' HD11 ' A' ' 50' ' ' ILE . 14.4 ttt -146.46 135.72 22.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.442 ' OD1' ' CZ ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -91.76 83.88 5.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.876 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -43.16 -55.95 3.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.508 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 33.7 p -46.95 -32.39 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.168 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.38 -19.82 21.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.61 122.49 17.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -51.6 130.84 28.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.439 HG21 ' HB ' ' A' ' 98' ' ' VAL . 95.7 t -72.81 131.83 83.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.589 0.709 . . . . 0.0 111.108 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.602 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.7 Cg_endo -69.81 -168.43 0.28 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.665 2.243 . . . . 0.0 112.371 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.502 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -129.6 161.22 60.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.661 0.744 . . . . 0.0 110.828 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.9 Cg_endo -69.71 -3.11 7.43 Favored 'Cis proline' 0 C--N 1.341 0.182 0 C-N-CA 122.69 -1.796 . . . . 0.0 112.361 -0.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.473 ' N ' ' HA ' ' A' ' 94' ' ' SER . 83.6 m-85 -33.77 127.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -131.7 102.42 5.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.736 HG22 HG21 ' A' ' 103' ' ' THR . 74.8 t -105.82 115.5 47.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -114.65 -47.41 2.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.94 127.61 7.5 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.488 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.541 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -100.06 154.95 36.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 0.0 110.867 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.7 Cg_endo -69.75 157.9 91.53 Favored 'Cis proline' 0 C--O 1.231 0.166 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.369 -0.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.736 HG21 HG22 ' A' ' 98' ' ' VAL . 44.6 m -133.1 101.84 5.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.515 HD13 ' CE1' ' A' ' 127' ' ' PHE . 82.6 mt -95.18 125.55 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 7.8 m-85 -122.02 -176.98 3.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 41.6 t80 -150.91 136.25 17.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.8 t -105.52 92.42 5.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.491 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.78 155.63 65.38 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.668 2.246 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.89 128.55 33.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 67.43 25.02 8.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.491 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 14.0 mtmt -134.38 56.02 1.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 114' ' ' ASN . 31.4 mmtt -80.11 -56.27 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.9 mp -37.8 -28.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 112' ' ' LYS . 12.6 m120 -148.71 107.63 3.5 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.912 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.502 ' CD ' ' HG2' ' A' ' 95' ' ' PRO . 53.4 Cg_endo -69.77 -174.97 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.72 2.28 . . . . 0.0 112.336 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.2 120.82 29.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 105' ' ' TYR . 13.2 ttmm -94.38 130.19 40.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -76.71 111.52 12.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -124.68 98.23 5.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.53 -137.84 2.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.38 126.96 8.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.443 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 63.9 mtm-85 -78.92 45.47 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 110.863 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -101.97 138.56 38.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.522 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.4 tm? -42.3 -51.3 4.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.7 p -70.59 -32.16 69.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -61.89 -34.65 76.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.515 ' CE1' HD13 ' A' ' 104' ' ' ILE . 31.0 m-85 -71.19 -35.21 71.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.2 mt -68.43 -52.01 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -63.75 -26.03 68.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -69.24 -47.68 64.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.923 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.695 HD21 HD13 ' A' ' 49' ' ' LEU . 17.6 mt -77.0 -42.65 37.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.916 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' LEU . 15.1 mt-30 -37.48 -31.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 131' ' ' LEU . 22.2 mmm180 -104.1 -53.81 2.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -50.01 -58.5 5.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -38.77 116.64 0.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -33.91 -75.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -73.33 -55.31 6.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.464 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.871 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.6 p90 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.953 0.406 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.443 ' C ' HD12 ' A' ' 16' ' ' LEU . 2.9 pp -105.51 -41.24 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.42 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.9 tttp -96.78 160.83 14.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.462 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 93.0 p -168.2 150.16 5.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.834 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.493 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 8.7 mm-40 -104.52 161.53 22.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.64 0.733 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.71 142.88 49.36 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.723 2.282 . . . . 0.0 112.337 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.489 HD11 ' CB ' ' A' ' 35' ' ' GLU . 40.7 mm -72.56 129.14 87.5 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.627 0.727 . . . . 0.0 111.151 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 169.87 17.87 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -88.95 -37.11 15.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -156.34 134.81 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.445 ' CB ' ' HD3' ' A' ' 30' ' ' LYS . 41.1 m-20 -111.39 47.75 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -52.19 -33.22 39.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -41.99 166.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.32 36.42 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.698 2.265 . . . . 0.0 112.304 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.89 117.78 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.144 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.647 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 10.0 mmtm -64.99 132.57 49.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.898 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.9 t -86.51 102.8 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.139 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.008 HG11 HG23 ' A' ' 41' ' ' VAL . 40.4 t -95.95 127.18 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.145 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 21' ' ' ILE . 27.1 m -123.08 146.25 28.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.871 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -31.71 -44.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.09 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.489 ' CB ' HD11 ' A' ' 21' ' ' ILE . 23.9 mt-10 -53.71 -50.77 65.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 33' ' ' VAL . 12.1 p-10 -112.26 33.92 4.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.9 ' CD2' HG21 ' A' ' 41' ' ' VAL . 14.1 t80 -74.33 -58.46 3.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -62.53 -8.79 6.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.45 -43.9 11.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.4 mt -98.78 -52.99 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.008 HG23 HG11 ' A' ' 32' ' ' VAL . 45.8 t -57.01 -61.94 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.51 115.75 11.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -160.73 105.04 1.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -84.71 8.68 16.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -104.49 -43.44 5.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -129.64 159.8 35.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -78.51 148.08 33.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.1 t -146.54 122.36 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.121 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 105' ' ' TYR . 16.0 tp -99.0 116.33 30.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 tp -105.25 130.75 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.08 115.35 21.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -89.68 116.6 27.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.54 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 18.6 p90 -121.6 171.6 8.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.966 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.448 ' HB1' ' CE2' ' A' ' 56' ' ' TRP . . . -126.71 130.74 23.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.593 0.711 . . . . 0.0 111.104 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.414 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.3 Cg_endo -69.76 -8.52 23.8 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 0.0 112.364 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.448 ' CE2' ' HB1' ' A' ' 54' ' ' ALA . 2.2 p-90 -112.82 7.9 18.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.2 t -107.92 130.62 55.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.25 -52.6 39.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.551 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -37.81 -39.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -64.93 -55.66 17.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -42.55 -47.11 5.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -73.1 -23.4 60.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 66' ' ' LYS . 41.6 tp -87.9 -18.42 29.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.53 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -46.84 -58.29 7.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.642 0.734 . . . . 0.0 110.872 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.2 Cg_endo -69.76 -31.91 19.61 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.699 2.266 . . . . 0.0 112.351 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.496 ' HB2' HD12 ' A' ' 63' ' ' LEU . 44.1 mtpt -68.2 -32.29 72.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.415 ' O ' ' C ' ' A' ' 68' ' ' LYS . 42.1 t80 -89.76 -50.41 6.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.87 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 67' ' ' TYR . 12.1 ttmt -36.9 -61.63 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -40.98 -56.66 2.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.846 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.462 ' N ' HD21 ' A' ' 124' ' ' LEU . 19.1 tp -42.48 -36.82 1.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -55.99 -69.05 1.39 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.45 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -66.88 -23.34 65.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.382 . . . . 0.0 110.874 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -67.44 -45.46 75.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 82' ' ' ILE . 95.0 mt -85.82 3.74 40.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.5 p -52.4 -29.79 25.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -62.13 -7.57 4.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -103.57 101.08 21.58 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.619 0.723 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 1.67 4.22 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.338 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.476 ' C ' ' OD1' ' A' ' 47' ' ' ASP . 78.1 m-20 -113.55 -39.92 3.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.9 mt -84.79 106.49 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.124 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.9 t -99.79 116.28 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.138 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 74' ' ' LEU . 31.7 mm -91.41 119.68 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.143 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.837 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -133.37 175.83 9.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.112 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -146.62 139.5 25.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.48 ' CE ' ' HB2' ' A' ' 90' ' ' ASN . 1.8 tmm? -134.5 149.83 50.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.54 ' OD1' ' CZ ' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -100.93 96.16 7.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.813 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -43.73 -66.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -40.69 -29.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -91.77 -30.67 16.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 15.8 m-80 -130.81 119.75 22.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.827 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -57.86 118.94 5.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.6 t -72.72 116.58 51.41 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.575 0.702 . . . . 0.0 111.134 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.7 Cg_endo -69.78 -172.08 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.65 2.233 . . . . 0.0 112.378 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.509 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -105.45 159.71 28.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.618 0.723 . . . . 0.0 110.858 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.6 Cg_endo -69.79 -20.85 10.59 Favored 'Cis proline' 0 C--O 1.232 0.177 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.297 0.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.482 ' C ' ' O ' ' A' ' 95' ' ' PRO . 93.6 m-85 -30.64 131.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.955 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.455 ' OE1' ' CZ ' ' A' ' 99' ' ' ARG . 13.7 mm-40 -141.92 119.27 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.881 HG22 HG21 ' A' ' 103' ' ' THR . 45.9 t -117.71 107.3 21.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.455 ' CZ ' ' OE1' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -125.41 33.1 5.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.59 113.66 0.29 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.533 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -97.72 155.09 37.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.664 0.745 . . . . 0.0 110.871 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.7 Cg_endo -69.79 145.54 79.79 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.651 -1.812 . . . . 0.0 112.334 0.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.881 HG21 HG22 ' A' ' 98' ' ' VAL . 9.8 m -122.57 124.29 43.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.475 HD12 ' NH1' ' A' ' 122' ' ' ARG . 27.7 mt -120.26 134.64 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.158 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.413 ' O ' HD12 ' A' ' 49' ' ' LEU . 10.8 m-85 -134.07 161.1 35.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -136.59 126.08 25.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 5.7 p -99.87 102.93 19.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.716 0.769 . . . . 0.0 110.815 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.501 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.4 Cg_endo -69.76 167.85 23.25 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.679 2.253 . . . . 0.0 112.352 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.448 ' O ' ' CE ' ' A' ' 111' ' ' LYS . . . -78.37 140.75 38.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.8 29.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.501 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.1 mtmt -130.36 48.44 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.465 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 6.5 mmpt? -70.81 -57.57 4.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 112' ' ' LYS . 54.9 mt -35.74 -43.09 0.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.417 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 3.4 m120 -132.61 95.67 19.78 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.651 0.739 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.7 Cg_endo -69.73 -164.44 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.719 2.28 . . . . 0.0 112.307 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -145.5 117.55 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.944 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -89.3 137.98 31.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.912 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.63 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 82.8 t80 -70.48 118.26 13.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -125.7 100.39 6.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.01 -155.38 25.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.18 139.58 22.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.472 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.475 ' NH1' HD12 ' A' ' 104' ' ' ILE . 53.4 mtt-85 -82.5 52.84 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.84 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 126' ' ' ASP . 13.0 tt0 -108.59 141.03 41.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.51 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.5 tm? -44.73 -50.93 9.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.7 p -69.8 -42.25 73.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.435 ' CG ' ' HB3' ' A' ' 123' ' ' GLU . 3.8 m-20 -49.44 -34.71 17.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.63 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 65.1 m-85 -73.03 -44.87 60.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.6 mt -57.21 -48.64 81.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.8 p -62.58 -46.94 85.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.508 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 5.1 t80 -56.03 -44.84 79.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.949 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.3 mt -72.56 -41.2 65.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -38.09 -40.49 0.49 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -97.84 -57.28 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.508 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 39.5 mm-40 -45.45 -58.71 3.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.65 153.71 27.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.088 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.05 -50.1 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 84.8 p -47.31 -54.93 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.824 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 m -115.53 89.5 3.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.902 0.382 . . . . 0.0 110.856 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.3 p -171.52 168.0 6.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.25 116.59 2.02 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.524 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 m -104.24 94.91 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.876 0.37 . . . . 0.0 110.893 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.2 t -47.37 -49.98 23.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.84 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.27 -157.03 49.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.504 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.427 ' O ' ' CG ' ' A' ' 9' ' ' ASP . 11.7 t80 -170.39 133.14 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 0.0 110.838 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 8' ' ' PHE . 39.4 m-20 -166.16 122.03 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.92 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.86 46.01 0.66 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.479 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 43.78 52.4 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.609 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -64.13 95.18 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.454 ' HE3' ' C ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -160.07 163.32 34.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.4 tpt85 -163.58 138.36 6.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 2.6 p90 -157.7 151.98 24.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 pp -108.56 -35.43 6.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 17.5 ttpt -110.61 154.27 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 4.8 m -159.75 143.94 14.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.437 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.2 mm-40 -89.97 161.56 37.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 0.0 110.888 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.437 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.9 Cg_endo -69.75 141.49 45.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.658 2.239 . . . . 0.0 112.343 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.689 HD13 HG21 ' A' ' 33' ' ' VAL . 36.1 mm -69.91 132.17 88.81 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.698 . . . . 0.0 111.15 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 142.02 47.07 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.681 2.254 . . . . 0.0 112.348 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -61.3 -32.38 72.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -166.35 133.99 2.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -110.75 54.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -81.43 58.13 3.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.63 -168.51 11.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.514 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.479 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 53.4 Cg_endo -69.75 -48.81 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.716 2.277 . . . . 0.0 112.355 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.81 127.6 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -73.08 134.79 44.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -84.63 113.25 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.147 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.862 HG11 HG23 ' A' ' 41' ' ' VAL . 22.0 t -109.35 117.92 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.12 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.689 HG21 HD13 ' A' ' 21' ' ' ILE . 18.2 m -110.64 152.05 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.163 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB2' ' HB2' ' A' ' 90' ' ' ASN . . . -41.03 -34.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.53 ' HB3' HD11 ' A' ' 21' ' ' ILE . 8.8 mt-10 -64.51 -45.81 85.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 29.3 p30 -114.11 34.5 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CE1' ' HG3' ' A' ' 93' ' ' PRO . 6.4 t80 -73.6 -56.99 4.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -66.99 -4.81 10.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -89.47 -42.94 11.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.5 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 18.2 mt -98.94 -46.42 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.862 HG23 HG11 ' A' ' 32' ' ' VAL . 97.2 t -65.0 -62.12 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -67.8 113.98 6.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.75 HD21 HG21 ' A' ' 48' ' ' VAL . 4.9 p30 -175.25 106.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.39 2.73 27.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -84.79 -43.53 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -135.31 150.64 50.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.36 148.29 41.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.75 HG21 HD21 ' A' ' 43' ' ' ASN . 63.7 t -146.85 144.36 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 82' ' ' ILE . 14.5 tp -117.92 119.15 33.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.575 HG12 ' CE1' ' A' ' 52' ' ' PHE . 2.2 tp -101.46 129.78 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -119.53 111.45 18.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.575 ' CE1' HG12 ' A' ' 50' ' ' ILE . 34.7 m-85 -88.61 130.73 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -138.59 -175.12 4.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.631 ' HB1' ' CE2' ' A' ' 56' ' ' TRP . . . -142.43 133.74 12.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.605 0.716 . . . . 0.0 111.098 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -25.44 28.84 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.711 2.274 . . . . 0.0 112.345 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.631 ' CE2' ' HB1' ' A' ' 54' ' ' ALA . 2.2 p-90 -84.54 -28.13 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 4.6 t -68.73 138.5 54.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.835 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.91 -35.06 7.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.45 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -71.58 -26.77 62.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.885 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.3 m -83.37 -37.3 23.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -62.39 -45.41 93.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -60.85 -9.53 4.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.842 HD12 ' HB2' ' A' ' 66' ' ' LYS . 11.9 tp -97.34 -22.53 16.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.529 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -34.6 -58.21 0.68 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.675 0.75 . . . . 0.0 110.887 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.5 Cg_endo -69.73 -24.57 29.65 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.715 2.276 . . . . 0.0 112.294 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.842 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.6 mmmp? -75.27 -27.04 59.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 63.6 t80 -94.8 -39.7 10.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.886 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.479 ' HG3' ' CG ' ' A' ' 28' ' ' PRO . 5.6 ttmm -46.22 -59.49 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.898 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -38.84 -60.15 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' N ' HD21 ' A' ' 124' ' ' LEU . 17.4 tp -38.39 -42.04 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.93 -58.74 12.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.515 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -70.5 -20.98 62.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 0.0 110.926 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -72.56 -46.31 55.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.54 HD12 HD11 ' A' ' 82' ' ' ILE . 97.0 mt -78.26 3.12 16.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.9 p -50.3 -25.0 3.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.835 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -79.09 11.62 2.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.922 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.43 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 4.6 t0 -117.82 97.95 51.2 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.566 0.698 . . . . 0.0 110.897 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.0 Cg_endo -69.72 -1.08 7.82 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.739 2.293 . . . . 0.0 112.311 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -109.77 -37.19 5.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.448 HD11 ' CB ' ' A' ' 135' ' ' ALA . 46.6 mt -93.8 133.26 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.078 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 48' ' ' VAL . 54.3 t -129.74 117.33 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.54 HD11 HD12 ' A' ' 74' ' ' LEU . 50.1 mm -86.39 134.77 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.114 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.775 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -147.26 167.16 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -135.67 155.02 51.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.484 ' CB ' HD11 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -148.87 132.05 16.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.899 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.756 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -84.83 94.96 8.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.87 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.04 -62.62 1.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.443 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -48.63 -35.06 12.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.756 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -80.78 -22.21 40.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.12 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -150.44 123.31 8.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -47.55 148.13 1.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.614 HG13 ' HD2' ' A' ' 93' ' ' PRO . 93.3 t -100.2 137.75 20.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.626 0.727 . . . . 0.0 111.14 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.614 ' HD2' HG13 ' A' ' 92' ' ' VAL . 53.9 Cg_endo -69.74 -163.81 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.654 2.236 . . . . 0.0 112.316 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.497 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -128.32 160.88 59.87 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.648 0.737 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.72 -6.45 9.36 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.328 -0.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.446 ' C ' ' O ' ' A' ' 95' ' ' PRO . 89.8 m-85 -34.35 121.14 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -127.58 131.9 49.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.803 HG22 HG21 ' A' ' 103' ' ' THR . 91.1 t -131.92 104.69 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -104.85 -39.62 6.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.86 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -128.21 132.48 7.37 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.461 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.543 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -100.03 154.24 37.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.637 0.732 . . . . 0.0 110.92 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.75 159.88 88.92 Favored 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.674 -1.802 . . . . 0.0 112.317 -0.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.803 HG21 HG22 ' A' ' 98' ' ' VAL . 44.4 m -135.02 102.97 5.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.1 mt -98.78 134.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.135 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.412 ' O ' HD12 ' A' ' 49' ' ' LEU . 8.9 m-85 -132.75 166.6 21.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -134.96 132.34 38.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.407 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 1.9 t -105.75 94.76 9.31 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.629 0.728 . . . . 0.0 110.864 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.46 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.8 Cg_endo -69.76 175.71 7.74 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.687 2.258 . . . . 0.0 112.357 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.27 137.08 32.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 49.31 25.59 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.46 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.2 mtmm -124.77 21.98 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.487 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 2.3 mptp? -50.85 -50.0 57.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -46.12 -38.92 8.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -134.26 91.48 22.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.602 0.715 . . . . 0.0 110.942 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -163.85 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.691 2.261 . . . . 0.0 112.344 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -142.26 145.51 34.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -119.6 117.87 29.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -57.33 111.47 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.931 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -125.12 91.56 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.5 -142.84 4.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.485 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.51 130.68 10.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 127' ' ' PHE . 45.4 mtm-85 -81.1 47.58 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 124' ' ' LEU . 4.1 tt0 -103.76 133.65 48.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 123' ' ' GLU . 3.1 tm? -34.17 -53.68 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.972 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 128' ' ' ILE . 14.8 m -67.2 -51.0 58.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -42.75 -31.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 122' ' ' ARG . 68.7 m-85 -76.74 -40.44 48.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' A' ' 125' ' ' SER . 32.3 mt -62.11 -55.99 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -57.79 -31.42 66.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.513 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 68.1 t80 -63.46 -45.06 92.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.964 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.1 mt -76.59 -39.13 53.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.945 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -46.63 -24.2 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.43 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.7 ptp85 -112.69 -37.02 5.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 2.9 mm-40 -70.01 -59.64 2.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.889 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.448 ' CB ' HD11 ' A' ' 80' ' ' ILE . . . -45.72 107.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.106 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 137' ' ' SER . 1.7 t -44.35 -50.55 9.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.432 ' N ' HG23 ' A' ' 136' ' ' THR . 46.1 m -68.64 -58.34 4.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.95 169.37 7.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.459 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 155.66 65.41 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.68 2.253 . . . . 0.0 112.35 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.8 p -56.44 -42.08 77.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.5 p -98.41 90.95 4.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.49 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.7 p -66.72 115.09 6.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.912 0.387 . . . . 0.0 110.88 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 t -111.26 158.59 18.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.45 164.31 10.0 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.515 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.7 p -114.92 150.71 35.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 0.0 110.856 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.2 t -69.54 169.06 13.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.849 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 137.68 -162.49 25.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.493 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -110.97 137.38 48.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.889 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 9' ' ' ASP . 0.9 OUTLIER -115.13 114.54 25.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.02 176.54 22.02 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.518 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -125.34 104.26 8.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 0.0 110.883 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 12' ' ' LEU . 5.6 mp -88.02 97.31 10.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.939 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -157.36 135.91 11.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.884 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -152.93 124.4 7.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.648 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 2.4 p90 -145.62 155.98 43.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 pp -104.27 -40.61 6.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 12.2 ttpt -109.1 154.73 21.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.1 p -155.59 144.74 20.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.459 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 3.8 mm-40 -91.77 161.23 34.42 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.638 0.732 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.459 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.7 Cg_endo -69.79 142.98 49.27 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.658 2.239 . . . . 0.0 112.366 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.49 HD13 ' CG2' ' A' ' 33' ' ' VAL . 40.2 mm -74.58 133.85 76.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 111.136 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 21' ' ' ILE . 54.0 Cg_endo -69.74 176.62 6.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.731 2.288 . . . . 0.0 112.326 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -101.54 -35.95 8.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.3 t -148.99 128.96 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -116.78 49.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.04 56.55 3.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.72 -171.89 13.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.489 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -38.71 7.47 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.687 2.258 . . . . 0.0 112.314 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.529 HG12 ' HG2' ' A' ' 84' ' ' LYS . 21.6 t -119.49 119.33 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.104 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.616 ' HZ1' HD13 ' A' ' 40' ' ' ILE . 1.6 mmmp? -68.97 125.73 27.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.1 t -74.81 124.33 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.765 HG11 HG23 ' A' ' 41' ' ' VAL . 42.0 t -123.9 125.65 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 35' ' ' GLU . 21.1 m -119.14 149.46 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.648 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.18 -42.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.064 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.529 ' HB2' HG23 ' A' ' 33' ' ' VAL . 9.4 mt-10 -55.57 -48.69 74.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' A' ' 33' ' ' VAL . 11.3 p-10 -114.08 38.85 2.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.588 ' CE1' ' HG3' ' A' ' 93' ' ' PRO . 4.6 t80 -77.95 -55.22 5.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.96 -11.12 55.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -83.28 -42.27 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.707 HD12 HG22 ' A' ' 32' ' ' VAL . 24.9 mt -99.24 -59.44 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.765 HG23 HG11 ' A' ' 32' ' ' VAL . 94.1 t -49.99 -62.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -66.46 115.77 6.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.84 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 45' ' ' ASN . 2.4 t30 -173.75 110.37 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -87.17 -4.53 59.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.478 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 78.7 m-20 -73.96 -48.47 30.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.87 153.91 51.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -67.67 142.25 56.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.8 t -137.52 143.79 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.468 HD23 HD12 ' A' ' 82' ' ' ILE . 31.1 tp -121.31 121.28 37.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.581 HD13 HG22 ' A' ' 41' ' ' VAL . 2.4 tp -109.76 133.4 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' OE1' ' C ' ' A' ' 52' ' ' PHE . 0.3 OUTLIER -124.0 118.22 26.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.869 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.43 ' C ' ' OE1' ' A' ' 51' ' ' GLU . 54.4 m-85 -95.0 114.93 26.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CE1' ' OD1' ' A' ' 86' ' ' ASP . 17.2 p90 -120.23 -179.19 3.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.404 ' HB3' ' CB ' ' A' ' 57' ' ' CYS . . . -136.76 134.49 19.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.578 0.704 . . . . 0.0 111.083 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.733 ' HD2' HG21 ' A' ' 88' ' ' THR . 53.6 Cg_endo -69.76 -11.05 30.04 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.708 2.272 . . . . 0.0 112.295 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -114.1 9.25 17.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.404 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . 48.4 t -106.32 113.27 26.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.71 -52.71 46.59 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.481 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -46.67 -39.13 10.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.731 0.301 . . . . 0.0 110.809 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 43.9 m -70.95 -39.84 72.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.912 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -40.58 76.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.894 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -73.21 -25.5 60.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.605 HD13 ' HB3' ' A' ' 122' ' ' ARG . 29.4 tp -83.24 -23.11 32.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.529 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -42.52 -57.88 4.23 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.623 0.725 . . . . 0.0 110.934 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.8 -36.03 11.43 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.679 2.252 . . . . 0.0 112.341 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HB2' HD12 ' A' ' 63' ' ' LEU . 17.1 mtpp -64.63 -28.34 69.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.434 ' OH ' HG23 ' A' ' 82' ' ' ILE . 57.0 t80 -93.04 -43.64 8.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -44.82 -58.52 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.925 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -41.64 -46.84 3.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.512 HD13 ' HB2' ' A' ' 127' ' ' PHE . 12.1 tp -53.32 -36.54 61.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.962 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -57.97 -57.04 21.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.17 -24.34 57.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.911 0.386 . . . . 0.0 110.911 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -72.14 -42.16 66.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 80' ' ' ILE . 81.3 mt -83.24 3.35 31.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.6 p -53.08 -39.67 63.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 17.6 tttt -57.88 -11.93 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.78 99.65 9.42 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.608 0.718 . . . . 0.0 110.859 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.5 Cg_endo -69.82 0.15 6.1 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.639 2.226 . . . . 0.0 112.332 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -109.98 -35.86 6.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.562 HG21 HD13 ' A' ' 74' ' ' LEU . 60.9 mt -90.61 104.08 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.46 110.02 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.468 HD12 HD23 ' A' ' 49' ' ' LEU . 50.2 mm -82.87 127.17 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.159 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.56 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -134.4 166.37 23.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.529 ' HG2' HG12 ' A' ' 29' ' ' VAL . 15.2 pttp -138.21 154.05 49.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.503 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 9.7 ttt -150.42 136.82 18.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.96 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 4.0 t70 -92.75 94.96 9.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -50.13 -64.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.733 HG21 ' HD2' ' A' ' 55' ' ' PRO . 1.2 t -41.63 -26.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.117 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -96.68 -26.52 15.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.503 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -141.15 109.39 5.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -44.25 136.58 3.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.581 HG13 ' HD2' ' A' ' 93' ' ' PRO . 72.8 t -86.08 136.63 35.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.596 0.713 . . . . 0.0 111.144 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.588 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.4 Cg_endo -69.74 -167.76 0.24 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.712 2.275 . . . . 0.0 112.312 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.505 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -121.74 161.33 42.52 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.731 0.777 . . . . 0.0 110.83 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.0 Cg_endo -69.75 -9.24 10.89 Favored 'Cis proline' 0 C--O 1.232 0.223 0 C-N-CA 122.679 -1.801 . . . . 0.0 112.318 -0.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 95' ' ' PRO . 93.9 m-85 -33.98 126.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.905 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.82 128.35 36.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 103' ' ' THR . 88.6 t -127.5 94.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -116.18 28.89 8.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.825 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.32 113.81 0.36 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.543 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -98.09 153.64 38.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.659 0.742 . . . . 0.0 110.874 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.77 156.5 92.79 Favored 'Cis proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 -1.79 . . . . 0.0 112.339 0.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.555 HG21 HG22 ' A' ' 98' ' ' VAL . 6.7 m -135.0 128.18 31.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.424 HD13 ' HE1' ' A' ' 127' ' ' PHE . 36.6 mt -123.36 136.65 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.549 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 9.8 m-85 -136.45 144.29 44.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -119.72 129.72 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -99.96 101.05 12.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.843 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.495 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.3 Cg_endo -69.76 168.09 22.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.706 2.27 . . . . 0.0 112.342 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.12 137.23 33.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.088 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 10.3 p30 51.86 24.94 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.495 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.2 mtmt -129.3 38.42 3.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.468 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 5.8 mmpt? -63.35 -59.34 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 112' ' ' LYS . 11.0 mp -35.41 -36.84 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 2.3 t-20 -134.47 96.82 14.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.642 0.734 . . . . 0.0 110.839 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.9 Cg_endo -69.72 -178.44 2.33 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.661 2.24 . . . . 0.0 112.373 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 147.99 49.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.549 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 10.7 ttpt -118.43 125.92 50.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -67.86 115.65 7.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -123.5 102.84 8.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.63 -149.75 11.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.465 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.91 138.9 14.79 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.5 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.605 ' HB3' HD13 ' A' ' 63' ' ' LEU . 1.1 mpp_? -79.0 45.59 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.774 0.321 . . . . 0.0 110.829 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 124' ' ' LEU . 8.2 tt0 -101.64 128.32 47.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.566 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -34.14 -56.09 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.9 m -59.23 -45.92 89.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 130' ' ' TYR . 6.4 t0 -49.33 -39.97 33.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.512 ' HB2' HD13 ' A' ' 70' ' ' LEU . 58.6 m-85 -67.41 -41.41 84.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.486 HD11 ' CD1' ' A' ' 124' ' ' LEU . 23.4 mt -62.28 -65.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.089 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 m -56.25 -34.8 66.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.41 ' CB ' ' O ' ' A' ' 126' ' ' ASP . 14.6 t80 -57.22 -45.73 83.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.943 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.93 -35.44 32.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -38.56 -41.85 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -98.11 -57.98 2.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -44.17 -56.76 3.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.0 105.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.133 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.423 HG23 ' N ' ' A' ' 137' ' ' SER . 1.6 t -40.41 -49.96 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 136' ' ' THR . 16.6 m -113.14 40.54 2.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.802 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -66.07 -173.78 5.11 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 148.09 64.48 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.6 p -174.14 113.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.5 m -95.91 83.74 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.531 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 m 48.51 48.43 19.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.843 0.354 . . . . 0.0 110.821 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 m -163.27 144.93 9.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.08 179.19 40.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.519 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 t -157.69 147.82 20.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.3 p -99.5 -59.1 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.48 -133.88 8.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.533 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -99.78 110.79 23.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.343 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.401 ' CG ' HD21 ' A' ' 113' ' ' LEU . 2.9 p30 -163.61 150.25 11.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' C ' HD23 ' A' ' 12' ' ' LEU . . . -170.95 -39.83 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.511 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.41 ' C ' HD23 ' A' ' 12' ' ' LEU . 7.6 p30 -92.56 91.05 7.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.866 0.365 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.591 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -140.38 107.02 5.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.91 -179.72 3.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.425 ' HD3' ' N ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -170.56 136.56 1.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.3 p90 -151.46 148.04 27.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.727 HD23 ' CG ' ' A' ' 91' ' ' ASP . 1.2 pt? -95.7 -35.7 11.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.902 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.502 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 10.5 ptmt -117.34 176.36 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.3 p -174.99 150.5 1.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.824 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 12.1 mm-40 -96.6 159.15 32.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 0.0 110.853 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 141.91 46.68 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.561 HD13 HG21 ' A' ' 33' ' ' VAL . 20.2 mm -69.47 131.43 90.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.565 0.698 . . . . 0.0 111.135 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 141.52 45.52 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.671 2.247 . . . . 0.0 112.394 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.1 -34.88 74.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.1 t -156.88 137.21 12.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -121.21 48.2 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.65 52.21 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.39 -167.08 13.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -41.59 4.1 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.668 2.245 . . . . 0.0 112.361 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.72 128.23 74.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.106 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.559 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 12.5 mmmt -74.9 117.33 16.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.581 HG22 ' HE3' ' A' ' 84' ' ' LYS . 78.5 t -73.48 122.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.95 HG11 HG23 ' A' ' 41' ' ' VAL . 39.8 t -115.81 124.31 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.116 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.561 HG21 HD13 ' A' ' 21' ' ' ILE . 30.6 m -115.84 146.06 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.151 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.449 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -34.34 -42.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.071 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.559 ' HB3' HD11 ' A' ' 21' ' ' ILE . 6.7 mt-10 -55.5 -47.2 76.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' VAL . 21.1 p-10 -114.07 33.42 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.781 ' CD2' HG21 ' A' ' 41' ' ' VAL . 13.5 t80 -72.2 -58.28 3.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -64.55 -6.09 6.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -89.31 -46.44 8.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 mt -97.11 -46.05 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.95 HG23 HG11 ' A' ' 32' ' ' VAL . 50.0 t -63.44 -58.82 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.134 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -78.08 124.68 28.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.738 HD21 HG23 ' A' ' 48' ' ' VAL . 5.1 p-10 -175.59 108.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.961 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.419 ' CD ' ' HA ' ' A' ' 110' ' ' ASN . 2.1 mm-40 -83.05 20.25 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -106.75 -39.55 5.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.503 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 16.8 pttm -137.74 166.6 23.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -94.17 139.24 31.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.738 HG23 HD21 ' A' ' 43' ' ' ASN . 23.4 t -136.33 148.18 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.815 HD12 ' O ' ' A' ' 105' ' ' TYR . 6.6 tp -116.51 109.86 17.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 tp -91.64 135.73 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.076 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' OE2' ' C ' ' A' ' 52' ' ' PHE . 1.9 tm-20 -127.02 117.85 23.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.448 ' C ' ' OE2' ' A' ' 51' ' ' GLU . 45.8 m-85 -93.32 124.33 37.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -128.84 -175.02 3.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.787 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -139.1 131.66 15.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.594 0.711 . . . . 0.0 111.091 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -3.09 11.32 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.688 2.259 . . . . 0.0 112.327 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.552 ' NE1' HG21 ' A' ' 88' ' ' THR . 6.7 p-90 -119.45 -3.37 10.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.787 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -93.44 133.5 36.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.93 -41.83 93.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.484 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -51.62 -28.06 13.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 64' ' ' GLU . 42.5 t -69.97 -44.73 68.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -62.81 -44.07 97.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -72.15 -34.41 68.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 66' ' ' LYS . 29.8 tp -84.6 -19.19 33.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.9 OUTLIER -45.3 -58.3 6.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.676 0.75 . . . . 0.0 110.89 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.72 -30.85 21.82 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.337 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.535 ' HB2' HD12 ' A' ' 63' ' ' LEU . 27.2 mtmm -70.06 -26.84 64.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.924 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -95.75 -41.89 8.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -48.84 -58.85 4.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.449 ' CD ' ' O ' ' A' ' 65' ' ' PRO . 1.2 mp0 -39.27 -51.25 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.408 ' N ' HD21 ' A' ' 124' ' ' LEU . 26.2 tp -48.65 -40.13 26.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.958 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.47 -55.11 30.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.444 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -67.06 -28.1 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.94 0.4 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.51 -45.36 54.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.604 HD12 HD11 ' A' ' 82' ' ' ILE . 94.2 mt -83.14 3.04 32.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.918 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.3 t -49.97 -25.39 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.32 21.91 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.42 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 0.9 OUTLIER -104.48 98.08 13.71 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.603 0.716 . . . . 0.0 110.837 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.6 Cg_endo -69.79 -4.29 13.75 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.658 2.239 . . . . 0.0 112.332 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -116.41 -39.77 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.8 mt -96.9 140.43 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 48' ' ' VAL . 72.0 t -138.43 114.56 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.115 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.604 HD11 HD12 ' A' ' 74' ' ' LEU . 44.5 mm -81.51 126.78 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -136.67 164.58 27.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.075 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.581 ' HE3' HG22 ' A' ' 31' ' ' VAL . 24.1 pttt -136.75 138.3 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.4 ttt -134.96 143.42 46.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 26.9 t0 -92.92 115.21 27.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 89' ' ' ALA . . . -68.89 -70.73 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.114 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.552 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -42.43 -23.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.606 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -99.03 -31.81 11.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 14.4 m-80 -129.14 111.38 12.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.727 ' CG ' HD23 ' A' ' 16' ' ' LEU . 8.3 t0 -45.92 129.55 9.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -77.41 130.23 75.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 0.0 111.16 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.6 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.7 Cg_endo -69.73 -163.86 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.678 2.252 . . . . 0.0 112.317 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -130.61 161.47 60.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.636 0.732 . . . . 0.0 110.872 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.3 Cg_endo -69.74 -4.62 8.38 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.733 -1.778 . . . . 0.0 112.301 -0.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 95' ' ' PRO . 78.8 m-85 -33.27 125.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -125.09 132.46 53.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.473 HG22 HG21 ' A' ' 103' ' ' THR . 38.6 t -143.42 124.34 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -129.65 -39.31 1.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.47 123.31 5.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.484 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.538 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.5 154.82 37.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.664 0.745 . . . . 0.0 110.89 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.538 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.6 Cg_endo -69.8 161.75 85.65 Favored 'Cis proline' 0 C--O 1.232 0.186 0 C-N-CA 122.676 -1.801 . . . . 0.0 112.334 0.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.473 HG21 HG22 ' A' ' 98' ' ' VAL . 62.5 m -140.1 109.82 6.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.3 mt -104.12 134.0 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.182 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.815 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.9 m-85 -129.86 177.36 7.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.405 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.6 t80 -145.3 129.0 17.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.78 97.73 8.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.669 0.747 . . . . 0.0 110.851 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.501 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.5 Cg_endo -69.75 167.56 24.08 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 2.246 . . . . 0.0 112.328 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -83.12 137.63 34.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.108 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.0 OUTLIER 48.14 27.89 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.501 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.3 mtmm -129.4 29.78 5.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -53.87 -57.14 12.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.922 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.401 HD21 ' CG ' ' A' ' 9' ' ' ASP . 68.9 mt -43.3 -48.37 6.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.13 87.48 34.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.632 0.729 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -163.9 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.716 2.277 . . . . 0.0 112.287 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -149.79 131.78 15.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 105' ' ' TYR . 21.6 tttt -102.49 136.46 42.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 70.2 t80 -66.42 110.93 3.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.32 97.31 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.88 -151.83 11.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.96 142.49 23.39 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.451 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -87.28 43.22 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.874 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 124' ' ' LEU . 2.7 tp10 -104.52 131.08 52.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 123' ' ' GLU . 2.8 tm? -34.07 -56.65 0.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 72.7 m -59.59 -50.73 72.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -46.6 -36.61 7.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 65.7 m-85 -70.3 -43.7 69.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.1 mt -58.73 -58.49 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.158 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.53 -31.36 69.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.469 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 52.2 t80 -60.31 -53.33 58.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' GLN . 43.7 mt -70.81 -39.78 72.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' LEU . 28.5 mm-40 -35.62 -36.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.8 mmp_? -106.77 -57.63 2.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.469 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 68.6 mm-40 -42.23 -49.5 4.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -61.66 109.57 1.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -33.99 -74.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.4 t -75.59 56.66 0.91 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.831 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -42.84 147.81 0.67 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.43 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 158.11 58.05 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.653 2.236 . . . . 0.0 112.373 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.1 t -72.57 158.28 35.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.836 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.4 t 57.52 45.89 18.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.848 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.5 p -115.03 147.81 39.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.369 . . . . 0.0 110.856 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 t -116.38 122.1 43.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.839 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.27 -95.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.8 p -58.65 149.01 27.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.856 0.36 . . . . 0.0 110.871 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.5 m -100.58 -55.97 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.811 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.81 -86.39 1.02 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.45 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 47.31 46.95 16.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 0.0 110.853 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -112.98 146.44 39.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.01 83.56 0.36 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.46 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -117.89 -13.35 10.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.354 . . . . 0.0 110.868 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.35 40.12 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -163.01 146.74 11.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 15' ' ' TYR . 1.8 tmm_? -173.55 118.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.733 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.6 p90 -142.72 157.23 44.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 17' ' ' LYS . 3.5 pp -103.86 -38.89 6.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 18' ' ' SER . 51.0 tttt -111.86 163.77 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.664 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 45.4 p -166.0 156.95 13.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.453 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 10.6 mm-40 -103.91 161.38 23.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.626 0.727 . . . . 0.0 110.865 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.7 144.15 53.42 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.694 2.263 . . . . 0.0 112.345 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.519 HD13 ' CG2' ' A' ' 33' ' ' VAL . 42.9 mm -74.92 130.95 79.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.632 0.73 . . . . 0.0 111.154 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 157.81 59.17 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.736 2.291 . . . . 0.0 112.321 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -70.77 -45.83 64.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.4 m -135.66 135.65 40.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -128.22 30.44 5.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.05 48.31 1.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.861 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.44 -162.95 18.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -40.65 5.07 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.326 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.685 HG11 ' HB3' ' A' ' 84' ' ' LYS . 74.2 t -120.01 119.68 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -66.77 113.75 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.6 t -73.04 108.24 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.061 HG11 HG23 ' A' ' 41' ' ' VAL . 39.2 t -106.77 128.03 61.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.129 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.519 ' CG2' HD13 ' A' ' 21' ' ' ILE . 26.9 m -122.25 148.99 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.733 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.84 -40.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.115 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 33' ' ' VAL . 16.0 mt-10 -56.42 -48.18 77.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 33' ' ' VAL . 22.0 p30 -115.12 35.41 4.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.617 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 15.7 t80 -75.17 -56.06 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.75 -5.02 10.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.834 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -92.23 -45.71 8.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.4 mt -96.88 -58.95 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.061 HG23 HG11 ' A' ' 32' ' ' VAL . 61.0 t -50.88 -60.83 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.126 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -70.62 115.16 9.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -167.28 111.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -88.49 6.61 36.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -92.19 -40.72 10.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 155.69 48.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.4 151.47 46.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.1 t -146.32 146.47 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.64 HD23 HD12 ' A' ' 82' ' ' ILE . 20.6 tp -125.15 127.75 47.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.937 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 105' ' ' TYR . 2.5 tp -109.15 140.55 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.139 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 1.9 tt0 -126.95 107.59 10.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -85.82 110.57 19.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -119.26 167.93 11.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.42 127.97 24.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.599 0.714 . . . . 0.0 111.094 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -6.63 19.04 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.71 2.273 . . . . 0.0 112.355 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.444 ' NE1' HG21 ' A' ' 88' ' ' THR . 7.2 p-90 -118.67 14.41 13.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.948 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.2 t -117.09 123.41 46.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -61.71 -61.37 6.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.508 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -39.65 -37.12 0.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.341 . . . . 0.0 110.853 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 81.8 m -74.98 -39.09 61.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' GLY . 5.4 ttmt -62.55 -35.73 80.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -73.86 -22.21 59.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 66' ' ' LYS . 18.7 tp -88.15 -23.71 23.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.532 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.4 tt0 -37.93 -58.14 1.47 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.635 0.731 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.75 -34.32 14.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.704 2.27 . . . . 0.0 112.334 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.682 ' HB2' HD12 ' A' ' 63' ' ' LEU . 20.1 mtpp -66.39 -24.98 66.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 55.5 t80 -96.07 -38.86 10.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -47.78 -56.51 7.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.46 -56.1 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 127' ' ' PHE . 24.4 tp -40.61 -42.04 1.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.39 -68.88 1.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.54 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.87 -25.81 61.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.374 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -74.69 -39.53 61.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.952 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.501 HD22 ' OD2' ' A' ' 77' ' ' ASP . 95.1 mt -88.96 1.73 55.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.3 t -51.51 -20.86 2.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -91.41 18.34 7.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.918 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.501 ' OD2' HD22 ' A' ' 74' ' ' LEU . 97.1 m-20 -109.55 99.9 39.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.59 0.709 . . . . 0.0 110.89 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.9 Cg_endo -69.71 -1.33 8.24 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.721 2.28 . . . . 0.0 112.354 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.07 -35.13 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.883 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 51.0 mt -99.21 142.2 15.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.02 106.97 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.095 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.64 HD12 HD23 ' A' ' 49' ' ' LEU . 47.3 mm -74.36 126.43 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.742 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -130.59 169.14 15.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.043 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.685 ' HB3' HG11 ' A' ' 29' ' ' VAL . 10.6 ptpp? -137.67 135.69 36.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.468 ' CB ' HD11 ' A' ' 50' ' ' ILE . 18.0 ttt -141.38 143.84 34.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.922 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 10.3 t0 -98.63 117.92 34.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.46 -59.24 3.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.444 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -56.03 -21.23 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.109 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.922 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -99.79 -25.13 14.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 86' ' ' ASP . 4.5 m-80 -134.62 104.18 5.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -40.24 122.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.84 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.66 123.51 89.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.639 0.733 . . . . 0.0 111.107 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.8 Cg_endo -69.76 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.679 2.253 . . . . 0.0 112.329 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.508 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.5 m -121.97 160.87 45.31 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.663 0.744 . . . . 0.0 110.848 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.76 -8.62 10.6 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.692 -1.795 . . . . 0.0 112.367 -0.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 95' ' ' PRO . 97.0 m-85 -34.14 123.08 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -130.45 115.34 16.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.781 HG22 HG21 ' A' ' 103' ' ' THR . 75.1 t -114.26 131.17 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 -50.05 1.02 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.88 125.77 6.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.464 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.528 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -96.77 154.71 38.28 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 0.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.528 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.73 154.96 93.38 Favored 'Cis proline' 0 C--O 1.232 0.207 0 C-N-CA 122.666 -1.806 . . . . 0.0 112.392 -0.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.781 HG21 HG22 ' A' ' 98' ' ' VAL . 61.2 m -132.78 102.11 5.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.157 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.424 HG12 ' CG ' ' A' ' 51' ' ' GLU . 74.8 mt -95.9 138.52 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.537 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 9.4 m-85 -135.87 140.29 44.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.474 ' HA ' HD12 ' A' ' 49' ' ' LEU . 14.6 t80 -114.88 130.47 56.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 17.3 m -101.91 97.63 8.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.669 0.747 . . . . 0.0 110.861 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.492 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.74 170.06 17.45 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.662 2.241 . . . . 0.0 112.37 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -86.0 142.16 28.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.5 p30 46.11 25.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.492 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.5 mtmt -126.09 39.13 4.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.461 ' O ' ' C ' ' A' ' 113' ' ' LEU . 36.4 mmtt -65.55 -61.38 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.893 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 112' ' ' LYS . 19.7 mt -33.66 -38.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.93 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 7.1 m120 -134.31 99.75 13.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.624 0.726 . . . . 0.0 110.852 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.3 Cg_endo -69.75 178.5 4.5 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.705 2.27 . . . . 0.0 112.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.67 127.01 41.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.537 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 15.6 ttpp -100.99 123.53 45.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -60.38 113.57 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -124.37 95.96 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.7 -148.82 7.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.535 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.84 136.49 14.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.484 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -83.67 45.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 110.869 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 124' ' ' LEU . 3.7 tp10 -104.83 132.05 51.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.541 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.5 tm? -35.29 -53.06 0.63 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.0 m -63.63 -45.65 89.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -46.83 -42.58 17.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.556 ' HB2' HD13 ' A' ' 70' ' ' LEU . 74.5 m-85 -64.95 -46.82 79.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 mt -53.91 -59.66 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.1 t -59.1 -37.46 77.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.438 ' CD1' HD23 ' A' ' 131' ' ' LEU . 22.3 t80 -56.67 -55.2 37.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.954 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.483 HD12 HD11 ' A' ' 74' ' ' LEU . 18.3 mt -68.67 -38.07 80.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -47.47 -44.54 25.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -93.72 -46.48 7.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.7 -62.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 131' ' ' LEU . . . -39.2 105.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.063 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.585 HG23 ' H ' ' A' ' 137' ' ' SER . 1.3 t -42.45 -56.25 3.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.101 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.585 ' H ' HG23 ' A' ' 136' ' ' THR . 1.1 t -66.3 -44.22 84.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.98 158.9 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.432 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 133.2 24.95 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.69 2.26 . . . . 0.0 112.307 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.6 t -78.62 -62.62 1.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.2 p 40.03 41.95 1.02 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.858 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.501 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -117.75 42.41 2.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.875 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 t -161.75 156.81 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.53 136.63 9.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 p -166.14 155.66 11.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.915 0.388 . . . . 0.0 110.858 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.6 m -130.15 115.33 16.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.849 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.95 119.13 0.61 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.435 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -122.8 -58.89 1.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.863 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -96.69 -57.35 2.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.837 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.96 95.02 0.5 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -89.76 106.65 18.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 110.895 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.548 ' H ' HD12 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -118.05 33.12 5.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.65 139.07 34.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.6 tpp85 -169.3 129.3 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.828 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.523 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.4 p90 -158.37 148.33 19.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.549 ' H ' HD23 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -92.62 -38.23 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.521 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -116.38 174.35 6.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 88.0 p -170.95 165.6 7.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.521 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 6.4 mm-40 -113.56 160.2 32.6 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.611 0.72 . . . . 0.0 110.906 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 145.75 57.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.697 2.264 . . . . 0.0 112.326 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 35' ' ' GLU . 20.5 mm -69.42 134.96 88.71 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.659 0.742 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.42 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 53.7 Cg_endo -69.77 137.98 36.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.71 2.273 . . . . 0.0 112.324 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.36 -32.24 62.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.8 t -128.46 106.51 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.442 ' CG ' ' HD3' ' A' ' 30' ' ' LYS . 9.7 t-20 -111.35 46.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -110.93 49.43 0.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.876 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.25 -162.34 14.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -48.25 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.677 2.251 . . . . 0.0 112.321 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 84' ' ' LYS . 22.2 t -115.88 116.05 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' HD3' ' CG ' ' A' ' 25' ' ' ASN . 7.7 mmtt -57.42 123.82 16.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.411 HG22 ' HE3' ' A' ' 84' ' ' LYS . 95.9 t -76.88 109.63 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.919 HG11 HG23 ' A' ' 41' ' ' VAL . 29.0 t -107.31 123.99 62.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.069 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 36' ' ' ASN . 28.5 m -119.07 147.11 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -32.4 -45.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.14 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.61 ' HB3' HD11 ' A' ' 21' ' ' ILE . 7.0 mt-10 -52.93 -49.78 65.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 33' ' ' VAL . 12.2 p-10 -113.25 35.86 3.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.576 ' CD2' HG21 ' A' ' 41' ' ' VAL . 21.5 t80 -74.03 -59.18 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.64 -5.21 7.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -87.97 -43.46 11.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mt -98.98 -54.07 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.123 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.919 HG23 HG11 ' A' ' 32' ' ' VAL . 57.6 t -55.08 -62.02 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.121 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -69.74 122.01 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -173.87 105.5 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -87.24 38.74 0.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -131.27 -40.83 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -129.83 151.56 50.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -75.54 127.19 32.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.84 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.17 143.24 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.422 HD22 HD11 ' A' ' 131' ' ' LEU . 38.0 tp -119.28 126.66 52.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 85' ' ' MET . 2.2 tp -113.07 135.56 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.21 118.51 26.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.907 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -93.06 128.76 39.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.44 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 6.9 p90 -136.12 174.05 11.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.18 135.02 25.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.585 0.707 . . . . 0.0 111.121 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -7.86 22.14 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.721 2.281 . . . . 0.0 112.327 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -123.67 26.49 7.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 43.4 t -125.13 106.44 9.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -46.15 -66.07 1.82 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.504 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 58' ' ' GLY . 89.8 m-70 -35.33 -45.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.3 m -63.73 -50.2 70.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.34 -37.01 54.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -71.36 -27.82 63.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.457 ' O ' ' C ' ' A' ' 64' ' ' GLU . 12.2 tp -82.47 -32.69 28.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.8 OUTLIER -33.95 -58.12 0.61 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.651 0.739 . . . . 0.0 110.931 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.1 Cg_endo -69.82 -35.47 12.39 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.719 2.279 . . . . 0.0 112.27 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -65.3 -27.85 68.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.854 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -93.79 -41.61 9.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -46.74 -57.01 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -40.5 -48.48 2.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.456 ' N ' HD21 ' A' ' 124' ' ' LEU . 14.5 tp -52.2 -39.69 60.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.88 -48.6 69.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.501 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -74.95 -21.95 58.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.95 0.405 . . . . 0.0 110.895 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -79.56 -50.6 10.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.918 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 77' ' ' ASP . 79.8 mt -77.39 -2.02 33.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' LEU . 7.8 t -37.98 -29.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 74' ' ' LEU . 37.8 mtmt -87.1 29.56 0.82 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 74' ' ' LEU . 39.9 p30 -102.79 95.3 6.16 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.585 0.707 . . . . 0.0 110.851 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 54.0 Cg_endo -69.77 -2.83 10.84 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.71 2.273 . . . . 0.0 112.309 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -120.55 -45.46 2.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.45 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 44.3 mt -87.11 145.42 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.1 t -135.18 105.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.126 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.626 HG22 HG13 ' A' ' 29' ' ' VAL . 34.9 mm -73.53 131.03 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.669 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -145.93 160.64 41.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.632 ' HB3' HG11 ' A' ' 29' ' ' VAL . 43.4 pttt -132.53 160.34 36.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.558 ' CB ' HD11 ' A' ' 50' ' ' ILE . 18.4 ttt -151.37 132.39 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -91.44 85.96 5.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -41.6 -65.74 0.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 87' ' ' ALA . 25.7 p -36.34 -35.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.521 ' HB1' ' CG ' ' A' ' 19' ' ' GLU . . . -87.24 -36.37 17.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.504 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.4 OUTLIER -129.02 112.7 14.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -41.22 155.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -103.21 125.58 34.73 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.63 0.728 . . . . 0.0 111.123 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.469 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.5 Cg_endo -69.84 -164.94 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.248 . . . . 0.0 112.313 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.496 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -122.19 161.23 44.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.596 0.713 . . . . 0.0 110.892 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.76 -11.74 11.99 Favored 'Cis proline' 0 C--O 1.232 0.182 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.352 -0.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.45 ' C ' ' O ' ' A' ' 95' ' ' PRO . 81.2 m-85 -33.05 125.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -134.04 117.04 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.874 HG22 HG21 ' A' ' 103' ' ' THR . 83.7 t -119.53 108.73 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -106.25 -41.28 5.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.09 131.32 7.19 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.418 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.524 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.5 OUTLIER -97.28 155.63 37.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.679 0.752 . . . . 0.0 110.828 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.1 Cg_endo -69.79 162.14 84.81 Favored 'Cis proline' 0 C--O 1.232 0.207 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.352 0.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.874 HG21 HG22 ' A' ' 98' ' ' VAL . 84.1 m -142.22 116.06 9.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.176 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.637 HD13 ' HE1' ' A' ' 127' ' ' PHE . 27.5 mt -110.2 140.63 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 117' ' ' LYS . 11.9 m-85 -139.36 142.74 37.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.404 ' HA ' HD12 ' A' ' 49' ' ' LEU . 29.9 t80 -111.43 143.6 42.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.7 m -114.46 93.83 33.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.686 0.755 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.494 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.5 Cg_endo -69.77 167.86 23.23 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -84.25 136.8 33.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 13.8 p30 49.98 26.8 2.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.494 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 12.8 mtmm -128.97 39.25 3.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 7.7 mmpt? -67.98 -45.59 73.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.3 mp -50.85 -38.2 47.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -134.88 88.37 27.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.605 0.717 . . . . 0.0 110.845 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -171.76 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.724 2.282 . . . . 0.0 112.295 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -137.86 118.92 14.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 105' ' ' TYR . 22.3 tttt -91.47 120.22 32.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -55.04 112.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -123.68 101.01 7.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.9 -139.65 4.32 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.452 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.37 139.71 14.71 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.47 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.428 ' CZ ' ' HG3' ' A' ' 102' ' ' PRO . 26.8 mtp180 -83.88 43.79 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.883 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 124' ' ' LEU . 3.5 tp10 -102.05 129.65 48.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.6 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.3 tm? -34.02 -55.46 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.93 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.2 t -59.43 -50.15 75.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 130' ' ' TYR . 6.0 t0 -44.05 -35.72 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.637 ' HE1' HD13 ' A' ' 104' ' ' ILE . 80.8 m-85 -73.31 -37.98 66.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.557 HD11 ' CD1' ' A' ' 124' ' ' LEU . 30.5 mt -63.03 -61.42 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.124 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.85 -34.86 73.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 126' ' ' ASP . 44.8 t80 -57.46 -48.8 78.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.422 HD11 HD22 ' A' ' 49' ' ' LEU . 68.3 mt -75.68 -34.4 60.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -43.49 -38.86 3.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.46 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.2 ptm180 -101.03 -47.05 4.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.46 ' N ' ' HG3' ' A' ' 133' ' ' ARG . 16.6 mm-40 -52.63 -57.79 8.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -48.7 110.88 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -36.36 -71.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.163 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.6 t -59.48 -57.08 14.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.887 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.96 159.97 34.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.49 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 140' ' ' SER . 53.7 Cg_endo -69.72 -24.21 30.14 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.721 2.281 . . . . 0.0 112.383 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 139' ' ' PRO . 16.4 m 34.65 41.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.7 t -112.59 -52.66 2.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.888 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.463 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 t -98.43 152.63 19.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 110.842 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -82.96 98.66 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -125.25 75.08 0.4 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 m -66.24 -60.52 2.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 110.826 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 t 52.49 42.51 31.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.58 -175.8 14.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.462 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 59.45 43.43 16.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.867 0.365 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -126.11 128.0 46.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.83 158.34 3.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.507 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.821 ' O ' HD12 ' A' ' 12' ' ' LEU . 11.0 t-20 -108.81 24.18 13.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 110.867 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 11' ' ' ASN . 0.4 OUTLIER 37.35 50.81 1.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.28 71.05 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.878 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -123.97 124.08 41.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 1.3 p90 -159.22 164.69 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.527 ' H ' HD23 ' A' ' 16' ' ' LEU . 1.6 pt? -109.04 -38.62 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.52 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 30.3 tttt -112.61 149.54 32.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.607 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 52.7 p -161.72 146.5 13.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -94.3 158.8 35.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.707 0.765 . . . . 0.0 110.835 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 150.29 68.1 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.644 2.229 . . . . 0.0 112.357 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.489 HD13 ' CG2' ' A' ' 33' ' ' VAL . 39.2 mm -79.74 132.36 61.44 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.625 0.726 . . . . 0.0 111.132 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' HG23 ' A' ' 21' ' ' ILE . 53.4 Cg_endo -69.76 173.34 11.12 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -97.31 -34.41 11.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p -141.99 135.79 29.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -132.23 38.76 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -78.43 57.73 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.83 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.98 -170.73 13.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.494 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -40.41 5.42 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.715 2.276 . . . . 0.0 112.374 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.462 HG13 HG22 ' A' ' 82' ' ' ILE . 23.5 t -120.63 117.11 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -64.22 143.08 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.893 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.48 HG22 ' HE3' ' A' ' 84' ' ' LYS . 73.2 t -91.44 119.6 38.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.997 HG11 HG23 ' A' ' 41' ' ' VAL . 21.2 t -116.55 126.5 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 35' ' ' GLU . 29.1 m -122.34 156.9 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.154 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.607 ' HB3' ' CB ' ' A' ' 18' ' ' SER . . . -48.47 -20.05 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.537 ' HB2' HG23 ' A' ' 33' ' ' VAL . 5.1 mt-10 -76.54 -34.21 58.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -129.12 33.72 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.668 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 7.6 t80 -69.35 -52.96 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.84 -6.76 28.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -89.52 -43.45 10.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.4 mt -98.4 -61.89 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.997 HG23 HG11 ' A' ' 32' ' ' VAL . 60.5 t -47.9 -61.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.151 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.46 135.08 52.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -173.62 106.36 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.941 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -85.71 14.66 5.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -111.02 -41.94 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -137.18 164.11 29.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 63.7 m-20 -80.31 154.23 27.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.2 t -145.2 147.74 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.5 tp -119.09 129.74 55.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.917 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 85' ' ' MET . 1.8 tp -119.95 133.4 66.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.468 ' CG ' HG12 ' A' ' 104' ' ' ILE . 4.9 tm-20 -126.82 116.38 20.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -90.11 140.08 30.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.45 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 5.9 p90 -143.98 176.08 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -128.61 133.43 25.17 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.612 0.72 . . . . 0.0 111.072 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -8.28 23.21 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.748 2.298 . . . . 0.0 112.349 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.434 ' CZ2' HG21 ' A' ' 88' ' ' THR . 5.0 p-90 -118.32 21.73 12.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 2.5 t -123.34 110.51 15.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -49.27 -47.83 33.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.482 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 58' ' ' GLY . 12.9 m170 -34.74 -45.89 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 110.839 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.1 t -70.91 -50.93 29.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.936 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -47.32 -34.08 6.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.852 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -86.77 -29.17 22.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.837 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.965 HD12 ' HB2' ' A' ' 66' ' ' LYS . 63.2 tp -83.13 -14.36 53.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.522 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.9 tt0 -46.08 -58.28 6.67 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.641 0.734 . . . . 0.0 110.943 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.1 Cg_endo -69.73 -17.53 37.64 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.644 2.229 . . . . 0.0 112.387 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.965 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.1 mmmp? -84.74 -30.17 24.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -93.67 -41.32 9.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -46.58 -56.63 5.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 70' ' ' LEU . 15.6 mt-10 -42.02 -62.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.478 ' CD1' HG12 ' A' ' 128' ' ' ILE . 22.3 tp -37.16 -35.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.51 -57.06 19.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.504 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -75.38 -19.93 59.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.718 ' HD3' HD11 ' A' ' 124' ' ' LEU . 4.1 mtpm? -73.95 -45.07 52.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.662 HD21 HG23 ' A' ' 128' ' ' ILE . 90.0 mt -86.86 -2.4 58.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.3 t -39.63 -26.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 74' ' ' LEU . 9.3 ttpp -82.86 22.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 74' ' ' LEU . 42.2 p30 -102.93 95.51 6.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.628 0.728 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.6 Cg_endo -69.76 -0.83 7.47 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.656 2.238 . . . . 0.0 112.372 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.31 -44.45 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.482 HD11 ' CB ' ' A' ' 135' ' ' ALA . 15.7 mt -88.22 143.76 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.155 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.0 t -133.28 115.41 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.137 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.526 HD11 HD12 ' A' ' 74' ' ' LEU . 30.8 mm -81.96 130.37 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.633 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -148.73 171.87 15.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.075 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.48 ' HE3' HG22 ' A' ' 31' ' ' VAL . 2.8 pttp -135.42 163.07 30.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.923 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.629 ' HB2' HD11 ' A' ' 50' ' ' ILE . 15.8 ttt -151.13 136.76 17.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -96.33 82.37 3.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -45.58 -58.35 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.434 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 22.8 p -46.77 -22.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.35 -18.47 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -144.74 108.44 4.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 90' ' ' ASN . 27.9 t70 -37.07 151.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -97.04 128.13 36.42 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.612 0.72 . . . . 0.0 111.12 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -173.34 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.6 m -118.7 160.54 39.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.658 0.742 . . . . 0.0 110.876 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.1 Cg_endo -69.69 -8.97 10.66 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.353 -0.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 95' ' ' PRO . 81.3 m-85 -35.13 143.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -151.59 129.23 11.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.586 HG13 ' OG1' ' A' ' 103' ' ' THR . 45.4 t -132.89 117.98 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.6 -36.92 3.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.23 121.55 4.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.538 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.28 154.16 38.17 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.66 0.743 . . . . 0.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.538 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.4 Cg_endo -69.69 160.03 88.47 Favored 'Cis proline' 0 C--O 1.231 0.143 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.382 -0.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.586 ' OG1' HG13 ' A' ' 98' ' ' VAL . 34.2 m -137.48 113.81 10.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.468 HG12 ' CG ' ' A' ' 51' ' ' GLU . 16.8 mt -105.9 138.24 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.109 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.52 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 10.8 m-85 -132.88 173.03 11.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.961 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -142.97 127.35 17.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 t -100.51 99.64 10.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.639 0.733 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.76 178.84 4.16 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.701 2.268 . . . . 0.0 112.361 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.481 ' N ' ' OD1' ' A' ' 47' ' ' ASP . . . -92.93 131.05 38.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 11.4 p30 51.0 29.07 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.933 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.466 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.3 mtmm -128.05 23.0 6.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -50.72 -56.37 12.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.0 mt -39.78 -37.13 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -134.86 90.22 22.91 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.635 0.731 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -172.34 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.664 2.243 . . . . 0.0 112.358 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -139.34 128.16 23.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.52 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 4.8 ttpm? -94.44 124.24 38.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.534 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 67.8 t80 -55.75 105.14 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -115.9 100.89 8.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.6 -152.38 17.58 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.497 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.01 131.69 11.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.519 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.421 ' HB2' ' NH1' ' A' ' 122' ' ' ARG . 19.8 mtm105 -83.88 49.0 1.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.905 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 124' ' ' LEU . 13.0 tt0 -107.78 134.32 50.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.718 HD11 ' HD3' ' A' ' 73' ' ' LYS . 3.5 tm? -34.81 -52.69 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.8 m -67.73 -47.7 68.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -47.37 -36.16 9.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.534 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 58.6 m-85 -69.24 -42.65 75.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.914 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.662 HG23 HD21 ' A' ' 74' ' ' LEU . 23.1 mt -63.52 -53.34 46.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -63.57 -21.98 66.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.808 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.405 ' CD1' ' C ' ' A' ' 130' ' ' TYR . 6.1 t80 -72.22 -46.86 54.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.1 mt -76.56 -39.0 54.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -40.05 -42.49 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -97.13 -58.73 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -46.23 -56.36 5.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.482 ' CB ' HD11 ' A' ' 80' ' ' ILE . . . -45.29 120.56 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.48 -70.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.1 t -58.01 -44.16 87.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.89 160.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.475 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 167.38 24.56 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.647 2.231 . . . . 0.0 112.374 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 t -109.5 101.62 10.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -159.45 168.0 27.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.467 -179.971 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t 60.36 41.7 15.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 110.876 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.9 t -145.91 153.79 41.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.838 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 45.72 -105.77 0.1 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.477 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.0 m 49.9 42.29 24.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 110.829 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 t -112.88 119.2 37.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.888 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.01 117.81 0.78 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.486 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -139.72 110.58 6.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.873 0.368 . . . . 0.0 110.854 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.77 90.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.04 -107.98 1.12 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.436 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -101.63 78.33 1.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 0.0 110.893 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.48 37.08 2.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.927 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.92 144.93 3.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.41 128.79 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.835 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 2.4 p90 -147.7 172.19 14.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' A' ' 17' ' ' LYS . 4.0 pp -114.2 -36.14 4.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.525 ' HB3' HD12 ' A' ' 16' ' ' LEU . 10.1 ptmt -119.89 165.64 14.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.441 ' CB ' ' HG3' ' A' ' 35' ' ' GLU . 2.3 m -158.22 161.04 37.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.842 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 4.2 mm-40 -105.88 160.94 24.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.647 0.737 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 54.0 Cg_endo -69.78 137.66 35.94 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.361 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.714 HD13 HG21 ' A' ' 33' ' ' VAL . 19.6 mm -71.41 129.46 88.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.606 0.717 . . . . 0.0 111.155 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 128.36 15.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.659 2.239 . . . . 0.0 112.335 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -40.37 -41.23 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -162.66 138.57 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -107.98 74.49 0.95 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -92.03 50.25 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.23 -178.13 15.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.467 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -39.99 5.9 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.662 2.241 . . . . 0.0 112.375 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.431 HG13 HG22 ' A' ' 82' ' ' ILE . 22.9 t -109.09 119.77 59.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.64 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 5.6 mmtp -66.96 128.47 36.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -82.86 117.56 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.102 HG11 HG23 ' A' ' 41' ' ' VAL . 21.8 t -112.93 124.3 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.714 HG21 HD13 ' A' ' 21' ' ' ILE . 19.1 m -117.89 147.25 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.094 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -36.91 -40.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HB3' HD11 ' A' ' 21' ' ' ILE . 11.1 mt-10 -57.6 -49.02 77.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.466 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 17.7 p-10 -110.49 24.75 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.884 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.741 ' CD2' HG21 ' A' ' 41' ' ' VAL . 31.0 t80 -63.34 -55.51 23.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -67.14 -5.14 12.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -88.79 -45.61 9.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.5 mt -97.56 -59.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.121 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.102 HG23 HG11 ' A' ' 32' ' ' VAL . 38.7 t -49.16 -59.4 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.33 122.96 19.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -167.34 114.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.11 3.51 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.38 -40.92 6.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.24 140.79 48.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.73 149.21 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.09 137.64 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.147 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 106' ' ' PHE . 13.2 tp -110.34 125.64 53.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 tp -113.48 131.15 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' CG ' HG12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -125.58 109.53 12.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -84.84 128.97 34.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -128.79 179.9 5.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.24 128.55 17.44 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 0.0 111.136 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -6.75 19.36 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 4.1 p-90 -119.12 18.95 13.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.931 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 38.1 t -119.14 124.62 47.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.84 -61.73 7.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.514 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -42.8 -38.84 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.818 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.3 m -67.95 -44.26 77.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -64.76 -32.77 74.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -76.37 -21.7 55.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.767 HD12 ' HB2' ' A' ' 66' ' ' LYS . 18.4 tp -90.55 -18.63 24.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -41.19 -58.24 2.97 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.707 0.765 . . . . 0.0 110.943 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.73 -32.22 19.1 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.747 2.298 . . . . 0.0 112.331 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.767 ' HB2' HD12 ' A' ' 63' ' ' LEU . 26.6 mtpt -68.69 -28.58 66.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -92.9 -38.65 11.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -47.42 -61.11 2.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -40.44 -55.13 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.405 ' N ' HD21 ' A' ' 124' ' ' LEU . 30.8 tp -41.25 -39.21 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.54 -64.94 3.56 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.477 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.18 -16.13 50.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -81.0 -44.89 17.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.903 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.631 HD12 HD11 ' A' ' 82' ' ' ILE . 95.3 mt -83.75 3.06 35.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.2 t -54.7 -19.02 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.02 10.48 16.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 53.1 m-20 -110.61 98.63 38.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.552 0.692 . . . . 0.0 110.859 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.2 Cg_endo -69.84 0.18 6.08 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.704 2.269 . . . . 0.0 112.309 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -110.69 -30.87 7.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 55.1 mt -105.65 139.01 28.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.99 110.38 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.631 HD11 HD12 ' A' ' 74' ' ' LEU . 42.0 mm -79.11 134.7 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.687 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -146.81 173.75 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -143.52 143.01 31.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.4 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 5.8 ttt -132.89 139.26 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -93.45 82.84 4.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -44.54 -57.45 3.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 88' ' ' THR . 1.6 p -39.36 -27.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.195 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 87' ' ' ALA . . . -102.25 -29.79 11.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.109 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -120.51 120.38 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -55.66 116.83 3.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.922 HG11 HG23 ' A' ' 98' ' ' VAL . 90.9 t -68.72 111.7 9.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.588 0.709 . . . . 0.0 111.112 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.7 Cg_endo -69.82 -178.18 2.24 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.707 2.271 . . . . 0.0 112.351 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.507 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -97.57 159.37 31.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.855 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.509 ' O ' ' C ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.71 -27.29 6.88 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.734 -1.778 . . . . 0.0 112.353 -0.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.509 ' C ' ' O ' ' A' ' 95' ' ' PRO . 82.1 m-85 -28.51 111.16 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -117.5 84.07 2.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.922 HG23 HG11 ' A' ' 92' ' ' VAL . 99.2 t -77.21 106.69 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -129.65 25.81 5.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.52 115.57 0.37 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.503 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.546 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -98.74 154.2 37.54 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.644 0.735 . . . . 0.0 110.903 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.7 Cg_endo -69.64 151.34 91.03 Favored 'Cis proline' 0 C--O 1.232 0.208 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.392 -0.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -129.04 123.14 31.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.132 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.403 HG12 ' CG ' ' A' ' 51' ' ' GLU . 44.1 mt -119.3 126.65 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.464 ' CZ ' ' HE3' ' A' ' 117' ' ' LYS . 8.1 m-85 -126.78 154.54 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.414 ' HA ' HD12 ' A' ' 49' ' ' LEU . 8.6 t80 -125.83 129.76 50.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.865 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.9 t -101.88 97.59 8.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.694 0.759 . . . . 0.0 110.861 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.498 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.79 171.15 15.03 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.664 2.243 . . . . 0.0 112.335 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.495 ' O ' ' ND2' ' A' ' 110' ' ' ASN . . . -85.11 133.4 34.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER 49.65 29.5 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.498 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 10.5 mtmm -130.93 6.69 4.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.94 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' N ' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -35.92 -53.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.0 mt -39.06 -52.27 1.84 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 5.5 t30 -120.92 94.93 49.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.625 0.726 . . . . 0.0 110.906 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.7 Cg_endo -69.76 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.729 2.286 . . . . 0.0 112.332 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -142.03 110.5 6.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.464 ' HE3' ' CZ ' ' A' ' 105' ' ' TYR . 31.5 tttt -71.53 144.29 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.903 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.437 ' CZ ' ' CE1' ' A' ' 127' ' ' PHE . 35.4 t80 -90.48 106.82 18.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.9 100.75 7.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.894 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.19 -140.15 3.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.52 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.59 130.03 10.14 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.492 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -79.25 45.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 110.893 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 124' ' ' LEU . 18.2 tt0 -101.43 134.17 44.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.442 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -36.28 -51.8 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.7 m -68.02 -45.99 72.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.38 -33.87 4.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.437 ' CE1' ' CZ ' ' A' ' 118' ' ' TYR . 54.0 m-85 -74.64 -42.01 59.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.3 mt -58.26 -53.01 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 t -65.27 -30.89 71.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.77 -47.83 84.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.6 mt -74.29 -42.52 59.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -39.54 -32.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -101.73 -60.68 1.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -47.98 -53.96 14.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.49 122.65 5.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -74.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.084 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.5 t -61.4 -54.91 37.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.01 -172.25 49.42 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.51 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -20.33 35.19 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.675 2.25 . . . . 0.0 112.367 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.3 t -47.87 96.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.7 m -98.9 164.84 12.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.852 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.478 -179.978 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.5 p -160.15 125.3 3.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.4 . . . . 0.0 110.841 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.6 m -151.79 153.33 34.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.815 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.03 81.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.7 p -134.71 110.39 9.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.893 0.377 . . . . 0.0 110.844 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 t -174.25 135.54 0.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.831 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 174.96 47.49 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -75.06 120.04 20.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 110.842 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -143.79 137.23 27.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.39 154.31 11.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.446 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -58.95 90.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.424 HD11 HD23 ' A' ' 113' ' ' LEU . 4.5 mt -71.41 92.99 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.916 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.56 129.97 7.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -174.28 122.07 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.591 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.8 p90 -151.64 150.53 30.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 pp -95.81 -36.03 11.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 18' ' ' SER . 25.9 tttp -118.04 157.45 26.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.462 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 58.2 p -159.57 158.02 30.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 9.1 mm-40 -107.99 160.79 25.59 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.641 0.734 . . . . 0.0 110.848 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.71 139.94 41.66 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.656 2.237 . . . . 0.0 112.346 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.574 HD13 HG21 ' A' ' 33' ' ' VAL . 19.2 mm -69.5 129.78 91.24 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.634 0.73 . . . . 0.0 111.126 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 132.34 23.15 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.675 2.25 . . . . 0.0 112.335 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 24' ' ' SER . 8.6 pt-20 -44.89 -42.71 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.441 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 3.3 m -159.44 137.75 10.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.825 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -111.32 80.65 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -101.94 55.35 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.32 -172.94 13.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.472 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -41.67 4.03 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.653 2.235 . . . . 0.0 112.297 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 82' ' ' ILE . 7.4 t -114.8 122.62 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.164 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.43 ' HZ2' HD13 ' A' ' 40' ' ' ILE . 1.8 mmmp? -68.26 130.33 42.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.3 t -81.11 110.36 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.103 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.055 HG11 HG23 ' A' ' 41' ' ' VAL . 39.2 t -105.16 114.97 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.574 HG21 HD13 ' A' ' 21' ' ' ILE . 35.9 m -108.86 146.35 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.591 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.54 -47.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.453 ' HB3' HD11 ' A' ' 21' ' ' ILE . 1.9 mm-40 -51.55 -48.79 62.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' VAL . 16.9 p-10 -110.38 28.15 8.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.49 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 8.9 t80 -73.33 -44.16 59.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -75.15 -4.57 39.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.53 -39.09 10.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.53 HD12 HG22 ' A' ' 32' ' ' VAL . 4.6 mt -98.91 -63.49 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.055 HG23 HG11 ' A' ' 32' ' ' VAL . 93.4 t -53.47 -60.81 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.109 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 24.8 m-20 -63.99 118.75 8.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 42' ' ' ASN . 38.7 m-20 -175.1 114.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.26 31.69 2.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -125.33 -38.05 2.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -127.88 161.13 29.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -80.94 137.92 36.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -144.51 136.9 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.0 tp -116.39 136.32 53.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.401 HD13 ' CG2' ' A' ' 41' ' ' VAL . 3.0 tp -116.45 137.14 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.534 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -127.25 110.97 13.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 103' ' ' THR . 69.8 m-85 -87.53 138.64 31.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 4.9 p90 -143.85 175.31 10.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.933 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.94 134.35 26.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.55 0.69 . . . . 0.0 111.107 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -16.36 37.48 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.689 2.259 . . . . 0.0 112.352 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -113.49 25.99 10.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.7 t -123.08 134.27 54.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.78 -59.77 8.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.475 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -38.26 -35.7 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.297 . . . . 0.0 110.832 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -52.59 61.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -57.19 -36.61 71.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -77.53 -35.85 52.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 66' ' ' LYS . 27.8 tp -81.12 -19.45 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.6 tt0 -46.98 -58.39 7.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.668 0.747 . . . . 0.0 110.886 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.8 -28.03 25.58 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.654 2.236 . . . . 0.0 112.37 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HB2' HD12 ' A' ' 63' ' ' LEU . 24.1 mtpp -72.85 -27.36 61.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.534 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 41.5 t80 -96.32 -46.07 6.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -41.81 -59.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 70' ' ' LEU . 25.5 mt-10 -39.48 -63.47 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.432 ' N ' HD21 ' A' ' 124' ' ' LEU . 15.7 tp -37.25 -34.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.5 -51.4 42.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.516 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.4 -18.32 57.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.503 ' HD3' HD11 ' A' ' 124' ' ' LEU . 6.3 mtpm? -76.86 -53.74 7.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' ASP . 98.0 mt -79.41 1.78 24.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.1 t -43.06 -23.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 74' ' ' LEU . 16.4 mtpt -89.89 23.74 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.911 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' LEU . 50.1 p-10 -101.36 98.06 8.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.595 0.712 . . . . 0.0 110.845 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.9 Cg_endo -69.77 1.04 4.8 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.683 2.255 . . . . 0.0 112.355 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -123.42 -43.29 2.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.456 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 62.1 mt -87.25 144.48 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.5 t -134.95 97.8 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.444 HG22 HG13 ' A' ' 29' ' ' VAL . 30.5 mm -70.55 122.2 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.703 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -138.09 171.28 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.051 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.421 ' HB3' HG11 ' A' ' 29' ' ' VAL . 41.5 pttt -140.82 159.01 43.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.4 ttt -150.76 135.45 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 87' ' ' ALA . 30.9 t0 -89.51 80.89 6.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -35.91 -62.94 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 88' ' ' THR . 19.9 p -37.87 -39.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.44 -28.81 20.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 87' ' ' ALA . 14.3 m-80 -124.38 110.39 14.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -49.11 130.24 18.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.481 HG11 HG23 ' A' ' 98' ' ' VAL . 65.2 t -76.97 118.81 74.37 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.626 0.727 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -164.57 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 2.252 . . . . 0.0 112.34 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -121.06 161.14 42.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.626 0.726 . . . . 0.0 110.887 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.7 Cg_endo -69.77 -12.91 12.34 Favored 'Cis proline' 0 C--N 1.341 0.176 0 C-N-CA 122.681 -1.799 . . . . 0.0 112.359 -0.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 95' ' ' PRO . 88.2 m-85 -33.86 136.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -141.29 119.23 11.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.572 HG22 HG21 ' A' ' 103' ' ' THR . 99.1 t -122.98 80.77 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.106 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -66.13 -45.43 81.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.67 -171.73 13.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.462 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.513 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -147.97 157.82 42.89 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.628 0.728 . . . . 0.0 110.861 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.8 166.99 72.73 Favored 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.68 -1.8 . . . . 0.0 112.323 0.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.572 HG21 HG22 ' A' ' 98' ' ' VAL . 88.1 m -146.2 131.18 18.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.452 HD13 ' CE1' ' A' ' 127' ' ' PHE . 20.6 mt -124.92 129.43 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.092 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -125.49 159.34 32.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.533 ' HB3' ' CG ' ' A' ' 116' ' ' LYS . 21.2 t80 -119.89 151.19 39.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 m -121.64 87.63 46.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.673 0.749 . . . . 0.0 110.837 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.502 ' O ' ' CE ' ' A' ' 112' ' ' LYS . 54.0 Cg_endo -69.79 168.23 22.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.671 2.247 . . . . 0.0 112.332 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.478 ' C ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.16 139.03 32.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.478 ' CG ' ' C ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER 49.84 25.02 1.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.486 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 19.1 mtmt -128.0 18.23 6.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' CE ' ' O ' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -46.44 -34.07 4.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.424 HD23 HD11 ' A' ' 12' ' ' LEU . 2.9 mt -82.76 -24.88 33.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 111' ' ' LYS . 10.9 m120 -119.43 63.02 7.09 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.616 0.722 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -164.72 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.657 2.238 . . . . 0.0 112.363 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.533 ' CG ' ' HB3' ' A' ' 106' ' ' PHE . 0.8 OUTLIER -160.63 155.55 24.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.9 ttpp -117.72 126.75 53.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.41 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 60.1 t80 -54.97 101.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -115.2 94.65 4.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.73 -141.64 4.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.504 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.78 134.8 12.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.502 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.451 ' HB2' ' NH1' ' A' ' 122' ' ' ARG . 10.3 mtp-105 -84.37 49.74 1.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.876 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 124' ' ' LEU . 26.9 tt0 -109.66 133.85 52.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.503 HD11 ' HD3' ' A' ' 73' ' ' LYS . 3.3 tm? -36.28 -53.85 0.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.5 p -65.16 -42.7 93.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.09 -27.93 36.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.452 ' CE1' HD13 ' A' ' 104' ' ' ILE . 58.0 m-85 -78.8 -47.32 16.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.7 mt -53.19 -50.73 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.12 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.0 p -60.67 -55.32 34.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.828 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -44.44 -45.09 8.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 135' ' ' ALA . 18.9 mt -76.51 -37.55 56.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.432 ' CD ' ' HG2' ' A' ' 139' ' ' PRO . 17.9 mm-40 -48.18 -45.89 34.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.445 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 12.9 ptm180 -86.45 -40.04 15.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.462 ' OE1' ' CD ' ' A' ' 116' ' ' LYS . 46.7 mm-40 -68.89 -65.02 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 131' ' ' LEU . . . -34.18 131.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -66.72 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.158 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.8 t -66.16 -43.88 85.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.07 135.55 0.43 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.451 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.432 ' HG2' ' CD ' ' A' ' 132' ' ' GLN . 53.1 Cg_endo -69.83 88.85 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.649 2.233 . . . . 0.0 112.32 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.5 m -158.19 118.43 3.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 55.6 m -146.45 166.95 24.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.85 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.486 -179.993 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.8 p -116.46 154.54 30.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.858 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 t -160.85 123.35 3.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.03 94.53 1.01 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.512 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -106.71 87.28 2.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.835 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -124.85 128.05 48.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.1 146.7 18.1 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 0.4 OUTLIER -123.34 81.7 1.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 110.892 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 8' ' ' PHE . 13.9 m-20 -166.7 167.05 15.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.16 126.65 2.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -123.57 111.14 15.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 0.0 110.874 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -97.06 18.45 14.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.925 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 144.96 48.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -170.36 121.77 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.407 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.2 p90 -154.1 156.22 36.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.1 pp -98.31 -43.87 6.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.567 ' N ' HD12 ' A' ' 16' ' ' LEU . 7.4 ttpm? -110.71 166.38 11.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.488 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 98.1 p -170.78 152.0 3.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.441 ' CG ' HD22 ' A' ' 90' ' ' ASN . 5.6 mm-40 -96.23 158.45 33.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.623 0.725 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 145.75 58.04 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.676 2.251 . . . . 0.0 112.365 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 35' ' ' GLU . 29.6 mm -73.13 133.45 81.42 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.739 . . . . 0.0 111.108 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' A' ' 21' ' ' ILE . 54.2 Cg_endo -69.77 174.11 9.99 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.361 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -97.23 -36.04 10.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -145.0 137.73 26.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -130.2 37.23 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.51 60.44 2.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.69 -168.43 12.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -41.14 4.54 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 0.0 112.332 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG13 HG22 ' A' ' 82' ' ' ILE . 30.7 t -119.13 122.14 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.59 131.13 42.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.0 t -78.77 135.14 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.983 HG11 HG23 ' A' ' 41' ' ' VAL . 38.8 t -132.15 120.03 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 36' ' ' ASN . 20.3 m -116.97 147.58 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.476 ' HB3' ' CB ' ' A' ' 18' ' ' SER . . . -34.3 -44.11 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 33' ' ' VAL . 15.6 mt-10 -53.77 -46.47 70.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 33' ' ' VAL . 18.1 p-10 -116.32 30.6 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.592 ' CZ ' ' HG3' ' A' ' 93' ' ' PRO . 5.2 t80 -69.98 -54.73 11.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.43 -5.69 20.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -90.6 -41.6 11.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.893 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.4 mt -97.5 -58.16 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.983 HG23 HG11 ' A' ' 32' ' ' VAL . 24.0 t -54.56 -60.1 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.09 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 34.3 m-20 -67.45 123.08 19.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.839 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 28.9 m-20 -171.89 108.5 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -83.43 0.42 46.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -85.68 -45.8 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -138.36 162.86 33.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.67 150.38 36.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.98 140.99 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.502 HD23 HD12 ' A' ' 82' ' ' ILE . 29.9 tp -112.95 126.07 55.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 85' ' ' MET . 1.9 tp -113.45 135.33 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.105 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' C ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -126.03 117.95 24.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.54 ' CG ' HG21 ' A' ' 98' ' ' VAL . 60.1 m-85 -91.59 120.44 32.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.564 ' CE1' ' OD2' ' A' ' 86' ' ' ASP . 28.6 p90 -128.47 178.84 6.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -135.24 132.44 20.07 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.564 0.697 . . . . 0.0 111.094 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.539 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.3 Cg_endo -69.79 -2.49 10.29 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.487 ' CZ3' ' SG ' ' A' ' 57' ' ' CYS . 7.3 p-90 -122.04 6.73 9.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -96.23 137.34 35.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.98 -58.17 4.51 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -50.5 -39.19 47.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.324 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.6 m -64.06 -38.95 92.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -64.12 -45.91 86.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -68.34 -14.56 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.835 HD12 ' HB2' ' A' ' 66' ' ' LYS . 14.2 tp -96.33 -24.76 16.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.535 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -37.62 -57.93 1.42 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.595 0.712 . . . . 0.0 110.875 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.4 Cg_endo -69.76 -27.74 26.11 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.686 2.257 . . . . 0.0 112.359 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.835 ' HB2' HD12 ' A' ' 63' ' ' LEU . 4.5 mtpm? -71.58 -32.5 68.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -88.69 -40.26 13.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -44.48 -59.33 2.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -38.78 -56.21 1.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.407 ' N ' HD21 ' A' ' 124' ' ' LEU . 28.0 tp -43.79 -39.89 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.07 -63.25 5.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.438 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.34 -26.28 67.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.875 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -72.12 -44.14 63.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.663 HD12 HD11 ' A' ' 82' ' ' ILE . 82.2 mt -89.55 3.19 53.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.1 t -52.09 -20.63 2.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -98.87 22.71 9.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 1.2 m-20 -103.29 99.28 14.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.61 0.719 . . . . 0.0 110.865 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.1 Cg_endo -69.75 -3.25 11.62 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.726 2.284 . . . . 0.0 112.334 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.19 -19.09 9.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.2 mt -123.29 134.44 66.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.2 t -130.2 103.98 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.663 HD11 HD12 ' A' ' 74' ' ' LEU . 51.4 mm -69.61 132.36 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.146 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.541 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -146.63 167.75 22.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 pttt -139.92 156.36 46.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.553 ' HB3' HD11 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -149.18 132.91 16.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.564 ' OD2' ' CE1' ' A' ' 53' ' ' TYR . 1.2 m-20 -86.67 101.39 13.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -58.14 -64.96 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.539 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -45.35 -21.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -92.58 -29.74 16.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -142.79 130.37 21.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -47.04 150.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.534 HG13 ' HD2' ' A' ' 93' ' ' PRO . 89.7 t -96.49 135.49 22.37 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.648 0.737 . . . . 0.0 111.088 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.592 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.5 Cg_endo -69.79 -163.55 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.683 2.255 . . . . 0.0 112.339 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.539 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -132.68 153.87 81.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.704 0.764 . . . . 0.0 110.839 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.85 -7.42 10.12 Favored 'Cis proline' 0 C--N 1.342 0.196 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.304 0.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.475 ' C ' ' O ' ' A' ' 95' ' ' PRO . 51.8 m-85 -31.7 131.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -142.77 126.74 17.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.54 HG21 ' CG ' ' A' ' 52' ' ' PHE . 81.8 t -133.83 115.59 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -123.0 -41.85 2.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.29 118.09 4.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.539 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -96.23 155.19 38.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.661 0.743 . . . . 0.0 110.905 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.5 Cg_endo -69.77 161.11 86.88 Favored 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.318 -0.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.506 HG21 HG22 ' A' ' 98' ' ' VAL . 57.9 m -141.71 115.04 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.508 HD13 ' CE1' ' A' ' 127' ' ' PHE . 68.3 mt -108.52 138.8 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.143 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.437 ' O ' HD12 ' A' ' 49' ' ' LEU . 10.5 m-85 -133.92 178.03 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.952 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -149.32 126.51 11.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -101.62 100.08 13.28 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.664 0.745 . . . . 0.0 110.833 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.496 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.75 171.04 15.18 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.609 2.206 . . . . 0.0 112.388 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.456 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -85.67 139.49 31.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.084 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.7 p30 46.85 25.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.496 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.2 mtmm -127.27 22.44 6.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 113' ' ' LEU . 7.7 mmpt? -45.86 -66.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 112' ' ' LYS . 6.9 mp -34.02 -44.43 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.942 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -122.44 90.14 49.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.593 0.711 . . . . 0.0 110.92 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -163.75 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.632 2.221 . . . . 0.0 112.31 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -141.7 131.31 24.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -100.04 134.13 43.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.85 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.453 ' HB3' HG22 ' A' ' 104' ' ' ILE . 60.3 t80 -79.24 111.84 15.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -124.15 98.3 5.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 179.57 -146.27 6.98 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.99 134.33 12.38 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.489 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -81.29 45.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.888 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 124' ' ' LEU . 9.0 tt0 -103.12 134.48 46.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.483 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -36.84 -54.92 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 60.4 p -60.84 -48.93 79.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -47.8 -34.97 9.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.508 ' CE1' HD13 ' A' ' 104' ' ' ILE . 33.1 m-85 -70.61 -37.31 73.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.4 mt -69.05 -57.55 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.113 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.6 t -60.29 -24.7 65.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -70.82 -48.57 53.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.935 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 25.8 mt -71.22 -38.18 72.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -40.24 -42.95 1.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -94.78 -67.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -40.53 -54.42 2.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 131' ' ' LEU . . . -44.57 100.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.069 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.3 t -44.2 -24.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 138' ' ' GLY . 1.2 t -116.33 48.46 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 137' ' ' SER . . . -36.36 145.05 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.497 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 88.29 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.695 2.264 . . . . 0.0 112.333 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.3 t -99.23 123.79 43.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.5 m -42.39 100.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.488 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 m -148.71 145.48 27.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.904 0.383 . . . . 0.0 110.879 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 p -166.92 174.79 8.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.18 134.31 6.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.6 p -128.24 154.96 45.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 110.858 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.2 m -116.71 -43.53 2.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.87 172.19 21.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.451 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -107.84 118.16 36.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.898 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -62.34 -65.15 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.9 168.91 4.52 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.474 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -94.61 110.91 22.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 110.896 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.483 ' H ' HD12 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -83.56 166.47 18.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.92 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.413 ' C ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -169.08 146.1 3.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -175.13 124.16 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.691 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.2 p90 -166.59 154.2 9.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 16' ' ' LEU . 1.9 pp -104.21 -37.04 7.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.934 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HE3' ' C ' ' A' ' 89' ' ' ALA . 17.0 ttpt -109.86 158.2 18.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.9 p -164.22 149.1 10.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -98.86 160.7 27.15 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.656 0.741 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 143.57 51.32 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.648 2.232 . . . . 0.0 112.333 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.602 HD13 HG21 ' A' ' 33' ' ' VAL . 20.9 mm -68.87 129.15 92.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.633 0.73 . . . . 0.0 111.154 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 136.15 32.41 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.667 2.245 . . . . 0.0 112.355 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 24' ' ' SER . 12.0 pt-20 -49.05 -50.24 37.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.874 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.407 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 11.6 t -149.53 137.28 20.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -111.43 50.31 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.55 -25.05 59.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.84 169.94 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.436 ' HG3' ' CG ' ' A' ' 68' ' ' LYS . 53.5 Cg_endo -69.79 -29.67 23.37 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.686 2.258 . . . . 0.0 112.332 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.5 t -111.73 121.0 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.42 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 9.0 mmtm -71.12 134.93 47.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.1 t -86.35 104.75 14.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.147 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.916 HG11 HG23 ' A' ' 41' ' ' VAL . 44.9 t -95.91 114.11 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.171 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.602 HG21 HD13 ' A' ' 21' ' ' ILE . 26.3 m -109.53 144.74 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.691 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -33.86 -43.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -56.09 -50.82 69.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.452 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 28.5 p30 -105.41 21.58 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CD2' HG21 ' A' ' 41' ' ' VAL . 14.4 t80 -62.8 -58.78 6.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.02 -6.97 7.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.858 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.97 -44.13 11.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.409 HD12 HG22 ' A' ' 32' ' ' VAL . 23.5 mt -97.21 -58.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.916 HG23 HG11 ' A' ' 32' ' ' VAL . 42.7 t -51.86 -61.55 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -69.06 114.61 7.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -167.08 106.72 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -91.11 31.88 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -126.4 -37.82 2.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.826 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.81 145.55 48.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.3 147.26 53.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.9 t -145.26 147.84 18.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.131 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.548 HD23 HD12 ' A' ' 82' ' ' ILE . 21.8 tp -124.57 126.9 46.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.945 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 41' ' ' VAL . 3.2 tp -107.72 139.51 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.083 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -127.28 105.13 8.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -84.78 115.33 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -125.6 179.69 5.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -131.66 132.91 23.67 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.569 0.7 . . . . 0.0 111.12 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.497 ' HD2' HG21 ' A' ' 88' ' ' THR . 53.7 Cg_endo -69.72 -1.65 8.79 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.744 2.296 . . . . 0.0 112.348 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.483 ' NE1' HG21 ' A' ' 88' ' ' THR . 6.9 p-90 -122.96 5.59 9.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.618 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -98.64 130.31 45.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -66.11 -59.65 7.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.497 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.559 ' CD2' ' HD3' ' A' ' 102' ' ' PRO . 3.1 p-80 -38.41 -31.65 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.875 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLY . 9.5 t -68.54 -49.6 58.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -53.68 -45.53 70.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -72.49 -24.86 61.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 66' ' ' LYS . 16.3 tp -87.68 -20.25 26.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.946 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -42.97 -58.31 4.11 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.657 0.741 . . . . 0.0 110.861 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.1 Cg_endo -69.74 -26.5 27.61 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.704 2.27 . . . . 0.0 112.328 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.621 ' HB2' HD12 ' A' ' 63' ' ' LEU . 42.1 mtpt -74.24 -27.35 60.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 40.3 t80 -96.32 -33.57 11.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.436 ' CG ' ' HG3' ' A' ' 28' ' ' PRO . 1.2 ttmp? -51.77 -57.62 8.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -40.53 -60.75 1.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.3 tp -38.48 -38.81 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.83 -65.61 3.21 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.84 -16.43 64.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -80.88 -42.66 21.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.633 HD12 HD11 ' A' ' 82' ' ' ILE . 80.6 mt -82.09 3.34 27.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.2 m -53.92 -24.78 17.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -78.1 6.9 7.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.917 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.435 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 4.1 t0 -113.49 98.98 48.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.659 0.742 . . . . 0.0 110.843 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.3 Cg_endo -69.72 0.3 5.82 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.71 2.273 . . . . 0.0 112.36 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -110.83 -36.83 5.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.475 HG21 HD13 ' A' ' 74' ' ' LEU . 64.3 mt -92.55 137.97 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.2 t -135.37 116.81 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.1 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.633 HD11 HD12 ' A' ' 74' ' ' LEU . 23.3 mm -89.05 132.45 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.844 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -142.03 171.53 13.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -139.74 138.13 35.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.489 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 12.4 ttt -132.5 143.19 49.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.746 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -95.88 95.27 8.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -48.77 -67.19 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.497 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -46.97 -23.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.746 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -93.52 -25.12 17.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.489 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -141.07 125.29 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.0 128.97 36.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.52 128.56 74.64 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.591 0.71 . . . . 0.0 111.141 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -169.77 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.663 2.242 . . . . 0.0 112.343 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.5 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.5 m -121.25 160.84 43.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.667 0.746 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.2 Cg_endo -69.69 -8.62 10.47 Favored 'Cis proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 -1.801 . . . . 0.0 112.387 -0.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.445 ' C ' ' O ' ' A' ' 95' ' ' PRO . 86.0 m-85 -34.04 123.37 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -125.74 130.16 50.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.885 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.907 HG22 HG21 ' A' ' 103' ' ' THR . 65.8 t -133.09 120.48 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.093 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -128.87 -38.64 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.79 123.3 5.32 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.516 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.546 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.4 OUTLIER -97.14 154.0 38.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.738 . . . . 0.0 110.878 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.559 ' HD3' ' CD2' ' A' ' 59' ' ' HIS . 53.1 Cg_endo -69.83 155.33 93.49 Favored 'Cis proline' 0 C--N 1.341 0.158 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.29 0.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.907 HG21 HG22 ' A' ' 98' ' ' VAL . 92.9 m -131.53 100.27 5.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.424 HG12 ' HG2' ' A' ' 51' ' ' GLU . 95.6 mt -94.79 141.93 14.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.151 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.418 ' HB2' HG23 ' A' ' 50' ' ' ILE . 8.9 m-85 -140.88 161.59 37.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 49' ' ' LEU . 15.4 t80 -128.25 136.95 51.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -105.3 93.27 6.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.843 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.498 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.6 Cg_endo -69.75 164.59 33.96 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.394 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.459 ' O ' ' CE ' ' A' ' 111' ' ' LYS . . . -78.04 145.44 35.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.2 p30 41.94 24.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.498 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.2 mtmt -128.66 68.07 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HA ' ' NZ ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -90.57 -49.01 6.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.935 HD22 ' O ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -59.75 -25.47 64.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.554 ' N ' HD13 ' A' ' 113' ' ' LEU . 2.8 t-20 -133.39 84.06 47.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.646 0.736 . . . . 0.0 110.91 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -163.8 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -148.43 137.09 21.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.475 ' HG2' ' N ' ' A' ' 118' ' ' TYR . 29.8 ttmt -105.19 151.4 24.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.549 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 68.4 t80 -94.58 108.83 20.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -121.58 100.0 6.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 178.73 -153.59 12.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.1 133.35 12.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.477 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -80.36 45.96 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.844 0.355 . . . . 0.0 110.914 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 124' ' ' LEU . 8.8 tt0 -105.39 133.29 50.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.649 ' CD1' HD11 ' A' ' 128' ' ' ILE . 3.4 tm? -34.8 -55.59 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.3 m -58.86 -52.21 66.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.827 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.03 -30.38 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.549 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 38.9 m-85 -78.19 -40.34 37.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.649 HD11 ' CD1' ' A' ' 124' ' ' LEU . 37.5 mt -63.64 -57.26 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.153 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -58.01 -35.49 71.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.582 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 16.9 t80 -53.95 -52.82 59.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.6 mt -74.84 -39.89 61.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -38.79 -39.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.93 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -98.98 -57.07 2.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.582 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 69.6 mm-40 -49.24 -53.68 20.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -42.51 104.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.157 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 137' ' ' SER . 2.1 t -46.83 -49.62 19.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.444 ' N ' HG23 ' A' ' 136' ' ' THR . 23.7 m -73.98 -45.38 50.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.91 168.14 31.36 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.504 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 148.47 65.56 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.367 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.2 t -63.88 131.93 49.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 57.7 p -111.82 89.99 3.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 t -156.71 155.71 32.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.88 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -99.98 -57.01 2.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.859 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.65 99.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -152.29 172.69 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.904 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.7 t -129.46 -55.59 1.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.851 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.54 -100.72 0.15 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.468 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.446 ' O ' HD11 ' A' ' 113' ' ' LEU . 19.9 m-85 -108.05 165.16 11.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.889 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -174.87 119.83 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.53 72.76 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 71.07 53.97 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.924 0.392 . . . . 0.0 110.905 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 tp -68.91 109.49 3.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.58 157.9 44.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -174.85 118.91 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.706 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 14.5 p90 -162.61 174.79 12.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 16' ' ' LEU . 1.5 pp -131.88 -40.21 1.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.933 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.4 ' HB3' ' H ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -97.12 125.25 41.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.735 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -142.1 156.74 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.847 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 4.5 mm-40 -106.0 161.68 22.08 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.652 0.739 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.4 Cg_endo -69.83 143.47 50.6 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.701 2.268 . . . . 0.0 112.306 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.57 HD13 HG21 ' A' ' 33' ' ' VAL . 23.2 mm -68.78 127.47 93.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.618 0.723 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.94 43.95 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.709 2.273 . . . . 0.0 112.351 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.59 -39.17 92.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 m -150.13 123.27 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -133.11 45.9 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.49 54.12 2.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.845 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.17 -160.11 23.4 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.491 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -41.55 4.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.63 2.22 . . . . 0.0 112.396 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 84' ' ' LYS . 18.4 t -119.53 107.19 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.116 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -53.48 124.98 16.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.8 t -75.4 126.1 35.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.033 HG11 HG23 ' A' ' 41' ' ' VAL . 30.0 t -118.51 120.31 63.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 21' ' ' ILE . 31.6 m -113.44 145.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 18' ' ' SER . . . -36.4 -38.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.091 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.536 ' HB3' HD11 ' A' ' 21' ' ' ILE . 10.7 mt-10 -59.51 -46.75 87.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' VAL . 22.2 p-10 -111.89 24.84 12.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.586 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 6.1 t80 -63.46 -58.06 8.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -65.29 -7.72 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -86.9 -44.22 11.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.7 mt -98.28 -62.3 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.033 HG23 HG11 ' A' ' 32' ' ' VAL . 97.1 t -48.14 -62.04 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.136 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -72.66 126.55 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.409 ' ND2' ' HE3' ' A' ' 46' ' ' LYS . 11.7 t-20 -172.91 108.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -87.6 29.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -124.14 -41.66 2.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HE3' ' ND2' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -136.28 130.13 32.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.57 151.95 5.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.499 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 89.4 t -146.33 152.58 13.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.599 HD23 HD12 ' A' ' 82' ' ' ILE . 39.8 tp -124.17 126.13 45.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.544 HD11 ' HB3' ' A' ' 85' ' ' MET . 1.8 tp -114.1 129.38 70.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.121 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 14.7 tm-20 -123.83 114.35 19.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -85.38 133.82 34.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -143.0 169.14 18.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.693 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -127.04 131.42 23.85 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.589 0.709 . . . . 0.0 111.074 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.465 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.2 Cg_endo -69.75 -10.13 27.82 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.376 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -115.58 5.11 14.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 7.5 t -101.71 126.89 48.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.15 -59.14 8.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -42.36 -45.64 4.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.6 m -69.82 -43.72 71.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -55.67 -35.88 66.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -74.62 -29.9 61.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.592 HD12 ' HB2' ' A' ' 66' ' ' LYS . 28.9 tp -83.15 -20.88 33.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.544 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -41.16 -57.58 3.4 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.652 0.739 . . . . 0.0 110.864 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.71 -27.72 26.36 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.705 2.27 . . . . 0.0 112.345 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.592 ' HB2' HD12 ' A' ' 63' ' ' LEU . 3.1 mmmt -71.92 -30.65 65.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 51' ' ' GLU . 60.1 t80 -91.01 -37.07 13.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -47.57 -54.37 11.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.833 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -43.35 -56.21 3.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 127' ' ' PHE . 21.7 tp -42.99 -38.5 2.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.29 -65.16 3.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.438 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -60.83 -27.55 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 0.0 110.89 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mmtm -67.95 -46.46 71.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.573 HD12 ' CG1' ' A' ' 82' ' ' ILE . 91.5 mt -84.72 2.98 39.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.6 t -48.64 -24.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -93.57 24.24 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.45 97.63 12.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.583 0.706 . . . . 0.0 110.857 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -2.17 9.72 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.664 2.243 . . . . 0.0 112.364 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -117.5 -42.85 2.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.9 mt -92.77 145.07 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.179 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.1 t -138.99 106.82 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.599 HD12 HD23 ' A' ' 49' ' ' LEU . 21.2 mm -76.87 135.8 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -145.62 169.17 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.603 ' HB3' HG11 ' A' ' 29' ' ' VAL . 19.9 pttp -143.34 149.51 37.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.544 ' HB3' HD11 ' A' ' 50' ' ' ILE . 1.0 OUTLIER -144.06 138.45 28.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.815 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -86.85 107.0 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.82 -51.74 68.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.125 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.465 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -59.94 -16.31 28.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.815 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -106.88 0.69 24.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.549 ' ND2' ' C ' ' A' ' 89' ' ' ALA . 3.8 m-80 -162.87 124.61 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 17' ' ' LYS . 23.4 t70 -55.92 130.05 42.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.401 HG11 HG23 ' A' ' 98' ' ' VAL . 88.4 t -78.34 125.33 85.01 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.641 0.734 . . . . 0.0 111.168 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -164.57 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.502 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -127.16 160.93 57.11 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.683 0.754 . . . . 0.0 110.857 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.0 Cg_endo -69.71 -3.03 7.38 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.74 -1.775 . . . . 0.0 112.381 -0.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.471 ' N ' ' HA ' ' A' ' 94' ' ' SER . 97.3 m-85 -36.4 125.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -129.31 125.11 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.542 HG22 HG21 ' A' ' 103' ' ' THR . 58.2 t -130.99 103.54 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.142 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -104.93 -35.48 7.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.837 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.57 134.28 6.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.478 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.518 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -98.14 156.94 35.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 0.0 110.92 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.75 165.52 76.42 Favored 'Cis proline' 0 C--O 1.231 0.164 0 C-N-CA 122.732 -1.778 . . . . 0.0 112.373 -0.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.542 HG21 HG22 ' A' ' 98' ' ' VAL . 71.2 m -147.16 105.08 3.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.117 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.825 HD13 ' HE1' ' A' ' 127' ' ' PHE . 21.2 mt -97.19 141.4 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.121 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -140.97 160.34 40.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 31.2 t80 -130.27 140.39 50.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.7 p -109.43 98.66 33.18 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.667 0.746 . . . . 0.0 110.859 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.5 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.76 166.49 27.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.622 2.215 . . . . 0.0 112.37 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -82.48 128.6 34.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.08 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.23 29.75 15.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.5 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.9 mtmt -135.0 40.93 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -64.05 -33.86 76.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.446 HD11 ' O ' ' A' ' 8' ' ' PHE . 4.6 mp -67.47 -36.21 80.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.557 ' ND2' ' N ' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -124.7 81.56 60.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.593 0.711 . . . . 0.0 110.875 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 178.11 4.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.463 ' CD ' ' HG3' ' A' ' 108' ' ' PRO . 7.9 mptt -114.93 127.41 55.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -101.92 108.0 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.435 ' CE1' ' CD2' ' A' ' 130' ' ' TYR . 55.3 t80 -55.21 108.69 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -125.52 90.92 3.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -172.73 -134.23 1.78 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.479 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.14 139.79 14.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 102' ' ' PRO . 32.9 mtp180 -84.8 37.86 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.757 0.313 . . . . 0.0 110.874 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 124' ' ' LEU . 15.1 tp10 -98.25 129.26 44.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.604 ' CD1' HD11 ' A' ' 128' ' ' ILE . 3.2 tm? -34.28 -55.29 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.9 p -57.65 -45.71 85.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 123' ' ' GLU . 2.1 t70 -53.43 -33.53 54.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.825 ' HE1' HD13 ' A' ' 104' ' ' ILE . 88.7 m-85 -73.58 -40.33 63.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.604 HD11 ' CD1' ' A' ' 124' ' ' LEU . 42.7 mt -61.58 -57.41 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.181 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.34 -35.18 78.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.435 ' CD2' ' CE1' ' A' ' 118' ' ' TYR . 13.8 t80 -53.56 -48.1 69.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.424 HD11 HD22 ' A' ' 49' ' ' LEU . 28.9 mt -76.22 -39.24 55.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.908 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -39.92 -40.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.3 mtp85 -92.0 -64.4 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 135' ' ' ALA . 21.8 mm-40 -41.78 -60.15 1.45 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -35.19 116.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.1 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.6 OUTLIER -35.19 -75.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.122 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 m -75.81 -55.69 5.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 100.13 -179.16 29.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 136.21 32.29 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.689 2.26 . . . . 0.0 112.322 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.7 t -61.04 125.8 25.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.0 m -113.64 42.28 2.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.453 -179.939 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t -138.78 161.25 37.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 110.827 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.0 p -76.51 163.48 26.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.05 137.16 38.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.506 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.4 m -107.24 96.64 6.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 0.0 110.841 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.6 m -135.31 128.56 31.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.848 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.57 -128.25 3.01 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.432 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -42.11 129.91 3.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -110.94 39.47 2.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.89 -130.47 17.11 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.504 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.416 ' CG ' ' HE2' ' A' ' 13' ' ' LYS . 11.8 t-20 -105.86 87.42 2.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.378 . . . . 0.0 110.918 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 tt -73.92 79.57 1.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HE2' ' CG ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -170.5 -178.02 2.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -175.65 129.29 0.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.627 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 4.3 p90 -156.25 153.94 29.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.958 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.1 pp -112.99 -36.91 4.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' N ' HD12 ' A' ' 16' ' ' LEU . 31.2 tttt -109.69 155.5 21.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.569 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 18.7 t -166.4 143.78 5.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.0 mm-40 -86.6 162.05 46.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.654 0.74 . . . . 0.0 110.882 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.77 142.32 47.56 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.649 2.233 . . . . 0.0 112.353 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.463 HD13 ' CG2' ' A' ' 33' ' ' VAL . 30.6 mm -71.65 131.83 85.83 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.644 0.735 . . . . 0.0 111.1 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 178.38 4.67 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.626 2.217 . . . . 0.0 112.37 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -103.13 -34.96 8.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 p -147.98 125.64 11.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -107.8 47.5 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -58.8 -26.92 64.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.53 168.87 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.486 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.459 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 54.1 Cg_endo -69.76 -25.66 28.35 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.685 2.256 . . . . 0.0 112.364 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.546 HG12 ' HG2' ' A' ' 84' ' ' LYS . 62.1 t -120.1 113.15 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -57.66 129.59 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.3 125.97 39.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.153 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.045 HG11 HG23 ' A' ' 41' ' ' VAL . 21.8 t -124.6 124.57 68.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.662 HG22 ' OD1' ' A' ' 36' ' ' ASN . 20.9 m -122.64 148.46 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.627 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -32.75 -40.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.121 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.583 ' HB2' HG23 ' A' ' 33' ' ' VAL . 12.7 mt-10 -55.75 -49.56 72.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.857 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.662 ' OD1' HG22 ' A' ' 33' ' ' VAL . 36.4 p-10 -115.77 34.91 4.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.615 ' CD2' HG21 ' A' ' 41' ' ' VAL . 21.4 t80 -71.09 -57.93 4.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -66.6 -5.67 12.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -87.08 -47.41 8.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.3 mt -96.92 -58.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.045 HG23 HG11 ' A' ' 32' ' ' VAL . 41.3 t -49.0 -61.64 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.167 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -68.56 126.91 31.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -174.33 118.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -95.64 0.45 52.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -95.54 -37.58 10.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -138.87 138.93 37.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.522 ' OD2' ' CG1' ' A' ' 80' ' ' ILE . 1.3 p30 -58.63 152.87 17.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.87 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 41' ' ' VAL . 52.1 t -148.42 142.72 19.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.445 HD23 HD12 ' A' ' 82' ' ' ILE . 39.4 tp -117.91 140.51 49.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.579 HD11 ' CB ' ' A' ' 85' ' ' MET . 2.1 tp -127.86 135.6 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.49 ' CD ' ' C ' ' A' ' 51' ' ' GLU . 5.8 tm-20 -126.77 121.88 33.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -95.74 118.7 32.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -126.34 179.08 5.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.26 134.56 17.76 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.625 0.726 . . . . 0.0 111.123 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.712 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.1 Cg_endo -69.73 -16.96 37.93 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.69 2.26 . . . . 0.0 112.339 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.413 ' CZ3' ' HB2' ' A' ' 57' ' ' CYS . 2.4 p-90 -105.85 6.53 31.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.413 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . 42.1 t -107.16 112.7 25.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.876 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -57.98 -57.16 21.3 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -41.02 -37.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 97.5 m -73.75 -34.66 64.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 58' ' ' GLY . 2.1 ttmm -62.33 -35.48 79.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -73.77 -27.75 61.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 66' ' ' LYS . 13.2 tp -81.36 -25.15 36.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.1 tt0 -37.53 -58.37 1.28 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.645 0.736 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.3 Cg_endo -69.82 -31.5 20.13 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.692 2.261 . . . . 0.0 112.28 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.632 ' HB2' HD12 ' A' ' 63' ' ' LEU . 16.0 mtpp -68.13 -29.98 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -92.47 -38.87 11.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HG3' ' CG ' ' A' ' 28' ' ' PRO . 5.5 ttmm -50.07 -58.68 5.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 9.6 mt-10 -41.59 -49.25 4.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 127' ' ' PHE . 25.1 tp -47.09 -41.39 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.56 -66.96 2.48 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.478 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.06 -26.54 68.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.85 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 69' ' ' GLU . 17.2 mmtt -70.09 -39.94 75.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.784 HD12 ' CG1' ' A' ' 82' ' ' ILE . 64.3 mt -79.13 4.86 13.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.3 t -56.97 -11.96 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.41 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 14.5 mmtp -82.68 -20.14 36.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.882 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CG ' ' O ' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -98.43 100.99 10.27 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.717 . . . . 0.0 110.855 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 53.4 Cg_endo -69.77 -2.91 10.98 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 0.0 112.322 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -107.7 -33.05 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.522 ' CG1' ' OD2' ' A' ' 47' ' ' ASP . 54.4 mt -92.05 117.93 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.1 t -118.2 125.44 74.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.106 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.784 ' CG1' HD12 ' A' ' 74' ' ' LEU . 30.7 mm -93.24 137.28 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.781 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -142.9 161.03 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.036 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.546 ' HG2' HG12 ' A' ' 29' ' ' VAL . 32.4 pttt -131.11 156.51 45.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.579 ' CB ' HD11 ' A' ' 50' ' ' ILE . 13.9 ttt -151.09 132.36 14.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 90' ' ' ASN . 26.1 t70 -91.32 95.85 10.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -52.28 -60.46 3.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.712 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -42.82 -27.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.38 -28.88 13.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.476 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.3 OUTLIER -134.88 114.97 13.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -47.2 131.24 13.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.423 HG13 ' HD2' ' A' ' 93' ' ' PRO . 93.0 t -80.86 132.85 56.2 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.59 0.709 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.468 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 53.6 Cg_endo -69.76 -165.83 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 0.0 112.326 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -124.13 160.89 50.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.645 0.736 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.5 Cg_endo -69.72 -8.75 10.59 Favored 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.356 -0.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 95' ' ' PRO . 98.3 m-85 -33.08 124.09 0.38 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -128.98 119.85 25.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.585 HG22 HG21 ' A' ' 103' ' ' THR . 71.0 t -121.66 96.47 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.17 -43.39 7.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.812 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.53 128.58 6.16 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.532 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -97.39 156.37 36.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.662 0.744 . . . . 0.0 110.858 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.6 Cg_endo -69.71 163.96 80.35 Favored 'Cis proline' 0 C--O 1.231 0.17 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.34 -0.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.585 HG21 HG22 ' A' ' 98' ' ' VAL . 50.2 m -145.73 106.09 4.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.145 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.407 HG22 ' CB ' ' A' ' 118' ' ' TYR . 22.5 mt -96.51 136.23 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.422 ' O ' HD12 ' A' ' 49' ' ' LEU . 8.4 m-85 -134.76 158.91 42.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -128.05 135.04 49.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 5.1 p -107.81 91.26 7.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.652 0.739 . . . . 0.0 110.832 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.497 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.8 Cg_endo -69.73 168.95 20.04 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.256 . . . . 0.0 112.339 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.24 140.11 35.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.01 31.36 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.497 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 13.7 mtmm -128.53 34.58 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 113' ' ' LEU . 27.3 mmtp -64.58 -58.24 6.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 112' ' ' LYS . 4.3 mm? -34.87 -41.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.909 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.405 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 4.8 m-80 -134.97 92.64 18.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.572 0.701 . . . . 0.0 110.86 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.8 Cg_endo -69.79 -173.44 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -135.66 121.02 19.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.25 123.89 34.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.63 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 60.6 t80 -57.45 96.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.906 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -109.7 95.04 5.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.918 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.34 -151.51 9.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.36 135.11 13.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.484 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 122' ' ' ARG . 13.1 mtm105 -80.59 45.62 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -102.43 137.05 41.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.476 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.3 tm? -40.48 -52.43 2.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.8 m -66.3 -47.34 73.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -46.69 -36.75 7.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.918 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.63 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 65.3 m-85 -70.52 -44.68 67.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.44 HG22 HE21 ' A' ' 132' ' ' GLN . 28.4 mt -57.66 -56.41 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.119 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -65.68 -25.01 67.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.456 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 8.3 t80 -63.9 -50.62 68.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 132' ' ' GLN . 23.5 mt -71.69 -41.66 68.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.44 HE21 HG22 ' A' ' 128' ' ' ILE . 36.3 mt-30 -37.74 -39.86 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -102.04 -51.4 3.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 7.4 mm-40 -51.98 -57.08 10.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.04 147.49 53.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.15 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.23 -49.06 20.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.2 m -42.88 -69.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.867 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.25 135.7 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -48.95 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.687 2.258 . . . . 0.0 112.368 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.6 m -147.99 126.38 12.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.84 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.3 m -135.71 133.97 38.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.6 p -171.09 167.17 7.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.377 . . . . 0.0 110.866 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -112.67 42.16 1.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.05 70.2 1.21 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 76.0 p -84.22 -44.48 13.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.914 0.388 . . . . 0.0 110.892 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 m -103.85 125.62 50.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.5 -172.19 13.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -83.43 103.71 13.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -107.34 178.4 4.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.56 60.96 0.39 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.5 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -96.47 83.39 3.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.854 0.359 . . . . 0.0 110.85 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.59 64.29 0.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.451 ' H ' ' CE ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -118.78 75.32 1.02 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -124.4 121.32 34.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.664 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 2.8 p90 -165.73 152.63 10.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 pp -102.9 -39.12 7.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.948 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -100.93 159.69 14.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.489 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 61.4 p -172.47 149.69 2.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 15.9 mm-40 -103.6 161.81 21.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.623 0.725 . . . . 0.0 110.908 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.78 144.63 54.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.259 . . . . 0.0 112.31 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.509 HD13 HG21 ' A' ' 33' ' ' VAL . 39.0 mm -71.93 132.97 84.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.619 0.723 . . . . 0.0 111.124 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 21' ' ' ILE . 54.0 Cg_endo -69.79 179.47 3.69 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.616 2.211 . . . . 0.0 112.349 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -104.1 -34.69 8.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 m -150.85 126.42 10.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -110.14 43.12 1.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.26 -28.81 44.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.04 165.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.421 ' CG ' ' HG3' ' A' ' 68' ' ' LYS . 53.6 Cg_endo -69.69 -20.56 35.01 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.277 . . . . 0.0 112.344 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.32 110.75 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -55.79 138.48 47.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.7 t -91.91 110.6 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.988 HG11 HG23 ' A' ' 41' ' ' VAL . 39.1 t -105.4 124.0 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.096 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 21' ' ' ILE . 27.0 m -119.77 145.78 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.664 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -31.64 -44.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.115 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -54.74 -49.12 71.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 33' ' ' VAL . 9.2 p-10 -114.25 38.36 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.741 ' CD2' HG21 ' A' ' 41' ' ' VAL . 8.4 t80 -75.32 -55.49 5.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.4 -15.23 62.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -78.99 -44.8 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.429 HD12 HG22 ' A' ' 32' ' ' VAL . 22.7 mt -97.46 -58.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.988 HG23 HG11 ' A' ' 32' ' ' VAL . 48.6 t -49.65 -61.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -73.2 126.99 31.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -172.53 106.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -79.15 -14.57 59.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -73.16 -44.24 60.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HE3' HG21 ' A' ' 81' ' ' VAL . 19.3 pttm -138.9 160.85 38.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.11 153.13 38.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.5 t -144.59 135.73 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.13 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 106' ' ' PHE . 14.4 tp -112.68 119.91 39.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' A' ' 85' ' ' MET . 1.8 tp -106.64 136.71 40.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' N ' HG13 ' A' ' 50' ' ' ILE . 1.2 tm-20 -127.5 115.46 18.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.409 ' C ' ' OE2' ' A' ' 51' ' ' GLU . 35.5 m-85 -91.64 139.54 30.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 10.4 p90 -144.63 177.12 8.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.536 ' HB1' ' CE2' ' A' ' 56' ' ' TRP . . . -132.72 131.14 21.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.598 0.713 . . . . 0.0 111.096 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.56 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.1 Cg_endo -69.72 -9.26 25.67 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.382 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.536 ' CE2' ' HB1' ' A' ' 54' ' ' ALA . 2.1 p-90 -110.6 23.21 14.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.4 t -134.2 108.74 8.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.41 -35.9 2.94 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.49 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.426 ' CD2' ' H ' ' A' ' 59' ' ' HIS . 16.3 m170 -42.59 -50.38 5.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.802 0.334 . . . . 0.0 110.872 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 64' ' ' GLU . 14.1 p -55.1 -42.13 72.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' N ' ' SG ' ' A' ' 60' ' ' CYS . 0.0 OUTLIER -62.37 -40.69 97.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.46 -36.96 71.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.71 HD12 ' HB2' ' A' ' 66' ' ' LYS . 39.4 tp -84.34 -20.07 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.543 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 3.3 tt0 -42.19 -57.95 3.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.649 0.738 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.0 Cg_endo -69.82 -34.09 15.07 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.366 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.71 ' HB2' HD12 ' A' ' 63' ' ' LEU . 26.6 mtmt -66.85 -28.67 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -93.53 -49.77 5.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 71' ' ' GLY . 6.4 ttmm -39.08 -64.33 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 22.2 mt-10 -39.58 -46.87 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.453 ' N ' HD21 ' A' ' 124' ' ' LEU . 19.5 tp -53.03 -39.48 63.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 68' ' ' LYS . . . -57.32 -65.5 3.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.504 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -67.43 -24.42 65.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.493 ' CG ' ' O ' ' A' ' 69' ' ' GLU . 16.5 mmtm -69.87 -46.13 66.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.578 HD12 HD11 ' A' ' 82' ' ' ILE . 93.6 mt -80.16 3.23 21.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.6 t -53.33 -36.09 60.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -59.88 -11.16 4.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.859 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.97 100.72 12.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.654 0.74 . . . . 0.0 110.874 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 1.07 4.77 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.722 2.281 . . . . 0.0 112.339 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -110.87 -39.56 4.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.2 mt -87.08 113.6 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.175 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.421 HG21 ' HE3' ' A' ' 46' ' ' LYS . 96.4 t -108.34 117.01 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.578 HD11 HD12 ' A' ' 74' ' ' LEU . 39.6 mm -91.98 123.05 43.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.175 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.829 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -138.01 171.29 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -138.96 154.94 48.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.417 ' HB3' HD11 ' A' ' 50' ' ' ILE . 6.5 ttt -148.02 134.11 19.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.57 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 8.9 t0 -86.03 87.76 7.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -42.73 -67.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.084 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.56 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -37.75 -30.93 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -89.58 -35.7 15.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 2.9 m-80 -124.0 115.38 21.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -47.05 119.23 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.5 t -75.89 120.05 79.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.632 0.73 . . . . 0.0 111.15 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.75 -174.88 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.727 2.285 . . . . 0.0 112.346 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.505 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -105.07 159.62 28.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.674 0.75 . . . . 0.0 110.845 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.516 ' O ' ' C ' ' A' ' 96' ' ' TYR . 53.2 Cg_endo -69.82 -23.49 9.09 Favored 'Cis proline' 0 C--O 1.231 0.143 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.312 0.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.516 ' C ' ' O ' ' A' ' 95' ' ' PRO . 76.2 m-85 -27.47 114.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -127.22 90.38 3.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 103' ' ' THR . 78.6 t -80.0 99.43 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.157 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.7 mmm-85 -98.04 -44.18 6.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.91 133.37 7.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.52 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -101.78 156.86 34.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.608 0.718 . . . . 0.0 110.903 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.0 Cg_endo -69.79 145.4 79.38 Favored 'Cis proline' 0 C--O 1.232 0.206 0 C-N-CA 122.648 -1.813 . . . . 0.0 112.388 0.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.599 HG21 HG22 ' A' ' 98' ' ' VAL . 56.4 m -118.48 126.64 52.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.509 HD13 ' CE1' ' A' ' 127' ' ' PHE . 25.7 mt -121.34 127.19 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.125 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -127.53 152.1 48.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.461 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 21.5 t80 -126.44 130.22 50.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.858 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 33.3 t -100.77 99.31 9.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.671 0.748 . . . . 0.0 110.843 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.499 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.81 164.14 35.71 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.672 2.248 . . . . 0.0 112.343 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' ND2' ' A' ' 110' ' ' ASN . . . -78.84 134.96 36.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.089 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER 48.33 31.81 2.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.499 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 20.7 mtmt -133.98 33.92 3.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -58.35 -55.07 39.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -43.17 -39.34 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -133.82 89.67 29.46 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.63 0.729 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HG3' ' HG2' ' A' ' 95' ' ' PRO . 53.1 Cg_endo -69.81 -167.58 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.733 2.289 . . . . 0.0 112.293 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -135.16 111.36 9.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -82.18 128.41 34.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.629 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 75.3 t80 -69.67 99.8 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -112.08 90.89 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.847 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -171.68 -150.96 7.44 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.43 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.23 140.39 16.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -79.59 44.1 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 124' ' ' LEU . 6.4 tt0 -101.28 127.92 47.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.458 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -35.11 -56.19 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 53.0 p -61.86 -47.31 85.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -47.16 -36.5 8.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.629 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 77.1 m-85 -72.49 -49.49 32.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.5 mt -50.33 -56.07 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -37.08 83.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.838 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.535 ' CE2' ' HG3' ' A' ' 134' ' ' GLU . 63.8 t80 -57.11 -45.52 83.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.915 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 132' ' ' GLN . 60.7 mt -72.83 -40.46 65.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.429 ' HB3' ' NH1' ' A' ' 133' ' ' ARG . 50.5 mt-30 -37.4 -41.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.429 ' NH1' ' HB3' ' A' ' 132' ' ' GLN . 12.8 mmp_? -100.49 -60.33 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.535 ' HG3' ' CE2' ' A' ' 130' ' ' TYR . 16.2 mm-40 -38.73 -52.99 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.72 152.11 46.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.36 -51.53 5.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.8 m -48.73 -60.95 2.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.87 145.33 0.32 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -25.01 29.12 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.668 2.245 . . . . 0.0 112.353 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.3 m 60.36 40.39 17.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.3 m 59.08 41.16 21.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.885 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 -179.981 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.5 t -131.01 -43.96 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.919 0.39 . . . . 0.0 110.831 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 t 58.49 42.65 20.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.38 84.34 0.17 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.485 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.5 m -65.87 138.23 57.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.6 t -169.34 125.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.84 -135.03 4.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.432 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -165.83 141.47 4.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.883 0.373 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -107.02 44.69 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.827 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.46 109.71 3.88 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.5 92.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 110.926 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.493 ' H ' ' CD2' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -101.71 21.68 14.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.943 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -89.56 134.84 33.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -157.46 127.29 6.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -156.22 156.16 33.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.704 HD23 ' CG ' ' A' ' 91' ' ' ASP . 1.3 pt? -104.56 -36.99 7.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.887 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.515 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -121.46 174.0 7.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.955 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 89.0 p -172.84 171.17 4.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.505 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 5.3 mt-10 -106.44 159.9 28.14 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.625 0.726 . . . . 0.0 110.907 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 134.99 29.27 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.339 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.454 HD13 ' CG2' ' A' ' 33' ' ' VAL . 30.6 mm -68.93 122.3 84.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.647 0.737 . . . . 0.0 111.148 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 172.14 13.19 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.707 2.271 . . . . 0.0 112.318 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 24' ' ' SER . 6.4 pt-20 -99.94 -39.04 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.444 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 7.1 t -130.68 137.1 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -132.54 35.96 3.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.81 61.92 1.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.44 -174.36 13.69 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -33.45 16.53 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.653 2.235 . . . . 0.0 112.342 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.3 t -127.66 111.15 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.174 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -59.61 135.96 57.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.5 t -83.84 115.77 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.017 HG11 HG23 ' A' ' 41' ' ' VAL . 39.1 t -113.17 121.24 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.114 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 35' ' ' GLU . 4.5 m -114.13 148.14 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.154 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -33.88 -45.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.485 ' HB2' HG23 ' A' ' 33' ' ' VAL . 2.2 mm-40 -54.45 -50.21 68.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.859 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.463 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 9.5 p-10 -109.23 33.29 4.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.477 ' HA ' ' CG1' ' A' ' 32' ' ' VAL . 7.4 t80 -74.9 -48.08 26.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -72.64 -4.61 32.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -90.01 -42.75 10.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.618 HD12 HG22 ' A' ' 32' ' ' VAL . 14.3 mt -99.44 -62.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.171 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.017 HG23 HG11 ' A' ' 32' ' ' VAL . 41.1 t -50.2 -62.66 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -61.47 116.9 5.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.431 ' C ' ' HE3' ' A' ' 112' ' ' LYS . 3.3 t-20 -172.75 120.88 0.39 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CA ' ' HE3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -106.92 30.34 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.63 -27.09 3.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -138.47 160.13 40.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.46 126.51 31.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.507 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 39.1 t -126.32 152.52 33.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.49 HD13 HD21 ' A' ' 131' ' ' LEU . 14.7 tp -132.4 125.45 30.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.561 HD11 ' CB ' ' A' ' 85' ' ' MET . 1.9 tp -116.06 134.75 58.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.091 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -126.92 115.71 19.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.874 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -90.03 116.24 27.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.55 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 26.9 p90 -116.63 174.73 5.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.15 128.94 23.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.582 0.706 . . . . 0.0 111.136 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -19.14 36.63 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.676 2.251 . . . . 0.0 112.336 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.515 ' NE1' HG21 ' A' ' 88' ' ' THR . 3.7 p-90 -101.51 14.87 30.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.404 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 2.0 t -129.19 103.87 7.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -37.41 -39.63 0.54 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.49 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' GLY . 32.7 m170 -36.89 -45.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.768 0.318 . . . . 0.0 110.836 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 64' ' ' GLU . 27.9 p -54.61 -48.07 72.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 58' ' ' GLY . 28.9 mmtt -63.0 -41.93 99.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -67.88 -30.66 70.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 66' ' ' LYS . 67.0 tp -92.4 -19.42 22.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.543 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.6 tt0 -43.68 -57.99 5.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.598 0.713 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.77 -28.62 24.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.659 2.239 . . . . 0.0 112.38 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.913 ' HB2' HD12 ' A' ' 63' ' ' LEU . 13.7 mtpp -72.06 -30.17 64.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -93.65 -46.45 7.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.012 0.434 . . . . 0.0 110.94 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 71' ' ' GLY . 14.2 ttmt -44.58 -60.69 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 68' ' ' LYS . 18.6 mt-10 -38.05 -54.66 1.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' A' ' 127' ' ' PHE . 17.9 tp -49.08 -38.03 23.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.953 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 68' ' ' LYS . . . -58.89 -65.19 3.65 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -64.29 -27.67 69.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.916 0.389 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -69.73 -45.49 68.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.521 HD12 HD11 ' A' ' 82' ' ' ILE . 94.9 mt -80.71 3.19 23.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.9 t -54.57 -28.77 48.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.844 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.92 0.18 7.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.958 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.47 99.94 39.39 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.608 0.718 . . . . 0.0 110.866 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -0.16 6.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.361 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -110.56 -34.62 6.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.54 112.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.2 t -109.57 119.35 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 74' ' ' LEU . 32.1 mm -93.29 117.47 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.76 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -128.42 166.18 19.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -134.37 155.77 49.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.938 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.561 ' CB ' HD11 ' A' ' 50' ' ' ILE . 11.9 ttt -149.24 161.29 42.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.865 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.908 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -109.2 119.58 39.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.0 -70.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.515 HG21 ' NE1' ' A' ' 56' ' ' TRP . 0.5 OUTLIER -47.77 -28.05 2.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.908 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -91.18 -31.1 16.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 8.0 m-80 -131.1 102.18 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.704 ' CG ' HD23 ' A' ' 16' ' ' LEU . 9.5 t0 -41.16 122.89 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 98' ' ' VAL . 92.2 t -82.04 121.67 79.16 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.661 0.744 . . . . 0.0 111.086 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 96' ' ' TYR . 54.1 Cg_endo -69.74 -167.21 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.717 2.278 . . . . 0.0 112.365 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.512 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -109.11 160.05 28.94 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.749 . . . . 0.0 110.833 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.5 Cg_endo -69.74 -20.18 10.85 Favored 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.634 -1.819 . . . . 0.0 112.373 -0.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.509 ' C ' ' O ' ' A' ' 95' ' ' PRO . 84.5 m-85 -28.55 113.36 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -122.87 85.85 2.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 92' ' ' VAL . 85.8 t -77.2 120.57 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.0 mmm-85 -122.05 -48.12 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -122.12 130.11 7.87 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.519 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -102.42 156.09 35.7 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.658 0.742 . . . . 0.0 110.886 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.9 Cg_endo -69.66 143.92 75.0 Favored 'Cis proline' 0 C--O 1.231 0.151 0 C-N-CA 122.713 -1.786 . . . . 0.0 112.338 -0.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.544 HG21 HG22 ' A' ' 98' ' ' VAL . 80.1 m -114.33 127.74 56.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.174 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.5 mt -120.18 135.91 58.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.165 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -134.26 169.99 16.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 31.1 t80 -139.5 131.72 28.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.8 t -101.65 97.98 8.77 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.618 0.723 . . . . 0.0 110.842 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.447 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.79 169.29 19.29 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.718 2.279 . . . . 0.0 112.329 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.62 126.49 36.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 64.59 26.48 13.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 8.3 mtmm -131.78 26.5 4.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -47.42 -57.94 4.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.1 mp -39.38 -41.99 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.936 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -134.39 99.45 13.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.652 0.739 . . . . 0.0 110.874 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -164.29 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.672 2.248 . . . . 0.0 112.337 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 106' ' ' PHE . 15.4 mmtm -133.34 118.21 18.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -88.52 148.49 24.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.941 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -94.84 108.42 20.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.942 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -118.68 92.43 3.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.46 -143.74 4.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.454 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.01 142.83 16.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.468 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -82.01 41.71 0.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 110.846 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 124' ' ' LEU . 16.4 tp10 -98.06 129.68 44.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.592 ' CD1' HD11 ' A' ' 128' ' ' ILE . 2.7 tm? -34.91 -56.55 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 64.7 p -57.62 -47.36 82.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.07 -32.61 22.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.555 ' HB3' HD22 ' A' ' 70' ' ' LEU . 52.2 m-85 -74.5 -39.3 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.592 HD11 ' CD1' ' A' ' 124' ' ' LEU . 24.9 mt -64.64 -65.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -54.08 -31.04 50.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.438 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 49.1 t80 -60.4 -47.91 84.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 49' ' ' LEU . 48.7 mt -73.72 -39.17 64.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -38.66 -38.65 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -102.29 -51.04 3.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.438 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 5.2 mm-40 -51.54 -57.16 9.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.72 150.26 41.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.75 -50.98 10.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.2 m -75.87 49.31 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -47.75 141.13 8.2 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.525 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 110.63 2.59 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.671 2.247 . . . . 0.0 112.394 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.4 t -84.29 80.12 9.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.852 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.8 p -45.33 151.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.838 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.454 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 m -81.92 45.46 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 0.0 110.824 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.2 t -85.74 148.35 25.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.5 107.2 0.25 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -81.17 107.37 13.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.368 . . . . 0.0 110.864 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m -107.78 110.13 21.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.822 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 8' ' ' PHE . . . -126.81 45.49 1.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.54 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' A' ' 7' ' ' GLY . 8.5 p90 -35.91 -53.0 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.797 0.332 . . . . 0.0 110.848 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -69.22 121.72 17.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.32 -151.21 15.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.506 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 57.15 40.88 27.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 110.872 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.459 ' CD2' ' O ' ' A' ' 94' ' ' SER . 2.4 tt -72.15 93.57 1.45 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.06 144.7 2.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -175.83 141.97 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -173.34 157.42 3.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.0 pp -106.28 -44.23 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.568 ' N ' HD12 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -112.48 152.54 28.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.884 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.433 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 3.3 m -162.86 166.57 23.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.852 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.453 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 5.1 mm-40 -105.3 162.27 20.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.672 0.748 . . . . 0.0 110.841 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 54.2 Cg_endo -69.75 143.47 50.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.736 2.291 . . . . 0.0 112.331 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.597 HD13 HG21 ' A' ' 33' ' ' VAL . 12.4 mm -69.08 135.1 89.42 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.639 0.733 . . . . 0.0 111.125 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 21' ' ' ILE . 53.3 Cg_endo -69.79 174.66 9.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.671 2.247 . . . . 0.0 112.303 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.6 -38.11 5.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 t -135.18 116.62 14.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.896 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -114.63 43.29 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.58 51.01 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.65 -176.83 16.16 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.517 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -42.21 3.57 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.692 2.261 . . . . 0.0 112.367 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.558 HG12 ' HG2' ' A' ' 84' ' ' LYS . 49.5 t -113.03 107.79 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.104 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.575 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -60.41 130.39 46.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.8 t -80.31 121.87 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.154 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.996 HG11 HG23 ' A' ' 41' ' ' VAL . 40.6 t -114.71 120.37 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.178 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 21' ' ' ILE . 18.6 m -111.69 142.88 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -33.49 -37.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HB3' HD11 ' A' ' 21' ' ' ILE . 9.4 mt-10 -60.52 -48.26 82.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 33' ' ' VAL . 14.5 p-10 -107.56 25.03 11.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.659 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 20.2 t80 -65.68 -55.21 18.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.427 ' HA ' ' CG ' ' A' ' 42' ' ' ASN . 6.2 t70 -67.72 -3.91 10.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -92.67 -43.57 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.506 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 14.2 mt -99.19 -52.65 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.179 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.996 HG23 HG11 ' A' ' 32' ' ' VAL . 89.3 t -60.79 -61.41 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.436 ' OD1' ' CE1' ' A' ' 37' ' ' PHE . 2.0 m-20 -67.31 123.22 19.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.616 HD21 HG21 ' A' ' 48' ' ' VAL . 7.6 p30 -175.54 111.88 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.71 33.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -128.04 -30.14 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' NZ ' HG21 ' A' ' 81' ' ' VAL . 34.5 pttt -138.16 166.31 24.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.86 144.86 25.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.616 HG21 HD21 ' A' ' 43' ' ' ASN . 93.1 t -146.58 148.76 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.4 tp -123.81 125.45 44.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.932 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.3 tp -110.83 134.35 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' OE1' ' CG1' ' A' ' 104' ' ' ILE . 3.1 tp10 -127.42 112.83 15.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.406 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 61.0 m-85 -87.21 115.57 24.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.95 171.81 7.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.968 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.13 131.78 23.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -6.24 18.12 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.727 2.285 . . . . 0.0 112.319 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.483 ' CZ2' HG21 ' A' ' 88' ' ' THR . 6.8 p-90 -124.39 25.98 7.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 10.2 t -128.75 112.46 14.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 61' ' ' LYS . . . -52.14 -61.55 6.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.493 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -41.54 -37.91 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.838 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 88.7 m -74.35 -34.76 63.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 58' ' ' GLY . 3.8 ttmt -70.29 -35.1 73.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -72.3 -23.34 61.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 64' ' ' GLU . 11.8 tp -85.24 -29.74 24.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.562 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.6 tp10 -36.74 -55.92 1.46 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.658 0.742 . . . . 0.0 110.851 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.8 Cg_endo -69.75 -36.15 11.37 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.675 2.25 . . . . 0.0 112.367 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -66.1 -28.07 68.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CZ ' HG23 ' A' ' 82' ' ' ILE . 35.9 t80 -95.3 -38.72 10.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -45.73 -58.8 3.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -43.69 -50.13 7.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.477 ' N ' HD21 ' A' ' 124' ' ' LEU . 17.9 tp -46.09 -37.08 6.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.58 -62.3 6.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.473 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -68.37 -22.9 64.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -72.65 -49.41 31.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.466 HD22 ' OD2' ' A' ' 77' ' ' ASP . 95.0 mt -80.06 2.98 21.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.939 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.4 t -51.02 -24.11 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -86.5 17.13 4.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.466 ' OD2' HD22 ' A' ' 74' ' ' LEU . 75.5 m-20 -110.21 98.11 33.81 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.592 0.71 . . . . 0.0 110.917 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.6 Cg_endo -69.78 -1.81 9.12 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 0.0 112.339 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -122.08 8.87 9.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.0 mt -134.72 142.47 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.522 ' HB ' HG22 ' A' ' 48' ' ' VAL . 87.1 t -139.12 106.64 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.53 HG23 ' CZ ' ' A' ' 67' ' ' TYR . 46.3 mm -83.73 125.92 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.129 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.744 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -143.35 170.92 14.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.133 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.558 ' HG2' HG12 ' A' ' 29' ' ' VAL . 54.5 pttt -140.63 154.01 46.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.3 ttt -140.85 142.51 34.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 26.7 t0 -91.54 82.28 5.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -41.4 -48.54 3.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.483 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 19.9 p -57.38 -33.34 67.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 86' ' ' ASP . . . -103.31 13.29 34.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.093 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.503 ' ND2' ' C ' ' A' ' 89' ' ' ALA . 8.6 m-80 -162.91 107.77 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -44.97 127.65 6.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.409 HG11 HG23 ' A' ' 98' ' ' VAL . 90.6 t -78.01 122.57 85.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.597 0.713 . . . . 0.0 111.164 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -166.51 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.378 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.494 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -118.85 161.78 34.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.727 . . . . 0.0 110.85 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 94' ' ' SER . 54.2 Cg_endo -69.66 -13.78 12.24 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.679 -1.8 . . . . 0.0 112.373 -0.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.468 ' C ' ' O ' ' A' ' 95' ' ' PRO . 83.2 m-85 -32.09 120.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.941 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -129.68 76.46 1.72 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.543 HG22 HG21 ' A' ' 103' ' ' THR . 86.4 t -74.41 125.17 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -123.2 -42.28 2.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.2 129.41 6.72 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.452 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.529 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -97.87 154.84 37.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.678 0.751 . . . . 0.0 110.848 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.1 Cg_endo -69.76 162.2 84.61 Favored 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.669 -1.805 . . . . 0.0 112.348 0.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.543 HG21 HG22 ' A' ' 98' ' ' VAL . 31.4 m -140.95 106.16 5.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.16 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.584 HD13 ' HE1' ' A' ' 127' ' ' PHE . 41.4 mt -101.1 123.86 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.49 ' CZ ' ' HE3' ' A' ' 117' ' ' LYS . 10.4 m-85 -123.92 147.05 48.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 24.6 t80 -117.78 133.79 55.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -103.73 94.46 6.26 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.678 0.751 . . . . 0.0 110.897 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.503 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.75 164.8 33.19 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.665 2.243 . . . . 0.0 112.356 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' A' ' 110' ' ' ASN . . . -80.75 139.74 35.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 1.8 p-10 47.85 25.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.503 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 23.4 mtmt -129.16 19.75 5.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.847 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -43.24 -68.28 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.929 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 112' ' ' LYS . 4.5 mm? -33.94 -51.75 0.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 11.5 m120 -112.16 96.19 33.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.721 . . . . 0.0 110.898 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.5 Cg_endo -69.75 -170.78 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 0.0 112.34 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -138.85 110.1 6.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.49 ' HE3' ' CZ ' ' A' ' 105' ' ' TYR . 30.0 tttt -73.83 156.54 37.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -106.35 96.58 6.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -111.51 102.13 10.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 179.56 -151.31 9.98 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.83 130.91 10.0 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -79.58 44.5 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.323 . . . . 0.0 110.908 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 124' ' ' LEU . 9.8 tt0 -105.66 133.48 50.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.602 HD13 ' C ' ' A' ' 124' ' ' LEU . 2.9 tm? -35.56 -55.79 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 44.8 p -57.9 -46.99 84.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -51.19 -37.13 44.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.584 ' HE1' HD13 ' A' ' 104' ' ' ILE . 61.7 m-85 -69.89 -45.79 66.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 124' ' ' LEU . 33.7 mt -59.0 -59.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -60.08 -30.27 69.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 130' ' ' TYR . 3.9 t80 -59.52 -45.63 91.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.927 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 132' ' ' GLN . 19.0 mt -76.02 -43.35 44.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.938 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 131' ' ' LEU . 45.1 mt-30 -36.12 -39.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.447 ' HB3' ' NH1' ' A' ' 133' ' ' ARG . 5.4 ptp180 -99.39 -48.43 4.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.78 -61.57 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -43.24 126.24 4.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.421 HG23 ' NZ ' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -52.89 -74.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.114 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 t -51.2 -57.14 9.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.13 172.06 43.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.51 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 160.42 49.8 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.652 2.235 . . . . 0.0 112.39 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.2 m -43.9 162.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.847 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 96.4 p -147.8 125.88 12.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.517 -179.954 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 t -144.33 164.81 29.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 0.0 110.849 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 p -115.78 152.23 33.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.17 82.76 0.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.5 m -98.58 154.01 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.904 0.383 . . . . 0.0 110.858 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.0 t -146.06 117.11 7.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.839 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 149.13 90.2 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.506 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -106.58 -52.92 2.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 110.822 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.65 93.17 1.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.43 -170.68 14.95 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.439 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -95.51 81.84 3.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 0.0 110.876 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.666 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -82.68 15.04 2.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.897 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HE3' ' CG ' ' A' ' 38' ' ' ASP . 1.4 mmpt? -71.24 123.2 21.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -158.39 125.35 4.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.861 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -169.87 160.37 8.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 17' ' ' LYS . 3.9 pp -103.17 -41.86 5.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.691 ' HB3' HD12 ' A' ' 16' ' ' LEU . 18.7 ptmt -130.23 157.96 41.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.52 ' OG ' ' HB3' ' A' ' 34' ' ' ALA . 8.7 t -162.08 166.05 26.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 3.5 mm-40 -105.6 161.7 21.98 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.684 0.754 . . . . 0.0 110.835 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.447 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.78 145.34 56.71 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.67 2.247 . . . . 0.0 112.349 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.683 HD11 ' HB3' ' A' ' 35' ' ' GLU . 28.4 mm -68.78 132.04 90.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.62 0.724 . . . . 0.0 111.144 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 175.74 7.71 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.69 2.26 . . . . 0.0 112.386 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 24' ' ' SER . 6.6 pt-20 -108.72 -37.5 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.419 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 85.3 p -129.62 130.14 45.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.891 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -133.77 43.03 2.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 27' ' ' GLY . 2.9 m-20 -72.65 -19.13 61.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -45.54 173.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.505 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -30.13 22.8 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.7 2.266 . . . . 0.0 112.313 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.676 HG12 ' HG2' ' A' ' 84' ' ' LYS . 39.8 t -116.84 106.65 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.15 132.16 52.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.1 t -83.11 125.34 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.168 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.827 HG11 HG23 ' A' ' 41' ' ' VAL . 18.0 t -120.79 129.93 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.515 HG22 ' OD1' ' A' ' 36' ' ' ASN . 15.0 m -121.86 145.85 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HB3' ' OG ' ' A' ' 18' ' ' SER . . . -37.8 -28.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.683 ' HB3' HD11 ' A' ' 21' ' ' ILE . 3.9 mt-10 -66.71 -45.06 79.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.515 ' OD1' HG22 ' A' ' 33' ' ' VAL . 39.9 p-10 -119.41 37.45 4.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.585 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 8.3 t80 -71.63 -51.43 23.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.43 ' CG ' ' HE3' ' A' ' 13' ' ' LYS . 3.4 m-20 -69.09 -12.33 61.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.41 -41.29 20.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.8 mt -99.34 -60.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.827 HG23 HG11 ' A' ' 32' ' ' VAL . 43.6 t -52.82 -62.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -72.74 130.35 40.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -173.55 106.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.416 ' HB3' ' NZ ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -83.25 36.27 0.52 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -133.72 -36.43 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -139.08 145.79 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 1.4 m-20 -66.35 135.59 54.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' A' ' 41' ' ' VAL . 60.7 t -130.48 145.08 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.841 HD13 HD21 ' A' ' 131' ' ' LEU . 6.7 tp -124.6 118.8 27.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.607 HD13 ' CG2' ' A' ' 41' ' ' VAL . 2.0 tp -106.09 137.55 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.25 117.65 22.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -93.23 137.98 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.908 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 53' ' ' TYR . 3.8 p90 -142.36 171.93 13.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.98 133.03 24.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.613 0.721 . . . . 0.0 111.119 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -0.76 7.41 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 0.0 112.308 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.422 ' CZ2' ' CG2' ' A' ' 88' ' ' THR . 2.4 p-90 -128.63 24.41 5.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.0 t -120.31 110.81 17.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -40.87 -58.5 2.65 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.464 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.469 ' C ' ' O ' ' A' ' 58' ' ' GLY . 3.7 t-160 -32.98 -62.49 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 110.839 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' GLU . 3.9 t -40.15 -49.81 2.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.886 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -56.77 -48.88 76.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -70.76 -21.95 62.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.29 -19.99 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 1.1 tt0 -43.32 -57.91 4.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 0.0 110.938 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.5 Cg_endo -69.78 -33.38 16.63 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.693 2.262 . . . . 0.0 112.335 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -66.37 -32.23 73.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 68' ' ' LYS . 31.7 t80 -89.22 -47.77 7.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 67' ' ' TYR . 14.8 ttmt -37.75 -60.15 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -38.78 -59.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 127' ' ' PHE . 24.5 tp -41.99 -36.99 1.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.2 -69.14 1.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.459 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -64.58 -23.01 67.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -71.51 -39.97 70.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.597 HD12 HD11 ' A' ' 82' ' ' ILE . 85.1 mt -88.58 3.16 51.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 t -55.15 -31.73 61.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' A' ' 76' ' ' LYS . 25.5 ttpt -73.0 1.47 8.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 3.6 t70 -102.5 100.07 14.92 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.88 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.4 Cg_endo -69.81 0.46 5.65 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.64 2.226 . . . . 0.0 112.34 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -111.69 -41.36 4.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.529 HG21 HD13 ' A' ' 74' ' ' LEU . 63.0 mt -90.74 138.09 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.9 t -133.94 113.5 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.597 HD11 HD12 ' A' ' 74' ' ' LEU . 39.6 mm -82.45 131.97 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.781 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -143.63 170.97 14.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.088 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.676 ' HG2' HG12 ' A' ' 29' ' ' VAL . 12.4 pttp -143.07 154.39 43.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.9 ttt -150.08 133.36 16.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -85.28 76.52 10.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -35.71 -61.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.06 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 87' ' ' ALA . 43.9 p -32.26 -41.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.136 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HB3' ' OD2' ' A' ' 86' ' ' ASP . . . -94.66 -31.14 13.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.094 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 87' ' ' ALA . 35.9 m-80 -111.14 101.54 10.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -43.58 123.8 3.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.448 HG11 HG23 ' A' ' 98' ' ' VAL . 73.1 t -66.66 129.2 94.11 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.572 0.701 . . . . 0.0 111.172 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -163.53 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.625 2.217 . . . . 0.0 112.383 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.503 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.4 m -131.41 160.85 65.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.649 0.738 . . . . 0.0 110.828 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.1 Cg_endo -69.82 -4.55 8.45 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.706 -1.789 . . . . 0.0 112.304 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.447 ' N ' ' HA ' ' A' ' 94' ' ' SER . 65.9 m-85 -34.55 127.44 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.63 116.08 18.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.678 HG22 HG21 ' A' ' 103' ' ' THR . 57.9 t -123.64 115.94 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.88 -47.0 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.855 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.19 130.42 8.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.5 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.534 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -99.08 155.81 36.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.692 0.758 . . . . 0.0 110.875 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.2 Cg_endo -69.68 163.16 82.34 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.375 -0.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.678 HG21 HG22 ' A' ' 98' ' ' VAL . 26.5 m -142.36 106.29 4.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.2 mt -95.5 142.8 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.479 ' HB2' HG23 ' A' ' 50' ' ' ILE . 7.5 m-85 -134.52 179.14 6.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' LYS . 19.3 t80 -147.75 135.49 20.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.43 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 33.8 t -104.72 94.62 7.59 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.696 0.76 . . . . 0.0 110.814 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.476 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.7 Cg_endo -69.74 159.68 52.52 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.67 2.247 . . . . 0.0 112.38 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.38 130.82 34.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.125 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 64.71 24.98 12.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.476 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 14.0 mtmt -131.75 18.31 4.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -44.25 -63.16 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.925 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -39.29 -32.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 1.9 t30 -134.02 98.31 14.48 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.647 0.737 . . . . 0.0 110.891 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.49 ' CD ' ' HG2' ' A' ' 95' ' ' PRO . 54.2 Cg_endo -69.75 179.24 3.83 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -134.77 125.18 26.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -90.65 146.22 24.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -83.92 121.87 27.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -122.24 104.09 9.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.91 -170.39 43.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.478 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.74 141.26 26.19 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.508 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.89 47.31 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 110.844 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 124' ' ' LEU . 27.2 tt0 -102.02 129.45 48.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.447 HD21 ' N ' ' A' ' 70' ' ' LEU . 2.4 tm? -33.75 -54.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.7 t -60.74 -47.1 87.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -44.35 -42.02 6.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.457 ' HB2' HD13 ' A' ' 70' ' ' LEU . 62.8 m-85 -68.31 -44.52 75.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.858 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.872 HG22 HE21 ' A' ' 132' ' ' GLN . 33.0 mt -59.06 -53.12 52.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 t -65.31 -39.5 92.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.53 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 36.4 t80 -56.71 -53.07 61.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.841 HD21 HD13 ' A' ' 49' ' ' LEU . 68.3 mt -67.21 -42.9 83.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.872 HE21 HG22 ' A' ' 128' ' ' ILE . 35.3 mt-30 -36.96 -40.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -99.15 -61.68 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.53 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 11.3 mm-40 -42.2 -54.2 3.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.72 132.0 30.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.58 -75.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.9 t -48.7 -62.07 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.6 144.07 16.25 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.451 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 140' ' ' SER . 53.9 Cg_endo -69.75 2.9 3.11 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.694 2.263 . . . . 0.0 112.386 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 139' ' ' PRO . 83.5 p -33.48 114.33 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.836 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.3 p -123.9 105.53 9.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.86 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.446 179.97 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -140.12 162.12 35.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.875 0.369 . . . . 0.0 110.844 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.3 p -147.55 167.96 23.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.44 96.51 0.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.518 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -150.04 134.42 17.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.888 0.375 . . . . 0.0 110.849 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.9 p -99.86 130.33 46.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.832 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.13 102.47 2.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.512 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -162.17 115.49 1.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 110.836 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -130.14 119.94 23.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.48 164.22 27.03 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.476 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -70.77 88.54 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.39 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.615 HD21 ' HD3' ' A' ' 95' ' ' PRO . 25.5 tp -95.83 89.58 5.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.465 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 0.7 OUTLIER -159.88 159.67 32.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -173.71 129.29 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.468 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 3.5 p90 -161.23 147.79 14.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.54 HD12 ' HB3' ' A' ' 17' ' ' LYS . 3.9 pp -94.79 -39.48 10.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.54 ' HB3' HD12 ' A' ' 16' ' ' LEU . 7.7 ptmt -116.49 156.93 26.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 76.8 p -160.61 149.58 16.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.437 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 10.2 mm-40 -92.53 161.3 32.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.62 0.724 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.437 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.6 Cg_endo -69.74 141.17 44.59 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.372 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.465 HD13 ' CG2' ' A' ' 33' ' ' VAL . 13.3 mm -69.44 130.84 90.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.731 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 160.59 49.13 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.682 2.255 . . . . 0.0 112.369 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.89 -38.65 13.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -141.77 105.3 4.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -122.65 46.56 2.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -87.5 39.48 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.12 -160.57 36.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.476 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -42.84 3.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 0.0 112.362 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.565 HG13 HG22 ' A' ' 82' ' ' ILE . 10.9 t -116.57 104.72 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -52.83 135.39 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.0 t -84.23 120.69 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.176 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.159 HG11 HG23 ' A' ' 41' ' ' VAL . 12.9 t -119.45 115.32 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.117 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 35' ' ' GLU . 27.9 m -111.52 141.71 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -30.44 -38.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 33' ' ' VAL . 6.7 mt-10 -56.3 -51.51 67.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 33' ' ' VAL . 53.1 p-10 -110.48 24.76 12.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.765 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 13.1 t80 -63.19 -51.15 67.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -4.95 18.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.831 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -92.17 -43.84 9.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.3 mt -97.11 -61.16 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.107 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.159 HG23 HG11 ' A' ' 32' ' ' VAL . 78.5 t -53.16 -62.17 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -65.46 120.18 12.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.435 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 4.1 t-20 -174.94 119.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' CA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -104.93 32.44 4.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -127.7 -31.22 2.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 14.3 pttp -138.29 136.95 36.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.81 138.6 53.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.57 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 40.9 t -137.31 159.13 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.51 ' N ' HG12 ' A' ' 48' ' ' VAL . 16.1 tp -140.21 132.17 27.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.923 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' A' ' 96' ' ' TYR . 3.3 tp -116.21 141.36 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.175 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.545 ' OE2' ' CG ' ' A' ' 67' ' ' TYR . 2.5 tt0 -125.49 118.74 26.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -98.9 108.42 21.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -115.75 -179.15 3.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.779 ' HB3' ' HB2' ' A' ' 57' ' ' CYS . . . -133.73 132.98 21.9 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 0.0 111.085 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 -1.01 7.74 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -126.31 5.79 7.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.779 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 1.3 m -99.89 129.47 45.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.836 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.16 -45.9 14.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.46 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -48.32 -27.72 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.836 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.0 m -80.13 -44.0 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -55.29 -42.33 73.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -70.49 -20.54 62.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.946 HD12 ' HB2' ' A' ' 66' ' ' LYS . 8.4 tp -94.22 -23.16 18.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.557 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 5.1 tt0 -33.71 -57.13 0.64 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 0.0 110.914 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.6 Cg_endo -69.78 -27.29 26.54 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.721 2.281 . . . . 0.0 112.328 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.946 ' HB2' HD12 ' A' ' 63' ' ' LEU . 2.7 mmpt? -72.39 -30.97 65.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.545 ' CG ' ' OE2' ' A' ' 51' ' ' GLU . 37.9 t80 -95.97 -40.09 9.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.471 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -55.66 -43.28 76.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -53.54 -53.42 51.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.463 ' N ' HD21 ' A' ' 124' ' ' LEU . 20.3 tp -43.45 -38.35 2.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.08 -64.56 3.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.97 -21.36 66.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.937 0.398 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -79.32 -45.05 20.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ASP . 78.6 mt -84.06 1.64 43.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 m -40.19 -27.94 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -85.0 25.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 74' ' ' LEU . 51.2 p-10 -103.9 93.41 5.29 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.618 0.723 . . . . 0.0 110.863 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 76' ' ' LYS . 54.1 Cg_endo -69.78 0.58 5.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.334 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -122.91 -44.72 2.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.452 ' O ' ' CG ' ' A' ' 77' ' ' ASP . 37.0 mt -87.71 144.59 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.5 t -136.0 107.38 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.179 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.565 HG22 HG13 ' A' ' 29' ' ' VAL . 38.2 mm -76.17 131.44 34.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.678 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -145.83 173.87 11.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.561 ' HG2' HG12 ' A' ' 29' ' ' VAL . 25.1 pttt -148.57 157.59 43.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.448 ' CB ' HD11 ' A' ' 50' ' ' ILE . 1.9 tmm? -149.59 148.11 28.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 90' ' ' ASN . 49.8 t0 -97.74 99.65 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.94 80.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.092 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 88' ' ' THR . 2.7 p -66.12 -17.27 64.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -117.89 -10.97 10.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 86' ' ' ASP . 14.1 m-80 -139.62 107.63 5.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.41 ' HB3' ' CB ' ' A' ' 15' ' ' TYR . 7.0 t0 -42.27 138.06 1.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.516 HG21 ' CG2' ' A' ' 98' ' ' VAL . 74.6 t -80.51 128.32 72.83 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.625 0.726 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 54.4 Cg_endo -69.72 -165.64 0.16 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.723 2.282 . . . . 0.0 112.35 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.535 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 0.8 OUTLIER -127.44 154.59 77.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.655 0.741 . . . . 0.0 110.851 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.615 ' HD3' HD21 ' A' ' 12' ' ' LEU . 54.1 Cg_endo -69.75 -6.03 9.19 Favored 'Cis proline' 0 N--CA 1.466 -0.13 0 C-N-CA 122.709 -1.788 . . . . 0.0 112.372 0.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.525 ' HE2' HG21 ' A' ' 50' ' ' ILE . 33.1 m-85 -33.01 137.45 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -151.63 120.89 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.843 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.516 ' CG2' HG21 ' A' ' 92' ' ' VAL . 39.7 t -113.42 110.07 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.11 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.8 -45.32 5.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -132.32 132.01 6.48 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.483 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.539 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -96.95 154.86 38.1 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.658 0.742 . . . . 0.0 110.899 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 54.0 Cg_endo -69.74 159.51 89.52 Favored 'Cis proline' 0 C--O 1.232 0.191 0 C-N-CA 122.696 -1.793 . . . . 0.0 112.379 0.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.457 ' OG1' HG13 ' A' ' 98' ' ' VAL . 93.4 m -137.98 111.55 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.147 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.451 HG12 ' CG ' ' A' ' 51' ' ' GLU . 86.9 mt -109.82 131.88 59.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -123.12 -176.38 3.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 29.1 t80 -152.82 132.22 12.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.887 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.2 t -103.6 96.31 8.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.69 0.757 . . . . 0.0 110.895 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.473 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.5 Cg_endo -69.68 168.26 21.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.719 2.279 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.404 ' HB3' HG21 ' A' ' 136' ' ' THR . . . -87.2 135.15 33.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 54.67 25.73 6.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.913 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.473 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 10.6 mtmt -129.53 21.59 5.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.513 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -49.33 -41.63 39.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -52.42 -39.7 61.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 6.8 m-80 -134.74 97.97 13.69 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.593 0.711 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 54.3 Cg_endo -69.69 -170.63 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.674 2.249 . . . . 0.0 112.372 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -136.27 139.07 42.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -107.21 137.03 46.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.433 ' CZ ' ' CD1' ' A' ' 127' ' ' PHE . 62.8 t80 -78.85 107.84 11.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -124.03 95.17 4.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -174.39 -139.52 3.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.95 128.52 9.18 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -79.7 49.52 1.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.761 0.315 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 124' ' ' LEU . 5.4 tp10 -112.74 132.46 55.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.563 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.5 tm? -34.44 -51.49 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.5 p -63.11 -53.22 56.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.17 -36.53 2.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.433 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 52.8 m-85 -68.91 -43.62 74.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.4 mt -55.89 -63.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.099 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.3 t -54.74 -36.54 64.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 134' ' ' GLU . 44.3 t80 -55.18 -50.87 68.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.916 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.3 -42.15 69.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -43.61 -41.44 4.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.43 ' CG ' ' N ' ' A' ' 134' ' ' GLU . 12.9 ptm180 -91.57 -53.06 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.435 ' HG3' ' CE1' ' A' ' 130' ' ' TYR . 26.1 mm-40 -51.93 -62.87 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -37.41 105.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.078 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 137' ' ' SER . 1.8 t -49.84 -52.78 29.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.494 ' H ' HG23 ' A' ' 136' ' ' THR . 1.3 t -74.5 -41.51 60.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.02 161.6 0.2 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.465 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 114.63 3.77 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.716 2.277 . . . . 0.0 112.309 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.6 p -121.61 168.93 11.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.0 t -115.89 153.83 30.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.0 p -119.85 99.17 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.886 0.374 . . . . 0.0 110.855 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.0 t -153.4 159.15 42.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.855 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.89 111.35 1.07 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 t -134.42 139.59 45.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 t -172.99 155.85 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.24 174.49 35.69 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -95.4 143.06 27.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.6 -53.09 62.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.34 66.57 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -82.32 39.53 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.2 mt -97.3 45.84 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -115.11 141.33 48.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.479 ' HD3' ' N ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -174.72 121.95 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.879 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -151.49 154.59 36.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -106.3 -33.32 7.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.944 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.456 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 10.7 mtpp -101.57 163.86 12.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.0 p -166.5 134.28 2.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.726 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 2.4 mm-40 -98.24 161.63 24.75 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.887 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.9 Cg_endo -69.75 140.07 41.8 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.679 2.253 . . . . 0.0 112.336 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.604 HD13 HG21 ' A' ' 33' ' ' VAL . 15.8 mm -70.46 123.41 88.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 111.107 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 130.19 18.91 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.671 2.248 . . . . 0.0 112.35 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.21 -46.81 69.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 t -144.96 133.22 21.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -106.7 48.71 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -50.28 -33.16 18.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -42.07 164.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.445 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -22.99 31.29 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.674 2.249 . . . . 0.0 112.341 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.454 HG13 HG22 ' A' ' 82' ' ' ILE . 32.9 t -119.33 112.19 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -57.89 137.23 56.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.7 t -90.49 116.24 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.133 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.819 HG11 HG23 ' A' ' 41' ' ' VAL . 19.6 t -105.98 124.73 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 21' ' ' ILE . 15.8 m -118.66 148.16 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.879 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -38.1 -36.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.152 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -62.78 -50.64 70.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.486 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 11.4 p-10 -108.33 28.57 8.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.583 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 5.5 t80 -67.51 -55.78 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.835 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -66.11 -5.26 9.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -88.42 -43.11 11.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.43 HD12 HG22 ' A' ' 32' ' ' VAL . 18.1 mt -98.35 -54.14 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.127 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.819 HG23 HG11 ' A' ' 32' ' ' VAL . 40.4 t -56.09 -61.58 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -67.44 112.67 4.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' ND2' ' HE2' ' A' ' 46' ' ' LYS . 13.4 t-20 -173.23 105.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.85 4.64 47.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -90.69 -35.03 15.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HE2' ' ND2' ' A' ' 43' ' ' ASN . 45.9 pttt -138.52 151.95 47.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.9 136.1 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.61 136.01 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.127 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.8 tp -116.11 119.24 35.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 105' ' ' TYR . 2.3 tp -106.81 134.88 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.166 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -127.21 120.08 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -95.87 122.47 38.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CE1' ' OD1' ' A' ' 86' ' ' ASP . 13.1 p90 -124.4 -179.6 4.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.927 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.63 133.48 21.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.565 0.698 . . . . 0.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.426 ' HD2' HG21 ' A' ' 88' ' ' THR . 53.6 Cg_endo -69.73 -6.28 18.2 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.687 2.258 . . . . 0.0 112.347 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -122.89 21.92 9.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t -120.2 111.14 17.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -43.06 -47.71 6.43 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -46.68 -37.25 8.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.771 0.32 . . . . 0.0 110.858 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 34.7 t -63.46 -44.5 94.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.908 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -65.5 -42.16 92.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -72.68 -35.0 67.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' A' ' 66' ' ' LYS . 14.0 tp -81.97 -26.77 33.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.527 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.3 tt0 -38.08 -58.1 1.54 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.608 0.718 . . . . 0.0 110.926 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.7 Cg_endo -69.82 -31.11 20.91 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.625 2.217 . . . . 0.0 112.332 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HB2' HD12 ' A' ' 63' ' ' LEU . 29.0 mtpt -68.63 -30.0 68.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -92.42 -45.21 8.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.933 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -41.65 -58.96 1.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.947 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 70' ' ' LEU . 16.4 mt-10 -41.07 -61.64 0.96 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.487 ' N ' HD21 ' A' ' 124' ' ' LEU . 22.2 tp -38.06 -35.63 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.35 -68.77 1.52 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.494 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -66.08 -19.69 65.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -75.28 -41.38 57.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.607 HD12 HD11 ' A' ' 82' ' ' ILE . 92.6 mt -86.46 3.35 44.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.2 t -54.07 -34.46 60.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -6.23 5.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 5.9 t70 -102.83 100.37 16.4 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.629 0.728 . . . . 0.0 110.873 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 53.7 Cg_endo -69.79 0.78 5.18 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.706 2.271 . . . . 0.0 112.346 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -110.46 -34.81 6.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 74' ' ' LEU . 71.8 mt -93.43 126.98 45.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 84.1 t -124.47 110.92 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.125 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.607 HD11 HD12 ' A' ' 74' ' ' LEU . 49.9 mm -82.99 123.7 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.142 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -133.75 161.47 34.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -134.65 150.43 50.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.455 ' CG ' ' OD1' ' A' ' 90' ' ' ASN . 10.7 ttt -141.45 140.12 33.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.629 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 7.6 t0 -95.41 91.16 6.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.804 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -45.0 -49.18 11.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.1 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.426 HG21 ' HD2' ' A' ' 55' ' ' PRO . 1.2 p -55.73 -28.56 56.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.14 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.726 ' HB1' ' CG ' ' A' ' 19' ' ' GLU . . . -94.05 -12.43 28.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.455 ' OD1' ' CG ' ' A' ' 85' ' ' MET . 0.5 OUTLIER -157.26 123.54 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.435 ' OD2' HD23 ' A' ' 16' ' ' LEU . 12.0 t0 -57.38 135.91 56.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.874 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.9 t -82.95 128.19 66.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.628 0.728 . . . . 0.0 111.087 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -168.21 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.663 2.242 . . . . 0.0 112.351 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 m -115.73 162.0 27.58 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.712 0.768 . . . . 0.0 110.84 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.4 Cg_endo -69.78 -10.83 11.73 Favored 'Cis proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 -1.795 . . . . 0.0 112.319 0.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 95' ' ' PRO . 98.0 m-85 -35.25 133.9 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -141.83 118.56 11.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.492 HG22 HG21 ' A' ' 103' ' ' THR . 77.4 t -120.96 116.11 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.093 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -118.14 -44.64 2.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.34 123.42 5.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.509 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.536 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -98.31 154.89 37.43 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.674 0.75 . . . . 0.0 110.864 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.536 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.2 Cg_endo -69.74 162.08 84.8 Favored 'Cis proline' 0 C--O 1.231 0.162 0 C-N-CA 122.686 -1.798 . . . . 0.0 112.327 -0.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.492 HG21 HG22 ' A' ' 98' ' ' VAL . 52.3 m -139.99 125.45 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.8 mt -116.25 138.57 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.54 ' CZ ' ' HD3' ' A' ' 117' ' ' LYS . 8.8 m-85 -134.54 162.66 31.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.946 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -133.5 136.33 45.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 t -104.47 93.02 5.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.882 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.502 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.3 Cg_endo -69.68 151.87 69.6 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.403 ' O ' ' HE3' ' A' ' 111' ' ' LYS . . . -69.59 145.46 52.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.4 p30 44.83 25.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.502 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 24.9 mtmt -130.4 41.28 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -66.06 -51.37 58.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.862 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -48.19 -49.08 34.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 2.9 m120 -122.32 91.79 49.1 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 54.4 Cg_endo -69.74 -163.8 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.661 2.241 . . . . 0.0 112.362 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -145.6 132.42 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.54 ' HD3' ' CZ ' ' A' ' 105' ' ' TYR . 17.2 ttpt -98.8 137.34 37.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -73.14 104.69 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -116.97 98.42 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.903 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.88 -144.63 6.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.452 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.53 130.73 10.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.503 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 -79.57 45.5 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.745 0.307 . . . . 0.0 110.866 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 124' ' ' LEU . 5.1 tp10 -106.42 132.83 51.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.628 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.2 tm? -37.37 -52.51 1.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.1 m -61.69 -43.04 99.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -51.78 -42.11 62.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -63.18 -40.59 97.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mt -60.16 -61.73 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.3 t -56.26 -32.57 64.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 20.8 t80 -57.9 -58.48 8.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.0 -39.1 92.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -41.32 -40.87 1.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 7.1 ptp180 -102.9 -38.11 7.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 71.6 mm-40 -67.03 -60.94 2.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -44.47 132.35 6.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.088 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.42 -75.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.164 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 t -49.73 -56.69 9.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.51 -179.63 31.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.527 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -0.53 7.01 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.728 2.285 . . . . 0.0 112.336 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.2 p -47.59 126.47 10.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.843 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.1 m -134.23 139.11 45.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.888 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.449 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 t -170.29 118.2 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.823 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m -145.58 131.59 19.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.833 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.42 128.41 1.01 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 m -151.63 169.33 22.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.844 0.354 . . . . 0.0 110.871 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.3 t -165.2 171.13 14.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.819 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.25 131.95 5.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.493 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 52.94 39.43 29.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.889 0.376 . . . . 0.0 110.883 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' C ' ' OD1' ' A' ' 9' ' ' ASP . 0.7 OUTLIER -98.87 121.13 40.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.882 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.04 168.68 13.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 m120 60.43 35.67 20.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.349 . . . . 0.0 110.881 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.445 ' H ' HD12 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -104.53 43.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.592 ' HD2' ' CE1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -68.18 121.25 15.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.488 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 11.5 tpt180 -135.5 131.64 36.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.592 ' CE1' ' HD2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -175.08 164.57 3.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.926 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 17' ' ' LYS . 4.0 pp -116.36 -36.93 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' A' ' 18' ' ' SER . 6.6 ttpm? -119.78 163.25 17.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.508 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 85.7 p -165.12 155.57 13.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.459 ' CD ' ' HD2' ' A' ' 20' ' ' PRO . 4.4 mm-40 -103.3 162.23 20.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.652 0.739 . . . . 0.0 110.884 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.459 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.74 143.4 50.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 0.0 112.33 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 35' ' ' GLU . 17.3 mm -70.04 132.56 88.32 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.722 . . . . 0.0 111.12 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 142.77 48.69 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.721 2.281 . . . . 0.0 112.347 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.25 -36.44 61.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.901 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 p -119.99 113.92 21.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.879 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.431 ' CG ' ' HD2' ' A' ' 30' ' ' LYS . 10.1 t-20 -125.11 47.0 2.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -111.11 61.74 0.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.15 -165.22 11.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.448 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -40.94 4.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.684 2.256 . . . . 0.0 112.35 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.501 HG12 ' HG2' ' A' ' 84' ' ' LYS . 21.3 t -120.6 108.9 23.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HD2' ' CG ' ' A' ' 25' ' ' ASN . 1.5 mmmt -59.35 136.38 57.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.431 HG22 ' HE3' ' A' ' 84' ' ' LYS . 95.3 t -84.65 125.01 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.88 HG11 HG23 ' A' ' 41' ' ' VAL . 31.3 t -119.38 119.61 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.479 HG21 HD13 ' A' ' 21' ' ' ILE . 18.1 m -115.54 148.11 18.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.088 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -35.31 -38.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.111 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' A' ' 21' ' ' ILE . 15.7 mt-10 -59.71 -48.93 79.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.449 ' C ' ' OD1' ' A' ' 36' ' ' ASN . 14.8 p-10 -111.44 30.16 7.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.739 ' CD2' HG21 ' A' ' 41' ' ' VAL . 15.4 t80 -68.48 -62.55 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.43 -8.8 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.56 -46.57 11.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.5 mt -97.46 -50.37 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.88 HG23 HG11 ' A' ' 32' ' ' VAL . 29.5 t -58.06 -60.88 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.104 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -76.16 125.34 28.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -169.13 105.19 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.28 -1.75 28.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -85.52 -46.63 10.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.01 166.62 23.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -83.12 151.0 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.41 ' O ' ' CD1' ' A' ' 106' ' ' PHE . 9.3 t -141.82 149.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.155 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.695 HD13 HD21 ' A' ' 131' ' ' LEU . 6.4 tp -122.84 120.01 32.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.411 HD11 ' CB ' ' A' ' 85' ' ' MET . 2.3 tp -107.4 137.11 40.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.49 ' OE1' ' CG1' ' A' ' 104' ' ' ILE . 3.7 tp10 -127.34 107.42 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.909 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.402 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 39.7 m-85 -83.82 126.62 33.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.442 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 9.6 p90 -132.87 176.0 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.893 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.03 133.07 24.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.713 . . . . 0.0 111.073 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -4.09 13.33 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.355 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.508 ' CZ2' HG21 ' A' ' 88' ' ' THR . 6.0 p-90 -123.56 17.7 9.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 43.6 t -116.09 100.63 8.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 59' ' ' HIS . . . -41.3 -51.1 4.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 58' ' ' GLY . 97.2 m-70 -37.4 -38.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.762 0.315 . . . . 0.0 110.855 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 64' ' ' GLU . 6.2 t -69.33 -51.34 37.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.52 -53.1 19.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -64.95 -18.09 64.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.688 HD12 ' HB2' ' A' ' 66' ' ' LYS . 45.8 tp -97.25 -18.41 19.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.585 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 2.5 tp10 -45.32 -55.12 12.44 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.69 0.757 . . . . 0.0 110.915 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 53.1 Cg_endo -69.83 -24.64 29.14 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 0.0 112.283 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.688 ' HB2' HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -76.99 -33.25 57.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -90.0 -31.94 16.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -53.81 -56.49 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.914 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -41.98 -56.81 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.469 ' N ' HD21 ' A' ' 124' ' ' LEU . 37.7 tp -41.14 -40.52 1.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.87 -69.09 1.4 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.496 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -59.36 -20.3 53.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.926 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -76.78 -46.56 24.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.693 HD12 HD11 ' A' ' 82' ' ' ILE . 96.8 mt -86.65 1.98 50.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -48.75 -22.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.02 22.91 4.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.607 ' OD2' HD22 ' A' ' 74' ' ' LEU . 72.6 m-20 -108.63 99.24 32.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.657 0.742 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 77' ' ' ASP . 54.4 Cg_endo -69.66 -0.82 7.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 0.0 112.36 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -117.62 -36.78 3.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.45 129.0 51.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.4 t -124.35 109.99 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.693 HD11 HD12 ' A' ' 74' ' ' LEU . 27.2 mm -80.36 133.57 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.146 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.754 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -147.65 169.12 20.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.501 ' HG2' HG12 ' A' ' 29' ' ' VAL . 40.2 pttt -136.4 153.16 51.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.411 ' CB ' HD11 ' A' ' 50' ' ' ILE . 14.4 ttt -146.46 135.72 22.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.442 ' OD1' ' CZ ' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -91.76 83.88 5.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.876 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -43.16 -55.95 3.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.508 HG21 ' CZ2' ' A' ' 56' ' ' TRP . 33.7 p -46.95 -32.39 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.168 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.38 -19.82 21.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.61 122.49 17.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -51.6 130.84 28.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.439 HG21 ' HB ' ' A' ' 98' ' ' VAL . 95.7 t -72.81 131.83 83.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.589 0.709 . . . . 0.0 111.108 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.602 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 53.7 Cg_endo -69.81 -168.43 0.28 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.665 2.243 . . . . 0.0 112.371 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.502 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.3 m -129.6 161.22 60.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.661 0.744 . . . . 0.0 110.828 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.9 Cg_endo -69.71 -3.11 7.43 Favored 'Cis proline' 0 C--N 1.341 0.182 0 C-N-CA 122.69 -1.796 . . . . 0.0 112.361 -0.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.473 ' N ' ' HA ' ' A' ' 94' ' ' SER . 83.6 m-85 -33.77 127.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -131.7 102.42 5.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.736 HG22 HG21 ' A' ' 103' ' ' THR . 74.8 t -105.82 115.5 47.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -114.65 -47.41 2.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.94 127.61 7.5 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.488 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.541 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -100.06 154.95 36.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 0.0 110.867 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.7 Cg_endo -69.75 157.9 91.53 Favored 'Cis proline' 0 C--O 1.231 0.166 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.369 -0.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.736 HG21 HG22 ' A' ' 98' ' ' VAL . 44.6 m -133.1 101.84 5.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.515 HD13 ' CE1' ' A' ' 127' ' ' PHE . 82.6 mt -95.18 125.55 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 7.8 m-85 -122.02 -176.98 3.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 41.6 t80 -150.91 136.25 17.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.8 t -105.52 92.42 5.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.491 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 54.0 Cg_endo -69.78 155.63 65.38 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.668 2.246 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.89 128.55 33.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 67.43 25.02 8.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.491 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 14.0 mtmt -134.38 56.02 1.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 114' ' ' ASN . 31.4 mmtt -80.11 -56.27 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.9 mp -37.8 -28.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 112' ' ' LYS . 12.6 m120 -148.71 107.63 3.5 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.912 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.502 ' CD ' ' HG2' ' A' ' 95' ' ' PRO . 53.4 Cg_endo -69.77 -174.97 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.72 2.28 . . . . 0.0 112.336 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.2 120.82 29.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 105' ' ' TYR . 13.2 ttmm -94.38 130.19 40.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -76.71 111.52 12.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -124.68 98.23 5.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.53 -137.84 2.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.38 126.96 8.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.443 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 63.9 mtm-85 -78.92 45.47 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 110.863 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -101.97 138.56 38.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.522 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.4 tm? -42.3 -51.3 4.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.7 p -70.59 -32.16 69.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -61.89 -34.65 76.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.515 ' CE1' HD13 ' A' ' 104' ' ' ILE . 31.0 m-85 -71.19 -35.21 71.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.2 mt -68.43 -52.01 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -63.75 -26.03 68.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -69.24 -47.68 64.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.923 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.695 HD21 HD13 ' A' ' 49' ' ' LEU . 17.6 mt -77.0 -42.65 37.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.916 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' LEU . 15.1 mt-30 -37.48 -31.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 131' ' ' LEU . 22.2 mmm180 -104.1 -53.81 2.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -50.01 -58.5 5.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 136' ' ' THR . . . -38.77 116.64 0.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -33.91 -75.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -73.33 -55.31 6.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.07 176.79 50.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.464 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 130.1 18.69 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.69 2.26 . . . . 0.0 112.323 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 t -81.04 138.45 36.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.83 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.8 t -118.09 -49.63 2.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.844 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.464 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.2 m -139.76 174.34 10.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.858 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.8 p -86.23 -56.83 3.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.877 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.63 129.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.505 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.9 p -143.68 136.76 27.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.381 . . . . 0.0 110.84 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.5 t -158.3 165.96 33.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.14 -176.95 32.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.46 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -88.39 140.71 29.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.352 . . . . 0.0 110.888 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -130.07 153.07 48.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.858 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.07 -131.13 10.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.487 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 68.84 36.0 2.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 0.0 110.877 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 76.4 mt -105.36 93.73 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -157.35 141.52 16.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 179.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -169.69 120.1 0.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.871 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 1.6 p90 -153.07 157.08 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.443 ' C ' HD12 ' A' ' 16' ' ' LEU . 2.9 pp -105.51 -41.24 5.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.42 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.9 tttp -96.78 160.83 14.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.462 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 93.0 p -168.2 150.16 5.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.834 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.493 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 8.7 mm-40 -104.52 161.53 22.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.64 0.733 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD2' ' CD ' ' A' ' 19' ' ' GLU . 53.8 Cg_endo -69.71 142.88 49.36 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.723 2.282 . . . . 0.0 112.337 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.489 HD11 ' CB ' ' A' ' 35' ' ' GLU . 40.7 mm -72.56 129.14 87.5 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.627 0.727 . . . . 0.0 111.151 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 169.87 17.87 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -88.95 -37.11 15.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -156.34 134.81 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.445 ' CB ' ' HD3' ' A' ' 30' ' ' LYS . 41.1 m-20 -111.39 47.75 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -52.19 -33.22 39.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -41.99 166.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.32 36.42 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.698 2.265 . . . . 0.0 112.304 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.89 117.78 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.144 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.647 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 10.0 mmtm -64.99 132.57 49.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.898 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.9 t -86.51 102.8 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.139 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.008 HG11 HG23 ' A' ' 41' ' ' VAL . 40.4 t -95.95 127.18 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.145 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 21' ' ' ILE . 27.1 m -123.08 146.25 28.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.871 ' HB1' ' CD2' ' A' ' 15' ' ' TYR . . . -31.71 -44.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.09 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.489 ' CB ' HD11 ' A' ' 21' ' ' ILE . 23.9 mt-10 -53.71 -50.77 65.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 33' ' ' VAL . 12.1 p-10 -112.26 33.92 4.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.9 ' CD2' HG21 ' A' ' 41' ' ' VAL . 14.1 t80 -74.33 -58.46 3.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -62.53 -8.79 6.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.45 -43.9 11.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.4 mt -98.78 -52.99 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.008 HG23 HG11 ' A' ' 32' ' ' VAL . 45.8 t -57.01 -61.94 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.51 115.75 11.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -160.73 105.04 1.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -84.71 8.68 16.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -104.49 -43.44 5.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -129.64 159.8 35.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -78.51 148.08 33.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.1 t -146.54 122.36 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.121 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 105' ' ' TYR . 16.0 tp -99.0 116.33 30.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 tp -105.25 130.75 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.08 115.35 21.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -89.68 116.6 27.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.54 ' CZ ' ' OD1' ' A' ' 86' ' ' ASP . 18.6 p90 -121.6 171.6 8.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.966 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.448 ' HB1' ' CE2' ' A' ' 56' ' ' TRP . . . -126.71 130.74 23.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.593 0.711 . . . . 0.0 111.104 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.414 ' HD2' HG21 ' A' ' 88' ' ' THR . 54.3 Cg_endo -69.76 -8.52 23.8 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 0.0 112.364 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.448 ' CE2' ' HB1' ' A' ' 54' ' ' ALA . 2.2 p-90 -112.82 7.9 18.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.2 t -107.92 130.62 55.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.25 -52.6 39.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.551 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -37.81 -39.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -64.93 -55.66 17.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -42.55 -47.11 5.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -73.1 -23.4 60.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 66' ' ' LYS . 41.6 tp -87.9 -18.42 29.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.53 ' N ' ' HD2' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -46.84 -58.29 7.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.642 0.734 . . . . 0.0 110.872 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 64' ' ' GLU . 54.2 Cg_endo -69.76 -31.91 19.61 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.699 2.266 . . . . 0.0 112.351 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.496 ' HB2' HD12 ' A' ' 63' ' ' LEU . 44.1 mtpt -68.2 -32.29 72.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' O ' ' C ' ' A' ' 68' ' ' LYS . 42.1 t80 -89.76 -50.41 6.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.87 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 67' ' ' TYR . 12.1 ttmt -36.9 -61.63 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -40.98 -56.66 2.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.846 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.462 ' N ' HD21 ' A' ' 124' ' ' LEU . 19.1 tp -42.48 -36.82 1.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -55.99 -69.05 1.39 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.45 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -66.88 -23.34 65.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.382 . . . . 0.0 110.874 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -67.44 -45.46 75.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 82' ' ' ILE . 95.0 mt -85.82 3.74 40.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.5 p -52.4 -29.79 25.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -62.13 -7.57 4.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -103.57 101.08 21.58 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.619 0.723 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 1.67 4.22 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.338 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.476 ' C ' ' OD1' ' A' ' 47' ' ' ASP . 78.1 m-20 -113.55 -39.92 3.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.9 mt -84.79 106.49 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.124 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.9 t -99.79 116.28 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.138 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 74' ' ' LEU . 31.7 mm -91.41 119.68 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.143 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.837 ' HB1' HG23 ' A' ' 32' ' ' VAL . . . -133.37 175.83 9.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.112 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -146.62 139.5 25.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.48 ' CE ' ' HB2' ' A' ' 90' ' ' ASN . 1.8 tmm? -134.5 149.83 50.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.54 ' OD1' ' CZ ' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -100.93 96.16 7.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.813 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 90' ' ' ASN . . . -43.73 -66.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -40.69 -29.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 86' ' ' ASP . . . -91.77 -30.67 16.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 15.8 m-80 -130.81 119.75 22.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.827 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -57.86 118.94 5.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.6 t -72.72 116.58 51.41 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.575 0.702 . . . . 0.0 111.134 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 96' ' ' TYR . 53.7 Cg_endo -69.78 -172.08 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.65 2.233 . . . . 0.0 112.378 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.509 ' HA ' ' C ' ' A' ' 95' ' ' PRO . 1.1 p -105.45 159.71 28.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.618 0.723 . . . . 0.0 110.858 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 94' ' ' SER . 53.6 Cg_endo -69.79 -20.85 10.59 Favored 'Cis proline' 0 C--O 1.232 0.177 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.297 0.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.482 ' C ' ' O ' ' A' ' 95' ' ' PRO . 93.6 m-85 -30.64 131.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.955 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.455 ' OE1' ' CZ ' ' A' ' 99' ' ' ARG . 13.7 mm-40 -141.92 119.27 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.881 HG22 HG21 ' A' ' 103' ' ' THR . 45.9 t -117.71 107.3 21.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.455 ' CZ ' ' OE1' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -125.41 33.1 5.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.59 113.66 0.29 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.533 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -97.72 155.09 37.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.664 0.745 . . . . 0.0 110.871 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 101' ' ' PHE . 53.7 Cg_endo -69.79 145.54 79.79 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.651 -1.812 . . . . 0.0 112.334 0.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.881 HG21 HG22 ' A' ' 98' ' ' VAL . 9.8 m -122.57 124.29 43.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.475 HD12 ' NH1' ' A' ' 122' ' ' ARG . 27.7 mt -120.26 134.64 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.158 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.413 ' O ' HD12 ' A' ' 49' ' ' LEU . 10.8 m-85 -134.07 161.1 35.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -136.59 126.08 25.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 108' ' ' PRO . 5.7 p -99.87 102.93 19.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.716 0.769 . . . . 0.0 110.815 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.501 ' HG2' ' CB ' ' A' ' 111' ' ' LYS . 53.4 Cg_endo -69.76 167.85 23.25 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.679 2.253 . . . . 0.0 112.352 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.448 ' O ' ' CE ' ' A' ' 111' ' ' LYS . . . -78.37 140.75 38.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.8 29.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.501 ' CB ' ' HG2' ' A' ' 108' ' ' PRO . 11.1 mtmt -130.36 48.44 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.465 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 6.5 mmpt? -70.81 -57.57 4.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.894 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 112' ' ' LYS . 54.9 mt -35.74 -43.09 0.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.417 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 3.4 m120 -132.61 95.67 19.78 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.651 0.739 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 114' ' ' ASN . 53.7 Cg_endo -69.73 -164.44 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.719 2.28 . . . . 0.0 112.307 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -145.5 117.55 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.944 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -89.3 137.98 31.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.912 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.63 ' CE2' ' CE1' ' A' ' 127' ' ' PHE . 82.8 t80 -70.48 118.26 13.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -125.7 100.39 6.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.01 -155.38 25.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.18 139.58 22.02 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.472 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.475 ' NH1' HD12 ' A' ' 104' ' ' ILE . 53.4 mtt-85 -82.5 52.84 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.84 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 126' ' ' ASP . 13.0 tt0 -108.59 141.03 41.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.51 HD13 ' C ' ' A' ' 124' ' ' LEU . 3.5 tm? -44.73 -50.93 9.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.7 p -69.8 -42.25 73.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.435 ' CG ' ' HB3' ' A' ' 123' ' ' GLU . 3.8 m-20 -49.44 -34.71 17.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.63 ' CE1' ' CE2' ' A' ' 118' ' ' TYR . 65.1 m-85 -73.03 -44.87 60.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.6 mt -57.21 -48.64 81.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.8 p -62.58 -46.94 85.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.508 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 5.1 t80 -56.03 -44.84 79.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.949 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.3 mt -72.56 -41.2 65.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.494 ' CD ' ' CG ' ' A' ' 139' ' ' PRO . 14.8 mm-40 -38.09 -40.49 0.49 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -97.84 -57.28 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.508 ' HG3' ' CZ ' ' A' ' 130' ' ' TYR . 39.5 mm-40 -45.45 -58.71 3.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.65 153.71 27.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.088 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.05 -50.1 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 84.8 p -47.31 -54.93 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.824 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.16 143.96 0.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.494 ' CG ' ' CD ' ' A' ' 132' ' ' GLN . 53.9 Cg_endo -69.76 -8.27 23.19 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.674 2.249 . . . . 0.0 112.336 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.3 m -105.4 126.96 52.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.5 t -103.77 90.53 3.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.804 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.495 179.951 . . . . . . . . 0 0 . 1 stop_ save_